Citrus Sinensis ID: 037189
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.969 | 0.893 | 0.424 | 1e-175 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.892 | 0.825 | 0.327 | 1e-94 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.937 | 0.823 | 0.298 | 1e-82 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.406 | 0.378 | 0.462 | 1e-76 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.899 | 0.843 | 0.300 | 3e-76 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.386 | 0.357 | 0.440 | 2e-69 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.798 | 0.767 | 0.309 | 7e-68 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.946 | 0.853 | 0.273 | 1e-64 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.373 | 0.327 | 0.410 | 8e-64 | |
| Q8H199 | 658 | Cysteine-rich receptor-li | no | no | 0.466 | 0.542 | 0.376 | 2e-60 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 617 bits (1590), Expect = e-175, Method: Compositional matrix adjust.
Identities = 353/831 (42%), Positives = 488/831 (58%), Gaps = 88/831 (10%)
Query: 3 SARLYFRFLLFQLPYYLHLAIAQNNGTVPVGATLIAGST---SFRWLSPSGDFAFGFRQL 59
S + L+ QL + + NG+VPVG +L A + S W SPSGDFAFGFR++
Sbjct: 5 SCSIIHLVLILQLQTFFVFSQNIRNGSVPVGESLTASESQQISSSWRSPSGDFAFGFRKI 64
Query: 60 DEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSA-VPRGSQVKLTADQGLVLNDPQGK 118
ND F LSI+++KI +KT+VW+ + + VP GS+V LTAD GLV+ DP+G+
Sbjct: 65 ----QPNDGFTLSIWFDKISDKTIVWHAQAVNTTTGLVPNGSKVTLTADGGLVIADPRGQ 120
Query: 119 QVWSSKIDIGTVAVGHMNDTGNFMLASSSS--------------SRAFFP----KIGHQ- 159
++W + + G+V+ G D GNF+L S + P ++G
Sbjct: 121 ELWRA-LSGGSVSRGRFTDDGNFVLFRDGSEDSDEVLWSSFENPTDTLLPNQNIEVGRNL 179
Query: 160 --------FSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMF 211
F +G F RL DGNL L+ N T D Y + + + +N G +++F
Sbjct: 180 SSRRTETSFKKGRFSLRLEDDGNLQLHSLNAETASESDIYSQYYESNTNDPNNPGIQLVF 239
Query: 212 SESGYMYILKRNSQRFDLTTGR---VVPAADFYHRATLNFDGVFAQYYYPRHGNG--NWS 266
++SG +Y+L+RN+ RF + R AA FY G P+
Sbjct: 240 NQSGEIYVLQRNNSRF-VVKDRDPDFSIAAPFYIST-----GFLLSTIIPKEARRIVGGC 293
Query: 267 VVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADF 326
++ DN+C + D LG+ ACG+N+ICSL +KRP C+CP+ + L D +++YG C DF
Sbjct: 294 LLGLCRDNMC-SPDDALGNMACGYNNICSLGNNKRPKCECPERFVLKDPSNEYGDCLPDF 352
Query: 327 DL-SCNGGGQGYNKE--LFDVYELKETDWPMSDYDFFSPYDEEHC--------------- 368
++ +C Q N + L++ L++T+WP DY+ ++ YDEE C
Sbjct: 353 EMQTCRPENQTANSDVNLYEFITLEKTNWPFGDYESYANYDEERCKASCLSDCLCAAVIF 412
Query: 369 --------WLKRLPLSNGRADTSVTGKAFIKYRKGDDPSPPLVPRPPDPEDKKKRKMMNA 420
W K+ PLS+G FIK R + + P KK +
Sbjct: 413 GTNRDLKCWKKKFPLSHGERSPRGDSDTFIKVR-----NRSIADVPVTGNRAKKLDWLII 467
Query: 421 TGSVLLGSSVFVNFALVCAF-----VLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELE 475
SVLLG+S FV F C++ + R + E NLR F+Y EL
Sbjct: 468 ACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQARDIGRTTATTTANELNLRVFTYGELA 527
Query: 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH 535
EAT +F EE+GRG+FGIVYKG ++ S VAVKKLD + D E+EFKNEV VIGQ H
Sbjct: 528 EATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEVKVIGQIH 587
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
HKNLVRL+GFC+EGQ++++VYEFL GTLA+FLF +P+W R NIA IARG+LYLHE
Sbjct: 588 HKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFRRPRPSWEDRKNIAVAIARGILYLHE 647
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
+CS QIIHCD+KPQNILLD++Y RISDFGLAKLL +NQ+ T+ T+IRGTKGYVAPEWFR
Sbjct: 648 ECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTL-TNIRGTKGYVAPEWFR 706
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715
NS IT+KVDVYS+GV+LLEI+ C+K+ D+ E+ IL +WA+DC+R G+L+ L D E
Sbjct: 707 NSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAYDCFRQGRLEDLTEDDSE 763
Query: 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
AMND+E +E+ V ++IWCIQE+ +RP ++ V QMLEGV++V PPNP P+
Sbjct: 764 AMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQVFDPPNPSPY 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 260/794 (32%), Positives = 393/794 (49%), Gaps = 110/794 (13%)
Query: 29 TVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSI-FYNKIPEKTVVWYT 87
T+P+G+ + A ++ W SP+ F+ F NS FL ++ F +P +W
Sbjct: 26 TIPLGSVIYASGSNQNWPSPNSTFSVSFVPSPSPNS----FLAAVSFAGSVP----IWSA 77
Query: 88 DNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASSS 147
D RGS ++L L L + G VW SK D V G + DTG F+L ++
Sbjct: 78 GTVDS-----RGS-LRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILLNNR 131
Query: 148 S----------------SRAFFPKIGHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAY 191
S S+ F G GL+ F+L + GNL L + A
Sbjct: 132 SVPVWSSFDNPTDTIVQSQNF--TAGKILRSGLYSFQLERSGNLTLR-------WNTSAI 182
Query: 192 YISHTYDGANSSNSGY-RVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYHRATLNF-- 248
Y +H + + SSN R+ +G + I + N L +V + D+ T F
Sbjct: 183 YWNHGLNSSFSSNLSSPRLSLQTNGVVSIFESNL----LGGAEIVYSGDYGDSNTFRFLK 238
Query: 249 ---DGVFAQYYYPRHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCD 305
DG Y +G + WS D V G CG ICS N D P+C
Sbjct: 239 LDDDGNLRIYSSASRNSGPVNAHWSAVDQCLV-------YGYCGNFGICSYN-DTNPICS 290
Query: 306 CP-KGYSLLDKTDKYGSCKADFDLS-CNGGGQGYNKELFDVYELK---ETDWPMSDYDFF 360
CP + + +D D+ CK +LS C+G N + D+ + D P S+ FF
Sbjct: 291 CPSRNFDFVDVNDRRKGCKRKVELSDCSG-----NTTMLDLVHTRLFTYEDDPNSE-SFF 344
Query: 361 SPYD--EEHCW-----LKRLPLSNGRADT--SVTGKAFIKYRKGDDPSPPLV----PRPP 407
+ +C L + +S+G + G F Y+ PS V P
Sbjct: 345 AGSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVPSTSYVKVCGPVVA 404
Query: 408 DPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKW---IRNSPGDGTIET 464
+ ++ + N + L ++ V A +LG + W R +P GT+ +
Sbjct: 405 NTLERATKGDDNNSKVHL-----WIVAVAVIAGLLGLVAVEIGLWWCCCRKNPRFGTLSS 459
Query: 465 NLRC----------FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD 514
+ F+YKEL+ T +FKE++G G FG VY+GV+ T+ T VAVK+L+
Sbjct: 460 HYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLE 515
Query: 515 IVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP 574
+ Q GE++F+ EV I THH NLVRL+GFC +G++RLLVYEF+ NG+L +FLF
Sbjct: 516 GIEQ-GEKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSA 574
Query: 575 ---NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631
W R NIA A+G+ YLHE+C I+HCD+KP+NIL+DD++ A++SDFGLAKLL
Sbjct: 575 KFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLN 634
Query: 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA 691
++ +S+RGT+GY+APEW N IT+K DVYS+G++LLE+++ +++FD+ +
Sbjct: 635 PKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHK 694
Query: 692 ILTDWAFDCYRNGKLDALVGGDM--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ WA++ + G A++ + + D+E + ++V S WCIQE P RPT+ KV+Q
Sbjct: 695 KFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQ 754
Query: 750 MLEGVVEVSVPPNP 763
MLEG+ E+ P P
Sbjct: 755 MLEGITEIKNPLCP 768
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 250/838 (29%), Positives = 390/838 (46%), Gaps = 120/838 (14%)
Query: 7 YFRFLLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSN 66
+F F L L H+ + G+ L A + W+S +G FA GF +
Sbjct: 16 FFCFFLVSLATEPHIGL---------GSKLKASEPNRAWVSANGTFAIGFTRF----KPT 62
Query: 67 DLFLLSIFYNKIP-EKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
D FLLSI++ ++P + T+VW + ++NS V + + ++L A LVL+D Q VW+S
Sbjct: 63 DRFLLSIWFAQLPGDPTIVW---SPNRNSPVTKEAVLELEATGNLVLSD-QNTVVWTSNT 118
Query: 126 DIGTVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSR----------------------- 162
V M+++GNF+L + + P I FS+
Sbjct: 119 SNHGVESAVMSESGNFLLLGTEVTAG--PTIWQSFSQPSDTLLPNQPLTVSLELTSNPSP 176
Query: 163 ---GLFQFRLLKDGN-----LVLNIANLP-TDFAY----DAYYISHTYDGANSSNSGYRV 209
G + ++L+ L NI P +++Y D ++ +++
Sbjct: 177 SRHGHYSLKMLQQHTSLSLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGSFKI 236
Query: 210 MFSES--GYMYILKR---------NSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYP 258
++ ES G +Y+ K NS LT V+ R L +G Y +
Sbjct: 237 VYGESSIGAVYVYKNPVDDNRNYNNSSNLGLTKNPVL------RRLVLENNGNLRLYRWD 290
Query: 259 RHGNGN--WSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPM-CDCPKGYSLLDK 315
NG+ W W+ N C +G CG N +C+L+ K+ C C G L
Sbjct: 291 NDMNGSSQWVPEWAAVSNPCDI------AGICG-NGVCNLDRTKKNADCLCLPGSVKLPD 343
Query: 316 TDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDYDFFSPYDEEHCWLK--RL 373
+ C + L F + ++ET++ S+ + K +
Sbjct: 344 QENAKLCSDNSSLVQECESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEM 403
Query: 374 PLSNGRADTSVTG----KAFIKYRKG------DDPSPPLVPRP---------PDPEDKKK 414
LS+ + SV G K + K DP L + + D K
Sbjct: 404 CLSDCKCVASVYGLDDEKPYCWILKSLNFGGFRDPGSTLFVKTRANESYPSNSNNNDSKS 463
Query: 415 RKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIY---KKKWIRNSPGDGTIETNLRC-FS 470
RK VL+ V LV +LG Y +K+ ++ + + I + F+
Sbjct: 464 RKSHGLRQKVLVIPIVVGMLVLVA--LLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFT 521
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV 530
Y++L+ T+NF + +G G FG VYKG + T VAVK+LD GEREF EV
Sbjct: 522 YRDLQNCTNNFSQLLGSGGFGTVYKGTV----AGETLVAVKRLDRALSHGEREFITEVNT 577
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQI 586
IG HH NLVRL G+C E +RLLVYE++ NG+L ++F + + +W R IA
Sbjct: 578 IGSMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVAT 637
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
A+G+ Y HE C ++IIHCD+KP+NILLDD++ ++SDFGLAK++ S + T IRGT+
Sbjct: 638 AQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVV-TMIRGTR 696
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
GY+APEW N IT K DVYS+G+LLLEI+ R++ D+ E WA+ NG
Sbjct: 697 GYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAYKELTNGTS 756
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV-EVSVPPNP 763
V ++ + + E + K + V+ WCIQ++ S+RP++ +V+++LEG E+++PP P
Sbjct: 757 LKAVDKRLQGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 288 bits (737), Expect = 1e-76, Method: Compositional matrix adjust.
Identities = 154/333 (46%), Positives = 222/333 (66%), Gaps = 22/333 (6%)
Query: 445 FFIYK-KKWIRNSPGDGTIETN---------LRCFSYKELEEATDNFKEEVGRGSFGIVY 494
F I+K KK I +P + + E N +R F+YK+L+ AT+NF ++G+G FG VY
Sbjct: 450 FRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSATNNFSVKLGQGGFGSVY 508
Query: 495 KGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554
+G T + +AVKKL+ + Q G++EF+ EV +IG HH +LVRL GFC EG +RLL
Sbjct: 509 EG----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLL 563
Query: 555 VYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQN 610
YEFL+ G+L ++F G++ +W+ R NIA A+GL YLHEDC ++I+HCD+KP+N
Sbjct: 564 AYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPEN 623
Query: 611 ILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGV 670
ILLDD++NA++SDFGLAKL+T QS T++RGT+GY+APEW N I+ K DVYS+G+
Sbjct: 624 ILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWITNYAISEKSDVYSYGM 682
Query: 671 LLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV-ECLEKLVMV 729
+LLE+I RK++D E +AF GKL +V G M+ ++ E +++ +
Sbjct: 683 VLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAMKT 742
Query: 730 SIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762
++WCIQED RP++ KV+QMLEGV V PP+
Sbjct: 743 ALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPS 775
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 248/826 (30%), Positives = 375/826 (45%), Gaps = 137/826 (16%)
Query: 24 AQNNGTVPVGATLIAGSTSFRWLSPS-GDFAFGFRQLDEENSSNDLFLLSIFYNKIP--- 79
A + +P+G++L+ S L S G F+ GF ++ F S++Y+K
Sbjct: 26 ASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEV-----YTHAFTFSVWYSKTEAAA 80
Query: 80 --EKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMN 136
KT+VW + N D+ R S + L D +VL D G VW + + T V +
Sbjct: 81 ANNKTIVW-SANPDR-PVHARRSALTLQKDGNMVLTDYDGAAVWRADGNNFTGVQRARLL 138
Query: 137 DTGNFMLASS----------SSSRAFFP-KIGHQFSRGLFQFRLLKDGNLVLNIANLPT- 184
DTGN ++ S S + F P ++ +R + + GN + ++L
Sbjct: 139 DTGNLVIEDSGGNTVWQSFDSPTDTFLPTQLITAATRLVPTTQSRSPGNYIFRFSDLSVL 198
Query: 185 DFAYDAYYISHTY----------DGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRV 234
Y +S Y DG N NS M ++SG + D G+
Sbjct: 199 SLIYHVPQVSDIYWPDPDQNLYQDGRNQYNSTRLGMLTDSGVL-------ASSDFADGQA 251
Query: 235 VPAADF----YHRATLNFDGVFAQYYYPRHGNGNWSV---VWSQPDNICVNLDGELGSGA 287
+ A+D R TL+ DG + Y +G+WSV +QP NI G
Sbjct: 252 LVASDVGPGVKRRLTLDPDGNL-RLYSMNDSDGSWSVSMVAMTQPCNI---------HGL 301
Query: 288 CGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYEL 347
CG N IC + P C CP GY+ + + C A + +C+ Y+K L
Sbjct: 302 CGPNGICHYS--PTPTCSCPPGYATRNPGNWTEGCMAIVNTTCDR----YDKRSMRFVRL 355
Query: 348 KETDWPMSDYDFFSP--------------------YDEE--HCWLKRLPLSNGRADTSVT 385
TD+ SD Y E C+ K S TS
Sbjct: 356 PNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTGSCYPKAYLFSGRTYPTSDV 415
Query: 386 GKAFIKYRKGDDPSPPLVPRPPDPEDKKKRKM---------------MNATGSVLLGSSV 430
++K G S L+PR D D R++ ++ TG S
Sbjct: 416 RTIYLKLPTGVSVSNALIPRS-DVFDSVPRRLDCDRMNKSIREPFPDVHKTGGG--ESKW 472
Query: 431 FVNFALVCAFVL--------GFFFIYKKK------WIRNSPGDGTIETNLRCFSYKELEE 476
F + + AF + +FF+ K++ W + G + +N R +SY+EL +
Sbjct: 473 FYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWA-SEKGYKAMTSNFRRYSYRELVK 531
Query: 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH 536
AT FK E+GRG G VYKGV++ R VAVKKL+ V Q G+ F+ E+ VIG+ +H
Sbjct: 532 ATRKFKVELGRGESGTVYKGVLEDDR----HVAVKKLENVRQ-GKEVFQAELSVIGRINH 586
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYL 593
NLVR+ GFC EG +RLLV E++ NG+LA+ LF GN+ +W R NIA +A+GL YL
Sbjct: 587 MNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWEGRFNIALGVAKGLAYL 646
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H +C +IHCD+KP+NILLD + +I+DFGL KLL S + +RGT GY+APEW
Sbjct: 647 HHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQNVSHVRGTLGYIAPEW 706
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDI--------EMVEEYAILTDWAFDCYRNGK 705
+ ITAKVDVYS+GV+LLE++ + ++ M+ + + +
Sbjct: 707 VSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSMLRKLVRMLSAKLEGEEQSW 766
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+D + + + L+ +++ C++ED S RPT++ +Q L
Sbjct: 767 IDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHAVQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 138/313 (44%), Positives = 203/313 (64%), Gaps = 17/313 (5%)
Query: 458 GDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF 517
GDGT L FSY+EL+ AT NF +++G G FG V+KG + ++ +AVK+L+ +
Sbjct: 476 GDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGAL----PDSSDIAVKRLEGIS 527
Query: 518 QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----L 572
Q GE++F+ EV IG H NLVRL GFC EG +LLVY+++ NG+L S LF N +
Sbjct: 528 Q-GEKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI 586
Query: 573 KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632
W LR IA ARGL YLH++C IIHCD+KP+NILLD + +++DFGLAKL+
Sbjct: 587 VLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGR 646
Query: 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692
+ S+ + T++RGT+GY+APEW ITAK DVYS+G++L E+++ R++ + E+
Sbjct: 647 DFSRVL-TTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRF 705
Query: 693 LTDWAFDCY-RNGKLDALVGGDMEA-MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
WA ++G + +LV +E D+E + + V+ WCIQ++ S RP + +V+Q+
Sbjct: 706 FPSWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQI 765
Query: 751 LEGVVEVSVPPNP 763
LEGV+EV+ PP P
Sbjct: 766 LEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 7e-68, Method: Compositional matrix adjust.
Identities = 216/697 (30%), Positives = 322/697 (46%), Gaps = 85/697 (12%)
Query: 83 VVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFM 142
VVW TDNK G+ + + L+L + G VW S + + MN TG
Sbjct: 103 VVWQTDNKQP------GTDFRFSETGNLILINDDGSPVWQSFDNPTDTWLPGMNVTG--- 153
Query: 143 LASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANS 202
L + +S R+ F S G + RL N + T + + + G
Sbjct: 154 LTAMTSWRSLFDP-----SPGFYSLRLSPSFNEFQLVYKGTTPYWSTGNWTGEAFVGVPE 208
Query: 203 SNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYH-----RATLNFDGVFAQYYY 257
Y F ++ N + +VP D R + +G QY +
Sbjct: 209 MTIPYIYRFH-----FV---NPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQLKQYTW 260
Query: 258 PRHGNGNWSVVWSQPDNIC--VNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDK 315
+W++ W QP++ C NL G+LG + C+ RP D +
Sbjct: 261 DPQTQ-SWNMFWLQPEDPCRVYNLCGQLGFCSSELLKPCACIRGFRPRNDAAW------R 313
Query: 316 TDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDYDFFSPYDEEHCWLKRLPL 375
+D Y G +E D E +T + D + + + RL +
Sbjct: 314 SDDYS--------------DGCRRENGDSGEKSDTFEAVGDLRY-----DGDVKMSRLQV 354
Query: 376 SNGRADTSVTGKAF---IKYRKGDDPSPPLVPRPPDPEDKKKRKMMNATGSVLL-----G 427
S + G + +++ + L+ P + ++ K N + S+++ G
Sbjct: 355 SKSSCAKTCLGNSSCVGFYHKEKSNLCKILLESPNNLKNSKG----NISKSIIILCSVVG 410
Query: 428 SSVFVNFALVCAFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGR 487
S + F L+ +L K+K R DG NL+ FS+KEL+ AT+ F ++VG
Sbjct: 411 SISVLGFTLLVPLIL-LKRSRKRKKTRKQDEDGFAVLNLKVFSFKELQSATNGFSDKVGH 469
Query: 488 GSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD 547
G FG V+KG T S+T VAVK+L+ GE EF+ EV IG H NLVRL GFC
Sbjct: 470 GGFGAVFKG---TLPGSSTFVAVKRLERP-GSGESEFRAEVCTIGNIQHVNLVRLRGFCS 525
Query: 548 EGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIARGLLYLHEDCSSQIIHC 604
E +RLLVY+++ G+L+S+L P +W R IA A+G+ YLHE C IIHC
Sbjct: 526 ENLHRLLVYDYMPQGSLSSYL-SRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHC 584
Query: 605 DMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVD 664
D+KP+NILLD YNA++SDFGLAKLL + S+ + T +RGT GYVAPEW IT K D
Sbjct: 585 DIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT-MRGTWGYVAPEWISGLPITTKAD 643
Query: 665 VYSFGVLLLEIIACRKSFDI--------EMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716
VYSFG+ LLE+I R++ + E E WA G +D++V +
Sbjct: 644 VYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNG 703
Query: 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753
+ E + ++ V+IWCIQ++ +RP + V++MLEG
Sbjct: 704 EYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (634), Expect = 1e-64, Method: Compositional matrix adjust.
Identities = 229/837 (27%), Positives = 358/837 (42%), Gaps = 112/837 (13%)
Query: 6 LYFRFLLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSS 65
LY L+ Y +A T+ G +L G +SP F GF SS
Sbjct: 9 LYLSLFLYFFLYESSMAA----NTIRRGESLRDGINHKPLVSPQKTFELGFFS---PGSS 61
Query: 66 NDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQ---VKLTADQGLVLNDPQGKQVWS 122
FL I+Y I +K VVW N A P Q + ++ D LVL D + VWS
Sbjct: 62 THRFL-GIWYGNIEDKAVVWVA-----NRATPISDQSGVLMISNDGNLVLLDGKNITVWS 115
Query: 123 SKIDIGTV----AVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKD------ 172
S I+ T V ++DTGNF+L+ + + R + H L Q R+ +
Sbjct: 116 SNIESSTTNNNNRVVSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDN 175
Query: 173 --------------GNLVLNI--ANLPTDFAYDAYYISHTYDGANSSN--SGYRVMFSES 214
GN L + + P ++ G +S +G M +
Sbjct: 176 HAFVSWRSETDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLT 235
Query: 215 GYMYILKRNSQRFDLTTGRV----VPA-ADFYHRATLNFDGVFAQYYYPRHGNGNWSVVW 269
Y+Y K +S + TG V VP+ R + ++G + + W+
Sbjct: 236 NYLYGFKLSSPPDE--TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRW-NETLKKWTKFQ 292
Query: 270 SQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLS 329
S+PD+ C + CG IC + G +C C GY + + C+ L
Sbjct: 293 SEPDSECDQYN------RCGKFGICDMKGSN-GICSCIHGYEQVSVGNWSRGCRRRTPLK 345
Query: 330 CNGGGQGYNKELFDVYELKETDWPMSDYDFFSPYDEEHCWLKRLPLSN----GRADTSVT 385
C E + +K D+ + +++ P D L+ + G +
Sbjct: 346 CERNISVGEDEFLTLKSVKLPDFEIPEHNLVDPEDCRERCLRNCSCNAYSLVGGIGCMIW 405
Query: 386 GKAFIKYRKGDDPSPPLVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFF 445
+ + ++ + L R D E + RK + + +V V L+ F L +
Sbjct: 406 NQDLVDLQQFEAGGSSLHIRLADSEVGENRKT-----KIAVIVAVLVGVILIGIFALLLW 460
Query: 446 FIYKKKWIRNS---------------------------------PGDGTIETNLRCFSYK 472
+KK + + G + L FS
Sbjct: 461 RFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLN 520
Query: 473 ELEEATDNF--KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV 530
+ AT++F + E+GRG FG VYKGV++ R +AVK+L G EFKNE+ +
Sbjct: 521 AIAIATNDFCKENELGRGGFGPVYKGVLEDGR----EIAVKRLSGKSGQGVDEFKNEIIL 576
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIA 587
I + H+NLVRLLG C EG+ ++LVYE++ N +L FLF K +W LR +I IA
Sbjct: 577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIA 636
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
RGLLYLH D +IIH D+K N+LLD N +ISDFG+A++ NQ++ + GT G
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707
Y++PE+ + K DVYSFGVLLLEI++ +++ + E+ L +A+ Y +G+ +
Sbjct: 697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS-SEHGSLIGYAWYLYTHGRSE 755
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG-VVEVSVPPNP 763
LV + + + V++ C+Q+ + RP + VL MLE ++ P P
Sbjct: 756 ELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 245 bits (626), Expect = 8e-64, Method: Compositional matrix adjust.
Identities = 129/314 (41%), Positives = 186/314 (59%), Gaps = 28/314 (8%)
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEV 528
F ++ELE+AT+NFK ++G G FG VYKG T T +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQI 586
+IG H NLV+L GFC G+ LLVYE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
ARGL YLH C +IIHCD+KP+NILL DH+ +ISDFGL+KLL +S ++ T++RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD----------- 695
GY+APEW N+ I+ K DVYS+G++LLE+++ RK+ ++ D
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRS-RSNSVTEDNNQNHSSTTTT 738
Query: 696 ---------WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746
+A D + G+ L +E + EKLV +++ C+ E+P+LRPT+
Sbjct: 739 STGLVYFPLYALDMHEQGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAA 798
Query: 747 VLQMLEGVVEVSVP 760
V+ M EG + + P
Sbjct: 799 VVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 141/375 (37%), Positives = 212/375 (56%), Gaps = 18/375 (4%)
Query: 387 KAFIKYRKGDDPSPPLVPRPPDPEDK--KKRKMMNATGSV--LLGSSVFVNFALVCAFVL 442
+AF + P P P P + KK + + G V ++ +V V F ++ A L
Sbjct: 242 EAFSRISLAPPPQSPAFPTLPAVTNTATKKGSITISIGIVWAIIIPTVIVVFLVLLA--L 299
Query: 443 GFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEE--VGRGSFGIVYKGVIQT 500
GF ++K + S D TI +L+ F +K +E+AT+ F E +GRG FG V+ GV+
Sbjct: 300 GFVVYRRRKSYQGSSTDITITHSLQ-FDFKAIEDATNKFSESNIIGRGGFGEVFMGVLNG 358
Query: 501 TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560
T VA+K+L + G REFKNEV V+ + HH+NLV+LLGFC EG+ ++LVYEF+
Sbjct: 359 TE-----VAIKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFVP 413
Query: 561 NGTLASFLFGNLKP---NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY 617
N +L FLF K +W R NI I RG+LYLH+D IIH D+K NILLD
Sbjct: 414 NKSLDYFLFDPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDADM 473
Query: 618 NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
N +I+DFG+A++ ++QS I GT+GY+ PE+ R + + + DVYSFGVL+LEII
Sbjct: 474 NPKIADFGMARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQFSTRSDVYSFGVLVLEIIC 533
Query: 678 CRKSFDIEMVEEYAI-LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQE 736
R + I + L +A+ +RN LV + + E + + + +++ C+Q
Sbjct: 534 GRNNRFIHQSDTTVENLVTYAWRLWRNDSPLELVDPTISENCETEEVTRCIHIALLCVQH 593
Query: 737 DPSLRPTIKKVLQML 751
+P+ RP++ + ML
Sbjct: 594 NPTDRPSLSTINMML 608
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | ||||||
| 109676362 | 2037 | CCHC-type integrase [Populus trichocarpa | 0.915 | 0.344 | 0.588 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.959 | 0.917 | 0.536 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.973 | 0.933 | 0.533 | 0.0 | |
| 255544746 | 800 | ATP binding protein, putative [Ricinus c | 0.939 | 0.9 | 0.536 | 0.0 | |
| 224057535 | 775 | predicted protein [Populus trichocarpa] | 0.934 | 0.923 | 0.524 | 0.0 | |
| 356575025 | 800 | PREDICTED: G-type lectin S-receptor-like | 0.950 | 0.91 | 0.519 | 0.0 | |
| 224053032 | 752 | predicted protein [Populus trichocarpa] | 0.913 | 0.930 | 0.524 | 0.0 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.840 | 0.931 | 0.537 | 0.0 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.868 | 0.951 | 0.536 | 0.0 | |
| 356555196 | 869 | PREDICTED: G-type lectin S-receptor-like | 0.919 | 0.810 | 0.499 | 0.0 |
| >gi|109676362|gb|ABG37663.1| CCHC-type integrase [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 866 bits (2237), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 452/768 (58%), Positives = 542/768 (70%), Gaps = 67/768 (8%)
Query: 10 FLLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLF 69
+L QL +A+AQ NG VP GA++ A S W S SG+FAFGFRQL+ + D F
Sbjct: 45 MVLLQL-----MAVAQTNGRVPTGASITATDDSPSWPSASGEFAFGFRQLE----NKDYF 95
Query: 70 LLSIFYNKIPEKTVVWYTDNKD--QNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI 127
LLSI+Y KIPEKTVVWY +D + AVPRGS+++LT D+GL+L DPQG Q+WSS I
Sbjct: 96 LLSIWYEKIPEKTVVWYAIGEDPTDDPAVPRGSKLELTDDRGLLLADPQGNQIWSSGIPP 155
Query: 128 G-TVAVGHMNDTGNFMLASSSSSR----------AFFP-------------KIGHQFSRG 163
G V+ G MNDTGNF+L + +S R P + FS G
Sbjct: 156 GAAVSSGVMNDTGNFVLQNRNSFRLWESFNNPTDTLLPTQIMEVGGVVSSRRTETNFSLG 215
Query: 164 LFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRN 223
FQ RLL +GNLVLN NLPT F YD YY S T D +NSSNSGYR++F+ESGYMYIL+RN
Sbjct: 216 RFQLRLLDNGNLVLNYMNLPTKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRN 275
Query: 224 SQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYPRHGNGN--WSVVWSQPDNICVNLDG 281
DLT +P DFYHRATLNFDGVF QY+YP+ +GN WS VWS+PD+ICVN+
Sbjct: 276 GLIEDLTK-TALPTIDFYHRATLNFDGVFTQYFYPKASSGNRSWSSVWSKPDDICVNMGA 334
Query: 282 ELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKEL 341
+LGSGACG+NSIC+L DKRP C CP+G+SLLD+ DKYGSC DF+LSC G ++
Sbjct: 335 DLGSGACGYNSICNLKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQ 394
Query: 342 FDVYELKETDWPMSDYDFFSPYDEEH-------------------CWLKRLPLSNGRADT 382
+D EL DWP SDY+ + P +E+ CW K+LPLSNGR D
Sbjct: 395 YDFVELINVDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDGCWKKKLPLSNGRFDI 454
Query: 383 SVTGKAFIKYRKGDDPSPPLVPRPPD--PEDKKKRKMMNATGSVLLGSSVFVNFALVCAF 440
+ GKAF+K+ KG P + RPP P +KKK + TGSV+LG+SVFVNF LV AF
Sbjct: 455 GMNGKAFLKFPKGYVP----LDRPPPQLPGEKKKPDIKFITGSVVLGTSVFVNFVLVGAF 510
Query: 441 VLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQT 500
L FIY+KK + G +ETNLR F+YKEL EAT++FK+EVGRG FG+VYKG IQ
Sbjct: 511 CLTSSFIYRKKTEKVKEGGSGLETNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQA 570
Query: 501 TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560
ST VAVKKLD V QDGE+EFK EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+
Sbjct: 571 --GSTRVVAVKKLDKVVQDGEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLS 628
Query: 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620
NGTLA+FLFG KPNW RT IAF IARGLLYLHE+C +QIIHCD+KPQNILLD++YNAR
Sbjct: 629 NGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNAR 688
Query: 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRK 680
ISDFGLAKLL ++QSKT +T+IRGTKGYVAPEWFRN IT KVDVYSFGV+LLEII CR+
Sbjct: 689 ISDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRR 747
Query: 681 SFDIEMVE-EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLV 727
+ D+E+ E E +LTDWA+DCY +G LD L+G D EA ND+ LE+L+
Sbjct: 748 NVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDTEAKNDISTLERLL 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 833 bits (2151), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/802 (53%), Positives = 543/802 (67%), Gaps = 67/802 (8%)
Query: 1 MASARLYFRF-LLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQL 59
MA L+ F LL LP + A++Q G + VGA+L + S + WLSPSGDFAFGF L
Sbjct: 1 MAFPILHLSFSLLIMLPPF---AVSQTGGNITVGASL-STSENTSWLSPSGDFAFGFHPL 56
Query: 60 DEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQ 119
+ LFLL+I+Y+KIPEKT+VWY + + P GS+ LTA++G+ L DPQG++
Sbjct: 57 ---YGNKYLFLLAIWYDKIPEKTIVWYANG---DKPAPTGSKAVLTANRGISLTDPQGRE 110
Query: 120 VWSSKIDIGTVAVGHMNDTGNFMLASSSSSR----------AFFP-------------KI 156
+W S+ IG VA G M D GNF+L S + P +
Sbjct: 111 LWRSETIIGVVAYGAMTDKGNFVLQDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQS 170
Query: 157 GHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGY 216
+ FS G FQ +L DGNL L NLP+D+ + YY S T G +SS+ GY+V+F+ESGY
Sbjct: 171 ENNFSMGRFQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGY 230
Query: 217 MYILKRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYPRHGNGN--WSVVWSQPDN 274
+YIL+ N Q F LT DFY RATLNFDG+F QYY+P+ GN W+ +WSQPDN
Sbjct: 231 LYILRENDQIFSLTQRVTASTGDFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDN 290
Query: 275 ICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGG 334
IC GSG CGFNS+C LN D+RP+C+CP GYSLLD +D+YGSC+ ++ SC
Sbjct: 291 ICQASFVSSGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDE 350
Query: 335 QGYNKELFDVYELKETDWPMSDYDFFSPYDEEHC---------------------WLKRL 373
++L+D EL TDWP SDY P+ EE C W K+L
Sbjct: 351 VAPVEDLYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKL 410
Query: 374 PLSNGRADTSVTGKAFIKYRKGDDPSPPLVPRPPD-PEDKKKRKMMNATGSVLLGSSVFV 432
PLSNGR T++ GKA +K R+ + + PR P P +KK R + GSV LG SVFV
Sbjct: 411 PLSNGRVQTNLDGKALLKVRRSN-----VNPRSPYFPNNKKDRDGLILVGSVFLGCSVFV 465
Query: 433 NFALVCAFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGI 492
NF LVCA + FFFIY+++ R DG +ETNLRCF+Y+EL EAT+ FKEE+GRG+FG+
Sbjct: 466 NFLLVCAIFMCFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGV 525
Query: 493 VYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552
VYKGV+ S+ VAVKKL+ V +D REFK EV VIGQTHHKNLVRLLGFC+EG R
Sbjct: 526 VYKGVVHIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQR 583
Query: 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612
LLVYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHE+CS+QIIHCD+KPQNIL
Sbjct: 584 LLVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNIL 643
Query: 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
LD++YNARISDFGLAKLL L+QS+T T+IRGTKGYVAPEWFRN +T KVDVYS+GVLL
Sbjct: 644 LDEYYNARISDFGLAKLLLLDQSQT-HTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLL 702
Query: 673 LEIIACRKSFDIE-MVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSI 731
LEII CR++ D + +EE AILTDWA+DCYR G LDALVG D A++D+E LE+ +M++
Sbjct: 703 LEIICCRRNVDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAF 762
Query: 732 WCIQEDPSLRPTIKKVLQMLEG 753
WCIQEDPSLRPT++KV QMLEG
Sbjct: 763 WCIQEDPSLRPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 823 bits (2127), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/815 (53%), Positives = 548/815 (67%), Gaps = 69/815 (8%)
Query: 1 MASARLYFRF-LLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQL 59
MA L+ F LL LP + A++Q G + VGA+L + S + WLSPSGDFAFGF QL
Sbjct: 1 MAFPILHLSFSLLIMLPPF---AVSQTGGNITVGASL-STSDNTSWLSPSGDFAFGFYQL 56
Query: 60 DEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQ 119
+ DLFLL+I+Y+KIP+KT+VWY + + P GS+ LTA++G+ L DPQG++
Sbjct: 57 ---YGNKDLFLLAIWYDKIPDKTIVWYANG---DKPAPTGSKAVLTANRGISLTDPQGRE 110
Query: 120 VWSSKIDIGTVAVGHMNDTGNFMLASSSSSR----------AFFP-------------KI 156
+W S+ IG VA G M DTGNF+L S + P +
Sbjct: 111 LWRSETIIGDVAYGAMTDTGNFVLRDRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQS 170
Query: 157 GHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGY 216
FS G FQ +L DGNLVL NLP+D+ + YY S T G +SS+ GY+V+F+ESGY
Sbjct: 171 ETNFSMGRFQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGY 230
Query: 217 MYILKRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYPRHGNGN--WSVVWSQPDN 274
+YIL++N Q F LT DFYHRATLNFDGVF QYY+P+ GN W+ +WSQPDN
Sbjct: 231 LYILRKNDQIFSLTQRVTASTGDFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDN 290
Query: 275 ICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGG 334
IC GSG CGFNS+C LN D RP+C+CP GYSLLD +D+YGSC+ ++ SC
Sbjct: 291 ICQASSVSAGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDE 350
Query: 335 QGYNKELFDVYELKETDWPMSDYDFFSPYDEEHC---------------------WLKRL 373
++L+D EL TDWP SDY P+ EE C W K+L
Sbjct: 351 VAPVEDLYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKL 410
Query: 374 PLSNGRADTSVTGKAFIKYRKGDDPSPPLVPRPPD-PEDKKKRKMMNATGSVLLGSSVFV 432
PLSNGR T V KA +K R+ + + PR P P +KK R + GSV LG SVFV
Sbjct: 411 PLSNGRVQTIVDAKALLKVRRSN-----VNPRSPYFPNNKKDRDGLILVGSVFLGCSVFV 465
Query: 433 NFALVCAFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGI 492
NF LVCA +GFFFIY+++ R DG +ETNLRCF+Y+EL EAT+ FKEE+GRG+FG+
Sbjct: 466 NFLLVCAICMGFFFIYRRRTKRIPQKDGAVETNLRCFTYQELAEATEGFKEELGRGAFGV 525
Query: 493 VYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552
VY+GV+ S+ VAVKKL+ V +D REFK EV VIGQTHHKNLVRLLGFC+EG R
Sbjct: 526 VYRGVVHIG--SSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQR 583
Query: 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612
LLVYEF++NG+L+SF+F + KP W +R IAF +ARGLLYLHED SQIIHCD+KPQNIL
Sbjct: 584 LLVYEFMSNGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHED--SQIIHCDIKPQNIL 641
Query: 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
LD+ NARISDFGLAKLL +Q+KT T+IRGTKGYVAPEWF+N +T KVD YSFG+LL
Sbjct: 642 LDESLNARISDFGLAKLLKTDQTKTT-TAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILL 700
Query: 673 LEIIACRKSFDIEMVEEYAI-LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSI 731
LE++ CRK+F+I ++E+ I L DWA DC + GKL+ LV D EAM D++ +E+ VMV+I
Sbjct: 701 LELVCCRKNFEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAI 760
Query: 732 WCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
WCIQEDPSLRP +KKV+QMLEG V+VSVPP+P F
Sbjct: 761 WCIQEDPSLRPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255544746|ref|XP_002513434.1| ATP binding protein, putative [Ricinus communis] gi|223547342|gb|EEF48837.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 798 bits (2062), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/781 (53%), Positives = 530/781 (67%), Gaps = 61/781 (7%)
Query: 24 AQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTV 83
AQN T+ VG L A + WLSPSGDFAFGFRQL+ +N L+LL+I YNKI +KT+
Sbjct: 23 AQNGDTIIVGDFLAAADPAESWLSPSGDFAFGFRQLENKN----LYLLAICYNKISDKTI 78
Query: 84 VWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFML 143
VWY + D P GS+V+LTAD+GLVL PQGK++W S I+IG A G MNDTGNF +
Sbjct: 79 VWYANGDD---PAPTGSKVELTADRGLVLTSPQGKEIWKSGINIGDAARGMMNDTGNFRI 135
Query: 144 ASSSSSR----------AFFPKIGHQ--------------FSRGLFQFRLLKDGNLVLNI 179
++ + P + FSRG FQFRL+ DGN VLN
Sbjct: 136 VNTGGEKLWQTFDDPKDTLLPGQALERGGKILSSRLRETNFSRGRFQFRLIPDGNGVLNA 195
Query: 180 ANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAAD 239
NL T AYDAYY ++T D AN SN+G R++F+ESGY+Y L+ +++R +T RVVP +
Sbjct: 196 NNLRTGDAYDAYYWTNTVD-ANLSNAGLRIVFNESGYLYTLRASNKRELITPERVVPTTE 254
Query: 240 FYHRATLNFDGVFAQYYYPRHG--NGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLN 297
+YHR TLNFDGV QY +P++ NGNWS+++S P+NIC L ++G+G CGFNS+C LN
Sbjct: 255 YYHRVTLNFDGVLTQYSHPKNSTDNGNWSIIFSAPENICF-LITDIGTGPCGFNSVCQLN 313
Query: 298 GDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDY 357
D+R +C CP +S +D D Y CK DF + E +D EL TDWP SDY
Sbjct: 314 ADQRAICRCPPRFSSVDPGDDYAGCKPDFSTQFCEDAPSTSPEDYDFLELTNTDWPTSDY 373
Query: 358 DFFSPYDEEHC-------------------WLKRLPLSNGRADTSVTGKAFIKYRKGDDP 398
+ + Y+ E C W K+LPLSNGR V G+AFIK RK D
Sbjct: 374 ERYDSYNIEECQKACIQDCFCNVVVFRGSCWKKKLPLSNGRQSEKVNGRAFIKVRKDDYM 433
Query: 399 SPPLVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPG 458
L PRP P K+ + + SVLLGSSVF+NF L+ F F Y KK G
Sbjct: 434 GRGLPPRPF-PNAKEDQDSLVLVISVLLGSSVFINFILIGLVTFCFLFFYHKKSTGIPQG 492
Query: 459 DGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ 518
+ ++NLRCFSYKEL EAT FKEE+GRGSFGIVYKG+I+ +T VAVKKLD V +
Sbjct: 493 E---KSNLRCFSYKELVEATKGFKEELGRGSFGIVYKGLIEMG--TTVPVAVKKLDRVVE 547
Query: 519 DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNL 578
GE+E+K EV IGQTHHKNLV+LLGFCDEGQ +LLVYE L+NGTLA+FLFG+ K +W
Sbjct: 548 YGEKEYKAEVKAIGQTHHKNLVQLLGFCDEGQQKLLVYELLSNGTLANFLFGDTKLSWKQ 607
Query: 579 RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
RT IAF IARGL+YLHE+C++QIIHCD+KPQNIL+D++Y+A+ISDFGLAKLL L+QS+T
Sbjct: 608 RTQIAFGIARGLVYLHEECNTQIIHCDIKPQNILVDEYYDAKISDFGLAKLLLLDQSQTF 667
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
T+IRGTKGYVAPEWFRN IT KVD YSFGVLLLEII R+S D E+ E AILTDWA+
Sbjct: 668 -TTIRGTKGYVAPEWFRNVPITVKVDAYSFGVLLLEIICSRRSVDTEISGERAILTDWAY 726
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
DCY G++D LV D EA++D++ +E+ +MV+IWCIQEDP+LRPT+K V+ MLEG+++V+
Sbjct: 727 DCYMEGRIDDLVENDEEALSDLKKVERFLMVAIWCIQEDPTLRPTMKTVILMLEGIIQVA 786
Query: 759 V 759
V
Sbjct: 787 V 787
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057535|ref|XP_002299255.1| predicted protein [Populus trichocarpa] gi|222846513|gb|EEE84060.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 795 bits (2053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/808 (52%), Positives = 538/808 (66%), Gaps = 92/808 (11%)
Query: 6 LYFRFLLFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSS 65
LYF FLLF P L +AQ NG VG +L AG + WLSP+ DFAFGFRQLD++
Sbjct: 9 LYFFFLLF--PSSL---VAQRNGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK--- 60
Query: 66 NDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKI 125
DL+LL+I+YNKIP+KT+VWY + + P+ S VKLTA+ G+VLN+PQG ++W S
Sbjct: 61 -DLYLLAIWYNKIPDKTIVWYANG---DRPAPKKSTVKLTAELGVVLNNPQGGEIWKSGP 116
Query: 126 DIGTVAVGHMNDTGNFMLASSSSSRAF---------------FPKIG--------HQFSR 162
G A G MNDTGNF++A+++ + + K G FS+
Sbjct: 117 GNGEAAYGFMNDTGNFLVANANGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQ 176
Query: 163 GLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKR 222
G FQFRL+ DGN VLN NLPT F Y+AY+ S T D +NSSN+GY+V+F+ESGY+Y+L+
Sbjct: 177 GRFQFRLIPDGNAVLNTINLPTGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRA 235
Query: 223 NSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYPRH--GNGNWSVVWSQPDNICVNLD 280
N+ R LT GRVVPA + YHRATL+FDGVF Y +P++ GN NWSVV + P+NIC +
Sbjct: 236 NNTREALTLGRVVPATENYHRATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVR 295
Query: 281 GELGSGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKE 340
G GSG CG+N +C+++ DKR +C CP+ +SLLD D YG CK DF E
Sbjct: 296 GLKGSGPCGYNGVCTISTDKRAICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPE 355
Query: 341 LFDVYELKETDWPMSDYDFFSPYD--------------------EEHCWLKRLPLSNGRA 380
+++ L DWP SDY+ ++PY+ E CW KRLPLSNGR
Sbjct: 356 DYELVPLTNIDWPESDYEMYTPYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQ 415
Query: 381 DTSVTGKAFIKYRKGDD--PSPPLVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVC 438
SV G +F+K RKG+ P PP +P K+ ++ SVLLG SVF NF LV
Sbjct: 416 GESVNGASFMKVRKGNYTLPGPPPIP---------KKNLLVV--SVLLGGSVFFNFVLVG 464
Query: 439 AFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVI 498
FFFIY K+ R + +++NLRCFSYKEL EAT+ FKEE+GRG+FGIVYKG+
Sbjct: 465 VVSFAFFFIYHNKFTRTPQVERAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLT 524
Query: 499 QTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558
Q S VA+KK+D ++ ++EFK EV VIG FCDEGQ+R+LVYEF
Sbjct: 525 QIG--SGVPVAIKKVDRFVKESDKEFKTEVDVIG------------FCDEGQHRMLVYEF 570
Query: 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN 618
L+NG LASFLFG++K +WN RT IAF IARGLLYLH++CS+QIIHCD+KPQNILLD+HY+
Sbjct: 571 LSNGALASFLFGDVKLSWNQRTQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYD 630
Query: 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC 678
ARI+DFGLAKL Q K GTKGYVAPEWFRN IT KVDVY+FGVLLLEII C
Sbjct: 631 ARIADFGLAKLFRNPQHK-------GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICC 683
Query: 679 RKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDP 738
R+S D E+ EE AILTDWA+DCY+ G + ALV D EA+ND++ LE+ VMV+IWCIQEDP
Sbjct: 684 RRSVDTEVGEERAILTDWAYDCYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDP 743
Query: 739 SLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
+LRPT+K V+ MLEG+++V VPP P PF
Sbjct: 744 NLRPTMKMVMLMLEGIIQVPVPPCPSPF 771
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575025|ref|XP_003555643.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2044), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/803 (51%), Positives = 540/803 (67%), Gaps = 75/803 (9%)
Query: 12 LFQLPYYLHLAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLL 71
L QLPY ++ N V +G TL+AG+ RWLSPS DFAFGF QLD NDL+LL
Sbjct: 17 LLQLPY-----VSATN--VSIGETLVAGNGGKRWLSPSEDFAFGFHQLD-----NDLYLL 64
Query: 72 SIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVA 131
+I Y IP + +WY + ++ P+GS+++L GLVL PQG ++W+S++ GT++
Sbjct: 65 AISYQNIPRDSFIWYANG---DNPAPKGSKLELNQYTGLVLKSPQGVELWTSQLISGTIS 121
Query: 132 VGHMNDTGNFMLASSSS----------SRAFFP-------------KIGHQFSRGLFQFR 168
G MNDTGNF L +S + P + FSRG FQFR
Sbjct: 122 YGLMNDTGNFQLLDENSQVLWDSFSNPTDTLVPTQIMEVKGTLSSRQKEANFSRGRFQFR 181
Query: 169 LLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFD 228
LL DGN VLN NLPT++ YDA+YIS TYD N++NSG++V+F SG +YILKR+ ++
Sbjct: 182 LLPDGNAVLNPINLPTNYTYDAHYISATYDSTNTTNSGFQVIFDNSG-LYILKRSGEKVY 240
Query: 229 LTTGRVVPAAD-FYHRATLNFDGVFAQYYYPRH--GNGNWSVVWSQPDNICVNLDGELG- 284
+T + + D +Y+RAT+NFDG F YP++ N +W+V+ + PDNIC+NL G G
Sbjct: 241 ITNPKDALSTDSYYYRATINFDGTFTISNYPKNPASNPSWTVMKTLPDNICMNLLGNTGG 300
Query: 285 SGACGFNSICSLNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDV 344
SG CGFNSIC+L D+RP C CP+GYS LD D+YGSCK + +L C GQ +L+ +
Sbjct: 301 SGVCGFNSICTLKADQRPKCSCPEGYSPLDSRDEYGSCKPNLELGCGSSGQSLQGDLYFM 360
Query: 345 YELKETDWPMSDYDFFSPYDEE--------------------HCWLKRLPLSNGRADTSV 384
E+ TDWP+SDY+ + PY+ E C+ K+LPLSNGR D +V
Sbjct: 361 KEMANTDWPVSDYELYKPYNSEDCKTSCLQDCLCAVSIFRDDSCYKKKLPLSNGRRDRAV 420
Query: 385 TGKAFIKYRKGDDPSPPLVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGF 444
AFIK K P P + + KK + + SVLLG SVF F LV A +GF
Sbjct: 421 GASAFIKLMKNGVSLSPPNPFIEEKKYKKDQDTLITVISVLLGGSVF--FNLVSAVWVGF 478
Query: 445 FFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTS 504
+F Y KK +S E+NL F++ EL +ATDNFKEE+GRGS GIVYKG T+
Sbjct: 479 YFYYNKK---SSTNKTATESNLCSFTFAELVQATDNFKEELGRGSCGIVYKGT-----TN 530
Query: 505 TTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL 564
+AVKKLD V +D ++EFK EV VIGQTHHK+LVRLLG+CDE Q+R+LVYEFL+NGTL
Sbjct: 531 LATIAVKKLDKVLKDCDKEFKTEVNVIGQTHHKSLVRLLGYCDEEQHRILVYEFLSNGTL 590
Query: 565 ASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624
A+FLFG+ KPNWN R IAF IARGL+YLHE+C +QIIHCD+KPQNILLD+ YNARISDF
Sbjct: 591 ANFLFGDFKPNWNQRVQIAFGIARGLVYLHEECCTQIIHCDIKPQNILLDEQYNARISDF 650
Query: 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDI 684
GL+KLL +N+S T +T IRGTKGYVAP+WFR++ IT KVDVYSFGVLLLEII CR++ D
Sbjct: 651 GLSKLLKINESHT-ETGIRGTKGYVAPDWFRSAPITTKVDVYSFGVLLLEIICCRRNVDG 709
Query: 685 EM-VEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT 743
E+ EE AILTDWA+DCYR G++D L+ D EA++D LE+ VMV+IWC+QEDPSLRP
Sbjct: 710 EVGNEEKAILTDWAYDCYRAGRIDILLENDDEAIDDTNRLERFVMVAIWCLQEDPSLRPP 769
Query: 744 IKKVLQMLEGVVEVSVPPNPYPF 766
+KKV+ MLEG+ V++PP+P P+
Sbjct: 770 MKKVMLMLEGIAPVTIPPSPSPY 792
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053032|ref|XP_002297673.1| predicted protein [Populus trichocarpa] gi|222844931|gb|EEE82478.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 785 bits (2028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/787 (52%), Positives = 526/787 (66%), Gaps = 87/787 (11%)
Query: 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWY 86
NG VG +L AG + WLSP+ DFAFGFRQLD++ DL+LL+I+YNKIP+KT+VWY
Sbjct: 2 NGNATVGDSLTAGDEATLWLSPAEDFAFGFRQLDKK----DLYLLAIWYNKIPDKTIVWY 57
Query: 87 TDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASS 146
+ + P+ S VKLTA+ G+VLN+PQG ++W S G A G MNDTGNF++A++
Sbjct: 58 ANG---DRPAPKKSTVKLTAELGVVLNNPQGGEIWKSGPGNGEAAYGFMNDTGNFLVANA 114
Query: 147 SSSRAF---------------FPKIG--------HQFSRGLFQFRLLKDGNLVLNIANLP 183
+ + + K G FS+G FQFRL+ DGN VLN NLP
Sbjct: 115 NGEKLWQSFELLTDTLLPTQIMEKGGILSSRLSETNFSQGRFQFRLIPDGNAVLNTINLP 174
Query: 184 TDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYHR 243
T F Y+AY+ S T D +NSSN+GY+V+F+ESGY+Y+L+ N+ R LT GRVVPA + YHR
Sbjct: 175 TGFPYEAYFWSKTVD-SNSSNAGYQVVFNESGYLYVLRANNTREALTLGRVVPATENYHR 233
Query: 244 ATLNFDGVFAQYYYPRH--GNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKR 301
ATL+FDGVF Y +P++ GN NWSVV + P+NIC + G GSG CG+N +C+++ DKR
Sbjct: 234 ATLHFDGVFVLYSHPKNSPGNENWSVVRTMPENICTVVRGLKGSGPCGYNGVCTISTDKR 293
Query: 302 PMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDYDFFS 361
+C CP+ +SLLD D YG CK DF E +++ L DWP SDY+ ++
Sbjct: 294 AICRCPQRFSLLDPDDPYGGCKPDFPTQVCAEEVPNAPEDYELVPLTNIDWPESDYEMYT 353
Query: 362 PYD--------------------EEHCWLKRLPLSNGRADTSVTGKAFIKYRKGDD--PS 399
PY+ E CW KRLPLSNGR SV G +F+K RKG+ P
Sbjct: 354 PYNIEDCKKACLQDFFCNVIVFGEGTCWKKRLPLSNGRQGESVNGASFMKVRKGNYTLPG 413
Query: 400 PPLVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPGD 459
PP +P K+ ++ SVLLG SVF NF LV FFFIY K+ R +
Sbjct: 414 PPPIP---------KKNLLVV--SVLLGGSVFFNFVLVGVVSFAFFFIYHNKFTRTPQVE 462
Query: 460 GTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD 519
+++NLRCFSYKEL EAT+ FKEE+GRG+FGIVYKG+ Q S VA+KK+D ++
Sbjct: 463 RAVQSNLRCFSYKELMEATNGFKEELGRGAFGIVYKGLTQIG--SGVPVAIKKVDRFVKE 520
Query: 520 GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR 579
++EFK EV VIG FCDEGQ+R+LVYEFL+NG LASFLFG++K +WN R
Sbjct: 521 SDKEFKTEVDVIG------------FCDEGQHRMLVYEFLSNGALASFLFGDVKLSWNQR 568
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639
T IAF IARGLLYLH++CS+QIIHCD+KPQNILLD+HY+ARI+DFGLAKL Q K
Sbjct: 569 TQIAFGIARGLLYLHDECSTQIIHCDIKPQNILLDEHYDARIADFGLAKLFRNPQHK--- 625
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699
GTKGYVAPEWFRN IT KVDVY+FGVLLLEII CR+S D E+ EE AILTDWA+D
Sbjct: 626 ----GTKGYVAPEWFRNMLITVKVDVYNFGVLLLEIICCRRSVDTEVGEERAILTDWAYD 681
Query: 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759
CY+ G + ALV D EA+ND++ LE+ VMV+IWCIQEDP+LRPT+K V+ MLEG+++V V
Sbjct: 682 CYQEGMMHALVESDEEALNDMKKLERFVMVAIWCIQEDPNLRPTMKMVMLMLEGIIQVPV 741
Query: 760 PPNPYPF 766
PP P PF
Sbjct: 742 PPCPSPF 748
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/783 (53%), Positives = 505/783 (64%), Gaps = 139/783 (17%)
Query: 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWY 86
NG++PVGA + A + WLS SG+FAFGF+ L+ + D FLLSI+Y KIPEKT+VWY
Sbjct: 1 NGSMPVGAFITATDDAPSWLSSSGEFAFGFQPLEYK----DHFLLSIWYAKIPEKTIVWY 56
Query: 87 TDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASS 146
+ ++ PR S+V+L D GLVL DPQG +WSS +GTV+ G MNDTGNF+L +S
Sbjct: 57 ANG---DNPAPRESKVELRGDSGLVLTDPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNS 113
Query: 147 SSSR----------AFFP-------------KIGHQFSRGLFQFRLLKDGNLVLNIANLP 183
+S R P + FS G FQ RLL +GNLVLN NLP
Sbjct: 114 NSFRLWESFSNPTDTLLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLP 173
Query: 184 TDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYHR 243
T F YD YY S T D +NSSNSGYR++F+ESGYMYIL+RN DLT +P DFYHR
Sbjct: 174 TKFVYDDYYSSETSDASNSSNSGYRLIFNESGYMYILRRNGLIEDLTK-TALPTIDFYHR 232
Query: 244 ATLNFDGVFAQYYYPRHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPM 303
ATLNFD +LGSGACG+NSIC+L DKRP
Sbjct: 233 ATLNFDA-------------------------------DLGSGACGYNSICNLKADKRPE 261
Query: 304 CDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDYDFFSPY 363
C CP+G+SLLD+ DKYGSC DF+LSC G ++ +D EL DWP SDY+ + P
Sbjct: 262 CKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPI 321
Query: 364 DEEHC-------------------WLKRLPLSNGRADTSVTGKAFIKYRKGDDPSPPLVP 404
+E+ C W K+LPLSNGR D + GKAF+K+ KG
Sbjct: 322 NEDECRKSCLNDCLCSVAIFRDGCWKKKLPLSNGRFDIGMNGKAFLKFPKG--------- 372
Query: 405 RPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPGDGTIET 464
YK + ++ G +ET
Sbjct: 373 -------------------------------------------YKTEKVKE--GGSGLET 387
Query: 465 NLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF 524
NLR F+YKEL EAT++FK+EVGRG FG+VYKG IQ ST VAVKKLD V QDGE+EF
Sbjct: 388 NLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKVVQDGEKEF 445
Query: 525 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 584
K EV VIGQTHHKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG KPNW RT IAF
Sbjct: 446 KTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAF 505
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
IARGLLYLHE+C +QIIHCD+KPQNILLD++YNARISDFGLAKLL ++QSKT +T+IRG
Sbjct: 506 GIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIRG 564
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE-EYAILTDWAFDCYRN 703
TKGYVAPEWFRN IT KVDVYSFGV+LLEII CR++ D+E+ E E +LTDWA+DCY +
Sbjct: 565 TKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMD 624
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763
G LD L+G D EA ND+ LE+L+ V IWCIQEDPSLRPT++KV QMLEGVVEV PNP
Sbjct: 625 GSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNP 684
Query: 764 YPF 766
+P+
Sbjct: 685 FPY 687
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/772 (53%), Positives = 511/772 (66%), Gaps = 107/772 (13%)
Query: 21 LAIAQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPE 80
+A+AQ NG VPVGA++ A S WLS SG+FAFGFRQL+ + D FLLSI+Y KIPE
Sbjct: 1 MAVAQTNGRVPVGASITATDDSPSWLSASGEFAFGFRQLENK----DYFLLSIWYEKIPE 56
Query: 81 KTVVWYTDNKD--QNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDT 138
KTVVWY +D + AVPRGS+V+LT D+GL+L DPQG +W+S+I +G V+ G MNDT
Sbjct: 57 KTVVWYAIGEDPTDDPAVPRGSKVELTDDRGLLLADPQGNLIWTSRILLGAVSSGVMNDT 116
Query: 139 GNFMLASSSSSR----------AFFP-------------KIGHQFSRGLFQFRLLKDGNL 175
GNF+L + +S R P + FS G FQ RLL +GNL
Sbjct: 117 GNFVLQNRNSERLWESFNNPTDTLLPTQIMEAGGVVSSRRTETNFSLGRFQLRLLDNGNL 176
Query: 176 VLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVV 235
VLN NL T FAYD YY S T D +NSSN+GYR++F+ESGY IL R + +
Sbjct: 177 VLNSMNLSTKFAYDDYYRSGTSDASNSSNTGYRLLFNESGY--ILWRPP-----PSPSSL 229
Query: 236 PAADFYHRATLNFDGVFAQYYYPRHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICS 295
+AD ++ + WS VWS+PD+ICVN+ +LGSGACG+NSIC+
Sbjct: 230 ISADIHYIQS-------------------WSSVWSKPDDICVNMGADLGSGACGYNSICN 270
Query: 296 LNGDKRPMCDCPKGYSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMS 355
L DKRP C CP+G+SLLD+ DKYGSC DF+LSC G ++ +D EL DWP S
Sbjct: 271 LKADKRPECKCPQGFSLLDQNDKYGSCIPDFELSCRDDGLNSTEDQYDFVELINVDWPTS 330
Query: 356 DYDFFSPYDEEHCWLKRLPLSNGRADTSVTGKAFIKYRKGDDPSPPLVPRPPDPEDKKKR 415
DY+ + P +E+ C ++ L++ ++ +R G KKK
Sbjct: 331 DYERYKPINEDEC--RKSCLNDCLCSVAI-------FRDG--------------CWKKKL 367
Query: 416 KMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELE 475
+ N + + F+ F G+ TNLR F+YKEL
Sbjct: 368 PLSNGRFDIGMNGKAFLKFPK------GY-------------------TNLRYFTYKELA 402
Query: 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH 535
EAT++FK+EVGRG FG+VYKG IQ ST VAVKKLD V QDGE+EFK EV VIGQTH
Sbjct: 403 EATNDFKDEVGRGGFGVVYKGTIQAG--STRVVAVKKLDKVVQDGEKEFKTEVQVIGQTH 460
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
HKNLVRLLGFCDEGQNRLLVYEFL+NGTLA+FLFG KPNW RT IAF IARGLLYLHE
Sbjct: 461 HKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGCSKPNWKQRTQIAFGIARGLLYLHE 520
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
+C +QIIHCD+KPQNILLD++YNARISDFGLAKLL ++QSKT +T+IRGTKGYVAPEWFR
Sbjct: 521 ECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKT-QTAIRGTKGYVAPEWFR 579
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE-EYAILTDWAFDCYRNGKLDALVGGDM 714
N IT KVDVYSFGV+LLEII CR++ D+E+ E E +LTDWA+DCY +G LD L+G D
Sbjct: 580 NRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDVLIGDDT 639
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
EA ND+ LE+L+ V IWCIQEDPSLRPT++KV QMLEGVVEV PNP+P+
Sbjct: 640 EAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPFPY 691
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555196|ref|XP_003545921.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/775 (49%), Positives = 518/775 (66%), Gaps = 71/775 (9%)
Query: 37 IAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAV 96
+AG+ + RWLSPSGDFAFGF QL N+ FLL+++Y+K+P KT++W+ + ++
Sbjct: 1 MAGNGTSRWLSPSGDFAFGFYQL-----PNEFFLLAVWYDKMPNKTIIWFANG---DNPA 52
Query: 97 PRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASSSS-------- 148
P GS+++L D GLVLN+PQG ++W S GT+ G MND GNF L ++
Sbjct: 53 PIGSRLELN-DSGLVLNNPQGLELWRSNFASGTIFNGLMNDDGNFQLLDQNAVSLWETFT 111
Query: 149 --------------SRAFFPKIGH-QFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYI 193
+ F + G FS G F+ L +D NLVL++ NLP++++Y+ YY
Sbjct: 112 HPTDTLVPNQVMELNGKLFSRRGEFNFSHGRFKLHLQEDVNLVLSLINLPSNYSYEPYYD 171
Query: 194 SHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTT-GRVVPAADFYHRATLNFDGVF 252
+ T D N +N G +++F +SG++YILK++ ++F +T + DFY++AT+N+DGVF
Sbjct: 172 TGTADANNQTNIGMKLIFDKSGFLYILKKSGEKFYITKPNETISTNDFYYKATINYDGVF 231
Query: 253 AQYYYP---RHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKG 309
YYP R G G W + P+NIC++ G G CGFNSIC+L D+RP+C+CP+
Sbjct: 232 TVSYYPKDLRKGQG-WVTTKTIPENICLSSTFTDGEGVCGFNSICNLKADQRPICNCPER 290
Query: 310 YSLLDKTDKYGSCKADFDLSCNGGGQGYNKELFDVYELKETDWPMSDYDFFSPYDEEHC- 368
YSL+D + YG C +F + C GGG +++ + + EL+ TDWP SDY+ SPY + C
Sbjct: 291 YSLIDSNNMYGGCVPNFQVVCQGGGYMVSQDDYIMKELRNTDWPTSDYETLSPYSLKECT 350
Query: 369 -------------------WLKRLPLSNGRADTSVTGKAFIKYRKGDDPSPPLVPRPPDP 409
W K+LPL+NGR D V + IK K D L+ P+P
Sbjct: 351 KSCLQDCLCVLVTFSGSSCWKKKLPLTNGRRDKGVNATSVIKLMKND----YLLTSFPNP 406
Query: 410 EDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPGDGTI-ETNLRC 468
KK ++ SVLL SV + LV A GF KK I +S + ++ + NL
Sbjct: 407 NGKKDHDVLIVVLSVLLAGSVLIILMLVGALYFGFSCNRKK--IESSRTNKSVAKKNLHD 464
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEV 528
F++KEL EAT+NF+EE+GRGSF IVYKG I+ T +VAVKKLD +FQD +REF+ EV
Sbjct: 465 FTFKELVEATNNFREELGRGSFSIVYKGTIEMT-----SVAVKKLDKLFQDNDREFQTEV 519
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
VIGQTHH+NLVRLLG+C+EGQ+R+LVYEF++NGTLASFLF +LK NW R +IA IAR
Sbjct: 520 NVIGQTHHRNLVRLLGYCNEGQHRILVYEFMSNGTLASFLFSSLKSNWGQRFDIALGIAR 579
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
GL+YLHE+C +QIIHCD+KPQNILLDD YNARISDFGLAKLL +NQS+T +T IRGTKGY
Sbjct: 580 GLVYLHEECCTQIIHCDIKPQNILLDDQYNARISDFGLAKLLLINQSRT-ETGIRGTKGY 638
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV-EEYAILTDWAFDCYRNGKLD 707
VAP+WFR++ ITAKVD YSFGVLLLEII CRK+ + E+V EE ILTDWA+DCY+ +L+
Sbjct: 639 VAPDWFRSAPITAKVDTYSFGVLLLEIICCRKNVEKELVNEEKGILTDWAYDCYKTRRLE 698
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762
L+ D EA+ND++ EKLVM++IWCIQE PSLRPT+KKVL MLEG VEV PP+
Sbjct: 699 ILLENDDEAINDIKSFEKLVMIAIWCIQEHPSLRPTMKKVLLMLEGNVEVLTPPS 753
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 766 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.378 | 0.349 | 0.47 | 3.4e-94 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.424 | 0.395 | 0.452 | 5.9e-78 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.429 | 0.397 | 0.424 | 1.6e-75 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.391 | 0.353 | 0.399 | 6.9e-66 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.271 | 0.238 | 0.497 | 5.4e-64 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.639 | 0.605 | 0.301 | 1.4e-60 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.631 | 0.611 | 0.301 | 1.4e-60 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.385 | 0.359 | 0.386 | 9.2e-60 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.428 | 0.493 | 0.394 | 5.4e-59 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.425 | 0.510 | 0.401 | 1.8e-58 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 733 (263.1 bits), Expect = 3.4e-94, Sum P(2) = 3.4e-94
Identities = 141/300 (47%), Positives = 208/300 (69%)
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEV 528
F+YKEL+ T +FKE++G G FG VY+GV+ T+ T VAVK+L+ + Q GE++F+ EV
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVL----TNRTVVAVKQLEGIEQ-GEKQFRMEV 528
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLK-PNWNLRTNIAFQ 585
I THH NLVRL+GFC +G++RLLVYEF+ NG+L +FLF + K W R NIA
Sbjct: 529 ATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALG 588
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
A+G+ YLHE+C I+HCD+KP+NIL+DD++ A++SDFGLAKLL ++ +S+RGT
Sbjct: 589 TAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGT 648
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
+GY+APEW N IT+K DVYS+G++LLE+++ +++FD+ + + WA++ + G
Sbjct: 649 RGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEEFEKGN 708
Query: 706 LDALVGGDM--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763
A++ + + D+E + ++V S WCIQE P RPT+ KV+QMLEG+ E+ P P
Sbjct: 709 TKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCP 768
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 5.9e-78, Sum P(2) = 5.9e-78
Identities = 158/349 (45%), Positives = 228/349 (65%)
Query: 430 VFVNFALVCAFVLGFFFIYK-KKWIRNSPGDGTIETN---------LRCFSYKELEEATD 479
V V ++ + F I+K KK I +P + + E N +R F+YK+L+ AT+
Sbjct: 435 VVVTVFIIAVLIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIR-FAYKDLQSATN 493
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
NF ++G+G FG VY+G T + +AVKKL+ + Q G++EF+ EV +IG HH +L
Sbjct: 494 NFSVKLGQGGFGSVYEG----TLPDGSRLAVKKLEGIGQ-GKKEFRAEVSIIGSIHHLHL 548
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHE 595
VRL GFC EG +RLL YEFL+ G+L ++F G++ +W+ R NIA A+GL YLHE
Sbjct: 549 VRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHE 608
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
DC ++I+HCD+KP+NILLDD++NA++SDFGLAKL+T QS T++RGT+GY+APEW
Sbjct: 609 DCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVF-TTMRGTRGYLAPEWIT 667
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715
N I+ K DVYS+G++LLE+I RK++D E +AF GKL +V G M+
Sbjct: 668 NYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSFAFKKMEEGKLMDIVDGKMK 727
Query: 716 AMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762
+ DV E +++ + ++WCIQED RP++ KV+QMLEGV V PP+
Sbjct: 728 NV-DVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPS 775
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 687 (246.9 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
Identities = 148/349 (42%), Positives = 219/349 (62%)
Query: 422 GSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNF 481
G+VL V V LV +L + ++K +R GDGT L FSY+EL+ AT NF
Sbjct: 443 GAVLGSLGVIVLVLLVVILILRY---RRRKRMRGEKGDGT----LSAFSYRELQNATKNF 495
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+++G G FG V+KG + ++ +AVK+L+ + Q GE++F+ EV IG H NLVR
Sbjct: 496 SDKLGGGGFGSVFKGALP----DSSDIAVKRLEGISQ-GEKQFRTEVVTIGTIQHVNLVR 550
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHED 596
L GFC EG +LLVY+++ NG+L S LF N + W LR IA ARGL YLH++
Sbjct: 551 LRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDE 610
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
C IIHCD+KP+NILLD + +++DFGLAKL+ + S+ + T++RGT+GY+APEW
Sbjct: 611 CRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVL-TTMRGTRGYLAPEWISG 669
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY-RNGKLDALVGGDME 715
ITAK DVYS+G++L E+++ R++ + E+ WA ++G + +LV +E
Sbjct: 670 VAITAKADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLE 729
Query: 716 A-MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763
D+E + + V+ WCIQ++ S RP + +V+Q+LEGV+EV+ PP P
Sbjct: 730 GDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 533 (192.7 bits), Expect = 6.9e-66, Sum P(3) = 6.9e-66
Identities = 125/313 (39%), Positives = 184/313 (58%)
Query: 458 GDGTIETNLRCFSYKELEEATDNF-KE-EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI 515
G + L FS + AT++F KE E+GRG FG VYKGV++ R +AVK+L
Sbjct: 506 GKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGRE----IAVKRLSG 561
Query: 516 VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP- 574
G EFKNE+ +I + H+NLVRLLG C EG+ ++LVYE++ N +L FLF K
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 575 --NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632
+W LR +I IARGLLYLH D +IIH D+K N+LLD N +ISDFG+A++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692
NQ++ + GT GY++PE+ + K DVYSFGVLLLEI++ +++ + E+
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRS-SEHGS 740
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAM-NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
L +A+ Y +G+ + LV + + E L + + V++ C+Q+ + RP + VL ML
Sbjct: 741 LIGYAWYLYTHGRSEELVDPKIRVTCSKREAL-RCIHVAMLCVQDSAAERPNMASVLLML 799
Query: 752 EG-VVEVSVPPNP 763
E ++ P P
Sbjct: 800 ESDTATLAAPRQP 812
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 5.4e-64, Sum P(3) = 5.4e-64
Identities = 107/215 (49%), Positives = 147/215 (68%)
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEV 528
F ++ELE+AT+NFK ++G G FG VYKG T T +AVKK+ G +EF E+
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKG----TLPDETLIAVKKITNHGLHGRQEFCTEI 560
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQI 586
+IG H NLV+L GFC G+ LLVYE++N+G+L LF P W R +IA
Sbjct: 561 AIIGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGT 620
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
ARGL YLH C +IIHCD+KP+NILL DH+ +ISDFGL+KLL +S ++ T++RGT+
Sbjct: 621 ARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEES-SLFTTMRGTR 679
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS 681
GY+APEW N+ I+ K DVYS+G++LLE+++ RK+
Sbjct: 680 GYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.4e-60, Sum P(2) = 1.4e-60
Identities = 160/530 (30%), Positives = 253/530 (47%)
Query: 259 RHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCD---CPKGYSLLDK 315
+H +W + + P+N C ++ G CG IC ++ + C PK +
Sbjct: 265 QHNGMDWELNFEAPENSC-----DI-YGFCGPFGICVMSVPPKCKCFKGFVPKSIEEWKR 318
Query: 316 TDKYGSCKADFDLSCNGGGQGYNKE-LFDVYELKETDWPMSDYDFFSPYDEEHCWLKRLP 374
+ C +L C G G + V +K D+ Y+F S D E C+ L
Sbjct: 319 GNWTDGCVRHTELHCQGNTNGKTVNGFYHVANIKPPDF----YEFASFVDAEGCYQICLH 374
Query: 375 LSNGRADTSVTGKAFIKYRKGXXXXXXXXXXXXXXXXXXXXXMM--NATGSVLLGSSVFV 432
+ A + G + + + + N +++ S V +
Sbjct: 375 NCSCLAFAYINGIGCLMWNQDLMDAVQFSAGGEILSIRLASSELGGNKRNKIIVASIVSL 434
Query: 433 NFALVCAFVLGFFFIYKKKW--------IRNSPG-DGTIE----TNLRCFSYKELEEATD 479
+ ++ AF F YK K I + + +E + L+ F ++ ATD
Sbjct: 435 SLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDVSGLKFFEMNTIQTATD 494
Query: 480 NFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK 537
NF ++G+G FG VYKG +Q + +AVK+L G+ EF NE+ +I + HK
Sbjct: 495 NFSLSNKLGQGGFGSVYKGKLQDGKE----IAVKRLSSSSGQGKEEFMNEIVLISKLQHK 550
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLH 594
NLVR+LG C EG+ RLLVYEFL N +L +FLF + L+ +W R NI IARGL YLH
Sbjct: 551 NLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLH 610
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
D ++IH D+K NILLD+ N +ISDFGLA++ + + + GT GY+APE+
Sbjct: 611 RDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYA 670
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY-RNGKLDALVGGD 713
+ K D+YSFGV+LLEII K + L +A++ + +G +D L
Sbjct: 671 WTGMFSEKSDIYSFGVILLEIITGEKISRFSYGRQGKTLLAYAWESWCESGGIDLLDKDV 730
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763
++ + +E +E+ V + + C+Q P+ RP ++L ML +++ P P
Sbjct: 731 ADSCHPLE-VERCVQIGLLCVQHQPADRPNTMELLSMLTTTSDLTSPKQP 779
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 562 (202.9 bits), Expect = 1.4e-60, Sum P(2) = 1.4e-60
Identities = 157/520 (30%), Positives = 252/520 (48%)
Query: 262 NG-NWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGY---SLLD-KT 316
NG +W + P N C ++ G CG C ++ P C C KG+ S+ + K
Sbjct: 260 NGLDWKSSYEGPANSC-----DI-YGVCGPFGFCVISDP--PKCKCFKGFVPKSIEEWKR 311
Query: 317 DKYGS-CKADFDLSCNGGGQGYNKELFD-VYELKETDWPMSDYDFFSPYDEEHCWLKRLP 374
+ S C +L C G G + +F V +K D+ Y++ + D E C+ L
Sbjct: 312 GNWTSGCARRTELHCQGNSTGKDANVFHTVPNIKPPDF----YEYANSVDAEGCYQSCLH 367
Query: 375 LSNGRADTSVTGKAFIKYRKGXXXXXXXXXXXXXXXXXXXXXMMNA--TGSVLLGSSVFV 432
+ A + G + + K ++ ++ S+V +
Sbjct: 368 NCSCLAFAYIPGIGCLMWSKDLMDTMQFSAGGEILSIRLAHSELDVHKRKMTIVASTVSL 427
Query: 433 NFALVCAFV-LGFF---FIYKKKWIRNSPGDGTIETNLRCFSYKELEEATDNFK--EEVG 486
++ F GF+ + W RN + L F ++ AT NF ++G
Sbjct: 428 TLFVILGFATFGFWRNRVKHHDAW-RNDLQSQDVP-GLEFFEMNTIQTATSNFSLSNKLG 485
Query: 487 RGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC 546
G FG VYKG +Q R +AVK+L + G++EF NE+ +I + H+NLVR+LG C
Sbjct: 486 HGGFGSVYKGKLQDGRE----IAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCC 541
Query: 547 DEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
EG+ +LL+YEF+ N +L +F+FG+ L+ +W R +I I RGLLYLH D ++IH
Sbjct: 542 VEGKEKLLIYEFMKNKSLDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIH 601
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663
D+K NILLD+ N +ISDFGLA+L +Q + + GT GY++PE+ + K
Sbjct: 602 RDLKVSNILLDEKMNPKISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKS 661
Query: 664 DVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECL 723
D+YSFGVLLLEII+ K EE L + ++C+ + L+ ++ + +
Sbjct: 662 DIYSFGVLLLEIISGEKISRFSYGEEGKALLAYVWECWCETRGVNLLDQALDDSSHPAEV 721
Query: 724 EKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763
+ V + + C+Q P+ RP ++L ML ++ +P P
Sbjct: 722 GRCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPLPKQP 761
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 521 (188.5 bits), Expect = 9.2e-60, Sum P(3) = 9.2e-60
Identities = 119/308 (38%), Positives = 179/308 (58%)
Query: 464 TNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE 521
+ L F +L+ AT+NF ++G+G FG VYKG +Q + +AVK+L G
Sbjct: 481 SGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKE----IAVKRLTSSSVQGT 536
Query: 522 REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPNWNL 578
EF NE+ +I + H+NL+RLLG C +G+ +LLVYE++ N +L F+F L+ +W
Sbjct: 537 EEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWAT 596
Query: 579 RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
R NI IARGLLYLH D +++H D+K NILLD+ N +ISDFGLA+L NQ +
Sbjct: 597 RFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDS 656
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
S+ GT GY++PE+ + K D+YSFGVL+LEII ++ ++ L +A+
Sbjct: 657 TGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGKDNKNLLSYAW 716
Query: 699 DCY-RNGKLDALVGG--DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
D + NG ++ L D +++N VE + V + + C+Q RP IK+V+ ML
Sbjct: 717 DSWSENGGVNLLDQDLDDSDSVNSVEA-GRCVHIGLLCVQHQAIDRPNIKQVMSMLTSTT 775
Query: 756 EVSVPPNP 763
++ P P
Sbjct: 776 DLPKPTQP 783
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 578 (208.5 bits), Expect = 5.4e-59, Sum P(2) = 5.4e-59
Identities = 139/352 (39%), Positives = 210/352 (59%)
Query: 430 VFVNFALVCAFVLGFFFIYKKKWIRNSP-GDGTIET--NLRCFSYKELEEATDNFKEEVG 486
V V+ AL ++ I + K +RNS D +E L+ +SY +++ T++F +G
Sbjct: 279 VGVSAALTLMILIVVVIIVRTKNMRNSEWNDQNVEAVAMLKRYSYTRVKKMTNSFAHVLG 338
Query: 487 RGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC 546
+G FG VYKG + S VAVK L + +GE EF NEV + +T H N+V LLGFC
Sbjct: 339 KGGFGTVYKGKLAD---SGRDVAVKILKVSEGNGE-EFINEVASMSRTSHVNIVSLLGFC 394
Query: 547 DEGQNRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHC 604
E R ++YEF+ NG+L ++ N+ K W ++A I+RGL YLH C ++I+H
Sbjct: 395 YEKNKRAIIYEFMPNGSLDKYISANMSTKMEWERLYDVAVGISRGLEYLHNRCVTRIVHF 454
Query: 605 DMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF-RN-SKITAK 662
D+KPQNIL+D++ +ISDFGLAKL +S +RGT GY+APE F +N ++ K
Sbjct: 455 DIKPQNILMDENLCPKISDFGLAKLCKNKESIISMLHMRGTFGYIAPEMFSKNFGAVSHK 514
Query: 663 VDVYSFGVLLLEIIACRKSFDIEMVEEYA-------ILTDWAFDCYRNGKLDALVGGDME 715
DVYS+G+++LE+I + +IE VE Y+ +W + + G++ + G D
Sbjct: 515 SDVYSYGMVVLEMIGAK---NIEKVE-YSGSNNGSMYFPEWVYKDFEKGEITRIFG-DSI 569
Query: 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE-VSVPPNPYPF 766
+ + +KLV+V++WCIQ +PS RP + KV++MLEG +E + VPPNP F
Sbjct: 570 TDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLEALQVPPNPLLF 621
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 581 (209.6 bits), Expect = 1.8e-58, Sum P(2) = 1.8e-58
Identities = 138/344 (40%), Positives = 194/344 (56%)
Query: 431 FVNFALVCAFVLGFFFIYKKKWIRNSPGDGTIE--TNLRCFSYKELEEATDNFKEEVGRG 488
F+ L+ +L FFF ++ P D ++ L+ +SY E+ + T F +G+G
Sbjct: 271 FLGATLITVCLLCFFFQKRRTSHHLRPRDNNLKGLVQLKQYSYAEVRKITKLFSHTLGKG 330
Query: 489 SFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE 548
FG VY G + R VAVK L +GE +F NEV + QT H N+V LLGFC E
Sbjct: 331 GFGTVYGGNLCDGRK----VAVKILKDFKSNGE-DFINEVASMSQTSHVNIVSLLGFCYE 385
Query: 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCSSQIIHCDM 606
G R +VYEFL NG+L FL N ++ T IA +ARGL YLH C ++I+H D+
Sbjct: 386 GSKRAIVYEFLENGSLDQFLSEKKSLNLDVSTLYRIALGVARGLDYLHHGCKTRIVHFDI 445
Query: 607 KPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN--SKITAKVD 664
KPQNILLDD + ++SDFGLAKL +S RGT GY+APE F +++ K D
Sbjct: 446 KPQNILLDDTFCPKVSDFGLAKLCEKRESILSLLDARGTIGYIAPEVFSGMYGRVSHKSD 505
Query: 665 VYSFGVLLLEIIACRKSFDIEMV----EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720
VYS+G+L+LE+I K+ +IE A DW + NG+ D GD + D
Sbjct: 506 VYSYGMLVLEMIGA-KNKEIEETAASNSSSAYFPDWIYKNLENGE-DTWKFGDEISREDK 563
Query: 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV-SVPPNP 763
E +K+ +V +WCIQ P RP + ++++M+EG ++V VPP P
Sbjct: 564 EVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLDVLEVPPKP 607
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4247 | 0.9699 | 0.8930 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 766 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-29 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-25 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-18 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-17 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-07 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 7e-07 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 1e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 6e-50
Identities = 78/271 (28%), Positives = 121/271 (44%), Gaps = 60/271 (22%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNLVRLL 543
+G G FG VY + T VA+K + E E+ ++ + +H N+V+L
Sbjct: 1 LGEGGFGTVYLARDKKTGKK---VAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCSSQII 602
G ++ + LV E+ G+L L N + + I QI GL YLH S+ II
Sbjct: 58 GVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 603 HCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE-WFRNSKIT 660
H D+KP+NILLD D+ +++DFGL+KLLT K++ +I GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 661 AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720
K D++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL--------------------------------------------- 187
Query: 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
L+ L+ +Q+DP RP+ K++L+ L
Sbjct: 188 PELKDLIR---KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-49
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 25/274 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKN 538
++G GSFG VYK + T VAVK L + ++ + E+ ++ + H N
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKI---VAVKILKKRSEKSKKDQTARREIRILRRLSHPN 59
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+VRL+ ++ + LV E+ G L +L + + IA QI RGL YLH +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW-FRNS 657
IIH D+KP+NILLD++ +I+DFGLAK L + S T+ GT Y+APE +
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGN 174
Query: 658 KITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716
KVDV+S GV+L E++ + F ++++ ++ L + D
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---------RRILGPPLEFDEPK 225
Query: 717 MNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ E + L+ C+ +DPS RPT +++LQ
Sbjct: 226 WSSGSEEAKDLI---KKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (434), Expect = 3e-48
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 35/277 (12%)
Query: 481 FKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKN 538
E++G GSFG VY +T + VA+K + +RE E+ ++ + H N
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKL----VAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
+VRL ++ LV E+ G L L G L + QI L YLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLH-- 114
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S I+H D+KP+NILLD+ + +++DFGLA+ L T+ GT Y+APE
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLG 170
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSF--DIEMVEEYAILTDWAFDC-YRNGKLDALVGGD 713
VD++S GV+L E++ + F D +++E + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP----- 225
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
EA + + + +DP R T ++ LQ
Sbjct: 226 -EAKDLIRK----------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 4e-45
Identities = 86/281 (30%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKN 538
+++G G+FG VYKG ++ T T VAVK L + ER EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHE 595
+VRLLG C +G+ +V E++ G L FL L +A QIA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE- 119
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN----QSKTIKTSIRGTKGYVAP 651
S +H D+ +N L+ ++ +ISDFGL++ + + + K I+ ++AP
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAP 173
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710
E ++ K T+K DV+SFGVLL EI + + EE + + D YR
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLELLEDGYR-------- 222
Query: 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ + C ++L + + C DP RPT ++++ L
Sbjct: 223 ---LPRPEN--CPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 4e-44
Identities = 86/279 (30%), Positives = 131/279 (46%), Gaps = 32/279 (11%)
Query: 481 FKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKN 538
+++G G+FG VYKG VAVK L + + EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 596
+V+LLG C E + +V E++ G L S+L +P +L + A QIARG+ YL
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV---APEW 653
S IH D+ +N L+ ++ +ISDFGL++ L RG K + APE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRK-RGGKLPIRWMAPES 174
Query: 654 FRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712
+ K T+K DV+SFGVLL EI + + EE + +NG
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGYR------ 221
Query: 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ C +L + + C EDP RPT +++++L
Sbjct: 222 -LPQPP--NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 1e-43
Identities = 83/279 (29%), Positives = 132/279 (47%), Gaps = 31/279 (11%)
Query: 481 FKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKN 538
+++G G+FG VYKG VAVK L + + EF E ++ + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 596
+V+LLG C E + ++V E++ G L +L N +L + A QIARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS---IRGTKGYVAPEW 653
S IH D+ +N L+ ++ +ISDFGL++ L + +K IR ++APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPES 175
Query: 654 FRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712
+ K T+K DV+SFGVLL EI + + E + + G
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGYR------ 222
Query: 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ + C +L + + C EDP RPT +++++L
Sbjct: 223 -LPKPPN--CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 88/287 (30%), Positives = 139/287 (48%), Gaps = 42/287 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVR 541
+++G G+FG VYKG ++ TT VAVK L + ER +F E V+ + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPN---WNLRTNIAFQIARGLLY 592
LLG C E + LV E++ G L +L F + + + + A QIA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----IRGTKGY 648
L S + +H D+ +N L+ + +ISDFGL++ + + KT IR +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707
+APE ++ T+K DV+SFGVLL EI + + + + R G
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP-------GLSNEEVLEYLRKGYR- 225
Query: 708 ALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ C ++L +M+S W Q DP RPT ++++ LE
Sbjct: 226 ------LPKPEY--CPDELYELMLSCW--QLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 14/200 (7%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNLV 540
E +GRGSFG VY + + +AVK +++ E + E+ ++ H N+V
Sbjct: 6 ELLGRGSFGSVYLA---LDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 541 RLLGFC-DEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
R G DE +N L ++ E+++ G+L+S L FG L +R QI GL YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEP-VIR-KYTRQILEGLAYLH-- 118
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S+ I+H D+K NIL+D +++DFG AK L ++ S+RGT ++APE R
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 657 SKITAKVDVYSFGVLLLEII 676
+ D++S G ++E+
Sbjct: 178 EEYGRAADIWSLGCTVIEMA 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 2e-31
Identities = 74/279 (26%), Positives = 126/279 (45%), Gaps = 38/279 (13%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREF-KNEVFVIGQTHHKNL 539
+++G+GSFG VY ++ +K++D+ ERE NEV ++ + +H N+
Sbjct: 5 IKQIGKGSFGKVYL--VRRKSDGKL-YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLYLHE 595
++ +E +V E+ + G L+ + K + Q+ L YLH
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S +I+H D+KPQNI L + ++ DFG++K+L+ KT + GT Y++PE +
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA-KTVV-GTPYYLSPELCQ 176
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTDWAFDCYRNGKLDALVGGD 713
N K D++S G +L E+ + F+ E + E IL G
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-----------------GQ 219
Query: 714 MEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ L LV +Q+DP RP+I ++LQ
Sbjct: 220 YPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 80/277 (28%), Positives = 125/277 (45%), Gaps = 37/277 (13%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+G+G FG V G + + VAVK L + F E V+ H NLV
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQK-----VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLV 63
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCS 598
+LLG +G +V E++ G+L +L + L + A + G+ YL E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE--- 120
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+H D+ +N+L+ + A++SDFGLAK + Q + K ++ T APE R K
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWT----APEALREKK 175
Query: 659 ITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
+ K DV+SFG+LL EI + R + +++ + YR MEA
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKGYR-----------MEAP 221
Query: 718 NDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
C ++ VM W + DP+ RPT K++ + L
Sbjct: 222 EG--CPPEVYKVMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 18/198 (9%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
E++G+G FG VYK + + VA+K + + ++ + + NE+ ++ + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKA---RHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNL-RTNIAFQIARGLL----YLHED 596
G + +V EF + G+L L + L + IA+ + + LL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT---LTESQIAY-VCKELLKGLEYLH-- 115
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S+ IIH D+K NILL ++ DFGL+ L+ +K T + GT ++APE
Sbjct: 116 -SNGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMV-GTPYWMAPEVING 171
Query: 657 SKITAKVDVYSFGVLLLE 674
K D++S G+ +E
Sbjct: 172 KPYDYKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKN 538
+ +GRG+FG+VYKG+ T VA+K++ + E + E+ ++ H N
Sbjct: 4 LGDLIGRGAFGVVYKGLNLET---GDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
+V+ +G + + ++ E+ NG+L + FG +L +Q+ +GL YLHE
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF--PESLVAVYVYQVLQGLAYLHE- 117
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
+IH D+K NIL +++DFG+A LN S+ GT ++APE
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEM 173
Query: 657 SKITAKVDVYSFGVLLLEIIACRKS-FDIE-MVEEYAILTDWAFDCYRNGKLDALVGGDM 714
S + D++S G ++E++ +D+ M + I+ D D +
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPP-----------L 219
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
E + L + C Q+DP+LRPT K++L+
Sbjct: 220 PEGISPELKDFL----MQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 69/216 (31%), Positives = 112/216 (51%), Gaps = 26/216 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDIVFQDGE----REFKNEVFVIGQTH 535
F +++G G FG V +T VAVK L+ GE +F+ E+ ++
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN---HSGEEQHRSDFEREIEILRTLD 64
Query: 536 HKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLL 591
H+N+V+ G C++ G++ L+ E+L +G+L +L + + NL+ + + QI +G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMD 123
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ----SKTIKTS-IRGTK 646
YL S + IH D+ +NIL++ +ISDFGLAK+L ++ K S I
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF--- 177
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKS 681
+ APE R SK ++ DV+SFGV L E+ S
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 5e-29
Identities = 76/287 (26%), Positives = 117/287 (40%), Gaps = 32/287 (11%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQ-TH 535
++G GSFG VY VA+K L + +E F E+ ++ H
Sbjct: 3 RILRKLGEGSFGEVYLAR------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGL 590
N+V+L F + + LV E+++ G+L L G L + L I QI L
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSAL 114
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTI----KTSIRGT 645
YLH IIH D+KP+NILLD ++ DFGLAKLL S + ++ GT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 646 KGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702
GY+APE + ++ D++S G+ L E++ F+ E T
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIIL 228
Query: 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+L + N + + + +DP R + L
Sbjct: 229 ELPTPSL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 6e-28
Identities = 73/228 (32%), Positives = 116/228 (50%), Gaps = 34/228 (14%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKL-DIVFQDGEREFKNEVF 529
E+ + F EE+G G+FG VYKG + R S T+VA+K L + ++EF+ E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 530 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--------- 580
++ H N+V LLG C + Q +++E+L +G L FL N P+ ++
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRN-SPHSDVGAESGDETVKS 119
Query: 581 --------NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632
+IA QIA G+ YL S +H D+ +N L+ + +ISDFGL++ +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 633 N-----QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
QSK++ +R ++ PE K T + D++SFGV+L EI
Sbjct: 177 ADYYRVQSKSL-LPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 79/288 (27%), Positives = 136/288 (47%), Gaps = 43/288 (14%)
Query: 484 EVGRGSFGIVYKGVIQTTRTST--TAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLV 540
E+G+GSFG+VY+G+ + T VA+K ++ ER EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFL--------FGNLK--PNWNLRTNIAFQIARGL 590
RLLG GQ L+V E + G L S+L P +A +IA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG--- 647
YL + +H D+ +N ++ + +I DFG+ + + ++ + +G KG
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRD--IYETDYYR---KGGKGLLP 184
Query: 648 --YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
++APE ++ T K DV+SFGV+L E+ A L + + N +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM---------------ATLAEQPYQGLSNEE 229
Query: 706 LDALVGGDMEAMNDVECL-EKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ V D ++ E +KL+ + C Q +P +RPT +++ L+
Sbjct: 230 VLKFV-IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 67/195 (34%), Positives = 100/195 (51%), Gaps = 8/195 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+E+G G+FG V KGV VAVK L G++EF E V+ Q H +VR
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQ 600
L+G C +G+ +LV E G L +L + P +L +A Q+A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDL-KELAHQVAMGMAYLES---KH 115
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTSIRGTKGYVAPEWFRNSKI 659
+H D+ +N+LL + + A+ISDFG+++ L T+ R + APE K
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 660 TAKVDVYSFGVLLLE 674
++K DV+S+GV L E
Sbjct: 176 SSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 8e-27
Identities = 92/346 (26%), Positives = 151/346 (43%), Gaps = 38/346 (10%)
Query: 428 SSVFVNFALVCAFVLGFFFIYKKKWI---RNSPGDGTIETNLRCFSYKELEEATDN---- 480
+ F ++ GF FI + + R DGT E F K + T N
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF--FDSKVSKSITINDILS 690
Query: 481 -FKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK 537
KEE + RG G YKG + ++ + +E+ +G+ H
Sbjct: 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS-------SEIADMGKLQHP 743
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
N+V+L+G C + L++E++ L+ L +W R IA IA+ L +LH C
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRC 800
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
S ++ ++ P+ I++D + L LL + I ++ YVAPE
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA------YVAPETRETK 853
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL----DALVGGD 713
IT K D+Y FG++L+E++ + D E + + +WA CY + L D + GD
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 714 MEAMNDVECLEKLVM-VSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ ++N E +E VM +++ C DP+ RP VL+ LE S
Sbjct: 913 V-SVNQNEIVE--VMNLALHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 34/228 (14%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ-THH 536
F + +G GSF V + T A+K LD ++ + + K E V+ + H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKE---YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 537 KNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYL 593
+++L F DE +N V E+ NG L ++ +G+L + A +I L YL
Sbjct: 62 PGIIKLYYTFQDE-ENLYFVLEYAPNGELLQYIRKYGSL--DEKCTRFYAAEILLALEYL 118
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL------------------TLNQS 635
H S IIH D+KP+NILLD + +I+DFG AK+L + ++
Sbjct: 119 H---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
+ S GT YV+PE D+++ G ++ +++ + F
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 71/267 (26%), Positives = 123/267 (46%), Gaps = 24/267 (8%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLG 544
G+GS G+VYK + + A+KK+ + + ++ E+ + +V+ G
Sbjct: 10 GQGSSGVVYKVR---HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 545 -FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
F EG+ + V E+++ G+LA L K + IA QI +GL YLH IIH
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIH 123
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663
D+KP N+L++ +I+DFG++K L + + GT Y++PE + +
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISK--VLENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181
Query: 664 DVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECL 723
D++S G+ LLE + F + L + A+ G ++ E
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQAICDGPPPSLPAEEFS 229
Query: 724 EKLV-MVSIWCIQEDPSLRPTIKKVLQ 749
+ +S C+Q+DP RP+ ++LQ
Sbjct: 230 PEFRDFISA-CLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 68/200 (34%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+ ++G G FG V+ G T TT VAVK L E F E ++ + H LV+
Sbjct: 11 ERKLGAGQFGEVWMG----TWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQ 65
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCSS 599
L C E + +V E+++ G+L FL L ++A QIA G+ YL S
Sbjct: 66 LYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SR 122
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWFRN 656
IH D+ +NIL+ ++ +I+DFGLA+L+ + T+ G K + APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDD----EYTAREGAKFPIKWTAPEAANY 178
Query: 657 SKITAKVDVYSFGVLLLEII 676
+ T K DV+SFG+LL EI+
Sbjct: 179 GRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG 532
E++ + ++G G FG V++G+ +TT VAVK L D + +F E ++
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPGTMDPK-DFLAEAQIMK 56
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGL 590
+ H L++L C + +V E + G+L +L G L ++A Q+A G+
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---G 647
YL + IH D+ +N+L+ ++ +++DFGLA+++ + I + G K
Sbjct: 117 AYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIK 169
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEII 676
+ APE ++ + K DV+SFG+LL EI+
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 76/283 (26%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVR 541
+ +G G FG V +G ++ VA+K L D +R +F E ++GQ H N++R
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600
L G + + +++ E++ NG+L FL N K + IA G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY-- 127
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS----KTIKTSIRGTKGYVAPEWFRN 656
+H D+ +NIL++ + ++SDFGL++ L +++ K K IR T APE
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APEAIAY 182
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716
K T+ DV+SFG+++ E+++ Y W N + ++A
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS------------YGERPYWDMS---NQDV-------IKA 220
Query: 717 MND-------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ D ++C L + + C Q+D + RPT +++ L+
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 85/289 (29%), Positives = 132/289 (45%), Gaps = 39/289 (13%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER--EFKNEVFV 530
E+E K ++G G +G VY+GV + + S T VAVK L +D EF E V
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWK--KYSLT-VAVKTLK---EDTMEVEEFLKEAAV 55
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 588
+ + H NLV+LLG C ++ EF+ G L +L + N +A QI+
Sbjct: 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK-- 646
+ YL IH D+ +N L+ +++ +++DFGL++L+T T+ G K
Sbjct: 116 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFP 168
Query: 647 -GYVAPEWFRNSKITAKVDVYSFGVLLLEII--ACRKSFDIEMVEEYAILTDWAFDCYRN 703
+ APE +K + K DV++FGVLL EI I++ + Y
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------------- 215
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
L+ G ME C K+ + C Q +PS RP+ ++ Q E
Sbjct: 216 ELLEK--GYRMERPEG--CPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 24/205 (11%)
Query: 480 NFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
E++G G+ G VYK T + VA+KK+ + + + NE+ ++ H N
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKE----VAIKKMRLR-KQNKELIINEILIMKDCKHPN 76
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN---IAF---QIARGLL 591
+V + L +V E+++ G+L + N +R N IA+ ++ +GL
Sbjct: 77 IVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLE 130
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
YLH S +IH D+K NILL + +++DFG A LT +SK + S+ GT ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAP 185
Query: 652 EWFRNSKITAKVDVYSFGVLLLEII 676
E + KVD++S G++ +E+
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 79/276 (28%), Positives = 124/276 (44%), Gaps = 34/276 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER----EFKNEVFVIGQTHHKNLV 540
+G G+FG VY V + +AVK +I QD + E +E+ V+ H NLV
Sbjct: 8 IGGGTFGKVYTAV---NLDTGELMAVK--EIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
+ G + + E+ + GTL L G + +R Q+ GL YLH S
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-YTLQLLEGLAYLH---SH 118
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT---SIRGTKGYVAPEWFRN 656
I+H D+KP NI LD + ++ DFG A L N + T+ S+ GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK-NNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 657 SKITAK---VDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
K D++S G ++LE+ ++ + E+ E+ I+ + G D
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS-ELDNEFQIM-------FHVGAGHKPPIPD 229
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
++ E + L C++ DP RPT ++LQ
Sbjct: 230 SLQLSP-EGKDFLDR----CLESDPKKRPTASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 49/284 (17%)
Query: 481 FKEEVGRGSFGIV----YKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQ 533
F +E+G G FG+V ++G I VA+K + ++G E +F E V+ +
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID--------VAIKMI----REGAMSEDDFIEEAKVMMK 55
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGL 590
H NLV+L G C + + +V E++ NG L ++L G L W L ++ + +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL--DMCSDVCEAM 113
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---G 647
YL + IH D+ +N L+ + ++SDFGLA+ + +Q TS +GTK
Sbjct: 114 EYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----TSSQGTKFPVK 166
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707
+ PE F S+ ++K DV+SFGVL+ E+ + K ++ + N ++
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM---------------PYERFSNSEVV 211
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
V ++ + C E P RP KK+L L
Sbjct: 212 ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 82/275 (29%), Positives = 129/275 (46%), Gaps = 39/275 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
E +G G FG V +G + VAVK K D+ Q F E V+ + HHKNLV
Sbjct: 12 EIIGEGEFGAVLQGEYTGQK-----VAVKNIKCDVTAQ----AFLEETAVMTKLHHKNLV 62
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
RLLG +V E ++ G L +FL G + + +A G+ YL S
Sbjct: 63 RLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---S 118
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+++H D+ +NIL+ + A++SDFGLA++ S + S K + APE ++ K
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVK-WTAPEALKHKK 173
Query: 659 ITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
++K DV+S+GVLL E+ + R + ++E + + YR ME
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKECVEKGYR-----------MEPP 219
Query: 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
++M S W + +P RP+ K+ + LE
Sbjct: 220 EGCPADVYVLMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 60/291 (20%)
Query: 480 NFK--EEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDIVFQ-DGEREFK-NEVFVIGQT 534
+FK +++G+GS+G VYK R S A+K++D+ ERE NE+ ++
Sbjct: 1 DFKVLKKLGKGSYGSVYK----VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56
Query: 535 HHKNLVR-----LLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPN---WNLRT 580
+H N++ L G N+L +V E+ G L+ + L P W
Sbjct: 57 NHPNIISYKEAFLDG------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--- 107
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
I Q+ RGL LHE +I+H D+K NILL + +I D G++K+L N +KT
Sbjct: 108 -IFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI- 162
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTDWAF 698
GT Y+APE ++ + K D++S G LL E+ F+ +++ Y +
Sbjct: 163 ---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR---- 215
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
GK + + L+ + +Q P LRP K+L
Sbjct: 216 -----GKYPPI------PPIYSQDLQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 486 GRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
G G+FG VYKGV I VA+K L + +E +E +V+ H ++VRLL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCSSQI 601
G C L+ + + G L ++ + K N + N QIA+G+ YL E ++
Sbjct: 76 GIC-LSSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTSIRGTKGYVAPEWFRNS 657
+H D+ +N+L+ + +I+DFGLAKLL +++ + K I+ ++A E +
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK----WMALESILHR 186
Query: 658 KITAKVDVYSFGVLLLEII 676
T K DV+S+GV + E++
Sbjct: 187 IYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 23/201 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
++G G FG V++G+ + VA+K L +++F+ EV + + HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR----VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLYLHEDCS 598
C G+ ++ E + G+L +FL L ++A Q+A G+ YL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLEE--- 122
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLT----LNQSKTIKTSIRGTKGYVAPEWF 654
IH D+ +NIL+ + +++DFGLA+L+ L+ K I + APE
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAA 176
Query: 655 RNSKITAKVDVYSFGVLLLEI 675
+ + K DV+SFG+LL E+
Sbjct: 177 SHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 74/290 (25%), Positives = 139/290 (47%), Gaps = 53/290 (18%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVRLL 543
+G G FG V++G+++ AVA+K L + + +R +F +E ++GQ H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
G + + +++ E++ NG L +L F + + LR IA G+ YL +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG-----IAAGMKYLSD-- 125
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IRGTKGYVAPE 652
+H D+ +NIL++ + ++SDFGL+++L + T TS IR T APE
Sbjct: 126 -MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT----APE 180
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712
K T+ DV+SFG+++ E+++ + +M
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV--------------------- 219
Query: 713 DMEAMND-------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
M+A+ND ++C + + + C Q+D + RP ++ +L+ ++
Sbjct: 220 -MKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 33/276 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+E+G G FG+V+ G R VA+K + E +F E V+ + H LV
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK----VAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLV 62
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+L G C E LV+EF+ +G L+ +L + ++ T + + G+ YL
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN- 120
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWFR 655
+IH D+ +N L+ ++ ++SDFG+ + + +Q TS GTK + +PE F
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY----TSSTGTKFPVKWSSPEVFS 174
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715
SK ++K DV+SFGVL+ E+ + K+ ++ N ++ +
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFSEGKT---------------PYENRSNSEVVETINAGFR 219
Query: 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ + + C +E P RP+ +L L
Sbjct: 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 72/223 (32%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+GSFG V + T A+K L I+ + E ++ + +H +V+
Sbjct: 1 LGKGSFGKVLLVRKKDTGK---LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 542 LL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF---QIARGLLYLH 594
L F E +L LV E+ G L S L G F +I L YLH
Sbjct: 58 LHYAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEER-----ARFYAAEIVLALEYLH 110
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
S II+ D+KP+NILLD + +++DFGLAK L+ S+T + GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCGTPEYLAPEVL 165
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTD 695
VD +S GVLL E++ + F E +E IL D
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 79/286 (27%), Positives = 123/286 (43%), Gaps = 47/286 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAV-KKLD-IVFQDGERE-FKNEVFVIGQTHHKNL 539
E +G+GSFG V K V R S + V K++D + E++ +EV ++ + H N+
Sbjct: 6 ETIGKGSFGTVRK-VR---RKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 540 VRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPN---------WNLRTNIAFQIAR 588
VR D L +V E+ G LA + K W I Q+
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWR----ILTQLLL 116
Query: 589 GLLYLH--EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
L H D + ++H D+KP NI LD + N ++ DFGLAK+L + S KT + GT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYV-GTP 174
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
Y++PE + K D++S G L+ E+ A F + A + GK
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI-------KEGKF 227
Query: 707 DALVGGDMEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ +N+V L DP RP+ +++LQ+
Sbjct: 228 RRIPYRYSSELNEVIKSMLNV-----------DPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 79/293 (26%), Positives = 141/293 (48%), Gaps = 45/293 (15%)
Query: 480 NFKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHH 536
E+G+GSFG+VY+G + + T VAVK ++ ER EF NE V+
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQI 586
++VRLLG +GQ L+V E + +G L S+L G P +A +I
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
A G+ YL+ + + +H D+ +N ++ + +I DFG+ + + ++ + +G K
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYR---KGGK 180
Query: 647 G-----YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701
G ++APE ++ T D++SFGV+L EI + L + +
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGL 225
Query: 702 RNGKLDALV--GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
N ++ V GG ++ ++ C E++ + C Q +P +RPT +++ +L+
Sbjct: 226 SNEQVLKFVMDGGYLDQPDN--CPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-23
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
E++G+G+FG VYKGV++ T VAVK + + D +R+F E ++ Q H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGN----TEVAVKTCRSTL-PPDLKRKFLQEAEILKQYDHPNIV 55
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI----ARGLLYLHED 596
+L+G C + Q +V E + G+L +FL K L Q+ A G+ YL
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK----GYVAPE 652
IH D+ +N L+ ++ +ISDFG+++ + I T G K + APE
Sbjct: 113 NC---IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPE 165
Query: 653 WFRNSKITAKVDVYSFGVLLLEI 675
+ T++ DV+S+G+LL E
Sbjct: 166 ALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 9e-23
Identities = 68/197 (34%), Positives = 104/197 (52%), Gaps = 14/197 (7%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-----DIVFQDGEREFKNEVFVIGQTHHKN 538
E+G G+FG V KG+ + ++ T VAVK L D +D E E V+ Q +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKD---ELLREANVMQQLDNPY 57
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+VR++G C E ++ +LV E G L FL N T + Q++ G+ YL E
Sbjct: 58 IVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE--- 113
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGTKGYVAPEWFRNS 657
+ +H D+ +N+LL + A+ISDFGL+K L +++ KT + + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 658 KITAKVDVYSFGVLLLE 674
K ++K DV+SFGVL+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 34/214 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G+FG V ++Q T A+K K V + R NE ++ + +H LV
Sbjct: 8 IGKGAFGKVC--IVQKRDTKKM-FAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 542 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ----------IARGL 590
L F DE +N LV + L G L ++L + F I L
Sbjct: 65 LWYSFQDE-ENMYLVVDLLLGGDL----------RYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YLH S IIH D+KP NILLD+ + I+DF +A +T + T+ TS GT GY+A
Sbjct: 114 EYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMA 167
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDI 684
PE + VD +S GV E + ++ +
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHHKNLVR 541
E +G+GSFG VYK + + + VA+K +D+ + E E E+ + Q + +
Sbjct: 7 ECIGKGSFGEVYKAID---KRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
G +G ++ E+ G+ L KP T IAF ++ GL YLHE+
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHEE-- 117
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
IH D+K NILL + + +++DFG++ LT SK + + GT ++APE + S
Sbjct: 118 -GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--RNTFVGTPFWMAPEVIKQSG 174
Query: 659 ITAKVDVYSFGVLLLEII 676
K D++S G+ +E+
Sbjct: 175 YDEKADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 18/206 (8%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLV 540
+E +G G FG V +G ++ VA+K L + + +R +F +E ++GQ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARGLLYLH 594
L G + + +++ EF+ NG L SFL F ++ LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAP 651
E +H D+ +NIL++ + ++SDFGL++ L + S TS G K + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIA 677
E K T+ DV+S+G+++ E+++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 40/286 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G FG V +G + S VAVK KLDI EF +E + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 543 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGL 590
+G C E + +++ F+ +G L SFL G L L+T + F IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTSIRGTK 646
YL + IH D+ +N +L + ++DFGL+K + Q + K ++
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK--- 180
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
++A E + T+K DV++FGV + E IA R VE + I +D R+G
Sbjct: 181 -WIAIESLADRVYTSKSDVWAFGVTMWE-IATRGQTPYPGVENHEI-----YDYLRHGN- 232
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+CL++L + C + DP RPT K+ ++LE
Sbjct: 233 --------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 83/297 (27%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 485 VGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDG-EREFKN-----EVF-VIGQTH 535
+G G+FG V K T+ VAVK L D E++ + E+ +IG+
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK-- 74
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI------------- 582
HKN++ LLG C + +V E+ +G L FL P +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 583 ---AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639
A+Q+ARG+ +L S + IH D+ +N+L+ + + +I+DFGLA+ +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWAF 698
T+ R ++APE + T + DV+SFGVLL EI S Y I + F
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS-------PYPGIPVEELF 244
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
+ G ME C ++L + C E PS RPT K++++ L+ ++
Sbjct: 245 KLLKEGY-------RME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 7e-22
Identities = 74/276 (26%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----REFKNEVFVIGQTHHK 537
E +G GSFG VY+G+ AVK++ + ++ + E+ ++ + H
Sbjct: 6 ELLGSGSFGSVYEGL---NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARGLLYLH 594
N+V+ LG E N + E + G+LA L +G+ P L T QI GL YLH
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH 119
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
+H D+K NIL+D + +++DFG+AK + K S +G+ ++APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--SFAK-SFKGSPYWMAPEVI 173
Query: 655 -RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ D++S G +LE+ + + +E A + ++ G+ +
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPPW--SQLEGVAAV-------FKIGR-----SKE 219
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + D E + C+Q DPSLRPT ++L+
Sbjct: 220 LPPIPDHLSDEAKDFILK-CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 14/206 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRL 542
VGRG+FGIV+ + + V +K++ + + +D +NE V+ H N++
Sbjct: 8 VGRGAFGIVH---LCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCSSQ 600
E + ++V E+ GTLA ++ + T + F QI LL LH +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI---LLALHHVHTKL 121
Query: 601 IIHCDMKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
I+H D+K QNILLD H +I DFG++K+L+ SK+ ++ GT Y++PE
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEGKPY 178
Query: 660 TAKVDVYSFGVLLLEIIACRKSFDIE 685
K D+++ G +L E+ + +++F+
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 71/204 (34%), Positives = 105/204 (51%), Gaps = 16/204 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G FG V ++ T A KKLD + + GE+ NE ++ + + +V
Sbjct: 1 LGKGGFGEVCACQVKAT---GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 542 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCS 598
L + E ++ L LV +N G L ++ +P + I A QI GL +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+I++ D+KP+N+LLDDH N RISD GLA + L K IK GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRA-GTPGYMAPEVLQGEV 170
Query: 659 ITAKVDVYSFGVLLLEIIACRKSF 682
VD ++ G L E+IA R F
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDIVFQDG--EREFKNEVFVIGQTHHKN 538
++G+GSFG+V+K V R + V A+K++D+ + E +E V+ +
Sbjct: 5 LNKIGKGSFGVVFKVV----RKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHE 595
++R + +V E+ NG L L G P + QI GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLH- 118
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S +I+H D+K N+ LD + N +I D G+AKL L+ + +I GT Y++PE
Sbjct: 119 --SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCE 174
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715
+ K DV++ GV+L E + FD + A++ G + +
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDAN--NQGALILKII-----RGVFPPVSQMYSQ 227
Query: 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + C+ +D RP ++L+
Sbjct: 228 QLAQLIDQ---------CLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 75/289 (25%), Positives = 142/289 (49%), Gaps = 45/289 (15%)
Query: 484 EVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLV 540
E+G+GSFG+VY+G+ + T VA+K ++ ER EF NE V+ + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLF----------GNLKPNWNLRTNIAFQIARGL 590
RLLG +GQ L++ E + G L S+L P+ +A +IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG--- 647
YL+ +++ +H D+ +N ++ + + +I DFG+ + + ++ + +G KG
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR---KGGKGLLP 184
Query: 648 --YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
+++PE ++ T DV+SFGV+L EI A L + + N +
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQGMSNEQ 229
Query: 706 LDALV--GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ V GG ++ ++ C + L + C Q +P +RP+ +++ ++
Sbjct: 230 VLRFVMEGGLLDKPDN--CPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 34/218 (15%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI----VFQDGERE------FKNEVFVIG 532
E +G+G++G VY + TT +AVK++++ + R+ ++E+ +
Sbjct: 7 ELIGKGTYGRVYLALNVTT---GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARG 589
H N+V+ LGF + + L ++ E++ G++ S L +G + L Q+ G
Sbjct: 64 DLDHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ--LVRFFTEQVLEG 120
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-----KTSIRG 644
L YLH S I+H D+K N+L+D +ISDFG++K +S I S++G
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYDNDQNMSMQG 172
Query: 645 TKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRK 680
+ ++APE + +AKVD++S G ++LE+ A R+
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 481 FKEEVGRGSFGIVYKG--VIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHK 537
K E+G G+FG V+ G VAVK L + D ++F+ E ++ H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------I 582
N+V+ G C EG ++V+E++ +G L FL + P+ + I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH-GPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS- 641
A QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 128 AVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 642 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
IR ++ PE K T + DV+SFGV+L EI
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 3e-21
Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 53/292 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI---VFQDGERE-------FKNEVFVIG 532
E +G G+FG VYK ++ +A+K++++ F +RE +EV +I
Sbjct: 6 EHLGSGAFGCVYK--VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 533 -QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---------WNLRTNI 582
Q H N+VR E +V + + L F +LK WN I
Sbjct: 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWN----I 118
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
Q+ L YLH++ +I+H D+ P NI+L + I+DFGLAK Q ++ TS+
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSV 173
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702
GT Y PE +N K DV++FG +L ++ + F Y
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF------------------YS 215
Query: 703 NGKLD---ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
L +V E + + E + V C+ D RP I +V M+
Sbjct: 216 TNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 64/204 (31%), Positives = 104/204 (50%), Gaps = 23/204 (11%)
Query: 482 KEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFK----NEVFVIGQTHH 536
E++G G++G+VYK +T VA+KK I + E E+ ++ + H
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEI----VALKK--IRLDNEEEGIPSTALREISLLKELKH 57
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYL 593
N+V+LL + LV+E+ + L +L G L PN +++ I +Q+ RGL Y
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-IKS-IMYQLLRGLAYC 114
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S +I+H D+KPQNIL++ +++DFGLA+ + + T Y APE
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEI 169
Query: 654 FRNSKI-TAKVDVYSFGVLLLEII 676
SK + VD++S G + E+I
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 79/292 (27%), Positives = 125/292 (42%), Gaps = 53/292 (18%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTT--AVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G G+FG VY+G+ + VAVK L + + E +F E ++ + +H+N+VR
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--------NIAFQIARGLLYL 593
L+G E R ++ E + G L SFL N +P + A +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLREN-RPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNAR---ISDFGLAKLLTLNQSKTIKTSIRGTKG--- 647
E + IH D+ +N LL R I+DFG+A + I + KG
Sbjct: 133 EE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--------RDIYRASYYRKGGRA 181
Query: 648 -----YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702
++ PE F + T+K DV+SFGVLL EI + L +
Sbjct: 182 MLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYPGRT 226
Query: 703 NGKLDALV--GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
N ++ V GG ++ C + + C Q P RP +L+ ++
Sbjct: 227 NQEVMEFVTGGGRLDP--PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 66/214 (30%), Positives = 109/214 (50%), Gaps = 11/214 (5%)
Query: 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDIVFQDGEREFKNEVFVIGQ 533
EE F +++G+G+FG V + +T VAVKKL + R+F+ E+ ++
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 534 THHKNLVRLLGFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARG 589
H N+V+ G C G+ L LV E+L G+L +L + + + R + + QI +G
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKG 120
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGTKGY 648
+ YL S + +H D+ +NIL++ +I DFGL K+L ++ ++ +
Sbjct: 121 MEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKS 681
APE SK + DV+SFGV+L E+ KS
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 51/285 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
F +E+G G FG+V+ G + + VA+K + +G E +F E V+ + H
Sbjct: 8 FMKELGSGQFGVVHLGKWR----AQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHP 59
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLH 594
LV+L G C + + +V EF+ NG L ++L G L + L ++ + G+ YL
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL--SMCQDVCEGMEYLE 117
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAP 651
+ IH D+ +N L+ ++SDFG+ + + ++ TS G K + P
Sbjct: 118 R---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY----TSSSGAKFPVKWSPP 170
Query: 652 EWFRNSKITAKVDVYSFGVLLLEI-----IACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
E F SK ++K DV+SFGVL+ E+ + K + E+VE + F YR
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR----GFRLYRP--- 223
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ +M E VM S W E P RPT ++L+ +
Sbjct: 224 ------KLASMTVYE-----VMYSCW--HEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 38/274 (13%)
Query: 485 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQD--GEREFK---NEVFVIGQTHHKN 538
+G G FG V+KG+ I + VA+K QD G + F+ + + +G H
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIK----TIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHE 595
+VRLLG C G + LV + G+L + +L P N QIA+G+ YL E
Sbjct: 71 IVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQ--RLLNWCVQIAKGMYYLEE 127
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
++H ++ +NILL +I+DFG+A LL + K + + ++A E
Sbjct: 128 HR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL-DALVGGDM 714
+ T + DV+S+GV + E++ S+ E YA + R ++ D L G+
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM----SYG---AEPYAGM--------RPHEVPDLLEKGER 229
Query: 715 EAMNDVECLE-KLVMVSIWCIQEDPSLRPTIKKV 747
A + ++ +VMV W I E+ +RPT K++
Sbjct: 230 LAQPQICTIDVYMVMVKCWMIDEN--VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 8/197 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+++G GSFG+V +G T+ VAVK L D +F E ++ H+NL+R
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCSS 599
L G ++V E G+L L + ++ + T + A QIA G+ YL S
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SK 116
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK-GYVAPEWFRNSK 658
+ IH D+ +NILL +I DFGL + L N+ + + APE R
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176
Query: 659 ITAKVDVYSFGVLLLEI 675
+ DV+ FGV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 76/279 (27%), Positives = 130/279 (46%), Gaps = 37/279 (13%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
F +E+G G FG+V G + VA+K + ++G E EF E V+ + H+
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYD----VAIK----MIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHED 596
LV+L G C + + +V E+++NG L ++L + K + + + G+ YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE-- 117
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV---APEW 653
S Q IH D+ +N L+DD ++SDFGL++ + ++ TS G+K V PE
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEV 172
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
SK ++K DV++FGVL+ E+ + L ++ + N + V
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYS---------------LGKMPYERFNNSETVEKVSQG 217
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ EK+ + C E RPT +++L +E
Sbjct: 218 LRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 62/199 (31%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNLVRLL 543
+G+G FG VY G + + AVK L+ + E E F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 544 GFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCSS 599
G C EG L+V ++ +G L +F+ + N ++ I F Q+A+G+ YL S
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTSIRGTKGYVAPEWFRNS 657
+ +H D+ +N +LD+ + +++DFGLA+ + + ++ T + ++A E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 658 KITAKVDVYSFGVLLLEII 676
K T K DV+SFGVLL E++
Sbjct: 178 KFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 65/214 (30%), Positives = 113/214 (52%), Gaps = 25/214 (11%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDIVFQDGERE-------FKNEVFVIGQTH 535
+G GSFG VY G+ +S +AVK+ L V + E+ ++ +
Sbjct: 8 IGSGSFGSVYLGM---NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 536 HKNLVRLLGFCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLY 592
H+N+V+ LG + L ++ E++ G++A+ L +G + L N QI +GL Y
Sbjct: 65 HENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEET--LVRNFVRQILKGLNY 121
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN----QSKTIKTSIRGTKGY 648
LH + IIH D+K NIL+D+ +ISDFG++K L N ++ + S++G+ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
+APE + + T K D++S G L++E++ + F
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 6e-20
Identities = 81/294 (27%), Positives = 129/294 (43%), Gaps = 37/294 (12%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKL-DIVFQDGEREFKNEVFV 530
EL + F EE+G +FG +YKG + VA+K L DI EF+ E +
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---------------GNLKPN 575
+ + HH N+V LLG + Q +++E+LN G L FL G +K +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 576 WNLRT--NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633
+ +IA QIA G+ YL S +H D+ +NIL+ + + +ISD GL++ +
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAIL 693
++ ++ PE K ++ D++SFGV+L EI F + Y
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI------FSFGLQPYYGFS 231
Query: 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKV 747
+ R +L + D C ++ + C QE PS RP K +
Sbjct: 232 NQEVIEMVRKRQL-------LPCSED--CPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 59/194 (30%), Positives = 103/194 (53%), Gaps = 10/194 (5%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNLVR 541
E +G+GSFG V+KG+ T+ VA+K +D+ + E E + E+ V+ Q + +
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQ---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
G +G ++ E+L G+ L + + T + +I +GL YLH S +
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLH---SEKK 122
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
IH D+K N+LL + + +++DFG+A LT Q K + + GT ++APE + S +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIQQSAYDS 180
Query: 662 KVDVYSFGVLLLEI 675
K D++S G+ +E+
Sbjct: 181 KADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 33/229 (14%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV 530
Y LE F++ +G G+FG V K I+ A + + +D R+F E+ V
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 60
Query: 531 IGQT-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA-- 587
+ + HH N++ LLG C+ L E+ +G L FL + + L T+ AF IA
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANS 116
Query: 588 ------------------RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629
RG+ YL + Q IH D+ +NIL+ ++Y A+I+DFGL++
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 173
Query: 630 LTLNQSKTI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
+ KT+ + +R ++A E S T DV+S+GVLL EI++
Sbjct: 174 QEVYVKKTMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 76/276 (27%), Positives = 123/276 (44%), Gaps = 33/276 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
E +GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+VR
Sbjct: 1 ERIGRGNFGEVFSGRL---RADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCSS 599
L+G C + Q +V E + G +FL P ++ I A G+ YL
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLESKHC- 115
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK----GYVAPEWFR 655
IH D+ +N L+ + +ISDFG+++ + + S G K + APE
Sbjct: 116 --IHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715
+ +++ DV+SFG+LL E +F + V YA L+ N + + +
Sbjct: 170 YGRYSSESDVWSFGILLWE------AFSLGAV-PYANLS--------NQQTREAIEQGVR 214
Query: 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
C + + + C + DP RP+ V Q L
Sbjct: 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 16/197 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNLVR 541
E +G+GSFG VYKG+ T+ VA+K +D+ + E E + E+ V+ Q + R
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKE---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
G +G ++ E+L G+ L KP T IA +I +GL YLH S
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLH---S 119
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+ IH D+K N+LL + + +++DFG+A LT Q K + + GT ++APE + S
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSA 177
Query: 659 ITAKVDVYSFGVLLLEI 675
K D++S G+ +E+
Sbjct: 178 YDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
K E+G G+FG V+ VAVK L + ++F E ++ H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRT--------NIAFQ 585
+V+ G C EG ++V+E++ +G L FL + L N +IA Q
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
IA G++YL S +H D+ +N L+ ++ +I DFG+++ + +
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 185
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
++ PE K T + DV+S GV+L EI K Y + + +C G+
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ------PWYQLSNNEVIECITQGR 239
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ C +++ + + C Q +P +R IK++ +L+ + + S
Sbjct: 240 V---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
DNF + +G GS GIV I T +++ VAVKK+D+ Q NEV ++ H N
Sbjct: 22 DNFVK-IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+V + G +V EFL G L + + + N + + + L +LH +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLH---A 133
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+IH D+K +ILL ++SDFG ++ + + S+ GT ++APE
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLP 191
Query: 659 ITAKVDVYSFGVLLLEII 676
+VD++S G++++E++
Sbjct: 192 YGTEVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHH 536
F + +G GSFG V + + S A+K K IV NE ++ H
Sbjct: 4 EFIKTLGTGSFGRVM---LVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 596
LV L G + N LV E++ G L S L + + + A Q+ L YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH-- 118
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S I++ D+KP+N+LLD +I+DFG AK + K ++ GT Y+APE +
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-----KGRTYTLCGTPEYLAPEIILS 172
Query: 657 SKITAKVDVYSFGVLLLEIIA 677
VD ++ G+L+ E++A
Sbjct: 173 KGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 24/202 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNL 539
+++G G FG V+ G T VA+K L + G F E ++ Q H L
Sbjct: 12 KKLGAGQFGEVWMGYYN----GHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRL 63
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDC 597
VRL + + ++ E++ NG+L FL +K N ++A QIA G+ ++
Sbjct: 64 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-- 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWF 654
IH D++ NIL+ + +I+DFGLA+L+ N+ T+ G K + APE
Sbjct: 121 -KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIKWTAPEAI 175
Query: 655 RNSKITAKVDVYSFGVLLLEII 676
T K DV+SFG+LL EI+
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 67/228 (29%), Positives = 108/228 (47%), Gaps = 19/228 (8%)
Query: 473 ELEEATDNFKEEV--GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV 530
E E D E V G+G++GIVY +T+ +A+K++ + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVR---IAIKEIPERDSRYVQPLHEEIAL 58
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIA 587
H+N+V+ LG E + E + G+L++ L +G LK N QI
Sbjct: 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL 118
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLT-LNQSKTIKTSIRGT 645
GL YLH++ QI+H D+K N+L++ + +ISDFG +K L +N + GT
Sbjct: 119 EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---PCTETFTGT 172
Query: 646 KGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA 691
Y+APE A D++S G ++E+ + F IE+ E A
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-IELGEPQA 219
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 74/281 (26%), Positives = 137/281 (48%), Gaps = 35/281 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVRLL 543
+G G FG V G ++ VA+K L + + +R +F +E ++GQ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
G + + ++V E++ NG+L +FL F ++ LR IA G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSD-- 124
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWF 654
+H D+ +NIL++ + ++SDFGL+++L + T RG K + APE
Sbjct: 125 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTT--RGGKIPIRWTAPEAI 181
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714
K T+ DV+S+G+++ E+++ + EM + I + YR L A +
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA--IEEGYR---LPAPMD--- 233
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
C L + + C Q+D + RP ++++ +L+ ++
Sbjct: 234 -------CPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-19
Identities = 55/185 (29%), Positives = 85/185 (45%), Gaps = 25/185 (13%)
Query: 507 AVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVRLLGFCDEGQ---NRLL-VYEFL 559
VA+K L + E + F+ E + + +H N+V LL D G+ L V+E++
Sbjct: 5 EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALL---DSGEAPPGLLFAVFEYV 61
Query: 560 NNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---D 614
TL L G L R + Q+ L H I+H D+KPQNI++
Sbjct: 62 PGRTLREVLAADGALPAGETGR--LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTG 116
Query: 615 DHYNARISDFGLAKLL-----TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFG 669
+A++ DFG+ LL + T T + GT Y APE R +T D+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 670 VLLLE 674
++ LE
Sbjct: 177 LIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ +G G++G VYK T VA+K + + D + E+ ++ + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGEL---VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLA---SFLFGNLKPNWNLRTNIAF---QIARGLLYLH 594
G +V E+ G+L G L IA+ + +GL YLH
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS-----ELQIAYVCRETLKGLAYLH 118
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
E + IH D+K NILL + + +++DFG++ LT +K + S GT ++APE
Sbjct: 119 E---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK--RKSFIGTPYWMAPEVA 173
Query: 655 ---RNSKITAKVDVYSFGVLLLE 674
R K D+++ G+ +E
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 35/284 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
K E+G G+FG V+ VAVK L + ++F+ E ++ H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-----------GNLKPNWNLR----TNIA 583
+VR G C EG+ L+V+E++ +G L FL G L IA
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
QIA G++YL S +H D+ +N L+ +I DFG+++ + +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703
++ PE K T + D++SFGV+L EI K Y + A +C
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ------PWYQLSNTEAIECITQ 239
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKV 747
G+ E C ++ + C Q +P R IK +
Sbjct: 240 GR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-19
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH 535
E D+F + +G GS GIV I T + + VAVKK+D+ Q NEV ++ H
Sbjct: 22 EYLDSFIK-IGEGSTGIV---CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
H+N+V + G +V EFL G L + + + N + + R L YLH
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLH- 135
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
+ +IH D+K +ILL ++SDFG ++ K + S+ GT ++APE
Sbjct: 136 --NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVIS 191
Query: 656 NSKITAKVDVYSFGVLLLEII 676
+VD++S G++++E+I
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-19
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 16/197 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNLVR 541
E++G+GSFG V+KG+ T+ VA+K +D+ + E E + E+ V+ Q + +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQK---VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
G + ++ E+L G+ L +P T IA +I +GL YLH S
Sbjct: 67 YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 119
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+ IH D+K N+LL +H +++DFG+A LT Q K + + GT ++APE + S
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSA 177
Query: 659 ITAKVDVYSFGVLLLEI 675
+K D++S G+ +E+
Sbjct: 178 YDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--------REFKNEVFVIGQT 534
E+G G++G VYK + VA+KK + E RE + ++ Q
Sbjct: 5 AEIGEGAYGTVYKA---RDLNTGRFVALKK--VRVPLSEEGIPLSTLRE----IALLKQL 55
Query: 535 ---HHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAF 584
H N+VRLL C D LV+E ++ LA++L KP T ++
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
Q+ RG+ +LH S +I+H D+KPQNIL+ +I+DFGLA++ + + TS+
Sbjct: 115 QLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVV 168
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
T Y APE S VD++S G + E+
Sbjct: 169 TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
DNF + +G GS GIV I T ++S VAVKK+D+ Q NEV ++ H+N
Sbjct: 23 DNFIK-IGEGSTGIV---CIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+V + G +V EFL G L + + + N + + + L LH +
Sbjct: 79 VVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLH---A 134
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+IH D+K +ILL ++SDFG +++ + S+ GT ++APE
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLP 192
Query: 659 ITAKVDVYSFGVLLLEII 676
+VD++S G++++E++
Sbjct: 193 YGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 71/298 (23%), Positives = 128/298 (42%), Gaps = 52/298 (17%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----REFKNEVFVIGQTHHK 537
+++G G+FG VY + + VA+KK+ F E RE K + H
Sbjct: 5 KQLGDGTFGSVYLAR---NKETGELVAIKKMKKKFYSWEECMNLREVK---SLRKLNEHP 58
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF-------GNLKPNWNLRTNIAFQIARGL 590
N+V+L E V+E++ L+ G +R +I +QI +GL
Sbjct: 59 NIVKLKEVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIR-SIIYQILQGL 112
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
++H H D+KP+N+L+ +I+DFGLA+ + +S+ T T+ Y A
Sbjct: 113 AHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTRWYRA 166
Query: 651 PEWF-RNSKITAKVDVYSFGVLLLEIIACRKSF----DIEMVEEYAILT--------DWA 697
PE R++ ++ VD+++ G ++ E+ R F +I+ + Y I + DW
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL--YKICSVLGTPTKQDWP 224
Query: 698 FDCYR-----NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ Y+ + + + E + ++ ++ DP RPT + LQ
Sbjct: 225 -EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIK-DMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 1e-18
Identities = 61/196 (31%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVRL 542
E+G G+FG V KGV + R VA+K L + R E E ++ Q + +VR+
Sbjct: 2 ELGSGNFGCVKKGVYKM-RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---FQIARGLLYLHEDCSS 599
+G C E + +LV E + G L FL G K + +N+ Q++ G+ YL
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEG---K 114
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGTKGYVAPEWFRNSK 658
+H D+ +N+LL + + A+ISDFGL+K L + S +++ + + APE K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 659 ITAKVDVYSFGVLLLE 674
+++ DV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 64/197 (32%), Positives = 103/197 (52%), Gaps = 18/197 (9%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
++G+G FG V+ G T TT VA+K L E F E V+ + H+ LV+L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLY 67
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCSSQI 601
E + +V E+++ G+L FL G + L ++A QIA G+ Y+
Sbjct: 68 AVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 123
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWFRNSK 658
+H D++ NIL+ ++ +++DFGLA+L+ N+ T+ +G K + APE +
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR 179
Query: 659 ITAKVDVYSFGVLLLEI 675
T K DV+SFG+LL E+
Sbjct: 180 FTIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 60/271 (22%), Positives = 119/271 (43%), Gaps = 28/271 (10%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G+G+FG + + V K++++ + + R+ NE+ ++ H N++
Sbjct: 8 LGKGAFGE---ATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--FQIARGLLYLHEDCSSQ 600
+ L+ E+ N GTL + + + FQI + Y+H+ +
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
I+H D+K NI L ++ DFG++K+L ++ ++ GT Y++PE + K
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPELCQGVKYN 179
Query: 661 AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720
K D+++ G +L E++ +++FD + +V G+ + V
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------------KIVQGNYTPVVSV 224
Query: 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
E L+ + +Q+DP RPT +VL
Sbjct: 225 YSSE-LISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 79/291 (27%), Positives = 134/291 (46%), Gaps = 43/291 (14%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKN----EVFVIGQTHHKN 538
VG GS+G+V K + + VA+KK F + E + K E+ ++ Q H+N
Sbjct: 9 VGEGSYGMVMKC---KHKETGQIVAIKK----FLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYLHE 595
LV L+ + LV+EF+++ L PN + FQI RG+ + H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCH- 117
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF- 654
S IIH D+KP+NIL+ ++ DFG A+ TL + T T+ Y APE
Sbjct: 118 --SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYTDYVATRWYRAPELLV 173
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSF----DIEMVEEYAILTDWAFDCYRNGKL---- 706
++K VD+++ G L+ E++ F DI+ + Y I+ R+ ++
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQL--YHIIKCLGNLIPRHQEIFQKN 231
Query: 707 DALVGGDMEAMNDVECLEKL------VMVSIW--CIQEDPSLRPTIKKVLQ 749
G + + ++E LEK +++ + C++ DP RP+ ++L
Sbjct: 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 2e-18
Identities = 61/196 (31%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 485 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G+FG VYKG+ + T VA+K L + EF +E ++ H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW--NLRTNIAFQIARGLLYLHEDCSSQ 600
LG C +L V + + +G L ++ + K N L N QIA+G++YL E +
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEE---RR 129
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
++H D+ +N+L+ + +I+DFGLA+LL ++ + + ++A E K T
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 661 AKVDVYSFGVLLLEII 676
+ DV+S+GV + E++
Sbjct: 190 HQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 22/196 (11%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G+G FG V G + + VAVK K D Q F E V+ Q H NLV+L
Sbjct: 14 IGKGEFGDVMLGDYRGNK-----VAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQL 64
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
LG E + L +V E++ G+L +L G + + + + YL ++
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---AN 121
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
+H D+ +N+L+ + A++SDFGL K + Q T K ++ T APE R K
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-TGKLPVKWT----APEALREKKF 176
Query: 660 TAKVDVYSFGVLLLEI 675
+ K DV+SFG+LL EI
Sbjct: 177 STKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 47/296 (15%)
Query: 485 VGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHHKNLVR 541
+G G FG V K R T VAVK L E R+ +E ++ Q +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------------NWN 577
L G C + LL+ E+ G+L SFL + K
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
+ A+QI+RG+ YL E +++H D+ +N+L+ + +ISDFGL++ + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDW 696
++ R ++A E + T + DV+SFGVLL EI+ + Y I +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN-------PYPGIAPER 237
Query: 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
F+ + G ME + C E++ + + C +++P RPT + + LE
Sbjct: 238 LFNLLKTGY-------RMERPEN--CSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 34/210 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDIVFQDGERE-----FKNEVFVIGQTHH 536
++G G++G VYK T VA+KK+ + + E+E E+ ++ + H
Sbjct: 5 AQIGEGTYGQVYKA----RNKKTGELVALKKIRM---ENEKEGFPITAIREIKLLQKLRH 57
Query: 537 KNLVRLLGFC-DEGQNRL-LVYEFLN---NGTLAS----FLFGNLKPNWNLRTNIAFQIA 587
N+VRL +G+ + +V+E+++ G L S F +K Q+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-------CYMKQLL 110
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
GL YLH S+ I+H D+K NIL+++ +++DFGLA+ T ++ T+ T
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYT-KRNSADYTNRVITLW 166
Query: 648 YVAPEWFRNSKI-TAKVDVYSFGVLLLEII 676
Y PE + +VD++S G +L E+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G FG V ++ T ++K I + GE NE ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------- 597
+ E ++ L + L NG G+LK + F+ R + Y E C
Sbjct: 67 YAYETKDALCLVLTLMNG-------GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+I++ D+KP+NILLDDH + RISD GLA + + + +TIK + GT GY+APE +N
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRV-GTVGYMAPEVVKNE 176
Query: 658 KITAKVDVYSFGVLLLEIIACRKSF 682
+ T D ++ G LL E+IA + F
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDIVFQDG-EREFKN---EVFVIGQTHH 536
E +G+G++G VY G+ + +AVK+ LD E+E++ EV ++ H
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 594
N+V+ LG C + + EF+ G+++S L FG L P QI G+ YLH
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTK-QILDGVAYLH 119
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL---TLNQSKT-IKTSIRGTKGYVA 650
+C ++H D+K N++L + ++ DFG A+ L L+ + + + S+ GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEI 675
PE S K D++S G + E+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 67/202 (33%), Positives = 102/202 (50%), Gaps = 24/202 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+++G G FG V+ G T T VAVK L E F E ++ + H LV+L
Sbjct: 12 KKLGNGQFGEVWMG----TWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL 66
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLK-PNWNLRTNIAFQIARGLLYLHEDC 597
E + +V E+++ G+L FL LK PN ++A Q+A G+ Y+
Sbjct: 67 YAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL---VDMAAQVAAGMAYIER-- 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWF 654
IH D++ NIL+ D +I+DFGLA+L+ N+ T+ +G K + APE
Sbjct: 121 -MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAA 175
Query: 655 RNSKITAKVDVYSFGVLLLEII 676
+ T K DV+SFG+LL E++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 26/202 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
E +G+G+FG V+KG ++ T VAVK K D+ Q+ + +F +E ++ Q H N+V
Sbjct: 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIV 55
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHED 596
+L+G C + Q +V E + G SFL K L+T A A G+ YL
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFL---RKKKDELKTKQLVKFALDAAAGMAYLE-- 110
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK----GYVAPE 652
S IH D+ +N L+ ++ +ISDFG+++ Q S G K + APE
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPE 164
Query: 653 WFRNSKITAKVDVYSFGVLLLE 674
+ +++ DV+S+G+LL E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 50/210 (23%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN--EVFVIGQTHHKNLV 540
++G G++G+VYK + + VA+KK+ + F+ E+ ++ + +H N++
Sbjct: 5 GKIGEGTYGVVYKA---RDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNII 61
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCSS 599
+LL + LV+EF++ L + + + +Q+ +GL + H S
Sbjct: 62 KLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
I+H D+KP+N+L++ +++DFGLA+ + +R YV W+R ++
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF--------GSPVRPYTHYVVTRWYRAPEL 169
Query: 660 -------TAKVDVYSFGVLLLEIIACRKSF 682
+ VD++S G + E+++ R F
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLF 199
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 77/302 (25%), Positives = 130/302 (43%), Gaps = 47/302 (15%)
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTST--TAVAVKKLDIV-FQDGEREFK 525
F L+E T +GRG FG V+ + T V VK L ++ + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 526 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------LKP---NW 576
E+ + + HKN+VRLLG C E + ++ E+ + G L FL LKP +
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 577 NLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS- 635
+ + QIA G+ +L +++ +H D+ +N L+ ++S L+K N
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEY 172
Query: 636 ---KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692
+ +R ++APE + + K DV+SFGVL+ E+ F +
Sbjct: 173 YKLRNALIPLR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV------FTQG-ELPFYG 221
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQM 750
L+D L+ L G +E C +L +M W + +P RP+ +++
Sbjct: 222 LSDEEV-------LNRLQAGKLELPVPEGCPSRLYKLMTRCWAV--NPKDRPSFSELVSA 272
Query: 751 LE 752
L
Sbjct: 273 LG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 6e-18
Identities = 64/216 (29%), Positives = 115/216 (53%), Gaps = 29/216 (13%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKN 538
+++G+G++GIV+K + + T+ VA+KK+ F+ D +R F+ +F+ H N
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKE---VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 539 LVRLLGF--CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 596
+V+LL + ++ LV+E++ L + + N+ + + R I +Q+ + L Y+H
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRY-IMYQLLKALKYIH-- 124
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT---LNQSKTIKTSIRGTKGYVAPEW 653
S +IH D+KP NILL+ +++DFGLA+ L+ N + T YVA W
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD------YVATRW 177
Query: 654 FRNSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
+R +I T VD++S G +L E++ + F
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDIVFQDGEREFKN----EVFVIGQTHH 536
VG G++G+V K R T VA+KK + + + K EV V+ Q H
Sbjct: 7 GVVGEGAYGVVLK-----CRNKATGEIVAIKKFKES--EDDEDVKKTALREVKVLRQLRH 59
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYL 593
+N+V L LV+E++ TL L P + + +Q+ + + Y
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELL--EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S IIH D+KP+NIL+ + ++ DFG A+ L + + YVA W
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRW 166
Query: 654 FR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
+R ++ VDV++ G ++ E++ F
Sbjct: 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 9e-18
Identities = 58/177 (32%), Positives = 91/177 (51%), Gaps = 14/177 (7%)
Query: 508 VAVKKLDIVFQDGER---EFKNEVFVIGQTHHKNLVRLLGFCDEGQNR--LLVYEFLNNG 562
VAVK L + G + K E+ ++ +H+N+V+ G C E L+ EFL +G
Sbjct: 36 VAVKSLKP--ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSG 93
Query: 563 TLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620
+L +L N K NL+ A QI +G+ YL S Q +H D+ +N+L++ + +
Sbjct: 94 SLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149
Query: 621 ISDFGLAKLLTLNQS-KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
I DFGL K + ++ T+K + + APE SK DV+SFGV L E++
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 57/204 (27%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 483 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHH---K 537
E +GRG++G VY+G + T R VA+K +++ D + + + EV ++ Q
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRV----VALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL----YL 593
N+ + G +G ++ E+ G++ + + K I+ I R +L Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISV-IIREVLVALKYI 117
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H +IH D+K NIL+ + N ++ DFG+A LL N SK +++ GT ++APE
Sbjct: 118 H---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEV 172
Query: 654 FRNSKI-TAKVDVYSFGVLLLEII 676
K K D++S G+ + E+
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNL 539
+G G FG VY+GV + AVAVK K E+ F E +++ Q H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDC 597
V+L+G E +V E G L S+L N K + +L + I ++Q++ L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLE--- 124
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLL---TLNQSKTIKTSIRGTKGYVAPEWF 654
S + +H D+ +N+L+ ++ DFGL++ L + ++ K I+ ++APE
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESI 180
Query: 655 RNSKITAKVDVYSFGVLLLEII 676
+ T+ DV+ FGV + EI+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G FG V ++ T A KKLD + + GE+ E ++ + + +V
Sbjct: 1 LGKGGFGEVCAVQVKNT---GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L + + LV +N G L ++ G + + QI G+L+LH S
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
I++ DMKP+N+LLDD N R+SD GLA + L KTI T GT GY+APE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTI-TQRAGTNGYMAPEILKEEPY 171
Query: 660 TAKVDVYSFGVLLLEIIACRKSF 682
+ VD ++ G + E++A R F
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 534 THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQ 585
+V+ G F DE + + + E+ G+L S ++ +K R IA
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR-GGRIGEKVLGKIAES 113
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+ +GL YLH S +IIH D+KP NILL ++ DFG++ L + + T GT
Sbjct: 114 VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GT 166
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
Y+APE + + DV+S G+ LLE+ R F
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 43/212 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHHKNL 539
E++G GS+G VYK + + VA+K + + + + +E E+ ++ Q +
Sbjct: 7 ILEKLGEGSYGSVYKA---IHKETGQVVAIKVVPV---EEDLQEIIKEISILKQCDSPYI 60
Query: 540 VRLLGFCDEGQNRLLVYEF----------------LNNGTLASFLFGNLKPNWNLRTNIA 583
V+ G + + +V E+ L +A+ L+ LK
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK---------- 110
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
GL YLH S++ IH D+K NILL++ A+++DFG++ LT +K T I
Sbjct: 111 -----GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR-NTVI- 160
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
GT ++APE + K D++S G+ +E+
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 70/219 (31%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFK-NEVFVIGQTHH 536
NF +G+GSFG K ++ + + A+K K D++ QD + E E V+
Sbjct: 3 NFLMVLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 537 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF---QIARGL 590
+ L C + +RL V E++N G L + G K + F +IA GL
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK-----EPHAVFYAAEIAIGL 114
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
+LH S II+ D+K N++LD + +I+DFG+ K + KT +T GT Y+A
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRT-FCGTPDYIA 169
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
PE VD ++FGVLL E++A + FD E +E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF-KNEVFVIGQT-HHKNLVRL 542
+G+GSFG V ++ T AV V K D++ QD + E E V+ H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTD-ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
C + ++RL V E++N G L + + + + A +I GL +LHE I
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE---RGI 117
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
I+ D+K N+LLD + +I+DFG+ K L T ++ GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPYGP 175
Query: 662 KVDVYSFGVLLLEIIACRKSFDIE 685
VD ++ GVLL E++A + F+ +
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 3e-17
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRT-STTAV-AVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+ +G++G V+ + + T A+ +KK D++ ++ + E ++ Q +V+L
Sbjct: 1 ISKGAYGRVF--LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 543 L-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
F + +N LV E+L G LAS L G+L + +I L YLH S+
Sbjct: 59 YYSFQGK-KNLYLVMEYLPGGDLASLLENVGSLDEDV--ARIYIAEIVLALEYLH---SN 112
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI------KTSIRGTKGYVAPEW 653
IIH D+KP NIL+D + + +++DFGL+K+ + + + I GT Y+APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 654 FRNSKITAKVDVYSFGVLLLEII 676
+ VD +S G +L E +
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 480 NFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHHK 537
E +G G+ +VY + + VA+K++D+ E + EV + Q +H
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEK----VAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLH 594
N+V+ G LV +L+ G+L + + IA ++ +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL---TLNQSKTIKTSIRGTKGYVAP 651
S+ IH D+K NILL + + +I+DFG++ L K KT + GT ++AP
Sbjct: 120 ---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAP 175
Query: 652 EWFRNSK-ITAKVDVYSFGVLLLEII 676
E K D++SFG+ +E+
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 4e-17
Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G FG V R + A KKL+ I + GE NE ++ + + + +V
Sbjct: 8 LGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 542 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCS 598
L + E ++ L LV +N G L ++ P ++ + A +I GL LH
Sbjct: 65 L-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---R 120
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+I++ D+KP+NILLDD+ + RISD GLA + + + +TI+ + GT GY+APE +N +
Sbjct: 121 ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRV-GTVGYMAPEVVKNER 177
Query: 659 ITAKVDVYSFGVLLLEIIACRKSF 682
T D + G L+ E+I + F
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 67/274 (24%), Positives = 124/274 (45%), Gaps = 31/274 (11%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN----EVFVIGQTHHKNL 539
E+G G+ G+V K + R + +AVK + + + E+ ++ + + +
Sbjct: 8 ELGAGNSGVVSKVLH---RPTGKIMAVK---TIRLEINEAIQKQILRELDILHKCNSPYI 61
Query: 540 VRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDC 597
V G F + G + + E+++ G+L L + IA + +GL YLHE
Sbjct: 62 VGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK- 119
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+IIH D+KP NIL++ ++ DFG++ L + +KT GT Y+APE + +
Sbjct: 120 -HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGN 174
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
+ K D++S G+ L+E+ R + E I L +V +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE----------LLQYIVNEPPPRL 224
Query: 718 -NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ + V++ C+ +DP RP+ K++L+
Sbjct: 225 PSGKFSPDFQDFVNL-CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 44/98 (44%), Positives = 59/98 (60%), Gaps = 5/98 (5%)
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
QI GL +LH+ +II+ D+KP+N+LLD+ N RISD GLA L QSKT G
Sbjct: 105 QIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT--KGYAG 159
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
T G++APE + + VD ++ GV L E+IA R F
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+++G G FG V+ G ++T VAVK L + F E ++ H LVRL
Sbjct: 12 KKLGAGQFGEVWMGYYN----NSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRL 66
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHEDCSSQ 600
+ + ++ E++ G+L FL + L I F QIA G+ Y+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KN 123
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWFRNS 657
IH D++ N+L+ + +I+DFGLA+++ N+ T+ G K + APE
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIKWTAPEAINFG 179
Query: 658 KITAKVDVYSFGVLLLEII 676
T K DV+SFG+LL EI+
Sbjct: 180 SFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 68/224 (30%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVR 541
+G+GSFG V ++ T A+KK D+V +D + E + V + H L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALA-WEHPFLTH 60
Query: 542 LLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L FC ++ V E+LN G L + + + + A +I GL +LH
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH---KK 115
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
II+ D+K N+LLD + +I+DFG+ K + K ++ GT Y+APE + K
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAPEILKGQKY 173
Query: 660 TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703
VD +SFGVLL E++ + F E +E FD N
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE-VFVIGQTHHKNLVR 541
+ + +G+FG VY ++T +KK D++ ++ K E ++ Q + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L LV E+LN G AS + G L +W + IA ++ G+ LH+
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLHQR--- 116
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
IIH D+KP+N+L+D + +++DFGL++ N+ GT Y+APE
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGD 170
Query: 660 TAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
D +S G ++ E + F E +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 9e-17
Identities = 65/240 (27%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 481 FKEEVGRGSFGIVY----KGVIQTTRTSTTA-------VAVKKLDI-VFQDGEREFKNEV 528
KE++G G FG V+ +G+ + VAVK L V + +F E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNI----- 582
++ + + N++RLLG C ++ E++ NG L FL ++ + NI
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 583 ------AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636
A QIA G+ YL S +H D+ +N L+ +HY +I+DFG+++ L
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI-IACRKSFDIEMVEEYAILTD 695
I+ ++A E K T DV++FGV L E+ C++ + Y++L+D
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE-------QPYSLLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 31/221 (14%)
Query: 474 LEEATDNF--KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVI 531
L + T F E +G G++G VYK + T VA+K +DI+ +D E E K E ++
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQ---LVAIKIMDII-EDEEEEIKEEYNIL 56
Query: 532 GQ-THHKNLVRLLG-------FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN- 581
+ ++H N+ G ++ Q L LV E G++ + G K L+
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQ--LWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 582 IAF---QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
IA+ + RGL YLHE +++IH D+K QNILL + ++ DFG++ L +
Sbjct: 115 IAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR- 170
Query: 639 KTSIRGTKGYVAPEWF-----RNSKITAKVDVYSFGVLLLE 674
T I GT ++APE ++ A+ DV+S G+ +E
Sbjct: 171 NTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 485 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE-----REFKNEVFVIGQTHHKN 538
+G+G+FG VY + T R +AVK++ E + E+ ++ H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRE----LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHER 65
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
+V+ G + + + E++ G++ L +G L + QI G+ YLH
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGAL--TETVTRKYTRQILEGVEYLH-- 121
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S+ I+H D+K NIL D N ++ DFG +K L T+ S T S+ GT +++PE
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 656 NSKITAKVDVYSFGVLLLEII 676
K DV+S G ++E++
Sbjct: 181 GEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 46/226 (20%)
Query: 484 EVGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKN 538
++G+G+FG V++ G++ T VAVK L + D + +F+ E ++ + H N
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYE--PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN--------------------- 577
+V+LLG C G+ L++E++ G L FL P
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHR-SPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 578 --LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL------AKL 629
+ IA Q+A G+ YL E + +H D+ +N L+ ++ +I+DFGL A
Sbjct: 129 CTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
+++ I IR ++ PE ++ T + DV+++GV+L EI
Sbjct: 186 YKASENDAI--PIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVI--QTTRTSTTAVAVKKL-DIVFQDGEREFKNEVF 529
E+ +T F EE+G FG VYKG + T AVA+K L D EFK+E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 530 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--------GNLKPNWNLRT- 580
+ + H N+V LLG + Q +++ + ++ L FL G+ + +++
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 581 -------NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK-LLTL 632
+I QIA G+ +L S ++H D+ +N+L+ D N +ISD GL + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
+ K + S+ + +++PE K + D++S+GV+L E+ +
Sbjct: 178 DYYKLMGNSLLPIR-WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 79/288 (27%), Positives = 133/288 (46%), Gaps = 42/288 (14%)
Query: 485 VGRGSFGIVYKGV---IQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLV 540
+G G+FG VY+G I + VAVK L D E+ EF E ++ +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PNWNLR--TNIAFQIARGLLYL 593
+LLG C + + ++ E + G L S+L P L+ +I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 594 HEDCSSQIIHCDMKPQNILLDDH-YNAR----ISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
+ IH D+ +N L+ + Y+A I DFGLA+ + + + +
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708
+APE + K T + DV+SFGVL+ EI+ + + Y L + +
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ-------QPYPALNN----------QEV 222
Query: 709 L----VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
L GG ++ + C +K+ + C +DPS RPT ++ ++L+
Sbjct: 223 LQHVTAGGRLQKPEN--CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 470 SYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEV 528
S ELE +G G+ G VYK VI R + A+K + +D R+ E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYK-VIH--RPTGRLYALKVIYGNHEDTVRRQICREI 123
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
++ +H N+V+ D ++ EF++ G+L G + ++A QI
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----GTHIADEQFLADVARQILS 179
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
G+ YLH I+H D+KP N+L++ N +I+DFG++++ L Q+ S GT Y
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAY 234
Query: 649 VAPEWFRNSKITAKV----------DVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
++PE +I + D++S GV +LE R F + ++A L
Sbjct: 235 MSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM--CA 287
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
C +A E + + C C+Q +P+ R + ++LQ
Sbjct: 288 ICMSQPP-EAPATASREFRHFISC----------CLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 77/286 (26%), Positives = 125/286 (43%), Gaps = 41/286 (14%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G FG V +G + S VAVK K+ I + +F +E + + H N++RL
Sbjct: 7 LGEGEFGSVMEGQL-NQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRL 65
Query: 543 LGFCDEGQNR------LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGL 590
+G C + +++ F+ +G L SFL G+ + + F IA G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTSIRGTK 646
YL S IH D+ +N +L+++ N ++DFGL+K + Q + K ++
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK--- 179
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
++A E + T K DV+SFGV + E IA R VE I +D R G
Sbjct: 180 -WIAIESLADRVYTTKSDVWSFGVTMWE-IATRGQTPYPGVENSEI-----YDYLRQGN- 231
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+CL+ L + C +P RP+ + + LE
Sbjct: 232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 32/290 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDI-VFQDGEREFKNEVFVIGQTHHKNLV 540
+G G FG V T VAVK L Q +K E+ ++ +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 541 RLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLYLHED 596
+ G C E G+ L+ E++ G+L +L K NL + F QI G+ YLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLH-- 124
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL-TLNQSKTIKTSIRGTKGYVAPEWFR 655
S IH D+ +N+LLD+ +I DFGLAK + ++ ++ + A E +
Sbjct: 125 -SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 656 NSKITAKVDVYSFGVLLLEIIA-C------RKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708
+K + DV+SFGV L E++ C K F EM+ +L
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVV-------RLIE 235
Query: 709 LV--GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
L+ G + + ++M + W + + RPT + ++ +L+ +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMKNCW--ETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 82/286 (28%), Positives = 129/286 (45%), Gaps = 40/286 (13%)
Query: 478 TDNFKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN----EVFVI 531
NFK E +G+G F +VYK VA+KK+ I F+ + + + E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA---ICLLDGRVVALKKVQI-FEMMDAKARQDCLKEIDLL 56
Query: 532 GQTHHKNLVRLL-GFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRT--NIAFQ 585
Q H N+++ L F + N L +V E + G L+ + F K RT Q
Sbjct: 57 KQLDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-SIRG 644
+ L ++H S +I+H D+KP N+ + ++ D GL + + SKT S+ G
Sbjct: 115 LCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVG 168
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704
T Y++PE + K D++S G LL E+ A + F + + Y++ C +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKKIE 221
Query: 705 KLD-ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
K D + D + E L LV CI DP RP I VLQ
Sbjct: 222 KCDYPPLPADHYS----EELRDLVSR---CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 480 NFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIG 532
NF+ E++G G++G+VYK + + VA+KK+ + D E E E+ ++
Sbjct: 1 NFQKVEKIGEGTYGVVYKA---RNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLK 54
Query: 533 QTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPN--WNLRTNIAFQIARG 589
+ +H N+V+LL +N+L LV+EFL+ L F+ + L + FQ+ +G
Sbjct: 55 ELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG 112
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L + H S +++H D+KPQN+L++ +++DFGLA+ + + T Y
Sbjct: 113 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYR 167
Query: 650 APEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSF 682
APE K + VD++S G + E++ R F
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 85/315 (26%), Positives = 135/315 (42%), Gaps = 54/315 (17%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYK----GVIQTTRTSTTAVAVKKL--DIVFQD-----GE 521
EL + +G G FG V G+ + VAVK L D +D E
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSE 67
Query: 522 REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-- 579
E +IG+ HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 68 MEMMK---MIGK--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFD 122
Query: 580 --------------TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFG
Sbjct: 123 TCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFG 179
Query: 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FD 683
LA+ + T+ R ++APE + T + DV+SFGVLL EI S
Sbjct: 180 LARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 684 IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT 743
I + E + +L + G M+ C +L M+ C PS RPT
Sbjct: 240 IPVEELFKLLKE---------------GHRMD--KPANCTHELYMIMRECWHAVPSQRPT 282
Query: 744 IKKVLQMLEGVVEVS 758
K++++ L+ V+ V+
Sbjct: 283 FKQLVEDLDRVLTVT 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G VY + T VA+K++++ Q + NE+ V+ + H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
L G +V E+L G+L + + + + + L +LH S+Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 137
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
H D+K NILL + +++DFG +T QSK ++++ GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 663 VDVYSFGVLLLEII 676
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 26/220 (11%)
Query: 467 RCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE--- 523
RC S E E+ +G G++GIVY+ TS VA+KK V D ER+
Sbjct: 2 RCRSVTEFEKLN-----RIGEGTYGIVYRA---RDTTSGEIVALKK---VRMDNERDGIP 50
Query: 524 --FKNEVFVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR 579
E+ ++ H N+V L + LV E+ LAS L P +
Sbjct: 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQ 109
Query: 580 TN-IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ Q+ RGL YLHE+ IIH D+K N+LL D +I+DFGLA+ L
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 639 KTSIRGTKGYVAPE-WFRNSKITAKVDVYSFGVLLLEIIA 677
+ T Y APE + T +D+++ G +L E++A
Sbjct: 167 PKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 71/291 (24%), Positives = 129/291 (44%), Gaps = 40/291 (13%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA----VAVKKLDIVFQDGEREFKNEVFVIGQTHH 536
K E+G G+FG V+ + + S T VAVK L ++F+ E ++ H
Sbjct: 9 LKRELGEGAFGKVF--LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN------------LKPNWNL----RT 580
+++V+ G C +G ++V+E++ +G L FL + + L
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 126
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+IA QIA G++YL S +H D+ +N L+ + +I DFG+++ + +
Sbjct: 127 HIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700
++ PE K T + DV+SFGV+L EI K ++ I +C
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI------EC 237
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
G++ +E C +++ + + C Q +P R IK++ ++L
Sbjct: 238 ITQGRV-------LERPR--VCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 74/283 (26%), Positives = 125/283 (44%), Gaps = 29/283 (10%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG 532
E+ + ++++G G FG V+ T T VAVK + E F E V+
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVW----MATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMK 56
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARG 589
H LV+L + + ++ EF+ G+L FL G+ +P L + + QIA G
Sbjct: 57 TLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-IDFSAQIAEG 114
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
+ ++ + IH D++ NIL+ +I+DFGLA+++ N+ T + + +
Sbjct: 115 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWT 170
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
APE T K DV+SFG+LL+EI+ + M I YR + +
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA--LERGYRMPRPEN- 227
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
C E+L + + C + P RPT + + +L+
Sbjct: 228 ------------CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 35/220 (15%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQT-HHKN 538
F++ +G G+FG V + +I+ A A+K L + ++ R+F E+ V+ + HH N
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNA-AIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-------------- 584
++ LLG C+ + E+ G L FL + + L T+ AF
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 585 ------QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+A G+ YL E Q IH D+ +N+L+ ++ ++I+DFGL++ + KT+
Sbjct: 121 LLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177
Query: 639 -KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
+ +R ++A E S T K DV+SFGVLL EI++
Sbjct: 178 GRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 81/274 (29%), Positives = 123/274 (44%), Gaps = 33/274 (12%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
++G+G FG V+ G T TT VA+K L E F E ++ + H LV L
Sbjct: 13 KLGQGCFGEVWMG----TWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLY 67
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHEDCSSQI 601
E + +V EF+ G+L FL L ++A QIA G+ Y+
Sbjct: 68 AVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNY 123
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK---GYVAPEWFRNSK 658
IH D++ NIL+ D+ +I+DFGLA+L+ N+ T+ +G K + APE +
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEY----TARQGAKFPIKWTAPEAALYGR 179
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
T K DV+SFG+LL E++ + MV + R ++ G
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-----QVERGYRMPCPQG------- 227
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
C E L + C ++DP RPT + + LE
Sbjct: 228 ---CPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 4e-16
Identities = 67/201 (33%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVR 541
+G+GSFG V+ ++ T A+KK D+V D + E + V + H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKK-DVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 60
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
L +N V E+LN G L + K + T A +I GL +LH S I
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGI 117
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
++ D+K NILLD + +I+DFG+ K L +KT + GT Y+APE K
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKYNT 175
Query: 662 KVDVYSFGVLLLEIIACRKSF 682
VD +SFGVLL E++ + F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 16/209 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKK--LDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G+ GIV+K R + VA+KK L + + E+ + H +V+L
Sbjct: 8 IGEGAHGIVFKAKD---RETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-IAFQIARGLLYLHEDCSSQI 601
L G +LV E++ L+ L +P + + +G+ Y+H + I
Sbjct: 65 LDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KIT 660
+H D+KP N+L+ +I+DFGLA+L + + + + T+ Y APE + K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGARKYD 179
Query: 661 AKVDVYSFGVLLLEIIACRKSF----DIE 685
VD+++ G + E++ F DIE
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIE 208
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 20/209 (9%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGERE-----FKNEVFVIGQTHH 536
+++G G+F Y+ + +T T +AVK++ V E+E + E+ ++ + +H
Sbjct: 6 QQLGTGAFSSCYQA--RDVKTGTL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 594
+++R+LG E + L E++ G+++ L +G K + N Q+ RGL YLH
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE--AVIINYTEQLLRGLSYLH 120
Query: 595 EDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLT--LNQSKTIKTSIRGTKGYVAP 651
E+ QIIH D+K N+L+D RI+DFG A L + + + GT ++AP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRK 680
E R + DV+S G +++E +A K
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIE-MATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 73/290 (25%), Positives = 128/290 (44%), Gaps = 44/290 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G+G FG V + +++ S VAVK K DI EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 543 LGFC--DEGQNRL----LVYEFLNNGTLASFLF----GNLKPNWNLRTNIAF--QIARGL 590
+G + RL ++ F+ +G L +FL G L+T + F IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL----TLNQSKTIKTSIRGTK 646
YL S IH D+ +N +L+++ ++DFGL+K + Q K ++
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK--- 180
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCYRNG 704
++A E ++ T DV++FGV + EI+ ++ +E E Y
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY-------------- 225
Query: 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754
+ L+ G+ +CLE + + C +P RP+ + + LE +
Sbjct: 226 --NYLIKGN-RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 82/303 (27%), Positives = 134/303 (44%), Gaps = 54/303 (17%)
Query: 485 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKL--DIVFQD-----GEREFKNEVFVIGQ 533
+G G FG V G+ + T VAVK L D +D E E +IG+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK---MIGK 82
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------------ 581
HKN++ LLG C + ++ E+ + G L +L P N
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 582 ----IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 197
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTD 695
T+ R ++APE + T + DV+SFGVLL EI S + + E + +L +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
G M+ ++ C +L M+ C PS RPT K++++ L+ ++
Sbjct: 258 ---------------GHRMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
Query: 756 EVS 758
++
Sbjct: 301 ALT 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G VY + T VA+K++++ Q + NE+ V+ + + N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQE---VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
L G +V E+L G+L + + + + + L +LH S+Q+I
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLH---SNQVI 137
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
H D+K NILL + +++DFG +T QSK ++++ GT ++APE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 663 VDVYSFGVLLLEII 676
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 64/218 (29%), Positives = 111/218 (50%), Gaps = 17/218 (7%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLV 540
E++G G++G+VYK R + +A+KK+ + +D E+ ++ + H N+V
Sbjct: 8 EKIGEGTYGVVYKA---RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCS 598
RL + LV+E+L+ L + + N L +QI RG+ Y H S
Sbjct: 65 RLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---S 120
Query: 599 SQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+++H D+KPQN+L+D NA +++DFGLA+ + +T + T Y APE S
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWYRAPEILLGS 178
Query: 658 K-ITAKVDVYSFGVLLLEIIACRKSF--DIEMVEEYAI 692
+ + VD++S G + E++ + F D E+ E + I
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216
|
Length = 294 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
++G GS GIV I + S VAVK +D+ Q NEV ++ H+N+V +
Sbjct: 28 KIGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
G+ ++ EFL G L + + N + + + L YLH S +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663
D+K +ILL ++SDFG ++ + K + S+ GT ++APE + +V
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 664 DVYSFGVLLLEII 676
D++S G++++E++
Sbjct: 199 DIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI----VFQDGE-----REFKNEVFVIGQTH 535
+G G++ +VYK + T VA+KK+ + +DG RE K ++ +
Sbjct: 8 LGEGTYAVVYKA--RDKETGRI-VAIKKIKLGERKEAKDGINFTALREIK----LLQELK 60
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFL--------NNGTLASFLFGNLKPNWNLRTNIAFQIA 587
H N++ LL N LV+EF+ + ++ ++K +
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI-VLTPADIK-------SYMLMTL 112
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
RGL YLH S+ I+H D+KP N+L+ +++DFGLA+ + T T+
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRW 167
Query: 648 YVAPEWFRNSKI-TAKVDVYSFGVLLLEII 676
Y APE ++ VD++S G + E++
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 7e-16
Identities = 54/194 (27%), Positives = 100/194 (51%), Gaps = 9/194 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G VY + T VA++++++ Q + NE+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVAT---GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
L G +V E+L G+L + + + + + L +LH S+Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLH---SNQVI 138
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
H D+K NILL + +++DFG +T QSK ++++ GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 663 VDVYSFGVLLLEII 676
VD++S G++ +E+I
Sbjct: 197 VDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 481 FKEEVGRGSFGIVYK----GVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQT- 534
F + +G G+FG V + G+ ++ + VAVK L ERE +E+ ++
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSD--AVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF--QIARGLLY 592
+H+N+V LLG C G L++ E+ G L +FL + L ++F Q+A+G+ +
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
L S IH D+ +N+LL +I DFGLA+ + + + +K + R ++APE
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 213
Query: 653 WFRNSKITAKVDVYSFGVLLLEI 675
N T + DV+S+G+LL EI
Sbjct: 214 SIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-16
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 44/218 (20%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKNLVR 541
VG G++G V T VA+KKL FQ R ++ E+ ++ H+N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK---VAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIG 78
Query: 542 LLG-FC-----DEGQNRLLVYEF----LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 591
LL F ++ Q+ LV LNN + K + + + +QI RGL
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNN------IVKCQKLSDDHIQFLVYQILRGLK 132
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
Y+H S+ IIH D+KP NI +++ +I DFGLA+ T T GYVA
Sbjct: 133 YIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH----------TDDEMT-GYVAT 178
Query: 652 EWFRNSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
W+R +I VD++S G ++ E++ + F
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 85/316 (26%), Positives = 139/316 (43%), Gaps = 60/316 (18%)
Query: 485 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-------DIVFQDGEREFKNEVFVIGQ 533
+G G FG V + G+ ++ T VAVK L D+ E E +IG+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMK---LIGK 76
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----------- 582
HKN++ LLG C + ++ E+ G L FL P + +I
Sbjct: 77 --HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 583 -----AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 135 DLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYK 191
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS-FDIEMVEEYAILTDW 696
++ R ++APE + T + DV+SFG+L+ EI S + VEE
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL------ 245
Query: 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV-- 754
F R G M+ ++ C +L M+ C P+ RPT K++++ L+ V
Sbjct: 246 -FKLLREGH-------RMDKPSN--CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 755 ------VEVSVPPNPY 764
+++S+P Y
Sbjct: 296 AVSEEYLDLSMPFEQY 311
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVI 531
EL+ + + +G G FG + +G ++ VA+ L D +R F E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIAR 588
GQ H N+VRL G G ++V E+++NG L SFL G L + + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM--GMLPGLAS 118
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG- 647
G+ YL E +H + +L++ +IS F L ++S+ I T++ G
Sbjct: 119 GMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPV 172
Query: 648 -YVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
+ APE + ++ DV+SFG+++ E+++
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 78/298 (26%), Positives = 146/298 (48%), Gaps = 55/298 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIGQTHHK 537
E++G G++G+VYKG + + VA+KK+ + + E E E+ ++ + H
Sbjct: 6 EKIGEGTYGVVYKGR---NKKTGQIVAMKKIRL---ESEEEGVPSTAIREISLLKELQHP 59
Query: 538 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLY 592
N+V L + ++RL L++EFL+ L +L +L + + +QI +G+L+
Sbjct: 60 NIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
H S +++H D+KPQN+L+D+ +++DFGLA+ + + T T Y APE
Sbjct: 117 CH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVRVYTHEVVTLWYRAPE 171
Query: 653 WFRNS-KITAKVDVYSFGVLLLEIIACRKSF--DIEMVEEYAI----------------- 692
S + + VD++S G + E+ + F D E+ + + I
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231
Query: 693 LTDW--AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748
L D+ F ++ G L + V +++ + ++ LEK+++ DP+ R + KK L
Sbjct: 232 LPDYKNTFPKWKKGSLRSAV-KNLDE-DGLDLLEKMLIY-------DPAKRISAKKAL 280
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 68/238 (28%), Positives = 104/238 (43%), Gaps = 51/238 (21%)
Query: 480 NFKEEVGRGSFGIVY----KGVIQTTR---------TSTTAVAVKKLDIVFQDGER-EFK 525
NF E++G G FG V+ G+ + + VAVK L D R +F
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 526 NEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------------- 568
EV ++ + N+ RLLG C ++ E++ NG L FL
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 569 -FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627
F L +A QIA G+ YL S +H D+ +N L+ +Y +I+DFG++
Sbjct: 128 SFSTLL-------YMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 628 KLLTLNQSKTIKTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRK 680
+ L + ++ IR ++A E K T K DV++FGV L EI+ CR+
Sbjct: 178 RNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 50/194 (25%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G V+ + VA+K++++ Q + NE+ V+ + + N+V
Sbjct: 25 EKIGQGASGTVFTA---IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF 81
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
L G +V E+L G+L + + + + + L +LH ++Q+I
Sbjct: 82 LDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLH---ANQVI 137
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
H D+K N+LL + +++DFG +T QSK ++++ GT ++APE K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 663 VDVYSFGVLLLEII 676
VD++S G++ +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 60/201 (29%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G FG V ++ T ++K I + GE NE ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCSSQI 601
+ E ++ L LV +N G L ++ P + + A +I GL LH +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NT 123
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
++ D+KP+NILLDD+ + RISD GLA + + + ++I+ + GT GY+APE N + T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 662 KVDVYSFGVLLLEIIACRKSF 682
D + G L+ E+I + F
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G FG V ++ T ++K I + GE NE ++ + + + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDCSSQI 601
+ E ++ L LV +N G L ++ P ++ + I A ++ GL L + +I
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
++ D+KP+NILLDD + RISD GLA + + + +T++ + GT GY+APE N K T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRV-GTVGYMAPEVINNEKYTF 180
Query: 662 KVDVYSFGVLLLEIIACRKSF 682
D + G L+ E+I + F
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 29/212 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREF-KNEVFVIGQTHHKNLVRL 542
+G GSFG +Y + ++ + +K++D+ E+E K EV ++ + H N+V
Sbjct: 8 IGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLLY 592
E +V E+ + G L + N + + F QI+ GL +
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRI--------NRQRGVLFSEDQILSWFVQISLGLKH 116
Query: 593 LHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+H+ +I+H D+K QNI L + A++ DFG+A+ LN S + + GT Y++P
Sbjct: 117 IHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR--QLNDSMELAYTCVGTPYYLSP 171
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
E +N K D++S G +L E+ + F+
Sbjct: 172 EICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 485 VGRGSFGIVYK----GVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQT-HHKN 538
+G G FG V G+ + VAVK L D + + +E+ ++ HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA--------------- 583
++ LLG C + ++ E+ + G L +L P +IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 584 -FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+Q+ARG+ YL S + IH D+ +N+L+ ++ +I+DFGLA+ + T+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
R ++APE + T + DV+SFGVL+ EI S I + E + +L +
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 254
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
G M+ C +L M+ C PS RPT K++++ L+ ++ ++
Sbjct: 255 ----------GHRMD--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 40/213 (18%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVR 541
+G G++G+V V RT VA+KK+ VF D +R + E+ ++ H+N++
Sbjct: 8 IGSGAYGVVCSAV--DKRTGRK-VAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIG 63
Query: 542 LLG-FCDEGQNRL----LVYEFLNNGT-LASFLFGNLKPNWNLRTN----IAFQIARGLL 591
LL +V E + T L + K L + +QI RGL
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELM--ETDLHKVI----KSPQPLTDDHIQYFLYQILRGLK 117
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGTKGYVA 650
YLH S+ +IH D+KP NIL++ + + +I DFGLA+ + ++ K T YV
Sbjct: 118 YLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------EYVV 168
Query: 651 PEWFR-------NSKITAKVDVYSFGVLLLEII 676
W+R +S+ T +D++S G + E++
Sbjct: 169 TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 73/289 (25%), Positives = 125/289 (43%), Gaps = 57/289 (19%)
Query: 488 GSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIGQTHHKNLVR 541
G+FG ++ G+ I V VK + +D E E ++ H+N++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTV----KDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 542 LLGFCDEGQNRLLV-YEFLNNGTLASFL-FGNLKPNWNLRT-------NIAFQIARGLLY 592
+L C E V Y ++N G L FL L N + ++A QIA G+ Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK--------LLTLNQSKTIKTSIRG 644
LH +IH D+ +N ++D+ +I+D L++ L N+++ +K
Sbjct: 133 LH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK----- 184
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCYR 702
++A E N + ++ DV+SFGVLL E++ ++ +I+ E A L D YR
Sbjct: 185 ---WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG----YR 237
Query: 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
+ + C ++L V C DP RP+ +++Q L
Sbjct: 238 LAQ-------------PINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 28/213 (13%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGER-EFKNEVFVIGQTHHKNLV 540
+++G GSFG K ++ ++ +K+++I ER E + EV V+ H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 590
+ +E N +V ++ G L + N + + F QI L
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKI--------NAQRGVLFPEDQILDWFVQICLAL 114
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
++H+ +I+H D+K QNI L ++ DFG+A++L + + +T I GT Y++
Sbjct: 115 KHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCI-GTPYYLS 169
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
PE N K D+++ G +L E+ + +F+
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 63/228 (27%), Positives = 112/228 (49%), Gaps = 38/228 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIGQTHHK 537
E++G G++G+VYK + + VA+KK+ + + E E E+ ++ + +H
Sbjct: 5 EKIGEGTYGVVYKA---RDKLTGEIVALKKIRL---ETEDEGVPSTAIREISLLKELNHP 58
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----AFQIARGLLYL 593
N+VRLL LV+EFL+ L ++ + P L + +Q+ +G+ Y
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG------TKG 647
H S +++H D+KPQN+L+D +++DFGLA+ + +R T
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV--------PVRTYTHEVVTLW 164
Query: 648 YVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSF--DIEMVEEYAI 692
Y APE S+ + VD++S G + E++ R F D E+ + + I
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRI 212
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 67/216 (31%), Positives = 109/216 (50%), Gaps = 35/216 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQT-HHKNLVRL 542
+G G+FG V K I+ A A+K++ + +D R+F E+ V+ + HH N++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF------------------ 584
LG C+ L E+ +G L FL + + L T+ AF
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 585 --QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KTS 641
+ARG+ YL + Q IH D+ +NIL+ ++Y A+I+DFGL++ + KT+ +
Sbjct: 118 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
+R ++A E S T DV+S+GVLL EI++
Sbjct: 175 VR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 56/217 (25%), Positives = 113/217 (52%), Gaps = 26/217 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVR 541
E++G G++ V+KG ++ + VA+K++ + ++G EV ++ H N+V
Sbjct: 12 EKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L ++ LV+E+L+ L ++ GN+ N++ + +QI RGL Y H
Sbjct: 69 LHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCHR---R 123
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR---- 655
+++H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 175
Query: 656 ---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+S+ + ++D++ G + E+ + R F VE+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 485 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G+FG VYKG+ I VA+K+L + +E +E +V+ + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
LG C +L + + + G L ++ N+ + L N QIA+G+ YL E
Sbjct: 75 LGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLL--NWCVQIAKGMNYLEE---R 128
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
+++H D+ +N+L+ + +I+DFGLAKLL ++ + + ++A E +
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188
Query: 660 TAKVDVYSFGVLLLEII 676
T + DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV--AVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G FG V ++ + T VKK IV + +E ++ + +H +V+L
Sbjct: 1 LGVGGFGRVEL--VKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58
Query: 543 L-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
F D+ + ++ E+ G L + L G + R IA + YLH +
Sbjct: 59 YRTFKDK-KYIYMLMEYCLGGELWTILRDRGLF-DEYTARFYIA-CVVLAFEYLH---NR 112
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
II+ D+KP+N+LLD + ++ DFG AK L +S + GT YVAPE N
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGY 169
Query: 660 TAKVDVYSFGVLLLEII 676
VD +S G+LL E++
Sbjct: 170 DFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 58/217 (26%), Positives = 112/217 (51%), Gaps = 26/217 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVR 541
+++G G++ V+KG ++ + VA+K++ + ++G EV ++ H N+V
Sbjct: 11 DKLGEGTYATVFKG---RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L + LV+E+L++ L +L GNL N++ FQ+ RGL Y H+
Sbjct: 68 LHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHK---R 122
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR---- 655
+I+H D+KPQN+L+++ +++DFGLA+ +K++ T + V W+R
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR------AKSVPTKTYSNE--VVTLWYRPPDV 174
Query: 656 ---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+++ + +D++ G +L E+ R F V+E
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 70/218 (32%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTT---AVAVKKLDIVFQDGEREFKN-EVFVIGQTH 535
NF +G+GSFG V+ R T A+ + K D+V QD + E E V+ +
Sbjct: 3 NFLMVLGKGSFG----KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 536 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLK-PNWNLRTNIAFQIARGLL 591
+ L C + +RL V E++N G L + G K P+ A +IA GL
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH---AVFYAAEIAIGLF 115
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+LH S II+ D+K N++LD + +I+DFG+ K + T + GT Y+AP
Sbjct: 116 FLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT--KTFCGTPDYIAP 170
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
E VD ++FGVLL E++A + F+ E +E
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/217 (27%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNLVR 541
+++G G++ VYKG ++ + VA+K++ + ++G EV ++ H N+V
Sbjct: 12 DKLGEGTYATVYKG---RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L ++ LV+E+L+ L +L GN N++ + FQ+ RGL Y H
Sbjct: 69 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCHR---R 123
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
+++H D+KPQN+L+++ +++DFGLA+ +K+I T + V W+R I
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNE--VVTLWYRPPDI 175
Query: 660 -------TAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+ ++D++ G + E+ R F VEE
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
E+G G+FG VYK + + A K + I ++ +F E+ ++ + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQ---HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 544 -GFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCSSQI 601
+ E + +L+ EF + G L S + + + Q+ L +LH S ++
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKV 124
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP-----EWFRN 656
IH D+K NILL + +++DFG++ K + + GT ++AP E F++
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKD 182
Query: 657 SKITAKVDVYSFGVLLLEI 675
+ K D++S G+ L+E+
Sbjct: 183 NPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 56/196 (28%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
VG G+FG V+ R S A+K + +++ E+ NE V+ + H ++R
Sbjct: 9 VGTGTFGRVHLV---RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIR 65
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
L + + ++ E++ G L S+L + + + + A +I L YLH S +I
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH---SKEI 122
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
++ D+KP+NILLD + +++DFG AK L + +T ++ GT Y+APE ++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRT--WTLCGTPEYLAPEVIQSKGHNK 177
Query: 662 KVDVYSFGVLLLEIIA 677
VD ++ G+L+ E++
Sbjct: 178 AVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 22/174 (12%)
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
LL +H S +IH D+K NILL + ++ DFG +K+ S + + GT YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
APE +R + K D++S GVLL E++ ++ FD E +EE T G+ D L
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT-------LAGRYDPL 265
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM------LEGVVEV 757
M ++ V+ + DP RP+ K+L M + G++E+
Sbjct: 266 PPSISPEMQEI--------VTA-LLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN--EVFVIGQTH---HKN 538
E+G G++G V+K + + VA+K++ + + EV V+ H N
Sbjct: 8 EIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 539 LVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLL 591
+VRL C D LV+E ++ L ++L +P T ++ FQ+ RGL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+LH S +++H D+KPQNIL+ +++DFGLA++ + + TS+ T Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAP 178
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
E S VD++S G + E+ + F
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 29/212 (13%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+E+G G FG V G S V VK+L D + F EV + +H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHED 596
LG C E LLV EF G L ++L N ++ +A ++A GLL+LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS------IRGTKGYVA 650
+ IH D+ +N L + +I D+GLA L T +R ++A
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR----WLA 170
Query: 651 PEW-------FRNSKITAKVDVYSFGVLLLEI 675
PE T K +++S GV + E+
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 40/224 (17%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI-VFQDG-----EREFKNEVFVIGQ 533
++G G+FG VYK T VA+KK+ + +DG RE K ++ +
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGR---VVALKKILMHNEKDGFPITALREIK----ILKK 63
Query: 534 THHKNLVRLLGFC-----DEGQNRLLVY--EFLNNGTLASFLFGNLKPNWNLR----TNI 582
H N+V L+ + R VY + L+ L N P+ L
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-EN--PSVKLTESQIKCY 120
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
Q+ G+ YLHE + I+H D+K NIL+D+ +I+DFGLA+
Sbjct: 121 MLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177
Query: 643 RGTKGY---VAPEWFR-------NSKITAKVDVYSFGVLLLEII 676
GT+ Y V W+R + T VD++ G + E+
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 29/216 (13%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTHHK 537
E+G+G++GIV + VA+KK+ VF RE K G HK
Sbjct: 7 ELGQGAYGIVCS-ARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HK 62
Query: 538 NLVRL--LGFCDEGQ-NRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYL 593
N+ L + G N L +YE L L + G + + ++ I +QI GL Y+
Sbjct: 63 NITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYI 121
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S+ ++H D+KP N+L++ +I DFGLA+ + N + YVA W
Sbjct: 122 H---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF----MTEYVATRW 174
Query: 654 FR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
+R T +DV+S G +L E++ + F
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNL 539
E +G G++G+V + + VA+KK+ F +R + E+ ++ H N+
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKK---VAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNI 66
Query: 540 VRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
+ + + ++ +V + L L + + +Q+ RGL Y+H
Sbjct: 67 IAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH- 124
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS--KTIKTSIRGTKGYVAPE- 652
S+ +IH D+KP N+L+++ RI DFG+A+ L+ + + K T T+ Y APE
Sbjct: 125 --SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL 182
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
+ T +D++S G + E++ R+ F
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEMLGRRQLF 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 5e-14
Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 25/208 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLVR 541
E VG G++G VYKG + +T A A+K +D+ D E E K E+ ++ + +HH+N+
Sbjct: 12 ELVGNGTYGQVYKG--RHVKTGQLA-AIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 542 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLY 592
G F + + LV EF G++ L N K N IA+ +I RGL +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH+ ++IH D+K QN+LL ++ ++ DFG++ L+++ + + GT ++APE
Sbjct: 127 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPE 181
Query: 653 WFR-----NSKITAKVDVYSFGVLLLEI 675
++ K D++S G+ +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 8/214 (3%)
Query: 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHH 536
NF +G+GSFG V + T A+ + K D+V QD + E E V+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT-DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK 59
Query: 537 KNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
+ L C + +RL V E++N G L + K A +I+ GL +LH
Sbjct: 60 PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR 119
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
II+ D+K N++LD + +I+DFG+ K ++ T + GT Y+APE
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT--RTFCGTPDYIAPEIIA 174
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
VD +++GVLL E++A + FD E +E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 10/215 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK-NEVFVIGQTHHKNLVRLL 543
+G+GSFG V ++ + AV V K D++ QD + E E ++ + + L
Sbjct: 3 LGKGSFGKVMLARLKESG-RLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 544 GFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
C + +RL V EF+N G L + + + + A +I L++LH+ II
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGII 118
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
+ D+K N+LLD + +++DFG+ K N T ++ GT Y+APE +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLYGPS 176
Query: 663 VDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTD 695
VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 58/212 (27%), Positives = 112/212 (52%), Gaps = 20/212 (9%)
Query: 480 NFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK-NEVFVIGQTHH 536
NFK E++G G++ VYKG RT+ VA+K++ + ++G E+ ++ + H
Sbjct: 1 NFKQLEKLGEGTYATVYKG---RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGLL 591
+N+VRL +LV+E+++ L ++ G L PN + +Q+ +G+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPN--TVKSFTYQLLKGIA 114
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+ HE+ +++H D+KPQN+L++ +++DFGLA+ + + + T Y AP
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 652 EWFRNSKI-TAKVDVYSFGVLLLEIIACRKSF 682
+ S+ + +D++S G ++ E+I R F
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 64/267 (23%), Positives = 122/267 (45%), Gaps = 22/267 (8%)
Query: 485 VGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G G+FG VYKG+ I VA+K L + +E +E +V+ + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
LG C +L V + + G L ++ N + N QIA+G+ YL E ++
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRL 130
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
+H D+ +N+L+ + +I+DFGLA+LL +++++ + ++A E + + T
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTH 190
Query: 662 KVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721
+ DV+S+GV + E++ +F + +D ++ L+
Sbjct: 191 QSDVWSYGVTVWELM----TFGAK-----------PYDGIPAREIPDLLEKGERLPQPPI 235
Query: 722 CLEKLVMVSIWCIQEDPSLRPTIKKVL 748
C + M+ + C D RP ++++
Sbjct: 236 CTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 64/199 (32%), Positives = 103/199 (51%), Gaps = 17/199 (8%)
Query: 485 VGRGSFGIVY--KGVIQTTRTSTTAVAV-KKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+GSFG V+ + + A+ V KK + +D R K E ++ + +H +V+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62
Query: 542 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDC 597
L F EG+ L+ +FL G L + L K ++ F ++A L +LH
Sbjct: 63 LHYAFQTEGK-LYLILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
S II+ D+KP+NILLD+ + +++DFGL+K ++ K S GT Y+APE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY--SFCGTVEYMAPEVVNRR 173
Query: 658 KITAKVDVYSFGVLLLEII 676
T D +SFGVL+ E++
Sbjct: 174 GHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVR 541
VG G+FG+V Q T VA+KK+ F +R ++ E+ ++ H+N++
Sbjct: 18 VGMGAFGLVCSARDQLT---GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIIS 73
Query: 542 LLG-FCDEGQNRLLVYEFLNNGT-LASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
L F ++ V E L GT L L L+ + +QI RGL Y+H S
Sbjct: 74 LSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQF--IQYFLYQILRGLKYVH---S 126
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE----WF 654
+ ++H D+KP NIL++++ + +I DFGLA++ Q + T T+ Y APE W
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQM-TGYVSTRYYRAPEIMLTW- 180
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTD 695
K +VD++S G + E++ + F + V +++I+TD
Sbjct: 181 --QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK-TSI 642
+QI RGL Y+H S+ ++H D+KP N+LL+ + + +I DFGLA++ T T
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 643 RGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSF 682
T+ Y APE NSK T +D++S G +L E+++ R F
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 66/231 (28%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 460 GTIETNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF 517
G N + L + TD ++ E +G+G++G VYK T + + AVK LD +
Sbjct: 3 GLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYK---VTNKKDGSLAAVKILDPI- 58
Query: 518 QDGEREFKNEVFVIGQ-THHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFG 570
D + E + E ++ +H N+V+ G GQ LV E N G++ + G
Sbjct: 59 SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKG 117
Query: 571 NLKPNWNL-RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629
L L I++ + LL L +++IIH D+K NILL ++ DFG++
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 630 LTLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEI 675
LT + + TS+ GT ++APE + A+ DV+S G+ +E+
Sbjct: 178 LTSTRLRR-NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 64/226 (28%), Positives = 111/226 (49%), Gaps = 32/226 (14%)
Query: 472 KELEEATDNFKE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKN 526
K + E D +++ +VG G++G V + RT VA+KKL FQ +R ++
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSAL--DRRTGAK-VAIKKLYRPFQSELFAKRAYR- 63
Query: 527 EVFVIGQTHHKNLVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 580
E+ ++ H+N++ LL D + LV F+ GT L + K + +
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQ 121
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+ +Q+ +GL Y+H ++ IIH D+KP N+ +++ +I DFGLA+ Q+ + T
Sbjct: 122 FLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMT 173
Query: 641 SIRGTKGYVAPE----WFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
T+ Y APE W T VD++S G ++ E++ + F
Sbjct: 174 GYVVTRWYRAPEVILNWMH---YTQTVDIWSVGCIMAEMLTGKPLF 216
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 63/208 (30%), Positives = 111/208 (53%), Gaps = 25/208 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLVR 541
E VG G++G VYKG + +T A A+K +D+ +D E E K E+ ++ + +HH+N+
Sbjct: 22 EVVGNGTYGQVYKG--RHVKTGQLA-AIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 542 LLG-FCDE---GQNR--LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLY 592
G F + G + LV EF G++ L N K N IA+ +I RGL +
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH + ++IH D+K QN+LL ++ ++ DFG++ L+++ + + GT ++APE
Sbjct: 137 LH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMAPE 191
Query: 653 WFR-----NSKITAKVDVYSFGVLLLEI 675
++ + D++S G+ +E+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK----NEVFVIG---QTHH 536
E+G G++G VYK S VA+K + + Q E EV ++ H
Sbjct: 7 EIGVGAYGTVYKA---RDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 537 KNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARG 589
N+VRL+ C D LV+E ++ L ++L P T ++ Q RG
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L +LH +C I+H D+KP+NIL+ +++DFGLA++ + + T + T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYR 174
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEI 675
APE S VD++S G + E+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 43/214 (20%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK------NEVFVIGQTHH 536
++G GS+G+V+K R + VA+KK F + E + E+ ++ Q H
Sbjct: 7 SKIGEGSYGVVFKC---RNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQLKH 59
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLH 594
NLV L+ + LV+E+ ++ T+ + L N + P ++ I +Q + + + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCH 117
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG----YVA 650
IH D+KP+NIL+ ++ DFG A++LT G YVA
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILT------------GPGDDYTDYVA 162
Query: 651 PEWFR-------NSKITAKVDVYSFGVLLLEIIA 677
W+R +++ VDV++ G + E++
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVR 541
+GRG++GIV + VA+KK+ F D +R + E+ ++ H+N++
Sbjct: 13 IGRGAYGIVCSAK---NSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIA 68
Query: 542 LLGFCDEGQNR-----LLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLY 592
+ +VYE ++ L ++ + L + +Q+ RGL Y
Sbjct: 69 IKDIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
+H S+ ++H D+KP N+LL+ + + +I DFGLA+ T ++ T T+ Y APE
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178
Query: 653 WFRN-SKITAKVDVYSFGVLLLEII 676
N S+ T +DV+S G + E++
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVR 541
+G+GSFG V ++ A+KK D+V D + E + V + + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKK-DVVLIDDDVECTMVEKRVLALAW-ENPFLTH 60
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
L ++ V EFLN G L + + + T A +I GL +LH S I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
I+ D+K N++LD + +I+DFG+ K ++ ++ GT Y+APE + K T
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKYTF 175
Query: 662 KVDVYSFGVLLLEIIACRKSF 682
VD +SFGVLL E++ + F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 37/220 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK---NEVFVIGQTHHK 537
F VG+GS+G V + RT +KKL++ RE K E ++ Q H
Sbjct: 4 FVRVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLR-NASRRERKAAEQEAQLLSQLKHP 59
Query: 538 NLVR--------------LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 583
N+V ++GFC+ G +Y L G L P N
Sbjct: 60 NIVAYRESWEGEDGLLYIVMGFCEGGD----LYHKLKEQK------GKLLPE-NQVVEWF 108
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
QIA L YLHE I+H D+K QN+ L ++ D G+A++L NQ T I
Sbjct: 109 VQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLI- 163
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
GT Y++PE F N K DV++ G + E+ + +F+
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 66/277 (23%), Positives = 119/277 (42%), Gaps = 24/277 (8%)
Query: 480 NFKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK 537
NF+ E +GRG F VY+ R V+ +++ ++ E+ ++ Q +H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARGLLYL 593
N+++ L E +V E + G L+ + F K RT + Q+ + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S +++H D+KP N+ + ++ D GL + + T S+ GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPER 177
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ K D++S G LL E+ A + F + + +++ C + + D
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL-------CQK------IEQCD 224
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ EKL + CI DP RP I V Q+
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLV 540
+E+G G FG V G + + + V VK+L + Q+ + +F E H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQE-QMKFLEEAQPYRSLQHSNLL 58
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHE 595
+ LG C E LLV EF G L +L + P+ +A +IA GLL+LH+
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629
+ IH D+ +N LL +I D+GL+
Sbjct: 119 N---NFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
E+G G+FG VYK Q T A A K +D ++ ++ E+ ++ H N+V+LL
Sbjct: 12 ELGDGAFGKVYKA--QNKETGVLAAA-KVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF-QIARGLLYLHEDCSSQII 602
N ++ EF G + + + +P + + Q L YLHE ++II
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTSIRGTKGYVAPEWF-----R 655
H D+K NIL + +++DFG++ ++TI + S GT ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 656 NSKITAKVDVYSFGVLLLEI 675
+ K DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNE 527
F+ ++L++ E+GRG+FG V K + + S T +AVK++ V + ++ +
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKML---HKPSGTIMAVKRIRSTVDEKEQKRLLMD 52
Query: 528 VFVIGQTHH-KNLVRLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW- 576
+ V+ ++ +V+ G C E L+ L+ +++ LK
Sbjct: 53 LDVVMRSSDCPYIVKFYGALFREGDCWICME-----LMDISLDK--FYKYVYEVLKSVIP 105
Query: 577 -NLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
+ IA + L YL E+ +IIH D+KP NILLD + N ++ DFG++ L
Sbjct: 106 EEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VD 160
Query: 636 KTIKTSIRGTKGYVAPEW---FRNSKITAKVDVYSFGVLLLEI 675
KT G + Y+APE + DV+S G+ L E+
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 5e-13
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 21/220 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV----AVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+G+GSFG V+Q + T + ++K IV + E V+ Q + +V
Sbjct: 1 IGKGSFG----KVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIV 56
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCS 598
L F + +L LV F+N G L F +L+ + A F A L L
Sbjct: 57 PL-KFSFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHK 111
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-SIRGTKGYVAPEWFRNS 657
+I+ D+KP+NILLD + + DFGL K LN KT + GT Y+APE
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCK---LNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTD 695
T VD ++ GVLL E++ F E V E IL +
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE 208
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 6e-13
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 37/212 (17%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHH-KNLV 540
EE+GRG++G+V K + T +AVK++ E + ++ + ++ V
Sbjct: 7 EELGRGAYGVVDK---MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 541 RLLG---------FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI----AFQIA 587
G C E + + +L F + +I A I
Sbjct: 64 TFYGALFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
+ L YLH S +IH D+KP N+L++ + ++ DFG++ L + +KTI G K
Sbjct: 114 KALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA---GCKP 168
Query: 648 YVAPEWF---RNSK-ITAKVDVYSFGVLLLEI 675
Y+APE N K K DV+S G+ ++E+
Sbjct: 169 YMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 50/205 (24%), Positives = 97/205 (47%), Gaps = 29/205 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIGQTHHK 537
E++G G++G V+K R + VA+K++ + D + E E+ ++ + HK
Sbjct: 6 EKIGEGTYGTVFKAK---NRETHEIVALKRVRL---DDDDEGVPSSALREICLLKELKHK 59
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
N+VRL + LV+E+ + F N + + + FQ+ +GL + H
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH--- 116
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
S ++H D+KPQN+L++ + +++DFGLA+ + +R V W+R
Sbjct: 117 SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--------PVRCYSAEVVTLWYRPP 168
Query: 658 KI-------TAKVDVYSFGVLLLEI 675
+ + +D++S G + E+
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 74/286 (25%), Positives = 137/286 (47%), Gaps = 46/286 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHHKNL 539
+E+G+G++G VYK + + T + +A+K++ + + + + E+ ++ + +
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVT---MAMKEIRLELDESKFNQIIMELDILHKAVSPYI 61
Query: 540 VRLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARGLL 591
V G F EG VY E+++ G+L G + P LR I + + +GL
Sbjct: 62 VDFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLR-RITYAVVKGLK 116
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+L E+ IIH D+KP N+L++ + ++ DFG++ L + + KT+I G + Y+AP
Sbjct: 117 FLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA---KTNI-GCQSYMAP 170
Query: 652 EWFR------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN-- 703
E + N T + DV+S G+ +LE+ R + E Y N
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET--------------YANIF 216
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+L A+V GD + + V+ C+ + P+ RPT ++L+
Sbjct: 217 AQLSAIVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN----EVFVIGQTHHKNL 539
++G G+ G V K T V KK +V + + E+ ++ + +
Sbjct: 12 DLGAGNGGSVSK----VKHIPTGTVMAKK--VVHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 540 VRLLG-FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
V G F +E N + EF++ G+L G + + IA + GL YL+
Sbjct: 66 VSFYGAFLNEN-NICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYN- 121
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
+I+H D+KP NIL++ ++ DFG++ L +I + GT Y++PE +
Sbjct: 122 -VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQG 176
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFD 683
K T K DV+S G+ ++E+ + F
Sbjct: 177 GKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 480 NFKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DIVFQDGEREFKNEVFVIGQT 534
NF+ E +GRG F VY+ T VA+KK+ D++ + E+ ++ Q
Sbjct: 3 NFRIEKKIGRGQFSEVYRA---TCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF--QIARGL 590
+H N+++ E +V E + G L+ + F K +T + Q+ L
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-SIRGTKGYV 649
++H S +++H D+KP N+ + ++ D GL + + SKT S+ GT Y+
Sbjct: 120 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---SKTTAAHSLVGTPYYM 173
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
+PE + K D++S G LL E+ A + F + + Y++ C + + D
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-------CKKIEQCDY- 225
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ + + E L +LV + CI DP RP I V +
Sbjct: 226 --PPLPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 45/305 (14%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA-------------VAVKKLDI-VFQDGEREFKN 526
FKE++G G FG V+ + + T VAVK L ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 527 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN--------------- 571
EV ++ + N++RLLG C + ++ E++ NG L FL +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 572 ----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627
+++ ++A QIA G+ YL S +H D+ +N L+ ++ +I+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEM 686
+ L I+ ++A E K T DV++FGV L EI+ C++ E+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 687 VEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746
+E I + A + +R+ + C + L + + C D RP+
Sbjct: 246 TDEQVI--ENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSD 297
Query: 747 VLQML 751
+ L
Sbjct: 298 IHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 69/270 (25%), Positives = 125/270 (46%), Gaps = 25/270 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
++E +G G+ G VYK TR AV V LDI + +++ +E+ ++ + ++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTR-RILAVKVIPLDITVEL-QKQIMSELEILYKCDSPYII 62
Query: 541 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
G F E NR+ + EF++ G+L ++ + P L IA + +GL YL S
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSLD--VYRKI-PEHVL-GRIAVAVVKGLTYL---WS 113
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+I+H D+KP N+L++ ++ DFG++ L +I + GT Y+APE +
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQ 169
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
DV+S G+ +E+ R + ++ + L L +V D +
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQL-------LQCIVDEDPPVLP 221
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748
+ EK V C+++ P RP + ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 61/217 (28%), Positives = 109/217 (50%), Gaps = 14/217 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVR 541
+G+GSFG V ++ T A+ V K D++ QD + + + + + H +
Sbjct: 3 LGKGSFGKVMLAELKGT-DEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKH--PFLT 59
Query: 542 LLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600
L C + ++RL V E++N G L + + K + A ++ L++LH
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
+I+ D+K NILLD + +++DFG+ K LN T T+ GT Y+APE + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEYG 174
Query: 661 AKVDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTD 695
VD ++ GVL+ E++A + F+ + ++ +IL D
Sbjct: 175 PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
E +G GSFG V + T +KK +I+ + E ++ + H +V
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 542 LL-GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLL---YLHE 595
++ F DE NR+ + EF+ G L F +L+ ++A F A +L YLH
Sbjct: 83 MMCSFQDE--NRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAELVLAFEYLH- 135
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S II+ D+KP+N+LLD+ + +++DFG AK + +T ++ GT Y+APE +
Sbjct: 136 --SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---DRTF--TLCGTPEYLAPEVIQ 188
Query: 656 NSKITAKVDVYSFGVLLLEIIA 677
+ VD ++ GVLL E IA
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIA 210
|
Length = 329 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 42/231 (18%)
Query: 472 KELEEATDNFKE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKN 526
K + E + ++ VG G++G V T+T VAVKKL FQ +R ++
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLR-VAVKKLSRPFQSIIHAKRTYR- 65
Query: 527 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN- 581
E+ ++ H+N++ LL ++ E N+ L + L G N+ L +
Sbjct: 66 ELRLLKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 121
Query: 582 ---IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ +QI RGL Y+H S+ IIH D+KP N+ +++ +I DFGLA+
Sbjct: 122 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------- 168
Query: 639 KTSIRGTKGYVAPEWFRNSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
T T GYVA W+R +I VD++S G ++ E++ R F
Sbjct: 169 HTDDEMT-GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 32/207 (15%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLL 543
E+G G+FG VYK + T A A K ++ ++ ++ E+ ++ +H +V+LL
Sbjct: 19 ELGDGAFGKVYKA--KNKETGALAAA-KVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 544 G-FCDEGQNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
G F +G+ +++ EF G + + + G +P + I Q+ L YLH S
Sbjct: 76 GAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLH---S 128
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-----SIRGTKGYVAP-- 651
+IIH D+K N+LL + +++DFG++ +K +KT S GT ++AP
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS-------AKNVKTLQRRDSFIGTPYWMAPEV 181
Query: 652 ---EWFRNSKITAKVDVYSFGVLLLEI 675
E +++ K D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 12/204 (5%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTT-AVAVKKLDIVFQDGEREF-KNEVFVIGQTHHKNLVRL 542
+GRGS+ V +++ +T A+ V K ++V D + ++ + E V Q + +
Sbjct: 3 IGRGSYAKVL--LVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 543 LGFCDEGQNRLL-VYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQ 600
L C + ++RL V E++N G L + K P + R A +I+ L YLHE
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RG 116
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
II+ D+K N+LLD + +++D+G+ K L T ++ GT Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDT-TSTFCGTPNYIAPEILRGEDYG 174
Query: 661 AKVDVYSFGVLLLEIIACRKSFDI 684
VD ++ GVL+ E++A R FDI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 21/171 (12%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+FQ+ARG+ +L S + IH D+ +NILL ++ +I DFGLA+ + + K S
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
R ++APE + T + DV+SFGVLL EI + S +++ EE+ C
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF---------C 287
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
R G M A + +M++ W Q DP RPT ++++L
Sbjct: 288 QRLKD-----GTRMRAPENATPEIYRIMLACW--QGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 62/248 (25%), Positives = 108/248 (43%), Gaps = 50/248 (20%)
Query: 481 FKEEVGRGSFGIVY----KGV---------IQTTRTSTTAVAVKKL-DIVFQDGEREFKN 526
FKE++G G FG V+ +G+ + + VAVK L + ++ +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 527 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------------ 568
E+ ++ + N++RLL C ++ E++ NG L FL
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 569 FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
+ L +A QIA G+ YL S +H D+ +N L+ +Y +I+DFG+++
Sbjct: 129 YSTLI-------FMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
Query: 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMV 687
L I+ +++ E K T DV++FGV L EI+ C++
Sbjct: 179 NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE------- 231
Query: 688 EEYAILTD 695
+ Y+ L+D
Sbjct: 232 QPYSQLSD 239
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 60/206 (29%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVR 541
+G G+FG+V+ T VA+KK+ VFQ+ +R F+ E+ ++ H N++
Sbjct: 8 IGYGAFGVVWS---VTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLS 63
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDC 597
L ++ + S L + L ++ +QI RGL YLH
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH--- 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
S+ I+H D+KP N+L++ + +I DFGLA++ ++SK + + T+ Y APE S
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGS 179
Query: 658 K-ITAKVDVYSFGVLLLEIIACRKSF 682
+ T+ VD++S G + E++ R F
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILF 205
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF-KNEVFVIGQTHHKNLVRLL 543
+GRGS+ V V A+ V K ++V D + ++ + E V Q + L
Sbjct: 3 IGRGSYAKVLL-VRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 544 GFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQI 601
C + +RL LV E++N G L + K P + R A +I L +LHE I
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHE---RGI 117
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA 661
I+ D+K N+LLD + +++D+G+ K L T T GT Y+APE R +
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTST-FCGTPNYIAPEILRGEEYGF 175
Query: 662 KVDVYSFGVLLLEIIACRKSFDI 684
VD ++ GVL+ E++A R FDI
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 61/234 (26%), Positives = 110/234 (47%), Gaps = 38/234 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNL 539
E +G+GS+G+V + T VA+KK++ VF+ D R + E+ ++ H ++
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEK---VAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDI 61
Query: 540 VRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGL 590
V + E ++ +V+E + S L +K N +L +Q+ R L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELME-----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
Y+H ++ + H D+KP+NIL + +I DFGLA++ + I + YVA
Sbjct: 117 KYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWT-----DYVA 168
Query: 651 PEWFRN--------SKITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTD 695
W+R SK T +D++S G + E++ + F +V + ++TD
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 30/212 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK--NEVFVIGQTHHKNLV 540
E++G GS+ VYKG+ +R + VA+K + + ++G F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKGI---SRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIV 66
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDC 597
L + V+E+++ LA ++ G L P +N+R FQ+ RGL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHP-YNVRL-FMFQLLRGLAYIH--- 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-- 655
I+H D+KPQN+L+ +++DFGLA+ +K+I + ++ V W+R
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSE--VVTLWYRPP 172
Query: 656 -----NSKITAKVDVYSFGVLLLEIIACRKSF 682
+ ++ +D++ G + +E++ + +F
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 12/204 (5%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF-KNEVFVIGQ-THHKNLVRL 542
+GRGS+ V ++ TR A+ V K ++V D + ++ + E V ++H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTR-RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQ 600
C + ++RL V EF++ G L + K P + R A +I+ L +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHE---RG 116
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
II+ D+K N+LLD + +++D+G+ K + T T GT Y+APE R
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTST-FCGTPNYIAPEILRGEDYG 174
Query: 661 AKVDVYSFGVLLLEIIACRKSFDI 684
VD ++ GVL+ E++A R FDI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 44/226 (19%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL---DIVFQDGEREFKNEVFVIGQTHHKNLV 540
+GRG+FG V+ T V A+K L D++ ++ + E ++ +V
Sbjct: 9 IGRGAFGEVW----LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 541 RLL-GFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
+L F DE ++ LV E++ G L + L F IA +L L
Sbjct: 65 KLYYSFQDE-EHLYLVMEYMPGGDLMNLLIRKDVFPEET-----ARFYIAELVLALDSVH 118
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--------------------------- 630
IH D+KP NIL+D + +++DFGL K +
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
Q + S GT Y+APE R + + D +S GV+L E++
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 22/201 (10%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVR 541
+G G+ GIV + VAVKKL FQ+ +R ++ E+ ++ +HKN++
Sbjct: 29 IGSGAQGIVCAAFDTVLGIN---VAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIIS 84
Query: 542 LLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
LL +E Q+ LV E ++ L + L + + + +Q+ G+ +LH
Sbjct: 85 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMEL--DHERMSYLLYQMLCGIKHLH- 140
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S+ IIH D+KP NI++ +I DFGLA+ N + T T+ Y APE
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVIL 195
Query: 656 NSKITAKVDVYSFGVLLLEII 676
VD++S G ++ E++
Sbjct: 196 GMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 63/215 (29%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRL 542
VG G++G V R VAVKKL FQ R E+ ++ H+N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGL 79
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTN----IAFQIARGLLYLH 594
L + E N L + L G N+ L + +Q+ RGL Y+H
Sbjct: 80 LDVFTPATS----IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH 135
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
S+ IIH D+KP N+ +++ RI DFGLA+ Q+ T GYVA W+
Sbjct: 136 ---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMT------GYVATRWY 181
Query: 655 RNSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
R +I VD++S G ++ E++ + F
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 56/212 (26%), Positives = 108/212 (50%), Gaps = 30/212 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK--NEVFVIGQTHHKNLV 540
E++G GS+ VYKG ++ + VA+K + + ++G F E ++ H N+V
Sbjct: 11 EKLGEGSYATVYKG---KSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIV 66
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYLHEDC 597
L + LV+E+++ L ++ G L P N++ + FQ+ RGL Y+H+
Sbjct: 67 LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQ-- 121
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-- 655
I+H D+KPQN+L+ D +++DFGLA+ +K++ + + V W+R
Sbjct: 122 -RYILHRDLKPQNLLISDTGELKLADFGLAR------AKSVPSHTYSNE--VVTLWYRPP 172
Query: 656 -----NSKITAKVDVYSFGVLLLEIIACRKSF 682
+++ + +D++ G + +E+I +F
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 73/273 (26%), Positives = 112/273 (41%), Gaps = 35/273 (12%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN---EVFVIGQTHHKNLV 540
E+G GSFG VY T + VAVKK+ + ++++ EV + Q H N +
Sbjct: 28 EIGHGSFGAVY---FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCSS 599
G + LV E+ G+ + L + KP + I +GL YLH
Sbjct: 85 EYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---WFRN 656
+IH D+K NILL + +++DFG A + S GT ++APE
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDE 194
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716
+ KVDV+S G I C IE+ E L F+ L + D
Sbjct: 195 GQYDGKVDVWSLG------ITC-----IELAERKPPL----FNMNAMSALYHIAQNDSPT 239
Query: 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ E + +C+Q+ P RP ++L+
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DIVFQDGERE---FKNEVFVIGQTHHKNL 539
+GRG+FG VY + + +AVK++ D Q+ +E + E+ ++ H +
Sbjct: 10 LGRGAFGEVY---LCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 540 VRLLGFC--DEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 594
V+ G C D + +L ++ E++ G++ L +G L N R QI +G+ YLH
Sbjct: 67 VQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR--YTRQILQGVSYLH 123
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTSIRGTKGYVAPEW 653
S+ I+H D+K NIL D N ++ DFG +K + T+ S T S+ GT +++PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180
Query: 654 FRNSKITAKVDVYSFGVLLLEII 676
K DV+S ++E++
Sbjct: 181 ISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 54/209 (25%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 475 EEATDNFKE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVI 531
E D+F+ E+G G+ G+V K + S +A K + + + R + E+ V+
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK---VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 532 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+ + +V G F +G+ + + E ++ G+L L + + ++ + RGL
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGL 116
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YL E QI+H D+KP NIL++ ++ DFG++ L ++ S GT+ Y++
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 170
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACR 679
PE + + + + D++S G+ L+E+ R
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 31/225 (13%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE--VF-VIGQTHHKNLVRL 542
GRG FG V + T A+KK DI+ +D E +F H LV L
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI---------AFQIARGLLY 592
C + ++ + V E+ G L ++ T++ A + GL Y
Sbjct: 68 FA-CFQTEDHVCFVMEYAAGGDLM----------MHIHTDVFSEPRAVFYAACVVLGLQY 116
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LHE+ +I++ D+K N+LLD +I+DFGL K +T ++ GT ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--STFCGTPEFLAPE 171
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTD 695
+ T VD + GVL+ E++ F + EE +I+ D
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-----FKNEVFVIGQTHHKNL 539
+G+G+FG VY + + +AVK++ + E + E+ ++ H+ +
Sbjct: 10 LGQGAFGRVY---LCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 540 VRLLGFCDEGQNRLL--VYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 595
V+ G + R L E + G++ L +G L N + QI G+ YLH
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRK--YTRQILEGVSYLH- 123
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTSIRGTKGYVAPEWF 654
S+ I+H D+K NIL D N ++ DFG +K L T+ S T S+ GT +++PE
Sbjct: 124 --SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 655 RNSKITAKVDVYSFGVLLLEIIACR 679
K D++S G ++E++ +
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN---EVFVIGQTHHKNLV 540
E+G GSFG VY + RT+ VA+KK+ + ++++ EV + Q H N +
Sbjct: 22 EIGHGSFGAVYFA--RDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTI 78
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCSS 599
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 79 EYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SH 134
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---WFRN 656
+ IH D+K NILL + +++DFG A L++ S GT ++APE
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN------SFVGTPYWMAPEVILAMDE 188
Query: 657 SKITAKVDVYSFGVLLLEIIACRK 680
+ KVDV+S G+ +E +A RK
Sbjct: 189 GQYDGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 3/93 (3%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+FQ+ARG+ +L S + IH D+ +NILL ++ +I DFGLA+ + + K
Sbjct: 179 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
R ++APE + T + DV+SFGVLL EI
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 18/205 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVI-GQTHHKNLVR 541
E +G+G++G V+K + + + + AVK LD + D + E + E ++ + H N+V+
Sbjct: 24 ETIGKGTYGKVFKVL---NKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVK 79
Query: 542 LLGF-----CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-IAFQIARGLLYLHE 595
G G LV E N G++ + G LK + IA+ + L+ L
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQH 139
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
++ IH D+K NILL ++ DFG++ LT + + TS+ GT ++APE
Sbjct: 140 LHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR-NTSV-GTPFWMAPEVIA 197
Query: 656 -----NSKITAKVDVYSFGVLLLEI 675
+S A+ DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 6e-11
Identities = 51/237 (21%), Positives = 94/237 (39%), Gaps = 65/237 (27%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-------REFKNEVFVIGQTHH 536
+GRG++G VYK + + A+KK + R E+ ++ + H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKD-GKEYAIKKFKGDKEQYTGISQSACR----EIALLRELKH 61
Query: 537 KNLVRLLGFCDEGQNRL--LVYEF-------------------LNNGTLASFLFGNLKPN 575
+N+V L+ E ++ L++++ + + S L
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL------- 114
Query: 576 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLT 631
+QI G+ YLH S+ ++H D+KP NIL+ + +I D GLA+L
Sbjct: 115 --------WQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF- 162
Query: 632 LNQSKTIKTSIRG-----TKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSF 682
+ +K T Y APE ++ T +D+++ G + E++ F
Sbjct: 163 ---NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 15/203 (7%)
Query: 483 EEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
E +G+G+F ++KG V T V +K LD ++ F ++ Q HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHE 595
LV G C G ++V E++ G+L ++L N + +W L +A Q+A L +L +
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLE--VAKQLAWALHFLED 118
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTSIRGTKGYVAPEW 653
+ H ++ +N+LL + + + KL S T+ K + +V PE
Sbjct: 119 ---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175
Query: 654 FRNSK-ITAKVDVYSFGVLLLEI 675
N + ++ D +SFG L EI
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 17/199 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+ VG G++G VYK + T A AVK + + D + E+F++ + H N+V
Sbjct: 15 QRVGSGTYGDVYKA--RNLHTGELA-AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCSS 599
G + + E+ G+L ++ P L+ IA+ + +GL YLH S
Sbjct: 72 FGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQ--IAYVCRETLQGLAYLH---SK 125
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF---RN 656
+H D+K NILL D+ + +++DFG+A +T +K + S GT ++APE +N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK--RKSFIGTPYWMAPEVAAVEKN 183
Query: 657 SKITAKVDVYSFGVLLLEI 675
D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 55/185 (29%), Positives = 86/185 (46%), Gaps = 28/185 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FK----NEVFVIGQTHHKNL 539
+G+G+FG V+K + + VA+KK V + E+E F E+ ++ H+N+
Sbjct: 20 IGQGTFGEVFKA---RHKKTKQIVALKK---VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 540 VRLLGFCD---EGQNR-----LLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARG 589
V L+ C NR LV+EF + LA L N + L + + G
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNG 131
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL--NQSKTIKTSIRGTKG 647
L Y+H ++I+H DMK NIL+ +++DFGLA+ +L N T+ T
Sbjct: 132 LYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188
Query: 648 YVAPE 652
Y PE
Sbjct: 189 YRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 19/220 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IVFQDGE-REFKNEVFVIGQTHHKNL 539
+VG+G +G V+ + + + VA+K++ ++F+ E R E ++ T + L
Sbjct: 7 TQVGQGGYGQVF---LAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
V+LL + + L E++ G + L G L + + F +A +
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMAEMFEAVDALH 118
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
IH D+KP+N L+D + +++DFGL+K T S+ G+ Y+APE R
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-YAILTDW 696
VD +S G +L E + F E + L W
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 34/207 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLDIVFQDGEREFKNEV--------FVIGQTH 535
+G+GSFG V + AVK V Q K E ++
Sbjct: 3 IGKGSFGKVL----LAKHKADGKFYAVK----VLQKKAILKKKEQKHIMAERNVLLKNVK 54
Query: 536 HKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARG 589
H LV L + + ++L V +++N G L L F + + A +IA
Sbjct: 55 HPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-----YAAEIASA 108
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L YLH S II+ D+KP+NILLD + ++DFGL K + SKT T GT Y+
Sbjct: 109 LGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTST-FCGTPEYL 163
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEII 676
APE R VD + G +L E++
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQTHHKNLVR 541
+G+G+FG VY T A V+ D + +E + E+ ++ H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ-FDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 542 LLG-FCDEGQNRLLVY-EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
G D + L ++ E++ G++ L +G L + + QI G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTES--VTRKYTRQILEGMSYLH--- 123
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAK-LLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S+ I+H D+K NIL D N ++ DFG +K L T+ S T S+ GT +++PE
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 657 SKITAKVDVYSFGVLLLEII 676
K DV+S G ++E++
Sbjct: 184 EGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/231 (25%), Positives = 110/231 (47%), Gaps = 50/231 (21%)
Query: 470 SYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----REF 524
+YK+L++ +G GS+ VYKG + T VA+K++ + ++G RE
Sbjct: 6 TYKKLDK--------LGEGSYATVYKGRSKLTGQ---LVALKEIRLEHEEGAPFTAIRE- 53
Query: 525 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTN 581
++ H N+V L + LV+E+L+ L ++ G L + N+R
Sbjct: 54 ---ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMH-NVRL- 107
Query: 582 IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641
FQ+ RGL Y H +++H D+KPQN+L+ + +++DFGLA+ +K++
Sbjct: 108 FLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR------AKSVP-- 156
Query: 642 IRGTKGY---VAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
+K Y V W+R +++ + +D++ G + E+ R F
Sbjct: 157 ---SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVR 541
VG G++G V + + T VA+KKL FQ +R ++ E+ ++ H+N++
Sbjct: 23 VGSGAYGSVCSAIDKRTGEK---VAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIG 78
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGLLYLHE 595
LL D + + EF + + ++ +L+ + + +Q+ GL Y+H
Sbjct: 79 LL---DVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S+ IIH D+KP N+ +++ +I DFGLA+ + GYV W+R
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GYVVTRWYR 181
Query: 656 NSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
++ VD++S G ++ E++ + F
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLF 215
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 48/226 (21%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FK----NEVFVIGQTHHKN 538
++G G++G VYK + T VA+KK V D E+E F E+ ++ Q +H+N
Sbjct: 14 QIGEGTYGQVYKARDKDT---GELVALKK---VRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 539 LVRL----------LGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPNWNLRTNIAF- 584
+V L L F + LV+E++++ G L S L +++ +F
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-----HFSEDHIKSFM 122
Query: 585 -QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
Q+ GL Y H+ +H D+K NILL++ +++DFGLA+L R
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLY-------NSEESR 172
Query: 644 GTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
V W+R + +DV+S G +L E+ + F
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 35/181 (19%)
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+ ++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + +K
Sbjct: 218 SFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWAF- 698
+ R ++APE N T + DV+S+G+LL EI + S Y + D F
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSS-------PYPGMPVDSKFY 327
Query: 699 ----DCYRNGKLDALVGGDMEAMNDVEC--LEKL-VMVSIWCIQEDPSLRPTIKKVLQML 751
+ YR M EC E +M S W DP RPT K+++Q++
Sbjct: 328 KMIKEGYR--------------MLSPECAPSEMYDIMKSCW--DADPLKRPTFKQIVQLI 371
Query: 752 E 752
E
Sbjct: 372 E 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 48/216 (22%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHHKNLVRL- 542
+G GSFG+VY+ + T + VA+KK V QD ++KN E+ ++ +H N++ L
Sbjct: 74 IGNGSFGVVYEAICIDT---SEKVAIKK---VLQD--PQYKNRELLIMKNLNHINIIFLK 125
Query: 543 --------------------LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNI 582
+ F + ++ + + NN L FL
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV----------KLY 175
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTS 641
++Q+ R L Y+H S I H D+KPQN+L+D + + ++ DFG AK L Q S
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVS 229
Query: 642 IRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEII 676
++ Y APE + T +D++S G ++ E+I
Sbjct: 230 YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 51/178 (28%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+FQ+A+G+ +L S + IH D+ +NILL ++ +I DFGLA+ + + K
Sbjct: 185 SFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
R ++APE + T + DV+SFGVLL EI + S +++ EE+ C
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF---------C 292
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
R + G M A + M+ W +PS RPT ++++ L +++ +
Sbjct: 293 RRLKE-----GTRMRAPDYTTPEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G+FG K ++ + S A+K L I+ +D E V+ T H L
Sbjct: 3 LGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 542 LLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600
L + + ++RL V E++N G L L + + +I L YLH S +
Sbjct: 60 L-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLH---SGK 115
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
I++ D+K +N++LD + +I+DFGL K + + T+KT GT Y+APE ++
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 661 AKVDVYSFGVLLLEIIACRKSF---DIEMVEEYAILTDWAF 698
VD + GV++ E++ R F D E + E ++ D F
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF 214
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 485 VGRGSFGIVYK------GVIQTTRTSTTAVAVKKLDIVFQDGERE------FKNEVFVIG 532
+G+G+FG VY+ I + + V K ++ GER F++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 533 QTHHKNLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGL 590
L F + + L LV ++++ G L F +L+ + A F IA +
Sbjct: 61 ----------LKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELV 106
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
L L I++ D+KP+NILLD + + DFGL+K L +KT T GT Y+A
Sbjct: 107 LALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNT-FCGTTEYLA 164
Query: 651 PEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
PE + K T VD +S GVL+ E+ F E ++
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 31/94 (32%), Positives = 55/94 (58%), Gaps = 6/94 (6%)
Query: 582 IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641
I+ + RGL YL E +I+H D+KP NIL++ ++ DFG++ L ++ S
Sbjct: 104 ISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANS 157
Query: 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
GT+ Y++PE + + T + D++S G+ L+E+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 52/209 (24%), Positives = 107/209 (51%), Gaps = 14/209 (6%)
Query: 475 EEATDNFKE--EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVI 531
E D+F++ E+G G+ G+V+K + + S +A K + + + R + E+ V+
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK---VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 532 GQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+ + +V G F +G+ + + E ++ G+L L + + ++ + +GL
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 116
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YL E +I+H D+KP NIL++ ++ DFG++ L ++ S GT+ Y++
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 170
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACR 679
PE + + + + D++S G+ L+E+ R
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 46/213 (21%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVR 541
+G G+ GIV + VA+KKL FQ+ +R ++ E+ ++ +HKN++
Sbjct: 24 IGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 542 LLG-FC-----DEGQNRLLVYEF------------LNNGTLASFLFGNLKPNWNLRTNIA 583
LL F +E Q+ LV E L++ ++ L+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLY-------------- 125
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
Q+ G+ +LH S+ IIH D+KP NI++ +I DFGLA+ T S + T
Sbjct: 126 -QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTS-FMMTPYV 178
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
T+ Y APE VD++S G ++ E+I
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 51/172 (29%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+ Q+A+G+ +L S IH D+ +N+LL D A+I DFGLA+ + + + +K +
Sbjct: 218 SSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWAFDCY 701
R ++APE + T + DV+S+G+LL EI + KS Y IL + F Y
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS-------PYPGILVNSKF--Y 325
Query: 702 RNGKLDALVGGDMEAMNDVECLE-KLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ K G + D E +M W + +P+ RPT ++ Q+++
Sbjct: 326 KMVK-----RGYQMSRPDFAPPEIYSIMKMCWNL--EPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 9/198 (4%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVA-VKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
NF +G GSFG V + A+ +K I+ Q +E ++ +H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
V L G + LV EF+ G +FL N + ++ A QI YL S
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQ---S 149
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
I++ D+KP+N+LLD +++DFG AK++ T ++ GT Y+APE N
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIAPEILLNVG 204
Query: 659 ITAKVDVYSFGVLLLEII 676
D ++ G+ + EI+
Sbjct: 205 HGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 29/226 (12%)
Query: 461 TIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG 520
TI+ +LE E+G G+ G VYK + + +AVK+ +
Sbjct: 4 TIDGQKYPADLNDLE-----NLGEIGSGTCGQVYK---MRFKKTGHVMAVKQ--MRRTGN 53
Query: 521 EREFKN---EVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--- 573
+ E K ++ V+ ++H +V+ G+ + + E + T L ++
Sbjct: 54 KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPI 111
Query: 574 PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633
P ++ + I + L YL E +IH D+KP NILLD N ++ DFG++ L +
Sbjct: 112 PE-DILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168
Query: 634 QSKTIKTSIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEI 675
++KT +++ G Y+APE N K + DV+S G+ L+E+
Sbjct: 169 KAKT-RSA--GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 58/199 (29%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN---EVFVIGQTHHKNLV 540
E+G GSFG VY + RT+ VA+KK+ + ++++ EV + + H N +
Sbjct: 32 EIGHGSFGAVY--FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCSS 599
G LV E+ G+ + L + KP + I +GL YLH S
Sbjct: 89 EYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SH 144
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---WFRN 656
+IH D+K NILL + +++DFG A + + S GT ++APE
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIA------SPANSFVGTPYWMAPEVILAMDE 198
Query: 657 SKITAKVDVYSFGVLLLEI 675
+ KVDV+S G+ +E+
Sbjct: 199 GQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 15/203 (7%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
VG GSFG + ++ S A+K +L E K E ++ + H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK-EAVLLAKMKHPNIVAF 63
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
+ + +V E+ + G L + G L P + Q+ G+ ++HE
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWFVQMCLGVQHIHE---K 119
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
+++H D+K +NI L + ++ DFG A+LLT + GT YV PE + N
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 660 TAKVDVYSFGVLLLEIIACRKSF 682
K D++S G +L E+ + F
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 9e-10
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 485 VGRGSFGIV---YKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKN 538
+G G+ GIV Y V+ VA+KKL FQ+ +R ++ E+ ++ +HKN
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 77
Query: 539 LVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 592
++ LL +E Q+ LV E ++ L + ++ + + + +Q+ G+ +
Sbjct: 78 IISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKH 134
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH S+ IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 135 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAPE 188
Query: 653 WFRNSKITAKVDVYSFGVLLLEII 676
VD++S G ++ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 32/218 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFV 530
D ++ E++G G++G VYK + + VA+KK + + RE + + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKA---RDKNTGKLVALKKTRLEMDEEGIPPTALREI-SLLQM 56
Query: 531 IGQTHHKNLVRLLGF----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWN-LRTNIA- 583
+ ++ + +VRLL G+ L LV+E+L++ L F+ N + L
Sbjct: 57 LSESIY--IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIK 113
Query: 584 ---FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIK 639
+Q+ +G+ + H ++H D+KPQN+L+D +I+D GL + ++
Sbjct: 114 SFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 640 TSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEII 676
+ T Y APE S + VD++S G + E+
Sbjct: 171 EIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG--QTHHKNLVRL 542
+GRG FG VY T + K I + GE NE ++ T +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
+ + ++L + + +N G L L + + A +I GL ++H + +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH---NRFV 118
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF-RNSKIT 660
++ D+KP NILLD+H + RISD GLA + SK + GT GY+APE + +
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYD 174
Query: 661 AKVDVYSFGVLLLEIIACRKSF 682
+ D +S G +L +++ F
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 58/232 (25%), Positives = 104/232 (44%), Gaps = 29/232 (12%)
Query: 525 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF 584
++E+ + H +V+ LL+ E+ + G L N + L+ ++ F
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDL------NKQIKQRLKEHLPF 166
Query: 585 Q-IARGLLY------LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
Q GLL+ L E S +++H D+K NI L ++ DFG +K + + S
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA 697
+ +S GT Y+APE + + + K D++S GV+L E++ + F E I+
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQVL 284
Query: 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ GK D M + L+ L + ++P+LRPT +++L
Sbjct: 285 Y-----GKYDPFPCPVSSGMKAL--LDPL-------LSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 36/111 (32%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
QI GL YLH + +IIH D+K +NI ++D I D G A+ + G
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAG 218
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS-FDIEMV--EEYAI 692
T APE K +K D++S G++L E++A + F+ EEY
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVK 269
|
Length = 357 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 22/201 (10%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEV----FVIGQTHHKNLV 540
+G+GSFG K ++ + AVK L +E K+ + ++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK-----PNWNLRTNIAFQIARGLLYLHE 595
L + V +F+N G L F +L+ P R A +IA L YLH
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAA-EIASALGYLH- 113
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S I++ D+KP+NILLD + ++DFGL K + QS T T+ GT Y+APE R
Sbjct: 114 --SINIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDT-TTTFCGTPEYLAPEVIR 169
Query: 656 NSKITAKVDVYSFGVLLLEII 676
VD + G +L E++
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 485 VGRGSFGIV---YKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKN 538
+G G+ GIV Y +++ VA+KKL FQ+ +R ++ E+ ++ +HKN
Sbjct: 32 IGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKN 84
Query: 539 LVRLLGF------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 592
++ LL +E Q+ +V E ++ L + ++ + + + +Q+ G+ +
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVI--QMELDHERMSYLLYQMLCGIKH 141
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH S+ IIH D+KP NI++ +I DFGLA+ T S + + T+ Y APE
Sbjct: 142 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TRYYRAPE 195
Query: 653 WFRNSKITAKVDVYSFGVLLLEII 676
VD++S G ++ E+I
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 36/225 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G+FG V + T +KK I+ +D E V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-K 61
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLLYL 593
+ + +RL V E+ N G L ++L F +I L YL
Sbjct: 62 YSFQTHDRLCFVMEYANGGELF----------FHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S +++ D+K +N++LD + +I+DFGL K ++ T+KT GT Y+APE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT-FCGTPEYLAPEV 166
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACR---------KSFDIEMVEE 689
++ VD + GV++ E++ R K F++ ++EE
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 12/196 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+GSFG V + ++K I+ + E+ +E V+ + + L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600
F + ++L V +++N G L L L+P A +IA L YLH S
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLH---SLN 116
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
I++ D+KP+NILLD + ++DFGL K + T ++ GT Y+APE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQPYD 174
Query: 661 AKVDVYSFGVLLLEII 676
VD + G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 20/199 (10%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN---EVFVIGQTHHKNLV 540
E+G GSFG VY ++ VA+KK+ + ++++ EV + + H N +
Sbjct: 22 EIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAFQIARGLLYLHEDCSS 599
+ G LV E+ G+ + L + KP + + +GL YLH S
Sbjct: 79 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---WFRN 656
+IH D+K NILL + ++ DFG A ++ GT ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDE 188
Query: 657 SKITAKVDVYSFGVLLLEI 675
+ KVDV+S G+ +E+
Sbjct: 189 GQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 17/198 (8%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK-NEVFVIGQ-THHKNLVRLL 543
G G+F V K Q+ +T A+K + F+ E+ E+ + + + H N++RL+
Sbjct: 8 GEGTFSEVLK--AQSRKTGKY-YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 544 GFC-DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT-NIAFQIARGLLYLHEDCSSQ 600
D RL LV+E L + L + G +P R + +Q+ + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNG 120
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE-WFRNSKI 659
I H D+KP+NIL+ D +++DFG + + T S T+ Y APE +
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYIS---TRWYRAPECLLTDGYY 176
Query: 660 TAKVDVYSFGVLLLEIIA 677
K+D+++ G + EI++
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IVFQDGERE--FKNEVFVIGQTHHKNLV 540
+G+GSFG K ++ ++ + AVK L + + E+ ++ H LV
Sbjct: 3 IGKGSFG---KVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLYLHED 596
L + V +++N G L F +L+ A ++A + YLH
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAEVASAIGYLH-- 113
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
S II+ D+KP+NILLD + ++DFGL K + T ++ GT Y+APE R
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRK 170
Query: 657 SKITAKVDVYSFGVLLLEII 676
VD + G +L E++
Sbjct: 171 EPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 6e-09
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 47/226 (20%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNLVRL 542
+G GS G+V+ V VAVKK IV D + + E+ +I + H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKR---VAVKK--IVLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 543 LGFCDEGQNRL--------------LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
+ L +V E++ LA+ L + R +Q+ R
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARL-FMYQLLR 125
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
GL Y+H S+ ++H D+KP N+ ++ + +I DFGLA+++ + S KG
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH---------KG 173
Query: 648 Y----VAPEWFRNSKI-------TAKVDVYSFGVLLLEIIACRKSF 682
Y + +W+R+ ++ T +D+++ G + E++ + F
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 21/219 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE--VFVIGQTHHKNLVRL 542
+GRG+FG V ++ T + K +++ + F+ E V V G +
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ---WITT 65
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
L + + +N L LV ++ G L + L F + P R F IA +L +H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQL 121
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR-GTKGYVAPEWFRN-- 656
+H D+KP N+LLD + + R++DFG L +NQ T+++S+ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 657 ---SKITAKVDVYSFGVLLLEIIACRKSFDIE-MVEEYA 691
K + D +S GV + E++ F E +VE Y
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 69/279 (24%), Positives = 124/279 (44%), Gaps = 41/279 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF---KNEVFVIGQTHHKNL 539
+ +G G++G VYK +T +A K+ I + GE +F + E+ ++ H N+
Sbjct: 15 QRIGSGTYGDVYKA----RNVNTGELAAIKV-IKLEPGE-DFAVVQQEIIMMKDCKHSNI 68
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASF--LFGNLKPNWNLRTNIAF---QIARGLLYLH 594
V G + EF G+L + G L + IA+ + +GL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-----ESQIAYVSRETLQGLYYLH 123
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
S +H D+K NILL D+ + +++DFG++ +T +K + S GT ++APE
Sbjct: 124 ---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVA 178
Query: 655 ---RNSKITAKVDVYSFGVLLLEIIACRKS-FDIEMVEEYAILTDWAFDCYRNGKLDALV 710
R D+++ G+ +E+ + FD+ + ++T F + +
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPK-------L 231
Query: 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
M+ N K+ + ++P RPT +K+LQ
Sbjct: 232 KDKMKWSNSFHHFVKMALT------KNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 37/246 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+GRG+FG V + T ++K D++ ++ + E ++ + +V++
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHC 604
+ N L+ EFL G + + L +K + F IA +L + IH
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETVLAIDSIHQLGFIHR 125
Query: 605 DMKPQNILLDDHYNARISDFGLAKLL----------TLNQS------------------- 635
D+KP N+LLD + ++SDFGL L LN S
Sbjct: 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETW 185
Query: 636 ----KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-Y 690
+ + S GT Y+APE F + D +S GV++ E++ F E +E Y
Sbjct: 186 KRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 691 AILTDW 696
+ +W
Sbjct: 246 KKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 48/238 (20%), Positives = 99/238 (41%), Gaps = 30/238 (12%)
Query: 522 REFKNEVFVIGQTHHKNLVRLLGF----CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWN 577
+NE+ + + N++++ GF D+ L+ E+ G L L ++
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
+ ++A +GL L++ + + ++ + L+ ++Y +I GL K+L+ K
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 638 IKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFD-IEMVEEYAILT 694
+ + Y + + + S+ T K D+YS GV+L EI + F+ + E Y
Sbjct: 181 VNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY---- 231
Query: 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
D ++ + ++C ++ + C D RP IK++L L
Sbjct: 232 ------------DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 9/218 (4%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G+FG V + T +KK IV +D E V+ + H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL-K 61
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
+ + +RL V E+ N G L L + + +I L YLH + +++
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVY 119
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663
D+K +N++LD + +I+DFGL K + T+KT GT Y+APE ++ V
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAV 177
Query: 664 DVYSFGVLLLEIIACRKSF---DIEMVEEYAILTDWAF 698
D + GV++ E++ R F D E + E ++ + F
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-08
Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 40/230 (17%)
Query: 485 VGRGSFGIVYKG--VIQTTRTSTTAVAVKKLDIVFQDGER---EFKNEVFVIGQTHHKNL 539
+G+G G VY + + R VA+KK+ + F E + H +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRR-----VALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-----NLKPNWNLRTNI-AF-----QIAR 588
V + C +G ++ TL S L +L +T++ AF +I
Sbjct: 65 VPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ-------------- 634
+ Y+H S ++H D+KP NILL I D+G A L +
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 635 --SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
S TI I GT Y+APE + D+Y+ GV+L +++ +
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 35/106 (33%), Positives = 47/106 (44%), Gaps = 7/106 (6%)
Query: 581 NIAFQIARGLL----YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636
A I R LL YLH IIH D+K +NI LD+ NA + DFG A L +
Sbjct: 185 EQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
GT +PE AK D++S G++L E+ +
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 53/228 (23%), Positives = 89/228 (39%), Gaps = 52/228 (22%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV----FQDGEREFKNEV---F-------V 530
+G G++G V K T T VA+KK+ I+ +R+ F +
Sbjct: 17 LGEGTYGKVEKAY--DTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 531 IGQTHHKNLVRLLG-FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------- 581
+ + H+N++ L+ + + F+N + + +LK + +
Sbjct: 74 MNEIKHENIMGLVDVYVEGD--------FIN--LVMDIMASDLKKVVDRKIRLTESQVKC 123
Query: 582 IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK------------L 629
I QI GL LH +H D+ P NI ++ +I+DFGLA+
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 630 LTLNQSKTIKTSIRGTKGYVAPE-WFRNSKITAKVDVYSFGVLLLEII 676
Q + TS T Y APE K VD++S G + E++
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 44/166 (26%), Positives = 85/166 (51%), Gaps = 24/166 (14%)
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
Q+ G+ Y+H+ +I+H D+K +NI L ++ +I DFG+++LL S + T+ G
Sbjct: 114 QLLLGVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM--GSCDLATTFTG 167
Query: 645 TKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704
T Y++PE ++ +K D++S G +L E+ +F E L+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-----EGQNFLS---------- 212
Query: 705 KLDALVGGDMEAMNDVECLE-KLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ +V G ++ + + +M S+ + +DPSLRP+ ++L+
Sbjct: 213 VVLRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 8/95 (8%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
A +I GL ++H + +++ D+KP NILLD+H + RISD GLA + SK +
Sbjct: 103 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHAS 155
Query: 643 RGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEII 676
GT GY+APE + + D +S G +L +++
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/199 (28%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G+FG V + T ++K I+ +D E V+ T H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL-K 61
Query: 545 FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
+ + +RL V E+ N G L L +I L YLH S +++
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH---SRDVVY 118
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663
D+K +N++LD + +I+DFGL K + + T+KT GT Y+APE ++ V
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT-FCGTPEYLAPEVLEDNDYGRAV 176
Query: 664 DVYSFGVLLLEIIACRKSF 682
D + GV++ E++ R F
Sbjct: 177 DWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 53/236 (22%)
Query: 485 VGRGSFG---IVYKGVIQTTRTSTTAVAVKKL---DIVFQDGEREFKNEVFVIGQTHHKN 538
+GRG+FG +V K + + A+KKL +++ ++ + E ++ + +
Sbjct: 9 IGRGAFGEVRLVQK------KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 539 LVRLL-GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
+V+L F DE L+ E+L G + + L +K + F IA +L +
Sbjct: 63 VVKLYYSFQDE-NYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETILAIDSIH 118
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--------------------------T 631
IH D+KP N+LLD + ++SDFGL L
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 632 LNQSKTIKT----------SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
++ + +T S GT Y+APE F + + D +S GV++ E++
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/254 (23%), Positives = 106/254 (41%), Gaps = 39/254 (15%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH 536
D+F+ + +GRG+FG V + T ++K D++ ++ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 596
+V++ + +N L+ EFL G + + L +K + F IA +L +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAI 117
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL-----------------------TLN 633
IH D+KP N+LLD + ++SDFGL L +N
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 634 QSKTIKT----------SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
+ +T S GT Y+APE F + D +S GV++ E++ F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 684 IEMVEE-YAILTDW 696
E +E Y + +W
Sbjct: 238 SETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 30/211 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGER--EFKNEVFVIGQTHH 536
E +G+G+F +YKGV++ +++ +V D F ++ Q H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF---GNLKPNWNLRTNIAFQIARGLLYL 593
K+LV+L G C +N ++V E++ G L FL N+ +W L ++A Q+A L YL
Sbjct: 61 KHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKL--DVAKQLASALHYL 117
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYN-------ARISDFGLAKLLTLNQSKTIKTSIRGTK 646
+ +++H ++ +NIL+ + ++SD G+ + L++ + ++
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERI----- 168
Query: 647 GYVAPEWFRN--SKITAKVDVYSFGVLLLEI 675
++APE RN + +T D +SFG LLEI
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 483 EEVGRGSFGIVYKGVIQ---------TTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ 533
E +GRG+ +Y G++ + V +K LD +D F ++ Q
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGL 590
HK++V L G C ++V EF+ G L F+ L W +A Q+A L
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118
Query: 591 LYLHEDCSSQIIHCDMKPQNILL-----DDHYNA--RISDFGLAKLLTLNQSKTIKTSIR 643
YL ED ++H ++ +NILL D ++SD G+ + Q +
Sbjct: 119 SYL-ED--KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP-- 173
Query: 644 GTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEI 675
++APE +SK ++ D +SFG L EI
Sbjct: 174 ----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 52/218 (23%), Positives = 103/218 (47%), Gaps = 14/218 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+GRG+FG V ++++ + K +++ + F E ++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCSSQIIH 603
+ + +V E++ G L NL N+++ A F A +L L S +IH
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH 165
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR-GTKGYVAPEWFR----NSK 658
D+KP N+LLD H + +++DFG + ++++ ++ GT Y++PE + +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIE-MVEEYAILTD 695
+ D +S GV L E++ F + +V Y+ + D
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
+ K VGRG FG V + T +KK ++ Q+ F+ E ++ ++ +
Sbjct: 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI 63
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCS 598
+L + N LV E+ G L S L ++A F +A +L +H
Sbjct: 64 PQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAIHSVHQ 120
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR--- 655
+H D+KP+N+L+D + +++DFG A LT N+ K + GT Y+APE
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMN 179
Query: 656 ---NSKITAKVDVYSFGVLLLEIIACRKSF 682
+ D +S GV+ E+I R F
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-07
Identities = 30/106 (28%), Positives = 44/106 (41%), Gaps = 10/106 (9%)
Query: 45 WLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKL 104
+S + F GF L ND I Y +TVVW + +++ V + L
Sbjct: 10 LVSGNSLFELGFFTL---IMQNDY--NLILYKSSS-RTVVWVAN---RDNPVSDSCTLTL 60
Query: 105 TADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSS 149
+D LVL D G+ VWSS V + D GN ++ S +
Sbjct: 61 QSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGN 106
|
Length = 114 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 554 LVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611
L+ +++N G L + L+ + + +R IA +I L +LH+ II+ D+K +NI
Sbjct: 82 LILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ---LGIIYRDIKLENI 136
Query: 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR--NSKITAKVDVYSFG 669
LLD + ++DFGL+K + S GT Y+APE R + VD +S G
Sbjct: 137 LLDSEGHVVLTDFGLSKEFLAE-EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLG 195
Query: 670 VLLLEIIACRKSFDIE 685
VL E++ F ++
Sbjct: 196 VLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKN----EVFVIGQTHHKN 538
VG G++G+V K + T+ VA+KK F+D E E K E+ ++ +N
Sbjct: 9 VGEGAYGVVLKCRHKETKE---IVAIKK----FKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
+V L LV+E++ L N P +R+ I +Q+ + + + H++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN- 119
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
I+H D+KP+N+L+ + ++ DFG A+ L+ S T T+ Y +PE +
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 658 KITAKVDVYSFGVLLLEI 675
VD++S G +L E+
Sbjct: 177 PYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EF--KNEVFVIGQTHHKNL 539
+E+G G FG V I T T V VK+L E+ EF + + + I Q H N+
Sbjct: 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKANASSKEQNEFLQQGDPYRILQ--HPNI 57
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------IAFQIARGLLY 592
++ LG C E LLV+E+ G L S+L + W+ R + +A +IA G+ +
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYL---SQEQWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
+H+ +H D+ +N L ++ D+G+ + + I+T V
Sbjct: 115 MHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETE---DDKCVPLR 166
Query: 653 W--------FRNSKITAK----VDVYSFGVLLLEIIACRK 680
W F ITA+ +V++ GV L E+
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA 206
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 5/102 (4%)
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
+I L +LH+ I++ D+K +NILLD + ++DFGL+K L++ K S G
Sbjct: 113 EIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYSFCG 168
Query: 645 TKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIIACRKSFDIE 685
T Y+APE R K VD +S G+L+ E++ F +E
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642
++Q+A G+ +L S +H D+ +N+L+ + +I DFGLA+ + + + K S
Sbjct: 245 SYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
++APE N+ T DV+SFG+LL EI
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 15/216 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+GRG+FG V ++ + K +++ + F+ E V+ ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 545 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
+ N LV ++ G L + L F + P R F +A ++ + +
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVIAIDSVHQLHYV 124
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR-GTKGYVAPEWFR-----N 656
H D+KP NIL+D + + R++DFG L L + T+++S+ GT Y++PE +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIE-MVEEYA 691
K + D +S GV + E++ F E +VE Y
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+ +Q+ARG+ +L S +H D+ +N+LL +I DFGLA+ + + + K
Sbjct: 241 SFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF-- 698
S ++APE ++ T DV+S+G+LL EI F + ++ D F
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI------FSLGGTPYPGMIVDSTFYN 351
Query: 699 ---DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
YR K D A +V +MV W +P RP+ + ++E ++
Sbjct: 352 KIKSGYRMAKPD-------HATQEV----YDIMVKCW--NSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 35/151 (23%), Positives = 49/151 (32%), Gaps = 50/151 (33%)
Query: 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWY 86
+ + G TL++ + F G F + I Y +TVVW
Sbjct: 1 SNPLSSGQTLVSSGSLFEL----GFFKLIMQ---------SRDYNLILYKGSS-RTVVWV 46
Query: 87 TDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASS 146
N+D + + L +D LV+ D G VWSS GN++L
Sbjct: 47 A-NRD--NPSGSSCTLTLQSDGNLVIYDGSGTVVWSS---------NTTRVNGNYVL--- 91
Query: 147 SSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177
LL DGNLVL
Sbjct: 92 ---------------------VLLDDGNLVL 101
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 7e-07
Identities = 33/110 (30%), Positives = 45/110 (40%), Gaps = 15/110 (13%)
Query: 80 EKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDI---GTVAVGHMN 136
+TVVW N+ N + L +D LVL D G+ VWSS G VAV +
Sbjct: 1 NQTVVWVA-NRL-NPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAV--LQ 56
Query: 137 DTGNFMLASSSSSRAF--FPKIGHQFSRGLFQFRLLKDGNLVLNIANLPT 184
D GN +L +S + F KDGN+V+ + T
Sbjct: 57 DDGNLVLYDNSGKVLWQSFDHPTDTL------LPGQKDGNVVIGGSRRLT 100
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 52/219 (23%), Positives = 100/219 (45%), Gaps = 43/219 (19%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FK----NEVFVI 531
D ++ + G++G+VY+ + T VA+KKL + + E+E F E+ ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKT---GEIVALKKLKM---EKEKEGFPITSLREINIL 58
Query: 532 GQTHHKNLVRL----LGFCDEGQNRL-LVYEF--------LNNGTLASFLFGNLKPNWNL 578
+ H N+V + +G +++ +V E+ + FL +K
Sbjct: 59 LKLQHPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLMETMK-QPFLQSEVK----- 109
Query: 579 RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ Q+ G+ +LH++ I+H D+K N+LL++ +I DFGLA+
Sbjct: 110 --CLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY- 163
Query: 639 KTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEII 676
T + T Y APE +K + +D++S G + E++
Sbjct: 164 -TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 6/134 (4%)
Query: 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL 613
L+ +++N G L + L + + +I L +LH+ II+ D+K +NILL
Sbjct: 82 LILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILL 138
Query: 614 DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR--NSKITAKVDVYSFGVL 671
D + + ++DFGL+K ++ + S GT Y+AP+ R + VD +S GVL
Sbjct: 139 DSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197
Query: 672 LLEIIACRKSFDIE 685
+ E++ F ++
Sbjct: 198 MYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-06
Identities = 20/70 (28%), Positives = 31/70 (44%), Gaps = 9/70 (12%)
Query: 240 FYHRATLNFDGVFAQYYYPRHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICSLNGD 299
Y R TL+ +G + + + +W++ WS P + C G CG C +N
Sbjct: 45 IYSRLTLSSEGSL-ERFTWIPNSQDWNLFWSAPKDQCDVY------GRCGPYGYCDVN-- 95
Query: 300 KRPMCDCPKG 309
P C+C KG
Sbjct: 96 TSPKCNCIKG 105
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 1e-06
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 18/160 (11%)
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGL 590
+ N ++L + +L+ +++ +G L F LK L I Q+ L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
LH IIH D+K +N+L D + D+GL K + GT Y
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK------IIGTPSCYDGTLDYF 173
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+PE + D ++ GVL E++ + F + EE
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 1e-06
Identities = 60/238 (25%), Positives = 109/238 (45%), Gaps = 51/238 (21%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTST----TAVAVKKLDIVFQDGEREFKN---EVFVIGQTH 535
+++G G FG V+ +++ RT A++ + L ERE EV V+ +
Sbjct: 19 KKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELK 70
Query: 536 HKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASF------LFGNLKPNWNLRTNIAFQIA 587
HKN+VR + F ++ +L ++ EF + G L+ +FG ++ + +I Q+
Sbjct: 71 HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH--AIVDITRQLL 128
Query: 588 RGLLYLHE----DCSSQIIHCDMKPQNILLD-------------DHYN----ARISDFGL 626
L Y H +++H D+KPQNI L ++ N A+I DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIIACRKSF 682
+K + + +++ S GT Y +PE K D+++ G ++ E+ + + F
Sbjct: 189 SKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+GRG+FG V ++TR + K +++ + F E ++ + +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCSSQIIH 603
+ + +V E++ G L NL N+++ A F A +L L S IH
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH 165
Query: 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR-GTKGYVAPEWFR----NSK 658
D+KP N+LLD + +++DFG + +N+ ++ GT Y++PE + +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 659 ITAKVDVYSFGVLLLEIIACRKSF 682
+ D +S GV L E++ F
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 13/207 (6%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV----AVKKLDIVF-QDGEREFKNEVFVIGQTHHKNL 539
+G+G +G V++ V + T T + +KK IV Q K E ++ H +
Sbjct: 4 LGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCS 598
V L+ G L+ E+L+ G L F +L+ + A F ++ L L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
II+ D+KP+NILLD + +++DFGL K + T + GT Y+APE S
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT--HTFCGTIEYMAPEILMRSG 176
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIE 685
VD +S G L+ +++ F E
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAE 203
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 54/185 (29%), Positives = 81/185 (43%), Gaps = 34/185 (18%)
Query: 508 VAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 567
V +K LD +D F ++ Q H +L + G C G ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 568 LF---GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624
L G + W + +A Q+A L YL ED ++H ++ +NILL AR+
Sbjct: 107 LRKEKGRVPVAWKI--TVAQQLASALSYL-ED--KNLVHGNVCAKNILL-----ARL--- 153
Query: 625 GLAKLLTLNQSKTIKTSIRGTK-------------GYVAPEWFRN-SKITAKVDVYSFGV 670
GLA+ S IK S G ++APE + ++ D +SFG
Sbjct: 154 GLAE----GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209
Query: 671 LLLEI 675
LLEI
Sbjct: 210 TLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 545 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
F DE N LV ++ G L + L F + P R F +A +L + +
Sbjct: 70 FQDE-NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYLAEMVLAIDSVHQLGYV 124
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR-GTKGYVAPEWFR-----N 656
H D+KP N+LLD + + R++DFG L L T+++++ GT Y++PE +
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIE-MVEEY 690
+ + D +S GV + E++ F E +VE Y
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 217
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 582 IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL-LTLNQSKTIKT 640
I + R + YLHE+ +IIH D+K +NI ++ + + DFG A + +N +K
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
+ GT APE VD++S G++L E+ C S
Sbjct: 244 A--GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+GRG+FG V + ++S A+K K +++ + F E ++ + + +V+
Sbjct: 51 IGRGAFGEVQ---LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 542 L-LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLLYLHEDCSS 599
L F D+ + +V E++ G L NL N+++ A F A +L L S
Sbjct: 108 LHYAFQDD-KYLYMVMEYMPGGDLV-----NLMSNYDIPEKWARFYTAEVVLALDAIHSM 161
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
IH D+KP N+LLD + +++DFG + N T++ GT Y++PE ++
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGG 220
Query: 660 TA----KVDVYSFGVLLLEII 676
+ D +S GV L E++
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 46/174 (26%), Positives = 66/174 (37%), Gaps = 40/174 (22%)
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA-FQIARGLL--- 591
H L L LV ++ G L L +P L +A F A LL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLALE 117
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTSIR------ 643
YLH I++ D+KP+NILL H + I SDF L+K + K +
Sbjct: 118 YLH---LLGIVYRDLKPENILL--HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 644 ---------------------GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
GT+ Y+APE + VD ++ G+LL E++
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN---- 633
L NI + L Y+HE I H D+KP+NI++D + I D+G+A ++
Sbjct: 127 LIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHI 183
Query: 634 -QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
SK K RGT Y + + +T + D+ S G +L+
Sbjct: 184 EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225
|
Length = 294 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 8/152 (5%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+ RG+FG VY G + VKK D++ ++ + + E + + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 545 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
N LV E+L G + S L +G ++ I+ ++A L YLH II
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY-IS-EVALALDYLHR---HGII 126
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634
H D+KP N+L+ + + +++DFGL+K +TLN+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSK-VTLNR 157
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 50/244 (20%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G G+FG V T ++K D++ ++ K E ++ + ++ +V+L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603
+ N V +++ G + S L + P R F IA L + IH
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLAR----FYIAELTLAIESVHKMGFIH 124
Query: 604 CDMKPQNILLDDHYNARISDFGLA------------------------------------ 627
D+KP NIL+D + +++DFGL
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 628 ---KLLTLNQ------SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC 678
+L TL Q + + S+ GT Y+APE T D +S GV+L E++
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 679 RKSF 682
+ F
Sbjct: 245 QPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 16/100 (16%)
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----------- 638
L YLH + I+H D+KP N+L+ + +++DFGL+K+ ++ + +
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 639 --KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
+ GT Y+APE VD ++ G++L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 29/95 (30%), Positives = 46/95 (48%), Gaps = 3/95 (3%)
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639
T +A Q+ + Y+H IIH D+K +N+L++ + + DFG A + S
Sbjct: 263 TAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
I GT APE T VD++S G+++ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 54/250 (21%), Positives = 95/250 (38%), Gaps = 62/250 (24%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G G+FG V T+ ++K D++ ++ K E ++ + ++ +VRL
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE-DCSSQ--- 600
+ N V +++ G + S L +R I F Y+ E C+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---------IRMGI-FPEDLARFYIAELTCAVESVH 118
Query: 601 ---IIHCDMKPQNILLDDHYNARISDFGLA------------------------------ 627
IH D+KP NIL+D + +++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 628 ---------KLLTL------NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
+L L + + S+ GT Y+APE + T D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 673 LEIIACRKSF 682
E++ + F
Sbjct: 239 YEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 52/241 (21%), Positives = 95/241 (39%), Gaps = 48/241 (19%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G G+FG V T ++K D++ ++ K E ++ + ++ +V+L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 545 FCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
+ N V +++ G + S L G + R IA ++ + +H+ I
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIA-ELTCAIESVHK---MGFI 123
Query: 603 HCDMKPQNILLDDHYNARISDFGL-----------------------------------A 627
H D+KP NIL+D + +++DFGL
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRC 183
Query: 628 KLLTL------NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS 681
+L L + + S+ GT Y+APE + T D +S GV+L E++ +
Sbjct: 184 RLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 243
Query: 682 F 682
F
Sbjct: 244 F 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 59/240 (24%), Positives = 94/240 (39%), Gaps = 58/240 (24%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+G+G+FG V ++Q T A+K L ++ +D K E V+ ++ +V
Sbjct: 9 IGKGAFGEVR--LVQKKDTGKI-YAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVS 65
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQIARGLLYLHEDCSS 599
L + Q L+ EFL G L + L ++ + F +A +L +
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLA-------------KL----------------- 629
IH D+KP NIL+D + ++SDFGL+ KL
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 630 -----LTLNQSKTIKT----------SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
LT++ I T S GT Y+APE F + D +S G ++ E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTT------RTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQ 533
F + +G G+FG V++ T + VAVK L ERE +E+ ++
Sbjct: 42 FGKTLGAGAFG----KVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 534 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 568
HKN+V LLG C G L++ E+ G L +FL
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 16/143 (11%)
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
N+V L + + LV + G L S + L A ++ L LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHR-- 103
Query: 598 SSQIIHC-DMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG---TKGYVAPEW 653
+ I C D+ P NILLDD + +++ F + ++ S G Y APE
Sbjct: 104 --EGIVCRDLNPNNILLDDRGHIQLTYFS--------RWSEVEDSCDGEAVENMYCAPEV 153
Query: 654 FRNSKITAKVDVYSFGVLLLEII 676
S+ T D +S G +L E++
Sbjct: 154 GGISEETEACDWWSLGAILFELL 176
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 50/217 (23%), Positives = 98/217 (45%), Gaps = 26/217 (11%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVR 541
+VGRG++G VYK + + A+K+++ + RE + ++ + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGK-DEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIA 62
Query: 542 LLG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPNWNLRT---NIAFQIARGLL 591
L F ++ L++++ + F N KP R+ ++ +QI G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 592 YLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTS-IRGTK 646
YLH ++ ++H D+KP NIL+ + +I+D G A+L + T
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 647 GYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSF 682
Y APE ++ T +D+++ G + E++ F
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 54/231 (23%), Positives = 103/231 (44%), Gaps = 33/231 (14%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVR 541
+VGRG++G VYK + + A+K+++ + RE + ++ + H N++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRD-YALKQIEGTGISMSACRE----IALLRELKHPNVIS 62
Query: 542 LLG-FCDEGQNRL-LVYEFLNNGTLASFLF-----GNLKPNWNLR---TNIAFQIARGLL 591
L F ++ L++++ + F N KP R ++ +QI G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 592 YLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTS-IRGTK 646
YLH ++ ++H D+KP NIL+ + +I+D G A+L + T
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 647 GYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIA------CRKSFDIEMVEEY 690
Y APE ++ T +D+++ G + E++ CR+ DI+ Y
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNPY 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.84 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.65 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.63 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.61 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.49 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.47 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.13 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.02 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.93 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.73 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.72 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.72 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.67 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.58 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.31 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.88 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.68 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.67 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.62 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.29 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.12 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.95 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 96.43 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.11 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.82 | |
| PLN02236 | 344 | choline kinase | 95.71 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.66 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.18 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.12 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.0 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.88 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.6 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.6 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.16 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 93.95 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.4 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 92.66 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=462.31 Aligned_cols=286 Identities=46% Similarity=0.774 Sum_probs=253.4
Q ss_pred cccccCHHHHHHHHHhhh--hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeE
Q 037189 465 NLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542 (766)
Q Consensus 465 ~~~~~~~~~l~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 542 (766)
..+.|++.|+.+||.+|+ ..||+|+||.||+|.+.+ +..||||++.....+..++|.+|+.++.+++|||||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~----~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~L 136 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD----GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKL 136 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC----CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccE
Confidence 578899999999999999 589999999999999973 47999998876443326679999999999999999999
Q ss_pred eeeeecCC-ceEEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCe
Q 037189 543 LGFCDEGQ-NRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA 619 (766)
Q Consensus 543 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 619 (766)
+|||.+.+ +.+||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.+.|+|||||++|||||+++++
T Consensus 137 lGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 137 LGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99999999 4999999999999999999865 88999999999999999999999989999999999999999999999
Q ss_pred EEeccCccccccc-CCCcceeecc-cccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH
Q 037189 620 RISDFGLAKLLTL-NQSKTIKTSI-RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA 697 (766)
Q Consensus 620 kl~Dfgla~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 697 (766)
||+|||+++.... .... ... .||.+|+|||++..+..++|+|||||||+|+||+||+++.+.........+..|+
T Consensus 217 KlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred EccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 9999999976554 2211 112 7999999999999999999999999999999999999998866544444588999
Q ss_pred HHHhhcCccceeccCccc-CCCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 698 FDCYRNGKLDALVGGDME-AMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
+..+.++.+.+++|+.+. ...+. +...++.+++.+|++.+|.+||+|.+|+++|+.+...
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999999976 44443 6888899999999999999999999999999776654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=389.24 Aligned_cols=253 Identities=34% Similarity=0.540 Sum_probs=211.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHHHHHHHHHccCCCCCeeeEeeeeecCC-ceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~ 556 (766)
.+.+.||+|+||+||+|.+.. ...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++||
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g----~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRG----TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred hhhhhcccCCceeEEEEEeCC----ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 345669999999999999973 2349999997644333 458999999999999999999999999988 799999
Q ss_pred eccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCc-eecCCCccceEEEcCCC-CeEEeccCccccccc
Q 037189 557 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQ-IIHCDMKPQNILLDDHY-NARISDFGLAKLLTL 632 (766)
Q Consensus 557 Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 632 (766)
|||++|+|.++++. ...+++..+++|+.|||+||.|||++ . ||||||||+|||++.++ ++||+|||+++....
T Consensus 120 Ey~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999988 57899999999999999999999965 5 99999999999999997 999999999997765
Q ss_pred CCCcceeecccccCccccccccc--CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFR--NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
.. ...+...||..|||||++. ...++.|+||||||++||||+||+.||....... . +....
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--~----~~~v~--------- 259 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--V----ASAVV--------- 259 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--H----HHHHH---------
Confidence 32 1124467999999999999 5699999999999999999999999998665411 1 11111
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+...+..++..+..++.+||+.||..||++.+++..|+.+..
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 1122333344478899999999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=387.70 Aligned_cols=264 Identities=30% Similarity=0.443 Sum_probs=224.8
Q ss_pred HHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 472 ~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
-++......+.++||+|.||.|+.|.++. ...||||.++.. ....+.|.+|+++|++++|+|||+++|+|..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcC----CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 45666777788999999999999999973 457999998764 4566889999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 552 RLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
++||||||+.|+|.+||+. +..++..+.+.++.|||+|++||+ +..+|||||.++||||+++..+||+||||++.
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999999986 567889999999999999999999 56999999999999999999999999999995
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
...+... ......-+..|.|||.+..+.|+.|||||||||+||||+| |+.|+......+. .+
T Consensus 353 ~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev-------~~--------- 415 (468)
T KOG0197|consen 353 IGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV-------LE--------- 415 (468)
T ss_pred cCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH-------HH---------
Confidence 5544432 2244456789999999999999999999999999999999 8888765543331 11
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~p 760 (766)
.++...+...+..|+.++.+||..||+.+|++|||++.+...|+.+.....+
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 2223344555778999999999999999999999999999999988765543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=365.56 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=210.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-eEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN-RLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~Ey 558 (766)
..+.||+|..|+|||+.++. .++.+|+|.+.... +...+++.+|++++++.+||+||+++|.|..... ..++|||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhcccCCCcEEEEEEEcC---CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 45789999999999999985 56799999995433 3345789999999999999999999999999884 9999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
|.+|+|++++...+++++....+|+.+|++||.|||+ ..+|+||||||+|||++..|++||+|||.++.+... .
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----I 233 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----h
Confidence 9999999999988899999999999999999999996 369999999999999999999999999999987654 2
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||..|||||.+.+..|+.++||||||+.++|+.+|+.|+........ ...+. +..++++......
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-~~~~L---------l~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-DIFEL---------LCAIVDEPPPRLP 303 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-CHHHH---------HHHHhcCCCCCCC
Confidence 3567899999999999999999999999999999999999999976421111 11111 1223332222222
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...++++++.++..||++||.+|||++|++++
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22588999999999999999999999998864
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=402.95 Aligned_cols=269 Identities=29% Similarity=0.487 Sum_probs=230.1
Q ss_pred HHHHHHHHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeec
Q 037189 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDE 548 (766)
Q Consensus 472 ~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (766)
.++......|.++||+|+||.||+|+..... .....||||.++..... ..++|++|++++..++|||||+|+|+|.+
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 4566666778899999999999999987644 45689999999876665 67899999999999999999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccC----------CC----CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGN----------LK----PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~----------~~----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
++..+||+|||.+|||.+||... .. ++..+.+.||.|||.|+.||- +..+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence 99999999999999999999632 22 667789999999999999999 45999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAIL 693 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 693 (766)
++..+||+||||++.....+.........-+.+||+||.|..++||++||||||||+|||+.+ |+.|+....-++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 999999999999998877666554434445789999999999999999999999999999999 999987654333
Q ss_pred HHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 037189 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759 (766)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~ 759 (766)
+.+.++++.+ ...+..++.++.+||..||+.+|.+||+++||-..|+.....+.
T Consensus 714 ---VIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 714 ---VIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred ---HHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 3444555544 23467789999999999999999999999999999988665443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=360.10 Aligned_cols=202 Identities=32% Similarity=0.500 Sum_probs=181.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|.|++||+|+++. ++..||||.+... .....+.+..|+.+|+.++|||||+|++++..++..+|||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ceehhhccCcceEEEEEeEecc---CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3456779999999999999986 4589999999765 3334556889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC------CCeEEeccCccccc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH------YNARISDFGLAKLL 630 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfgla~~~ 630 (766)
|||.+|+|.+||+..+.+++.....++.|||.||++||+ .+|+||||||+||||+.. -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999994 599999999999999764 45899999999998
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~ 689 (766)
..... ....+|++-|||||++..++|+.|+|+||+|+|||++++|+.||+.....+
T Consensus 166 ~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 166 QPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred CchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 85543 356899999999999999999999999999999999999999998766554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=358.56 Aligned_cols=254 Identities=26% Similarity=0.410 Sum_probs=208.8
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-------CHHHHHHHHHHHccCCCCCeeeEeeeee
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-------GEREFKNEVFVIGQTHHKNLVRLLGFCD 547 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~ 547 (766)
....+-.++.||+|+||.|-+|..+. .++.||||+++..... ......+|+++|++++|||||++++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee
Confidence 44555667899999999999999875 5789999999653211 2233579999999999999999999999
Q ss_pred cCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEecc
Q 037189 548 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISDF 624 (766)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Df 624 (766)
..+..|||||||++|+|.+++-.++.+.+..-..++.|++.|+.||| +.+|+||||||+|||+..+ ..+||+||
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999999999999999999999999999999999 4599999999999999766 78999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCC---CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI---TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|+|+..+... .....|||+.|.|||++.+... ..+.|+||+|||||-+++|.+||.....+.. +.+.+
T Consensus 324 GlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------l~eQI 394 (475)
T KOG0615|consen 324 GLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------LKEQI 394 (475)
T ss_pred chhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc------HHHHH
Confidence 9999877432 3366899999999999987643 3478999999999999999999976543221 12223
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..|+... ......+.+++..+++.+||..||+.|||+.|+++
T Consensus 395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3333221 12234567889999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=382.52 Aligned_cols=272 Identities=24% Similarity=0.453 Sum_probs=232.0
Q ss_pred ccccCHHHHHHHHHhhh-----------hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHcc
Q 037189 466 LRCFSYKELEEATDNFK-----------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQ 533 (766)
Q Consensus 466 ~~~~~~~~l~~~t~~f~-----------~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~ 533 (766)
...++|++--.|-.+|. +.||.|.||.||+|.++..++....||||.++... +....+|+.|..+|.+
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQ 686 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQ 686 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhccc
Confidence 45678887777777665 35999999999999999888788999999998654 4456789999999999
Q ss_pred CCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 534 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
++||||++|.|+.......+||.|||+||+|+.||+.+ .++.+.+...++++||.|++||. ..++|||||.++|||
T Consensus 687 FdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNIL 763 (996)
T ss_pred CCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhhee
Confidence 99999999999999999999999999999999999865 57899999999999999999999 559999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecc--cccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSI--RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEE 689 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~ 689 (766)
++.+..+||+|||++|.+..+..... +.. .-+.+|.|||.+...+++.+|||||||+|+||.++ |.+|+-.....+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eccceEEEeccccceeecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 99999999999999997765542221 222 23679999999999999999999999999999998 999986544322
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
. .. .+....+...+.+|+..|.+||+.|||+|-.+||++.+++.+|++++..
T Consensus 843 V-------Ik---------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 V-------IK---------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred H-------HH---------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1 11 1233455667889999999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=369.75 Aligned_cols=249 Identities=26% Similarity=0.374 Sum_probs=213.8
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
.++...+.||+|||+.+|+++... .+..+|+|.+... .....+...+||++.++++|||||+++++|++.+..|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceE
Confidence 345556789999999999999853 5679999999752 3445677899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||.|+|.+++|.++++.++.+++.+++.++.||+.||.||| +.+|+|||||..|+||+++.++||+|||||..+..+
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999999999999999999999999999999 559999999999999999999999999999988765
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.... ...+||+.|+|||++.....+..+||||+|||||-||.|++||+.....+... .++..
T Consensus 172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~~--------- 233 (592)
T KOG0575|consen 172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKLN--------- 233 (592)
T ss_pred cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHhc---------
Confidence 4332 56899999999999999999999999999999999999999998765433211 11111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+...+.+..+|+.++|+.||.+|||+.+|+..
T Consensus 234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 112234556788899999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=335.55 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=210.8
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccCHHHHHHHHHHHccCCCCCeeeEee-eeecCC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRLLG-FCDEGQ 550 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~ 550 (766)
...+.+.+.++||+|.||+|||+.... +++.+|.|.++. .+....+....|+.+|++++|||||++++ -+.++.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeecc---CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 345667788999999999999999875 577999999863 23344567899999999999999999998 455555
Q ss_pred c-eEEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcC-CCceecCCCccceEEEcCCCCeEEecc
Q 037189 551 N-RLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC-SSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 551 ~-~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
+ ..|||||+..|+|...++. .+.+++..+++++.|++.||.++|... ...|+||||||.||+|+++|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 8899999999999998863 467899999999999999999999632 123999999999999999999999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
|+++.+...... ....+|||.||+||.+...+++.||||||+||++|||+.-.+||...+..+ +.+.+.++
T Consensus 173 GL~r~l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-------L~~KI~qg 243 (375)
T KOG0591|consen 173 GLGRFLSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-------LCKKIEQG 243 (375)
T ss_pred hhHhHhcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-------HHHHHHcC
Confidence 999998765443 356789999999999999999999999999999999999999998764322 22333333
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
+. ......-.+..+.+|+..|+..||+.||+...+++.+
T Consensus 244 d~--------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 244 DY--------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred CC--------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 32 2222356788999999999999999999955555444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=345.87 Aligned_cols=268 Identities=25% Similarity=0.388 Sum_probs=221.5
Q ss_pred HHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCH-HHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 471 ~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
..|..+..-.|.|+||+|-||.|.++... ....||||+++....... ++|.+|+++|.+++||||++|+|+|..+
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEec----CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 44666677778899999999999999986 368999999987665544 8999999999999999999999999999
Q ss_pred CceEEEeeccCCCchhhhhccCCC--CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
+.+++|+|||++|+|..|+..... +.-..-.+|+.||+.|++||. +..++||||.++|+|++.++++||+|||++
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence 999999999999999999987643 344556789999999999999 679999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh--CCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA--CRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
+.+..++.........-+.+|||||.+..++++.++|||+||+.|||+++ ...|++....+..... .....+.+.
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven---~~~~~~~~~ 761 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN---AGEFFRDQG 761 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh---hhhhcCCCC
Confidence 98887776665555567889999999999999999999999999999865 6678865544332222 112222222
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
... ....+.-++..+.+++.+||..+..+||+++++...|.+.
T Consensus 762 ~~~------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQV------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cce------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 211 1233566889999999999999999999999999988653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.43 Aligned_cols=266 Identities=24% Similarity=0.269 Sum_probs=209.1
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (766)
..++-.++||+|.||.||||+... .++.||+|+++... +....-..+||.+|++++||||++|.+...+. ..+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 344456789999999999999875 57899999998654 33345568999999999999999999998776 689
Q ss_pred EEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 553 LLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
|||+|||++ +|.-++.. ..++++.++..++.|++.||.|+| +.+|+|||||.+|||||++|.+||+|||||+++.
T Consensus 194 YlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999999998 88888776 467899999999999999999999 5699999999999999999999999999999888
Q ss_pred cCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH-----HHhhcCc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF-----DCYRNGK 705 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~ 705 (766)
....... +..+-|.+|.|||.+.+. .|+.++|+||.||||.||+.|++.+....+-+....+-.+. ..|...+
T Consensus 270 ~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 7665543 677789999999999875 79999999999999999999999998876544332221111 1111111
Q ss_pred cce--eccCcccCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDA--LVGGDMEAM-----NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~--~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.. ...+..... .-...+...++|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 110 000000000 012235667889999999999999999998854
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=378.76 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=218.8
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCc--eeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTS--TTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~--~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
+......+.+.||+|.||.||.|.......+ ...||||.++.. +.+...+|++|..+|++++|||||+++|+|.+..
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4455566777899999999999998865433 456999999764 4556678999999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccC-------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 551 NRLLVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
..+|++|||++|+|..||++. ..+.....+.|+.|||+|+.||+ +.++|||||.++|+||++...+||+|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999865 35678888999999999999999 45999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+|+.+...+.........-+.+|||||.+..+.|+.|+|||||||+|||++| |..||......+. .....+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~ 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLE 919 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHh
Confidence 999996665544333222244679999999999999999999999999999999 8888875443221 111222
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+ +...+..|++.+.+||..||+.+|++||++..+++.++.+..
T Consensus 920 gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 920 GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 22 233467789999999999999999999999999998877654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=318.87 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=204.8
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
-..++|+|+||.|||+++++ .++.||||++....++. .+-.++|+++|++++|+|+|.|+.+|......+||+||
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred hhhccccCcceEEEEeccCC---cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 34579999999999999885 57899999996544322 34579999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
++.--|.+.-+.....+.+...+++.|+++|+.|+| +.+++||||||+||||+.++.+||+|||+|+.+... ...
T Consensus 83 ~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p--gd~ 157 (396)
T KOG0593|consen 83 CDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP--GDN 157 (396)
T ss_pred cchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC--cch
Confidence 999777766555566788899999999999999999 559999999999999999999999999999988742 223
Q ss_pred eecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH--------HHHhh-cCccce
Q 037189 639 KTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA--------FDCYR-NGKLDA 708 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~ 708 (766)
.+.++.|.+|.|||.+.+ .+|...+||||+||++.||++|.+.|...+.-+..-..... ..... +....-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 367889999999999987 68999999999999999999999999776543322211111 11111 111111
Q ss_pred eccCcccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+.-+......+ +.....+.+++..|++.||++|++-++++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111111 234557889999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=355.91 Aligned_cols=265 Identities=29% Similarity=0.388 Sum_probs=215.2
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeE-EEEEEeec---ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTA-VAVKKLDI---VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~-vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
.....+.++||+|+||.||+|.+......... ||||..+. ......++|++|.++|++++|||||+++|++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 33444568999999999999999875432233 99999875 335556889999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+++|||+|.||+|.+||.... .++..+++.++.++|.||+||| +..++||||.++|+|+..+..+||+|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999999999876 5999999999999999999999 569999999999999999999999999998865
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
...... .....-+.+|+|||.+....++.++|||||||++||+.+ |..|+......+. ..++ ..++
T Consensus 313 ~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---~~kI---~~~~----- 379 (474)
T KOG0194|consen 313 SQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---KAKI---VKNG----- 379 (474)
T ss_pred cceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---HHHH---HhcC-----
Confidence 411111 112245789999999999999999999999999999999 8889876554321 1111 0111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~p 760 (766)
.+...+...+..+..++.+||..+|++||+|.++.+.|+.+.....+
T Consensus 380 ----~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 380 ----YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11222335577788899999999999999999999999887765544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.87 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=204.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC--ceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 555 (766)
.....+.||+|.||.||++...+ .+...|||.+........+.+.+|+++|++++|||||+.+|...... .+++.
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhhccccCccceEEEEEEecC---CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 34566889999999999999875 36789999987653333567899999999999999999999854444 58899
Q ss_pred eeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++|+|.+++...+ .++++.+..++.||++||+||| +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999998765 7999999999999999999999 569999999999999999 799999999999977641
Q ss_pred -CCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 -QSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 -~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..........||+.|||||++..+ ....++|||||||++.||+||++||... .....+......+....
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P---- 242 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP---- 242 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC----
Confidence 111222457899999999999964 3446999999999999999999999753 11112222222222111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..+...+.+..+++.+|++.+|++|||+.++++..
T Consensus 243 -----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 243 -----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 22444678889999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.02 Aligned_cols=251 Identities=26% Similarity=0.317 Sum_probs=212.3
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
...|.+.||+|+|++|++|+... .++.+|||.+.+. .+...+-...|-..|.+| +||.|++|+-.|.++..+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred hcchhheeccccceeEEEeeecC---CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 45688999999999999999875 5789999998642 234445677888889998 8999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|+||+++|+|.++|++.+.+++.....++.+|+.||+||| +.+||||||||+|||||.++++||.|||-|+.+.+.
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999 669999999999999999999999999999988654
Q ss_pred CCc---------ce--eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 634 QSK---------TI--KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 634 ~~~---------~~--~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
... .. ....+||..|.+||++..+..+..+|+|+||||||+|+.|.+||...++.- .+...
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--iFqkI------ 299 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--IFQKI------ 299 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--HHHHH------
Confidence 322 11 144789999999999999999999999999999999999999998665321 11110
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
+ .+....++..++.+.+|+.+.|..||.+|+|.+++-++.
T Consensus 300 -------~--~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 300 -------Q--ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -------H--HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 0 122334555668889999999999999999999988764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=343.66 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=210.2
Q ss_pred HHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 472 ~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
-||......+.+.||+|.||+||+|.+.. .||||.+..... +..+.|.+|+..+++-+|.||+-++|+|...
T Consensus 387 WeIp~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 387 WEIPPEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccCHHHhhccceeccccccceeeccccc------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34555555667899999999999999864 699999976543 3457899999999999999999999999988
Q ss_pred CceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
.. .||..+|++.+|+.+|+-. .+++....+.||.|||+|+.||| .++|||||||..||+|.+++++||.|||++.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccccee
Confidence 77 9999999999999999864 67888999999999999999999 5699999999999999999999999999997
Q ss_pred ccccCCCcceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
.-..-..........|...|||||+++. .+|++.+||||||+|+|||++|..|+.....+. +.-.+..|.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq-------IifmVGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ-------IIFMVGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh-------eEEEecccc
Confidence 5433211111123447788999999974 379999999999999999999999998433221 111111221
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+. +++ ......++.+|.+|+..||..++++||.+.+|+..|+.++.
T Consensus 610 l~----pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 610 LM----PDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cC----ccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 10 000 11134578899999999999999999999999999988766
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.08 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=208.2
Q ss_pred cCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec
Q 037189 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE 548 (766)
Q Consensus 469 ~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (766)
..+++|.+. +=||.|+.|.||+|++. ...||||+++... ..+|+-|++++|+||+.+.|+|..
T Consensus 121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~-----netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 121 IPFEEISEL-----EWLGSGAQGAVFLGRLH-----NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred CCHHHhhhh-----hhhccCcccceeeeecc-----CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 445555443 34999999999999986 5689999986432 346888999999999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
..-++||||||..|-|...|+.+..+.......+..+||.|+.|||.+ .|||||||+-||||..+..+||+|||-++
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 999999999999999999999999999999999999999999999954 99999999999999999999999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
..... .....++||..|||||++.+.+.++|+|||||||||||||||..|+..-.... + .|.
T Consensus 261 e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--I-------IwG------ 322 (904)
T KOG4721|consen 261 ELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--I-------IWG------ 322 (904)
T ss_pred hhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--e-------EEe------
Confidence 76543 22356889999999999999999999999999999999999999986432110 0 000
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
+-...+....+..+++-+.-|+++||+-.|..||++++++.+|+-
T Consensus 323 VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 323 VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 111223445577889999999999999999999999999999953
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=349.72 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=203.4
Q ss_pred HHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC-c
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ-N 551 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~ 551 (766)
..+.+.++||+|+||.||+|.... ....+..||||+++.... ...+.+.+|+.++.++ +||||++++++|...+ .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 445677899999999999998642 122456899999875332 2345789999999999 8999999999987654 5
Q ss_pred eEEEeeccCCCchhhhhccC------------------------------------------------------------
Q 037189 552 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 571 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 571 (766)
.++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999998642
Q ss_pred --CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCccc
Q 037189 572 --LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649 (766)
Q Consensus 572 --~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 649 (766)
..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...............++..|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 125566778899999999999994 599999999999999999999999999998764433222222344678899
Q ss_pred ccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHH
Q 037189 650 APEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVM 728 (766)
Q Consensus 650 aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 728 (766)
|||++.+..++.++||||||++||||++ |..||......+. .......+... ..+...+..+.+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~l~~ 308 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTRM---------RAPENATPEIYR 308 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCCC---------CCCCCCCHHHHH
Confidence 9999999999999999999999999997 9999875432211 11111111111 112234567899
Q ss_pred HHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 729 VSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 729 l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
++.+||+.||++|||+.++++.|+.+++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=331.61 Aligned_cols=267 Identities=28% Similarity=0.406 Sum_probs=205.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc--CCCCCeeeEeeeeecCC----ce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDEGQ----NR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~ 552 (766)
.++.+.||+|+||.||||++. .+.||||++.. +..+.|++|-.+.+. ++|+||+++++.-.... ++
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-----~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-----NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-----CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 446789999999999999996 47999999863 456678888777665 68999999999987666 88
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC------CCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------SSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
.||+||.+.|+|.+||..+ .++|....+|+..+++||+|||++. .++|+|||||++||||.+|++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999765 5799999999999999999999875 56799999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCC-CC-----cccCeeehhHHHHHHHhCCcCCCchhhhhhhh-H------
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK-IT-----AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-L------ 693 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~------ 693 (766)
|..+..+.........+||.+|||||++.+.- +. .+.||||+|.|||||++.-..+......++.. .
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 99998777666556688999999999997652 22 36999999999999999665443211111110 0
Q ss_pred ---HHHHHHHhhcCc-cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 694 ---TDWAFDCYRNGK-LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 694 ---~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
.+..+..+..++ -..+.+.-. ....+..+++.+..||..|++.|.|+.=|.+.+.++..+.
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p~~W~----~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIPDAWR----KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCHHHHHHHHHhhccCCCChhhhh----cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 011111111111 111111111 1234677899999999999999999998888887765544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.27 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=207.5
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHH--HHHHHHHccCC-CCCeeeEeeeeecCC-
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF--KNEVFVIGQTH-HKNLVRLLGFCDEGQ- 550 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f--~~E~~~l~~l~-H~niv~l~g~~~~~~- 550 (766)
....|...++||.|.||.||+|+... .+..||||+++..... .++. ++|++.|++++ ||||++|..++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 34456778999999999999999875 4567999999764433 3333 78999999999 999999999998888
Q ss_pred ceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..++|||||+. +|.+.++++ ..+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+..+||+|||+||.
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccc
Confidence 89999999976 899999876 5679999999999999999999954 999999999999999999999999999998
Q ss_pred cccCCCcceeecccccCccccccccc-CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc-
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD- 707 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 707 (766)
+...... +.++.|.+|.|||++. .+.|+.+.|+||+|||++|+.+-++.|.+.++-+... .+.+.+.....+
T Consensus 160 v~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~---KIc~VLGtP~~~~ 233 (538)
T KOG0661|consen 160 VRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY---KICEVLGTPDKDS 233 (538)
T ss_pred cccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH---HHHHHhCCCcccc
Confidence 7755433 6788999999999874 6689999999999999999999999997765433211 111111111100
Q ss_pred ----------------eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ----------------ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ----------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.....+.... ...+.+..+++.+|++-||.+|||+.+.+++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00011111111 2367889999999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.91 Aligned_cols=261 Identities=20% Similarity=0.326 Sum_probs=208.7
Q ss_pred cccccCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeee
Q 037189 465 NLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVR 541 (766)
Q Consensus 465 ~~~~~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~ 541 (766)
+++.++++++...+ ...||+|+++.||+|... ++.||||.++...... .+.|.+|+.++.+++||||++
T Consensus 11 ~~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 82 (283)
T PHA02988 11 DIKCIESDDIDKYT---SVLIKENDQNSIYKGIFN-----NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILK 82 (283)
T ss_pred cceecCHHHcCCCC---CeEEeeCCceEEEEEEEC-----CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEE
Confidence 45556666663211 136999999999999873 5789999997654333 467889999999999999999
Q ss_pred Eeeeeec----CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC
Q 037189 542 LLGFCDE----GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY 617 (766)
Q Consensus 542 l~g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 617 (766)
+++++.+ ....++||||+++|+|.+++.....+++....+++.|++.||.|||+ ..+++||||||+||++++++
T Consensus 83 ~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 83 IYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENY 160 (283)
T ss_pred EeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCC
Confidence 9999876 34678999999999999999988889999999999999999999995 24788999999999999999
Q ss_pred CeEEeccCcccccccCCCcceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHH
Q 037189 618 NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD 695 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 695 (766)
.+||+|||+++.+.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.
T Consensus 161 ~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~----- 230 (283)
T PHA02988 161 KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI----- 230 (283)
T ss_pred cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence 99999999998654322 23457889999999976 6899999999999999999999999975543221
Q ss_pred HHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..+. .....+..++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 231 --~~~i~~~~--------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 231 --YDLIINKN--------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred --HHHHHhcC--------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111110 111122345678999999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=324.49 Aligned_cols=241 Identities=28% Similarity=0.357 Sum_probs=202.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
..++.+.||+|+||.||.++.++ .++.+|+|.+++.. ....+...+|..+|.+++||+||+++-.|.+.++.||
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 34456899999999999999874 56789999886533 3345678899999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|+||+.||.|..+|.+...+++....-.+..|+.||.||| +.+|+||||||+|||||++|.++|+|||+++..-...
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 9999999999999999999999999999999999999999 5699999999999999999999999999999654433
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....+||+.|||||++.+..++..+|.||+|+++|||++|.+||...+.... .+.+..+++
T Consensus 180 ~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k~-------- 242 (357)
T KOG0598|consen 180 DA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGKL-------- 242 (357)
T ss_pred Cc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCcC--------
Confidence 22 2457999999999999999999999999999999999999999987654331 111112221
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
...+.-.+.+.++++.+.|+.||++|-
T Consensus 243 -~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 243 -PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111222467788999999999999995
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=330.00 Aligned_cols=260 Identities=22% Similarity=0.355 Sum_probs=209.2
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
....+.+.+.||+|+||.||+|.+.........+|+|.++.... .....|.+|+..+.+++||||+++++++...+..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 44556678899999999999998865555678999999875432 23457899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999764 568999999999999999999995 5999999999999999999999999998765432
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. ......+.
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~~~~------ 225 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-------IKAVEDGF------ 225 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCC------
Confidence 2111 1112335678999999999999999999999999999875 9999975443221 11111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
....+..++..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 226 ---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112334567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=301.17 Aligned_cols=259 Identities=23% Similarity=0.303 Sum_probs=205.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
|.-.++||+|.||.||+|+... .++.||||+++.... .-.....+|++.|+.++|+||+.|++++.+.+...||+
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4445789999999999999775 567899999976432 22457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+. +|+..+++. ..+...++..++.++++||+||| ...|+||||||.|+|+++++.+||+|||+++.+.....
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 99986 899999876 45678889999999999999999 45999999999999999999999999999998876543
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc------e
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD------A 708 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 708 (766)
.. +..+-|.+|.|||.+.+. .|+...|+||.|||+.||+-|.+.|.+.+.-+.... +...+.....+ .
T Consensus 157 ~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~---If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 157 IQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSK---IFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHH---HHHHcCCCCcccCccccc
Confidence 32 334679999999998765 699999999999999999999998877654332221 12222111111 1
Q ss_pred ec---------cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 LV---------GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~~---------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+. .+.... .-..+...+.+++..++..||.+|+|++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 10 111111 112345667999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=335.12 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=211.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
++||+|.-|.||.+.-.. .++.||||++........+-+.+|+.+|+..+|+|||++++.+...++..+|||||++|
T Consensus 279 ~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKIS---TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hhhccccccceeeeeecc---CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCC
Confidence 579999999999998764 45689999998877777777899999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecc
Q 037189 563 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642 (766)
Q Consensus 563 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 642 (766)
+|.|.+... .+++.++..|+.++++||+||| ..+|+|||||.+|||++.++.+||+|||++..+...... ....
T Consensus 356 sLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~Tm 429 (550)
T KOG0578|consen 356 SLTDVVTKT-RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTM 429 (550)
T ss_pred chhhhhhcc-cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccc
Confidence 999988654 4899999999999999999999 569999999999999999999999999999988766542 3567
Q ss_pred cccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHH
Q 037189 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVEC 722 (766)
Q Consensus 643 ~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (766)
.||+.|||||++....|.+|.||||||++++||+-|.+||-.+..... .+.... .+.++...+...
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa~--------ng~P~lk~~~kl 495 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIAT--------NGTPKLKNPEKL 495 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHhh--------cCCCCcCCcccc
Confidence 899999999999999999999999999999999999999976443221 111111 223344446667
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 723 LEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 723 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+..+.+++.+||+.|+++||++.|+|++
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 8899999999999999999999999874
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.97 Aligned_cols=252 Identities=34% Similarity=0.548 Sum_probs=199.6
Q ss_pred hhhhccccccceEEEEEEe-cCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQ-TTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~-~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.||.|.||.||+|.+. ........|+||.++.... ...++|.+|++.+++++||||++++|+|.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999998 4555678999999965332 2367899999999999999999999999988889999999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+++|+|.++|... ..+++..+..|+.||++||+|||+ .+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 778999999999999999999995 48999999999999999999999999999877433332
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
...........|+|||.+....++.++||||||+++|||++ |+.|+......+ + ...+.++..
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~----~~~~~~~~~--------- 223 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---I----IEKLKQGQR--------- 223 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---H----HHHHHTTEE---------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---c----ccccccccc---------
Confidence 22233456789999999999999999999999999999999 678876543221 1 111122211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
...+..++..+.+++.+||+.+|++||||+++++.|
T Consensus 224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112333567788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.83 Aligned_cols=262 Identities=27% Similarity=0.406 Sum_probs=204.8
Q ss_pred HHHHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (766)
....+.+.+.||+|+||.||+|+... .......||||.++... ....+.+.+|++++..+ +||||++++++|.+.+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 34456678999999999999997532 12345689999986433 23345789999999999 8999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCC----------------------------------------------------------
Q 037189 551 NRLLVYEFLNNGTLASFLFGNL---------------------------------------------------------- 572 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 572 (766)
..++||||+++|+|.+++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999985421
Q ss_pred -----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 573 -----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 573 -----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
.+++..+.+++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 35677888999999999999994 5999999999999999999999999999987654332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ...+..+..
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~~~~-------- 335 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF----YKMIKEGYR-------- 335 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH----HHHHHhCcc--------
Confidence 222223345678999999999999999999999999999998 888886433211 11 111111110
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
...+...+.++.+++.+||+.||++||++.+|++.|++.
T Consensus 336 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 -MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011122356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=335.09 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=207.5
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc----cc-cCHHHHHHHHHHHccCC-CCCeeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV----FQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 550 (766)
..+.+.+.||+|.||.|++|.+.. .+..||||.++.. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345567889999999999998875 3478999976542 11 23456678999999999 999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCcccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKL 629 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~ 629 (766)
..++||||+.+|+|.+++....++.+.....++.|++.|++||| +.+|+||||||+|||++.+ +++||+|||++..
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999999999889999999999999999999999 5699999999999999999 9999999999998
Q ss_pred cccCCCcceeecccccCcccccccccCCC-CC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSK-IT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
... ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... ....+..+..
T Consensus 171 ~~~--~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-------l~~ki~~~~~- 240 (370)
T KOG0583|consen 171 SPG--EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-------LYRKIRKGEF- 240 (370)
T ss_pred cCC--CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-------HHHHHhcCCc-
Confidence 741 112225678999999999999977 86 78999999999999999999998743221 1111222221
Q ss_pred eeccCcccCCCcHHH-HHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 708 ALVGGDMEAMNDVEC-LEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..+... +.++..++.+|++.||.+|+|+.+++ .-.-+.
T Consensus 241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 112223 77889999999999999999999999 443344
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.71 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=202.9
Q ss_pred HHhhhhhccccccceEEEEEEecCC-------------CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTR-------------TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~-------------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (766)
.+.+.++||+|+||.||++...... ..+..||+|.+.... .....+|.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 4456788999999999999864321 234579999987532 22346799999999999999999999
Q ss_pred eeeecCCceEEEeeccCCCchhhhhccC-------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecC
Q 037189 544 GFCDEGQNRLLVYEFLNNGTLASFLFGN-------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHC 604 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 604 (766)
+++.+.+..++||||+++|+|.+++... ..+++..+++++.||+.||.|||+ .+|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 9999999999999999999999998542 135677888999999999999995 589999
Q ss_pred CCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh--CCcCC
Q 037189 605 DMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA--CRKSF 682 (766)
Q Consensus 605 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt--g~~p~ 682 (766)
||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999999999987654433222233446789999999998899999999999999999987 55666
Q ss_pred CchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 683 DIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
......+. ........+...... ....+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus 243 ~~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQV---IENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHHH---HHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332221 111111111111100 011123356788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=376.20 Aligned_cols=269 Identities=26% Similarity=0.494 Sum_probs=212.1
Q ss_pred cCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec
Q 037189 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE 548 (766)
Q Consensus 469 ~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (766)
++++++... ....+.||+|+||.||+|+... .+..||||+++..... ...|++.+++++||||++++++|.+
T Consensus 683 ~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~ 754 (968)
T PLN00113 683 ITINDILSS-LKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS 754 (968)
T ss_pred hhHHHHHhh-CCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc
Confidence 444444432 2234579999999999999854 4678999998643322 2356888999999999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
++..++||||+++|+|.++++ .++|..+.+|+.|+++||+|||+.++++|+||||||+||+++.++.+++. |+...
T Consensus 755 ~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 755 EKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 999999999999999999995 37899999999999999999998878899999999999999999988876 66554
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
..... ....+|..|+|||++.+..++.++|||||||++|||++|+.|++.... ....+..|+...........
T Consensus 831 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 831 LLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhh
Confidence 33211 223578999999999999999999999999999999999999864322 12234455554444444444
Q ss_pred eccCcccC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 709 LVGGDMEA--MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 709 ~~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+++.... ..+.++..++.+++.+||+.+|++||||.||++.|+++..
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 44444322 2345667788999999999999999999999999998765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.85 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=211.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||.|+-|.|-+|++.. .|+.+|||.+.... ......+.+|+-+|+.+.|||+++|++++++..+.|||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred eeccccccCCCCceehhhhccc---ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 4467889999999999998875 57899999997642 22245688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
.||+++|-|.+++...+.+.+....+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+-.++.-
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 9999999999999999999999999999999999999994 5999999999999999999999999999987665433
Q ss_pred cceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....||.+.|.|||++.+.+|. .++||||.|||||.||+|+.||+.++.. .+...+..|..+
T Consensus 168 ---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir-------~LLlKV~~G~f~------- 230 (786)
T KOG0588|consen 168 ---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR-------VLLLKVQRGVFE------- 230 (786)
T ss_pred ---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH-------HHHHHHHcCccc-------
Confidence 2567899999999999999986 6899999999999999999999855432 223333444321
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
.+...+.+..+|+.+|+..||++|.|++||+++-
T Consensus 231 ---MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 231 ---MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 2445677888999999999999999999999863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.90 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=209.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC-HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..|++.++||.|.-++||+|.... .+..||||++....-.. .+.+.+|+..|+.++||||++++..|..+...++|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 346677899999999999999874 34799999997544333 57899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|.||.+|++.+.++.. ..+++..+..|++++++||.|||+ .+.||||||+.||||+++|.+||+|||.+-.+-..
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999764 457889999999999999999995 49999999999999999999999999988765443
Q ss_pred CCc-cee-ecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 634 QSK-TIK-TSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 634 ~~~-~~~-~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
... ... ....||+.|||||++.. ..|+.|+||||||+...||.+|..||.....-.. .-...++....+
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-------Ll~tLqn~pp~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-------LLLTLQNDPPTL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-------HHHHhcCCCCCc
Confidence 322 222 45689999999999643 3689999999999999999999999975543221 111122222222
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.-..+...........+++++..||++||.+|||+.++++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 22223333345566789999999999999999999999853
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=342.95 Aligned_cols=264 Identities=25% Similarity=0.405 Sum_probs=205.9
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccccc-CHHHHHHHHHHHccC-CCCCeeeEeeeeecC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQT-HHKNLVRLLGFCDEG 549 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (766)
+....+.+.+.||+|+||.||+|+.... ......||||+++..... ....+.+|+++++.+ +|+||++++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3445666789999999999999986432 223467999999754322 345688999999999 899999999999999
Q ss_pred CceEEEeeccCCCchhhhhccC----------------------------------------------------------
Q 037189 550 QNRLLVYEFLNNGTLASFLFGN---------------------------------------------------------- 571 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~---------------------------------------------------------- 571 (766)
...++||||+++|+|.++++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999988532
Q ss_pred ------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 572 ------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 572 ------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
..+++..+++++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 135667788999999999999994 59999999999999999999999999999866543322222
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....++..|+|||++.+..++.++||||||+++|||++ |+.||........ .......+. ....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~---------~~~~ 336 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGY---------QMSR 336 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHccc---------CccC
Confidence 23345678999999999999999999999999999997 9999875432211 111111110 0111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+...+.++.+++.+||+.||++|||+.+|+++|++++
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1123567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=334.54 Aligned_cols=260 Identities=27% Similarity=0.406 Sum_probs=218.9
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
|+++.......+||.|.||.||.|.+++ -...||||.++.. ....++|+.|..+|+.++|||+|+|+|+|..+...
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeec---cceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555555566899999999999999985 3568999999753 45678999999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
|||.|||.+|+|.+||+.. ..++.-..+.++.||+.|+.||. ...+|||||.++|+|+.++..+||+|||+++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999864 44566677889999999999999 559999999999999999999999999999998
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
..+..... ....-++.|.|||.+....++.|+|||+|||+||||.| |..|+....... +...
T Consensus 416 tgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~L--------- 478 (1157)
T KOG4278|consen 416 TGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGL--------- 478 (1157)
T ss_pred cCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHH---------
Confidence 76643222 33344778999999999999999999999999999999 888886543222 2222
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+....+...+..|++.+.+|++.||+-+|.+||++.|+-+.+|.+..
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 22334445577789999999999999999999999999999988653
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=327.95 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=210.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+...+.||+|.||.||||+-+. +.+.||+|.+.+.... ..+.+.+|++++++++||||+.+++.|+...+.++|.
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred hhHHHHhcCCccceeeeccccc---ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4456899999999999998775 5679999999765433 3456899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+.+ +|..+|.....++++.+..|+.+++.||.||| +.+|+|||+||+|||++.++.+|++|||+++.+....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence 99988 99999999999999999999999999999999 5699999999999999999999999999999887643
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.+.+.+.||+-|||||...+++|+..+|.||+||||||+.+|++||....... .+... ..+.+
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~------Lv~~I-~~d~v---------- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ------LVKSI-LKDPV---------- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH------HHHHH-hcCCC----------
Confidence 33467899999999999999999999999999999999999999997544322 12111 11111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+..++...|++||..|.|-.+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1234667888999999999999999999998854
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.21 Aligned_cols=258 Identities=30% Similarity=0.474 Sum_probs=207.7
Q ss_pred HHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+.+.||+|+||.||+|...... .....+++|.+..... ....+|.+|++++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 4557789999999999999976532 2346799998864332 234578999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC
Q 037189 555 VYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN 618 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 618 (766)
+|||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 99999999999998653 346677888999999999999995 59999999999999999999
Q ss_pred eEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHH
Q 037189 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWA 697 (766)
Q Consensus 619 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 697 (766)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------~ 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------V 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------H
Confidence 99999999987654332222233456788999999998899999999999999999998 999987543322 1
Q ss_pred HHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
...+..+... ..+..++.++.+|+.+||+.||++||++.+|++.|+++
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1112222111 12345678899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.24 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=221.5
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecC-CCceeEEEEEEeec-ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDI-VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~-~~~~~~vavK~l~~-~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
++.++.....+.||.|.||.||+|..... ++....||||..+. ...+..+.|+.|..+|++++||||++|+|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 45556666778999999999999998765 34456799999876 445567789999999999999999999999976 5
Q ss_pred ceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...+|||.++-|.|.+||..+ ..++......++.||..+|+||| +...|||||..+|||+.....+|++|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 678999999999999999865 56788888899999999999999 66999999999999999999999999999999
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
+..+..... +...-+..|||||.+.-.+++.++|||.|||.+||++. |..||..-. +.++.-
T Consensus 541 ~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~ 603 (974)
T KOG4257|consen 541 LEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIG 603 (974)
T ss_pred ccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEE
Confidence 876654433 23345778999999999999999999999999999998 999997422 222223
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+....+...++.|+..|..|+.+||..+|.+||.+.++...|+.+.+
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 333444556688899999999999999999999999999988876554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.52 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=212.6
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCH---HHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
-.+..++|.+.||+|.||.|-++.... .++.||||.++......+ -.+.+|+++|+.++||||+.++.+|+..+
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 356678899999999999999998643 678999999976554444 45789999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.+.|||||..+|.|.+|+..++.+++....+++.||..|+.|+|. .+++|||||.+|||||+++++||+|||++.++
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999999999999999999999999999999999994 59999999999999999999999999999887
Q ss_pred ccCCCcceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
..+.. ...++|++-|.+||.+.+.+|. +..|-|||||+||-|+.|.-||+..+... + ++ .+..|
T Consensus 204 ~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---l---vr-QIs~G----- 268 (668)
T KOG0611|consen 204 ADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---L---VR-QISRG----- 268 (668)
T ss_pred ccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---H---HH-Hhhcc-----
Confidence 65433 3668999999999999999985 78999999999999999999998754321 1 11 11112
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..+ +++.+....-|++|||..||++|-|+.+|..+.
T Consensus 269 ---aYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 269 ---AYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---ccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 222345567799999999999999999998764
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=320.16 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=208.6
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.+.||+|+||.||+|.+...+.+...+|||.++.... ....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 345567899999999999999876544567899999875432 2346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999998764 468899999999999999999994 599999999999999999999999999999875322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.........++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ......+..
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~----~~~~~~~~~------- 226 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---V----IKAVEDGYR------- 226 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---H----HHHHHcCCC-------
Confidence 2211122345678999999999999999999999999999998 999985433221 1 111111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
...+..++..+.+++.+||+.+|++||++.+|+++|+++
T Consensus 227 --~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 227 --LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011223457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=327.62 Aligned_cols=240 Identities=25% Similarity=0.280 Sum_probs=196.2
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||.||++.... .++.+|+|.++.. .......+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCC
Confidence 7999999999999864 4568999998643 233446788999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
|+|.+++.....+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 152 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT 152 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence 9999999888889999999999999999999994 5999999999999999999999999999986433221 1134
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . .....+.. ..+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~-~~~~~~~~----------~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------Y-RKILQEPL----------RFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------H-HHHHcCCC----------CCCCc
Confidence 5689999999999999999999999999999999999999975433221 1 11111111 11233
Q ss_pred HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPT---IKKVLQ 749 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~ 749 (766)
.+.++.+++.+||+.||.+||+ +.++++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 4577889999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.33 Aligned_cols=243 Identities=23% Similarity=0.274 Sum_probs=199.2
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||+|+||.||++.... .++.+|||.++... ......+.+|+.++.+++||||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 469999999999998864 46789999987532 223456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~ 152 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence 999999999888889999999999999999999994 5999999999999999999999999999875332211 11
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~~~----------~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEEI----------RFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC----------CCC
Confidence 345699999999999999999999999999999999999999975433221 111111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+.++.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 33467788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=322.03 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=208.3
Q ss_pred HHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
..++.+.+.||+|+||.||+|..... ......+|||.++..... ..+.|.+|++++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 45677889999999999999987643 234578999998765443 356899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC--------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC
Q 037189 553 LLVYEFLNNGTLASFLFGN--------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN 618 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 618 (766)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 9999999999999999643 236778889999999999999994 59999999999999999999
Q ss_pred eEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHH
Q 037189 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWA 697 (766)
Q Consensus 619 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 697 (766)
+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 99999999986543322222223345788999999999999999999999999999998 9999865433221
Q ss_pred HHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
......+... ..+...+..+.+++.+||+.||++||++.||++.|++
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLL---------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111122211 1122356778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=300.68 Aligned_cols=235 Identities=29% Similarity=0.317 Sum_probs=202.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
.++.+.||.|+||.|.+++.+. .+..+|+|.++...- ...+...+|..+|+.+.||+++++.+.+.+.+..+||
T Consensus 46 fe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 46 FERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhheeeeccCccceEEEEEEcc---CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3456789999999999999875 467899999975432 2344578899999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||.++|.|..+++..+++++....-+|.||+.||+||| +..|++|||||+|||||.+|.+||.|||+|+.+...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 999999999999999999999999999999999999999 569999999999999999999999999999987644
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.-..|||+.|+|||.+....+..++|.|||||++|||+.|.+||...+... ..+.+-++.+
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~KI~~~~v--------- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYEKILEGKV--------- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHHHHHhCcc---------
Confidence 256899999999999999999999999999999999999999998765421 2222222322
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLR 741 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~R 741 (766)
..+.-....+.+|+...|+.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1244566778899999999999988
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=321.88 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=199.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
...+.||+|+||.||++.... .++.+|||.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence 345789999999999999875 46789999886432 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||+++++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999999887643 35788899999999999999999 4599999999999999999999999999998754332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 221 (285)
T cd05631 157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQ--------- 221 (285)
T ss_pred e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhccc---------
Confidence 1 13456899999999999999999999999999999999999999764432110 00111111110
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
...+...+..+.+|+.+||+.||.+||+ +.++++.
T Consensus 222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112334667889999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=323.14 Aligned_cols=259 Identities=25% Similarity=0.449 Sum_probs=209.2
Q ss_pred HhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|+.... ......+++|.+........+.+.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 44567899999999999986532 2245678999987655555678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeE
Q 037189 557 EFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 620 (766)
||+++++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 999999999998643 236888999999999999999994 5999999999999999999999
Q ss_pred EeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHH
Q 037189 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 699 (766)
|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .+
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~ 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV-------IE 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HH
Confidence 999999986654332222233456788999999999999999999999999999999 9999865433221 11
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+.... .+..++..+.+++.+||+.+|++|||+++|+++|+++..
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 122222111 122345678999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.57 Aligned_cols=262 Identities=22% Similarity=0.325 Sum_probs=204.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+...+.||+|+||.||+++... .+..+|+|.+..... .....+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 34456789999999999999864 456899998875322 23467999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 9999999999998888889999999999999999999952 369999999999999999999999999987654322
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc-----------
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK----------- 705 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 705 (766)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.... .......+.
T Consensus 159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hcccccccccCCccccCccc
Confidence 1335689999999999999999999999999999999999999965433221110 000000000
Q ss_pred -----------------------cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 706 -----------------------LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 706 -----------------------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
...+.............+.++.+++.+||+.||++|||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000001111123467789999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=337.48 Aligned_cols=263 Identities=23% Similarity=0.366 Sum_probs=205.6
Q ss_pred HHHHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeecccc-cCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCc
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQN 551 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 551 (766)
...+.+.+.||+|+||.||+|+..... .....||||+++.... ...+.|.+|++++++++ ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 445557789999999999999875322 2245799999965332 23457999999999996 9999999999999999
Q ss_pred eEEEeeccCCCchhhhhccC------------------------------------------------------------
Q 037189 552 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 571 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 571 (766)
.+|||||+++|+|.++|...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999988542
Q ss_pred ------------------------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 572 ------------------------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 572 ------------------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
..+++..+..++.|+++||+|||+ .+|+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 125566778899999999999994 59999999999999999
Q ss_pred CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHH
Q 037189 616 HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILT 694 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 694 (766)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 99999999999987644332222223446788999999999999999999999999999997 8899865432211
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.......+. ....+...+..+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 349 --~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111111111 111223456788999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=330.26 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=204.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .+..||||.++... ......+.+|++++.+++||||+++++++.+.+..++|
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence 3456789999999999999864 35689999987532 23345788999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 9999999999999888888999999999999999999995 5999999999999999999999999999986543
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +..+ . ... ....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-----~-~~~----~~~~ 221 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-----K-ETL----QRPV 221 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-----c-ccc----cCCC
Confidence 1134568999999999999999999999999999999999999997654332111 1100 0 000 0000
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+.++.+++.+||+.+|.+||++.+++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000012346778899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.70 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=206.5
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
+......+.+.||+|++|.||+|... ..+.+|+|.++.. ....++|.+|+.++++++|+||+++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 34455677899999999999999865 3467999998653 234678999999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 554 LVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999999999997643 68899999999999999999995 599999999999999999999999999998775
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
....... .....+..|+|||++.+..++.++||||||++++||++ |+.||....... .........
T Consensus 155 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~----- 221 (261)
T cd05068 155 EDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VLQQVDQGY----- 221 (261)
T ss_pred CCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC-----
Confidence 3322111 12233468999999999999999999999999999999 999986543221 111111110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
....+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 222 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 ----RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ----CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0111223467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=327.35 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=199.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||+|+||.||++.... .+..+|||.+.... ......+.+|+++++.++||||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCC
Confidence 468999999999998764 46789999987532 233457889999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 152 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM 152 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence 999999999888889999999999999999999994 5999999999999999999999999999875432211 11
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~~~----------~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILMEDI----------KFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccCCc----------cCC
Confidence 345689999999999999999999999999999999999999975433221 111111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+.++.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23456788999999999999997 89988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=318.01 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=205.5
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
....+.++||+|+||.||+|.... .++.+|+|.+... .....++.+|++++.+++|+||+++++++..+...++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 344566889999999999999864 4668999988643 334567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999998653 457889999999999999999994 599999999999999999999999999998765432
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... ......+..|+|||.+.+..++.++||||||+++|||++ |..|+......+. ......+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~--------- 221 (263)
T cd05052 159 YTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKG--------- 221 (263)
T ss_pred eec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC---------
Confidence 211 112234668999999999999999999999999999998 8899865433221 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.....+...+.++.+++.+||+.+|++||++.+++++|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112233467899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.76 Aligned_cols=263 Identities=25% Similarity=0.454 Sum_probs=209.6
Q ss_pred HHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+.+.+.||+|+||.||++..... ......+|+|.+........+.+.+|++++.+++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 33445678899999999999986432 2245678999987655555678999999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCC-------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeE
Q 037189 554 LVYEFLNNGTLASFLFGNL-------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~-------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 620 (766)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 47888999999999999999995 5999999999999999999999
Q ss_pred EeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHH
Q 037189 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 699 (766)
|+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 999999986654332222223345778999999999999999999999999999998 899886543222 111
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+.... .+...+..+.+++.+||+.+|.+|||+.+|++.|+++...
T Consensus 234 ~i~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 122222111 1112346789999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.20 Aligned_cols=245 Identities=23% Similarity=0.275 Sum_probs=202.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||+|+... .++.+|||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 19 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred heEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 34567899999999999999864 45689999986432 2334578999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 99999999999999888888999999999999999999995 599999999999999999999999999998764322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+.++...
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~i~~~~~~------- 233 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYEKILAGRLK------- 233 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHHHHhcCCcC-------
Confidence 23468999999999999999999999999999999999999997543221 11112222111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
.+...+.++.+++.+||+.||.+||+ +++++++
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11224567889999999999999997 6777744
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.85 Aligned_cols=245 Identities=26% Similarity=0.398 Sum_probs=211.6
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
.+.||+|.||.||||.... .++.||+|.+.... .+...+.++|+.++.+.+|+||.++++.+..+....++||||.
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred chhccccccceeeeeeecc---ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 3789999999999999875 56799999997543 3445789999999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
+|++.+.|.....+++....-|+.++..||.|||. .+.+|||||+.|||+..++.+|++|||++..+....... .
T Consensus 95 gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~ 169 (467)
T KOG0201|consen 95 GGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--K 169 (467)
T ss_pred CcchhhhhccCCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--c
Confidence 99999999988888999999999999999999995 499999999999999999999999999999887655443 4
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcH
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (766)
..+||+.|||||++....|+.|+||||||+..+||.+|.+|+....+. ++..++-+........
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPPRLDG 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCCcccc
Confidence 578999999999999889999999999999999999999999754431 2223333333333344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 721 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.++..+.+++..||++||+.||++.+++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 678889999999999999999999998864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=325.54 Aligned_cols=244 Identities=25% Similarity=0.268 Sum_probs=201.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence 3456889999999999999864 45789999986432 22345688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 9999999999999888888999999999999999999994 599999999999999999999999999998764321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~--------- 215 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------YEKILAGKL--------- 215 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCc---------
Confidence 234689999999999999999999999999999999999999976543221 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
..+......+.+++.+||+.||.+||+ +++++++
T Consensus 216 -~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 -EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223567889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.28 Aligned_cols=246 Identities=25% Similarity=0.288 Sum_probs=200.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||++....+...++.+|||.++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999876554567899999987432 22335678899999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.....+.+..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 156 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV-- 156 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCc--
Confidence 9999999999888888888899999999999999994 59999999999999999999999999998754322211
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+.. ..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~~~~~~----------~~ 219 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKILKGKL----------NL 219 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC----------CC
Confidence 1345689999999999998899999999999999999999999975443211 111111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
+...+..+.+++.+||+.+|++|| ++.++++.
T Consensus 220 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 223456788999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.48 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=205.1
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCC-ceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+...+.||+|+||.||+|++..++. ....||||.++... ....++|.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3445556789999999999999764332 23458999986432 23456799999999999999999999999764 577
Q ss_pred EEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+|+||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999764 467888999999999999999994 5999999999999999999999999999997764
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
............+..|+|||++.+..++.++||||||+++|||++ |+.|+......+. ......+.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~------ 228 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEKGE------ 228 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhCCC------
Confidence 433222122334678999999999999999999999999999998 9999875432221 11111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+..++..+.+++.+||+.+|++||++.+++..|..+..
T Consensus 229 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111122345678899999999999999999999999976553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.87 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=202.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|....++.. ...+++|.+..... ....++..|+..+++++||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~ 87 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVT 87 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEE
Confidence 34567899999999999998643322 23578888754322 223578888889999999999999999864 4578899
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 88 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 99999999999975 4568999999999999999999995 5899999999999999999999999999987654432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ ...+..+...
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~------- 230 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKGERL------- 230 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCCCcC-------
Confidence 222233457789999999998999999999999999999998 9999875433221 1111222111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
..+..++..+.+++.+||..+|++|||+.|+++.|+.+..
T Consensus 231 --~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 --AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111234567889999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=341.75 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=214.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeee-eec------CCce
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGF-CDE------GQNR 552 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~-~~~------~~~~ 552 (766)
+.+.|.+|||+.||.|++... +..+|+|++-..++...+...+|+++|++++ |+|||.+++. ... .-+.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~---~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKG---GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEccCCcEEEEEEEecCC---CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 457899999999999998742 3799999998777777888999999999997 9999999993 211 2367
Q ss_pred EEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+|.||||++|.|-|++..+ ..+++.++++|+.++++|+++||.. .++|||||||-+||||.++++.||||||.+.-.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~ 196 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTK 196 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence 8999999999999999854 5699999999999999999999975 888999999999999999999999999998754
Q ss_pred ccCCCcc--e---e--ecccccCcccccccc---cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHH
Q 037189 631 TLNQSKT--I---K--TSIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 631 ~~~~~~~--~---~--~~~~gt~~y~aPE~~---~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
....... . . -...-|+.|+|||.+ .+.++++|+|||||||+||-|+....||+...
T Consensus 197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------------- 262 (738)
T KOG1989|consen 197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------------- 262 (738)
T ss_pred cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------------
Confidence 3332110 0 0 012358999999987 57789999999999999999999999997431
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~p 760 (766)
..+|++........+.++..|.+||..||++||++||++-+|+..+-.+...+.|
T Consensus 263 -----~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 263 -----KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred -----ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 2356666666666678999999999999999999999999999999887766544
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.75 Aligned_cols=243 Identities=23% Similarity=0.260 Sum_probs=198.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||+|+||.||++.... .+..+|+|.++... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCC
Confidence 468999999999998764 46789999987532 223456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 999999999888889999999999999999999994 5999999999999999999999999999875332211 11
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. ..+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------~~~~~~~~----------~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------ELILMEEI----------RFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCC----------CCC
Confidence 3356899999999999999999999999999999999999999754332211 11111111 112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+.++.+++.+||+.||.+|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 23457788999999999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=295.77 Aligned_cols=260 Identities=25% Similarity=0.289 Sum_probs=211.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----ce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 552 (766)
.+.+.++||+|||+-||+++.-. .+..+|+|++.....++.+..++|++..++++|||++++++++..+. +.
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred eEEEeeeecCCCceeeeeecccC---cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45677899999999999998543 56789999998877778889999999999999999999999885433 48
Q ss_pred EEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
+|+++|...|+|.+.+.. +..+++.+.++|+.+|++||++||+. .++++||||||.|||+.+.+.+++.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999864 34688999999999999999999976 4569999999999999999999999999987
Q ss_pred ccccCCCc-------ceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH
Q 037189 629 LLTLNQSK-------TIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698 (766)
Q Consensus 629 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 698 (766)
...-.-.. .......-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 65421110 0012234688999999985 55689999999999999999999999974322
Q ss_pred HHhhcCccc-eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 699 DCYRNGKLD-ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 699 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+.+.+. ++..+.+........++.+.+++.+|++.||.+||++.+++..++.+.
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 122222 333444444445558899999999999999999999999999998764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=315.39 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=203.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc------
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------ 551 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 551 (766)
.+.+.||+|+||.||+|.+..+......+|||+++... .....++.+|++.++.++|+||+++++++.+...
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 35678999999999999987655456789999987532 2234578999999999999999999999876554
Q ss_pred eEEEeeccCCCchhhhhccC------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccC
Q 037189 552 RLLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 625 (766)
.++++||+++++|..++... ..+++.....++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 78999999999999988532 357888899999999999999995 599999999999999999999999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
+++................+..|+|||.+.+..++.++||||||+++|||++ |..||......+ . ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I----YDYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcC
Confidence 9987654432221122335678999999998899999999999999999999 888886533221 1 1111111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.. ...+..++.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 232 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 232 NR---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CC---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11 1112345678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.19 Aligned_cols=259 Identities=29% Similarity=0.424 Sum_probs=205.8
Q ss_pred HHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||++...... .....+|+|.+.... .....++.+|+.++.++ +|+||+++++++..++..+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3455678999999999999876432 345789999887532 22345688999999999 7999999999999999999
Q ss_pred EEeeccCCCchhhhhcc----------------CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC
Q 037189 554 LVYEFLNNGTLASFLFG----------------NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY 617 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 617 (766)
++|||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCC
Confidence 99999999999999853 2457788889999999999999994 5999999999999999999
Q ss_pred CeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHH
Q 037189 618 NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 696 (766)
.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+......+.
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------ 243 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL------ 243 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH------
Confidence 999999999987654332222122345678999999998999999999999999999998 8888865433221
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
......+. ....+..++..+.+++.+|++.+|++|||+.++++.|++++
T Consensus 244 -~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 -FKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111111 11122334667889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.52 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=200.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...+.+.||+|+||.||++... +...+|+|.+... .....+|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HcEEeeEecCCcCceEEEEEec----cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 3456688999999999999875 3457899987633 3345789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999998753 467899999999999999999995 59999999999999999999999999999865433221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .+.++..
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~----~i~~~~~--------- 219 (256)
T cd05114 157 SS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VE----MISRGFR--------- 219 (256)
T ss_pred cc-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHCCCC---------
Confidence 11 22335678999999998899999999999999999999 8999865432221 11 1111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011123467899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.05 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=203.9
Q ss_pred HHHhhhhhccccccceEEEEEEecC-CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~-~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
....+.++||+|+||.||+|..... ......+++|.+.... .....+|.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4456778999999999999986432 2345789999987432 2234678999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC-----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC
Q 037189 555 VYEFLNNGTLASFLFGN-----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY 617 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 617 (766)
||||+++++|.+++... ..+++...+.++.|+++||+|||+ .+++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 99999999999998522 236777888999999999999995 5999999999999999999
Q ss_pred CeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHH
Q 037189 618 NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 696 (766)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999987654332222233445778999999998889999999999999999998 888886433211
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
+.+........ ..+..++.++.+++.+||+.+|++||++.++++.|.+
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111111 1122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=318.31 Aligned_cols=259 Identities=27% Similarity=0.380 Sum_probs=206.1
Q ss_pred HHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
...+.+.++||+|+||.||+|....+ ......+|||.++..... ....|.+|+.++.+++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 45577889999999999999987643 234578999999754332 235688999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC
Q 037189 553 LLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH 616 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 616 (766)
++++||+++++|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 9999999999999998522 236677788999999999999994 599999999999999999
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTD 695 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 695 (766)
+.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH------
Confidence 9999999999887654332222233446789999999998889999999999999999998 888886543322
Q ss_pred HHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
....+..+... ..+..++..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 235 -~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 -VIEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11112222111 1123456778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=320.80 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=201.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+++... .+..+|||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred ceEEEEecccCCEEEEEEEECC---CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 3456789999999999999864 45689999986532 223467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||++++.|..+......+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 999998887766555678899999999999999999994 59999999999999999999999999999876543222
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH---------HHHhhcCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA---------FDCYRNGKLD 707 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 707 (766)
.. ....|+..|+|||++.+..++.++|||||||++|||++|+.||......+........ ..........
T Consensus 157 ~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 157 NY-TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred cc-cccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 11 3456899999999999989999999999999999999999999764432211110000 0000000000
Q ss_pred eeccCcccC------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 ALVGGDMEA------MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 ~~~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
....+.... ......+..+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 001124567999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=314.51 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=203.5
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.++||+|+||.||+|... +...+|+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34556789999999999999865 3457899987643 234578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999865 3567888899999999999999995 599999999999999999999999999998765432
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... .....++..|+|||++....++.++||||||+++|||++ |+.||........ ... ...+.
T Consensus 158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~~-------- 221 (261)
T cd05072 158 YTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----LQRGY-------- 221 (261)
T ss_pred eec-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----HHcCC--------
Confidence 211 123345778999999998899999999999999999998 9999865432211 111 11111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
........+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0011123456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=328.13 Aligned_cols=248 Identities=24% Similarity=0.283 Sum_probs=203.6
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
...+.+.+.||+|+||.||+|..... ....+|+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 33466778999999999999987642 34689999986432 23346788999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++||||+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999999999888889999999999999999999994 5999999999999999999999999999987543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+..
T Consensus 184 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~------ 245 (340)
T PTZ00426 184 RT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGII------ 245 (340)
T ss_pred Cc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCC------
Confidence 21 34568999999999999889999999999999999999999997544321 1111111111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||.+|+ ++++++++
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 01222345678999999999999995 89988765
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.46 Aligned_cols=263 Identities=21% Similarity=0.353 Sum_probs=203.4
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
....+++.++||+|+||.||++.... .+..+|+|.+.... ......+.+|++++++++|+||+++++++.+++..+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34456677899999999999998864 45678999886532 223467899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++++|.+++.....+++.....++.|+++||.|||+ ..+|+|+||||+|||+++++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 999999999999999887788899999999999999999995 247999999999999999999999999998765432
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc-------
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL------- 706 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 706 (766)
. .....|+..|+|||++.+..++.++|||||||++|||++|+.||........... ......+..
T Consensus 158 ~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 229 (333)
T cd06650 158 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM----FGCPVEGDPAESETSP 229 (333)
T ss_pred c----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHH----hcCcccCCccccccCc
Confidence 1 1335689999999999998999999999999999999999999975432211100 000000000
Q ss_pred --------------------------ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 --------------------------DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 --------------------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+.............+.++.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred ccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000011234678899999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=315.49 Aligned_cols=259 Identities=24% Similarity=0.455 Sum_probs=207.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+...+.||+|+||.||+|.+...+.....+++|.++... ....+++.+|++++++++|+||+++.+++.+.+..++||
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT 85 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence 3445678999999999999987655455689999986542 233567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 999999999999754 568899999999999999999994 5999999999999999999999999999987654332
Q ss_pred ccee-ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 636 KTIK-TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 636 ~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.... .....+..|+|||++.+..++.++||||||+++|||++ |+.||......+ .......+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i~~~~-------- 227 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAINDGF-------- 227 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhcCC--------
Confidence 2111 11223457999999998889999999999999999998 999986543221 111111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
........+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11112234577899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=316.27 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=205.0
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.++||+|+||.||++.... .......+++|.+..........|.+|++++++++|+||+++++++.+....+++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV 85 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence 34466899999999999997542 2234668999998766555667899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC---------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeE
Q 037189 556 YEFLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 620 (766)
+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+|
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEE
Confidence 9999999999998653 246788899999999999999994 5999999999999999999999
Q ss_pred EeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHH
Q 037189 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 699 (766)
|+|||++................++..|+|||.+.+..++.++||||||+++|||++ |++||......+. . .
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~----~ 235 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I----E 235 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H----H
Confidence 999999986644332222122345678999999999999999999999999999998 8888854332211 0 1
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
....+. ....+..++..+.+++.+||+.||++||++.+|++.|++
T Consensus 236 ~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111 011122345678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=317.57 Aligned_cols=258 Identities=26% Similarity=0.455 Sum_probs=201.7
Q ss_pred HHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
..+.+.++||+|+||.||+|..... ......+|||++.... .....+|.+|+.+++.++|+||+++++++.+....+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 3455678999999999999987531 1235679999885432 223457899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccC----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 554 LVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
+||||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECC
Confidence 999999999999998642 124667788999999999999994 5999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||........ .....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-------~~~~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-------LRFVM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHH
Confidence 999986644332211122345778999999999999999999999999999999 7888865432221 11111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
++.... .+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 236 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.90 Aligned_cols=262 Identities=26% Similarity=0.401 Sum_probs=203.8
Q ss_pred HHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecC-Cc
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG-QN 551 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 551 (766)
..+.+.+.||+|+||.||+|..... ...++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4567789999999999999976432 12357899999874332 2235678899999999 899999999988654 56
Q ss_pred eEEEeeccCCCchhhhhccC------------------------------------------------------------
Q 037189 552 RLLVYEFLNNGTLASFLFGN------------------------------------------------------------ 571 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~------------------------------------------------------------ 571 (766)
.++++||+++++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988532
Q ss_pred -CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccc
Q 037189 572 -LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650 (766)
Q Consensus 572 -~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~a 650 (766)
..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 256788899999999999999994 5999999999999999999999999999987644332222223456778999
Q ss_pred cccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHH
Q 037189 651 PEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMV 729 (766)
Q Consensus 651 PE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 729 (766)
||++.+..++.++|||||||+||||++ |..||......+. + ......+.. ...+...+.++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~---------~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLKEGTR---------MRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHhccCC---------CCCCccCCHHHHHH
Confidence 999999999999999999999999998 9999865332211 1 111111111 01122345678999
Q ss_pred HHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 730 SIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 730 ~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+.+||+.+|++||++.+++++|+.+++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=311.46 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=197.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||+|.... +++.+|+|...... ......|.+|++++++++||||++++++|......++||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 469999999999999864 46789999875432 23356799999999999999999999999999999999999999
Q ss_pred CchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 562 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 562 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
++|.+++... ..+++..++.++.|+++||+||| +.+++|+||||+||+++.++.+||+|||+++............
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9999999754 46789999999999999999999 4599999999999999999999999999988654322111111
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....+..|+|||.+.+..++.++||||||+++|||++ |..|+........ ....... .....+
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~---------~~~~~~ 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG---------VRLPCP 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC---------CCCCCc
Confidence 1223567999999999999999999999999999998 8888864432211 1111111 011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...+..+.+++.+|++.+|++|||+.+|+++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 334678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=331.20 Aligned_cols=265 Identities=24% Similarity=0.402 Sum_probs=205.3
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccccC-HHHHHHHHHHHccCC-CCCeeeEeeeeec
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDG-EREFKNEVFVIGQTH-HKNLVRLLGFCDE 548 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 548 (766)
++......+.++||+|+||.||+|.+... ......||||+++...... .+.+.+|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 34444555678999999999999997532 2245689999997543222 357899999999997 9999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCC--------------------------------------------------------
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNL-------------------------------------------------------- 572 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------------------------------------------------- 572 (766)
.+..++|+||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986421
Q ss_pred ------------------------------------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccce
Q 037189 573 ------------------------------------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQN 610 (766)
Q Consensus 573 ------------------------------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 610 (766)
.+++.....++.|+++||+||| +.+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcce
Confidence 2345566789999999999999 4599999999999
Q ss_pred EEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhh
Q 037189 611 ILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEE 689 (766)
Q Consensus 611 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~ 689 (766)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986543322111123346788999999998899999999999999999998 888886433211
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
. .......+ .....+...+.++.+++.+||+.+|.+||++++|++.|++++
T Consensus 350 ~------~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 Q------FYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H------HHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11111111 111112334678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=310.64 Aligned_cols=253 Identities=30% Similarity=0.447 Sum_probs=204.0
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
++||+|+||.||+|+..........+|+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999998765543457899999875443 24567999999999999999999999876 4568999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-ee
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT 640 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 640 (766)
++|.+++.....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.+........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 9999999887788999999999999999999995 5899999999999999999999999999987654432211 11
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +... ...... ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~----~~~~~~---------~~~~ 220 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM----LESGER---------LPRP 220 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHcCCc---------CCCC
Confidence 2224568999999999999999999999999999998 999987543322 1111 111110 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..++..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 334578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=306.65 Aligned_cols=262 Identities=25% Similarity=0.326 Sum_probs=203.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccCHHHHHHHHHHHccCCCCCeeeEeeeeec-----CCceEE
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQNRLL 554 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~~l 554 (766)
.+.||+|+||.|.++.... .+..||||++.. ...-..++-.+|+++|+.++|+||+.+++.+.. -...|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi 103 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL 103 (359)
T ss_pred cccccCcceeeEEEEEEcC---CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence 4679999999999999875 458999999973 334445788999999999999999999998854 457899
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|+|+|+ -+|...++.++.++.....-++.|+++||.|+| +.+|+||||||+|++++.+..+||+|||+|+......
T Consensus 104 V~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 104 VFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred ehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 999994 589999998888999999999999999999999 6699999999999999999999999999999886543
Q ss_pred CcceeecccccCccccccccc-CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH--------HHHHhhcCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW--------AFDCYRNGK 705 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~ 705 (766)
.....+....|.+|.|||.+. ...++.+.||||.|||+.||++|++.|.+...-....+... ....+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 333336778899999999875 45799999999999999999999999976553222211111 111111111
Q ss_pred cceeccCc-ccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDALVGGD-MEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~~~~~-~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+..- .....+ +.......+|+.+||..||.+|+|++|.+++
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111100 000001 1345677899999999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=311.05 Aligned_cols=254 Identities=24% Similarity=0.319 Sum_probs=201.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--------------ccCHHHHHHHHHHHccCCCCCeeeEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--------------QDGEREFKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--------------~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (766)
++.+.++||+|.||.|-+|.... +++.+|||.+.... ....+...+||.+|++++|||||+|+
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred heehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 35567899999999999998764 57899999996421 11235789999999999999999999
Q ss_pred eeeecC--CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEE
Q 037189 544 GFCDEG--QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 544 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
.+..+. +..|||+|||..|.+...=.....+++.+.++++.+++.||+||| ..+|+||||||+|+||++++++||
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEEe
Confidence 998664 578999999999887654333344889999999999999999999 459999999999999999999999
Q ss_pred eccCcccccccCCCc---ceeecccccCcccccccccCCC----CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH
Q 037189 622 SDFGLAKLLTLNQSK---TIKTSIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT 694 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 694 (766)
+|||.+.....+... .......||+.|+|||...++. .+.+.||||+||.||.|+.|+.||..+...+.
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l---- 327 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL---- 327 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH----
Confidence 999999876433211 1113367999999999987742 35689999999999999999999976654321
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.+ .++...+.....++..+++.+|++++|++||+.|.+..+|..+.=
T Consensus 328 ---~~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 328 ---FD--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred ---HH--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11 222233333334466788999999999999999999999987763
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=311.04 Aligned_cols=249 Identities=30% Similarity=0.418 Sum_probs=200.2
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+||+|+||.||+|.+.... .+..+|+|.++.... ...+++.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCC-CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 6899999999999875332 467899998864332 23467999999999999999999999885 4567899999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-ee
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT 640 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 640 (766)
++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999999877788999999999999999999994 5899999999999999999999999999987654432211 12
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...++..|+|||.+....++.++||||||+++|||++ |+.||......+ . .....++.. ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~----~~~i~~~~~---------~~~~ 220 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V----TQMIESGER---------MECP 220 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCC---------CCCC
Confidence 2234678999999988889999999999999999998 999997543322 1 111122111 1112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
...+.++.+++.+||+.||++||++.+|.+.|++
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 3356778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=314.41 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=207.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+++.+.||+|+||.||+|.....+.....+|||.+.... .....+|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34567789999999999999988665556689999987542 33356899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999753 567899999999999999999995 599999999999999999999999999988665432
Q ss_pred Ccceeec-c--cccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 635 SKTIKTS-I--RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 635 ~~~~~~~-~--~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
....... . ..+..|+|||.+.+..++.++||||||+++|||++ |..||......+ ...++ ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----~~~------ 227 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----EQD------ 227 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcC------
Confidence 2111111 1 12457999999999999999999999999999887 999986543322 11111 111
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.....+.+++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ---YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111234456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=310.91 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=208.5
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.++||.|+||.||+|.... +..+++|.+.........++.+|+.+++.++|+||+++++++.+....++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN----RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC----CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3456677999999999999999863 568999998766554567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999753 457889999999999999999995 58999999999999999999999999999876433
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... .....++..|+|||.+.+..++.++||||||+++++|++ |+.||......+.. ... ..+
T Consensus 158 ~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~---~~~----~~~-------- 220 (261)
T cd05148 158 VYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY---DQI----TAG-------- 220 (261)
T ss_pred ccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHH----HhC--------
Confidence 211 123345778999999998899999999999999999998 89998654432211 111 111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.....+..++..+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 221 -YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11112334567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.68 Aligned_cols=242 Identities=26% Similarity=0.256 Sum_probs=197.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.||+|+||.||++....+...+..+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 579999999999998755444678999999875322 233467889999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
+|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++........ ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~--~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc--ee
Confidence 99999999887889999999999999999999994 59999999999999999999999999998865433221 13
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcH
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (766)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. . ........ ..+.
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~-~~i~~~~~----------~~p~ 219 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------M-TMILKAKL----------GMPQ 219 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------H-HHHHcCCC----------CCCC
Confidence 45689999999999988899999999999999999999999975433221 1 11111111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHH
Q 037189 721 ECLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 721 ~~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
..+..+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 34567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.90 Aligned_cols=268 Identities=26% Similarity=0.411 Sum_probs=211.0
Q ss_pred HHHHHHhhhhhccccccceEEEEEEec----CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeee
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCD 547 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~----~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 547 (766)
+....+.+.+.||+|+||.||+++... .......+|+|.+.... ....+++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 445555677899999999999998532 22245689999886432 23356789999999999 8999999999999
Q ss_pred cCCceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 548 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
.....++||||+++++|.+++... ..+++..++.++.||++||+|||+ .+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 999999999999999999998753 235677888999999999999995 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
++++++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||++ |..|+......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999987654332222223446678999999998899999999999999999998 7788765433221
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~p 760 (766)
......+.. ...+..++..+.+++.+||+.+|.+|||+.++++.|++++.+...
T Consensus 249 -------~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 249 -------FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred -------HHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 111111111 111234567889999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=338.84 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=201.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|....+ ....||+|++..........+.+|+.+++.++||||+++++++...+..+|||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 55678999999999999987543 2457788877554444456788899999999999999999999999999999999
Q ss_pred cCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 559 LNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 559 ~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999988754 3457788889999999999999994 599999999999999999999999999998765443
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+...
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~------- 289 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-------IMQQVLYGKYD------- 289 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-------
Confidence 3223345679999999999999999999999999999999999999997543221 11111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 112234567899999999999999999998864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.87 Aligned_cols=254 Identities=20% Similarity=0.219 Sum_probs=200.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.||+|+||.||+++.......++.+|+|.+.... ....+.+.+|+.++.++ +|+||+++++++.+++..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45688999999999999876544567899999986432 22335678899999999 59999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999999999888889999999999999999999995 599999999999999999999999999998654332
Q ss_pred CcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... .....||..|+|||++.+. .++.++|||||||++|||++|+.||......... ..+........
T Consensus 160 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~-------- 227 (332)
T cd05614 160 KER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKCD-------- 227 (332)
T ss_pred CCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcCC--------
Confidence 221 1345789999999999865 4788999999999999999999999643221110 01111111100
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+...+..+.+++.+||+.||++|| ++++++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111223456788999999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=324.32 Aligned_cols=244 Identities=23% Similarity=0.259 Sum_probs=198.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||+|+||.||++.... .+..+|+|.++... ......+.+|++++..++||||+++.+++...+..++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 468999999999998764 46789999987532 223456788999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++|+|..++.....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~ 153 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--c
Confidence 999999999888889999999999999999999994 258999999999999999999999999998754322111 1
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~~~----------~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEI----------RFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcCCC----------CCC
Confidence 3356899999999999999999999999999999999999999754432211 11111111 012
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+.++.+++.+||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23456788999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.74 Aligned_cols=254 Identities=26% Similarity=0.328 Sum_probs=194.2
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC---c--eEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ---N--RLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---~--~~lV~E 557 (766)
+.+|.|.||.||+|++... ...||||++-...+ .--+|+++|++++|||||+|+-++.... + ..||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~---~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRET---EEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeecccceEEEEEEcCC---CceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 6799999999999999853 67999999854322 2256899999999999999999885433 2 348999
Q ss_pred ccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~ 632 (766)
||+. +|.++++. +.+++.-.+.-++.||.+||+||| +.+|+||||||+|+|+|.+ +.+||+|||.|+.+..
T Consensus 103 ymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 103 YMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 9997 88888874 567777788889999999999999 4699999999999999966 9999999999999877
Q ss_pred CCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC-------
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG------- 704 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 704 (766)
++.. ....-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|.+++..+.....-.+...-..+
T Consensus 179 ~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 179 GEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 6654 334568899999998765 69999999999999999999999998866543322222121111111
Q ss_pred -----ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 -----KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 -----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...++.............+.+..+++.++++.+|.+|.++.|++.+
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1111111111111233456788999999999999999999998853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.41 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=216.2
Q ss_pred hhhhccccccceEEEEEEecCC-CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
-.++||+|+||+||||.+--.+ .-..+||||.+.... .....+|++|+..|.+++||||+||+|+|.... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 3578999999999999975433 234689999886543 445689999999999999999999999998766 8899999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+.|+|.+|++. +..+.....+.|..|||+||.|||+ ..++||||..+|||+..-..+||.|||+++.+..+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999975 4677888899999999999999995 499999999999999999999999999999988776554
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......-.+.|||-|.+....++.++|||||||.+||++| |..|++....++.. .++....+.
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~----------------dlle~geRL 919 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP----------------DLLEKGERL 919 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh----------------HHHhccccC
Confidence 4344455778999999999999999999999999999999 99999876654422 222233345
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+++.+...+..++.+||..|++.||+++++...+.++..
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 5678899999999999999999999999999988876543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.11 Aligned_cols=274 Identities=26% Similarity=0.376 Sum_probs=203.1
Q ss_pred HHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 554 (766)
.+.+.+.||+|+||.||++.... ....+..+|+|++........+.|.+|++++++++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 34567889999999999998642 223567899999876655556789999999999999999999998754 346789
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 99999999999999754 468999999999999999999995 59999999999999999999999999999876543
Q ss_pred CCcce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..... .....++..|+|||++.+..++.++||||||++++||++|..++..........+............+...+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 32111 11122345699999999889999999999999999999987765322110000000000000000000001111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
......+...+.++.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111112234567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.53 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=201.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.... ...+|||.+... .....+|.+|+.++.+++||||+++++++.+....++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~----~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG----QYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC----CCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 34567889999999999998752 346999988643 3345789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..++.++.||+.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999764 467899999999999999999994 59999999999999999999999999998866443221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ......+...
T Consensus 157 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~~-------- 220 (256)
T cd05113 157 S-SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET-------VEKVSQGLRL-------- 220 (256)
T ss_pred e-cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHhcCCCC--------
Confidence 1 122345678999999998889999999999999999999 9999865432211 1111111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011123578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=320.80 Aligned_cols=243 Identities=24% Similarity=0.345 Sum_probs=197.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|+... .+..+|||.++... ......+..|.+++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeC
Confidence 469999999999999764 45689999987532 23345677888888865 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|..++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999999999888889999999999999999999995 5999999999999999999999999999875432221 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ......+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDDV----------LY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC----------CC
Confidence 1345689999999999999999999999999999999999999976543221 111111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRP-------TIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RP-------t~~~vl~~ 750 (766)
+...+.++.+++.+||+.||++|| ++++++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 222456788999999999999999 78887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.70 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
++.+.||+|-||.||.|..+. ..-.||+|.+... ..+-.+++.+|+++-+.++||||+++++++.+....||++
T Consensus 25 eigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred cccccccCCccccEeEeeecc---CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 467899999999999999875 4568999998643 2344678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhc--cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||.+.|.|...|+ ...++++.....+..|+|.||.|+| .+.|+||||||+|+|++..+..||+|||.+..-..+.
T Consensus 102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k 178 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK 178 (281)
T ss_pred EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCC
Confidence 9999999999999 5577899999999999999999999 5699999999999999999999999999987644222
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....+||..|++||...+...+.++|+|++|++.||++.|.+||+.....+. ...++. .
T Consensus 179 ----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-------YkrI~k----------~ 237 (281)
T KOG0580|consen 179 ----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-------YKRIRK----------V 237 (281)
T ss_pred ----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-------HHHHHH----------c
Confidence 2557899999999999999999999999999999999999999987653321 111111 1
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+...+...+....+++.+|+..+|.+|.+..|+++.
T Consensus 238 ~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122245567788999999999999999999998864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=312.79 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=205.7
Q ss_pred HHHHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
...+.+.+.||+|+||.||+|...... .....+|+|.+.... ......+.+|+.++..++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 344556688999999999999986432 345789999986432 23345789999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 553 LLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
++||||+++++|.+++... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998642 23577889999999999999999 4599999999999999999999999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HHHH
Confidence 9999987654332222223446789999999998899999999999999999998 8999865433221 1111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
..+... ..+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 1122346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.45 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=202.3
Q ss_pred HHHHhhhhhccccccceEEEEEEecCC-----------CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEe
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTR-----------TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~-----------~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (766)
...+.+.++||+|+||.||++.....+ .....+|+|.++... ......|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 445667789999999999998875321 123468999986532 22345799999999999999999999
Q ss_pred eeeecCCceEEEeeccCCCchhhhhccCC------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNL------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
+++...+..++||||+++++|.+++.... .+++..++.++.|+++||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 99999999999999999999999985431 35678889999999999999994 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh--CCcCCCchhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA--CRKSFDIEMVEE 689 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt--g~~p~~~~~~~~ 689 (766)
++++++.+||+|||++................++..|+|||.+.+..++.++||||||++++||++ +..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999987654332222122345778999999998899999999999999999998 556765433222
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
. + ............. .....+...+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus 241 ~--~-~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 V--I-ENTGEFFRNQGRQ------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred H--H-HHHHHhhhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1 1 1111111111000 0011122345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.71 Aligned_cols=265 Identities=25% Similarity=0.402 Sum_probs=206.4
Q ss_pred HHHhhhhhccccccceEEEEEEecCCC-------------ceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRT-------------STTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRL 542 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~-------------~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l 542 (766)
..+.+.++||+|+||.||++.....+. ....+|+|.+..... ...++|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 345677899999999999998765332 235689999875432 345678999999999999999999
Q ss_pred eeeeecCCceEEEeeccCCCchhhhhccCC-----------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
++++..+...++++||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 999999999999999999999999997654 67889999999999999999994 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh--CCcCCCchhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA--CRKSFDIEMVEE 689 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt--g~~p~~~~~~~~ 689 (766)
++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999987654433222234456788999999998899999999999999999998 667775432211
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.........+..... .....+..++.++.+++.+||+.||.+|||+.+|++.|+.
T Consensus 242 ---~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 ---VIENAGHFFRDDGRQ------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHhcccccccc------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111111 0111122345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=321.66 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=197.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||++.... .++.+|||.++... ....+.+.+|..++.++ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeC
Confidence 468999999999999864 46789999997532 22345688899999888 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence 9999999999887889999999999999999999994 5999999999999999999999999999875322111 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh--hhhHHHHHHHHhhcCccceeccCcccC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+...... ......+.......+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR--------- 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---------
Confidence 134578999999999999999999999999999999999999996422111 111112222222222111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPT------IKKVLQ 749 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~~vl~ 749 (766)
.+...+.++.+++.+||+.||.+||+ +.++++
T Consensus 224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12234567889999999999999997 667764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.77 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=193.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|+... .++.+|||.+.... ....+.+..|..++..+ +||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcC
Confidence 469999999999999764 46789999986432 23445677888888776 699999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--~ 152 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--T 152 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--c
Confidence 9999999999888889999999999999999999994 5999999999999999999999999999875432211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV----------VY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCC----------CC
Confidence 1345689999999999999999999999999999999999999976543221 111111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
+...+.++.+++.+||+.||.+||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.31 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=203.1
Q ss_pred hhhhhccccccceEEEEEEecCC--CceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||+|+||.||+|...... .....+++|.+..... ....++.+|+.+++.++||||+++++.+...+..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 35678999999999999875322 2335788888764332 23457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC------------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 557 EFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
||+.+++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 999999999997532 235677889999999999999994 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYA 691 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~ 691 (766)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||.......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-- 237 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-- 237 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 99999999999999986543332211123345678999999988899999999999999999999 999986543322
Q ss_pred hHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 692 ILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+......+. ....+...+.++.+++.+||+.+|++||++.++++.|+++..
T Consensus 238 -----~~~~~~~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -----LFNLLKTGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHhCCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111111 111123345678899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=313.87 Aligned_cols=271 Identities=25% Similarity=0.351 Sum_probs=203.8
Q ss_pred hhhhhccccccceEEEEEEecC-CCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~-~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 555 (766)
.+.+.||+|+||.||++..... ...+..+|+|.++.... .....|.+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5668899999999998765421 23567899999875432 3456789999999999999999999998654 357899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++... .+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999998764 58999999999999999999995 5999999999999999999999999999987654322
Q ss_pred cc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ..................++...
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLERGM 241 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhhcCC
Confidence 11 11223456679999999988999999999999999999999999854321110 00000000000001111111112
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+...+.++.+++.+||+.+|++|||+++++++|+.+.
T Consensus 242 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=318.40 Aligned_cols=242 Identities=27% Similarity=0.346 Sum_probs=193.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .+..||||.++... ....+.+..|..++.. .+||||+++++++..++..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999864 45689999987532 2234456667766665 5899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++.....++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~ 152 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence 9999999999887788999999999999999999995 5999999999999999999999999999986533221 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~----------~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILNDR----------PHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCC----------CCC
Confidence 2345689999999999999999999999999999999999999976543221 11111110 111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIK-KVLQ 749 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl~ 749 (766)
+...+.++.+++.+||+.+|.+||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 223456778999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.29 Aligned_cols=245 Identities=27% Similarity=0.305 Sum_probs=195.1
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||+||++.... .++.+|+|.+..... ...+.+..|++++++++|+||+++.+++......++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCC
Confidence 7999999999998764 457899999864322 2235678899999999999999999999999999999999999
Q ss_pred Cchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 562 GTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 562 gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||++++++.+||+|||++..+......
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~- 153 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK- 153 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-
Confidence 999988743 3467899999999999999999994 59999999999999999999999999999876543322
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ........ ... ..
T Consensus 154 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~--------~~~--~~ 219 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQRIL--------NDS--VT 219 (280)
T ss_pred -ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHhhc--------ccC--CC
Confidence 13456899999999999999999999999999999999999999754321100 00011010 111 11
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
.+...+..+.+++.+||+.||++|| ++++++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1234567788999999999999999 77888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.80 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=198.5
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------Cce
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QNR 552 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 552 (766)
+.+.||+|+||.||+|+....+ ....+|+|.++.. .....+.|.+|++++++++|+||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDD-SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCC-CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 5678999999999999986533 2346899987643 233356789999999999999999999988532 246
Q ss_pred EEEeeccCCCchhhhhcc------CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 553 LLVYEFLNNGTLASFLFG------NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
++++||+++|+|.+++.. ...+++.....++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998742 2347888999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHcCC
Confidence 987654332111122345678999999999999999999999999999999 788886533211 111222221
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.. ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 232 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=321.10 Aligned_cols=250 Identities=25% Similarity=0.316 Sum_probs=196.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||++.... .++.+|+|.++... ....+.+.+|+.++.++ +||||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeC
Confidence 469999999999999874 45689999987532 22345678888888776 899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|..++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~ 152 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T 152 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence 9999999999888889999999999999999999995 5999999999999999999999999999875432211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh--hhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE--EYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....||..|+|||++.+..++.++||||||+++|||++|+.||...... .......+..........
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence 13456899999999999999999999999999999999999999532111 111112222222222211
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPT------IKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt------~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||.+||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 112334567889999999999999998 4566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=318.16 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=203.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|....++ ....+++|.++.. .....+.|.+|++++.++ +||||+++++++.+....++|+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDG-LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCC-CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 446688999999999999986543 2345788877642 223346789999999999 7999999999999999999999
Q ss_pred eccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeE
Q 037189 557 EFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~k 620 (766)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+|
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEE
Confidence 9999999999996432 36778889999999999999995 5999999999999999999999
Q ss_pred EeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHH
Q 037189 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 699 (766)
|+|||++......... .....+..|+|||++.+..++.++||||||+++|||++ |..||......+. ..
T Consensus 160 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------~~ 229 (297)
T cd05089 160 IADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------YE 229 (297)
T ss_pred ECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence 9999998643211110 11223567999999998899999999999999999998 9999975443221 11
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp~ 762 (766)
....+ .....+..++..+.+++.+||+.+|.+||++.++++.|+++.....+..
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~~ 283 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAYV 283 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcccc
Confidence 11111 1111122345778899999999999999999999999998876654433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.14 Aligned_cols=269 Identities=22% Similarity=0.266 Sum_probs=203.1
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHHHHHHHHHccCCCCCeeeEeeeee--cCCceEEEee
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLLVYE 557 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~E 557 (766)
.+.|++|.||.||+|+.+. ....||+|+++...+.. .-.-++||.+|.+.+|||||.+..+.. +-+..|||||
T Consensus 81 lnrI~EGtyGiVYRakdk~---t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKK---TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HhhcccCcceeEEEeccCC---cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 4679999999999999875 46799999998644221 234589999999999999999988774 4457999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||++ +|...+... +++...++..++.|+++|++|||+ ..|+|||||++|+|+.+.|.+||+|||+|+.+.....
T Consensus 158 ~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred HHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 9998 888888775 478888999999999999999995 5999999999999999999999999999998765422
Q ss_pred ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---ccc---ee
Q 037189 637 TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---KLD---AL 709 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~ 709 (766)
..+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||+++++.|.....-+.... +...+... .-. .+
T Consensus 233 -~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 -PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred -cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCCCcccc
Confidence 22566789999999998875 599999999999999999999999987665332221 11111110 000 00
Q ss_pred --c---------cCcccCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 037189 710 --V---------GGDMEAMNDVE-CLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763 (766)
Q Consensus 710 --~---------~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp~p 763 (766)
. ...++..+... ..+.-.+|+...+..||.+|.|+.|.++. +=..+.+.|..|
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P 373 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDP 373 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCCh
Confidence 0 00011111111 34677889999999999999999998865 123444444433
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.60 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=214.8
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
....+.|+||+|.||.|++|.+...+.+...||||.++..... ...+|++|+..|.+|+|+|++||+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 3344668999999999999999987777889999999865544 56789999999999999999999999988 788999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|.++.|+|.+.|+.. ..+.......++.|||+||.||. +.+.|||||..+|+||-....+||+||||.+.+...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999873 34556677889999999999999 569999999999999999999999999999998876
Q ss_pred CCcceee-cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 QSKTIKT-SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 ~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
+...... ...-...|.|||.+....|+.++|||+|||.||||+| |..||-...... +. +.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q-------IL---------~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ-------IL---------KNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH-------HH---------Hhcc
Confidence 6544332 3445778999999999999999999999999999999 778886544322 11 2233
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
...+...+..|++.+.++++.||..+|++|||+..+.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 3444556778999999999999999999999999997443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.80 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=192.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.++||+|+||.||+|+... .++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred hhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 456889999999999998764 457899999864322 2346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+.. ..++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+......
T Consensus 154 ~~~~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~-- 224 (353)
T PLN00034 154 MDGGSLEGTH----IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP-- 224 (353)
T ss_pred CCCCcccccc----cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc--
Confidence 9999987542 34567778899999999999995 59999999999999999999999999999876433211
Q ss_pred eecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 639 KTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+.... ...
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~~---------- 291 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CMS---------- 291 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hcc----------
Confidence 133568999999998853 23456899999999999999999999743322211111100 000
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+.++.+++.+||+.||++|||+.|++++
T Consensus 292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111123456788999999999999999999999986
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.26 Aligned_cols=250 Identities=27% Similarity=0.432 Sum_probs=200.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...+.+.||+|+||.||+|... ....+|+|.+... .....+|.+|++++++++|+||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEec----CCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 3557789999999999999875 3457899987542 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999999999753 467899999999999999999995 58999999999999999999999999999865432211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . .....+. .
T Consensus 157 ~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~----~~~~~~~---------~ 219 (256)
T cd05059 157 S-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---V----ESVSAGY---------R 219 (256)
T ss_pred c-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH---H----HHHHcCC---------c
Confidence 1 112224567999999999999999999999999999999 7888865433221 1 1111110 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...+...+.++.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1112235678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.43 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=205.1
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
....+.+.||+|+||.||+|....++.. ...||+|.++... .....++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 3445668899999999999987643322 3458999986432 3335678999999999999999999999975 45789
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
++||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999999999764 568999999999999999999994 59999999999999999999999999999877543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..........++..|+|||.+.+..++.++||||||+++|||++ |..||....... +..+ +..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----~~~~~~------ 229 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDL----LEKGER------ 229 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCc------
Confidence 32211122345678999999999999999999999999999998 889986433221 1111 111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
...+...+..+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 230 ---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 ---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1112234567889999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=314.74 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=197.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|.... .+..||+|.++... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4556889999999999998764 45689999986533 2234578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++ +|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~ 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc
Confidence 9985 899888654 456888899999999999999994 59999999999999999999999999999765432211
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH-----HHhhc----Ccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF-----DCYRN----GKL 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~----~~~ 706 (766)
.....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+......... ..+.. ...
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred --ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 133467899999999865 568999999999999999999999997654332211110000 00000 000
Q ss_pred ceeccCcccCC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAM----NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..... .......++.+++.+||+.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00111100000 011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=306.37 Aligned_cols=251 Identities=33% Similarity=0.506 Sum_probs=207.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccC-HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||+|...........+++|.+....... .+.+.+|++.+.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999987532346789999987654333 67899999999999999999999999999999999999999
Q ss_pred CchhhhhccC---------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 562 GTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 562 gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++|.+++... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 67899999999999999999999 45999999999999999999999999999988765
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
...........++..|+|||.+....++.++||||||++++||++ |+.||......+. ......+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC------
Confidence 432222234557889999999998899999999999999999999 6999876532221 11111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
....+...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11123344678999999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.37 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=203.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|++|.||+|.+.........+|||.+..... ...+.|.+|+.++++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999876444456799999976554 456789999999999999999999999988 889999999999
Q ss_pred CchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc-ce
Q 037189 562 GTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-TI 638 (766)
Q Consensus 562 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 638 (766)
++|.+++.... .+++...+.++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.+...... ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997653 67899999999999999999994 59999999999999999999999999999877543221 11
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....++..|+|||++.+..++.++||||||+++|||++ |+.|+......+. .... ..... ...
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~---~~~~~---------~~~ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKI---DKEGE---------RLE 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---HhcCC---------cCC
Confidence 123456789999999999999999999999999999999 9999864433221 1101 00110 001
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12234578899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=323.55 Aligned_cols=272 Identities=24% Similarity=0.346 Sum_probs=199.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----c
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----N 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 551 (766)
+.+.+.||+|+||.||+|.... .+..||||++.... ......+.+|++++++++||||+++++++.... .
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence 3456789999999999999764 46789999986432 223457899999999999999999999885432 4
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++||||+. ++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 79 IYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 799999996 6899999887789999999999999999999995 599999999999999999999999999998654
Q ss_pred cCCC-cceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHH--------HHHHH
Q 037189 632 LNQS-KTIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD--------WAFDC 700 (766)
Q Consensus 632 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~ 700 (766)
.... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||............. .....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 3221 111234568999999999876 678999999999999999999999996543211110000 00000
Q ss_pred hhcCccceecc---CcccCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCC
Q 037189 701 YRNGKLDALVG---GDMEAM---NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEV 757 (766)
Q Consensus 701 ~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~ 757 (766)
+.......... ...... .....+..+.+++.+||+.||++|||+.++++. ++++...
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 00000000000 000000 001234567899999999999999999999965 4444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.21 Aligned_cols=263 Identities=27% Similarity=0.434 Sum_probs=203.9
Q ss_pred HHHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
...+.+.+.||+|+||.||+|.... .+.....+|+|.+..... .....+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 3455667899999999999998653 223456899998764322 2234688999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 553 LLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999642 223456778899999999999994 599999999999999999999999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ....
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------LKFV 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH
Confidence 9999986544332221122345678999999999999999999999999999999 7888864332221 1111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
..+... ..+...+..+.+++.+|++.+|++|||+.++++.|++.+..
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 235 MDGGYL---------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred HcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 111110 11223357899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=319.06 Aligned_cols=264 Identities=28% Similarity=0.420 Sum_probs=206.8
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCC----CceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeee
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCD 547 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 547 (766)
+....+.+.+.||+|+||.||++...... .....+|+|.++... .....++.+|+.++.++ +|+||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33455677899999999999999865322 123579999987532 23345788999999999 7999999999999
Q ss_pred cCCceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 548 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
..+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence 999999999999999999999753 246788899999999999999994 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
+++.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+.
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~ 251 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 999999999999999886643222111122234568999999998899999999999999999998 8888865433221
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
......+. ....+...+.++.+++.+||+.+|++||||.+|++.|+.+++
T Consensus 252 -------~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 -------FKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred -------HHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111111 111123346788899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.12 Aligned_cols=242 Identities=29% Similarity=0.364 Sum_probs=194.8
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .+..+|||.++... ......+..|..++.. ++||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeC
Confidence 469999999999999864 45689999987532 2334556778877776 5899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-- 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc--
Confidence 9999999999887788999999999999999999994 59999999999999999999999999998754322211
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-------FQSIRMDNP----------CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC----------CC
Confidence 1345689999999999999999999999999999999999999975443221 111111110 01
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIK-KVLQ 749 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl~ 749 (766)
+.....++.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222456788999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=325.96 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=196.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||+|+||.||+|.... .++.+|||++.... ......+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred eEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 356789999999999998764 46789999986532 223456899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC-
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS- 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 635 (766)
||+++|+|.+++.....+++..+..++.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999999888888999999999999999999994 5999999999999999999999999999764321100
Q ss_pred --------------------------------------------cceeecccccCcccccccccCCCCCcccCeeehhHH
Q 037189 636 --------------------------------------------KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVL 671 (766)
Q Consensus 636 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvv 671 (766)
........||..|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123469999999999999899999999999999
Q ss_pred HHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHH--ccccCCCCCCCHHHHHH
Q 037189 672 LLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIW--CIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 672 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPt~~~vl~ 749 (766)
+|||++|+.||......+... ....... ..........+.++.+++.+ |+..++..||++.++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~------~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQL------KVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHH------HHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999997654322110 0000000 00111111234567777776 55667777999999987
Q ss_pred H
Q 037189 750 M 750 (766)
Q Consensus 750 ~ 750 (766)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.84 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=205.2
Q ss_pred HHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (766)
....+.+.||+|+||.||++..... ......+|||.++.... ...+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3455678999999999999986421 22456899998875432 2345789999999999 799999999999999999
Q ss_pred EEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
++||||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997543 37899999999999999999995 59999999999999999999999999999866
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ......+.
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~----~~~~~~~~---- 261 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F----YKLIKEGY---- 261 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H----HHHHHcCC----
Confidence 54332222223345778999999999999999999999999999998 9999865432211 1 11111111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
....+...+.++.+++.+|++.+|++|||+.++++.|+++
T Consensus 262 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0011122356789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.92 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=206.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.+.||+|+||.||+|.....+.....+|+|.++... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34556789999999999999986554456689999986532 22346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999764 467889999999999999999994 599999999999999999999999999998765433
Q ss_pred Cccee-ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTIK-TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..... ....++..|+|||++.+..++.++||||||+++||+++ |+.||......+. .. ...++.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~----~~~~~~------- 226 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IK----AIEEGY------- 226 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HH----HHhCCC-------
Confidence 21111 11223568999999999899999999999999999887 9999865433221 11 111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
........+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=310.13 Aligned_cols=250 Identities=25% Similarity=0.307 Sum_probs=199.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
++..+.||+|+||.||++.... .++.||||.+.... ......+.+|+.++++++|+||+++++.+..++..++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEE
Confidence 3455789999999999998764 46789999986432 22235678899999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999888643 457899999999999999999995 59999999999999999999999999999875433
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... ....|+..|+|||++.+..++.++||||||+++|||++|+.||......... ..+........
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~-------- 221 (285)
T cd05605 156 ETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQ-------- 221 (285)
T ss_pred Ccc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhcc--------
Confidence 221 2346899999999999889999999999999999999999999754332111 11111111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 --EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred --cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111234567789999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.10 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=199.5
Q ss_pred HhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.+.... .....+++|...... ......|.+|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 345578999999999999986411 145688999886433 22345799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCC-------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC---CeEEeccC
Q 037189 556 YEFLNNGTLASFLFGNL-------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---NARISDFG 625 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg 625 (766)
|||+++++|.+++.... .+++..++.++.||++||+|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999986542 47888899999999999999995 5899999999999998654 59999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
+++................+..|+|||++.+..++.++|||||||++|||++ |+.||......... . .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~----~~~~~ 237 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E----FVTGG 237 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----HHHcC
Confidence 9987643222111112233568999999999999999999999999999997 99998754432211 1 11111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.....+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 238 ---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 ---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 011112334578889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.57 Aligned_cols=241 Identities=27% Similarity=0.332 Sum_probs=194.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .+..+|+|.++... ......+..|..++.. .+||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECC
Confidence 469999999999999874 45689999987532 2334556778877765 4899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R 152 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence 9999999999887788999999999999999999994 5999999999999999999999999999875322211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .+....+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-------~~~~~~~~~----------~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-------FESIRVDTP----------HY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC----------CC
Confidence 2346789999999999999999999999999999999999999975443221 111111110 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIK-KVL 748 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl 748 (766)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 122456788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.74 Aligned_cols=243 Identities=25% Similarity=0.319 Sum_probs=197.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||++.... .+..+|||.++... ......+.+|.+++..+ +||||+++++++...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999864 45689999987532 23345677888888877 799999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|..++.....+++..+..++.|++.||+||| +.+|+||||||+||++++++.+||+|||+++........
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 152 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-- 152 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence 999999999988888999999999999999999999 459999999999999999999999999998753222211
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------FQSILEDEV----------RY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCC----------CC
Confidence 1334689999999999999999999999999999999999999975443221 111111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTI-----KKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~~ 750 (766)
+...+..+.+++.+||+.||.+||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 22345678899999999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=306.38 Aligned_cols=252 Identities=28% Similarity=0.428 Sum_probs=201.3
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.++||+|+||.||+|... .+..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. ....+++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 345677889999999999999875 34568999887533 34567999999999999999999999885 4568899
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999999753 457899999999999999999995 48999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .... ...+
T Consensus 156 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~-------- 219 (260)
T cd05070 156 EYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQ----VERG-------- 219 (260)
T ss_pred ccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcC--------
Confidence 22111 22335678999999998899999999999999999999 888886543221 1111 1111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.....+...+..+.+++.+|++.+|++|||+.++.+.|++
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 -YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111123446779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.61 Aligned_cols=254 Identities=30% Similarity=0.457 Sum_probs=204.3
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
+...++++.++||+|+||.||+|... +++.+|+|.+... .....+|.+|+.++++++|+||+++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC----CCceEEEEEecCC-CCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45677788899999999999999865 3567999998743 334568999999999999999999999874 45789
Q ss_pred EEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 554 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
++|||+++++|.+++... ..+++.++..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999999998653 46788899999999999999999 4599999999999999999999999999998765
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
...... .....++..|+|||++.+..++.++||||||++++||++ |+.||......+. .. ....+.
T Consensus 154 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~----- 220 (260)
T cd05067 154 DNEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQ----NLERGY----- 220 (260)
T ss_pred CCCccc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHHcCC-----
Confidence 332211 123345678999999998899999999999999999999 9999975432221 11 111110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
....+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 221 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 ----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.51 Aligned_cols=244 Identities=25% Similarity=0.299 Sum_probs=194.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||++.... .++.+|+|.++... ....+.+.+|+.++.++ +||||+++++++.+.+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeC
Confidence 469999999999999864 45789999997532 22345678899998887 699999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T 152 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence 9999999999887889999999999999999999995 5999999999999999999999999999875322111 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........................ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CC
Confidence 13457899999999999999999999999999999999999999643322211112222222222111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
+...+..+.+++.+||+.||.+||++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 22345677899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.05 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=196.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.||+|+||.||+|++..++ ....+++|.++... ......+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCC-CeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 46899999999999987532 23467888886432 33446789999999999 79999999999999999999999999
Q ss_pred CCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEecc
Q 037189 561 NGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 561 ~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
+++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 999999986432 36788889999999999999995 59999999999999999999999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
|++........ ......+..|+|||++.+..++.++||||||++++||++ |..||......+. ......
T Consensus 157 gl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~ 226 (270)
T cd05047 157 GLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKLPQ 226 (270)
T ss_pred CCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHHhC
Confidence 99863321111 111234567999999998899999999999999999997 9999865332211 111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+. ....+...+..+.+++.+|++.+|.+|||+.++++.|+++++
T Consensus 227 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 227 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 10 011122345678899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.17 Aligned_cols=250 Identities=27% Similarity=0.411 Sum_probs=198.3
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
.||+|+||.||+|.+...+ .+..+|+|.+..... ...++|.+|+.++++++|+||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~-~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCC-CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999876432 355799998865432 22456999999999999999999999885 45789999999999
Q ss_pred chhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-ee
Q 037189 563 TLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-KT 640 (766)
Q Consensus 563 sL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~ 640 (766)
+|.+++.. ...+++..+++++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++.......... ..
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 99999975 4568999999999999999999995 5999999999999999999999999999986544332211 11
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+..+. ....+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~~~ 220 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV-------MSFIEQGK---------RLDCP 220 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHHCCC---------CCCCC
Confidence 2234578999999998889999999999999999996 9999975433221 11111111 11122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
..+++++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 34567888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.12 Aligned_cols=245 Identities=26% Similarity=0.321 Sum_probs=196.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 555 (766)
.+.+.||+|+||.||+|+... .++.+|||.++... ....+.+..|++++..++| ++|+++.+++.+.+..++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 79 (324)
T ss_pred eEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence 466889999999999999764 45689999987532 2344668889999999876 4688899999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 9999999999999888888999999999999999999995 5999999999999999999999999999875322211
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~--------- 218 (324)
T cd05587 157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNV--------- 218 (324)
T ss_pred --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence 11345689999999999999999999999999999999999999975443221 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTI-----KKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+||+. +++++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1122345678899999999999999976 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.33 Aligned_cols=263 Identities=23% Similarity=0.388 Sum_probs=207.4
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCC-CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeec-CCc
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQN 551 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 551 (766)
....+.+.+.||+|+||.||+|.....+ .....|++|++.... ......+.+|+.++++++|+||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3445566789999999999999987422 236789999886432 2234668899999999999999999998866 567
Q ss_pred eEEEeeccCCCchhhhhccC--------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 552 RLLVYEFLNNGTLASFLFGN--------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
.++++||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998643 357888999999999999999994 5999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+ +..+ ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH----HH
Confidence 999987654433222223446778999999998899999999999999999999 999997543322 1111 11
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+. .......++.++.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 234 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 DGY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred cCC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 111122345678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.19 Aligned_cols=253 Identities=29% Similarity=0.450 Sum_probs=202.3
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.++||+|+||.||+|+... ...+|+|+++.. ....++|.+|++++++++|+||+++++++.+ ...++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 3456778899999999999998753 346999998743 2345689999999999999999999998754 567899
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||.++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999753 457889999999999999999994 59999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ......+.
T Consensus 156 ~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~~~~~~------- 220 (262)
T cd05071 156 EYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGY------- 220 (262)
T ss_pred cccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHHHhcCC-------
Confidence 3221 123346678999999998899999999999999999999 8888865432221 11111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
........+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 221 --~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0111234567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=325.16 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=203.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.+|||.++... ......+.+|++++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence 3456789999999999999864 46789999987532 23456789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC-
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ- 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 634 (766)
|||+++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 9999999999999888888999999999999999999995 599999999999999999999999999998765433
Q ss_pred --------------------------CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh
Q 037189 635 --------------------------SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE 688 (766)
Q Consensus 635 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~ 688 (766)
.........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001113356899999999999999999999999999999999999999765432
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT-IKKVLQM 750 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~~ 750 (766)
... .. +.... ...........+..+.+++.+|++ +|.+||+ +.++++.
T Consensus 237 ~~~------~~-i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETY------NK-IINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HH-HhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 210 00 11100 000111111146778899999998 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.95 Aligned_cols=266 Identities=25% Similarity=0.424 Sum_probs=208.1
Q ss_pred HHHhhhhhccccccceEEEEEEecC-CCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeec--CCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~-~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~ 552 (766)
....+.+.||+|+||.||+|.+... ...+..+|||.+...... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 3455678999999999999997642 335678999998754433 46789999999999999999999999977 5578
Q ss_pred EEEeeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 99999999999999997654 68999999999999999999995 599999999999999999999999999998876
Q ss_pred cCCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh--------hHHHHHHHHhh
Q 037189 632 LNQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA--------ILTDWAFDCYR 702 (766)
Q Consensus 632 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~ 702 (766)
..... .......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 33221 1111234556799999999889999999999999999999999987543221100 00001111111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.......+..++.++.+++.+||+.+|++||||.+|+++|+++
T Consensus 241 ---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 ---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111112234457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=306.31 Aligned_cols=254 Identities=26% Similarity=0.493 Sum_probs=197.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeee-cCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~Ey~~ 560 (766)
+.||+|+||.||+|...........+|+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999986555556789999985432 233567889999999999999999999875 4556889999999
Q ss_pred CCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-
Q 037189 561 NGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI- 638 (766)
Q Consensus 561 ~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~- 638 (766)
+++|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+|||+++++.+||+|||+++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 445677788999999999999995 5999999999999999999999999999986543221111
Q ss_pred -eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhC-CcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 639 -KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 639 -~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....++..|+|||.+.+..++.++||||||+++|||++| .+|+......+ +... ...+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~----~~~~~~---------~ 221 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY----LLQGRR---------L 221 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HhcCCC---------C
Confidence 1223457789999999988999999999999999999995 45554332211 1111 111110 0
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..+...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 222 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 112223567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=296.71 Aligned_cols=262 Identities=26% Similarity=0.343 Sum_probs=201.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCC-eeeEeeeeecCC---
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQ--- 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~--- 550 (766)
..+...++||+|.||+||+|..+. .++.||+|+++...+ .......+|+.++++++|+| |++|.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence 344456789999999999999886 457999999986544 23456799999999999999 999999998877
Q ss_pred ---ceEEEeeccCCCchhhhhccCC----CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 551 ---NRLLVYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 551 ---~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
..+||+||+.. +|..++.... .++...+..++.||++||+||| +.+|+||||||+||||++++.+||+|
T Consensus 88 ~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 88 GIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeec
Confidence 78899999865 8999987643 4566788999999999999999 45999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+|+...-.... .+...+|.+|.|||++.+. .|+...||||+|||+.||+++++.|....+.+... .+.+.+.
T Consensus 164 FGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lG 238 (323)
T KOG0594|consen 164 FGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLG 238 (323)
T ss_pred cchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcC
Confidence 9999966532211 2456789999999999887 79999999999999999999999998766533211 1222221
Q ss_pred cCc------cceeccCcc--cCCC-cH-------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NGK------LDALVGGDM--EAMN-DV-------ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~~------~~~~~~~~~--~~~~-~~-------~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
... +..+.+-.. .... +. .......+++.+|++.+|.+|.|++.++++
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 110 111111110 0000 10 111367889999999999999999999986
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.87 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=202.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.++||+|+||.||+|+... +++.+|+|.+..........+.+|+.++.+++||||+++++.+..++..++|+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 345677899999999999999764 46789999987654455567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..+..++.|+++||.|||+ .+|+||||||+||++++++.+||+|||++..+......
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162 (267)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence 999999999999877788999999999999999999994 59999999999999999999999999999876432211
Q ss_pred ceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 637 TIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.....++..|+|||.+. ...++.++||||||+++|||++|+.|+......+... ....... ..+.
T Consensus 163 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~ 230 (267)
T cd06646 163 --RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPK 230 (267)
T ss_pred --cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCC
Confidence 12345788999999884 4457889999999999999999999985432211000 0000000 0000
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
. ......+..+.+++.+||+.+|++|||++++++.|
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 11123457889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=305.19 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=192.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||+|..... .....+|+|+++.... .....|.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 3689999999999987542 2456799998865432 2335789999999999999999999999999999999999999
Q ss_pred CchhhhhccC-----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 562 GTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 562 gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 9999998643 234667778899999999999994 59999999999999999999999999998754433222
Q ss_pred ceeecccccCcccccccccCC-------CCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 637 TIKTSIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.. . ..+.. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~----~~~~~-~~~~ 229 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--T----YTVRE-QQLK 229 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--H----HHhhc-ccCC
Confidence 111234567889999998642 35789999999999999996 99999654322210 0 01111 1111
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
+..+.. .....+.+.+++..|+ .+|++|||+++|++.|+
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 1123456778999998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=308.36 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=190.5
Q ss_pred hccccccceEEEEEEecC---------------------CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeE
Q 037189 484 EVGRGSFGIVYKGVIQTT---------------------RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~---------------------~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 542 (766)
.||+|+||.||+|.+... ......|++|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986431 11235689999876544445678999999999999999999
Q ss_pred eeeeecCCceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----
Q 037189 543 LGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---- 617 (766)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---- 617 (766)
+++|.+....++||||+++|+|..++.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999865 4678899999999999999999994 5999999999999997543
Q ss_pred ---CeEEeccCcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHH-hCCcCCCchhhhhhhh
Q 037189 618 ---NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEII-ACRKSFDIEMVEEYAI 692 (766)
Q Consensus 618 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~ell-tg~~p~~~~~~~~~~~ 692 (766)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999987644322 22346788999998875 56899999999999999995 6888886543322111
Q ss_pred HHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...... .. +......+.+++.+||+.+|++|||+.+|++.|+
T Consensus 233 -------~~~~~~-------~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 233 -------FYEKKH-------RL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -------HHHhcc-------CC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 011000 00 1112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.82 Aligned_cols=243 Identities=24% Similarity=0.378 Sum_probs=192.0
Q ss_pred hhccccccceEEEEEEecCC---------CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 483 EEVGRGSFGIVYKGVIQTTR---------TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~---------~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
+.||+|+||.||+|+..... .....+++|.+..........|.+|+.++++++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864321 123468889887654555567899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC-------eEEeccC
Q 037189 554 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN-------ARISDFG 625 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-------~kl~Dfg 625 (766)
+||||+++++|..++... ..+++..++.++.||++||+||| +.+|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998753 56889999999999999999999 459999999999999987664 8999999
Q ss_pred cccccccCCCcceeecccccCccccccccc-CCCCCcccCeeehhHHHHHHH-hCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEII-ACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.|+......+... .. .
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~-~ 223 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY-E 223 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH-h
Confidence 98765322 2234778899999987 567899999999999999998 5888876443222110 00 1
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
+.. .. .......+.+++.+||+.||++||++.++++.|+
T Consensus 224 ~~~--------~~--~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQC--------ML--VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCc--------cC--CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 110 00 1112457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=287.55 Aligned_cols=248 Identities=27% Similarity=0.396 Sum_probs=203.8
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc----CH----HHHHHHHHHHccC-CCCCeeeEeeeeecCCc
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD----GE----REFKNEVFVIGQT-HHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~----~~----~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (766)
-.+.||+|..+.|-+..++. .+...|+|++...... .. +.-.+|+.+|+++ .||+|+.+.++++.+.-
T Consensus 21 pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hHHHhcccchhhhhhhhhcc---cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 35689999999999998875 4567888887542211 12 3346789999997 69999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++|+|.|+.|.|.|+|.+...+++....+|+.|+.+|+.||| ...|+||||||+|||+|++.++||+|||++..+.
T Consensus 98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 9999999999999999999999999999999999999999999 5699999999999999999999999999999888
Q ss_pred cCCCcceeecccccCcccccccccCC------CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
+++.. ...+||++|+|||.+... .|+...|.||+|||+|.|+.|.+||.....- ...+.+.+|.
T Consensus 175 ~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-------lMLR~ImeGk 244 (411)
T KOG0599|consen 175 PGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-------LMLRMIMEGK 244 (411)
T ss_pred CchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-------HHHHHHHhcc
Confidence 76543 568999999999998643 5788899999999999999999999643221 1223333443
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+. ....-.+.+....+|+.+||+.||.+|.|++|++++
T Consensus 245 yqF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred ccc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 321 112234567888999999999999999999998853
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.47 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=204.4
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.+.||+|+||.||+|... +..+|||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 34567789999999999999864 56799999976533 5678999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999997654 68999999999999999999994 599999999999999999999999999998764322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
. ....+..|+|||.+.+..++.++||||||++++||++ |+.||......+. ......+.
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~-------- 216 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHVEKGY-------- 216 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 1 2234668999999998899999999999999999998 9999865432221 11111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
....+...+..+.+++.+||+.+|++|||+.+++++|+.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 217 -RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111223467889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=316.98 Aligned_cols=238 Identities=26% Similarity=0.295 Sum_probs=191.0
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHH-HHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .++.+|||.+.... ....+++.+|.. +++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcC
Confidence 469999999999999864 46789999986532 222344555554 56789999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T 152 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence 9999999999888888999999999999999999995 5999999999999999999999999999875432211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+.. . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~--------~--~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------YDNILNKPL--------R--L 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcCCC--------C--C
Confidence 1345689999999999999999999999999999999999999975433221 111111111 0 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 745 (766)
....+..+.+++.+||+.||.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 122356788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.48 Aligned_cols=256 Identities=29% Similarity=0.460 Sum_probs=200.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (766)
.+.+.+.||+|+||.||+|.+..++ ....+++|+++... .....+|.+|++++.++ +|+||+++++++.+++..++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCC-ceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4456788999999999999986432 23467888776432 33456789999999999 899999999999999999999
Q ss_pred eeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCe
Q 037189 556 YEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA 619 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 619 (766)
|||+++++|.+++.... .+++..++.++.|+++||+|||+ .+++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 99999999999986432 46788899999999999999994 599999999999999999999
Q ss_pred EEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHH
Q 037189 620 RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAF 698 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 698 (766)
||+|||++........ ......+..|+|||++.+..++.++||||||++++||+| |..||......+. .
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~---- 233 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y---- 233 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---H----
Confidence 9999999864321111 111234668999999988889999999999999999998 9999865433221 1
Q ss_pred HHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.....+ .....+...+..+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 234 EKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111111 0011122245678899999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.75 Aligned_cols=256 Identities=20% Similarity=0.230 Sum_probs=194.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.++||+|+||.||++.... .++.||+|... ...+.+|++++++++||||+++++++......++|+|+
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECC---CCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 5567899999999999998864 45689999753 23578999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+. ++|.+++.....+++..++.++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++........ .
T Consensus 165 ~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~-~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-K 239 (391)
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc-c
Confidence 85 6899998877788999999999999999999995 59999999999999999999999999999754322111 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh-----hhhhHHHHHHHHhhc----------
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE-----EYAILTDWAFDCYRN---------- 703 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~---------- 703 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....+.. +......
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchh
Confidence 13457999999999999999999999999999999999999876432110 0000000 0000000
Q ss_pred Ccccee---------ccCcccC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 704 GKLDAL---------VGGDMEA--MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 704 ~~~~~~---------~~~~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+..+ ..+.... ......+.++.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0000000 001134567889999999999999999999985
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=310.48 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=201.5
Q ss_pred HHhhhhhccccccceEEEEEEec-------------CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT-------------TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~-------------~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (766)
.+.+.++||+|+||.||++.... .......+|+|.+.... .....+|.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 35667899999999999986432 12234679999987542 23346799999999999999999999
Q ss_pred eeeecCCceEEEeeccCCCchhhhhccCC-----------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNL-----------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
+++...+..++||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 99999999999999999999999986532 35567889999999999999995 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh--CCcCCCchhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA--CRKSFDIEMVEEY 690 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt--g~~p~~~~~~~~~ 690 (766)
++.++.+||+|||+++.+.............++..|+|||...++.++.++||||||+++|||++ |..|+......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 99999999999999987654332222122334678999999888899999999999999999998 6677764433221
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.. ............. ....+..++..+.+++.+||+.||.+||++.+|++.|++
T Consensus 243 ~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IE---NTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1111111110000 011122345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.98 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=210.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-eEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN-RLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~l 554 (766)
.+...+++|+|+||.++..+++. +.+.+++|++.... ....+...+|+.++++++|||||.+.+.+.+++. .+|
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred hhhhhhhcCccccchhhhhhhcc---CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 46677899999999999988875 45689999986543 3334568999999999999999999999999988 899
Q ss_pred EeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 555 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||+|++||+|.+.+... ..++++.+.+++.|++.|+.|||+ ..|+|||||+.||+++.+..+||.|||+|+.+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999999765 457888999999999999999995 4999999999999999999999999999999887
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+.... . .+..+ +
T Consensus 159 ~~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L---i---~ki~~-~-------- 221 (426)
T KOG0589|consen 159 EDSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL---I---LKINR-G-------- 221 (426)
T ss_pred chhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH---H---HHHhh-c--------
Confidence 6522 2567899999999999999999999999999999999999999987654331 1 11111 0
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..++.++..++..|++.+|..||++.+++.+
T Consensus 222 -~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 -LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1122355678899999999999999999999999865
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.79 Aligned_cols=266 Identities=28% Similarity=0.423 Sum_probs=207.7
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCC----CceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeee
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCD 547 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 547 (766)
+....+.+.+.||+|+||.||++...... .....+|+|.++... ....+++.+|++++.++ +||||++++++|.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 34456677899999999999999864321 123478999886432 22346799999999999 7999999999999
Q ss_pred cCCceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 548 EGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
+....++++||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence 999999999999999999998642 246778888999999999999995 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.....++.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999987654322211122334568999999999999999999999999999998 8888865443221
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
......+.. ...+..++.++.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 246 -------~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 -------FKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred -------HHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 111111111 1112234567889999999999999999999999999887444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.74 Aligned_cols=256 Identities=23% Similarity=0.361 Sum_probs=204.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|+... .++.+|||.+.... ......|.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 4566889999999999999864 45689999875422 22345689999999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
+||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988853 3457888899999999999999995 599999999999999999999999999988765
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... .....++..|+|||.+.+..++.++|+||||+++|||++|+.|+........ ... .......
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~----~~~~~~~------ 224 (267)
T cd08228 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC----QKIEQCD------ 224 (267)
T ss_pred chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH----HHHhcCC------
Confidence 43221 1234578899999999988899999999999999999999999864332111 111 1111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.........+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111112345677899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.38 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=205.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||++.... ++..++||.+.... .....+|.+|+.+++.++|+||+++++++.+++..++
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~ 79 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 79 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEE
Confidence 35567899999999999999764 45689999876432 2234578999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 555 VYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+|||+++++|.+++.. ...+++..++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999998863 3567899999999999999999994 59999999999999999999999999998876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
...... .....++..|+|||++.+..++.++||||||+++|||++|..||......... . .......
T Consensus 157 ~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~----~~~~~~~------ 223 (267)
T cd08229 157 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-L----CKKIEQC------ 223 (267)
T ss_pred ccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-H----hhhhhcC------
Confidence 543221 12346888999999999989999999999999999999999998643322110 0 0111110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
..........++.+.+++.+||+.+|++||||.+|++.++++
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011111234567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.71 Aligned_cols=252 Identities=23% Similarity=0.265 Sum_probs=194.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||+|+||.||++.... .++.+|||.++... ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 456789999999999998764 46789999987532 223356788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++|+|.+++.....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 99999999999988888999999999999999999999 459999999999999999999999999998765321100
Q ss_pred ---------------------------------ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCC
Q 037189 637 ---------------------------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683 (766)
Q Consensus 637 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~ 683 (766)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123469999999999999999999999999999999999999997
Q ss_pred chhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 037189 684 IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQ--EDPSLRPTIKKVLQM 750 (766)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~--~dp~~RPt~~~vl~~ 750 (766)
.....+.. ..+..... .+..+ .....++++.+++.+++. .++..||++.|++++
T Consensus 238 ~~~~~~~~-------~~i~~~~~-~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETPQETY-------KKVMNWKE-TLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCHHHHH-------HHHHcCcC-cccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 65432211 11111000 00000 011134456666666443 344467999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.52 Aligned_cols=251 Identities=25% Similarity=0.319 Sum_probs=200.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----- 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 550 (766)
.+.+.+.||+|+||.||++.... .++.+|||.++... ......+.+|+..+..++|+||+++...+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 45567899999999999998764 46789999986532 333457889999999999999999988764432
Q ss_pred ---ceEEEeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 551 ---NRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 551 ---~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 257999999999999998643 45778889999999999999999 45999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||......+. . .....
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~-~~~~~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------M-HKTLA 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------H-HHHhc
Confidence 9999876543333333456799999999999999999999999999999999999999975443221 1 11111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+... ..+...+.++.+++.+||+.+|.+||++.+++++
T Consensus 260 ~~~~---------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYD---------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 1123356788999999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.82 Aligned_cols=240 Identities=25% Similarity=0.303 Sum_probs=193.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (766)
.+.+.||+|+||.||+|.... .+..+|||.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv 79 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV 79 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence 456789999999999998864 45689999987532 22334567788887776 589999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 9999999999999888889999999999999999999994 5999999999999999999999999999875432221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ..+.....
T Consensus 157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~---~----~~i~~~~~--------- 218 (323)
T cd05616 157 --TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL---F----QSIMEHNV--------- 218 (323)
T ss_pred --ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH---H----HHHHhCCC---------
Confidence 11345689999999999999999999999999999999999999976543221 1 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
..+...+.++.+++.+||+.+|.+|++.
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1122345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.60 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=203.5
Q ss_pred HHHhhhhhccccccceEEEEEEec----CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~----~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (766)
..+.+.++||+|+||.||+++... .......+|+|.++... .....++.+|+.++.++ +||||+++++++.+..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 445567899999999999998642 12235678999887432 22345788999999999 6999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 551 NRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
..++||||+++|+|.+++... ..+++..+.+++.|++.||.|||+ .+++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 999999999999999998643 246778888999999999999995 5999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAIL 693 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 693 (766)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--- 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--- 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 999999999999987654322211122234567999999999899999999999999999999 8888865433221
Q ss_pred HHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
......+.. ...+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus 246 ----~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 ----FKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred ----HHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111111 0112334567889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.26 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=197.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||+|... ++..+|+|.++.... .....|.+|++++++++||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 46899999999999864 356899998865432 2234689999999999999999999999999999999999999
Q ss_pred CchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 562 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 562 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
++|.+++... ..+++..+..++.|++.+|.|||+ .+++|+||||+||++++++.+||+|||++.......... ..
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SG 152 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CC
Confidence 9999998753 457899999999999999999994 599999999999999999999999999987644322111 11
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...++..|+|||++.+..++.++||||||+++||+++ |..||........ ......+. ....+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~~~ 216 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGY---------RMSCP 216 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHHcCC---------CCCCC
Confidence 2234678999999998899999999999999999998 9999865433221 11111111 11112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 234678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=323.90 Aligned_cols=251 Identities=22% Similarity=0.238 Sum_probs=195.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.++||+|+||.||++.... .++.+|||.+.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred eEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 456789999999999998764 46789999986432 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++|+|.+++.....+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 99999999999988888889999999999999999999 459999999999999999999999999999643211000
Q ss_pred ---------------------------------------------ceeecccccCcccccccccCCCCCcccCeeehhHH
Q 037189 637 ---------------------------------------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVL 671 (766)
Q Consensus 637 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvv 671 (766)
.......||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 00012468999999999999999999999999999
Q ss_pred HHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCC---CCHHHHH
Q 037189 672 LLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLR---PTIKKVL 748 (766)
Q Consensus 672 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~~vl 748 (766)
+|||++|+.||......+.. ........ .+........+.++.+++.+|++ +|.+| |++.+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~------~~i~~~~~-------~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 238 MFECLIGWPPFCSENSHETY------RKIINWRE-------TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHH------HHHHccCC-------ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999999754432210 00100000 00001111235678889999997 66664 6999988
Q ss_pred HH
Q 037189 749 QM 750 (766)
Q Consensus 749 ~~ 750 (766)
++
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.34 Aligned_cols=245 Identities=24% Similarity=0.293 Sum_probs=193.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHH---HccCCCCCeeeEeeeeecCCceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFV---IGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~---l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.||+|+||.||+|.... .++.+|||.++... ....+.+.+|+++ +++++||||+++++++.+.+..+
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~ 78 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVC 78 (324)
T ss_pred eEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEE
Confidence 356789999999999998764 46789999987532 2233456666654 45678999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++++|..++.. ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 79 lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 79 FVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999999999988864 468999999999999999999994 59999999999999999999999999998754322
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~~~------- 218 (324)
T cd05589 155 GD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------FDSIVNDEV------- 218 (324)
T ss_pred CC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC-------
Confidence 21 11345689999999999999999999999999999999999999976543221 111111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 11223456788999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=319.88 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=201.1
Q ss_pred HHHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecC-C
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG-Q 550 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~ 550 (766)
...+.+.+.||+|+||.||+|..... ...++.||||+++.... .....+.+|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34567789999999999999985421 22467899999975332 2345688999999999 689999999988654 4
Q ss_pred ceEEEeeccCCCchhhhhccC-----------------------------------------------------------
Q 037189 551 NRLLVYEFLNNGTLASFLFGN----------------------------------------------------------- 571 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~----------------------------------------------------------- 571 (766)
..++||||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999998642
Q ss_pred --------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeeccc
Q 037189 572 --------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643 (766)
Q Consensus 572 --------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~ 643 (766)
..+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124666778899999999999994 599999999999999999999999999998764332221112234
Q ss_pred ccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHH
Q 037189 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVEC 722 (766)
Q Consensus 644 gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (766)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ ......++... ..+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~---------~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRM---------RAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCC---------CCCCCC
Confidence 5678999999998899999999999999999997 8888864322111 11111111110 011123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 723 LEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 723 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+.++.+++.+||+.+|++|||+.+|++.|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 4568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=289.31 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=203.9
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
....+.+.+.||+|.|+.||+..+.. .++..|+|.+.. ....+.+++.+|+++-+.++||||++|.....+....
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 34456677899999999999988764 455666666642 2334667899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCcccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKL 629 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~ 629 (766)
+||+|+|.+++|..=+-.+...++...-+.+.||+++|.|+| ..+|+|||+||+|+++. ...-+||+|||++..
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999999776655566677888889999999999999 55999999999999995 344589999999998
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
+..+ .......||++|||||++...+++..+|||+.|||||-|+.|.+||..+.... +.+.+..+..+
T Consensus 163 l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------lye~I~~g~yd-- 230 (355)
T KOG0033|consen 163 VNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYEQIKAGAYD-- 230 (355)
T ss_pred eCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------HHHHHhccccC--
Confidence 8732 23356889999999999999999999999999999999999999998744322 22333333321
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.....-....++..+|+++||..||.+|.|+.|.++
T Consensus 231 ----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 ----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111122345678889999999999999999988775
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.20 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=201.7
Q ss_pred HHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||++..... +.....+|+|.+.... .....+|.+|+.++++++||||+++++++.++...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 345567899999999999987531 2246789999986532 2234679999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC----------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 555 VYEFLNNGTLASFLFGN----------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
|+||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheE
Confidence 99999999999998642 135677788999999999999994 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYA 691 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~ 691 (766)
+++++.+||+|||+++.+..............+..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~- 241 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV- 241 (288)
T ss_pred ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999886543322111122334678999999998999999999999999999998 8888854332221
Q ss_pred hHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 692 ILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
......+... ..+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 242 ------~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 242 ------IYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1112222211 0122345788999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.57 Aligned_cols=238 Identities=25% Similarity=0.278 Sum_probs=190.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHH-HHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|+... .+..+|+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcC
Confidence 469999999999999864 46789999986432 222345556654 67889999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|..++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T 152 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence 9999999999887788888999999999999999994 5999999999999999999999999999875322211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ......+.. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM-------YDNILHKPL----------QL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH-------HHHHhcCCC----------CC
Confidence 1345689999999999999999999999999999999999999976542221 111111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 745 (766)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.63 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=198.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||+|+||.||++.... .++.||||.+.... ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred eEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 456789999999999999864 45689999997532 223456788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999999888889999999999999999999995 59999999999999999999999999998765322110
Q ss_pred c------------------------------------eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCc
Q 037189 637 T------------------------------------IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRK 680 (766)
Q Consensus 637 ~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~ 680 (766)
. ......||+.|+|||++....++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0 0012458999999999999999999999999999999999999
Q ss_pred CCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 037189 681 SFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT---IKKVLQM 750 (766)
Q Consensus 681 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~~ 750 (766)
||......+.. .... ... ...........++.+.+++.+|+. +|.+|++ +.+++++
T Consensus 238 Pf~~~~~~~~~------~~i~-~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 238 PFCSDNPQETY------RKII-NWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCHHHHH------HHHH-cCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99765432210 0111 100 000111111235677889999996 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.69 Aligned_cols=253 Identities=19% Similarity=0.262 Sum_probs=199.1
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
..+.+.+.||+|+||.||+++... .+..+|+|.+.... ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345566889999999999999864 46789999986422 233455789999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999998654 47788888899999999999994 59999999999999999999999999999876433
Q ss_pred CCcceeecccccCcccccccccCC----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+.....
T Consensus 196 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~--- 264 (370)
T cd05596 196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------YSKIMDHKN--- 264 (370)
T ss_pred Cccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-------HHHHHcCCC---
Confidence 2111 1345699999999998654 478999999999999999999999976543211 111111100
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~ 750 (766)
..........+.++.+++.+||+.+|.+ ||++.+++++
T Consensus 265 ---~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ---SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111112234678889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.67 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=191.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccC---CCCCeeeEeeeee-----c
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQT---HHKNLVRLLGFCD-----E 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~ 548 (766)
+.+.+.||+|+||.||+|..... .+..+|||.++... ......+.+|+.+++++ +||||++++++|. .
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 45668899999999999987532 35689999886533 22234566777766655 6999999999985 3
Q ss_pred CCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
....++||||+. ++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 5899988653 457889999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHHHHHHHhhcCc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWAFDCYRNGK 705 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 705 (766)
++...... ......||..|+|||.+.+..++.++|||||||++|||++|++||......+. ..+............
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 98654331 12345689999999999988999999999999999999999999976543221 111110000000000
Q ss_pred c------ceeccCcccC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 706 L------DALVGGDMEA---MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 706 ~------~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. .......... ......+..+.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 0000000000 001124566789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=307.33 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=202.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
..+.||+|+||.||+++-+. .+..+|+|+++... ....+....|-.+|...++|.||+|+-.|.+.+.+|||||
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred hheeeccccceeEEEEEEcc---CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 34679999999999999875 56799999997643 3344567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC----
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN---- 633 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~---- 633 (766)
|++||++..+|.....+++......+.+++-|+.-||+ .+++||||||+|+|||..|++||+||||+.-+...
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999999999999999999999999999999999995 59999999999999999999999999998643210
Q ss_pred ------------------CCcc-----------------------eeecccccCcccccccccCCCCCcccCeeehhHHH
Q 037189 634 ------------------QSKT-----------------------IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672 (766)
Q Consensus 634 ------------------~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl 672 (766)
+... ......|||.|+|||++.+..++..+|.||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0000 01124699999999999999999999999999999
Q ss_pred HHHHhCCcCCCchhhhh-hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 037189 673 LEIIACRKSFDIEMVEE-YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT---IKKVL 748 (766)
Q Consensus 673 ~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl 748 (766)
||||.|.+||..+.+.+ .+.+..|..... .........+..+||.+|+. ||++|-- ++||-
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~--------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLK--------------FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhcc--------------CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999998877644 444444432211 11122344788999999999 9999975 55555
Q ss_pred H
Q 037189 749 Q 749 (766)
Q Consensus 749 ~ 749 (766)
+
T Consensus 444 ~ 444 (550)
T KOG0605|consen 444 K 444 (550)
T ss_pred c
Confidence 4
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.44 Aligned_cols=251 Identities=21% Similarity=0.240 Sum_probs=200.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|+|.++... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence 3456889999999999998764 46789999987532 22345688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++|+|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999999875 678999999999999999999994 599999999999999999999999999998765433
Q ss_pred CcceeecccccCccccccccc------CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..........
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~-- 227 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF-- 227 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc--
Confidence 22 123356899999999986 45678999999999999999999999975443221 1111111110
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+..+.+++..|++ +|.+||++.++++.
T Consensus 228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0111122345678899999998 99999999998854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=305.63 Aligned_cols=260 Identities=25% Similarity=0.389 Sum_probs=206.2
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+.+.+.||+|+||.||+|...........++||...... ....+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 344567789999999999999986543345678999886544 3345679999999999999999999999875 55789
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999999764 457899999999999999999994 59999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....++..|+|||.+....++.++||||||++++||++ |..||......+.. . ....+.
T Consensus 161 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~----~~~~~~------- 225 (270)
T cd05056 161 SYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---G----RIENGE------- 225 (270)
T ss_pred ccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---H----HHHcCC-------
Confidence 2211 122334568999999988889999999999999999996 99999654432211 1 111111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+..++..+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001123446788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=315.64 Aligned_cols=241 Identities=26% Similarity=0.293 Sum_probs=191.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHH-HHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEV-FVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~-~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+++... .++.+|+|.+.... ......+..|. .+++.++|+||+++++++.+.+..++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeC
Confidence 469999999999998764 45689999986432 22233455554 456789999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.....+.+.....++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~ 152 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T 152 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence 9999999999887778888888999999999999994 5999999999999999999999999999875432221 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------~~~i~~~~~----------~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPL----------QL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCc----------CC
Confidence 2345699999999999999999999999999999999999999975443221 011111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
....+..+.+++.+||+.+|.+||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 223456788999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.81 Aligned_cols=239 Identities=26% Similarity=0.297 Sum_probs=191.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHH-HHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+++... +++.+|+|.+.... .....++..|.. +++.++||||+++++.+...+..++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcC
Confidence 469999999999998764 46789999986432 223345566654 56779999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|..++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++....... .
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 152 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T 152 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence 9999999999888889999999999999999999994 5999999999999999999999999999875432211 1
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||..|+|||++.+..++.++|||||||++|||++|+.||......+. ......+... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~~~~~~~~----------~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-------YDNILHKPLV----------L 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-------HHHHHcCCcc----------C
Confidence 1345689999999999999999999999999999999999999975443221 1111111110 1
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
.+..+..+.+++.+|++.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1124566789999999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.68 Aligned_cols=268 Identities=27% Similarity=0.396 Sum_probs=205.2
Q ss_pred HHHHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cc
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QN 551 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 551 (766)
..++...++||+|+||.||+++... ....+..+|+|.++... ......+.+|++++++++||||+++.+++.+. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3455667889999999999998643 22356789999987543 33346799999999999999999999998775 56
Q ss_pred eEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 88999999999999999654 457999999999999999999994 59999999999999999999999999999876
Q ss_pred ccCCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh--------hhhHHHHHHHHh
Q 037189 631 TLNQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--------YAILTDWAFDCY 701 (766)
Q Consensus 631 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~ 701 (766)
...... .......++..|+|||++.+..++.++||||||+++|||++++.|........ ............
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 543321 11123456778999999998899999999999999999999876643211100 000000011111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..+. ....+..++..+.+++.+||+.+|++|||++++++.|+++.
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 240 EEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred HcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1111 11112335678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.04 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=202.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|++|.||+|.... .+..+++|.+... ......++.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 456789999999999999864 4578999988643 23445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999999764 567888999999999999999994 5999999999999999999999999999887654322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||++.+..++.++||||||++++||++|+.||........ ......+...
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~-------- 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-------ILKIIRGVFP-------- 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCC--------
Confidence 1 1234678899999999999999999999999999999999999975542211 1111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 220 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 -PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1122456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=302.50 Aligned_cols=251 Identities=29% Similarity=0.437 Sum_probs=199.6
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.++||+|++|.||+|.... ...+|+|.+... ....+.|.+|++++++++|+|++++++++. ....++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 345667889999999999998753 335899987643 234567899999999999999999999875 45688999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999754 347888999999999999999995 589999999999999999999999999998764332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ....+.
T Consensus 157 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~~~~~~-------- 220 (260)
T cd05069 157 YTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LE----QVERGY-------- 220 (260)
T ss_pred ccc-cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCC--------
Confidence 211 122345678999999998899999999999999999999 8889865432221 11 111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
....+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 -RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123456788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.01 Aligned_cols=254 Identities=30% Similarity=0.472 Sum_probs=204.2
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
....+.+.++||+|+||.||+|..+ +...+|||.+... ....+++.+|+.++++++|+||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3445567789999999999999875 3467899988743 3456789999999999999999999999999899999
Q ss_pred EeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 555 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++..+..
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999999764 468899999999999999999995 4899999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
...... .....+..|+|||.+.+..++.++||||||++++||++ |+.||........ .. ....+
T Consensus 156 ~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~----~~~~~------- 220 (261)
T cd05034 156 DEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LE----QVERG------- 220 (261)
T ss_pred hhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcC-------
Confidence 221111 12234568999999998899999999999999999999 9999865432211 11 11111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.....+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 --YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111122335678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.47 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=199.0
Q ss_pred hhccccccceEEEEEEecCC---CceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTR---TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~---~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|+..... .....++||.+.... .....+|.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999876422 233678999876432 23456899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-----CeEEeccCc
Q 037189 559 LNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-----NARISDFGL 626 (766)
Q Consensus 559 ~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfgl 626 (766)
+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.+. .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999642 336788899999999999999994 5899999999999999877 899999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
++...............++..|+|||++.+..++.++||||||+++|||++ |+.||......+. .. ....+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HH----HHhcCC
Confidence 986654332222123345678999999999999999999999999999998 9999864432211 11 111111
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
....+...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111123356788999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=301.89 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=198.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee-cCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV 555 (766)
..+.+.+.||+|+||.||++... +..+++|.++.. ...+.|.+|+.++++++|+|++++++++. +++..++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 78 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-----CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence 34556789999999999999764 457899988642 34567999999999999999999999764 45678999
Q ss_pred eeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||+++++|.+++.... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999987643 47889999999999999999994 59999999999999999999999999998865432
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
. .....+..|+|||++.+..++.++||||||+++|||++ |+.|+......+ +... ...+..
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~~------ 217 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGYK------ 217 (256)
T ss_pred C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCCC------
Confidence 2 22334568999999999899999999999999999998 998886443221 1111 111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
......++..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 218 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 ---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223467889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.90 Aligned_cols=243 Identities=24% Similarity=0.398 Sum_probs=191.7
Q ss_pred hhccccccceEEEEEEecCCC----ceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRT----STTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.....+. ....+++|.+........++|.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998764322 2346888887655444556889999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC--------eEEeccCcccc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN--------ARISDFGLAKL 629 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Dfgla~~ 629 (766)
+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999764 457899999999999999999994 59999999999999987765 58999998865
Q ss_pred cccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCC-cCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACR-KSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
.... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+.......... .... .
T Consensus 158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~-~-- 221 (258)
T cd05078 158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED-R-- 221 (258)
T ss_pred cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc-c--
Confidence 4322 22457889999999986 45799999999999999999985 5554322211100 0010 0
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
. ..+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 ------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------H--QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------c--cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 011123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=310.52 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=193.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.+|||.++.... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECC---CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4566889999999999999864 466899999875432 233567899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+. ++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 996 577777654 3567888899999999999999994 5999999999999999999999999999875432211
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc---------c
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK---------L 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~ 706 (766)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+ ........... .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 159 -TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QL-ERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred -cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HH-HHHHHHhCCCChhhccchhhc
Confidence 1133567899999999865 4588999999999999999999999975322110 00 11111000000 0
Q ss_pred ceeccCcccCCCc---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 707 DALVGGDMEAMND---------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 707 ~~~~~~~~~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
............+ ...+..+.+++.+||+.||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 012356789999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.13 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=206.9
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+++.+.||+|+||+||++.... .++.+|+|.+.... ....+.+.+|+++++.++||||+++++++......++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4456778999999999999998764 45688999876432 3345789999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++++|.+++.....+++.....++.+++.+|.|||+ ..+++|+||||+||++++++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999999999877788999999999999999999995 2479999999999999999999999999987553221
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh-----hhhHHHHHHHHhhcCcccee
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-----YAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 709 (766)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ...+..........
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 228 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------ 228 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------
Confidence 1 23468999999999988899999999999999999999999997544321 11111111111111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..........+..+.+++.+|++.||++|||+.|++++.
T Consensus 229 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 229 ---PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111111223567789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.54 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=194.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.++||+|+||.||+|.... .++.+|+|.+.... ......+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 355789999999999999764 46789999986532 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC-
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS- 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 635 (766)
||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999999887778888999999999999999995 5999999999999999999999999999754321000
Q ss_pred --------------------------------------------cceeecccccCcccccccccCCCCCcccCeeehhHH
Q 037189 636 --------------------------------------------KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVL 671 (766)
Q Consensus 636 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvv 671 (766)
........||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000112468999999999999999999999999999
Q ss_pred HHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHH
Q 037189 672 LLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT---IKKVL 748 (766)
Q Consensus 672 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl 748 (766)
+|||++|+.||......+.. ....... ...........+.++.+++.+++ .+|.+|++ +.+++
T Consensus 238 l~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQ------MKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHH------HHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 99999999999765432211 0000000 00111111223456677777765 49999997 77776
Q ss_pred HH
Q 037189 749 QM 750 (766)
Q Consensus 749 ~~ 750 (766)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=305.80 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=206.1
Q ss_pred HHHhhhhhccccccceEEEEEEecCCC-ceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
..+.+.+.||+|+||.||+|....++. ....+|+|.+..... ....++.+|+.++.+++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 344567899999999999999865432 235789998865432 234678999999999999999999999987 78899
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+++|+||||+||++++++.+||+|||+++.+...
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999764 468899999999999999999995 59999999999999999999999999999877643
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..........++..|+|||.+....++.++||||||+++||+++ |+.||......+. .. ....+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PD----LLEKGER------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH----HHhCCCC------
Confidence 32221122234568999999988899999999999999999999 9999976543221 11 1111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+..+...+.+++.+||..+|.+||++.++++.|+.+..
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 01122234568899999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=319.59 Aligned_cols=252 Identities=20% Similarity=0.266 Sum_probs=196.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||++.... .++.+|+|.+... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 44566789999999999999864 4568999988642 22234568899999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||++.......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999998654 57888889999999999999994 599999999999999999999999999998764332
Q ss_pred CcceeecccccCcccccccccCC----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 197 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~----- 264 (370)
T cd05621 197 MV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKN----- 264 (370)
T ss_pred ce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCc-----
Confidence 21 11345699999999998754 378899999999999999999999976543221 111111100
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQM 750 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~ 750 (766)
..........+..+.+++..|++.++.+ ||++.+++++
T Consensus 265 --~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 --SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111112234667788999999865544 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.82 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=202.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .+..+++|.+..........+.+|+.+++.++|+||+++++.+....+.++||||
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4455789999999999998653 4568999998766555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.. ..+++.++..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 999999999864 357888999999999999999994 59999999999999999999999999998865433221
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ + ......+ ......
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~----~~~~~~~--------~~~~~~ 238 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L----YLIATNG--------TPELQN 238 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H----HHHhcCC--------CCCCCC
Confidence 1234688899999999988899999999999999999999999975443211 0 1111111 001111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+......+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 23455678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.07 Aligned_cols=251 Identities=21% Similarity=0.277 Sum_probs=201.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-----cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
+...+.||+|++|.||++.... .+..+++|.+..... ...+.+.+|++++++++||||+++++++.+....+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred ccccceecCCCceEEEEEEEcC---CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEE
Confidence 3456789999999999998764 456899998764321 12356889999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|+||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999999999999887778899999999999999999995 59999999999999999999999999999865432
Q ss_pred CCcce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~-------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQP-------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHHHhccC--------
Confidence 21111 0234578899999999999999999999999999999999999865322111 01111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111233456678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.00 Aligned_cols=244 Identities=25% Similarity=0.337 Sum_probs=192.4
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||.||++.... .+..+|+|.+.... ......+..|++++.+++||||+++.+++.++...++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCC
Confidence 7999999999999864 46789999986422 22234567799999999999999999999999999999999999
Q ss_pred CchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 562 GTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 562 gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........ .
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~ 151 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---I 151 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---e
Confidence 9999888643 357888889999999999999994 5999999999999999999999999999887654321 1
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...... ....... . ..
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~-~~~~~~~--------~-~~ 219 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRR-TLEDEVK--------F-EH 219 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHH-hhccccc--------c-cc
Confidence 3356899999999999989999999999999999999999999653321110 011111 1111110 0 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...+.++.+++.+||+.||++||+++|+++
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 134567899999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=311.46 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=200.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.+.||+|+||.||++.... .+..+|+|.+.... .....++.+|++++.+++||||+++++++.+++..++||||
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 456789999999999998764 45678888886432 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.....+++..+..++.|+++||.|||+ ..+++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 9999999999888888999999999999999999995 24899999999999999999999999999876543211
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC-c------------
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG-K------------ 705 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~------------ 705 (766)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...................... .
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 -NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred -ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 33568899999999988889999999999999999999999986443211110000000000000 0
Q ss_pred --------cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 --------LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 --------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+.............+.++.+++.+||+.+|++|||+.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000011245678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=302.27 Aligned_cols=254 Identities=26% Similarity=0.439 Sum_probs=202.5
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
+....+.+.++||+|+||.||++... ....+++|.+... ....+.|.+|++++++++|+||+++.+++.+ ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec----CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34556677889999999999999865 3456899987643 2345679999999999999999999999887 7789
Q ss_pred EEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 554 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
++|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999999753 456888899999999999999995 599999999999999999999999999998664
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
...... .....++..|+|||++....++.++|+||||++++++++ |+.||....... +.. ....+..
T Consensus 154 ~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~---- 221 (260)
T cd05073 154 DNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR----ALERGYR---- 221 (260)
T ss_pred CCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHhCCCC----
Confidence 332211 123345678999999998899999999999999999999 899986543221 111 1111111
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.......+.++.+++.+|++.+|++||++.++++.|+.
T Consensus 222 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=320.38 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=197.5
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----ceE
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NRL 553 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 553 (766)
..+.||+|+||.||++.... .++.||||++.... ....+.+.+|+++++.++|+||+++++++.... ..+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred ccceeeeCCCEEEEEEEECC---CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 45789999999999998754 46789999986432 223467899999999999999999999998776 789
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|+||+. ++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999997 5888888877889999999999999999999994 59999999999999999999999999999875443
Q ss_pred CCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHH----------------H
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD----------------W 696 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~----------------~ 696 (766)
..... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||............. .
T Consensus 157 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 32221 334578999999998874 47899999999999999999999997654322111000 0
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+....... .............++++.+++.+||+.||++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCC-CchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 00000000112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=302.48 Aligned_cols=254 Identities=28% Similarity=0.404 Sum_probs=191.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
++||+|+||.||+|..... .....+++|.+..... .....|.+|+..++.++|+||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3699999999999986543 3456789998764332 2345789999999999999999999999999999999999999
Q ss_pred CchhhhhccCC-----CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 562 GTLASFLFGNL-----KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 562 gsL~~~l~~~~-----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+|.+++.... ..++.....++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997542 23567788999999999999995 59999999999999999999999999998764433221
Q ss_pred ceeecccccCcccccccccC-------CCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.......++..|+|||++.. ..++.++||||||+++|||++ |..||......+ . .......... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~----~~~~~~~~~~-~ 229 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--V----LKQVVREQDI-K 229 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--H----HHHHhhccCc-c
Confidence 11123345678999998743 456889999999999999999 777876443221 1 1111111111 1
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
+..+. .+...+..+.+++..|+ .||++|||+++|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 12234566777888888 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.46 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=196.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+++... .++.+|||.+.... ......+.+|++++.+++|+||+++++.+.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence 3456789999999999999764 46789999986432 22345688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 9999999999999888888889999999999999999995 5999999999999999999999999999753321000
Q ss_pred -----------------------------------------cceeecccccCcccccccccCCCCCcccCeeehhHHHHH
Q 037189 636 -----------------------------------------KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674 (766)
Q Consensus 636 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~e 674 (766)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000113468999999999999999999999999999999
Q ss_pred HHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 037189 675 IIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP---TIKKVLQM 750 (766)
Q Consensus 675 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---t~~~vl~~ 750 (766)
|++|+.||......+... .. ..... ..........+.++.+++.+|+ .+|.+|+ ++.++++.
T Consensus 237 ll~G~~Pf~~~~~~~~~~------~i-~~~~~------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAETQL------KV-INWET------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHHHH------HH-hccCc------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997654322111 00 00000 0000111123456677777766 5999999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=315.16 Aligned_cols=240 Identities=25% Similarity=0.297 Sum_probs=201.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 554 (766)
..|.+.||+|.||.|+++.++.+ +..+|||.+++. ..+..+..+.|.+++.... ||.|+.|+..+...++.++
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~---~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGT---NEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCC---CcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 44678999999999999999864 458888888753 3556677888988888875 9999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+.+|++.. +.+...+++....-++..|+.||.|||++ +||+||||.+|||||.+|.+||+|||+++......
T Consensus 447 vmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 447 VMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 999999999443 34556789999999999999999999954 99999999999999999999999999998654222
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .+...+||+.|||||++.+..|+.++|.|||||+||||+.|..||..+++++..+ .+...
T Consensus 523 ~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------sI~~d---------- 583 (694)
T KOG0694|consen 523 D--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------SIVND---------- 583 (694)
T ss_pred C--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcC----------
Confidence 2 2367899999999999999999999999999999999999999999877665321 11111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
+..++...+.+...++.++|.++|++|--+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 122356678889999999999999999866
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=298.49 Aligned_cols=248 Identities=27% Similarity=0.428 Sum_probs=198.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
++||+|+||.||++.... ++.+++|.+...... ....|.+|++++++++|+||+++++++.+....++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~----~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG----NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC----CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999762 578999988754433 456799999999999999999999999999999999999999
Q ss_pred CchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 562 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 562 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
++|.+++... ..+++..+..++.+++.+|+|||+ .+++||||||+||+++.++.+||+|||++.............
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 9999999653 467888899999999999999995 599999999999999999999999999998654322111111
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....+..|+|||.+.+..++.++|+||||++++||++ |..||......... .....+ .....+
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~---------~~~~~~ 217 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESG---------YRMPAP 217 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcC---------CCCCCC
Confidence 2234567999999998899999999999999999999 88888654322111 111111 011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
...+.++.+++.+|++.+|++|||+.+|++.|++
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 3346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=312.84 Aligned_cols=241 Identities=26% Similarity=0.313 Sum_probs=194.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 554 (766)
.++.+.||+|+||.||++.... .++.||+|.+.... ....+.+..|..++..+. |++|+++.+++.+.+..++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~l 78 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYF 78 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEE
Confidence 3567889999999999998764 46789999987532 233456788888888875 5778889999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 99999999999999888889999999999999999999994 599999999999999999999999999987543222
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .........
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~~~-------- 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEHNV-------- 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC--------
Confidence 1 11345689999999999999999999999999999999999999976543221 111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
..+...+.++.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1122345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=321.45 Aligned_cols=266 Identities=20% Similarity=0.216 Sum_probs=201.3
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
....+.+.+.||+|+||.||++..... .....||||.+... +.+.+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~-~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCC-ccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 334566778999999999999976532 24678899987532 345789999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||++. ++|.+++.....+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999986 6888888777789999999999999999999995 599999999999999999999999999998765443
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce------
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA------ 708 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 708 (766)
.........||..|+|||++.+..++.++|||||||++|||++|+.||..............+...........
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 32222345799999999999999999999999999999999999999965432111000000111111000000
Q ss_pred --------e---ccCcccC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 --------L---VGGDMEA---MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 --------~---~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. ..+.... ........++.+++.+||+.||++|||+.+++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0 0000000 0001224567889999999999999999999876
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.67 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=199.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+++.+.||+|+||.||+|.... .+..+++|.+........+.+.+|+++++.++||||+++++++..+...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4566889999999999998864 4568899988765555567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|..++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~- 159 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR- 159 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence 999999998765 4568999999999999999999995 59999999999999999999999999998765432211
Q ss_pred eeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 638 IKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.....++..|+|||++. +..++.++|||||||++|||++|++||......+. .........
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~~------- 225 (282)
T cd06643 160 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEP------- 225 (282)
T ss_pred -cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcCC-------
Confidence 12346889999999984 44578899999999999999999999865432211 111111000
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 -PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123346788999999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.54 Aligned_cols=254 Identities=20% Similarity=0.318 Sum_probs=201.9
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.+.||+|+||.||+|.... .++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 356677899999999999998764 45689999987654444567889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++...+.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..+.....
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 999999999999888889999999999999999999995 4999999999999999999999999999876543221
Q ss_pred ceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 637 TIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
......|+..|+|||++. ...++.++|||||||++|||++|+.|+........ . ... ...... .+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--~----~~~-~~~~~~---~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--L----FLM-TKSNFQ---PPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--H----Hhh-hccCCC---CCc
Confidence 113456899999999974 45688999999999999999999999854332111 0 000 001100 000
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.. .....+..+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 011234678899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.36 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=189.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
++||+|+||.||+|...... ....+++|.+.... ....+.|.+|+.+++.++||||+++++.|.+....++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDT-GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCC-CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 36999999999999865432 34567777776433 23456899999999999999999999999999999999999999
Q ss_pred CchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 562 GTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 562 gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+|.+++... ...++.....++.||++||+|||+ .+++||||||+|||++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 9999999753 234556678899999999999995 589999999999999999999999999986432221111
Q ss_pred eeecccccCcccccccccC-------CCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 638 IKTSIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
......++..|+|||++.. ..++.++||||||+++|||++ |..|+......+ .......++ ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIKDQ-QVKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhhc-cccc
Confidence 1133567889999998753 245789999999999999997 566775433211 111111111 1112
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.++... ....+.+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222221 124466788899999 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.84 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=199.9
Q ss_pred hhhhhccccccceEEEEEEecCCCc-eeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...+.||+|+||.||+|....++.. ...+|+|.+..... ....++.+|+.++++++||||++++++|... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 3457899999999999998654322 24678888865332 2234789999999999999999999998754 4679999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++........
T Consensus 89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 99999999998764 357888999999999999999994 59999999999999999999999999999876543322
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........ ..+ ...+..
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~~--------- 229 (303)
T cd05110 166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI---PDL----LEKGER--------- 229 (303)
T ss_pred cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHCCCC---------
Confidence 11123345678999999999999999999999999999998 8899865432221 111 111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+..++..+.+++.+||..+|++||++.++++.|+.+.+
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01112234678899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.89 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=195.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.+.||+|+||.||+|.... .+..+|+|.+.... .....+|.+|++++.+++||||+++++++...+..++||||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred hheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 466889999999999998764 45689999886432 23346799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|..+. .+++.....++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---- 149 (279)
T cd06619 81 MDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---- 149 (279)
T ss_pred CCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----
Confidence 9999997653 46778888999999999999994 599999999999999999999999999998654322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....................... .....
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------PPVLP 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------CCCCC
Confidence 1335689999999999999999999999999999999999999964322111100000111111111 01111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+.++.+++.+|++.+|++||+++++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 12245678899999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.30 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=201.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+...+.||+|+||.||+|.+.. .+..+|+|.++... ....+.+.+|++++++++||||+++++++......++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 345566889999999999998764 45689999886433 23345789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.. ..+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 999999999998864 457888999999999999999994 5999999999999999999999999999987654321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||++.+..++.++||||||+++|||++|+.|+........ ......+. .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~~~~~~---------~ 218 (277)
T cd06642 157 K--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFLIPKNS---------P 218 (277)
T ss_pred h--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------HhhhhcCC---------C
Confidence 1 1234578899999999998999999999999999999999999864332111 00111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+..+.+++.+||+.+|++||+|.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11123356778899999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.96 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=198.9
Q ss_pred HHHHHhhh--hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 475 EEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 475 ~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
+.++.++. ..||+|+||.||+|.... .+..+++|.+........+.+.+|++++++++|+||+++++++..++..
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLS---TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecC---CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 34445554 479999999999998764 4568999988765555667899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC-CCC--ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFLFGN-LKP--NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~ 628 (766)
++|+||+++++|.+++... ..+ ++..+..++.||++||+|||+ .+|+||||||+||+++. ++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999999764 344 778888899999999999994 59999999999999976 6799999999987
Q ss_pred ccccCCCcceeecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
........ .....++..|+|||++.+.. ++.++||||||+++|+|++|+.|+.......... +.....
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~----- 227 (268)
T cd06624 158 RLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMF----- 227 (268)
T ss_pred ecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhh-----
Confidence 65432221 12345788999999987643 7889999999999999999999986432211100 000000
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+....+++.+++.+||+.+|.+|||+.++++.
T Consensus 228 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111133456778899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=301.97 Aligned_cols=256 Identities=23% Similarity=0.405 Sum_probs=199.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------c
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------N 551 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 551 (766)
.+.+.||+|+||.||+|.+......+..+|||.+.... ....+++.+|++++++++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999987655567899999886432 233567899999999999999999999886542 2
Q ss_pred eEEEeeccCCCchhhhhccC------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccC
Q 037189 552 RLLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 625 (766)
.++++||+++|+|.+++... ..+++...+.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 37889999999999887432 246778889999999999999995 599999999999999999999999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
+++...............++..|++||.+....++.++||||||+++|||++ |++|+......+ +.. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~----~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYN----YLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHH----HHHcC
Confidence 9987654332211122345678999999998889999999999999999999 888886443211 111 11111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.. . ..+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ~~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 0 01123457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=302.00 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=200.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHH--HHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER--EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~--~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
++.+.||+|+||+||++.... .+..+|+|.+......... ...+|+.++++++||||+++++++.+....++|||
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECC---CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccc
Confidence 456889999999999999875 4568999999765433322 34569999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|+++||.+||+. +++|+||||+||++++++.++|+|||.+..... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 79 YCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp EETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--ccc
Confidence 999999999998777889999999999999999999964 999999999999999999999999999986521 112
Q ss_pred eeecccccCccccccccc-CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......++..|+|||++. +...+.++||||+|+++++|++|+.|+................. ..... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~----~~~~~----~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK----RPLPS----SS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH----THHHH----HT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc----ccccc----cc--
Confidence 224566899999999998 88899999999999999999999999986522111111110000 00000 00
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.........+.+++.+||+.||++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111378999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=314.35 Aligned_cols=254 Identities=19% Similarity=0.246 Sum_probs=197.1
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
..+.+.+.||+|+||.||++.... .++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.++...+
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 445566889999999999999875 46789999986422 223456788999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++|+|.+++... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 120 lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 999999999999998654 4778888899999999999999 459999999999999999999999999999876533
Q ss_pred CCcceeecccccCcccccccccCC----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..........
T Consensus 196 ~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~--- 265 (371)
T cd05622 196 GMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNHKNS--- 265 (371)
T ss_pred Cccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCc---
Confidence 2211 1345699999999998754 378999999999999999999999976543211 1111111110
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQML 751 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~L 751 (766)
.........+..+.+++.+|++.++.+ ||++.+++++.
T Consensus 266 ----~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 266 ----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred ----ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111112235677889999999854443 78999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=311.48 Aligned_cols=253 Identities=19% Similarity=0.224 Sum_probs=195.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+++... .++.+|+|.+.... ......+.+|+.++..++|+||+++++++.+.+..++|
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 3456789999999999998764 45689999986421 22344588899999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++|+|.+++.. ...+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 999999999999976 467888899999999999999999 4599999999999999999999999999998765433
Q ss_pred CcceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
... .....||+.|+|||++.+ +.++.++||||||++||||++|+.||......+. ............
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (331)
T cd05624 157 TVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERFQ- 228 (331)
T ss_pred cee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCccc-
Confidence 221 123568999999999875 5678999999999999999999999975443221 111111100000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~ 750 (766)
. .......++++.+++.+|++.++++ |+++++++++
T Consensus 229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0001124567888999988865544 5688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.77 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=206.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.+.||+|+||.||++.... .+..+|+|.+........+.+.+|+.+++.++|+||+++++++..++..++||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 344556789999999999998753 46689999997655555677899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999999864 357888999999999999999995 59999999999999999999999999998876443221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ... ...+....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~--------~~~~~~~~ 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLI--------ATNGTPEL 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eee--------ccCCCCCC
Confidence 12345788999999999999999999999999999999999999654321100 000 00011111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ--MLEGVVEV 757 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~Le~~~~~ 757 (766)
..+...+..+.+++.+||+.+|++||++.++++ .++...+.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 123345567889999999999999999999998 44443333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=302.17 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=202.0
Q ss_pred hhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
...+.||+|+||.||+|+.+... ...+.+++|.+...... ...++.+|++++++++|+||+++++++.+.+..++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 34568999999999999976432 23567999988654333 3467999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCC---------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 557 EFLNNGTLASFLFGNL---------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~---------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999997654 68899999999999999999995 58999999999999999999999999998
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
.......... .....++..|+|||.+.+...+.++||||||+++++|++ |..||....... .......+..
T Consensus 165 ~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~ 236 (275)
T cd05046 165 KDVYNSEYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL 236 (275)
T ss_pred cccCcccccc-cCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcCCc
Confidence 7543322111 123345778999999998889999999999999999999 778885432211 1111111111
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
. ...+..++..+.+++.+||+.+|.+|||+.++++.|++
T Consensus 237 ~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 237 E--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred C--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 1 11122345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=298.02 Aligned_cols=250 Identities=27% Similarity=0.464 Sum_probs=199.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...+.+.||+|+||.||++.... +..+|+|.+... .....+|.+|++++++++|||++++++++......++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~----~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE----KRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC----CCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 34567889999999999998752 457899988643 3345689999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..++++.+..++.|++.+|+|||+ .+++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999764 457889999999999999999995 48999999999999999999999999998865433221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. ....++.+|+|||.+.+..++.++||||||+++|||++ |+.||........ . ....++. ..
T Consensus 157 ~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~----~~~~~~~--~~------ 220 (256)
T cd05112 157 SS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V----ETINAGF--RL------ 220 (256)
T ss_pred cc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H----HHHhCCC--CC------
Confidence 11 22235678999999998899999999999999999998 9999865432211 1 1111110 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
..+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 -~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 -YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011123567899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=306.46 Aligned_cols=253 Identities=28% Similarity=0.351 Sum_probs=211.7
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCC-CCCeeeEeeeeecCC
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ 550 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 550 (766)
....+.+.++||+|.||.||+++.+. .+..+|+|.+...... ....+.+|+.+|+++. |||||.+.+.+++..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 34456677899999999999999885 3678999998764443 3458999999999998 999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC----CCeEEeccCc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH----YNARISDFGL 626 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgl 626 (766)
..++|||++.+|.|.+.+... .+++.....++.|++.+++||| +.+|+||||||+|+|+... +.+|++|||+
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999999776 4889999999999999999999 5699999999999999633 5799999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
+...... ......+||+.|+|||++....++..+||||+||++|.|++|.+||.......... .+..+..
T Consensus 186 a~~~~~~---~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~ 255 (382)
T KOG0032|consen 186 AKFIKPG---ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF 255 (382)
T ss_pred ceEccCC---ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence 9988762 22367899999999999999999999999999999999999999998776433211 2222222
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......-...++.+.+++..|+..||.+|+|+.+++++
T Consensus 256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222234457888999999999999999999999985
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=303.77 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=202.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.+.+.||.|++|.||+|.... .+..+++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 345789999999999998754 46789999997665556678899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++++|.+++... .+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~ 172 (296)
T cd06655 99 AGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--R 172 (296)
T ss_pred CCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--C
Confidence 999999988654 58899999999999999999994 59999999999999999999999999998876543321 1
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....++..|+|||.+.+..++.++|||||||++|+|++|+.||.......... .. ...... ....+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~------~~-~~~~~~-------~~~~~ 238 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LI-ATNGTP-------ELQNP 238 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhcCCc-------ccCCc
Confidence 23468889999999999899999999999999999999999997654322110 00 000000 01112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 3345678899999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=298.06 Aligned_cols=248 Identities=27% Similarity=0.399 Sum_probs=199.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---------HHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---------EREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
.+.+.||+|++|.||+|.... .+..+|+|.+....... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD 79 (267)
T ss_pred cccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Confidence 456789999999999998764 45689999886433221 246889999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999999999887788899999999999999999995 59999999999999999999999999999877
Q ss_pred ccCCCcc----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 631 TLNQSKT----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 631 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~-~~~~-- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFK-IGEN-- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHH-Hhcc--
Confidence 5322111 11224578899999999988999999999999999999999999975432110 000 0010
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.....+...+..+.+++.+||+.+|.+||++.++++
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 -------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 011112345678889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.14 Aligned_cols=253 Identities=20% Similarity=0.225 Sum_probs=194.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.++||+|+||.||+++... .++.+|+|.+... .......|.+|+.++..++|+||+++++++.+.+..++|
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence 3456889999999999999864 4568999998642 222334588899999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 999999999999976 4578888999999999999999994 599999999999999999999999999987654332
Q ss_pred CcceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
... .....||+.|+|||++. ...++.++|||||||++|||++|+.||......+. ............
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (332)
T cd05623 157 TVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQ- 228 (332)
T ss_pred cce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCcccc-
Confidence 211 12356999999999986 34688999999999999999999999975443221 111111100000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPS--LRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~--~RPt~~~vl~~ 750 (766)
........+.++.+++.+|+..+++ .|+++.+++++
T Consensus 229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011123456788888888865444 47899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.82 Aligned_cols=248 Identities=25% Similarity=0.281 Sum_probs=197.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
..+.||+|+||.||++.... .++.+|+|.+.... ......+.+|++++++++|+||+++.+.+..++..++|||
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred EEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 44789999999999998864 46789999986432 2223457889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 99999999988643 46899999999999999999999 45999999999999999999999999999876543221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....|+..|+|||++.+..++.++|+||||+++|||++|+.||.......... ...........
T Consensus 158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~---~~~~~~~~~~~--------- 222 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE---EVDRRVLETEE--------- 222 (285)
T ss_pred ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhhhcccc---------
Confidence 133568999999999999999999999999999999999999997543321110 01111111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
......+..+.+++.+|++.||++||+ +.++++.
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 223 -VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 112234567789999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=296.19 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=205.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4567889999999999999874 4568999987632 223356799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
|||+++++|.+++.. ...+++..+..++.++++||+|||+ .+++|+||+|+||+++.++.++|+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998853 3457889999999999999999994 599999999999999999999999999988654
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .. .......+..
T Consensus 158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~~----- 225 (267)
T cd08224 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKKIEKCDY----- 225 (267)
T ss_pred CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HH-HHhhhhcCCC-----
Confidence 33211 123457889999999998899999999999999999999999986443211 01 1111111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
........+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 226 ---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 ---PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11112245678899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=295.39 Aligned_cols=248 Identities=24% Similarity=0.371 Sum_probs=202.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.... .+..+++|.+..... .+++.+|++++++++|+||+++++++.+....++++|
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 35567889999999999999874 357899999875432 6789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK 155 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc
Confidence 9999999999975 4567999999999999999999995 59999999999999999999999999999876543211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+.......... ...... ....
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~-------~~~~ 219 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-------MIPNKP-------PPTL 219 (256)
T ss_pred --cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-------hhccCC-------CCCC
Confidence 123457889999999999999999999999999999999999997543221100 000000 0111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+......+.+++.+||+.+|++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 123345577899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=332.82 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=199.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.++||+|+||.||+|.... .++.||||+++..... ..++|.+|++++++++||||+++++++.+++..++|
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 3456789999999999998764 4678999998653222 245799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEecc
Q 037189 556 YEFLNNGTLASFLFGN-----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
|||+++++|.+++... ...++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEec
Confidence 9999999999988631 223456678899999999999995 59999999999999999999999999
Q ss_pred CcccccccCCCc----------------ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh
Q 037189 625 GLAKLLTLNQSK----------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE 688 (766)
Q Consensus 625 gla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~ 688 (766)
|+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999876221100 0111246899999999999999999999999999999999999999753321
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcC
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGVVE 756 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~Le~~~~ 756 (766)
... .. ..+ ..+ .........+..+.+++.+|++.||++|| +++++++.|+....
T Consensus 238 ki~------~~----~~i---~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 238 KIS------YR----DVI---LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh------hh----hhc---cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 110 00 000 000 00001123456788999999999999996 67778787776543
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=296.95 Aligned_cols=241 Identities=27% Similarity=0.439 Sum_probs=191.2
Q ss_pred hhccccccceEEEEEEecCC-------CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTR-------TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~-------~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.||+|+||.||+|.+.... .....+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999987533 11245777876544332 6789999999999999999999999988 788999
Q ss_pred eeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-------CeEEeccCcc
Q 037189 556 YEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-------NARISDFGLA 627 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~Dfgla 627 (766)
|||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 7889999999999999999999 45999999999999999887 7999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCC--CCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
...... ....++..|+|||++... .++.++||||||+++|||++ |..|+......+.. . .+...
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~----~~~~~ 222 (259)
T cd05037 156 ITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---R----FYQDQ 222 (259)
T ss_pred cccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---H----HHhcC
Confidence 865431 223466789999999876 78999999999999999999 56666544321110 0 01100
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
. ... ......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 223 ~-------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RLP----MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CCC----CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000 001267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.03 Aligned_cols=248 Identities=27% Similarity=0.314 Sum_probs=196.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
...+.||+|+||.||++.... .++.+|||.+..... .....+.+|+.++++++|+|++++++.+.+.+..++||
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence 345789999999999999875 467999999864322 22345788999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999998643 35788899999999999999999 4599999999999999999999999999987654332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....|+..|+|||.+.+..++.++||||||+++|||++|+.||............. .......
T Consensus 157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~~--------- 221 (285)
T cd05630 157 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVQ--------- 221 (285)
T ss_pred cc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhhh---------
Confidence 21 23468999999999999999999999999999999999999997543211100000 0000000
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~ 749 (766)
.......+..+.+++.+||+.||++||| ++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 -EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0012234567889999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=298.63 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=202.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||.|++|.||+|.... .+..+|+|.+.... ......+.+|++++++++|+||+++++++.++...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 4567889999999999999864 46789999986543 3345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++........
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 154 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK- 154 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-
Confidence 99999999999765 78999999999999999999994 58999999999999999999999999999877643211
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ......+....+ .
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~~-----~-- 219 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLIPKNNPPSL-----E-- 219 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHhhhcCCCCC-----c--
Confidence 1334678899999999998999999999999999999999999965432111 011111111111 0
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+..+.+++.+||+.+|++|||++++++.
T Consensus 220 -~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 220 -GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11145678899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.19 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=195.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+...++||+|+||.||+|.... .+..+|+|.++... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred eEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 4456789999999999998764 45689999987543 2234568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++ +|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 9985 788877654 457888899999999999999995 59999999999999999999999999998765432211
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH--------HHhhcC-cc
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF--------DCYRNG-KL 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~-~~ 706 (766)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+......... ...... ..
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 123457899999998865 468899999999999999999999997654322211111000 000000 00
Q ss_pred ceeccCccc----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 707 DALVGGDME----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 707 ~~~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...-.+... .......+.++.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 0001124567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=298.74 Aligned_cols=247 Identities=25% Similarity=0.386 Sum_probs=194.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecC------Cc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG------QN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------~~ 551 (766)
+.+.+.||+|+||.||+|.... .++.+|+|.+... .....++.+|+.++.++ +|+||+++++++... ..
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 4456789999999999998864 4678999998654 34456789999999998 699999999998653 35
Q ss_pred eEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 552 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 78999999999999998763 457888999999999999999995 5999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
....... .....|+..|+|||++. ...++.++|||||||++|||++|+.||.......... .... .
T Consensus 161 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~-~ 231 (272)
T cd06637 161 LDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR-N 231 (272)
T ss_pred ccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc-C
Confidence 5432211 13456889999999986 3457889999999999999999999996433211110 0001 0
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.. ........+..+.+++.+||+.+|.+|||+.++++
T Consensus 232 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 PA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 11112234567889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.65 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=202.3
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+...+.||+|+||.||+|.... .+..+|+|.+.... ......+.+|+.++++++|+||+++++++.++...++||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 44556789999999999998764 45689999886432 334567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.. ..+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 99999999999865 457888889999999999999994 59999999999999999999999999999876543221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..... ....
T Consensus 158 --~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------~~~~~---------~~~~ 219 (277)
T cd06640 158 --RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPK---------NNPP 219 (277)
T ss_pred --cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-------hhhhc---------CCCC
Confidence 12345788999999999889999999999999999999999998754322110 00111 1111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2244567889999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=311.11 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=189.0
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccC---CCCCeeeEeeeeecCCceEEEeec
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQT---HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
||+|+||.||+|+... .+..+|||.+..... .....+..|..++.+. +||||+++++.+.+....++||||
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcC
Confidence 7999999999998864 467899999864321 1223455666666554 699999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-- 152 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-- 152 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence 9999999999888889999999999999999999995 59999999999999999999999999998754332211
Q ss_pred eecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 639 KTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||......+. ...+..+... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~------~--- 216 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGKVR------F--- 216 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCCCC------C---
Confidence 1345689999999998765 479999999999999999999999975443221 1111111110 0
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRP----TIKKVLQ 749 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RP----t~~~vl~ 749 (766)
.....+..+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112356778999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=295.50 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=203.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... ....+++|.+........+.+.+|++++++++||||+++++++.+....+++|||
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred eEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 4566789999999999999864 3467999998766555677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999998775 678999999999999999999995 5999999999999999999999999999886543221
Q ss_pred eeecccccCcccccccccCC---CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 638 IKTSIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... ....... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~~-----~~ 224 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNFP-----PP 224 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccCC-----Cc
Confidence 11334678899999999877 889999999999999999999999975432221100 0011000 00
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123345678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=293.38 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=196.3
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHc--cCCCCCeeeEeeeeecCC----ceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG--QTHHKNLVRLLGFCDEGQ----NRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~--~l~H~niv~l~g~~~~~~----~~~ 553 (766)
.+.+.||+|+||.||+|.+. +..||||.+.. .+++.+.+|.++.. .++|+||+.+++.-..+. ..+
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-----Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-----GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred EEEEEecCccccceeecccc-----CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45578999999999999996 56899999864 34566767666655 479999999999875443 568
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
||.+|.++|||.|||.. ..++-+..++++..+|.||+|||.+. .+.|.|||||+.|||+..++...|+|+|||.
T Consensus 286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 99999999999999977 56788899999999999999999764 6789999999999999999999999999998
Q ss_pred ccccCCC-c-ceeecccccCcccccccccCC----CCC--cccCeeehhHHHHHHHhCC----------cCCCchhhhhh
Q 037189 629 LLTLNQS-K-TIKTSIRGTKGYVAPEWFRNS----KIT--AKVDVYSFGVLLLEIIACR----------KSFDIEMVEEY 690 (766)
Q Consensus 629 ~~~~~~~-~-~~~~~~~gt~~y~aPE~~~~~----~~s--~~sDV~s~Gvvl~elltg~----------~p~~~~~~~~~ 690 (766)
....... . ......+||.+|||||++... .|. ..+||||||.|+||+...- .||....+.+.
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP 444 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP 444 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence 7665422 1 122457899999999999653 222 3599999999999996532 34432211110
Q ss_pred hhHHHHHHHHhhcCccceeccCccc-----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDME-----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
... ..++ -+...+++ .....+....+.++++.||..+|..|-|+-.+-+.|.++.+.
T Consensus 445 -s~e-eMrk--------VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 445 -SFE-EMRK--------VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred -CHH-HHhc--------ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 000 0000 11111111 223457788999999999999999999999999999887754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.87 Aligned_cols=251 Identities=21% Similarity=0.301 Sum_probs=200.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.++||+|+||.||+|+... .+..+++|.+........+.+.+|+.++++++|+||+++++.+..+...++|||
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 45677899999999999998864 457899999876555556789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|..++.. ...+++..+..++.|++.+|+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999988754 4568899999999999999999994 59999999999999999999999999998754322111
Q ss_pred ceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 637 TIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.....++..|+|||++. ...++.++|||||||++|||++|+.|+........ .... .....
T Consensus 167 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~-~~~~~----- 232 (292)
T cd06644 167 --RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKI-AKSEP----- 232 (292)
T ss_pred --cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHH-hcCCC-----
Confidence 12345788999999985 34578899999999999999999999865432111 1111 11100
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+...+.++.+++.+||+.+|++||++.++++.
T Consensus 233 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 --PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111123445678899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=295.23 Aligned_cols=251 Identities=31% Similarity=0.511 Sum_probs=203.0
Q ss_pred hhhhccccccceEEEEEEecCC-CceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.||+|+||.||+++..... .....+|+|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 5678999999999999987532 22478999999755433 567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCC--CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999976544 8999999999999999999994 59999999999999999999999999999877654222
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. ....++..|+|||.+.+..++.++||||+|++++||++ |+.|+........ ......+..
T Consensus 160 ~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~--------- 222 (258)
T smart00219 160 KK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-------LEYLKKGYR--------- 222 (258)
T ss_pred cc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCCC---------
Confidence 11 12336789999999988889999999999999999998 7888765332211 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
...+...+.++.+++.+|++.+|++|||+.++++.|
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222567889999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=300.80 Aligned_cols=261 Identities=25% Similarity=0.307 Sum_probs=190.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccC---CCCCeeeEeeeeec-----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQT---HHKNLVRLLGFCDE----- 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 548 (766)
+.+.+.||+|+||.||+|.... .++.+|+|.++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~ 78 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR 78 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence 3456789999999999999874 467899998865322 2234566777766655 79999999998854
Q ss_pred CCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
....++||||+++ +|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 79 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 79 ETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred CceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 2457899999985 888888653 347899999999999999999995 5999999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHHHH----HHh
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDWAF----DCY 701 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~----~~~ 701 (766)
++........ ....+|..|+|||++.+..++.++|||||||++|||++|++||......... .+..... ..+
T Consensus 155 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 9876432211 2345789999999999989999999999999999999999999654332211 1111000 000
Q ss_pred hcC-cc-ceeccCccc---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 702 RNG-KL-DALVGGDME---AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 702 ~~~-~~-~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
... .. .....+... ........+.+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00 000000000 0001234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=294.65 Aligned_cols=247 Identities=22% Similarity=0.313 Sum_probs=199.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.+.||+|+||.||+++... .+..+|+|.++... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 456889999999999998764 45688999886432 33456788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||++++++.++++|||++.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 9999999988643 457888899999999999999994 59999999999999999999999999999866432221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....++..|+|||++.+..++.++|+||||+++|+|++|+.||........ . .....+....
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~~-------- 219 (255)
T cd08219 157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------I-LKVCQGSYKP-------- 219 (255)
T ss_pred --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------H-HHHhcCCCCC--------
Confidence 1335688899999999998999999999999999999999999975432211 1 1111111111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+...+..+.+++.+||+.||++||++.+++..
T Consensus 220 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 -LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.26 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||++.... .+..+|+|.++.......+.|.+|++++++++|+||+++++.+..+...++|||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 36677899999999999999864 457899999876655556789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 99999999998764 568999999999999999999995 59999999999999999999999999998765432211
Q ss_pred ceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 637 TIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .. ....+...
T Consensus 160 --~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~~~---- 226 (280)
T cd06611 160 --RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LL-----KILKSEPP---- 226 (280)
T ss_pred --cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HH-----HHhcCCCC----
Confidence 12345888999999975 34577899999999999999999999975432211 11 11111110
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111122345678899999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=310.25 Aligned_cols=244 Identities=28% Similarity=0.390 Sum_probs=202.5
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCc
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 563 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (766)
.||+|.||+||.|+... ....+|||-+........+.+.+|+.+.++++|+|||+++|.|.+++..-+.||..+||+
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 59999999999999874 456899999987777777889999999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCC--ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCcccccccCCCccee
Q 037189 564 LASFLFGN-LKP--NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 564 L~~~l~~~-~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
|.+.|+.. +++ ++...--..+||++||.|||+. .|||||||-.|||++ -.|.+||+|||-++.+..-... .
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--T 733 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--T 733 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcc--c
Confidence 99999865 555 6777778899999999999964 999999999999996 6789999999999877543322 2
Q ss_pred ecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 640 TSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
....||..|||||++..++ |..++|||||||.+.||.||++||-......... + +-|.. .....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM-----F---kVGmy------KvHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM-----F---KVGMY------KVHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh-----h---hhcce------ecCCC
Confidence 4567999999999998764 8899999999999999999999996433222110 0 11111 11233
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+.+.+.+...++++|+.++|.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 46778889999999999999999999999885
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.99 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=200.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----------ccCHHHHHHHHHHHcc-CCCCCeeeEeeeee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----------QDGEREFKNEVFVIGQ-THHKNLVRLLGFCD 547 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~ 547 (766)
+.+.+.||+|+||.||+|....+ ..+.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 34668899999999999998742 35689999875321 2223457788887765 79999999999999
Q ss_pred cCCceEEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 548 EGQNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
+++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988743 3467888999999999999999995 24799999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
||++....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ . ....+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~-~~~~~ 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------A-TKIVE 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------H-HHHhh
Confidence 99998765433 12345688899999999998899999999999999999999999864432211 0 11111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
+... .......+..+.+++.+||+.||++||++.||..+++.
T Consensus 228 ~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 228 AVYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ccCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1111 01111245678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=321.01 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=187.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--------C
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------Q 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~ 550 (766)
+.+.+.||+|+||.||+|.... .+..||||++... .....+|+.++++++||||+++++++... .
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 4566889999999999999864 4568999988532 22346799999999999999999876432 1
Q ss_pred ceEEEeeccCCCchhhhhc----cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccC
Q 037189 551 NRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFG 625 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg 625 (766)
..++||||+++ +|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999985 6666654 34668889999999999999999994 5999999999999998664 79999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH-----H
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF-----D 699 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~ 699 (766)
+++.+...... ....+|+.|+|||++.+. .++.++|||||||++|||++|.+||......+......... .
T Consensus 217 la~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99876543221 235679999999998654 68999999999999999999999997654322111000000 0
Q ss_pred Hhh--cCccc-----eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 CYR--NGKLD-----ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ~~~--~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+. ..... .+....+....+...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000 00000 0000011111122245678999999999999999999999843
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.60 Aligned_cols=251 Identities=23% Similarity=0.272 Sum_probs=195.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
++.+.||+|+||.||++.... .++.+|||.++... ......+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 345789999999999999874 46789999986432 233456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++|+|.+++.....+++.....++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999999999988888999999999999999999999 459999999999999999999999999998755321100
Q ss_pred ---------------------------------ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCC
Q 037189 637 ---------------------------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683 (766)
Q Consensus 637 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~ 683 (766)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00113468999999999999999999999999999999999999997
Q ss_pred chhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 037189 684 IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT---IKKVLQM 750 (766)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~~ 750 (766)
........ ..+..... .+ ........+.++.+++.+++. +|.+|++ +.+++++
T Consensus 238 ~~~~~~~~-------~~i~~~~~-~~-----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 238 SETPQETY-------RKVMNWKE-TL-----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCHHHHH-------HHHHcCCC-ce-----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 65432211 11111000 00 000011234567778888664 9999985 5666554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.17 Aligned_cols=251 Identities=22% Similarity=0.378 Sum_probs=199.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+++.+.||+|+||.||++.... .+..+|+|.+.... ......+.+|+.++++++|+||+++++.+...+..++||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 35677899999999999998864 46789999886432 223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 557 EFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||+++++|..++... ..+++..+..++.|++.||.|||+ +.+++|+||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999999999998763 368899999999999999999995 348999999999999999999999999998765432
Q ss_pred CCcceeecccccCcccccccccCCC------CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSK------ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
.. ....++..|+|||.+.+.. ++.++|+|||||++|||++|+.||......... ... .....+.
T Consensus 157 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~-~~~~~~~-- 226 (286)
T cd06622 157 LA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQL-SAIVDGD-- 226 (286)
T ss_pred cc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHH-HHHhhcC--
Confidence 21 2345788999999986543 488999999999999999999999654321110 000 0011111
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+..++.++.+++.+||+.+|++||++.++++.
T Consensus 227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111233467788999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.27 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=208.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
|++.+.||+|.|..|-++++-- .+..||||.++...-+ ....+.+|++.|+.++|||||+|+.+......+|||.
T Consensus 20 YDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhc---ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4566889999999999988764 4678999999765433 3457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE-cCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL-DDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|.-.+|+|.+||-. ...+.++...+++.||+.|+.|+| ...+|||||||+||.+ ..-|-+||.|||++-.+.+++
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999999865 467899999999999999999999 4599999999999976 567889999999999888776
Q ss_pred CcceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. +..+|...|-|||++.+..|+ ++.||||||||||.|++|++||+..+..+.... ++|
T Consensus 174 kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImD-- 233 (864)
T KOG4717|consen 174 KL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMD-- 233 (864)
T ss_pred hh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhc--
Confidence 54 567899999999999999887 689999999999999999999987655442211 111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
-....+...+.++.+||..||+.||.+|.+.++++.
T Consensus 234 CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 223446678899999999999999999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=294.10 Aligned_cols=249 Identities=23% Similarity=0.354 Sum_probs=202.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||.++... .+..+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred ceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence 3456889999999999988764 45689999876432 344567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999999764 457888999999999999999995 589999999999999999999999999998765433
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ......++..|+|||.+.+..++.++||||||+++|||++|+.||......+. .... ..+...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~-~~~~~~------- 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKI-VQGNYT------- 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-HcCCCC-------
Confidence 2 12345688999999999988899999999999999999999999975433221 1111 111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
......+.++.+++.+||+.+|++||++.++++.+
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 --PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred --CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11233467788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=304.85 Aligned_cols=197 Identities=22% Similarity=0.394 Sum_probs=159.1
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceEEEeecc
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFL 559 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~ 559 (766)
.++||+|+||.||+|..... ...+.+|+|.+... .....+.+|++++++++||||+++++++.. +...++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 35899999999999987532 24578999998643 234568899999999999999999998854 44678999998
Q ss_pred CCCchhhhhccC---------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE----cCCCCeEEeccCc
Q 037189 560 NNGTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGL 626 (766)
Q Consensus 560 ~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgl 626 (766)
.+ +|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 65 777776421 246788889999999999999994 599999999999999 4567899999999
Q ss_pred ccccccCCCc-ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCch
Q 037189 627 AKLLTLNQSK-TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIE 685 (766)
Q Consensus 627 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~ 685 (766)
++........ .......+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9876543221 111345689999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.76 Aligned_cols=261 Identities=23% Similarity=0.279 Sum_probs=192.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----- 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 550 (766)
.+...+.||+|+||.||++.... .+..+|||.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 22 RYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred ceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34556789999999999998764 4678999998643 2234567889999999999999999999986443
Q ss_pred -ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 551 -NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 551 -~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..++||||+++ +|...+.. .+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 46899999976 56555532 46788888999999999999995 5999999999999999999999999999976
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hH---------------
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-IL--------------- 693 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~--------------- 693 (766)
...... .....+|..|+|||.+.+..++.++||||||+++|||++|+.||......... ..
T Consensus 173 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 173 ACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 543221 13456899999999999999999999999999999999999999754321100 00
Q ss_pred HHHHHHHhhcC-cc-----ceeccCcc---cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 694 TDWAFDCYRNG-KL-----DALVGGDM---EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 694 ~~~~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+....... .. .+...... ...........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 00 00000000 000111234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.61 Aligned_cols=244 Identities=29% Similarity=0.490 Sum_probs=196.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||++.. .+..+|+|.++.. .....+.+|+.++++++|||++++++++..+ ..++|||
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 7 KLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HceeeeeeccCCCCceEeccc-----CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 456678999999999999874 3557899988643 2346799999999999999999999998664 4799999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++++|.+++... ..+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 79 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999999754 357888899999999999999994 599999999999999999999999999987643321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||......+. ......+.
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~--------- 214 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGY--------- 214 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCC---------
Confidence 12234568999999998899999999999999999998 9999875443221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
........+..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122346778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.83 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=198.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc------cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+.||+|+||.||+|... .+..+|||.++.... .....+.+|++++++++|+||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred cccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEE
Confidence 34578999999999999764 456899998864321 12245889999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|+||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999999999877778899999999999999999994 58999999999999999999999999998865321
Q ss_pred CC----cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 634 QS----KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 634 ~~----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.. ........++..|+|||.+.+..++.++||||||++++||++|+.||......... .......+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~--- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAHRGLM--- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhccCCC---
Confidence 11 11112345889999999999988999999999999999999999999653321110 0000000111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...+...+.++.+++.+||+.+|++||++.++++
T Consensus 228 ------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1112235677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=306.28 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=194.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+++... .++.+|+|.+... .....+.|.+|+.++..++|+||+++++++.+++..++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence 4466889999999999999874 4578999998642 223345688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 999999999999975 4568889999999999999999994 599999999999999999999999999987654332
Q ss_pred CcceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ............+
T Consensus 157 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQF 229 (331)
T ss_pred Ccc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCcccC
Confidence 211 123468999999999863 4578899999999999999999999975433221 1111111110010
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccC--CCCCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQED--PSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~d--p~~RPt~~~vl~~ 750 (766)
. ......+..+.+++.+|+..+ +..||+++++++.
T Consensus 230 ~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 P------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 001124567778888877543 3448899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=316.23 Aligned_cols=259 Identities=21% Similarity=0.221 Sum_probs=192.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||++.+.. .++.||||... ...+.+|++++++++|+||+++++++..++..++|||+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECC---CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3455789999999999999875 35689999643 23467899999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+. ++|.+++... ..+++..++.|+.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6888888654 568999999999999999999994 599999999999999999999999999998765433222
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchh-hhhhhhHHHHHHHHhhcCcc--cee---cc
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEM-VEEYAILTDWAFDCYRNGKL--DAL---VG 711 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~---~~ 711 (766)
......||..|+|||++.+..++.++|||||||+||||++|..++.... ..........+.+.+..... ..+ ..
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234579999999999999999999999999999999999876543211 10000000001111111000 000 00
Q ss_pred --------------CcccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 --------------GDMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 --------------~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........ ......+.+|+.+||+.||.+|||+.|++++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000 0123467889999999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=310.13 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=193.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------ 549 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (766)
.+.+.+.||+|+||.||++.... .++.+|||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 34556889999999999998764 45689999986432 23346788999999999999999999987543
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++||||+++ +|.+++.. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 357999999976 66666643 46788889999999999999994 5999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHH-------------
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTD------------- 695 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~------------- 695 (766)
...... .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+... ...
T Consensus 176 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 176 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 543221 134568999999999999999999999999999999999999997543221100 000
Q ss_pred --HHHHHhhcCc-c-----ceeccCc---ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 696 --WAFDCYRNGK-L-----DALVGGD---MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 696 --~~~~~~~~~~-~-----~~~~~~~---~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+........ . ..+.... ............+.+++.+||+.||.+|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0 0000000 0000111234578899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.42 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=192.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------ 549 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (766)
.+...+.||+|+||.||++.... .++.+|||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 34456789999999999998754 46789999986532 22346788999999999999999999988543
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++||||+++ +|.+.+.. .+++..+..++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 356899999976 56666543 47788888999999999999994 5999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HH--------------
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LT-------------- 694 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~-------------- 694 (766)
...... .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+... ..
T Consensus 169 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 169 AGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred CCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 543221 133568999999999999999999999999999999999999997543211100 00
Q ss_pred -HHHHHHhhcC-ccceec------cCcc--cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 695 -DWAFDCYRNG-KLDALV------GGDM--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 695 -~~~~~~~~~~-~~~~~~------~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......... ....+. +... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000111000 000000 0000 000112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=295.42 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=192.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-----cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cce
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR 552 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (766)
...+.||+|+||.||+|.... .+..+++|++..... .....+.+|+.++++++||||+++++++.+. ...
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred cccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 345789999999999998764 456899998864321 1234688999999999999999999988653 567
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++++||+++++|.+++.....+++...+.++.|++.||+||| +.+|+|+||||+||++++++.+||+|||+++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 899999999999999988777889999999999999999999 45999999999999999999999999999986543
Q ss_pred CCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.... .......++..|+|||++.+..++.++||||||+++|||++|+.||........ ........
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~~~------- 225 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIATQP------- 225 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhcCC-------
Confidence 2111 111234578899999999998999999999999999999999999974422110 11111110
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.....+....+.+.+++ +||..+|++||+++||++
T Consensus 226 --~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 --TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 01111233445566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.56 Aligned_cols=256 Identities=17% Similarity=0.209 Sum_probs=193.2
Q ss_pred hhhhcccc--ccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 481 FKEEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 481 f~~~LG~G--~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.++||+| +|++||++.... ++..||+|+++... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEE
Confidence 56789999 688999998874 56789999987532 223356778999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999999864 3457889999999999999999994 599999999999999999999999998654432111
Q ss_pred C-c----ceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 635 S-K----TIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 635 ~-~----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
. . .......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... .+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-----~~~~~ 228 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-----NGTVP 228 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-----cCCcc
Confidence 0 0 01112346778999999976 4689999999999999999999999974332110 00000 00000
Q ss_pred eecc------------------------------------CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 ALVG------------------------------------GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 ~~~~------------------------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...+ ..............+.+++.+||+.||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 00000112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=299.99 Aligned_cols=245 Identities=27% Similarity=0.409 Sum_probs=198.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
..||+|+||.||++.... .+..+|||.+........+.+.+|+..+++++|+||+++++.+...+..++||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKH---TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECC---CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 569999999999998764 45689999987655555677999999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecc
Q 037189 563 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642 (766)
Q Consensus 563 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 642 (766)
+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++......... ....
T Consensus 105 ~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~ 178 (292)
T cd06658 105 ALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSL 178 (292)
T ss_pred cHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Ccee
Confidence 99998854 457889999999999999999995 59999999999999999999999999998765433221 1234
Q ss_pred cccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHH
Q 037189 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVEC 722 (766)
Q Consensus 643 ~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (766)
.++..|+|||.+.+..++.++||||||+++|||++|+.||........ . ...... .. .... .....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~-----~~~~~~-~~----~~~~--~~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--M-----RRIRDN-LP----PRVK--DSHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-----HHHHhc-CC----Cccc--ccccc
Confidence 578999999999988899999999999999999999999875432211 0 011110 00 0000 11224
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 723 LEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 723 ~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+..+.+++.+|++.+|.+|||++++++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 5578889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=308.39 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=199.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEee--cc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc--eE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN--RL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~--~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~ 553 (766)
.|.++||+|+|-+||||.+.. .+..||=-.++ .. .+...+.|..|+.+|+.|+||||++++....+... ..
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 366789999999999999864 34444432222 11 22334789999999999999999999999877665 67
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 632 (766)
+|+|.|..|+|..|+...++.+.....+|++||++||.|||.+ .++|+|||||-.||+|+ ..|.+||+|+|||..+..
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 8999999999999999999999999999999999999999987 88999999999999997 558999999999998876
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... ....|||.|||||.+. ..|++.+||||||+.++||+|+..|+..... ...+.+.+-.|.-...+..
T Consensus 199 s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 199 SHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred ccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhc
Confidence 543 3367999999999988 7899999999999999999999999975432 1223444444433222211
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
- ...++.++|.+|+.. ..+|||+.|+|+.
T Consensus 268 V--------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 V--------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred c--------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 135688999999998 9999999999863
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=299.60 Aligned_cols=259 Identities=22% Similarity=0.283 Sum_probs=197.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-----CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.||+|+||.||+|.... .++.++||.++..... ....+..|++++++++|+||+++++++.+.+..++
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred eeeeeeeeccccEEEEEEECC---CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEE
Confidence 456789999999999999764 3568999999754322 23567889999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+ +++|.+++.... .+++..+..++.||++||+|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 99999 899999998765 78999999999999999999995 59999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc---------
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN--------- 703 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 703 (766)
... .....++..|+|||.+.+ ..++.++||||||++++||++|.++|......+. +.. .......
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 156 NRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGK-IFEALGTPTEENWPGV 230 (298)
T ss_pred Ccc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHH-HHHHcCCCchhhhhhc
Confidence 211 122346788999998864 4678999999999999999999888765432111 100 1110000
Q ss_pred CccceeccCcccC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVGGDMEA-----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
............. ......+..+.+++.+||+.+|++|||+.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000 0112335788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.13 Aligned_cols=196 Identities=22% Similarity=0.397 Sum_probs=158.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 560 (766)
.+||+|+||.||+|..... .....+|+|.++.. .....+.+|++++++++||||+++++++.. +...++|+||++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred eEeccCCCeeEEEEEecCC-CccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 4799999999999997543 24578999988643 234568899999999999999999998853 456789999987
Q ss_pred CCchhhhhcc---------CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE----cCCCCeEEeccCcc
Q 037189 561 NGTLASFLFG---------NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLA 627 (766)
Q Consensus 561 ~gsL~~~l~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla 627 (766)
+ +|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+||++ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67666642 1246778889999999999999994 599999999999999 56678999999999
Q ss_pred cccccCCCc-ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCch
Q 037189 628 KLLTLNQSK-TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIE 685 (766)
Q Consensus 628 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~ 685 (766)
+........ .......+|..|+|||.+.+. .++.++|||||||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 111335689999999998764 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.04 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=198.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc----------CHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD----------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~----------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
..+.||+|+||.||+|.... .+..+|+|.++..... ..+.+.+|+.++++++|+||+++++++...+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ecceecccCceEEEEEeecC---CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 34689999999999998764 4568999987532111 1245788999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999999999999887888999999999999999999995 59999999999999999999999999999865
Q ss_pred ccCCCcceeecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.............++..|+|||.+.... ++.++|+||||+++||+++|+.|+....... ......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc-cCC
Confidence 4322222223456889999999987654 8899999999999999999999986432211 011111111 000
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..........+..+.+++.+||+.+|++||++.+|+++
T Consensus 232 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 ----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111122356788999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.55 Aligned_cols=264 Identities=22% Similarity=0.307 Sum_probs=200.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+++.+.||+|+||.||+|.... .++.+|+|++.... ....+.+.+|+.++++++|+||+++++++......++||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred eeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 3456789999999999999864 46789999886432 223456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|..++.....+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 999999999888777778999999999999999999995 59999999999999999999999999999876543321
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHHHHH-------HhhcCc-c
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDWAFD-------CYRNGK-L 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~-------~~~~~~-~ 706 (766)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... +...... .+.... .
T Consensus 157 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 157 --YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred --ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 123457889999999876 467899999999999999999999997544322111 1000000 000000 0
Q ss_pred ceeccCcccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+......+ ...+..+.+++.+||+.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000000000 1235678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.54 Aligned_cols=258 Identities=24% Similarity=0.263 Sum_probs=197.2
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHH---HccCCCCCeeeEeeeeecCCceEEEee
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFV---IGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.||+|+||.||++.... .++.+|+|.+..... .....+.+|..+ +...+|+||+.+.+++..++..++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe
Confidence 48999999999998764 467899998864321 222334455433 344579999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||++........
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 99999999999888889999999999999999999994 5899999999999999999999999999875543221
Q ss_pred eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
....|+..|+|||.+.+ ..++.++||||||++++||++|+.||..........+ ...... ...
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~----------~~~ 216 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLT----------VNV 216 (279)
T ss_pred --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhhc----------CCc
Confidence 23468999999999864 5689999999999999999999999965432211111 110000 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH--H-------hcCcCCCCCCCCCC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM--L-------EGVVEVSVPPNPYP 765 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~--L-------e~~~~~~~pp~p~~ 765 (766)
..+...+.++.+++.+||+.||.+|| |+++++++ + +.+...+.|+.|+|
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 279 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPPLIPPR 279 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCCCCCCC
Confidence 12334567889999999999999999 69999885 2 22345566666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.64 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=198.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-CceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-QNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 555 (766)
+.+.+.||+|++|.||+++... .++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence 3567889999999999999864 35689999986432 23346789999999999999999999987644 457899
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++++|.+++... ..+++.++..++.|++.||++||+ .+++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 9999999999999753 457899999999999999999995 59999999999999999999999999999876432
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......+++.|+|||.+.+..++.++||||||++++||++|+.||....... .... ...+...
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~-~~~~~~~------ 220 (257)
T cd08223 156 CD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYR-IIEGKLP------ 220 (257)
T ss_pred CC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHH-HHhcCCC------
Confidence 22 1133457899999999999999999999999999999999999987543221 1111 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+|++.+|++|||+.+++++
T Consensus 221 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 ---PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1123456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=293.19 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=200.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-----ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+.||+|+||.||+|.... ++..+++|.+.... ....+.+.+|+.++++++|+||+++.+++..+...++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred cccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEE
Confidence 345789999999999998864 45689999886533 1234678999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
++||+++++|.+++.....+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999999877778999999999999999999994 599999999999999999999999999988764433
Q ss_pred CcceeecccccCcccccccccCCC-CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....... ............
T Consensus 157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~------ 221 (258)
T cd06632 157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKELP------ 221 (258)
T ss_pred ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccCC------
Confidence 113456888999999988776 8999999999999999999999996543211 111111101111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 222 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 ---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1122345778899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.63 Aligned_cols=262 Identities=21% Similarity=0.309 Sum_probs=195.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|.... .+..||+|.++... ......+.+|+.++++++||||+++++++......++|||
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 4456789999999999998764 45689999986433 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|++ ++|.+++... ..+++..+..++.|+++||+||| +.+|+|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 998 5888888653 56788899999999999999999 459999999999999999999999999999765432211
Q ss_pred ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc----
Q 037189 637 TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG---- 711 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 711 (766)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||......+...................+..
T Consensus 161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1234568899999988654 578899999999999999999999976543321111000000000000000000
Q ss_pred -----CcccC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 712 -----GDMEA----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 712 -----~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+.... ......+..+.+++.+||+.||.+|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 001123567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.35 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=194.3
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|++|.||+|.... .+..+|||+++... ....+.+.+|+.++++++||||+++++++.++...++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred eEeeEecccCceEEEEEEECC---CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 355789999999999999764 45689999886432 2234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|++ ++|.+++... ..+++..+..++.|+++||+|||+ .+++|+||||+||++++++.+||+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 998 6888887542 467889999999999999999994 599999999999999999999999999997654322
Q ss_pred CcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHHH----HHHhhc-----
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDWA----FDCYRN----- 703 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~----~~~~~~----- 703 (766)
. ......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ..... ...+..
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 R--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred c--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 1 11233568899999988654 57899999999999999999999997543321100 00000 000000
Q ss_pred ---CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 ---GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........... .......+.++.+++.+||+.||++|||+.+|++.
T Consensus 234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 00011245678899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.38 Aligned_cols=265 Identities=24% Similarity=0.327 Sum_probs=202.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+++.+.||+|+||.||+|.... .+..++||.++... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 4456789999999999999864 35689999886432 233467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||++++.|..++.....+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 999998888777776778999999999999999999995 49999999999999999999999999999877654321
Q ss_pred ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH--------Hh-hcCcc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD--------CY-RNGKL 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~-~~~~~ 706 (766)
.. ....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.......... .. .....
T Consensus 157 ~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 11 335678899999999888 889999999999999999999999875433221110000000 00 00000
Q ss_pred c--eecc---Cc-ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 D--ALVG---GD-MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~--~~~~---~~-~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .... .. .....+...+.++.+++.+||+.+|++||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 0000 00 0001112236789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=291.03 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=200.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.+|++.... .++.+|+|.+.... ....+++.+|+.++++++||||+++++++.+.+..++|+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence 3456789999999999998764 46689999986432 233467999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999998754 356888899999999999999995 599999999999999999999999999998654332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....++..|+|||++.+..++.++|+||||+++++|++|+.|+......+ .+.... .+..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~-------- 218 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGSY-------- 218 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCCC--------
Confidence 11 123457889999999999999999999999999999999999987543222 111111 1111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+...+..+.+++.+||+.+|++||++.+|++.
T Consensus 219 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 -PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred -CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11123456778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=319.81 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=188.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC------CCCeeeEeeeeecC-C
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH------HKNLVRLLGFCDEG-Q 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~-~ 550 (766)
.+.+.++||+|+||.||+|.... .+..||||+++... ...+++..|++++.+++ |.+++++++++... .
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 34556889999999999999864 45789999986432 22344566666666654 45689999988765 4
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-------------
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY------------- 617 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~------------- 617 (766)
+.++|||++ +++|.+++.....+++..+..|+.||+.||.|||+ ..+|+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 678999987 67898988877789999999999999999999995 24899999999999998765
Q ss_pred ---CeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH
Q 037189 618 ---NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT 694 (766)
Q Consensus 618 ---~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 694 (766)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 283 ~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 283 DPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643221 13467899999999999999999999999999999999999999764432211111
Q ss_pred H---------HHHH--------Hhhc-CccceeccCc-----c--cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 695 D---------WAFD--------CYRN-GKLDALVGGD-----M--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 695 ~---------~~~~--------~~~~-~~~~~~~~~~-----~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. |... .+.. +.+....++. . ...........+++|+.+||+.||.+|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1 1000 0000 0000000000 0 00000112356789999999999999999999987
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.41 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=199.0
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
...||+|+||.||++.... .+..+|+|.+........+.+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred hhhcCCCCceeEEEEEEcC---CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 3479999999999998763 4568999998765555567789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
++|..++.. ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......... ...
T Consensus 103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 176 (297)
T cd06659 103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS 176 (297)
T ss_pred CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence 999997754 457899999999999999999994 59999999999999999999999999998765433211 133
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..++..|+|||++.+..++.++||||||++++||++|+.||......+.. ..+....... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~~~~-------~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSPPPK-------LKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhccCCCC-------ccccCC
Confidence 56889999999999889999999999999999999999999754332211 0111111000 001122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+..+.+++.+||+.+|++||++.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 35668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=285.72 Aligned_cols=268 Identities=24% Similarity=0.321 Sum_probs=213.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...++.+.||+|.-|+||++.+.. .....|+|.+.... .....+.+.|-++|+.++||.++.|++.++.++..+
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 344566899999999999999985 34789999997543 333456788999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 554 LVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
||||||+||+|...++.+ +.+++..+.-++..++-||+||| ..|||.|||||+||||-++|.+.|+||.|+..+.
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999988764 67889999999999999999999 5699999999999999999999999999986552
Q ss_pred cCC---------------------------------Cc---------------------ceeecccccCcccccccccCC
Q 037189 632 LNQ---------------------------------SK---------------------TIKTSIRGTKGYVAPEWFRNS 657 (766)
Q Consensus 632 ~~~---------------------------------~~---------------------~~~~~~~gt~~y~aPE~~~~~ 657 (766)
... .. ......+||-.|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 100 00 001124688999999999999
Q ss_pred CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccC
Q 037189 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQED 737 (766)
Q Consensus 658 ~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~d 737 (766)
..+.++|.|+|||+||||+.|..||....-.+.. ..++...+.....+..+..+.+||++.|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999999876543321 1122223333334467788999999999999
Q ss_pred CCCCCC----HHHHHHH--Hhc----CcCCCCCCC-CCC
Q 037189 738 PSLRPT----IKKVLQM--LEG----VVEVSVPPN-PYP 765 (766)
Q Consensus 738 p~~RPt----~~~vl~~--Le~----~~~~~~pp~-p~~ 765 (766)
|.+|.- +.||-++ +++ ++....||. |.+
T Consensus 376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~ 414 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKP 414 (459)
T ss_pred hhhhhccccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence 999998 7777653 233 345555554 543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=298.27 Aligned_cols=254 Identities=19% Similarity=0.264 Sum_probs=200.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||+|+||.||++.... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred eEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 456789999999999998864 45789999886542 223457889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC-
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS- 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 635 (766)
||+++++|.+++.....+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999999887788999999999999999999995 5999999999999999999999999999874211100
Q ss_pred ------------cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 636 ------------KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 636 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
........++..|+|||.+.+..++.++|+||||+++|||++|+.||......+ +......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~~~~ 230 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQVIS 230 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHh
Confidence 001112457889999999998899999999999999999999999996543221 1111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
+.... + ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~~---~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIEW---P----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccCC---C----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11110 0 0111345678999999999999999997777776655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=306.62 Aligned_cols=189 Identities=24% Similarity=0.325 Sum_probs=160.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.... ....||+|..... ....|+.++++++|+||+++++++.+....++|+|
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 35566889999999999999864 4568898875322 34579999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+. ++|.+++.. ...+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 985 588888764 4668999999999999999999995 5999999999999999999999999999975432211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
.....||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 213 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 13456899999999999999999999999999999999965554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=299.30 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=199.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|.... .++.+|+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 3456889999999999999864 357899998754322 23467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|..+......+++..++.++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 999999999888776678999999999999999999995 59999999999999999999999999999876543321
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHHHHH-------HHhhcCcc-
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWAF-------DCYRNGKL- 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~-------~~~~~~~~- 706 (766)
.....++..|+|||++.+ ..++.++||||||+++|||++|++||......+. ..+..... .......+
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07846 157 --YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF 234 (286)
T ss_pred --cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence 123457889999999875 4578899999999999999999999865432211 11111000 00000000
Q ss_pred ceeccCcccC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEA-----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+.... ...+..+..+.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 0012346778999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=289.86 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=205.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
++.+.||+|++|.||+++... .++.++||++..... ....++.+|+..+.+++|+||+++++++......++|+||
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 456889999999999999875 467899999876443 3467899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.....+++..++.++.|+++||+|||+ ..+++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 9999999999887888999999999999999999994 1699999999999999999999999999998765433221
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....++..|+|||.+.+..++.++||||||+++|+|++|+.|+............... ...... ..
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~---------~~ 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPP---------SL 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCC---------CC
Confidence 2345788999999999999999999999999999999999999655321111111111 111111 11
Q ss_pred cHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVE-CLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~-~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 222 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=328.88 Aligned_cols=254 Identities=22% Similarity=0.295 Sum_probs=195.9
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec--C
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--G 549 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~ 549 (766)
+....+.+.++||+|+||.||++.... ....+|+|.+.... ......|..|+.++.+++||||+++++++.+ .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 344456677899999999999999874 45688888886432 2334678999999999999999999998854 3
Q ss_pred CceEEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcC----CCceecCCCccceEEEcCC-----
Q 037189 550 QNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC----SSQIIHCDMKPQNILLDDH----- 616 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivH~dlk~~NIll~~~----- 616 (766)
...+|||||+++++|.++|.. ...+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 568899999999999999865 256899999999999999999999642 1459999999999999642
Q ss_pred ------------CCeEEeccCcccccccCCCcceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 617 ------------YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 617 ------------~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
..+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|+.||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 3489999999987643321 134568999999999854 45889999999999999999999999
Q ss_pred CchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 683 DIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 683 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
....... . +...+..+. .+. ....+..+.+|+..||+.+|.+||++.++++
T Consensus 244 ~~~~~~~-----q-li~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANNFS-----Q-LISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCcHH-----H-HHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 6433211 1 111111111 000 1123567889999999999999999999984
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.84 Aligned_cols=250 Identities=22% Similarity=0.243 Sum_probs=199.0
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
++.+.||+|++|.||++.... .++.+|+|.+...... ..+.+.+|++++.+++|+||+++++.+.+....++||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred EEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 445789999999999998864 4678999998754322 3457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+.+++|.+++... ..+++..+..++.|+++||+||| +.+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998754 56788899999999999999999 4599999999999999999999999999987653321
Q ss_pred Ccc---------------------------eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh
Q 037189 635 SKT---------------------------IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687 (766)
Q Consensus 635 ~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~ 687 (766)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 110 01123578899999999998899999999999999999999999975443
Q ss_pred hhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 037189 688 EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT----IKKVLQM 750 (766)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt----~~~vl~~ 750 (766)
... . .... .. ..........+..+.+++.+||+.+|++||+ ++++++.
T Consensus 238 ~~~--~----~~~~-~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 238 DET--F----SNIL-KK--------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred HHH--H----HHHh-cC--------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 211 0 1111 11 1111111225678999999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=292.87 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=201.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|++|.||++.... .++.+++|.+.... ....+++.+|++++++++||||+++++.+......++++|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 4567899999999999999864 46789999887543 2345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++.....++.|+++||+|||. ..+++|+||||+||++++++.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999999865 678888999999999999999994 169999999999999999999999999998765432211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
...++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .......... ... ...
T Consensus 158 ----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-~~~--------~~~ 223 (265)
T cd06605 158 ----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIV-NEP--------PPR 223 (265)
T ss_pred ----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHh-cCC--------CCC
Confidence 25678899999999999999999999999999999999999865421110 0111111111 111 111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+.++.+++.+||..+|++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111256778999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=291.66 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=200.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 555 (766)
++.+.||.|+||.||++.... .+..+|+|.+.... ....+.+.+|++++++++|+||+++++++.. +...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred eeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 456789999999999998764 45688999886432 2334578899999999999999999998754 4457899
Q ss_pred eeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcC--CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 556 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
|||+++++|.+++.. ...+++..++.++.|+++||.|||..+ +.+++|+||||+||++++++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 356889999999999999999999443 56899999999999999999999999999987
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
....... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... +. .....+...
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~~~~-- 228 (265)
T cd08217 160 LGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LA----SKIKEGKFR-- 228 (265)
T ss_pred ccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HH----HHHhcCCCC--
Confidence 6544321 133468899999999999889999999999999999999999997654221 11 111111111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+|++.+|++||++++|+++
T Consensus 229 -------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 -------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1233456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=290.82 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=195.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-----cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cce
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNR 552 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (766)
...+.||+|+||.||+|.... .+..+|||.+..... ...+.+.+|++++++++||||+++++++.+. ...
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred eEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 345789999999999998764 457899998753221 1235688899999999999999999988664 457
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+++|||+++++|.+++.....+++.....++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 7999999999999999877778888899999999999999995 5899999999999999999999999999986543
Q ss_pred CCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~-------- 224 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIATQ-------- 224 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhcC--------
Confidence 2111 111234588899999999988899999999999999999999999964322111 0111100
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+......+.+++.+|+. +|++||++++|++.
T Consensus 225 -~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 -PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01112234456678889999985 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.82 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=192.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeee-----cCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCD-----EGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~~ 552 (766)
+.+.+.||+|+||.||++.... .++.+|+|.++.. .....++.+|+.++.++ +|+||+++++++. .+...
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 3455789999999999999864 4568899987642 23346788999999998 6999999999884 34568
Q ss_pred EEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
++||||+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||++++++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 999999999999998752 3467888899999999999999994 599999999999999999999999999988
Q ss_pred ccccCCCcceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
.+...... .....|+..|+|||++.. ..++.++|||||||++|||++|+.|+........ + .. ...
T Consensus 173 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~----~~-~~~ 243 (286)
T cd06638 173 QLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--L----FK-IPR 243 (286)
T ss_pred ecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--H----hh-ccc
Confidence 76433211 123468999999999853 4578899999999999999999999865432111 0 00 000
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..... ...+......+.+++.+||+.+|++|||+.++++.+
T Consensus 244 ~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 244 NPPPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred cCCCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00000 011122346788999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=303.57 Aligned_cols=260 Identities=26% Similarity=0.317 Sum_probs=199.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-C-----CCeeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-H-----KNLVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~ 551 (766)
++.+.+.||+|.||.|-|+.... .++.||||+++.. ..-..+-..|+.+|..++ | -|+|++++++...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecC---CCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 56678999999999999999875 4679999999753 233456678999999987 4 389999999999999
Q ss_pred eEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC--CCeEEeccCcc
Q 037189 552 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH--YNARISDFGLA 627 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla 627 (766)
.|||+|.+.. +|.++|+.+ ..++...+..|+.||++||.+||+ .+|||+||||+||||.+. ..+||+|||.+
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999998865 999999865 467889999999999999999995 599999999999999744 46999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHH--------HHHH
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD--------WAFD 699 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~ 699 (766)
........ ...-+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|.++++.+...... ++.+
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 87654432 3446788999999999999999999999999999999999997766533322111 1111
Q ss_pred H-------hhc-Cccceec----------------------cCc-c-------cCCCcHHHHHHHHHHHHHccccCCCCC
Q 037189 700 C-------YRN-GKLDALV----------------------GGD-M-------EAMNDVECLEKLVMVSIWCIQEDPSLR 741 (766)
Q Consensus 700 ~-------~~~-~~~~~~~----------------------~~~-~-------~~~~~~~~~~~l~~l~~~Cl~~dp~~R 741 (766)
. ... ....... +.. . ...........+.+++++||+.||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 1 001 0000000 000 0 000111334668999999999999999
Q ss_pred CCHHHHHHH
Q 037189 742 PTIKKVLQM 750 (766)
Q Consensus 742 Pt~~~vl~~ 750 (766)
+|..+.+++
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999865
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.89 Aligned_cols=249 Identities=26% Similarity=0.388 Sum_probs=200.6
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.++||+|+||.||+|.... .+..+|||.+.... ......+.+|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 345566789999999999998754 45789999876432 23346788999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.. ..+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 81 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999999865 357899999999999999999995 5999999999999999999999999999876643221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..|+........ . ........
T Consensus 157 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~-~~~~~~~~--------- 218 (277)
T cd06641 157 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------L-FLIPKNNP--------- 218 (277)
T ss_pred h--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------H-HHHhcCCC---------
Confidence 1 1234578899999999988899999999999999999999999864332110 0 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+..+.+++.+|++.+|.+||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11123345778899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=305.52 Aligned_cols=259 Identities=23% Similarity=0.298 Sum_probs=190.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------ 549 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (766)
.+...+.||+|+||.||+|.... .+..||||++..... ...+.+.+|++++++++||||+++++++...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34456789999999999998764 456899999864322 2345678999999999999999999987543
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++++|++ +++|.+++.. ..+++..+..++.||++||.|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcccee
Confidence 3568999987 6789887754 468899999999999999999995 5999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHH-------HHHH
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDW-------AFDC 700 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~ 700 (766)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......... ..... ....
T Consensus 168 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 34568999999999876 56899999999999999999999999654321110 00000 0000
Q ss_pred hhcCccceeccCcccCCCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 701 YRNGKLDALVGGDMEAMND-------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.......... .+..... ......+.+++.+||+.||.+|||+.+++++
T Consensus 243 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000000 0123457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=288.94 Aligned_cols=251 Identities=28% Similarity=0.403 Sum_probs=200.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...+.||+|+||.||+|.... .+..+++|.++..... ..+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred eeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 455789999999999998764 4578999998765443 45789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999999887778999999999999999999994 599999999999999999999999999998765433221
Q ss_pred e--eecccccCcccccccccCCC---CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 638 I--KTSIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 638 ~--~~~~~gt~~y~aPE~~~~~~---~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
. .....++..|+|||++.+.. .+.++||||||++++||++|+.||........ .... ...+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~-~~~~~------- 223 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFH-VGAGH------- 223 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHH-HhcCC-------
Confidence 1 12346788999999998766 88999999999999999999999964321110 0000 00010
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.............+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0011111223667889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=283.51 Aligned_cols=248 Identities=22% Similarity=0.308 Sum_probs=210.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.++.++||+|.||.|||+.++. .+..+|||++.. +...+++..|+.+|.+.+.|++|+++|.+.......+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 4466899999999999999874 678999999865 45678999999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|.-|++.+.++. ++.+.+..+..++...++||+|||. ..-+|||||+.||||+.+|.+||+|||++..+...- .
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 999999999975 4778999999999999999999995 478999999999999999999999999998775432 2
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
....+.||+-|||||++..-.|+.++||||||+...||.-|++|+....+-.. ....-..+.....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMIPTKPPPTFK 250 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEeccCCCCCCCC
Confidence 23567899999999999999999999999999999999999999975432110 0000112223334
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+.+.+.++.++++.||-++|++|-|+.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 567788999999999999999999999888764
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.00 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=200.1
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~ 552 (766)
...+...++||+||-+.|||+... +...+|+|++.. .+.+....|.+|+.+|.+++ |.+||+|++|-..++.+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 344567789999999999999865 456788888753 33445678999999999996 99999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCC--ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
||||||-+ -+|..+|...... +| .+..+..|++.++.++|++ +|||.||||.|+|+- .|.+||+|||+|..+
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeeccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99999854 5999999876432 34 7788999999999999976 999999999999986 469999999999999
Q ss_pred ccCCCcceeecccccCcccccccccCC-----------CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNS-----------KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 699 (766)
..+.........+||..||+||.+... +++.++||||+|||||+|+.|++||..... . |.
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~--~a-- 580 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q--IA-- 580 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H--HH--
Confidence 988777776778999999999998432 367899999999999999999999963221 1 11
Q ss_pred HhhcCccceeccCcccCCCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 CYRNGKLDALVGGDMEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
++..+.++..+.+++. ....++.++++.||+.||.+|||..++++.
T Consensus 581 -----Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -----KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233444433222221 112238999999999999999999999875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=296.19 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=194.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+...+.||+|+||.||+|+... .+..+|+|.+..... ...+++.+|+++++.++||||+++.++|.+.+..++|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 5666889999999999999864 456899998864332 2235688999999999999999999999999999999
Q ss_pred eeccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+||+. |+|.+++. ....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 46666654 34568999999999999999999994 59999999999999999999999999998765432
Q ss_pred CcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ ...... ..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~-~~------ 230 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQ-ND------ 230 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhc-CC------
Confidence 2345788999999874 45688999999999999999999999865432211 111111 00
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+..+.+++.+||+.+|++||++.+++++
T Consensus 231 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 --SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111123456789999999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=291.96 Aligned_cols=245 Identities=25% Similarity=0.372 Sum_probs=199.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
.+.||+|++|.||++.... .+..+++|+++.......+.+.+|+.+++.++|+||+++++++...+..++|+||+++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred ceEeccCCCeEEEEEEECC---CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 3689999999999998764 4568999998765555566789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
++|.+++.. ..+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......... ...
T Consensus 101 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~ 174 (285)
T cd06648 101 GALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKS 174 (285)
T ss_pred CCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--ccc
Confidence 999999877 568889999999999999999994 59999999999999999999999999988765433211 123
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..|+..|+|||.+.+..++.++||||||++++||++|+.||........ .. ........ .. .....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~-~~~~~~~~-----~~--~~~~~ 240 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MK-RIRDNLPP-----KL--KNLHK 240 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HH-HHHhcCCC-----CC--ccccc
Confidence 4588999999999988899999999999999999999999865432211 11 11111110 00 01122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+..+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 4568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=290.84 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=198.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.++... .....++.+|+.++++++ |||++++++++.++...++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 3456789999999999999864 45789999886532 334567889999999886 9999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++++|.+++... .+++...+.++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 99999999999998664 68899999999999999999994 599999999999999999999999999998765443
Q ss_pred CcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||........ . ........ +.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~-----~~ 221 (277)
T cd06917 156 SK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKP-----PR 221 (277)
T ss_pred cc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCC-----CC
Confidence 21 1334688899999998754 578999999999999999999999975432211 0 00000000 00
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .....+.++.+++.+||+.||++||++.++++.
T Consensus 222 ~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 L---EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred C---CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1 011245678899999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=290.23 Aligned_cols=251 Identities=25% Similarity=0.401 Sum_probs=199.4
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccc------cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
..+.||+|++|.||+|.... .+..+|+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccceecCcCceEEEEEEEcC---CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 45789999999999998753 456899998864321 124678999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 633 (766)
|+||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .+||+|||++......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999887788999999999999999999995 5999999999999998775 5999999999876543
Q ss_pred CCc--ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 QSK--TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
... .......++..|+|||.+.+..++.++||||+|+++++|++|+.||.......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~--------- 225 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIAS--------- 225 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhc---------
Confidence 211 11123457889999999988889999999999999999999999986433211111 1110000
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.......+.....++.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111223445678899999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.79 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=198.3
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
..+...+.||+|+||.||+|+... .+..+|+|.+..... ....++.+|++++++++|+|++++++++.++...+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 335566789999999999999764 456899998864322 22357889999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99999975 77776643 4568899999999999999999994 5999999999999999999999999999875432
Q ss_pred CCCcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
. ....++..|+|||++. .+.++.++||||||+++|||++|+.||........ . ......+.
T Consensus 178 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~~~~~~~---- 241 (317)
T cd06635 178 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQNES---- 241 (317)
T ss_pred c------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H----HHHHhccC----
Confidence 2 2345788999999974 45789999999999999999999999865332111 1 11111110
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
........+..+.+++.+||+.+|.+||++.++++.+--....
T Consensus 242 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 -----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1111223556789999999999999999999999876544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=294.73 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=202.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||++.... .+..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 45566889999999999998653 356899999875555556788999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~- 171 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-
Confidence 99999999998654 47788899999999999999994 59999999999999999999999999998766543321
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....++..|+|||.+.+..++.++||||||+++|++++|+.||.......... .... .+.....
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~--------~~~~~~~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPELQ 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhc--------CCCCCCC
Confidence 123458889999999998889999999999999999999999997543321100 0000 0011111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122345678899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=287.46 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=198.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||++.... ....+|||.+.... ......+.+|++++++++||||+++++.+..++..++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred ceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence 3456789999999999998764 46789999886432 234567899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCcccccccC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLN 633 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~ 633 (766)
||+++++|.+++... ..+++..+..++.+++++|+|||+ .+++|+||+|+||+++++ ..+||+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999999764 357888999999999999999995 599999999999999855 45899999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .... ..+....
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~-~~~~~~~----- 220 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKI-MSGTFAP----- 220 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHH-HhcCCCC-----
Confidence 221 234578899999999988899999999999999999999999975443221 1111 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 221 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 ----ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122346678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=293.86 Aligned_cols=243 Identities=26% Similarity=0.293 Sum_probs=200.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence 3456789999999999999874 45789999886432 22346788999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 9999999999999888889999999999999999999995 59999999999999999999999999999876543
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||....... .......+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~--------- 215 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------IYEKILEGKV--------- 215 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCc---------
Confidence 133468899999999988889999999999999999999999997544211 1111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
..+...+..+.+++.+||+.+|.+|| +++++++
T Consensus 216 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 -RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11222357788999999999999999 7777663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.95 Aligned_cols=261 Identities=20% Similarity=0.289 Sum_probs=194.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.++... ......+.+|++++++++|+||+++++++.+....++|+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred ceeEEEecccCCeEEEEEEECC---CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence 3456789999999999999864 45689999886432 223456888999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++ +|.+++.. ...+++..++.++.||++||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 99975 77777754 4678999999999999999999995 5999999999999999999999999999986543221
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc------cce
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK------LDA 708 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 708 (766)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+......... + ........... +..
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-H-HHHHHHhCCCChHHhHHhhh
Confidence 1 1234578899999998765 4789999999999999999999886432221100 0 00110000000 000
Q ss_pred ecc----Cccc-----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 LVG----GDME-----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~~~----~~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+ +... .......+.++.+++.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0000 00112345778899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=292.82 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=197.1
Q ss_pred CHHHHHHHHHhh--hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeee
Q 037189 470 SYKELEEATDNF--KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFC 546 (766)
Q Consensus 470 ~~~~l~~~t~~f--~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (766)
.+.++.+++.+| .+.||+|+||.||++.... .++.+|+|.+... .....++.+|+.++.++ +|||++++++++
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 334444444444 4689999999999998764 4678999988643 22346778899999988 899999999998
Q ss_pred ecC-----CceEEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC
Q 037189 547 DEG-----QNRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY 617 (766)
Q Consensus 547 ~~~-----~~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~ 617 (766)
... ...++|+||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 653 357999999999999998853 4567899999999999999999995 5999999999999999999
Q ss_pred CeEEeccCcccccccCCCcceeecccccCcccccccccCC-----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh
Q 037189 618 NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~ 692 (766)
.+||+|||+++......... ....++..|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-- 241 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-- 241 (291)
T ss_pred CEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--
Confidence 99999999988755332111 234578899999998644 368899999999999999999999875432111
Q ss_pred HHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+ .. ...+....+ ..+......+.+++.+||+.+|++||++.++++.
T Consensus 242 ~----~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 L----FK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred H----HH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 11 111111111 1122345678999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=321.82 Aligned_cols=264 Identities=27% Similarity=0.410 Sum_probs=212.8
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCc----eeEEEEEEeeccccc-CHHHHHHHHHHHccC-CCCCeeeEeeee
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTS----TTAVAVKKLDIVFQD-GEREFKNEVFVIGQT-HHKNLVRLLGFC 546 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~----~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (766)
|+......+.+.||+|.||.|++|........ ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 34444445667999999999999997653332 678999999764433 457899999999998 599999999999
Q ss_pred ecCCceEEEeeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccce
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQN 610 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 610 (766)
......++|.||+++|+|.+||+... .+.....+.++.|||.|++||+ +.+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence 99999999999999999999998655 3667788999999999999999 5589999999999
Q ss_pred EEEcCCCCeEEeccCcccccccCCCcceeecc-cccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhh
Q 037189 611 ILLDDHYNARISDFGLAKLLTLNQSKTIKTSI-RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVE 688 (766)
Q Consensus 611 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~ 688 (766)
||+..+..+||+|||+++.............. .-+..|||||.+....|+.|+||||||++||||+| |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999976655443321111 13567999999999999999999999999999999 88888652211
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
. . +.+.+++|. +...+..+..++.++++.||+.+|++||++.++++.|+..
T Consensus 529 ~-----~-l~~~l~~G~---------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 E-----E-LLEFLKEGN---------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H-----H-HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1 1 122333332 2334666788999999999999999999999999999884
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=288.19 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=202.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+++.+.||.|+||.||+|.... .+..+++|.+.... ....+.+.+|++.++.++|+||+++++.+..+...++|+|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4566889999999999998764 45689999886432 2245789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
++++++|.+++... ..+++.....++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999999763 457899999999999999999994 599999999999999999999999999998766443
Q ss_pred Ccc--eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 635 SKT--IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 635 ~~~--~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
... ......++..|+|||.+... .++.++|+||||++++||++|+.||....... ... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~----~~~~~-~~----- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM----LTLQN-DP----- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHH----HHhcC-CC-----
Confidence 221 22334688999999998877 78999999999999999999999997543221 111 11111 00
Q ss_pred CcccCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAM-NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+..... .....+..+.+++.+||+.||++||++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 001100 112456788999999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=290.52 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=202.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|++|.||+|.... .+..+++|.+..... ....+.+|++.+++++|+|++++++.+......++|+||
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred chHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 4456789999999999999874 456899999875433 567889999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++.... .+++..+..++.|++.||+||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 172 (286)
T cd06614 97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK- 172 (286)
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-
Confidence 99999999998776 7899999999999999999999 469999999999999999999999999998765432211
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....++..|++||.+.+..++.++||||||+++|+|++|+.|+......... . . ....... ...
T Consensus 173 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~-~~~~~~~-------~~~ 237 (286)
T cd06614 173 -RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----L-ITTKGIP-------PLK 237 (286)
T ss_pred -hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----H-HHhcCCC-------CCc
Confidence 12334788999999999888999999999999999999999998754332110 0 0 0011111 011
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 122256778999999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=285.91 Aligned_cols=243 Identities=24% Similarity=0.290 Sum_probs=197.5
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||.|++|.||++.... .+..+++|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCC
Confidence 7999999999999864 46789999886432 23346799999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
++|.+++.....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++........ ...
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~~~ 151 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWT 151 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---ccc
Confidence 9999999887778999999999999999999994 5999999999999999999999999999987654321 123
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..++..|++||.+.+..++.++|+||||+++|||++|..|+.....+.... ..... . .......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~-~--------~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI----YNDIL-K--------GNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHH----HHHHh-c--------cCCCCCCCcc
Confidence 467889999999988889999999999999999999999997554211111 11111 0 0111112223
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPT-----IKKVLQ 749 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~ 749 (766)
.+..+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.18 Aligned_cols=240 Identities=26% Similarity=0.353 Sum_probs=198.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCH---HHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~---~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||.|.||.||-+.... ...+||||++.-...+.. .+++.|+..|.+++|||++.+.|++..+....||||||
T Consensus 32 rEIGHGSFGAVYfArd~~---n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred HHhcCCccceeEEeeccC---ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH
Confidence 479999999999998765 456999999976544443 46899999999999999999999999999999999999
Q ss_pred CCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 560 NNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 560 ~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
-| +-.|.+. ..+++.+..+..|+.+.+.||+||| +.+.||||||+.||||++.+.+||+|||.+....+.
T Consensus 109 lG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA----- 179 (948)
T KOG0577|consen 109 LG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA----- 179 (948)
T ss_pred hc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch-----
Confidence 65 6666665 3466788899999999999999999 569999999999999999999999999999876654
Q ss_pred eecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 639 KTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
..+.||+.|||||++. .+.|+-|+||||||+...||.-.++|+...+.-. .+.....+ ...
T Consensus 180 -nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQN---------esP 243 (948)
T KOG0577|consen 180 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN---------ESP 243 (948)
T ss_pred -hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhc---------CCC
Confidence 4578999999999985 5789999999999999999999999976544211 11111111 112
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+.+..++.++..||++-|.+|||..+++++
T Consensus 244 tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 244 TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22356788999999999999999999999998865
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=291.46 Aligned_cols=261 Identities=22% Similarity=0.299 Sum_probs=199.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .+..++||++.... ......+.+|+.++++++|+||+++++++..+...++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred ceEEeecccCCCcEEEEEEECC---CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence 3456789999999999999764 46789999987543 233567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+ +++|.+++.. ...+++..++.++.||++||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 79 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 79 EYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred ccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999 9999999865 3568899999999999999999994 5999999999999999999999999999987654432
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC----------
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---------- 704 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 704 (766)
.. .....++..|+|||.+.+. .++.++||||+|++++||++|+++|......... ..........
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 RL-YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred Cc-cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccC
Confidence 11 1334688999999998654 4689999999999999999998888654322110 1111111000
Q ss_pred --ccceeccCcccC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 --KLDALVGGDMEA----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 --~~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+....... ....+....+.+++.+||+.+|++|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 0011235788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.91 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=196.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 553 (766)
.+.+.+.||+|+||.||+|+... .++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45567899999999999999864 456899999875432 2234678899999999999999999998777 8899
Q ss_pred EEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+.+ +|.+++... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99999985 898888654 458999999999999999999995 5899999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHH-------HHHHh--
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDW-------AFDCY-- 701 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~-- 701 (766)
.... .....++..|+|||.+.+. .++.++|+||||+++|||++|+.||......... .+... .+..+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 3211 1234568899999998764 4689999999999999999999999754432111 00000 00000
Q ss_pred ----hcCccceeccCcccCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 702 ----RNGKLDALVGGDMEAMNDVE-CLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 702 ----~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.................+.. ..+.+.+++.+||+.+|++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000111111111 36678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.86 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=189.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHH-HccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||++.... .++.||+|+++... .....++..|+.. ++..+||||+++++++..++..+++||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred eEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 456789999999999999864 46799999987543 2234556667665 666789999999999999999999999
Q ss_pred ccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 558 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 558 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|++ ++|.+++.. ...+++..++.++.||+.||+|||+ ..+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 678777653 3467899999999999999999995 238999999999999999999999999999876432
Q ss_pred CCcceeecccccCcccccccccC----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.. .....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||....... ..+ .... .+....
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~----~~~~-~~~~~~- 227 (283)
T cd06617 158 VA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQL----KQVV-EEPSPQ- 227 (283)
T ss_pred cc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHH----HHHH-hcCCCC-
Confidence 21 123457889999998865 456889999999999999999999986422110 001 1111 111000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
......+.++.+++.+||+.+|++||++.++++
T Consensus 228 -------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 -------LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -------CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011234677899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.16 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=192.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeec------CC
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE------GQ 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~ 550 (766)
.+.+.+.||+|+||.||+|.... .++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ..
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 34455789999999999999864 45689999886532 3345788899999998 69999999999853 45
Q ss_pred ceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
..+++|||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 679999999999999998653 456788888999999999999994 599999999999999999999999999987
Q ss_pred ccccCCCcceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
........ .....++..|+|||.+. ...++.++||||||+++|||++|+.||........ . .. ...
T Consensus 170 ~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~----~~-~~~ 240 (282)
T cd06636 170 QLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--L----FL-IPR 240 (282)
T ss_pred hhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--h----hh-Hhh
Confidence 65432211 12345888999999986 34678899999999999999999999964332111 0 00 000
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. .........++..+.+++.+||+.||.+|||+.++++
T Consensus 241 ~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 N--------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C--------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 0111112235678999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.64 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=197.4
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEEEe
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY 556 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (766)
+.++||+|+||.||+|.... .+..+|+|++.... ......+.+|++++++++|+|++++++++... +..++|+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKK---TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeEEeccCCCeEEEEEEECC---CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 45789999999999999864 35789999997653 33346788999999999999999999999888 7899999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++ +|.+++... ..+++..++.++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 99985 888888765 578899999999999999999995 5899999999999999999999999999987655432
Q ss_pred cceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC------ccce
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG------KLDA 708 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 708 (766)
.. .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ........ ....
T Consensus 156 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 156 AD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK---IFELCGSPTDENWPGVSK 231 (287)
T ss_pred cc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchhhcccccc
Confidence 11 133456788999998765 4678999999999999999999999976543221111 11100000 0000
Q ss_pred e-----------ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 L-----------VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~-----------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+ ............++..+.+++.+||+.+|.+||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 00000000011126778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=281.95 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=203.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
...+.||+|++|.||++.... ++..+++|++........+.+.+|++.+++++|+|++++++++......++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred eeeeeeccCCceEEEEEEECC---CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 345789999999999999864 45789999997655556678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 560 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 560 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
++++|.+++... ..+++..+..++.|++++|+|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999999776 678999999999999999999994 6999999999999999999999999999987765432
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....++..|+|||.+.+...+.++||||||+++++|++|+.|+.......... .. .......+ ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~-~~~~~~~~-------~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KI-ATNGPPGL-------RN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HH-HhcCCCCc-------Cc
Confidence 134567889999999998889999999999999999999999987543221110 00 00111111 11
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+..+.+++.+||+.||++|||+.++++.
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11235778999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.07 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=193.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.++||+|+||.||++.... .+..+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 355789999999999999864 46789999986433 233467899999999996 9999999999999999999999
Q ss_pred ccCCCchhhh---hc--cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 558 FLNNGTLASF---LF--GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~---l~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
|+.. +|.++ +. ....+++.....++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44443 32 23568889999999999999999995 34899999999999999999999999999976543
Q ss_pred CCCcceeecccccCcccccccccCC---CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.... ....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .......... +..
T Consensus 161 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~-~~~--- 228 (288)
T cd06616 161 SIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK-GDP--- 228 (288)
T ss_pred CCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC-CCC---
Confidence 3211 233578899999999876 689999999999999999999999864331 0011111111 111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+..........+.++.+++.+||+.+|++|||+++|++.
T Consensus 229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011111123456789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=282.75 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=204.4
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEEEe
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY 556 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (766)
..+.||+|++|.||+|.... .++.+++|.+..... ...+.+.+|+..+++++|+||+++++.+.+. ...++|+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKD---TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred eeeEeeecCceEEEEEEECC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 34789999999999999864 467899998865442 3467899999999999999999999999988 8899999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..+..++.|++++|+|||+ .+++|+||+|+||+++.++.+||+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999999999887789999999999999999999995 59999999999999999999999999999877655431
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.......++..|+|||.+.+...+.++||||||+++++|++|+.||....... ........ .....
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~---------~~~~~ 223 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGS---------SGEPP 223 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccc---------cCCCc
Confidence 11234568889999999998889999999999999999999999997544111 11111110 01111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1233346789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=290.82 Aligned_cols=258 Identities=25% Similarity=0.339 Sum_probs=193.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+..+.||+|++|.||+|+... .+..+|||+++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred eeeeeecCCCceEEEEEEECC---CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 345789999999999998864 45689999886432 2234578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+. ++|.+++.. ...+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 996 689888865 3567889999999999999999994 5999999999999999999999999999876543321
Q ss_pred cceeecccccCcccccccccCCC-CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc-----------
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN----------- 703 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 703 (766)
. .....++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +..... ....
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFR-TLGTPDEVVWPGVTS 230 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHH-HhCCCChhhhhhhhH
Confidence 1 12334688999999887654 68899999999999999999999965432211 111000 0000
Q ss_pred -----CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 -----GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 -----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
............. .......++.+++.+||+.||.+|||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 011234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=287.19 Aligned_cols=246 Identities=26% Similarity=0.308 Sum_probs=200.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.||.|+||.||++.... .+..+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred eEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence 456789999999999998764 45689999986533 234578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 155 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL- 155 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-
Confidence 999999999999877788999999999999999999995 5899999999999999999999999999887654321
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+........ ......... ...
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~~ 219 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------ADV 219 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------ccc
Confidence 1345678899999999988899999999999999999999999976543211 111111110 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTI--KKVL 748 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~--~~vl 748 (766)
..+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1223345788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=288.39 Aligned_cols=248 Identities=27% Similarity=0.359 Sum_probs=199.1
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||.||++.... .+..+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++|+||+++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCC
Confidence 6899999999999864 356899998865332 3456789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc-----
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK----- 636 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----- 636 (766)
++|.+++.....+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999999877788999999999999999999995 59999999999999999999999999998865433211
Q ss_pred -ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 -TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.......++..|+|||.......+.++||||||++++||++|+.||......+. . .....+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~-~~~~~~~~~-------- 219 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------F-QNILNGKIE-------- 219 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHhcCCcC--------
Confidence 111334578899999999888899999999999999999999999975543221 1 111111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.......+..+.+++.+||+.+|.+|||+.++.+.|+.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00111136788999999999999999999777776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.10 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=195.3
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~------ 550 (766)
.+.+.+.||+|++|.||+|.... .+..+++|.+.... ...++|.+|+.+++++ +|+||+++++++....
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred heeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34556889999999999999864 35689999886543 3456799999999998 7999999999996644
Q ss_pred ceEEEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 551 NRLLVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
..++||||+++++|.+++.. ...+++..+..++.|+++||.||| +.+++|+||+|+||++++++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998864 356889999999999999999999 45999999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
+......... .....++..|+|||.+.. ..++.++||||||+++++|++|+.||....... .+ ...
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----~~~- 230 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--AL----FKI- 230 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HH----HHh-
Confidence 8765432211 133458889999998753 346789999999999999999999996432211 11 111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+.. .....+...++++.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 011112335678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=287.93 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=196.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (766)
.+.+.||.|++|.||++.... .+..+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred EEEEEeccCCceEEEEEEECC---CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 345789999999999999864 467899998875332 3456799999999999999999999998653 4689999
Q ss_pred eccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 557 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 557 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988753 3457888899999999999999995 5999999999999999999999999999876543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh--hhhhHHHHHHHHhhcCccceec
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE--EYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
... ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+...... .......+. .......+.
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH----hcCCchhhc
Confidence 221 2345788999999999999999999999999999999999999755321 111111111 111111110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+ . .......++.+.+++.+||+.+|.+|||+.|+++
T Consensus 230 ~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 D-E--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred c-C--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0 0 0111234678899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.17 Aligned_cols=261 Identities=18% Similarity=0.187 Sum_probs=185.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCH-----------HHHHHHHHHHccCCCCCeeeEeee
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----------REFKNEVFVIGQTHHKNLVRLLGF 545 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g~ 545 (766)
..+.+.+.||+|+||.||+|....+......+|+|.......... .....+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 345677899999999999999865432245566665432221111 112233455667889999999997
Q ss_pred eecCC----ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEE
Q 037189 546 CDEGQ----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 546 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
+.... ..++++|++.. ++.+.+......++..+..|+.|+++||+|||+ .+|+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEE
Confidence 65543 33677777643 555665554446778888999999999999994 59999999999999999999999
Q ss_pred eccCcccccccCCCc-----ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh--HH
Q 037189 622 SDFGLAKLLTLNQSK-----TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI--LT 694 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~--~~ 694 (766)
+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+++||++|+.||.......... ..
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999999876432211 11123469999999999999999999999999999999999999997653211110 00
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.-.......+.. . ...++..+.+++..|++.+|++||++.++++.|+
T Consensus 248 ~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 248 CDFIKRLHEGKI--------K---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHhhhhhh--------c---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 001111111111 1 1123577889999999999999999999999874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.85 Aligned_cols=260 Identities=20% Similarity=0.327 Sum_probs=192.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|++|.||+|+... .++.+|||.+...... ....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 3456789999999999999764 4568999998653322 23567889999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+.+ +|.+++... ..+++.....++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 9985 899988654 467888999999999999999994 59999999999999999999999999998754322111
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---ccc-----
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---KLD----- 707 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~----- 707 (766)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... + .......... ...
T Consensus 160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-L-HKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-H-HHHHHhcCCCChhhhhhhhhc
Confidence 122346788999999875 45889999999999999999999999654311100 0 0001100000 000
Q ss_pred -eecc--------CcccC-CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 -ALVG--------GDMEA-MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 -~~~~--------~~~~~-~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.... ..... .........+.+++.+||+.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 000111266789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=287.54 Aligned_cols=246 Identities=25% Similarity=0.372 Sum_probs=198.1
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
..+||+|+||.||++.... .+..+|||++..........+.+|+.++++++|+||+++++++...+..++||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcC---CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 3679999999999998864 5679999998765555566799999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
++|.+++.. ..+++.....++.|++.+|+|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 999998754 357888999999999999999995 59999999999999999999999999998765433211 123
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..++..|+|||.+.+..++.++||||||+++|||++|..||.......... .. .... . .... ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~----~~~~-~----~~~~--~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MI----RDNL-P----PKLK--NLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH----HhhC-C----cccC--Cccc
Confidence 457899999999988889999999999999999999999987543322111 01 0000 0 0000 0112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+..+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 35567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=289.89 Aligned_cols=258 Identities=21% Similarity=0.232 Sum_probs=202.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.||+|++|.||+++.......+..+|||.++... ....+.+.+|++++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 45678999999999999876544456789999886432 22345688999999999 59999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++++|.+++.....+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 99999999999999877778899999999999999999994 599999999999999999999999999988765432
Q ss_pred CcceeecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... .....++..|+|||.+.+.. .+.++||||||++++||++|..||....... ............
T Consensus 160 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~--------- 227 (288)
T cd05583 160 EER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS--------- 227 (288)
T ss_pred ccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc---------
Confidence 211 12345788999999987665 7889999999999999999999986432110 001111111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
. ...+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 228 ~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 228 K--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred C--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 111223456788999999999999999999998888653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=289.20 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=190.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.+.||+|+||.||+|.... .+..+++|.+..... .....+.+|+.+++.++|+||+++.+++..+...++|+||
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 345789999999999998764 356899999865432 2335678999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+. ++|.+++.. ...+.+..+..++.|++.||.|||+ .+|+|+||||+||+++.++++||+|||+++........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 96 577666644 3456788888999999999999995 59999999999999999999999999998764332111
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc-------------
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN------------- 703 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 703 (766)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||............ .+.....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK--IWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH--HHHHcCCCChhhhhhhhhcc
Confidence 1234468899999998764 5788999999999999999999999754332111110 0000000
Q ss_pred CccceeccCcccC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 704 GKLDALVGGDMEA-----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 704 ~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
............. .........+.+++.+|++.||.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 000112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=289.38 Aligned_cols=262 Identities=24% Similarity=0.317 Sum_probs=195.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.++||.|++|.||+|.... .+..+|+|++.... ......+.+|++++++++|+|++++++++.+.+..+++||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred chheEecCCCCeEEEEEEEcC---CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence 356789999999999999864 46789999886543 2234678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|++ ++|.+++.... .+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 79 FLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred ccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 995 68999987654 68999999999999999999995 5999999999999999999999999999976543221
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHHHH-------HHHhhc--C
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDWA-------FDCYRN--G 704 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~-------~~~~~~--~ 704 (766)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||........ ....... +..... +
T Consensus 155 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 T--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred c--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 1 1223468899999988654 578999999999999999999999965433111 1100000 000000 0
Q ss_pred ccceeccCcc--cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 KLDALVGGDM--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ~~~~~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+..... ........+..+.+++.+|++.+|.+|||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 000012234678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.06 Aligned_cols=266 Identities=23% Similarity=0.331 Sum_probs=198.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----Cce
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR 552 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (766)
...+.||+|+||.||+|.... .++.||||.+... .......+.+|+.++++++|+||+++++++... ...
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred eEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 345789999999999998764 4678999998643 233345678899999999999999999988654 347
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++|+||+. ++|.+++.....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 99999996 6899999887889999999999999999999994 5999999999999999999999999999987644
Q ss_pred CCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH--------HHhhc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF--------DCYRN 703 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~ 703 (766)
... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................ .....
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 KGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred Ccc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 321 1133457889999998865 468999999999999999999999996543211111000000 00000
Q ss_pred Cccceec-------cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 037189 704 GKLDALV-------GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVV 755 (766)
Q Consensus 704 ~~~~~~~-------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~ 755 (766)
......+ ..... ......+.++.+++.+||+.+|++|||++++++. ++.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000000 00000 0012346778999999999999999999999977 65544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.13 Aligned_cols=245 Identities=23% Similarity=0.288 Sum_probs=192.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHH-HccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .++.+|||.++.... .....+..|..+ ....+|+|++++++++..++..++|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEec
Confidence 569999999999998864 456899998864321 122334455444 4556899999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 150 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----- 150 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence 9999999999887788999999999999999999994 59999999999999999999999999998764331
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....++..|+|||.+.+..++.++||||||+++|||++|..||........ ......+... .....
T Consensus 151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~------~~~~~ 216 (260)
T cd05611 151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-------FDNILSRRIN------WPEEV 216 (260)
T ss_pred -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcccC------CCCcc
Confidence 234578899999999888899999999999999999999999975443221 1111111110 00111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
...++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1234678899999999999999998877666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=284.79 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=198.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||+|.... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred eEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 456789999999999999875 45678999986532 2345678899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 634 (766)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999998754 357899999999999999999994 5999999999999999885 46999999998765332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....|+..|+|||++.+..++.++||||||++++||++|+.|+....... ...... .+....
T Consensus 157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~------ 221 (257)
T cd08225 157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKIC-QGYFAP------ 221 (257)
T ss_pred cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHh-cccCCC------
Confidence 21 123458889999999988889999999999999999999999987543221 111111 111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..+.+++.+|++.+|++|||+.++++.
T Consensus 222 ---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 ---ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=286.34 Aligned_cols=243 Identities=28% Similarity=0.316 Sum_probs=193.0
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||+||++.... .++.+|+|.+.... ......+.+|++++++++||||+++++.+...+..++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCC
Confidence 6999999999998764 46689999886432 22345678899999999999999999999999999999999999
Q ss_pred CchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 562 GTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 562 gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--- 151 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--- 151 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence 99999997654 68889999999999999999995 59999999999999999999999999998865432211
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
....++..|+|||.+.+..++.++||||||+++++|++|+.||......... .......... ....+
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~----------~~~~~ 218 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLEM----------AVEYP 218 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhccccc----------cccCC
Confidence 2345788999999998888999999999999999999999999654321100 0001100000 11112
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
...+..+.+++.+||+.+|.+|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23467788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.51 Aligned_cols=267 Identities=22% Similarity=0.346 Sum_probs=196.6
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecC--C
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG--Q 550 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~ 550 (766)
...+.+.+.||+|+||.||+|.... .+..+|||++... .......+.+|+.+++++ +|+||+++++++... .
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 3456677899999999999998764 4578999988542 223345678899999999 999999999998654 3
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||++ ++|..++... .+++..+..++.||+.||+|||+ .+|+|+||||+||++++++.+||+|||++...
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 6799999997 5999988766 77888999999999999999994 59999999999999999999999999999876
Q ss_pred ccCCCc---ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHHH-------H
Q 037189 631 TLNQSK---TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDWA-------F 698 (766)
Q Consensus 631 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~-------~ 698 (766)
...... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 543321 11133468899999998765 46789999999999999999999999654322110 000000 0
Q ss_pred HHhhcCccceecc----Cccc--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 699 DCYRNGKLDALVG----GDME--AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 699 ~~~~~~~~~~~~~----~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..........+++ .... .......+.++.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 0000 00011246778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=297.81 Aligned_cols=273 Identities=22% Similarity=0.329 Sum_probs=198.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----Cce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (766)
+.+.+.||+|+||.||+|.... .+..||||.+.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4456789999999999998764 45789999986422 23345688999999999999999999987544 357
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++|+||+.+ +|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 999999975 77777643 468889999999999999999994 5999999999999999999999999999987543
Q ss_pred CCCcc-eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---ccc
Q 037189 633 NQSKT-IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---KLD 707 (766)
Q Consensus 633 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 707 (766)
..... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCCHHHHH
Confidence 22211 1123467899999998754 56899999999999999999999999654321110 0000000000 000
Q ss_pred eeccC---------cccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCC-CCCCC
Q 037189 708 ALVGG---------DMEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEV-SVPPN 762 (766)
Q Consensus 708 ~~~~~---------~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~-~~pp~ 762 (766)
.+.+. ...... ....+.++.+++.+||+.+|++|||+.++++. ++..... +.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccC
Confidence 00000 000000 01235678899999999999999999999987 6665433 34443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=286.11 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=195.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.++||+|++|.||+|+... .+..+|||.++.... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred eEeeeeccCCceEEEEEEECC---CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 456789999999999999864 467899999875433 2346778999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++ +|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 985 888887643 357899999999999999999994 5899999999999999999999999999976543221
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHH-------HHHHhhcCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDW-------AFDCYRNGKL 706 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~-------~~~~~~~~~~ 706 (766)
. .....++..|++||.+.+. .++.++||||||+++|+|++|+.||......+... .... .+..+. ..
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 231 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS--QL 231 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh--cC
Confidence 1 1234568899999988654 57889999999999999999999997554322111 0000 000000 00
Q ss_pred ceeccCccc------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDME------AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...... ....+..+..+.+++.+|++.||.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 00012335678899999999999999999998853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=285.63 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=192.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecC--CceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEG--QNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV 555 (766)
.+.++||+|+||.||+|.... .+..+|+|+++... ........+|+..+.++. |+||+++++++.+. +..++|
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred ceEeeccccccceEEEEEEcC---CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 356789999999999999764 45689999886532 222334567888888885 99999999999887 889999
Q ss_pred eeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+||++ ++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++. +.+||+|||+++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 99997 577777765 3568999999999999999999995 59999999999999999 999999999998765432
Q ss_pred CcceeecccccCccccccccc-CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHH-------HHHHHhhcCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTD-------WAFDCYRNGK 705 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~-------~~~~~~~~~~ 705 (766)
.. ....++..|+|||.+. +..++.++|||||||++|||++|..||......+.. .... .+........
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 21 2245788999999765 456789999999999999999999999754432211 0000 0000111111
Q ss_pred cceeccCcccC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDALVGGDMEA----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+.... ......+..+.+++.+||+.+|++||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 0012346889999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=287.47 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=194.8
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC---
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--- 550 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--- 550 (766)
...+.+.+.||+|+||.||+|.... .++.+|+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 3445567899999999999999874 45689999987543 223456788999999999999999999987654
Q ss_pred -------ceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 551 -------NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 551 -------~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
..++|+||+++ +|..++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 666666543 468899999999999999999995 599999999999999999999999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|||++.......... .....++..|+|||.+.+ ..++.++||||||++++||++|++||......+.... +....
T Consensus 159 dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~---~~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL---ISRLC 234 (302)
T ss_pred cccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHh
Confidence 999998765433211 122345778999998865 4578999999999999999999999975433221111 11111
Q ss_pred hcCc------ccee-----ccC------cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 702 RNGK------LDAL-----VGG------DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 702 ~~~~------~~~~-----~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.... +... .+. .... .....+..+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000 000 0000 011235778999999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=288.98 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=195.4
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
...++...+.||+|+||.||+|+... .+..+++|.+.... ....+++.+|+++++.++|+|++++++++.....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence 33445556789999999999999864 45689999886422 2234568899999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 552 RLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999999997 577777643 4567888999999999999999994 59999999999999999999999999998765
Q ss_pred ccCCCcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
... ....++..|+|||.+. ...++.++||||||+++|||++|+.|+........ ... +..+..
T Consensus 166 ~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~~- 231 (308)
T cd06634 166 APA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNES- 231 (308)
T ss_pred cCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-HhhcCC-
Confidence 432 2345788999999974 35678899999999999999999999864332111 111 111111
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
........+..+.+++.+||+.+|++||++.++++..
T Consensus 232 -------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 -------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1111224567788999999999999999999999774
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=279.57 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=202.0
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|++|.||+++... .++.+++|.+..... .....+.+|++++++++|+|++++++++.+....++++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 456789999999999998764 456899999876543 345679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999988788999999999999999999999 459999999999999999999999999999877654322
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....++..|+|||...+...+.++||||+|+++++|++|+.|+........ ..... .... ..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~-~~~~---------~~ 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIV-QDDH---------PP 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHh-ccCC---------CC
Confidence 1234578899999999888889999999999999999999999864332110 01111 0110 11
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12234577889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=272.13 Aligned_cols=281 Identities=22% Similarity=0.280 Sum_probs=201.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeec-CCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 554 (766)
++...+||+|.||.||||.-.+++.. .+.+|+|+++..... -.....+|+.+++.++||||+.|..++.. +...+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 44567899999999999976654422 358999999754322 23568899999999999999999999877 778899
Q ss_pred EeeccCCCchhhhhcc-----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC----CCeEEeccC
Q 037189 555 VYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH----YNARISDFG 625 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg 625 (766)
++||.++ +|.+.|+. ...++...+..|+.||+.|+.||| +.-|+||||||.|||+..+ |.+||+|+|
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999998 77777652 245778888999999999999999 4599999999999999877 999999999
Q ss_pred cccccccCCC-cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh------hHHHHH
Q 037189 626 LAKLLTLNQS-KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA------ILTDWA 697 (766)
Q Consensus 626 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~------~~~~~~ 697 (766)
+++.+...-. ......++-|.+|.|||.+.+. .|+.+.||||.|||+.||+|-.+.|......... +-...+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 9998764321 1122345679999999999875 6999999999999999999999988654321110 011111
Q ss_pred HHHhhcCcccee------------ccC-cccCCCc----------HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 698 FDCYRNGKLDAL------------VGG-DMEAMND----------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 698 ~~~~~~~~~~~~------------~~~-~~~~~~~----------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.+.+.....+.. +.. +...-.+ ..-+....+|+.++|+.||-+|.|+++.++.. -.
T Consensus 262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF 340 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YF 340 (438)
T ss_pred HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-cc
Confidence 111111000000 000 0000000 00122367889999999999999998887653 34
Q ss_pred cCCCCCCCCC
Q 037189 755 VEVSVPPNPY 764 (766)
Q Consensus 755 ~~~~~pp~p~ 764 (766)
.+-+.||.|.
T Consensus 341 ~~d~lpp~pt 350 (438)
T KOG0666|consen 341 TEDPLPPLPT 350 (438)
T ss_pred ccCCCCCCcc
Confidence 4556666664
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=280.95 Aligned_cols=245 Identities=27% Similarity=0.366 Sum_probs=201.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.++||+|+||.||+++... .+..+++|.+.... .....++.+|++++++++|+||+++.+++.+....++|+|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred eEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 456789999999999998764 45689999886532 2335578899999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 558 FLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 558 y~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+++++|.+++.. ...+++..+..++.|++.||+||| +.+++|+||+|+||++++++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999866 356788899999999999999999 559999999999999999999999999999876554
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
. .....++..|++||.+.+..++.++|+||||++++||++|+.||......+. ......+...
T Consensus 157 ~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~------ 219 (256)
T cd08530 157 M----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RYKVQRGKYP------ 219 (256)
T ss_pred C----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcCCCC------
Confidence 1 1234578899999999999999999999999999999999999975543221 1111111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.++.+++.+|++.+|++||++.++++.
T Consensus 220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 ---PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ---CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1123456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=282.00 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=196.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-----ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 551 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.+.... ......+.+|++++++++|+||+++++++.+. ..
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCE
Confidence 3456889999999999998764 46689999875321 22345788999999999999999999998664 45
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++++||+++++|.+++.....+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 78999999999999999877778889999999999999999994 599999999999999999999999999998654
Q ss_pred cCCC-cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQS-KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
.... ........++..|+|||++.+..++.++|+||||++++||++|+.||........ +......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~------- 224 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIATQ------- 224 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHHcC-------
Confidence 3211 1111234588999999999988899999999999999999999999975322110 1111111
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+....+.+.+++.+|++ +|.+||+..+++.+
T Consensus 225 --~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 --PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11112244456788999999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=311.26 Aligned_cols=267 Identities=19% Similarity=0.282 Sum_probs=183.8
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEE------------------EEeecccccCHHHHHHHHHHHccCCCC
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAV------------------KKLDIVFQDGEREFKNEVFVIGQTHHK 537 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vav------------------K~l~~~~~~~~~~f~~E~~~l~~l~H~ 537 (766)
...+.+.++||+|+||.||++..+... ....++ |++. ........+.+|+.++.+++|+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRAST--EEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccc--hhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 445667789999999999998765321 111111 1111 1122345688999999999999
Q ss_pred CeeeEeeeeecCCceEEEeeccCCCchhhhhccC-----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 538 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
||+++++++.+.+..++|+|++. ++|.+++... ..........|+.||+.||.|||+ .+|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99999999999999999999985 4677766432 122345567899999999999994 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcC-CCchhhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS-FDIEMVEEYA 691 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p-~~~~~~~~~~ 691 (766)
++.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.+ +.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999876543221 11345689999999999999999999999999999999998754 3322111111
Q ss_pred hHHHHH-----------------HHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 692 ILTDWA-----------------FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 692 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+.... +..+....+................+..+.+++.+||+.||.+|||+.|++++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 00000000000000000000001123456778999999999999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=278.39 Aligned_cols=255 Identities=22% Similarity=0.311 Sum_probs=208.2
Q ss_pred hhhhhccccccceEEEEEEecC--CCceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-CceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-QNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 555 (766)
..+..+-+|.||.||+|.+... ..+.+.|-||.++.. ++-....|+.|-.++..+.|||+..+.+++.++ ...+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 3445789999999999987642 223456777776532 233446688999999999999999999999654 578999
Q ss_pred eeccCCCchhhhhccC--------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 556 YEFLNNGTLASFLFGN--------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
|.++.-|+|..||... +.+...+...++.|++.|++||| +.+|+|.||..+|++||+..++||+|-.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999721 23455667789999999999999 559999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
|.+-+.+..........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+...
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~-------------- 509 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEH-------------- 509 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHH--------------
Confidence 98887777666555556889999999999999999999999999999999 999987655544211
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.+....+..++..|+++|..++.-||..+|++||++++++.-|.+
T Consensus 510 --ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 510 --YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred --HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 122233445577899999999999999999999999999998865
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=293.26 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=205.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
-+++...||.|+||.|||++.+. .+...|-|.+....+....+|+-||++|+..+||+||+|++.|..++...++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 35567789999999999999874 445677888887777778899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||.||-++..+-. ...+.+.++.-++.|++.||.||| +..|+|||||+.|||++-+|.++|+|||++...... .
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 9999999988754 567899999999999999999999 569999999999999999999999999998654321 1
Q ss_pred ceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 637 TIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.....+.||+.|||||+.. ..+|+.++||||||+.|.||.-+.+|....++-. .+ ...... .
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--Vl----lKiaKS-e------ 251 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VL----LKIAKS-E------ 251 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HH----HHHhhc-C------
Confidence 1124577999999999874 4689999999999999999999999976433211 11 111111 1
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+......+.+++.+||.+||..||++.+++++
T Consensus 252 -PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 -PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11223355677889999999999999999999998864
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=294.27 Aligned_cols=270 Identities=21% Similarity=0.283 Sum_probs=195.8
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------ceE
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------NRL 553 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 553 (766)
.+.||+|+||.||+|+... .+..+|||++.... ......+.+|+.++++++|+||+++++++.... ..+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred EEEeeecCCeEEEEEEeCC---CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 3679999999999998764 45689999886432 223456889999999999999999999986543 468
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+|+||+.. +|..++. ..+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 97 lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~ 170 (342)
T cd07879 97 LVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE 170 (342)
T ss_pred EEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence 99999975 6776652 357888999999999999999995 58999999999999999999999999998765322
Q ss_pred CCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH--------HHHHhhcC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW--------AFDCYRNG 704 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~ 704 (766)
. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. ........
T Consensus 171 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07879 171 M-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245 (342)
T ss_pred C-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence 1 23457889999999876 4688999999999999999999999976432211100000 00000000
Q ss_pred ccceeccC--c-ccCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCCCCCCC
Q 037189 705 KLDALVGG--D-MEAM---NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEVSVPPNPYP 765 (766)
Q Consensus 705 ~~~~~~~~--~-~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~~~pp~p~~ 765 (766)
........ . .... ..+.....+.+++.+||+.||.+||++.++++. ++...+.+..+.|.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~ 314 (342)
T cd07879 246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP 314 (342)
T ss_pred chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc
Confidence 00000000 0 0000 001234568899999999999999999999955 888776655554443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=271.53 Aligned_cols=267 Identities=23% Similarity=0.305 Sum_probs=210.8
Q ss_pred ccCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeee
Q 037189 468 CFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFC 546 (766)
Q Consensus 468 ~~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~ 546 (766)
+-+++++.+.|. +.||+|+|+.|--++... .+..+|||++++..........+|++++.+.+ |+||++|+.+|
T Consensus 72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF 145 (463)
T KOG0607|consen 72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF 145 (463)
T ss_pred cchHHHHHHhHH---HHhcCccceeeeeeeeec---cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence 345666666553 679999999998887654 56789999998887777889999999999985 99999999999
Q ss_pred ecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEec
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARISD 623 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 623 (766)
+++.+.|||||-|.+|+|..+|..+..+++.+..++..+|+.||.+|| ..+|.||||||+|||-..... +||+|
T Consensus 146 Edd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 146 EDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeec
Confidence 999999999999999999999999999999999999999999999999 569999999999999975544 89999
Q ss_pred cCcccccccCCCcc-----eeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh----
Q 037189 624 FGLAKLLTLNQSKT-----IKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE---- 689 (766)
Q Consensus 624 fgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~---- 689 (766)
|.+..-+....... .....+|+..|||||+.. ...|+.+.|.||||||||-|++|.+||......+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 99887554322211 113457889999999873 3358899999999999999999999997543321
Q ss_pred ----hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 690 ----YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 690 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
-..=.+.+++.+.+|..+. ....-...+.+..+++...+..++.+|-++.++++
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeF------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEF------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcC------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1111223333344443321 01112345677888999999999999999999887
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=291.87 Aligned_cols=261 Identities=22% Similarity=0.257 Sum_probs=195.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--------------HHHHHHHHHHHccCCCCCeeeEeeee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--------------EREFKNEVFVIGQTHHKNLVRLLGFC 546 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (766)
+.+.||+|+||.||+|.... .++.+|||.++...... ...+.+|++++++++|+||+++++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY 89 (335)
T ss_pred hhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence 34679999999999998764 46789999886432221 12578999999999999999999999
Q ss_pred ecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
..++..++||||+. ++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 90 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 90 VEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred ecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999997 6999999887788999999999999999999994 5999999999999999999999999999
Q ss_pred ccccccCCC------------cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhH
Q 037189 627 AKLLTLNQS------------KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAIL 693 (766)
Q Consensus 627 a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~ 693 (766)
+........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-- 243 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL-- 243 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 986651110 0111223467889999998764 4689999999999999999999999765432211
Q ss_pred HHHHHHHhhcCccc---eec-----cC---ccc---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 694 TDWAFDCYRNGKLD---ALV-----GG---DME---AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 694 ~~~~~~~~~~~~~~---~~~-----~~---~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..+.......... ... .+ ... .......+.++.+++.+||+.+|++||++.+++..-
T Consensus 244 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 244 -GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred -HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 1111111100000 000 00 000 000112356788999999999999999999999743
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=281.60 Aligned_cols=243 Identities=24% Similarity=0.257 Sum_probs=189.6
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHH---HHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEV---FVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~---~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.||+|+||.||++.... .++.+|+|.+..... .....+..|. +.++..+||||+++.+++.+.+..++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe
Confidence 48999999999998764 466899998864321 1222344443 34455679999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 99999999999887889999999999999999999995 5899999999999999999999999999876543221
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........... ....... ..
T Consensus 153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~----------~~ 216 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM----------AV 216 (278)
T ss_pred --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc----------CC
Confidence 234689999999999754 689999999999999999999999975432111110 0000000 01
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+.++.+++.+|++.+|.+|| ++.++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11223467889999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=293.23 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=193.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------C
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------Q 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 550 (766)
+...+.||+|+||.||+|.... .+..+|||.+... .......+.+|+.++++++|+||+++++++... .
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4455789999999999998764 4678999988642 223345688899999999999999999988543 3
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+.+ +|.+.+... ++...+..++.|++.||+|||. .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 57999999964 888877544 7888889999999999999995 59999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHH--------------
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTD-------------- 695 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~-------------- 695 (766)
..... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..+..
T Consensus 169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 169 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 43322 1234578899999999999999999999999999999999999965432110 00000
Q ss_pred -HHHHHhhcCc------cceeccCcc----cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 696 -WAFDCYRNGK------LDALVGGDM----EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 696 -~~~~~~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......... ...+..... ........+..+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000000000 000112346678899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=288.33 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=192.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+.+.++||+|+||.||+|.... .+..+|||.+.... ......+.+|++++++++||||++++++|....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4556789999999999998764 46789999886432 222345678999999999999999999986654
Q ss_pred --ceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 551 --NRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 551 --~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
..++||||+.+ +|.+++... ..+++..+..++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 777777654 367899999999999999999995 49999999999999999999999999999
Q ss_pred cccccCCCc--ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 628 KLLTLNQSK--TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 628 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
......... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.....................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 876443221 111234578899999988764 47889999999999999999999997654432222211111100000
Q ss_pred cccee-----------ccCccc----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 KLDAL-----------VGGDME----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ~~~~~-----------~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..... ...... ..........+.+++.+||+.||++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000 000000 00000123466789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=288.48 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=191.8
Q ss_pred hhcccc--ccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 483 EEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G--~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
++||+| +||+||+++... .++.||||.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence 467777 889999998754 46799999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+.+++|.+++... ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++||+.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 9999999998764 35788888899999999999999 459999999999999999999999999865433221110
Q ss_pred -ce----eecccccCcccccccccCC--CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH----------
Q 037189 637 -TI----KTSIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD---------- 699 (766)
Q Consensus 637 -~~----~~~~~gt~~y~aPE~~~~~--~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---------- 699 (766)
.. .....++..|+|||++.+. .++.++||||||++++||++|+.||......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~ 235 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITT 235 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccc
Confidence 00 0112345679999999764 4789999999999999999999999754321110 000000
Q ss_pred ------Hh----------------hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 ------CY----------------RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ------~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.. ....................+...+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 0000001111111222234567789999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=286.75 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=190.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCc----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQN---- 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~---- 551 (766)
+...+.||+|+||.||+|.... .++.||||.++... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred ceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 3455789999999999999864 46789999876532 223467889999999995 6999999999877665
Q ss_pred -eEEEeeccCCCchhhhhccC-----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEecc
Q 037189 552 -RLLVYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDF 624 (766)
Q Consensus 552 -~~lV~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Df 624 (766)
.++||||+++ +|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeec
Confidence 7999999986 788887542 356889999999999999999994 59999999999999998 899999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
|+++........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......... .. +......
T Consensus 156 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~~~ 230 (295)
T cd07837 156 GLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLLGT 230 (295)
T ss_pred ccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHhCC
Confidence 998865432111 122346788999998865 45789999999999999999999999654322110 00 0010000
Q ss_pred Cccc---ee---cc----Cccc----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLD---AL---VG----GDME----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~---~~---~~----~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.... .. .. +... ....+..+.++.+++.+||+.||.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00 00 0000 00012346778999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=289.66 Aligned_cols=265 Identities=21% Similarity=0.284 Sum_probs=193.3
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (766)
.+.++||+|+||.||+|..... ..+..+|+|.+.... ......+.+|+.++++++||||+++++++.+. ...++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4567899999999999998642 146789999987632 33446788999999999999999999999888 78999
Q ss_pred EeeccCCCchhhhhccC-----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC----CCCeEEeccC
Q 037189 555 VYEFLNNGTLASFLFGN-----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD----HYNARISDFG 625 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg 625 (766)
||||+++ +|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999986 566655321 25778889999999999999999 459999999999999999 9999999999
Q ss_pred cccccccCCCc-ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhh-------hhhHHHH
Q 037189 626 LAKLLTLNQSK-TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-------YAILTDW 696 (766)
Q Consensus 626 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~-------~~~~~~~ 696 (766)
++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||....... ...+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 99876543221 111234678899999988764 57899999999999999999999997543321 0001110
Q ss_pred HHHHhhc------------CccceeccCcccCCCc---------H--HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 697 AFDCYRN------------GKLDALVGGDMEAMND---------V--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 697 ~~~~~~~------------~~~~~~~~~~~~~~~~---------~--~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+ ..... .......+.......+ . ....++.+++.+||+.||++|||+.+++++
T Consensus 238 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 F-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred H-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 00000 0000000000000000 0 234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=284.17 Aligned_cols=254 Identities=22% Similarity=0.251 Sum_probs=197.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.||+|+||.||++........+..+|+|.+.... ....+.+.+|++++.++ +|+||+++.+.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 35678999999999999876544467889999986432 12346688999999999 59999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++++|.+++.....+++.....++.|+++||.|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 83 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 83 ILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 99999999999999887788889999999999999999994 599999999999999999999999999998764432
Q ss_pred CcceeecccccCcccccccccCC--CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... .....|+..|+|||.+.+. ..+.++||||||+++|+|++|+.|+....... .............
T Consensus 160 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~-------- 228 (290)
T cd05613 160 VER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE-------- 228 (290)
T ss_pred ccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC--------
Confidence 221 1234588899999998753 46789999999999999999999986432111 0111111111100
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
...+......+.+++.+|++.+|++|| ++.+++..
T Consensus 229 ---~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ---PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 011223456788999999999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=292.40 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=205.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|.|+.|.+|++.. .+..||||.++...... ...+.+|+++|..++|||||+++.+.......++||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred eeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 3456789999999999999886 46799999997654333 245899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+.+|.+.+|+....+..+.....++.|+..+++||| +..|+|||||++||||+.+.++||+|||++..+..+..
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~- 210 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM- 210 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccccc-
Confidence 99999999999999888888899999999999999999 45999999999999999999999999999998874432
Q ss_pred ceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....+|++.|.|||++.+..+ .+++|+||+|++||-|+.|..||+.....+.+. ..+.+.++
T Consensus 211 --lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk~r 273 (596)
T KOG0586|consen 211 --LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGKYR 273 (596)
T ss_pred --ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeeeec
Confidence 256789999999999998876 478999999999999999999998655432110 01111122
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. +.-...++.++++++|..+|.+|++++++.+.
T Consensus 274 I--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 I--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred c--cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1 22234567789999999999999999998754
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=288.27 Aligned_cols=260 Identities=26% Similarity=0.298 Sum_probs=192.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (766)
+++.+.||+|+||.||+|.... .+..||+|.++..... ....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4456789999999999999864 4568999998643322 234567899999999999999999998655 46899
Q ss_pred EeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+.+ +|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 78888765 3568899999999999999999995 58999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC--c----c
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG--K----L 706 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~----~ 706 (766)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ........ . .
T Consensus 162 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 162 AKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPGF 236 (309)
T ss_pred cCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchhh
Confidence 211 122345788999999865 4578999999999999999999999975543221111 00100000 0 0
Q ss_pred ------cee-ccCc-ccC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 ------DAL-VGGD-MEA--MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ------~~~-~~~~-~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
... .... ... ......+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 0000 000 0001135677899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=292.63 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=204.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-----c
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----N 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 551 (766)
+.+.+.||+|++|.||+|+... .+..++||++.... ....+.+.+|+.++++++|+||+++++++.... .
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence 3456789999999999999764 36789999987543 334567999999999999999999999997775 7
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++||||+++ +|.+++.....+++..++.++.|+++||+|||+ .+|+|+||||+||+++.++.++|+|||++....
T Consensus 79 ~~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 79 VYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred eEEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 8999999984 899999887789999999999999999999994 599999999999999999999999999998765
Q ss_pred cCCCc-ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh-------
Q 037189 632 LNQSK-TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR------- 702 (766)
Q Consensus 632 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 702 (766)
..... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+.... +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCChhHh
Confidence 44210 111334578899999999887 889999999999999999999999976543221110 000000
Q ss_pred ----cCccceeccC-ccc-----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcC
Q 037189 703 ----NGKLDALVGG-DME-----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVE 756 (766)
Q Consensus 703 ----~~~~~~~~~~-~~~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~ 756 (766)
.......+.. ... .......+..+.+++.+||+.+|++||++.++++. ++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000000 000 00011245678999999999999999999999985 665543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=293.35 Aligned_cols=265 Identities=22% Similarity=0.331 Sum_probs=196.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec----CCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~ 552 (766)
+.+.+.||+|+||.||+|.... .+..+|+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3455789999999999998764 46689999986532 2335678889999999999999999998753 3467
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++||||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 99999996 6899999877779999999999999999999995 5999999999999999999999999999986643
Q ss_pred CCCc--ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH--------HHHHh
Q 037189 633 NQSK--TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW--------AFDCY 701 (766)
Q Consensus 633 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~ 701 (766)
.... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 3221 11123468889999999865 4688999999999999999999999965432211100000 00000
Q ss_pred hcCccceeccCc-ccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 702 RNGKLDALVGGD-MEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 702 ~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+.+....+.. ..... ....+..+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000010000000 00000 12246789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=277.39 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=202.3
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||++.... .+..+++|.+..... ...+++.+|++++++++|+|++++++.+......++|+|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 345789999999999999864 457899999875433 445678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 558 FLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 558 y~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999999763 678899999999999999999995 49999999999999999999999999999876544
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|+....... .... ........
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~----- 222 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALK-ILKGQYPP----- 222 (258)
T ss_pred cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHH-HhcCCCCC-----
Confidence 31 1233468889999999998899999999999999999999999986543221 1111 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 223 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 223 ----IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122345778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=280.64 Aligned_cols=240 Identities=28% Similarity=0.302 Sum_probs=199.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeec---ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI---VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||+||||.||-.+... .++.+|.|++.. ....++.-.++|-.+|.+++.+.||.+--.++..+..+||+..|
T Consensus 191 RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRA---TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred EEEecccccceeEEEEec---chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEee
Confidence 579999999999998875 567889998854 23455667899999999999999999999999999999999999
Q ss_pred CCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 560 NNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 560 ~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
.+|+|.-+|.+.. .+++....-.+.+|+.||++||+ ..||.|||||+|||||+.|+++|+|+|+|..+..++..
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcc-
Confidence 9999999998765 67888889999999999999995 49999999999999999999999999999988876654
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
....||.+|||||++.++.|+...|.||+||+||||+.|+.||.......... .+.+...+. ...
T Consensus 344 --~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~~----------~~e 408 (591)
T KOG0986|consen 344 --RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLED----------PEE 408 (591)
T ss_pred --ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhcc----------hhh
Confidence 45689999999999999999999999999999999999999997543322110 011111111 112
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
.+...+++..+|....|++||.+|--.
T Consensus 409 y~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 409 YSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccccCHHHHHHHHHHHccCHHHhccC
Confidence 345567888888889999999998643
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.73 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=191.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|++|.||+|.... .++.+|+|++..... ...+.+.+|++++++++|+||+++++++......++||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 3456789999999999999764 456899998864322 23467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCC--CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCcccccccC
Q 037189 557 EFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTLN 633 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 633 (766)
||++ ++|.+++..... .++.....++.||+.||+|||+ .+++|+||+|+||+++. +..+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 578887755433 4677778899999999999995 59999999999999985 567999999999765432
Q ss_pred CCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc------
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL------ 706 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 706 (766)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+.. .. ..........
T Consensus 157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~-~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FK-IFRILGTPNEETWPGV 231 (294)
T ss_pred ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCChhhcccc
Confidence 111 123456889999998876 45789999999999999999999999754332110 00 0110000000
Q ss_pred ceecc-----CcccC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVG-----GDMEA----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~-----~~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+.+ +.... ......+.++.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00000 0012235678899999999999999999999863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=277.55 Aligned_cols=239 Identities=20% Similarity=0.245 Sum_probs=185.6
Q ss_pred hhhh--ccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~--LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+. ||+|+||.||++.... .+..+|+|.+....... . |+..... .+|+||+++++.+...+..++|||
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred cccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3444 5999999999998764 45678888876432111 1 2222222 279999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++.....+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||++......
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 99999999999887788999999999999999999995 5899999999999999988 9999999998765432
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
....++..|+|||++.+..++.++||||||++++||++|+.||....... .....+.... ... .
T Consensus 164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~----------~ 227 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QKK----------L 227 (267)
T ss_pred ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--ccc----------C
Confidence 22457889999999999899999999999999999999999997433221 1111111110 100 0
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPT-IKKVLQ 749 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~ 749 (766)
......+..+.+++.+||+.+|.+||+ ++++++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 112245678899999999999999996 688874
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=281.01 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=194.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|++|.||+|+... .++.++||++...... ......+|+..+.+++ |+||+++++++.+++..++|||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred eeheeeccCCceEEEEEEECC---CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 456789999999999999864 3568999998654322 2334567999999999 9999999999999999999999
Q ss_pred ccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+ +++|.+++.... .+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 889999887654 78999999999999999999995 5999999999999999999999999999986643322
Q ss_pred cceeecccccCccccccccc-CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHH---------HHHHHHhhcC
Q 037189 636 KTIKTSIRGTKGYVAPEWFR-NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILT---------DWAFDCYRNG 704 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~---------~~~~~~~~~~ 704 (766)
. ....++..|+|||.+. +..++.++|+||||++++||++|+.||......+.. ... .|........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1 2345788999999885 456789999999999999999999998654322110 000 0100000000
Q ss_pred ccceeccCcccC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 KLDALVGGDMEA---MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ~~~~~~~~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
............ .........+.+++.+||+.+|++|||++|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 111000000000 0001124678899999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=284.70 Aligned_cols=241 Identities=26% Similarity=0.354 Sum_probs=190.1
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.++||+|+||.||+|+... .+..+++|.+...... ....+.+|++++++++|||++++++++.+....++||||
T Consensus 26 ~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred ceeeccCCCeEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 4679999999999998754 4678999998643322 235688999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+. ++|.+++.. ...+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~---- 174 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA---- 174 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC----
Confidence 96 467776654 4568899999999999999999994 59999999999999999999999999998643221
Q ss_pred eeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 638 IKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....++..|+|||++. ...++.++||||||+++|||++|..|+........ ........ ..
T Consensus 175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~-~~------- 238 (313)
T cd06633 175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND-SP------- 238 (313)
T ss_pred --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-CC-------
Confidence 2346788999999984 45688999999999999999999999865432111 11111111 10
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+..+.+++.+||+.+|.+||++.++++.
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 -TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122234568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=283.20 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=198.1
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
..+.||+|++|.||++.... ++..+++|.+...... ....+.+|++++++++|+||+++++++..+...++|+||
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred cceeeecCCCceEEEEEcCC---CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 45789999999999999764 4678999988654322 356788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++ +|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||||+||++++++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--
Confidence 986 888877653 578899999999999999999995 5999999999999999999999999999987765431
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---ccce-----
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---KLDA----- 708 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~----- 708 (766)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+... ......... ....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF---KIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCchHhcccchhhh
Confidence 11234578889999998876 78999999999999999999999996544322100 000000000 0000
Q ss_pred ------eccCccc--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 ------LVGGDME--AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ------~~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....... .......+.++.+++.+||+.||.+||++.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000 01123456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.69 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=191.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .+..+|||.++... .....++..|+.++.+.. |+||+++++++.+....++||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred heeeeEeeccCCeEEEEEEECC---CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4567899999999999999864 36789999987543 223456777887776665 999999999999999999999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+.+ +|.+++.. ...+++..+..++.|+++||+|||+ ..+|+||||+|+||++++++.+||+|||++..+.....
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 99864 66666554 3567889999999999999999995 24899999999999999999999999999887643322
Q ss_pred cceeecccccCcccccccccCCC----CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ..+ ...... ....
T Consensus 171 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~----~~~~~~-~~~~--- 238 (296)
T cd06618 171 K---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVL----TKILQE-EPPS--- 238 (296)
T ss_pred c---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHH----HHHhcC-CCCC---
Confidence 2 2234778999999987654 7889999999999999999999996532211 011 111111 1000
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+++++.+++.+||+.||++||++.+++++
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00111245678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=279.79 Aligned_cols=258 Identities=26% Similarity=0.326 Sum_probs=192.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccC---CCCCeeeEeeeeecCCc---
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQT---HHKNLVRLLGFCDEGQN--- 551 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~--- 551 (766)
++.+.||+|+||.||+|+... .+..+|+|.++..... ....+.+|+.++.++ +|+||+++++++...+.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred eEEEEecccCceEEEEEEECC---CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 345789999999999999864 4678999998743222 234566787766555 69999999999988776
Q ss_pred --eEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 552 --RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 552 --~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
.+++|||+.+ +|.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 898888654 357899999999999999999995 58999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
......... ....++..|+|||.+.+..++.++||||||+++|||++|++||......+. ...............
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHh
Confidence 876443221 233478899999999999999999999999999999999999876543221 111111000000000
Q ss_pred ---------eeccCccc---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 ---------ALVGGDME---AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 ---------~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........ ..........+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011234577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=261.22 Aligned_cols=248 Identities=23% Similarity=0.359 Sum_probs=193.7
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+...||.|..|.|++..... .+..+|||.+...... ..+.++..+.++.+-+ +|.||+.+|+|..+....+.||.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred hHHhhcCCCccceEEEEEcc---cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 55789999999999999874 5689999999764433 3467788888777765 89999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|.- .++..+.. ...+++...-++...+++||.||.+ ..+|+|||+||+|||+|+.|++|++|||++.++......
T Consensus 173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 853 34444433 3457888888999999999999987 569999999999999999999999999999887655433
Q ss_pred eeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 638 IKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
+...|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.....+-. .+ ..+.++.. ..+.
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~l-----tkvln~eP-P~L~--- 316 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VL-----TKVLNEEP-PLLP--- 316 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HH-----HHHHhcCC-CCCC---
Confidence 34568889999999963 4688999999999999999999999987544221 11 11111111 1111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....++..+.+++..||++|+.+||...+++++
T Consensus 317 ---~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 ---GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 122267888999999999999999999888754
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=282.46 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=200.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||++.... .+..+++|.+... .....+.+.+|++++.+++ |+||+++++++...+..++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence 3456789999999999999864 4678999988642 2233467889999999998 9999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++++|.+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999999888789999999999999999999995 599999999999999999999999999998665432
Q ss_pred Cc------------------ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH
Q 037189 635 SK------------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 635 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 696 (766)
.. .......++..|+|||.+.+..++.++||||||++++++++|+.|+....... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~--- 231 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF--- 231 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH---
Confidence 11 11123457889999999998889999999999999999999999997544211 11
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTI----KKVLQ 749 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~----~~vl~ 749 (766)
.... . .....+...++.+.+++.+||+.+|.+||++ +++++
T Consensus 232 -~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 -QKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 0 0111123346778999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=282.82 Aligned_cols=260 Identities=17% Similarity=0.188 Sum_probs=191.0
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+|.|+++.||++.. .++.+|||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 6 i~~~~~~~~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred hhHhhcCCceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 344555555655555543 4678999998754 233456899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+++++|.+++... ..+++.....++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 9999999999753 457888889999999999999995 59999999999999999999999999988755432111
Q ss_pred -----ceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh----hc--
Q 037189 637 -----TIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY----RN-- 703 (766)
Q Consensus 637 -----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~-- 703 (766)
.......++..|+|||++.. ..++.++||||||+++|||++|+.||........ ..+...... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCc
Confidence 11123456788999999876 3588999999999999999999999975432111 111000000 00
Q ss_pred -----Cccce----ecc----CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 -----GKLDA----LVG----GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 -----~~~~~----~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..... ..+ .............++.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00000 000 001111223456778899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=277.28 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=194.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||++...........+++|.+... ......++..|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 34668899999999999988654333334444444322 1223446778999999999999999999999999999999
Q ss_pred eccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 557 EFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 557 Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++|+||+|+||++++ +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998853 3568899999999999999999995 59999999999999975 5699999999887644
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+....... .... ...+.
T Consensus 158 ~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~------~~~~-~~~~~------- 221 (260)
T cd08222 158 SCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS------VVLR-IVEGP------- 221 (260)
T ss_pred Cccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHH-HHcCC-------
Confidence 3221 123457889999999988889999999999999999999999986433211 0111 11111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+...+.++.+++.+||+.+|++||++.++++.
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111234556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=302.00 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=187.9
Q ss_pred HHHhhh--hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeee------
Q 037189 477 ATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCD------ 547 (766)
Q Consensus 477 ~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~------ 547 (766)
--.+|. +.||+||||.|||++.+- +++.+|||++.... ........+|++++++++|||||+++....
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 334555 479999999999999875 68899999997653 223356889999999999999999885300
Q ss_pred ------------------------------------------------------------------------c-------
Q 037189 548 ------------------------------------------------------------------------E------- 548 (766)
Q Consensus 548 ------------------------------------------------------------------------~------- 548 (766)
+
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred --------------------------C--------CceEEEeeccCCCchhhhhccCCCC-ccchhhhHHHHHHHHHHHh
Q 037189 549 --------------------------G--------QNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYL 593 (766)
Q Consensus 549 --------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~l-~~~~~~~i~~~ia~gL~yL 593 (766)
+ ...||-||||+.-+|.+++..+... .....++++.+|++||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1236778999998888888766544 4667889999999999999
Q ss_pred hhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc----------------CCCcceeecccccCcccccccccCC
Q 037189 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL----------------NQSKTIKTSIRGTKGYVAPEWFRNS 657 (766)
Q Consensus 594 H~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~~ 657 (766)
|+ .+||||||||.||+++++..+||+|||++..... +......+...||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 95 5899999999999999999999999999987320 0111123567899999999999765
Q ss_pred ---CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHcc
Q 037189 658 ---KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCI 734 (766)
Q Consensus 658 ---~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl 734 (766)
+|+.|+|+||+|+||+||+. ||...++-. .+...++.+.+..- ..........-..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999986 465443211 12233344443221 1111222334467999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 037189 735 QEDPSLRPTIKKVLQM 750 (766)
Q Consensus 735 ~~dp~~RPt~~~vl~~ 750 (766)
+.||.+|||+.|+++.
T Consensus 856 ~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLNS 871 (1351)
T ss_pred cCCCccCCCHHHHhhc
Confidence 9999999999999864
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-33 Score=314.47 Aligned_cols=246 Identities=28% Similarity=0.378 Sum_probs=200.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
..||.|.||.||-+.... .+...|+|-++.... ...+...+|+.++..++|||+|+++|+-.+.+..+|.||||+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred cccCCcceeeeEEeecCC---ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhc
Confidence 469999999999999875 456788887765433 334568899999999999999999999999999999999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC--cce
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS--KTI 638 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~ 638 (766)
+|+|.+.+......++.....+..|++.|++|||++ +||||||||.||+|+.+|-+|++|||.|..+..... ...
T Consensus 1318 ~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1318 GGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred cCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 999999999888888888888999999999999954 999999999999999999999999999998865421 111
Q ss_pred eecccccCcccccccccCCC---CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH-HHhhcCccceeccCcc
Q 037189 639 KTSIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF-DCYRNGKLDALVGGDM 714 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~---~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 714 (766)
.....||+.|||||++.+.. ...+.||||+|||+.||+||++||...+. +|.. -.+..|...
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~V~~gh~P------- 1460 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYHVAAGHKP------- 1460 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhHHhccCCC-------
Confidence 13567999999999997643 45689999999999999999999964321 1211 122222222
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.+-.+++..||+.||.+|-++.|++++
T Consensus 1461 --q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 --QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2244467788899999999999999998877765
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=278.77 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=197.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.||+|++|.||+|+... .+..+++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred eehcccccCcceEEEeeecC---CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 45789999999999999874 36789999987643 33346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
++ ++|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||+++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-
Confidence 98 5899999876 578999999999999999999995 49999999999999999999999999999876543221
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHH-------HHHHhh-----c
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDW-------AFDCYR-----N 703 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~~-----~ 703 (766)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+.. .+... .+.... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 1223457789999998776 7899999999999999999999999764432111 00000 000000 0
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
............ ...+.....+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000 001122567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=289.38 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=190.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC---------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------- 549 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------- 549 (766)
+.+.+.||.|+||.||+|.... .++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4456789999999999998764 4678999998766656667899999999999999999999876543
Q ss_pred -----CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEec
Q 037189 550 -----QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISD 623 (766)
Q Consensus 550 -----~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~D 623 (766)
...++|+||++ ++|.+++.. ..+++.....++.||++||.|||+ .+++||||||+||+++ ++..+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 589888754 357889999999999999999995 5999999999999997 556789999
Q ss_pred cCcccccccCCCcc-eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHH----
Q 037189 624 FGLAKLLTLNQSKT-IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDW---- 696 (766)
Q Consensus 624 fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~---- 696 (766)
||+++.+....... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+... ....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99998654321111 1122357889999998754 568889999999999999999999996543211100 0000
Q ss_pred ---HHHHhhcCccceeccCcccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 697 ---AFDCYRNGKLDALVGGDMEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 697 ---~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...................... ......++.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000000000000000000 1123467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.79 Aligned_cols=264 Identities=23% Similarity=0.284 Sum_probs=191.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecC----Cce
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG----QNR 552 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~~ 552 (766)
.+.+.||+|+||.||++...... .+..+|+|++.... ....+.+.+|++++.++ +||||+++++++... ...
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETS-EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCC-cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 45678999999999999986431 25689999886432 22346788999999998 599999999976432 356
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++++||+. ++|.+++.....+++..+..++.||++||.|||+ .+++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 78889886 6899999888889999999999999999999994 5999999999999999999999999999986653
Q ss_pred CCCc--ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhH-H--------HHHHHH
Q 037189 633 NQSK--TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAIL-T--------DWAFDC 700 (766)
Q Consensus 633 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~-~--------~~~~~~ 700 (766)
.... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... . ......
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 11123468999999998765 4689999999999999999999999975432111000 0 000000
Q ss_pred hhcC------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 701 YRNG------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 701 ~~~~------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.... ........... .........+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 00000000000 000112467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=288.32 Aligned_cols=274 Identities=23% Similarity=0.271 Sum_probs=197.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+...+.||+|+||.||++.... .+..||||++.... ......+.+|++++++++|+||+++++++..+.
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3345789999999999998764 46789999885422 222356889999999999999999999986554
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 358999998 6789888764 468899999999999999999994 59999999999999999999999999999865
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHH-------HHHHHh
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTD-------WAFDCY 701 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~-------~~~~~~ 701 (766)
.... ....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||........ ..... .....+
T Consensus 169 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 169 DSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred ccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 4321 23457889999999876 4588999999999999999999999975432110 00000 000000
Q ss_pred hcCccceeccC--ccc----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHHhcCcCCCCCCCCCC
Q 037189 702 RNGKLDALVGG--DME----AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL--QMLEGVVEVSVPPNPYP 765 (766)
Q Consensus 702 ~~~~~~~~~~~--~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl--~~Le~~~~~~~pp~p~~ 765 (766)
........... ... ..........+.+++.+|++.||.+|||+.+++ ..++...+.+..+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~ 315 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPP 315 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCC
Confidence 00000000000 000 000112345688999999999999999999999 45555555444444433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=283.40 Aligned_cols=264 Identities=22% Similarity=0.256 Sum_probs=189.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+.+.++||+|+||.||+|.... .+..+|||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4456789999999999999764 456799998864322 22346789999999999999999999875433
Q ss_pred --ceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 551 --NRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 551 --~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
..++|+||+.. +|...+.. ...+++..+..++.|+++||.||| +.+++|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence 45899999976 56666554 457899999999999999999999 459999999999999999999999999999
Q ss_pred cccccCCCcc---------eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH
Q 037189 628 KLLTLNQSKT---------IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA 697 (766)
Q Consensus 628 ~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 697 (766)
+......... ..+...+++.|+|||.+.+. .++.++||||||+++|||++|++||...............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 8664332111 11233568889999987654 5889999999999999999999999754432211110000
Q ss_pred HHHhhc------Cccceec----cCcccCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 698 FDCYRN------GKLDALV----GGDMEAM---NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 698 ~~~~~~------~~~~~~~----~~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...... ..+.... ....... ........+.+++.+||+.+|.+|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0000000 0000000 00122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=271.92 Aligned_cols=237 Identities=27% Similarity=0.279 Sum_probs=194.2
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
||+|+||.||++.... .+..+++|.+..... .....+.+|+.++++++|+||+++++.+..+...++||||+++
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCC
Confidence 6999999999999864 456899998865332 2345789999999999999999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
++|.+++.....+++.....++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT 152 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence 9999999888788999999999999999999995 5999999999999999999999999999987654321 1134
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
..++..|++||.+.+...+.++|+||||+++|||++|+.||....... .. .. ..... ...+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~---~~-~~~~~----------~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IY---EK-ILKDP----------LRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HH---HH-HhcCC----------CCCCCC
Confidence 567889999999998889999999999999999999999996543211 11 11 11111 111222
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
.+..+.+++.+||+.||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3677889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=239.03 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=199.2
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
-.|+||+|.||+||||+... ....||+|+++... +.-.....+|+-+++.++|+|||++++....+....+|+||
T Consensus 6 kmekigegtygtvfkarn~~---t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred HHHhhcCCcceeeEecccCC---ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 34789999999999999875 56789999987543 33356789999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|.. +|..|..+ ++.++.+....++.|+++||.++| +..+.||||||+|.||+.+|+.|++|||+++.+.-....
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvrc- 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC- 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-
Confidence 965 77777754 467888899999999999999999 559999999999999999999999999999987643221
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCc---cceeccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGK---LDALVGG 712 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 712 (766)
.....-|.+|.+|.++.+. -++...|+||-|||+.|+.. |++.|.....++.....-|......++. +..+.|-
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy 236 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY 236 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence 1334568999999999876 48999999999999999988 7777766655443332223222222221 2222222
Q ss_pred cccCCCc---------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMND---------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~---------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+ +.....=++++...+.-+|..|.++++.++.
T Consensus 237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222 1222334678888888899999999988764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=284.16 Aligned_cols=266 Identities=23% Similarity=0.289 Sum_probs=191.6
Q ss_pred HHHHHHHHhh--hhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeee
Q 037189 472 KELEEATDNF--KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCD 547 (766)
Q Consensus 472 ~~l~~~t~~f--~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 547 (766)
.++...+.+| .+.||+|+||.||+|.... .+..||+|++.... ....+.+.+|+.++.+++|+||+++++++.
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 3444444444 4679999999999998764 46789999986432 223456889999999999999999999885
Q ss_pred cC------CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEE
Q 037189 548 EG------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 548 ~~------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEE
Confidence 43 3467888876 77998877654 58899999999999999999995 59999999999999999999999
Q ss_pred eccCcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHH----
Q 037189 622 SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTD---- 695 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~---- 695 (766)
+|||+++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... ...
T Consensus 162 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred ecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999987643221 23457889999999876 568899999999999999999999996433211100 000
Q ss_pred ---HHHHHhhcCccceec---cCcccCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 696 ---WAFDCYRNGKLDALV---GGDMEAM---NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 696 ---~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+........+ ....... .......++.+++.+|++.||.+||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000000000 0000000 000134568899999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=286.76 Aligned_cols=197 Identities=30% Similarity=0.440 Sum_probs=169.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------ceE
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------NRL 553 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~ 553 (766)
-.+.||+|+||.||+|+++. .+..||||..+.... ...+...+|+++|++++|+|||++++.-++.. ...
T Consensus 17 ~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ehhhhcCCccceeeeecccc---cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35789999999999999875 678999999876443 33456789999999999999999999876544 568
Q ss_pred EEeeccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCC--CeEEeccCc
Q 037189 554 LVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHY--NARISDFGL 626 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgl 626 (766)
+|||||.+|||...|.+. ..+++...+.++.++..||.|||++ +|+||||||.||++- .++ ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999764 4689999999999999999999965 999999999999983 334 379999999
Q ss_pred ccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchh
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEM 686 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~ 686 (766)
|+.+..+. ......||..|++||.+.. +.++..+|.|||||++|+.+||..||....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99887665 3367889999999999994 889999999999999999999999997543
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=278.20 Aligned_cols=258 Identities=24% Similarity=0.304 Sum_probs=190.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeec-CCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~ 556 (766)
.+.+.||+|+||.||++.... .+..+|||++... .....+.+.+|++++.+++||||+++.+++.. ....++|+
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred EEEEeecccCCeEEEEEEECC---CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 345789999999999998764 4678999987532 22345678899999999999999999998865 56788999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+ +++|.+++... .+++.....++.|+++||+|||+ .+|+|+||+|+||++++++.+||+|||++.......
T Consensus 90 e~~-~~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-- 162 (328)
T cd07856 90 ELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-- 162 (328)
T ss_pred ehh-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc--
Confidence 998 45898887643 46777888899999999999994 599999999999999999999999999987543221
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHHH-------HHHHhhcCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDW-------AFDCYRNGKLD 707 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~-------~~~~~~~~~~~ 707 (766)
....++..|+|||.+.+ ..++.++||||||++++||++|+.||........ ..+.+. +......+...
T Consensus 163 ---~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 163 ---TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred ---CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 23456889999998866 5689999999999999999999999965432111 111100 00000000000
Q ss_pred eec-cCcccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALV-GGDMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~-~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+. ........+ ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000001 1235788999999999999999999998766
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=269.12 Aligned_cols=266 Identities=24% Similarity=0.328 Sum_probs=204.5
Q ss_pred cCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccC-----HHHHHHHHHHHccCCCCCeee
Q 037189 469 FSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDG-----EREFKNEVFVIGQTHHKNLVR 541 (766)
Q Consensus 469 ~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~-----~~~f~~E~~~l~~l~H~niv~ 541 (766)
|.-.-+....+-+...||+|||+.|||+.... ..+.||||+-.. ...+. .+...+|.++.+.++||.||+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK 531 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK 531 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence 44344455566667889999999999998754 456788886532 22222 244688999999999999999
Q ss_pred Eeeeee-cCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCC
Q 037189 542 LLGFCD-EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHY 617 (766)
Q Consensus 542 l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~ 617 (766)
+++++. +.+..+-|+||+++.+|+-||...+.+++.....|+.||+.||.||.+. +++|+|-||||.||||. .-|
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 999985 4556789999999999999999999999999999999999999999976 89999999999999995 447
Q ss_pred CeEEeccCcccccccCCCc-----ceeecccccCcccccccccCC----CCCcccCeeehhHHHHHHHhCCcCCCchhhh
Q 037189 618 NARISDFGLAKLLTLNQSK-----TIKTSIRGTKGYVAPEWFRNS----KITAKVDVYSFGVLLLEIIACRKSFDIEMVE 688 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~ 688 (766)
.+||.|||+++.+..+... .......||.+|++||++.-+ +++.|+||||.|||+|..+.|+.||..+...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999998765433 233456799999999998533 5788999999999999999999999876543
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.... .+..+.... .......+....+...++++||+..-++|....++..
T Consensus 691 QdIL---------qeNTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 QDIL---------QENTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHH---------hhhchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 3211 111111000 0111122345667889999999999999988877653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=268.41 Aligned_cols=221 Identities=20% Similarity=0.156 Sum_probs=178.9
Q ss_pred cccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCchhhh
Q 037189 488 GSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 567 (766)
Q Consensus 488 G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 567 (766)
|.+|.||++.... .++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999875 45689999986532 344556666667799999999999999999999999999999999
Q ss_pred hccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCc
Q 037189 568 LFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647 (766)
Q Consensus 568 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 647 (766)
+.....+++.....++.|+++||.|||+ .+++||||||+||+++.++.++++|||.+..+.... ....++..
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 9877778999999999999999999994 599999999999999999999999999886654321 22345678
Q ss_pred ccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHH
Q 037189 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLV 727 (766)
Q Consensus 648 y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 727 (766)
|+|||.+.+..++.++||||+|+++|||++|+.|+....... .. ......+...+..+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~---------~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT---------HTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc---------ccccCCcccCCHHHH
Confidence 999999988889999999999999999999998764321100 00 000011223456788
Q ss_pred HHHHHccccCCCCCCCHH
Q 037189 728 MVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 728 ~l~~~Cl~~dp~~RPt~~ 745 (766)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=285.63 Aligned_cols=258 Identities=23% Similarity=0.286 Sum_probs=191.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc------
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------ 551 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 551 (766)
.+.+.||+|++|.||+|.... .+..+|||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred EEEEEeccCCceEEEEEEECC---CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 345789999999999999864 45689999886432 2234567889999999999999999998766554
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.+||+|||++....
T Consensus 95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 5699998865 468999999999999999999994 599999999999999999999999999998654
Q ss_pred cCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh-hhHHHH-------HHHHhh
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-AILTDW-------AFDCYR 702 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~-------~~~~~~ 702 (766)
... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ..+... ....+.
T Consensus 170 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 170 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 321 33457889999999865 3678999999999999999999999965432111 000000 000000
Q ss_pred cCccceeccCcccC---CC---cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NGKLDALVGGDMEA---MN---DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~~~~~~~~~~~~~---~~---~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......++...... .. ....+.++.+++.+||+.+|++|||+.+|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 00 01135778999999999999999999999863
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=258.00 Aligned_cols=239 Identities=24% Similarity=0.256 Sum_probs=196.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
.+|.+.||+|.||.|-+++-+. .++.+|+|++++...-. ...-+.|-++|...+||.+..|.-.+...++.++|
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred hhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4577999999999999988764 57899999997543222 33446788999999999999999889999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||..+|.|.-+|.....+++....-.-..|+.||.||| +.+|+.||||.+|.|||.+|.+||.|||+++.--...
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g- 322 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG- 322 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc-
Confidence 999999999999998888998888888999999999999 5699999999999999999999999999998533221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
......+||+.|+|||++....|..+.|.|.+|||+|||++|+.||.....+.. .+.+.-+++
T Consensus 323 -~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL-------FeLIl~ed~--------- 385 (516)
T KOG0690|consen 323 -DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL-------FELILMEDL--------- 385 (516)
T ss_pred -ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH-------HHHHHhhhc---------
Confidence 122568999999999999999999999999999999999999999976543322 121111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
..+.....+...|+.-.|.+||.+|.
T Consensus 386 -kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 -KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 12344556777888889999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=258.06 Aligned_cols=260 Identities=25% Similarity=0.338 Sum_probs=199.5
Q ss_pred ccccCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHcc-CCCCCeeeEe
Q 037189 466 LRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQ-THHKNLVRLL 543 (766)
Q Consensus 466 ~~~~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~-l~H~niv~l~ 543 (766)
+-.|+-.+++.. .+||.|.||+|+|-.++. .++..|||+++.... ...++++.|.+...+ -+.||||+++
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfy 129 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFY 129 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCc---cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHh
Confidence 344555555442 579999999999988874 678999999986443 445678888865544 5799999999
Q ss_pred eeeecCCceEEEeeccCCCchhhhh---c--cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC
Q 037189 544 GFCDEGQNRLLVYEFLNNGTLASFL---F--GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN 618 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 618 (766)
|.+..++...+.||.|.- ||+.+- . ...+++++..-+|+...++||.||.+ ...|+|||+||+||||+..|.
T Consensus 130 Ga~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 130 GALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred hhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999999999999999964 554433 2 34678899999999999999999997 468999999999999999999
Q ss_pred eEEeccCcccccccCCCcceeecccccCcccccccccCC--CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH
Q 037189 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 619 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 696 (766)
+||+|||++..+..+-.. +...|-..|||||.+... .++.+|||||||+.|+|+.||+.|+...+. .-+.
T Consensus 207 vKLCDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeq 278 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQ 278 (361)
T ss_pred EeeecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHH
Confidence 999999999877654332 334678899999999643 488999999999999999999999975443 1111
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+. .+..|+...+.... ...+....+..++-.|+.+|..+||...++.+
T Consensus 279 l~-~Vv~gdpp~l~~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 279 LC-QVVIGDPPILLFDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred HH-HHHcCCCCeecCcc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 22334433332221 12346678899999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=299.00 Aligned_cols=143 Identities=27% Similarity=0.374 Sum_probs=127.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.++||+|+||.||+|.... .++.||||.++.... .....+.+|+.++..++|+||+++++++......+|||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred EEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 456789999999999999864 467899999865322 22367889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
||+.+++|.+++.....+++...+.|+.||+.||.|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999877778899999999999999999995 499999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=279.56 Aligned_cols=239 Identities=26% Similarity=0.302 Sum_probs=193.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.|...+|.|+|+.|-++.... +.+..+||++... ..+-.+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 323 ~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 323 SYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhccccccCCCCccceeeeeccc---cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 45566779999999999988765 4567888988654 22345677555554 7999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE-cCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL-DDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|.+.++-|.+.+....... ..+..|+.+|+.++.|||+ .+++||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999888887765555 7777899999999999995 599999999999999 58999999999999987654
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....+-|..|.|||++....+++++|+||||++||+|++|+.||.....+. . +...+..+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--e----i~~~i~~~~---------- 530 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--E----IHTRIQMPK---------- 530 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--H----HHHhhcCCc----------
Confidence 123456889999999999999999999999999999999999997544331 1 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+++..+|+.+||+.||.+||+|.++...
T Consensus 531 --~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 --FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 124567888999999999999999999998754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=251.58 Aligned_cols=245 Identities=23% Similarity=0.249 Sum_probs=191.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeec----CCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE----GQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~lV~E 557 (766)
++||-|-.|.|-....+. .+...|+|.+... ....+|+++.-+. .|||||++++++.. ....++|||
T Consensus 68 qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE 139 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKR---TQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME 139 (400)
T ss_pred hhhccccCCceEEEEecc---chhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence 689999999999888875 4557888887542 3457888877665 59999999999854 345678999
Q ss_pred ccCCCchhhhhccCCC--CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~ 632 (766)
.|++|.|...+..+.. +++.+...|+.||..|+.||| +..|.||||||+|+|.. .|..+||+|||+|+.-..
T Consensus 140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999987654 788999999999999999999 56999999999999996 456799999999987543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.. .....+-|+.|.|||++...+++...|+||+||++|-|++|.+||..... ..+..-....++.+..+
T Consensus 217 ~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy~----- 285 (400)
T KOG0604|consen 217 PG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQYE----- 285 (400)
T ss_pred Cc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCcc-----
Confidence 22 12456789999999999999999999999999999999999999965432 11111122222222211
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....-...++...++++..|..+|.+|.|+.+++..
T Consensus 286 -FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 286 -FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred -CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 0111123467788899999999999999999998864
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=293.31 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=213.3
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeec---ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI---VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
...+.+.+.||+|+||.|..++++. ..+.+|.|++.. .......-|..|-.+|..-+.+=|+.|.-.|.++.+.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 4455667899999999999999985 467999999976 3345566788999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
|||||||+||+|-..+....++++.....++..|+-||.-|| +.|+|||||||+|||||..|++||+|||.+-.+..
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999999988888999999999999999999999 67999999999999999999999999999988875
Q ss_pred CCCcceeecccccCccccccccc----C-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhh-hhhHHHHHHHHhhcCcc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFR----N-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-YAILTDWAFDCYRNGKL 706 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 706 (766)
+..... ...+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..+...+ +..+. ....
T Consensus 228 dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm-------~hk~- 298 (1317)
T KOG0612|consen 228 DGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM-------NHKE- 298 (1317)
T ss_pred CCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh-------chhh-
Confidence 543322 4467999999999995 2 578999999999999999999999998665422 21111 1111
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHHHH-------hcCcCCCCCCCC
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT---IKKVLQML-------EGVVEVSVPPNP 763 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt---~~~vl~~L-------e~~~~~~~pp~p 763 (766)
.+..+...+.+++..+||++.+. +|+.|-. +.++-.+- ++|.+..+|-.|
T Consensus 299 ------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 299 ------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred ------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 11111234477888899988776 7777777 77776543 555666555554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=268.02 Aligned_cols=242 Identities=27% Similarity=0.409 Sum_probs=193.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
|.||+|.||+||-|+++. .++.||||.+++.. ...+.++.+|+.+|.+++||.||.|.-.|+..++.++|||-+.
T Consensus 570 evLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred hhccCCcceeeecceecc---cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence 679999999999999986 57799999987532 4456789999999999999999999999999999999999986
Q ss_pred CCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEeccCcccccccCCCc
Q 037189 561 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 561 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 636 (766)
+.=|+-.|.. ..++++..-.-++.||+.||.|||. .+|+|+||||+||||.+. -++||+|||+++.+.....
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 6555555543 3678888778889999999999995 599999999999999644 4699999999999886543
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....||+.|+|||++.++.|+..-|+||.|||+|--++|-.||..+.. +.+. +.+.. ++- ..
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQ----IQNAa---FMy---Pp 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQ----IQNAA---FMY---PP 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHH----hhccc---ccc---CC
Confidence 3567899999999999999999999999999999999999999974332 1111 11111 110 11
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
..-.+...+..+++...||..-++|-|...-+
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 11234566778888888998888888886654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=250.96 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=197.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeec--ccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------- 549 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 549 (766)
+.-..+||+|.||.||+|...+ .++.||+|++-. ....-....++|+++|..++|+|++.++..|...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3344679999999999998875 455688887643 2223344568999999999999999999988432
Q ss_pred -CceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 550 -QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 550 -~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
...+||+++|++ +|...|... .+++..++.+++.+++.||.|+|+ ..|+|||+|+.|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 247899999988 888888765 678899999999999999999995 59999999999999999999999999999
Q ss_pred cccccCCC--cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 628 KLLTLNQS--KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 628 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
+.+..... ....+...-|.+|++||.+.+. .++++.|||+.|||+.||.++.+.++.+.......+..........+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87654332 1223456679999999998765 68999999999999999999999998876654443333332111111
Q ss_pred -----c---c------ceeccCcccCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 -----K---L------DALVGGDMEAMN----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 -----~---~------~~~~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+ + +.+..+..+... +---..+.++|+..++..||.+||++.+++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 0 001111111000 00012367789999999999999999988754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=258.54 Aligned_cols=239 Identities=29% Similarity=0.371 Sum_probs=194.6
Q ss_pred ccceEEEEEEecCCCceeEEEEEEeecccccC-HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCchhhh
Q 037189 489 SFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 567 (766)
Q Consensus 489 ~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 567 (766)
+||.||+|+... .+..+++|.+....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.++
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence 589999999864 35789999997655444 67899999999999999999999999999999999999999999999
Q ss_pred hccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCc
Q 037189 568 LFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647 (766)
Q Consensus 568 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 647 (766)
+.....+++..+..++.++++++.|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 9876668899999999999999999995 499999999999999999999999999998776542 1134557889
Q ss_pred ccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHH
Q 037189 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLV 727 (766)
Q Consensus 648 y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 727 (766)
|++||.+.+..++.++||||||+++++|++|..|+....... .+ .+....+.... .......+.++.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~~-------~~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--EL----FKKIGKPKPPF-------PPPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH----HHHHhccCCCC-------ccccccCCHHHH
Confidence 999999998889999999999999999999999986521111 11 11111111110 000001457889
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 037189 728 MVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 728 ~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=261.37 Aligned_cols=245 Identities=27% Similarity=0.332 Sum_probs=201.5
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeec
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE 548 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 548 (766)
-+..+..+|...||+|+||.|-++..+. ....+|||.++... .+..+--+.|-++|... +-|.++++..++..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT 421 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT 421 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh
Confidence 4555667899999999999999998764 45689999887532 22233346778888887 46889999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
-++.|+||||+.+|+|--+++.-.++.+....-.|..||-||-+|| +.+|+.||||..||+||.+|.+||+|||+++
T Consensus 422 mDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK 498 (683)
T KOG0696|consen 422 MDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 498 (683)
T ss_pred hhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence 9999999999999999999999899999999999999999999999 5699999999999999999999999999987
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.--.+. ......+||+.|+|||++..++|+.++|.|||||+||||+.|++||+.+.+++. ...+.+..
T Consensus 499 Eni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-------F~aI~ehn--- 566 (683)
T KOG0696|consen 499 ENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQAIMEHN--- 566 (683)
T ss_pred ccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHHcc---
Confidence 432221 122568999999999999999999999999999999999999999998776552 12222211
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
..++...+.+...+....|.+.|.+|.
T Consensus 567 -------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 -------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123556677888888899999999885
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=258.79 Aligned_cols=274 Identities=22% Similarity=0.282 Sum_probs=206.4
Q ss_pred ccccccCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC--CC---
Q 037189 464 TNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH--KN--- 538 (766)
Q Consensus 464 ~~~~~~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H--~n--- 538 (766)
.+.-.|...+.....+.+.+.+|+|.||.|-+..... ....||||+++.... -.+..+-|+++|.++.+ |+
T Consensus 76 dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 76 DGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred CceEEEEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCce
Confidence 3445667777778888888999999999999998775 367899999976432 23456778999999842 22
Q ss_pred -eeeEeeeeecCCceEEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 539 -LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 539 -iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
+|.+.+++.-.++.++|+|.| +-|+.++|..+. ..+..++..|+.|+++++++|| +.+++|-||||+|||+.+
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVS 227 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEec
Confidence 788889999999999999987 448999998764 5678889999999999999999 559999999999999831
Q ss_pred --------------------CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHH
Q 037189 616 --------------------HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675 (766)
Q Consensus 616 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~el 675 (766)
+..+||+|||.|..-.... ..+..|..|.|||++.+-.++.++||||+||||.|+
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 3358999999998765443 456789999999999999999999999999999999
Q ss_pred HhCCcCCCchhhhhhhhHHHHH--------------HHHhhcCccc-----------eeccCcc----cCCCcHHHHHHH
Q 037189 676 IACRKSFDIEMVEEYAILTDWA--------------FDCYRNGKLD-----------ALVGGDM----EAMNDVECLEKL 726 (766)
Q Consensus 676 ltg~~p~~~~~~~~~~~~~~~~--------------~~~~~~~~~~-----------~~~~~~~----~~~~~~~~~~~l 726 (766)
.+|...|+.....+...+.+.+ .+....+.++ ...+... .......+..+|
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 9999999754422211111111 1111112111 0000000 001123456779
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 037189 727 VMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 727 ~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+|+.+||..||.+|+|+.|++++
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999998864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=273.93 Aligned_cols=258 Identities=22% Similarity=0.297 Sum_probs=177.5
Q ss_pred HhhhhhccccccceEEEEEEecC-------------CCceeEEEEEEeecccccCHHHH--------------HHHHHHH
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTT-------------RTSTTAVAVKKLDIVFQDGEREF--------------KNEVFVI 531 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~-------------~~~~~~vavK~l~~~~~~~~~~f--------------~~E~~~l 531 (766)
+.+.++||+|+||.||+|.+... ...++.||||++........++| ..|+..+
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 44557899999999999975321 12446799999875433333333 4466777
Q ss_pred ccCCCCCe-----eeEeeeeec--------CCceEEEeeccCCCchhhhhccC------------------------CCC
Q 037189 532 GQTHHKNL-----VRLLGFCDE--------GQNRLLVYEFLNNGTLASFLFGN------------------------LKP 574 (766)
Q Consensus 532 ~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~------------------------~~l 574 (766)
.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766654 778888753 35689999999999999988642 123
Q ss_pred ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccc
Q 037189 575 NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654 (766)
Q Consensus 575 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 654 (766)
++..+..++.|++++|.|||+ .+|+||||||+|||++.++.+||+|||+++.+........ ....+++.|+|||.+
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSPPEEL 382 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeChhhh
Confidence 456778899999999999995 5899999999999999999999999999976543322111 122347899999988
Q ss_pred cCCCC----------------------CcccCeeehhHHHHHHHhCCc-CCCchhhh--h----hhhHHHHHHHHhhcCc
Q 037189 655 RNSKI----------------------TAKVDVYSFGVLLLEIIACRK-SFDIEMVE--E----YAILTDWAFDCYRNGK 705 (766)
Q Consensus 655 ~~~~~----------------------s~~sDV~s~Gvvl~elltg~~-p~~~~~~~--~----~~~~~~~~~~~~~~~~ 705 (766)
..... ..+.||||+||+++||+++.. |+...... + ...+..| +.+....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccC
Confidence 54321 134799999999999999875 65432110 0 0111111 1111111
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDP---SLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPt~~~vl~~ 750 (766)
. .........+...+++.++|..+| .+|+|++|++++
T Consensus 461 ~--------~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 Y--------DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred C--------CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1 111122345778899999999766 689999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=279.52 Aligned_cols=260 Identities=20% Similarity=0.204 Sum_probs=164.5
Q ss_pred HhhhhhccccccceEEEEEEecC-CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeee------eecCCc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGF------CDEGQN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~-~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~~~~~ 551 (766)
+.+.+.||+|+||.||+|.+..+ ...+..+|||++..... .+.+..| .+....+.++..++.. +.++..
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 34567899999999999998753 11257899998764221 1112221 1122222222222211 345668
Q ss_pred eEEEeeccCCCchhhhhccCCC--------------------CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 552 RLLVYEFLNNGTLASFLFGNLK--------------------PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
.++||||+.+++|.+++..... .....+..++.||++||+|||+ .+|+||||||+||
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NI 286 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNI 286 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHE
Confidence 8999999999999998864321 0122345789999999999994 5999999999999
Q ss_pred EEcC-CCCeEEeccCcccccccCCCcceeecccccCcccccccccCC----------------------CCCcccCeeeh
Q 037189 612 LLDD-HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS----------------------KITAKVDVYSF 668 (766)
Q Consensus 612 ll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~sDV~s~ 668 (766)
|+++ ++.+||+|||+++.+....... .....++++|+|||.+... .++.++|||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 9985 5899999999998665432221 1345689999999965322 23456799999
Q ss_pred hHHHHHHHhCCcCCCchhhhhhh-------hHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCC
Q 037189 669 GVLLLEIIACRKSFDIEMVEEYA-------ILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLR 741 (766)
Q Consensus 669 Gvvl~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 741 (766)
||+||||+++..+.+.....-.. .+..|.... .......+. .... ..........+|+.+||+.||++|
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~-~~~~--~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLV-EPRASPDLR-RGFE--VLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhh-ccccchhhh-hhhh--hccccchHHHHHHHHHccCCcccC
Confidence 99999999977665432211100 011111100 000000000 0000 000112345689999999999999
Q ss_pred CCHHHHHHH
Q 037189 742 PTIKKVLQM 750 (766)
Q Consensus 742 Pt~~~vl~~ 750 (766)
||+.+++++
T Consensus 442 ~ta~e~L~H 450 (566)
T PLN03225 442 ISAKAALAH 450 (566)
T ss_pred CCHHHHhCC
Confidence 999999975
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-30 Score=263.83 Aligned_cols=247 Identities=21% Similarity=0.238 Sum_probs=200.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
..||-|+||.|=+++...........++|+.+.......+....|-.+|...+.|.||+|+..+.+....|++||-|-+|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 46999999999998876432212223344444555566667888999999999999999999999999999999999999
Q ss_pred chhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecc
Q 037189 563 TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSI 642 (766)
Q Consensus 563 sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 642 (766)
.|...|+.++.++.....-++..+++|+.||| +.+|+.|||||+|.+|+.+|-+||.|||+|+.+..+... -..
T Consensus 506 ElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT---wTF 579 (732)
T KOG0614|consen 506 ELWTILRDRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT---WTF 579 (732)
T ss_pred hhhhhhhhcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCce---eee
Confidence 99999999999999999999999999999999 569999999999999999999999999999998765432 357
Q ss_pred cccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHH
Q 037189 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVEC 722 (766)
Q Consensus 643 ~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 722 (766)
+||+.|.|||++.+...+.++|.||||++++||++|++||...++-....+ +..| --....+...
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-------ILkG--------id~i~~Pr~I 644 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-------ILKG--------IDKIEFPRRI 644 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-------HHhh--------hhhhhccccc
Confidence 999999999999999999999999999999999999999987654322111 1111 1111224445
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 723 LEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 723 ~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
.....+|+++.+..+|.+|-- +.|+-++
T Consensus 645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred chhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 667778899989999999975 5566544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=268.68 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=203.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeee-----cCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCD-----EGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~-----~~~~ 551 (766)
+..|.+.||.|.+|.||+++... .++..|||++... .+..++...|.++++.. +|||++.++|++. .++.
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 34577899999999999999875 4567788877643 45567888889888887 6999999999984 3568
Q ss_pred eEEEeeccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 552 RLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
+.||||||.+|+..|.+++ ..++.|..+.-|+..++.||.+|| ...++|||||-.|||++.++.+|+.|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 8999999999999999875 467889999999999999999999 45999999999999999999999999999987
Q ss_pred cccCCCcceeecccccCcccccccccCC-----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
+...-.. .....||+.|||||++... .|+..+|+||||++..||--|.+|+........ ++.
T Consensus 173 ldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~----- 239 (953)
T KOG0587|consen 173 LDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFL----- 239 (953)
T ss_pred eeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hcc-----
Confidence 7643322 2346799999999999644 467889999999999999999999876543211 111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..-.+.+....+....+++.+++..||.+|-+.||++.+++++
T Consensus 240 ---IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 240 ---IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1123344445577789999999999999999999999988764
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-29 Score=244.52 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=196.5
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----CceEE
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNRLL 554 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~l 554 (766)
.+-||.|+||.||.+.... +++.||.|++..... ...+.+.+|+++|..++|.|++..++...-. .++|+
T Consensus 58 DRPIGYGAFGVVWsVTDPR---dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPR---SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCcccccceeEEEeccCCC---CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3679999999999998764 678999999865432 2357899999999999999999998876433 25678
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+.|.|.. +|...+-+.+.++.+.+.-+..||++||+||| +.+|.||||||.|.|++.|..+||+|||+++.-..++
T Consensus 135 ~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 8898865 88888888888999999999999999999999 5699999999999999999999999999999877666
Q ss_pred CcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH--------HHhhcCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF--------DCYRNGK 705 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 705 (766)
...+ +...-|..|.|||.+.+. .|+.+.||||.|||+.||+..+..|+...+-+...+..-.. +..-+|.
T Consensus 211 ~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 5554 445578999999999876 68999999999999999999998887654422221111000 0000111
Q ss_pred cceeccCc--------cc-CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 706 LDALVGGD--------ME-AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 706 ~~~~~~~~--------~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
-..++... +. ...+...-.+...+..+++..||++|.+..+.+..+
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01111111 10 001112233455677889999999999999888765
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=274.29 Aligned_cols=239 Identities=31% Similarity=0.418 Sum_probs=185.5
Q ss_pred hhccccccce-EEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGI-VYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~-Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.+|.|.-|+ ||+|... ++.||||++-. ....-..+|+..|..- +||||||+++.-.+.+..||..|.|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-----~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-----GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEeeC-----CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 5689999885 6999985 67999999853 2234568999999887 59999999999999999999999997
Q ss_pred CCchhhhhccC-CCC---ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-----CCCeEEeccCcccccc
Q 037189 561 NGTLASFLFGN-LKP---NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-----HYNARISDFGLAKLLT 631 (766)
Q Consensus 561 ~gsL~~~l~~~-~~l---~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~ 631 (766)
. +|.+++... ... .-...+.+..|+++||+||| +.+|+||||||+||||+. ..+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6 999999874 111 11334678899999999999 679999999999999975 2579999999999987
Q ss_pred cCCCcc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhC-CcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 632 LNQSKT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 632 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.+...- ......||-+|+|||++....-+.++||||+|||+|+.++| .+||...-..+...+ ..+..+..+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~~~L~~L 735 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGNYTLVHL 735 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCccceeee
Confidence 665432 23457799999999999999888999999999999999995 899975433221111 111111111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. ...++ +..+||.+|+.++|..||++.+|+.
T Consensus 736 -----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 -----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 11122 7789999999999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=222.79 Aligned_cols=196 Identities=27% Similarity=0.388 Sum_probs=163.8
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEeecc
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.+.||+|++|.|=+-++.. .+...|||+++.... +..++.++|+.+..+ ..+|.+|.++|...+.....+.||.|
T Consensus 51 i~elGrGayG~vekmrh~~---sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhcCCccchhhheeecc---CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 4689999999998877764 678999999976443 334567888877665 47999999999999999999999999
Q ss_pred CCCchhhhh----ccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 560 NNGTLASFL----FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 560 ~~gsL~~~l----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
.- ||+.|- .....+++...-+|+..+++||.|||+ ...++|||+||+||||+.+|++|++|||.+..+..+-.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 65 666653 456788999999999999999999998 57899999999999999999999999999988765433
Q ss_pred cceeecccccCcccccccccC----CCCCcccCeeehhHHHHHHHhCCcCCCchh
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN----SKITAKVDVYSFGVLLLEIIACRKSFDIEM 686 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~ 686 (766)
. +-..|-..|||||.+.. ..|+.|+||||||+.+.||.+++.|++...
T Consensus 205 k---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 205 K---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred H---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 3 22457788999999853 368999999999999999999999997543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=237.32 Aligned_cols=244 Identities=25% Similarity=0.304 Sum_probs=193.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEe
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+...||+|.|..|-.+.+..+ .+.+|+|.+++. .....+-.+.|-.+..+. +||.+|.|..++..+++.++|.
T Consensus 254 ll~vigrgsyakvl~~~~~~t---~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi 330 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKT---DQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI 330 (593)
T ss_pred eeeeecCcchhhhhheehccc---ceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence 457899999999999998864 467888877642 233344567777777765 7999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||.++|+|--++....+++++...-....|.-||.||| +.+|+.||||..|+|+|..+.+|+.|+|+.+.--...
T Consensus 331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g-- 405 (593)
T KOG0695|consen 331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG-- 405 (593)
T ss_pred EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCC--
Confidence 99999999999999999999999999999999999999 5699999999999999999999999999998532221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh-hhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV-EEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
......+||+.|+|||.+.+..|....|.|++||+++||+.|+.||+.-.. .....-.+++.+.+.+..+.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------- 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence 223568999999999999999999999999999999999999999975321 11222233444444333221
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
. +...+.+...+++.-|.+||.+|.
T Consensus 478 i--prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 I--PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred c--cceeehhhHHHHHHhhcCCcHHhc
Confidence 1 222344556778888999999884
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=228.28 Aligned_cols=211 Identities=36% Similarity=0.552 Sum_probs=182.8
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCc
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGT 563 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (766)
||+|.+|.||++.... .+..+++|........ ..+.+.+|++.++.++|++++++++++......++++||+++++
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence 6899999999999864 3678999998754332 34689999999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCcccccccCCCcceeec
Q 037189 564 LASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 564 L~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
|.+++... ..+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99999765 568899999999999999999995 49999999999999999 89999999999987654321 1123
Q ss_pred ccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcH
Q 037189 642 IRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (766)
..+...|++||.+... ..+.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577889999999887 888999999999999998
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 721 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..+.+++.+|++.+|++||++.++++.|
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4567899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-27 Score=232.89 Aligned_cols=267 Identities=25% Similarity=0.308 Sum_probs=190.6
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec------CCceEEE
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQNRLLV 555 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~~lV 555 (766)
.+|.|.- .|--+... ..+..||+|++.... ....+...+|..++..++|+||++++.++.- ..+.++|
T Consensus 24 p~~~g~~-~v~~a~D~---v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQ---VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred ccCCCCc-eEEecchh---hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 3566665 44444332 245789999885432 3345678999999999999999999999843 3467899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+|.. +|...+. ..++-+....|..|++.|++||| +.+|+||||||+||++..+..+||.|||+++.-....
T Consensus 100 ~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~- 172 (369)
T KOG0665|consen 100 MELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF- 172 (369)
T ss_pred HHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCccc-
Confidence 999965 7777766 44666778889999999999999 5699999999999999999999999999998765441
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh-hhhh---------------hHHHHHHH
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV-EEYA---------------ILTDWAFD 699 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~-~~~~---------------~~~~~~~~ 699 (766)
..+.+..|..|.|||++.+..+.+.+||||+||++.||++|+..|.+..- +... .+..-+..
T Consensus 173 --~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 173 --MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred --ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 23567789999999999988899999999999999999999988864321 1110 11111111
Q ss_pred HhhcCc------cce-eccCcc--cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH--h---cCcCCCCCCCC
Q 037189 700 CYRNGK------LDA-LVGGDM--EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML--E---GVVEVSVPPNP 763 (766)
Q Consensus 700 ~~~~~~------~~~-~~~~~~--~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L--e---~~~~~~~pp~p 763 (766)
.++... ... +.|... ..+.+......+.+++.+||..||++|.++++++++= + .-.+++.||+|
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 111110 000 011111 1111223345678899999999999999999999762 3 33455555555
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-27 Score=247.53 Aligned_cols=201 Identities=25% Similarity=0.351 Sum_probs=170.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.||-|+||.|.++.-.+ ....+|.|.|++.+ .........|-.+|...+.+=||+|+-.|.+.+.+|+||||+
T Consensus 635 k~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecc---hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEecc
Confidence 459999999999987654 35688999887543 223345678889999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc--------
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT-------- 631 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~-------- 631 (766)
++|++-.+|...+.+.++.....+..+..|+++.| ..++|||||||.|||||.+|.+||.||||+.-+.
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999999888999999999999999999999 6799999999999999999999999999986442
Q ss_pred -cCC-----Cc--------------------------ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCC
Q 037189 632 -LNQ-----SK--------------------------TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACR 679 (766)
Q Consensus 632 -~~~-----~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~ 679 (766)
.+. +. ......+||+.|+|||++....++..+|.||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 100 00 0112346999999999999999999999999999999999999
Q ss_pred cCCCchhhhh
Q 037189 680 KSFDIEMVEE 689 (766)
Q Consensus 680 ~p~~~~~~~~ 689 (766)
.||-.....+
T Consensus 869 ~pf~~~tp~~ 878 (1034)
T KOG0608|consen 869 PPFLADTPGE 878 (1034)
T ss_pred CCccCCCCCc
Confidence 9998766533
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=244.95 Aligned_cols=192 Identities=22% Similarity=0.322 Sum_probs=165.7
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--------CHHHHHHHHHHHccCC---CCCeeeEeeeeecCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--------GEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQ 550 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~ 550 (766)
.+.+|+|+||.|+.+.++. ....|+||.+.+..-- ..-..-.|+++|+.++ |+||++++++|++++
T Consensus 566 lq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred eeeccccccceEEEeeecc---cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 3579999999999999985 4678999988642211 1112567999999998 999999999999999
Q ss_pred ceEEEeecc-CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 551 NRLLVYEFL-NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 551 ~~~lV~Ey~-~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..+|++|-. ++-+|.+++.-...+++....-|+.||+.|+++|| +.+|+|||||-+|++++.+|-+||+|||.+.+
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999976 56799999999999999999999999999999999 55999999999999999999999999999988
Q ss_pred cccCCCcceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCC
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFD 683 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~ 683 (766)
...+.. ...+||.+|.|||++.+.+|- ..-|||++|++||.++....||.
T Consensus 720 ~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 TKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 765543 345799999999999998875 55899999999999998888874
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=212.28 Aligned_cols=258 Identities=19% Similarity=0.322 Sum_probs=189.2
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCC--ceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ--NRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~~ 553 (766)
..+++.+++|+|-|+.||.|..-. +...++||.++.. ..+.+.+|+.+|..+. ||||++|++...+.. ...
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccC---CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 345677899999999999998654 3457888988753 4567899999999997 999999999987654 567
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~ 632 (766)
||+||..+.+..... ..++...+.-.+.++++||.|+| +.||+|||+||.|++||.. -.++|+|+|+|.+..+
T Consensus 112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999997765543 34556667778999999999999 6799999999999999954 5699999999999988
Q ss_pred CCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhh--hhhH---------HHHHHHH
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAIL---------TDWAFDC 700 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~--~~~~---------~~~~~~~ 700 (766)
+..... ...+..|-.||.+.. +.++.+-|+|||||+|.+|+..+.||-...... ...+ ...+...
T Consensus 186 ~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 765433 345667889999864 468899999999999999999999995433221 1111 1111100
Q ss_pred --hhcCccceeccCccc--------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 701 --YRNGKLDALVGGDME--------AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 701 --~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........++....+ .....-...+..+++...|..|-.+|||++|...
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000011111111110 0011123467889999999999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=221.91 Aligned_cols=197 Identities=30% Similarity=0.462 Sum_probs=171.6
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.+.||+|++|.||++.... .+..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||+
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred eeeEeecCCCeEEEEEEEcC---CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 45789999999999999874 3568999999765444 5678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCC-CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 560 NNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 560 ~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
++++|.+++..... +++.....++.++++++.+||+ .+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-L 155 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-c
Confidence 99999999987666 8899999999999999999995 49999999999999999999999999999877654311 1
Q ss_pred eecccccCcccccccc-cCCCCCcccCeeehhHHHHHHHhCCcCCCc
Q 037189 639 KTSIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIIACRKSFDI 684 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~-~~~~~s~~sDV~s~Gvvl~elltg~~p~~~ 684 (766)
.....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1234577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=226.14 Aligned_cols=135 Identities=27% Similarity=0.405 Sum_probs=109.5
Q ss_pred HHHH-HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-----C---CCeeeEe
Q 037189 473 ELEE-ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-----H---KNLVRLL 543 (766)
Q Consensus 473 ~l~~-~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~ 543 (766)
++.. ..|...++||-|.|++||++.... ..+.||+|..+.. +.-.+..+.||++|++++ | ..||+|+
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 3444 566677899999999999999875 4678999998743 333456788999999874 3 3699999
Q ss_pred eeeec----CCceEEEeeccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 544 GFCDE----GQNRLLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 544 g~~~~----~~~~~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
++|.. +.+.+||+|++-. +|..+|.. .+.++...+.+|+.||+.||.|||++| +|+|-||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 99954 5689999999854 67777754 366889999999999999999999975 999999999999983
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=240.75 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=202.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.....+|.|.||.|||++... .+...|||.++....+...-.+.|+-+++.-+|+||+.++|-+...+...+.|||
T Consensus 17 yellqrvgsgTygdvyKaRd~~---s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred hhheeeecCCcccchhhhcccc---cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3455789999999999999875 5678899998877777777889999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+.+|+|.+.-+....+++.++...++...+||+||| +.+-+|||||-.||++++.+.+|++|||.+..+...-. .
T Consensus 94 cgggslQdiy~~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~--K 168 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA--K 168 (829)
T ss_pred cCCCcccceeeecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh--h
Confidence 999999999888889999999999999999999999 66899999999999999999999999999877654322 1
Q ss_pred eecccccCcccccccc---cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 639 KTSIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~---~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....||+.|||||+. ..+.+..++|||++|+...|+--..+|.......... ...-. ...+ ...
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-------~LmTk----S~~q-pp~ 236 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-------FLMTK----SGFQ-PPT 236 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-------HHhhc----cCCC-CCc
Confidence 2456799999999987 3567899999999999999997777775433321111 11000 0111 111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........+.+.++++.|+-++|.+||+++.+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2223445778899999999999999999987664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-25 Score=232.23 Aligned_cols=272 Identities=21% Similarity=0.216 Sum_probs=204.6
Q ss_pred cccCHHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC------CCCee
Q 037189 467 RCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH------HKNLV 540 (766)
Q Consensus 467 ~~~~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~------H~niv 540 (766)
-.+.+.|+....|...-..|+|-|++|-+|.... .+..||||+++.. +...+.=+.|+++|++++ .-|++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 4456778888888888899999999999998875 3459999999753 222344578999999996 35899
Q ss_pred eEeeeeecCCceEEEeeccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-
Q 037189 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH- 616 (766)
Q Consensus 541 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~- 616 (766)
+|+..|.+.+++|||+|-+ ..+|.+.|... ..+....+..++.|+.-||..|.. .+|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence 9999999999999999976 45899998754 346778888999999999999994 599999999999999866
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 696 (766)
..+||||||.|......+. +.+.-+.-|.|||++.+.+|+...|+||.||.||||.||+..|.+..-.....+.--
T Consensus 574 ~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 4589999999987665432 333446679999999999999999999999999999999999976543322211111
Q ss_pred H-----HHHhhcCcc---------------------------ceeccC------cc-----cCCCcHHHHHHHHHHHHHc
Q 037189 697 A-----FDCYRNGKL---------------------------DALVGG------DM-----EAMNDVECLEKLVMVSIWC 733 (766)
Q Consensus 697 ~-----~~~~~~~~~---------------------------~~~~~~------~~-----~~~~~~~~~~~l~~l~~~C 733 (766)
+ ...++.+.. ...+.+ .+ ...........+.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 1 011111100 000001 00 0111234567889999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 037189 734 IQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 734 l~~dp~~RPt~~~vl~~ 750 (766)
+..||++|.|..+.|++
T Consensus 730 l~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKH 746 (752)
T ss_pred hccChhhcCCHHHHhcC
Confidence 99999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-25 Score=225.36 Aligned_cols=195 Identities=25% Similarity=0.367 Sum_probs=160.9
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
.++||+|.|++||++.+.........||+|.+... .......+|+++|..+. +.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 46899999999999998764335678999998754 34567899999999985 9999999999999999999999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCcccccccCC-----
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQ----- 634 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~----- 634 (766)
+....++..+ ++...+...+..+.+||+++| ..+|+||||||+|+|.+ ..+.-.|.|||++.......
T Consensus 119 H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 119 HDRFRDLYRS---LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 9988888754 457788889999999999999 55999999999999998 45678999999998221000
Q ss_pred -------------------------------------CcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHH
Q 037189 635 -------------------------------------SKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEII 676 (766)
Q Consensus 635 -------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~ell 676 (766)
.........||+||.|||++.. ..-++++||||.|||++.++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 0001123469999999999865 45789999999999999999
Q ss_pred hCCcCCCc
Q 037189 677 ACRKSFDI 684 (766)
Q Consensus 677 tg~~p~~~ 684 (766)
+++.||-.
T Consensus 273 s~~~PFf~ 280 (418)
T KOG1167|consen 273 SRRYPFFK 280 (418)
T ss_pred cccccccc
Confidence 99999853
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=209.55 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=185.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeee-eecCCceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGF-CDEGQNRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV 555 (766)
.+++.+.||+|.||.+-++.++. ..+.+++|-+... ....++|.+|...--.+ .|.||+.-++. +...+..+++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 35677899999999999999874 5678888887643 33467899998654444 59999988775 4556677899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~ 633 (766)
+||++.|+|..-+... .+.+..-.+++.|++.||.||| +..+||||||.+||||- +..++||+|||+.+.....
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999888653 3567777889999999999999 56999999999999993 4457999999998865533
Q ss_pred CCcceeecccccCcccccccccCC-----CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
. .....+..|.+||..... ...+.+|||.||+|++.++||+.|++.....+. .-|-+..|..+....
T Consensus 177 V-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~~~ 248 (378)
T KOG1345|consen 177 V-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKNPA 248 (378)
T ss_pred e-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccCcc
Confidence 2 122345678999976432 357889999999999999999999985433221 233444555554443
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.+.. ...++.+.++.++-+..++++|-...++.++
T Consensus 249 ~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 249 LPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 32221 1245677788888999999999554444433
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=192.81 Aligned_cols=110 Identities=31% Similarity=0.602 Sum_probs=96.1
Q ss_pred eecccccCCCCCCCCceEEEccCCcEEEEecCcceeeeccCccccCCCceEEEEeccCccEEEEeccCCCCCCceEEecc
Q 037189 192 YISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYHRATLNFDGVFAQYYYPRHGNGNWSVVWSQ 271 (766)
Q Consensus 192 ~~sg~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~~G~l~~~~w~~~~~~~W~~~~~~ 271 (766)
||+|+|||. .+.+.+.+.....+.+.|..+.++.++++. ..+.+.++|++||++|++|+|.|. +..++|.+.|.+
T Consensus 1 wrsG~WnG~--~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~--~~~~s~~~r~~ld~~G~l~~~~w~-~~~~~W~~~~~~ 75 (110)
T PF00954_consen 1 WRSGPWNGQ--RFSGIPEMSSNSLYNYSFVSNNEEVYYTYS--LSNSSVLSRLVLDSDGQLQRYIWN-ESTQSWSVFWSA 75 (110)
T ss_pred CCccccCCe--EECCcccccccceeEEEEEECCCeEEEEEe--cCCCceEEEEEEeeeeEEEEEEEe-cCCCcEEEEEEe
Confidence 899999998 456666666666788888888888888864 557788999999999999999996 568999999999
Q ss_pred cCCccccccCCCCccccCCCcccccCCCCCCcccCCCCCccCC
Q 037189 272 PDNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLLD 314 (766)
Q Consensus 272 p~~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~Gf~~~~ 314 (766)
|.|+||+ |+.||+||+|+.+ ..|.|+||+||+|++
T Consensus 76 p~d~Cd~------y~~CG~~g~C~~~--~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 76 PKDQCDV------YGFCGPNGICNSN--NSPKCSCLPGFEPKN 110 (110)
T ss_pred cccCCCC------ccccCCccEeCCC--CCCceECCCCcCCCc
Confidence 9999999 8999999999764 788999999999874
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=258.42 Aligned_cols=197 Identities=18% Similarity=0.214 Sum_probs=139.8
Q ss_pred ccCCC-CCeeeEeeee-------ecCCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCcee
Q 037189 532 GQTHH-KNLVRLLGFC-------DEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602 (766)
Q Consensus 532 ~~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 602 (766)
+.++| .||++++++| .+....++++||+ +++|.++|... ..+++.+++.++.||++||.||| +.+|+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv 102 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV 102 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 34556 6888888877 2334567788987 55999999753 45899999999999999999999 45999
Q ss_pred cCCCccceEEEcC-------------------CCCeEEeccCcccccccCCC--------------cceeecccccCccc
Q 037189 603 HCDMKPQNILLDD-------------------HYNARISDFGLAKLLTLNQS--------------KTIKTSIRGTKGYV 649 (766)
Q Consensus 603 H~dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~--------------~~~~~~~~gt~~y~ 649 (766)
||||||+||||+. ++.+|++|||+++....... ........||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566667776654221000 00001235788999
Q ss_pred ccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHH
Q 037189 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMV 729 (766)
Q Consensus 650 aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 729 (766)
|||++.+..++.++|||||||+||||++|.+|+..... ..... .... ..+. ......+...+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~-----~~~~----~~~~-----~~~~~~~~~~~ 244 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSL-----RHRV----LPPQ-----ILLNWPKEASF 244 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHH-----HHhh----cChh-----hhhcCHHHHHH
Confidence 99999999999999999999999999999888653211 01010 0000 0000 01112345678
Q ss_pred HHHccccCCCCCCCHHHHHHH
Q 037189 730 SIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 730 ~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.+||+++|.+||+|.|++++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHhCCCChhhCcChHHHhhc
Confidence 889999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=200.96 Aligned_cols=166 Identities=23% Similarity=0.196 Sum_probs=125.9
Q ss_pred CchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceee
Q 037189 562 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640 (766)
Q Consensus 562 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 640 (766)
|+|.+++... ..+++.+++.|+.|+++||+|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 5689999999999999999999964 2 999999999999999 99988754322
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcH
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 720 (766)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.... ....... .. ......
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~-~~~~~~~------~~-~~~~~~ 133 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILL-NGMPADD------PR-DRSNLE 133 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHH-HHhccCC------cc-ccccHH
Confidence 258899999999999999999999999999999999999996543211 1111111 1111000 00 001122
Q ss_pred HHHH--HHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 721 ECLE--KLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 721 ~~~~--~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.... ++.+++.+||+.+|.+||++.++++++..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2333 689999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-24 Score=205.66 Aligned_cols=252 Identities=20% Similarity=0.346 Sum_probs=197.7
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEee--cccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~--~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
+.-...++..+|.+...|..|+|+++.. .+++|.+. .......++|..|.-.|+-+.||||+.++|.|....+
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgn-----divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn 261 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGN-----DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN 261 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCc-----chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence 3344456777899999999999999743 45555553 3334445789999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe--ccCcc
Q 037189 552 RLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS--DFGLA 627 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~--Dfgla 627 (766)
..++..||+.|+|...|+... ..+-.+..+++.+||+|++|||+- .+-|..--|++..+++|++.+++|+ |--++
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceee
Confidence 999999999999999998764 457888999999999999999964 4556666799999999999998885 32221
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCC---cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT---AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
-. .....-.+.|++||.++..+-+ .++|+|||+++||||.|...||.....-+-..
T Consensus 341 fq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------ 399 (448)
T KOG0195|consen 341 FQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------ 399 (448)
T ss_pred ee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------
Confidence 11 0223457889999999877644 57999999999999999999997654322111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.+.-+.++...++..+..+.+|+.-|+.+||.+||.+..++-+||+++
T Consensus 400 ---kialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 400 ---KIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---hhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 112233444556777888999999999999999999999999999865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=206.65 Aligned_cols=164 Identities=21% Similarity=0.137 Sum_probs=125.3
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-----cccCHHHHHHHHHHHccCCCCCeee-EeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-----FQDGEREFKNEVFVIGQTHHKNLVR-LLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~-l~g~~~~~~~ 551 (766)
.+.+.+.||+|+||.||+|.+... .+..+|||++... .....+.|.+|+++|.+++|+|+++ ++++ ..
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 355678899999999999987642 2456899987532 1122456899999999999999985 4432 46
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCC-ccceEEEcCCCCeEEeccCccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDM-KPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.+|||||+++++|... ... ....++.+++++|.|||+ .+|+|||| ||+|||++.++++||+|||+++.+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~------~~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH------GDPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc------chHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 7999999999999732 111 125688999999999995 59999999 999999999999999999999977
Q ss_pred ccCCCcce------eecccccCcccccccccCC
Q 037189 631 TLNQSKTI------KTSIRGTKGYVAPEWFRNS 657 (766)
Q Consensus 631 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 657 (766)
........ -+...++..|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 65432111 1345688899999998643
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=168.94 Aligned_cols=112 Identities=26% Similarity=0.371 Sum_probs=93.1
Q ss_pred CeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEEEe
Q 037189 34 ATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLN 113 (766)
Q Consensus 34 ~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~ 113 (766)
+.|..|+ .|+|++|.|++|||++.. ...++++|||.+.+ +++||.||++.| ....+.|.|+.||||+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~----q~~dgnlv~~~~~~-~~~vW~snt~~~---~~~~~~l~l~~dGnLvl~ 70 (116)
T cd00028 2 NPLSSGQ---TLVSSGSLFELGFFKLIM----QSRDYNLILYKGSS-RTVVWVANRDNP---SGSSCTLTLQSDGNLVIY 70 (116)
T ss_pred cCcCCCC---EEEeCCCcEEEecccCCC----CCCeEEEEEEeCCC-CeEEEECCCCCC---CCCCEEEEEecCCCeEEE
Confidence 3455666 668999999999999764 21389999999887 899999999984 345688999999999999
Q ss_pred CCCCCeeeeeeccC-CcceEEEeccCCCEEEecCCCCeeeeeccC
Q 037189 114 DPQGKQVWSSKIDI-GTVAVGHMNDTGNFMLASSSSSRAFFPKIG 157 (766)
Q Consensus 114 ~~~~~~~w~t~~~~-~~~~~~~l~d~GN~vl~~~~~~~~w~~~~~ 157 (766)
|.+|.+||+|++.. ....+++|+|||||||++.++.++| ++++
T Consensus 71 ~~~g~~vW~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W-~Sf~ 114 (116)
T cd00028 71 DGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLW-QSFD 114 (116)
T ss_pred cCCCcEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEE-cCCC
Confidence 99999999999875 4456889999999999998877776 5554
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=168.27 Aligned_cols=111 Identities=28% Similarity=0.395 Sum_probs=92.2
Q ss_pred CeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEEEe
Q 037189 34 ATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLN 113 (766)
Q Consensus 34 ~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~ 113 (766)
+.|..|+ .|+|+++.|++|||.+.. . .++++|||++.+ +++||+|||+.|.. .++.|.|+.||||+|+
T Consensus 2 ~~l~~~~---~l~s~~~~f~~G~~~~~~----q-~dgnlV~~~~~~-~~~vW~snt~~~~~---~~~~l~l~~dGnLvl~ 69 (114)
T smart00108 2 NTLSSGQ---TLVSGNSLFELGFFTLIM----Q-NDYNLILYKSSS-RTVVWVANRDNPVS---DSCTLTLQSDGNLVLY 69 (114)
T ss_pred cccCCCC---EEecCCCcEeeeccccCC----C-CCEEEEEEECCC-CcEEEECCCCCCCC---CCEEEEEeCCCCEEEE
Confidence 3456666 679999999999999754 2 479999999887 89999999998543 3488999999999999
Q ss_pred CCCCCeeeeeecc-CCcceEEEeccCCCEEEecCCCCeeeeeccC
Q 037189 114 DPQGKQVWSSKID-IGTVAVGHMNDTGNFMLASSSSSRAFFPKIG 157 (766)
Q Consensus 114 ~~~~~~~w~t~~~-~~~~~~~~l~d~GN~vl~~~~~~~~w~~~~~ 157 (766)
|.+|.+||+|++. .....+++|+|+|||||++..+.++| ++++
T Consensus 70 ~~~g~~vW~S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W-~Sf~ 113 (114)
T smart00108 70 DGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLW-QSFD 113 (114)
T ss_pred eCCCCEEEEecccCCCCceEEEEeCCCCEEEECCCCCEEe-CCCC
Confidence 9999999999986 34456899999999999998887776 5554
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=196.33 Aligned_cols=260 Identities=20% Similarity=0.222 Sum_probs=189.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC----CCeeeEeeee-ecCCce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH----KNLVRLLGFC-DEGQNR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~ 552 (766)
.+.+.++||+|+||.||++...... ...+|+|............+..|+.++..+.+ +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 4556789999999999999976532 45677777655433333367888888888863 6889999988 477788
Q ss_pred EEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-----CCeEEeccC
Q 037189 553 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-----YNARISDFG 625 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfg 625 (766)
++||+.. +.+|.++.... ..++..+.+.|+.|++.+|.+|| +.+++||||||.|+++... ..+.|.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999975 66899877433 67899999999999999999999 5699999999999999755 469999999
Q ss_pred cccccc--cCCC------cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhh-hhhhHHHH
Q 037189 626 LAKLLT--LNQS------KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVE-EYAILTDW 696 (766)
Q Consensus 626 la~~~~--~~~~------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~-~~~~~~~~ 696 (766)
+++... .... .......+||.+|.++++..+...+.+.|+||++.++.|++.|..|+...... ........
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 999332 2211 11113456999999999999999999999999999999999999998644321 11111111
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
........ .....+.++.++...+-..+..++|....+...|.....
T Consensus 253 ----~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 253 ----PRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred ----hhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 00000000 111234455566666666899999999999988866543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=221.01 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=188.2
Q ss_pred hhhhccccccceEEEEEEecCCCce--eEEEEEEeecccccCHH----HHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTST--TAVAVKKLDIVFQDGER----EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~--~~vavK~l~~~~~~~~~----~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
..+.+|.|.+|.|+..+........ +..++| .. ....++ .+..|+.+-..++|+|++..+..+.+.....-
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~--~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK--PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcc-cC--CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 3467999999977776654322111 112222 10 111222 25567777888999999999888888777777
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+|||+++ +|..++.....+....+..++.|+++|+.||| ..+|.|||||++|++++.++.+||+|||.+..+....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 7999999 99999988878888999999999999999999 5599999999999999999999999999998876554
Q ss_pred Cc--ceeecccccCcccccccccCCCCCcc-cCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 635 SK--TIKTSIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 635 ~~--~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.. ......+|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||......+... ......+.. .+.
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~-~~~- 547 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQR-NIF- 547 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcccccc-ccc-
Confidence 43 34456889999999999999999864 899999999999999999997654432211 000000000 000
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..........+.+...++.++|+.+|.+|.|+++|++
T Consensus 548 -~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 548 -EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001112345677788999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.9e-19 Score=190.22 Aligned_cols=258 Identities=28% Similarity=0.369 Sum_probs=194.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCC-CeeeEeeeeecCCceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHK-NLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV 555 (766)
...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +++++.+++......+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 76 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLV 76 (384)
T ss_pred eeEEeecCCCCeEEEEEEec------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEE
Confidence 34567999999999999875 57888888654433 367899999999999988 799999999777778999
Q ss_pred eeccCCCchhhhhccCC---CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~ 631 (766)
+|++.+++|.+++.... .+.......++.|++.++.|+|+ .+++|||+||+||+++... .++++|||.++...
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999997777654 67888999999999999999995 4899999999999999988 79999999998665
Q ss_pred cCCCcc----eeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC
Q 037189 632 LNQSKT----IKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG 704 (766)
Q Consensus 632 ~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 704 (766)
...... ......|+..|+|||.+.+ ...+...|+|++|++++++++|..|+...... .............
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~ 230 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILEL 230 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhc
Confidence 443221 2255679999999999987 57889999999999999999999997654321 0000111111111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..... ...............+.+++..|+..+|..|.++.+....
T Consensus 231 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 231 PTPSL-ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCccc-ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11000 0000000002223567889999999999999999887654
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=197.10 Aligned_cols=218 Identities=27% Similarity=0.444 Sum_probs=165.6
Q ss_pred HccCCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccc
Q 037189 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQ 609 (766)
Q Consensus 531 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 609 (766)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.|.+.. ...+++.....++.+|++||+|||. ++-..|+.|+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeeccc
Confidence 4578999999999999999999999999999999999987 5678999999999999999999996 333399999999
Q ss_pred eEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCC-------CCCcccCeeehhHHHHHHHhCCcCC
Q 037189 610 NILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 610 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
|+++|....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 999999999999999999877531111111222345579999999763 1467899999999999999999999
Q ss_pred Cchhhhhh-hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 683 DIEMVEEY-AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 683 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
........ ..+...+.. .+. ....+.... ..+..+++..++..||..+|.+||++++|-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKK---GGS--NPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHh---cCC--CCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 76443221 122222221 011 111111111 114445788999999999999999999999998876543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=169.69 Aligned_cols=257 Identities=19% Similarity=0.213 Sum_probs=189.6
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV 555 (766)
..+...++||.|+||.+|.|..-. .+..||||.-+... ...++..|.++...++| ..|..+..|..+...-.||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred cceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 345567899999999999999875 56799999865432 23467888899998876 6788888899999999999
Q ss_pred eeccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~ 631 (766)
||.+ +-+|++.+. ....++..+.+-++-|++.-++|+|. .+++||||||+|+|..- -..+.++|||+++...
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9986 558888764 45678888999999999999999995 59999999999999863 3568899999999876
Q ss_pred cCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 632 LNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 632 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
...+.. ......||.+|.+-....+..-+.+.|+=|+|.+|.+..-|..||+...........+.+.+....-.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 543221 123456999999998888888899999999999999999999999875543322211222221111122
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
+.++.+ .+.++...+.-|=..--++-|...-+.+.+
T Consensus 246 e~LC~G---------~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 246 EVLCKG---------FPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred HHHhCC---------CcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 222221 345566666667776777777765555544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-19 Score=203.83 Aligned_cols=251 Identities=23% Similarity=0.251 Sum_probs=181.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHH--HccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFV--IGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.||+++|=.|.++++.. | .|+||.+-... .-..+.|.++++- ...++|||.+++.-.-..+...|||
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~e----G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDRE----G-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred eeeecccCchhhhhhhhccCCC----c-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHH
Confidence 4466889999999999998763 3 47888764433 3345556554433 5567899999998887777788899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc--ccC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--TLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~--~~~ 633 (766)
-+|..+ +|.|.|..+.-+..-+...|+.|++.||.-+| ..+|+|||||.+||||+.-.=+.|+||..-+.. +.+
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 999877 89999888777777888889999999999999 459999999999999999888999999876543 222
Q ss_pred CCcce---eecccccCcccccccccC----------CC-CCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHH
Q 037189 634 QSKTI---KTSIRGTKGYVAPEWFRN----------SK-ITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAF 698 (766)
Q Consensus 634 ~~~~~---~~~~~gt~~y~aPE~~~~----------~~-~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 698 (766)
..... ....+.-.+|+|||.+.. .. .+++.||||+||++.||++ |+++|.....-.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~a--------- 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLA--------- 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHh---------
Confidence 21111 111122347999998743 12 6789999999999999999 788887543222
Q ss_pred HHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
++.+. .......++.. ....+++++..|++.||++|.++++.++.-.++
T Consensus 247 --Yr~~~-~~~~e~~Le~I----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 --YRSGN-ADDPEQLLEKI----EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HhccC-ccCHHHHHHhC----cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 12221 11001111111 123578899999999999999999999886553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=171.57 Aligned_cols=140 Identities=15% Similarity=0.147 Sum_probs=107.3
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--C-------HHHH-----------------HHHHHHHccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--G-------EREF-----------------KNEVFVIGQTH 535 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~ 535 (766)
.+.||+|+||.||+|... +++.||||.++..... . ...| .+|++.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV 77 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999875 4679999999753211 1 1122 34899999998
Q ss_pred CCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 536 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
|+++.....+.. ...+|||||+++++|...+.....++......++.|++.+|.|||+ ..+|+||||||+|||++
T Consensus 78 ~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~- 152 (190)
T cd05147 78 TAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH- 152 (190)
T ss_pred HCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence 877644333222 2348999999998877654445678888899999999999999943 34999999999999998
Q ss_pred CCCeEEeccCccccc
Q 037189 616 HYNARISDFGLAKLL 630 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~ 630 (766)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-18 Score=170.33 Aligned_cols=259 Identities=19% Similarity=0.250 Sum_probs=187.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (766)
+...++||+|.||.++.|+... ...+||||.-...+ ..-++..|.+..+.+. .++|...+-|-.++.+-.||+|
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred ceeccccccCcceeeecccccc---cCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 3467899999999999998764 46799999865432 2346777888888775 6899999988889989999999
Q ss_pred ccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-----CCCeEEeccCcccccc
Q 037189 558 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-----HYNARISDFGLAKLLT 631 (766)
Q Consensus 558 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~ 631 (766)
.+ +-+|+|.+. ...+++..++..||.|++.-++|+|+ ...|.|||||+|+||.. ...+.|+|||+++...
T Consensus 105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 87 557877664 45678999999999999999999995 49999999999999963 3458899999999876
Q ss_pred cCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 632 LNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 632 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
...+.. ......||.+||+-....+..-+.+.|.=|+|-++++.|-|..||+....+.....-+.+-+..+.-.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i 260 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPI 260 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCH
Confidence 554321 123456999999999999999999999999999999999999999865432211111111111122223
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..++.+ .++++..-+.-.=..+-.+-|..+-+...+..++
T Consensus 261 ~~Lc~g---------~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 261 EVLCEG---------FPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred HHHHhc---------CHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 333222 3444444444444456666777665555554433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.8e-18 Score=171.68 Aligned_cols=172 Identities=13% Similarity=0.104 Sum_probs=128.9
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHH---------HHHHHHHHccCCCCCeeeEe
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---------FKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~---------f~~E~~~l~~l~H~niv~l~ 543 (766)
++....+...+.||.|+||.||+... +...+|||.++......... |.+|++.+.+++|++|..+.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 34445555567899999999998543 24469999997544333322 68899999999999999999
Q ss_pred eeeecC--------CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 544 GFCDEG--------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 544 g~~~~~--------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
+++... ...+|||||+++.+|.++.. ++ .....+++.+|..||+ .+++|||+||+||+++.
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~----~~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----IS----EDVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSK 170 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh----cc----HHHHHHHHHHHHHHHH---cCCccCCCChHHEEEeC
Confidence 886533 35789999999999988732 22 2356699999999995 59999999999999998
Q ss_pred CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHH
Q 037189 616 HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~el 675 (766)
++ ++|+|||..+......... .+.....+..++|+|+||+.+.-+
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHH
Confidence 88 9999999887553222111 122334466789999999988765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.2e-18 Score=165.83 Aligned_cols=142 Identities=15% Similarity=0.082 Sum_probs=110.0
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--------------------------HHHHHHHHHHHccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--------------------------EREFKNEVFVIGQTH 535 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--------------------------~~~f~~E~~~l~~l~ 535 (766)
.+.||+|++|.||+|.+. +++.||||.++...... ...+..|.+.+.++.
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 77 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY 77 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH
Confidence 357999999999999875 46799999987542110 112357889999999
Q ss_pred CCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 536 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
|+++.....+... ..+|||||++++++.........++......++.|++.++.+||+ ..+|+||||||+||+++
T Consensus 78 ~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 78 EAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred hCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 9987544444332 348999999988654443334556778889999999999999996 15999999999999999
Q ss_pred CCCeEEeccCccccccc
Q 037189 616 HYNARISDFGLAKLLTL 632 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~ 632 (766)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.1e-17 Score=160.46 Aligned_cols=133 Identities=19% Similarity=0.229 Sum_probs=103.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-----CCCCeeeEeeeeecCC---ceE-
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-----HHKNLVRLLGFCDEGQ---NRL- 553 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~~~- 553 (766)
+.||+|+||.||+ ++. . ...+||++........+++.+|+.+++++ +||||++++|++.++. ..+
T Consensus 8 ~~LG~G~~~~Vy~--hp~---~-~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPE---D-AQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred ceecCCCceEEEE--CCC---C-cCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 5799999999995 442 2 23368888765445567899999999999 5799999999998764 333
Q ss_pred EEeec--cCCCchhhhhccCCCCccchhhhHHHHHHHHH-HHhhhcCCCceecCCCccceEEEcC----CCCeEEeccCc
Q 037189 554 LVYEF--LNNGTLASFLFGNLKPNWNLRTNIAFQIARGL-LYLHEDCSSQIIHCDMKPQNILLDD----HYNARISDFGL 626 (766)
Q Consensus 554 lV~Ey--~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgl 626 (766)
+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +.+++|+|++.
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5689999999664 34444 45678888777 99995 59999999999999973 34799999544
Q ss_pred c
Q 037189 627 A 627 (766)
Q Consensus 627 a 627 (766)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.4e-18 Score=184.22 Aligned_cols=235 Identities=23% Similarity=0.214 Sum_probs=183.7
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+|+|.||.|+++.-..+...+..+|.|.++...... ......|-.++...+ ||.++++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 789999999987655444566778888775432211 114456677788887 99999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeec
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 641 (766)
|.|...+......+..........++-++.++| +.+|+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------ 152 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------
Confidence 999999988888888888888889999999999 56999999999999999999999999999987654332
Q ss_pred ccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHH
Q 037189 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVE 721 (766)
Q Consensus 642 ~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 721 (766)
.+||.-|||||++. ....++|.||||++.+||+||-.||..+. ...+ + ..+...+.+
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~---~~~I----------------l--~~~~~~p~~ 209 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT---MKRI----------------L--KAELEMPRE 209 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH---HHHH----------------h--hhccCCchh
Confidence 27999999999998 56788999999999999999999998611 1111 1 111223555
Q ss_pred HHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 037189 722 CLEKLVMVSIWCIQEDPSLRPTI--KKVLQML 751 (766)
Q Consensus 722 ~~~~l~~l~~~Cl~~dp~~RPt~--~~vl~~L 751 (766)
....+.+++..+...+|..|--. ..+.+++
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 66677778888888888888644 3444443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.8e-17 Score=190.26 Aligned_cols=199 Identities=23% Similarity=0.232 Sum_probs=162.3
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC---CCCeeeEeeeeecC
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEG 549 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~ 549 (766)
++....+.+.++||+|+||.||+|...+ ++.+|+|.-+ +....+|.--.+++.+++ -+-|+.+...+.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~----~~~~alK~e~---P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN----GKLVALKVEK---PPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC----CcEEEEEeec---CCCceeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 3444445566789999999999999763 7899999865 334556666666677776 12334444444556
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-------CCCCeEEe
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-------DHYNARIS 622 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-------~~~~~kl~ 622 (766)
+..+||+||.+.|+|.+++...+.++|...+.|+.|+++.+.+||. .+|||+||||+|+||. +...++|+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 7889999999999999999999999999999999999999999995 5999999999999994 34568999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcC
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS 681 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p 681 (766)
|||-+..+..-.........++|-.+-.+|...|.+++..+|.|.|+.+++-||.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999877655544444677889999999999999999999999999999999998753
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.4e-17 Score=156.21 Aligned_cols=185 Identities=16% Similarity=0.072 Sum_probs=135.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccC----HHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEe
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG----EREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~----~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 556 (766)
...|++|+||+||.+.- .+..++.+.+.....-. ...|.+|+++|++++ |+++++++++ +..+++|
T Consensus 7 ~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred ceeecCCCcceEEEeec-----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 35799999999996543 34566666665432211 125789999999995 5889999886 4579999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCC-ccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDM-KPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+.+.+|...+.. ....++.|++++|.++|+ .+|+|||| ||+|||++.++.++|+|||++........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999998754321 124578899999999995 59999999 79999999999999999999986554331
Q ss_pred c-------c----eeecccccCcccccccccCC-CCC-cccCeeehhHHHHHHHhCCcCCCch
Q 037189 636 K-------T----IKTSIRGTKGYVAPEWFRNS-KIT-AKVDVYSFGVLLLEIIACRKSFDIE 685 (766)
Q Consensus 636 ~-------~----~~~~~~gt~~y~aPE~~~~~-~~s-~~sDV~s~Gvvl~elltg~~p~~~~ 685 (766)
. . .......++.|+.|+...-. ..+ ...+.++-|.-+|.++|++.+.-.+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 01122357777888754322 333 5678889999999999999876543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=163.55 Aligned_cols=227 Identities=21% Similarity=0.276 Sum_probs=144.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCC----------CCeeeEeeee--
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHH----------KNLVRLLGFC-- 546 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H----------~niv~l~g~~-- 546 (766)
.+.||.|+++.||.+++.. .+...|||...... ....+++.+|......+.+ -.++-.++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEETTEEEEEEEETT---TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred ccccccCCceEEEEEEEcc---CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3579999999999999875 46788998875433 2234567777766655432 1222222221
Q ss_pred -------ecCC--------ceEEEeeccCCCchhhhhc---cC-C---CCccchhhhHHHHHHHHHHHhhhcCCCceecC
Q 037189 547 -------DEGQ--------NRLLVYEFLNNGTLASFLF---GN-L---KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHC 604 (766)
Q Consensus 547 -------~~~~--------~~~lV~Ey~~~gsL~~~l~---~~-~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 604 (766)
.... ..+++|+-+ .++|.+++. .. . .+....++.+..|+++.+++||+ .+++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1111 235677766 458877753 22 1 23344567788999999999995 499999
Q ss_pred CCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccC--------CCCCcccCeeehhHHHHHHH
Q 037189 605 DMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN--------SKITAKVDVYSFGVLLLEII 676 (766)
Q Consensus 605 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~s~Gvvl~ell 676 (766)
||+|+|++++.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999998776544321 11334577999997643 25788999999999999999
Q ss_pred hCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCC
Q 037189 677 ACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLR 741 (766)
Q Consensus 677 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 741 (766)
+++.||........... ..... . +.++.+..|+..+|+.||++|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DFSRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GGTTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cchhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 99999986543221100 11111 2 678889999999999999988
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.1e-16 Score=140.49 Aligned_cols=93 Identities=26% Similarity=0.353 Sum_probs=64.1
Q ss_pred CceEEEEecCCCCCCCCCCCcEEEEeccCcEEEeCCCCCeeeee-eccCC--cceEEEeccCCCEEEecCCCCeeeeecc
Q 037189 80 EKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSS-KIDIG--TVAVGHMNDTGNFMLASSSSSRAFFPKI 156 (766)
Q Consensus 80 ~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~w~t-~~~~~--~~~~~~l~d~GN~vl~~~~~~~~w~~~~ 156 (766)
++|+||+|||+.|+.+.+..+.|.|+.||||+|+|.++++||++ ++... ....|.|+|+|||||+|..+..+| +++
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW-~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLW-QSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEE-EST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEE-eec
Confidence 37999999999976431245899999999999999998999999 55543 368999999999999997666666 777
Q ss_pred CCCCCCCceEEEEec--CCceE
Q 037189 157 GHQFSRGLFQFRLLK--DGNLV 176 (766)
Q Consensus 157 ~~dps~G~~~~~~~~--~g~~~ 176 (766)
+. ++.+.+..+. +++..
T Consensus 80 ~~---ptdt~L~~q~l~~~~~~ 98 (114)
T PF01453_consen 80 DY---PTDTLLPGQKLGDGNVT 98 (114)
T ss_dssp TS---SS-EEEEEET--TSEEE
T ss_pred CC---CccEEEeccCcccCCCc
Confidence 76 6888888876 66544
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.2e-17 Score=174.27 Aligned_cols=172 Identities=25% Similarity=0.373 Sum_probs=129.5
Q ss_pred ceEEEeeccCCCchhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 551 NRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
..++.|+++.-.+|.+||.++ ...++...+.++.|++.|+.| .+.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 467899999999999999754 456788899999999999999 38999999999999999999999999999
Q ss_pred cccccCC----CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 628 KLLTLNQ----SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 628 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
....... .....+...||..||+||.+.+..++.|+||||||+||+||+. -...++... ...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence 8776554 1223355679999999999999999999999999999999987 333332111 111222
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKV 747 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~v 747 (766)
.+.+.. ..-.+.+ +-..++.+++.+.|.+||++.++
T Consensus 474 ~g~ip~--------~~~~d~p-~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGIIPP--------EFLQDYP-EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCCCh--------HHhhcCc-HHHHHHHHhcCCCcccCchHHHH
Confidence 333220 0011111 22468889999999999955443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.7e-16 Score=157.36 Aligned_cols=198 Identities=23% Similarity=0.280 Sum_probs=136.1
Q ss_pred CCCCCeeeEeeeeec---------------------------CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHH
Q 037189 534 THHKNLVRLLGFCDE---------------------------GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 586 (766)
Q Consensus 534 l~H~niv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~i 586 (766)
-+|||||+++++|.+ ....|+||...+. +|.+++..+..- ...+.-|+.|+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s-~r~~~~~laQl 350 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRS-YRTGRVILAQL 350 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCc-hHHHHHHHHHH
Confidence 469999999887632 3456888887765 899998776543 34455688899
Q ss_pred HHHHHHhhhcCCCceecCCCccceEEE--cCCC--CeEEeccCccccccc--CC--CcceeecccccCcccccccccCCC
Q 037189 587 ARGLLYLHEDCSSQIIHCDMKPQNILL--DDHY--NARISDFGLAKLLTL--NQ--SKTIKTSIRGTKGYVAPEWFRNSK 658 (766)
Q Consensus 587 a~gL~yLH~~~~~~ivH~dlk~~NIll--~~~~--~~kl~Dfgla~~~~~--~~--~~~~~~~~~gt~~y~aPE~~~~~~ 658 (766)
++|+.|||++ +|.|||+|++|||+ |++. .+.|+|||.+-.... -+ .........|...-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999955 99999999999998 3444 367899997643221 00 111112345777899999886432
Q ss_pred -----C-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHH
Q 037189 659 -----I-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIW 732 (766)
Q Consensus 659 -----~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 732 (766)
. -.|+|.|+.|.+.||+++...||....+.. +. ...+++..+.. .+..++..+.+++..
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---~r~Yqe~qLPa---------lp~~vpp~~rqlV~~ 492 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---TRTYQESQLPA---------LPSRVPPVARQLVFD 492 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---hhhhhhhhCCC---------CcccCChHHHHHHHH
Confidence 1 258999999999999999999996521100 00 00122222222 234466778899999
Q ss_pred ccccCCCCCCCHHHHHHHH
Q 037189 733 CIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 733 Cl~~dp~~RPt~~~vl~~L 751 (766)
.|+.||.+|++..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999976544443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1e-15 Score=155.51 Aligned_cols=141 Identities=17% Similarity=0.173 Sum_probs=108.0
Q ss_pred hhhhhccccccceEEEEE-EecCCCceeEEEEEEeeccccc------------------------CHHHHHHHHHHHccC
Q 037189 480 NFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQD------------------------GEREFKNEVFVIGQT 534 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~-~~~~~~~~~~vavK~l~~~~~~------------------------~~~~f~~E~~~l~~l 534 (766)
.+.+.||+|+||.||+|. ... .+..||||.++..... ....+.+|++.+.++
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred HhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 456789999999999998 332 4678999998753210 012356899999999
Q ss_pred CCC--CeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCc-eecCCCccceE
Q 037189 535 HHK--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQ-IIHCDMKPQNI 611 (766)
Q Consensus 535 ~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivH~dlk~~NI 611 (766)
.+. .+.+++++ ...++||||+++.+|.........+.......++.|++.++++||+ .+ ++||||||+||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 763 34455543 2358999999999987766444445555667899999999999995 48 99999999999
Q ss_pred EEcCCCCeEEeccCcccccc
Q 037189 612 LLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~ 631 (766)
+++ +++++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-15 Score=152.45 Aligned_cols=134 Identities=19% Similarity=0.252 Sum_probs=111.2
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccccc--------CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.||+|++|.||+|... +..++||+....... ....+.+|++++..++|+++.....++......++
T Consensus 2 ~~l~~G~~~~vy~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccccCceEEEEEEeeC-----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEE
Confidence 57899999999999863 346778875432211 12357889999999999999888888777788899
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
||||+++++|.+++..... .+..++.+++.+|.+||+ .+++|+|++|+||+++ ++.++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999999865432 788999999999999994 5999999999999999 78999999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.7e-15 Score=149.28 Aligned_cols=130 Identities=19% Similarity=0.302 Sum_probs=104.8
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeeccc-cc-------CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QD-------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
.||+|+||.||+|... +..+++|...... .. ....+.+|++++..++|+++.....++......++|
T Consensus 1 ~ig~G~~~~vy~~~~~-----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeecC-----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 3899999999999853 4578888754321 11 125577899999999988766655566666778999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
|||+++++|.+++..... .++.+++++|.+||+ .+++|+|++|+||+++ ++.++++|||+++.
T Consensus 76 ~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999999998754321 789999999999994 5999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-15 Score=169.88 Aligned_cols=133 Identities=16% Similarity=0.228 Sum_probs=107.6
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEe-ecc-cc------cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIV-FQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l-~~~-~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
..+.||+|+||.||+|.+... .+++|+. ... .. ...+.+.+|++++.+++|++++....++......
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~-----~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR-----DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccceeccCCcEEEEEEeecCc-----cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 357899999999999987532 2233322 111 11 1134688999999999999999988888887888
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
++||||+++++|.+++. .+..++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999875 457799999999999995 599999999999999 6789999999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.3e-15 Score=146.01 Aligned_cols=137 Identities=17% Similarity=0.180 Sum_probs=106.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc----------------------CHHHHHHHHHHHccCCC
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD----------------------GEREFKNEVFVIGQTHH 536 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~----------------------~~~~f~~E~~~l~~l~H 536 (766)
+.+.+.||+|+||.||++... ++..+|||.++..... ....+..|..++.++.|
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 455688999999999999875 4678999987542210 11236778888888888
Q ss_pred C--CeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 537 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 537 ~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
+ .+++.++. ...++||||+++++|...... .....++.++++++.++|+ .+++|+||||+||+++
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVD 159 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEc
Confidence 7 44555442 355899999999999775421 3456789999999999995 5999999999999999
Q ss_pred CCCCeEEeccCccccccc
Q 037189 615 DHYNARISDFGLAKLLTL 632 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~ 632 (766)
+++.++|+|||++..+..
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.3e-13 Score=130.02 Aligned_cols=133 Identities=22% Similarity=0.182 Sum_probs=113.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC--CCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.||+|.++.||++.... ..+++|....... ...+.+|+..+..++| .++++++++....+..++++||++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-----~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-----EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred eecccccccceEEEEecC-----CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 579999999999999752 5788998765332 5679999999999986 589999999888888999999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
++.+..+ +......++.++++++++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9887654 4566778899999999999975446899999999999999989999999998865
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.4e-14 Score=162.71 Aligned_cols=205 Identities=21% Similarity=0.259 Sum_probs=138.4
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
-++.|..|+||.||.+.++.+ .+..|.|.-+.. .+.+- ++.....|.+|
T Consensus 87 ~IklisngAygavylvrh~~t---rqrfa~kiNkq~------lilRn--ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKET---RQRFAMKINKQN------LILRN--ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred eeEeeccCCCCceeeeecccc---ccchhhcccccc------hhhhc--cccccCCccee--------------------
Confidence 347899999999999988743 345666322110 01110 22223333333
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC-----
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS----- 635 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----- 635 (766)
|+-...+...+.++-. ++.+++||| +.+|+|||+||+|.+|+.-|.+|+.|||+++.....-.
T Consensus 136 -gDc~tllk~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 -GDCATLLKNIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred -chhhhhcccCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 3434444443333322 278999999 67999999999999999999999999999885432111
Q ss_pred -------cc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 636 -------KT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 636 -------~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
+. .....+||+.|+|||++..+.|...+|.|++|+|+||.+-|..||..+..++... ..+ ...+
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~vi-----sd~i- 275 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVI-----SDDI- 275 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhh-----hhhc-
Confidence 11 1134589999999999999999999999999999999999999999887655211 111 1111
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
...+.....+.++.+++.+.|+.+|.+|-
T Consensus 276 ------~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 ------EWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ------cccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 01111223456778889999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=134.31 Aligned_cols=139 Identities=18% Similarity=0.183 Sum_probs=95.9
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccC--HHHH----------------------HHHHHHHccCCCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREF----------------------KNEVFVIGQTHHK 537 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~--~~~f----------------------~~E~~~l~~l~H~ 537 (766)
.+.||+|+||.||+|... ++..||||.++...... ...+ ..|...+.++.+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEA 77 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHc
Confidence 467999999999999875 45689999876432111 1111 2455555555433
Q ss_pred --CeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 538 --NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 538 --niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
.+.+.+++ ...++||||++++.+........... .....++.+++.++.++|. +.+|+|+||||+||+++
T Consensus 78 ~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 78 GVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 24444443 24689999999954432111111111 6678899999999999995 16999999999999999
Q ss_pred CCCeEEeccCccccccc
Q 037189 616 HYNARISDFGLAKLLTL 632 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~ 632 (766)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-14 Score=164.45 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=187.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|.|+.|-....... ....+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccchhhhhhhcCC--CcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34556699999999987765432 34567777776543 122233344666666666 99999999999999999999
Q ss_pred eeccCCCchhhhh-ccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCccccccc
Q 037189 556 YEFLNNGTLASFL-FGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTL 632 (766)
Q Consensus 556 ~Ey~~~gsL~~~l-~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 632 (766)
.||..++++.+.+ .... ..+.......+.|+..++.|+|. ..++.|+||||+|.+++..+ ..|++|||+|.....
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999999999988 5443 56677778899999999999993 24899999999999999999 999999999998876
Q ss_pred -CCCcceeecccc-cCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 633 -NQSKTIKTSIRG-TKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 633 -~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|. +..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~-----~~~---- 247 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWK-----SNK---- 247 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeec-----ccc----
Confidence 444333355678 9999999999884 5567899999999999999999998754432210 01110 000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
................++..+++..+|..|.+.+++.
T Consensus 248 --~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 --GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000111122345567788888989999999987764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=8.3e-13 Score=134.56 Aligned_cols=134 Identities=16% Similarity=0.115 Sum_probs=103.0
Q ss_pred hhcc-ccccceEEEEEEecCCCceeEEEEEEeeccc-------------ccCHHHHHHHHHHHccCCCCCe--eeEeeee
Q 037189 483 EEVG-RGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-------------QDGEREFKNEVFVIGQTHHKNL--VRLLGFC 546 (766)
Q Consensus 483 ~~LG-~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~ 546 (766)
..|| .|+.|+||++... +..++||+..... ......+.+|++++.+++|++| ++.+++.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred ceeecCCCCccEEEEEeC-----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 4687 8999999998874 4467888774311 1223567889999999998875 7777775
Q ss_pred ecCC----ceEEEeeccCC-CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEE
Q 037189 547 DEGQ----NRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 547 ~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
.... ..++|+|++++ .+|.+++... .++. ..+.+|+++|.+||+ .+|+|+||||+|||++.++.++|
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 4432 23599999997 6899887543 2332 346789999999995 59999999999999999899999
Q ss_pred eccCcccc
Q 037189 622 SDFGLAKL 629 (766)
Q Consensus 622 ~Dfgla~~ 629 (766)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-12 Score=128.04 Aligned_cols=200 Identities=20% Similarity=0.225 Sum_probs=138.0
Q ss_pred HHHccCCCCCeeeEeeeeecC-----CceEEEeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCC
Q 037189 529 FVIGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSS 599 (766)
Q Consensus 529 ~~l~~l~H~niv~l~g~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 599 (766)
..|-++-|.|||++..|..+. .+..++.|||+.|+|..+|+.. ..+....-.+++.||..||.|||.. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 445566799999999987543 4578999999999999999753 4566667778999999999999965 89
Q ss_pred ceecCCCccceEEEcCCCCeEEeccCcccccccCCC---cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHH
Q 037189 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS---KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676 (766)
Q Consensus 600 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ell 676 (766)
.|+|+++..+-|++..++-+||.- +.......... ........+-++|.+||+-.....+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999999998888742 21111111110 00112234678999999988888889999999999999997
Q ss_pred hCCcCCC-chhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 677 ACRKSFD-IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 677 tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+..--. .....+...... .....+... .-+.++..|++..|..||+|++++.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia---------~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIA---------NVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhh---------hheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 7664321 111100000000 000000000 11246778999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-11 Score=135.20 Aligned_cols=141 Identities=21% Similarity=0.215 Sum_probs=98.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccC----------------------------------------HH
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG----------------------------------------ER 522 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~ 522 (766)
+.||+|++|.||+|++. +++.||||..+...... +-
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El 198 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL 198 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence 35999999999999987 46789999986421100 01
Q ss_pred HHHHHHHHHccCC----CCCeeeEeeee-ecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHH-HHHHhhhc
Q 037189 523 EFKNEVFVIGQTH----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR-GLLYLHED 596 (766)
Q Consensus 523 ~f~~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 596 (766)
+|.+|.+.+.+++ |.+-+.+-..+ ...+..+|||||+++++|.++..... .. ..+.+++..+++ .+..+|+
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~-~~~~~ia~~~~~~~l~ql~~- 275 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AG-LDRKALAENLARSFLNQVLR- 275 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cC-CCHHHHHHHHHHHHHHHHHh-
Confidence 2455555555542 33333333333 33456799999999999988764321 01 134567777776 4677784
Q ss_pred CCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 597 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
.+++|+|+||.||+++++++++++|||++..+..
T Consensus 276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 5999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-11 Score=132.78 Aligned_cols=257 Identities=24% Similarity=0.259 Sum_probs=184.5
Q ss_pred HHHHHHHHHhhhhhccc--cccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCC-CCCeeeEeee
Q 037189 471 YKELEEATDNFKEEVGR--GSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTH-HKNLVRLLGF 545 (766)
Q Consensus 471 ~~~l~~~t~~f~~~LG~--G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~ 545 (766)
..+.++....+.+.+|. |.+|.||.+.... ..+...+|+|+-+.... .....=.+|....++++ |+|.++....
T Consensus 108 ~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~-~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~ 186 (524)
T KOG0601|consen 108 FDSFFDQRFPISSRTGSLPGSKGSVFKSRCTN-SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA 186 (524)
T ss_pred ccchhhhhcccccccccCCCCCceeecccCCc-ccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence 34556666677788999 9999999998733 33677889998554333 33333355666666664 9999998888
Q ss_pred eecCCceEEEeeccCCCchhhhhccCCC-CccchhhhHHHHHHH----HHHHhhhcCCCceecCCCccceEEEcCC-CCe
Q 037189 546 CDEGQNRLLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIAR----GLLYLHEDCSSQIIHCDMKPQNILLDDH-YNA 619 (766)
Q Consensus 546 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~ 619 (766)
....+..++-.|++. .+|..+.+.... ++....+....+... ||.++| +..++|-|+||.||++..+ ...
T Consensus 187 ~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 187 WEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccccee
Confidence 999999999999886 688888776543 667777778888888 999999 6799999999999999998 889
Q ss_pred EEeccCcccccccCCCccee---ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH
Q 037189 620 RISDFGLAKLLTLNQSKTIK---TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 696 (766)
++.|||+...+......... ....|...|++||.+.+ -++.+.|+|++|.+..+..++.......-.. .|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SW 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc
Confidence 99999999988765522111 12257788999998764 5788999999999999999988766432111 11
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...+.+- +.++ .-.....++..++.++++.+|..|++.+.+..
T Consensus 336 --~~~r~~~---ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 --SQLRQGY---IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --ccccccc---Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111111 0000 01112344555888999999999999877654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.1e-10 Score=110.83 Aligned_cols=130 Identities=19% Similarity=0.123 Sum_probs=95.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.|+.|.++.||++... +..+++|....... ....+.+|++.+..+.+.++ .+++.+.. ...++||||+++
T Consensus 4 ~~l~~G~~~~vy~~~~~-----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eecCCcccCceEEEEEC-----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 56889999999998864 45789998754321 23456888988888866554 44555432 345899999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC--CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
.++.+. ......++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 887653 1123456789999999999642 22369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.02 E-value=7.2e-10 Score=124.29 Aligned_cols=142 Identities=15% Similarity=0.143 Sum_probs=91.0
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccccc----------------------------------------CHH
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD----------------------------------------GER 522 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~----------------------------------------~~~ 522 (766)
+.||+|++|.||+|++++ .++.||||.++..... .+-
T Consensus 125 ~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~El 201 (537)
T PRK04750 125 KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDEL 201 (537)
T ss_pred hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhh
Confidence 369999999999999974 3678999998643110 001
Q ss_pred HHHHHHHHHccCC----CCCeeeEeeeeec-CCceEEEeeccCCCchhhhh--ccCCCCccchhhhHHHHHHHHHHHhhh
Q 037189 523 EFKNEVFVIGQTH----HKNLVRLLGFCDE-GQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHE 595 (766)
Q Consensus 523 ~f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~gL~yLH~ 595 (766)
+|.+|+..+.+++ +.+.+.+-.++.+ ..+.+|||||++|+.|.+.- ...+ .+ +..++...++. |+++
T Consensus 202 D~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d---~~~la~~~v~~--~~~Q 275 (537)
T PRK04750 202 DLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TD---MKLLAERGVEV--FFTQ 275 (537)
T ss_pred CHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CC---HHHHHHHHHHH--HHHH
Confidence 2445554444442 4444444444433 45688999999999998742 2211 11 12233222221 1111
Q ss_pred cCCCceecCCCccceEEEcCCC----CeEEeccCcccccccC
Q 037189 596 DCSSQIIHCDMKPQNILLDDHY----NARISDFGLAKLLTLN 633 (766)
Q Consensus 596 ~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~~ 633 (766)
-...+++|+|+||.||+++.++ +++++|||+...+...
T Consensus 276 if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 276 VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 1134999999999999999888 9999999999877543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.8e-09 Score=115.68 Aligned_cols=164 Identities=18% Similarity=0.189 Sum_probs=120.0
Q ss_pred ceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHH
Q 037189 504 STTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 583 (766)
Q Consensus 504 ~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~ 583 (766)
++.+|.|...+...........+-++.|+.++||||++++.....++..|||+|-+. -|..++... ......-.+
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~~Gl 110 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVCLGL 110 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHHHHH
Confidence 456777777765544334456778899999999999999999999999999999764 344555432 244455568
Q ss_pred HHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCccc
Q 037189 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKV 663 (766)
Q Consensus 584 ~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~s 663 (766)
.||+.||.+||+. ..++|++|....|+++..|..||++|.++........ ......--..|..|+.+.... -..
T Consensus 111 ~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~ 184 (690)
T KOG1243|consen 111 FQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSI 184 (690)
T ss_pred HHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cch
Confidence 8999999999974 5899999999999999999999999998765432211 001111222455665443222 346
Q ss_pred CeeehhHHHHHHHhC
Q 037189 664 DVYSFGVLLLEIIAC 678 (766)
Q Consensus 664 DV~s~Gvvl~elltg 678 (766)
|.|.||++++|++.|
T Consensus 185 D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 185 DSWGLGCLIEELFNG 199 (690)
T ss_pred hhhhHHHHHHHHhCc
Confidence 999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.8e-09 Score=106.03 Aligned_cols=142 Identities=17% Similarity=0.212 Sum_probs=108.2
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCC--CCeeeEeeeeecCC---ceEEEe
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ---NRLLVY 556 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~ 556 (766)
+.|+.|..+.+|++...+ +..+++|....... .....+.+|.+++..+++ .++.+++.+..+.. ..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~----g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG----GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC----CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 458999999999998742 46788998754322 135578999999999876 44677888876643 668999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC---------------------------------------
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC--------------------------------------- 597 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 597 (766)
||+++.+|.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988876532 34566677788888888888888521
Q ss_pred --------------CCceecCCCccceEEEcC--CCCeEEeccCcccc
Q 037189 598 --------------SSQIIHCDMKPQNILLDD--HYNARISDFGLAKL 629 (766)
Q Consensus 598 --------------~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~ 629 (766)
...++|+|+++.||++++ +..+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-08 Score=108.44 Aligned_cols=166 Identities=20% Similarity=0.261 Sum_probs=128.7
Q ss_pred ceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee----cCCceEEEeeccCC-Cchh
Q 037189 491 GIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----EGQNRLLVYEFLNN-GTLA 565 (766)
Q Consensus 491 g~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~lV~Ey~~~-gsL~ 565 (766)
.+.||+.... ++..+++|+++....+.......-++.++++.|.|+|++..++. .+..+++||+|.++ ++|.
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ceeEeeeecc---CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 5779998765 57789999996554444444455678899999999999999875 34578899999987 7787
Q ss_pred hhhccC---------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 566 SFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 566 ~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+.-+.. ...+++..|.++.|+..||.++|+ .|..-+-|.+++||++.+.+++|+.+|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeee
Confidence 765421 245678899999999999999994 58888999999999999999999999988776
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcC
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS 681 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p 681 (766)
..+.... +. --.+-|.=.||.+++.|.||...
T Consensus 444 ~~d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 6543111 11 12356888899999999999643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.4e-10 Score=120.56 Aligned_cols=243 Identities=20% Similarity=0.188 Sum_probs=173.2
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHH--HHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeec
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE--FKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~--f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
...||.|.|+.|++.... ..++..+++|.+.........+ -..|+.+...+ .|.++++....+......++=-||
T Consensus 270 v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred eEEccCCccccceeeeec--CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 357999999999998743 2356788888876543332222 24566555555 488899988888788888899999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~~ 637 (766)
++++++...+.....++...++++..|++.++.++| ++.++|+|+||+||++..+ +.-++.|||.+..+.....
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-- 422 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-- 422 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc--
Confidence 999998888755567788899999999999999999 6799999999999999876 8889999999875322111
Q ss_pred eeecccccCcc-cccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGY-VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y-~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....+..| .+++......+-.+.|+++||.-+.|.+++...-..... | ..++.+...
T Consensus 423 --~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~--~~i~~~~~p--------- 481 (524)
T KOG0601|consen 423 --VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------S--LTIRSGDTP--------- 481 (524)
T ss_pred --cccccccccccchhhccccccccccccccccccccccccCcccCccccc--------c--eeeeccccc---------
Confidence 112233344 466666677888999999999999999998765432110 0 011111111
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
......+.+..+...++.+++..||.+.++..+.+-
T Consensus 482 -~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 482 -NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -CCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 011122566677788999999999999888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=99.25 Aligned_cols=141 Identities=14% Similarity=0.190 Sum_probs=97.9
Q ss_pred hhccccccceEEEEEEecCC---CceeEEEEEEeecccc----------------------cCHHHH----HHHHHHHcc
Q 037189 483 EEVGRGSFGIVYKGVIQTTR---TSTTAVAVKKLDIVFQ----------------------DGEREF----KNEVFVIGQ 533 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~---~~~~~vavK~l~~~~~----------------------~~~~~f----~~E~~~l~~ 533 (766)
..||.|--+.||.|....+. ..+..+|||..+.... ...+.+ .+|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46889999999999754210 0246889997753110 001223 378989988
Q ss_pred CCC--CCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHh-hhcCCCceecCCCccce
Q 037189 534 THH--KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL-HEDCSSQIIHCDMKPQN 610 (766)
Q Consensus 534 l~H--~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~dlk~~N 610 (766)
+.. -++.+++++ ...+|||||+.+..+....-....++......+..+++.+|..| | ..+++|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 864 466677765 56789999998754432221222334445667889999999999 6 4599999999999
Q ss_pred EEEcCCCCeEEeccCcccccc
Q 037189 611 ILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 611 Ill~~~~~~kl~Dfgla~~~~ 631 (766)
|+++ ++.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 4689999999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-08 Score=94.92 Aligned_cols=132 Identities=20% Similarity=0.322 Sum_probs=99.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEE-eecccccC-------HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKK-LDIVFQDG-------EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~-l~~~~~~~-------~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.+++|+-+.+|.+.+. +..+++|. +++..... ...-.+|.+++.+++--.|.-..=+..+.+...|
T Consensus 2 ~~i~~GAEa~i~~~~~~-----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLI 76 (204)
T ss_pred chhhCCcceeEEeeecc-----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEE
Confidence 35788999999998664 22333332 22211111 1345789999999876666666666778888999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+|||.++..|.+.+... +..++..+-+.+.-||. .+|+|+||.++||++..+. +.++||||+..-
T Consensus 77 ~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 77 VMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999999999988655 46788888889999995 5999999999999998765 999999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.4e-09 Score=119.35 Aligned_cols=194 Identities=24% Similarity=0.257 Sum_probs=142.2
Q ss_pred CCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 535 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
+||-+++..--+.-.....|+++|..+++|..-|+.....+.+-.......+...++||| +..+.|+|++|.|+++.
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIA 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccc---cchhhcccccccchhhc
Confidence 446566555445566788999999999999999988877777776777778889999999 45689999999999999
Q ss_pred CCCCeEEeccCcccccccC---------------------CC----c----ceeecccccCcccccccccCCCCCcccCe
Q 037189 615 DHYNARISDFGLAKLLTLN---------------------QS----K----TIKTSIRGTKGYVAPEWFRNSKITAKVDV 665 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~---------------------~~----~----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV 665 (766)
.++..++.||+.......- .. . .......+|+.|++||.+.+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 9999999999844332110 00 0 01123468999999999999999999999
Q ss_pred eehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 037189 666 YSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 666 ~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 745 (766)
|++|++++|.++|.+||........ .+.+..+.+.. ...+.+...+..+++...+..+|.+|-.|.
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~-------f~ni~~~~~~~-------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQI-------FENILNRDIPW-------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhh-------hhccccCCCCC-------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999999999999986654331 12122222111 112334455667777788888999998775
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.6e-08 Score=87.47 Aligned_cols=78 Identities=22% Similarity=0.335 Sum_probs=61.5
Q ss_pred EEEEeccCcEEEeCCC-CCeeeeeeccCC--cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 101 QVKLTADQGLVLNDPQ-GKQVWSSKIDIG--TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 101 ~l~~~~~g~l~l~~~~-~~~~w~t~~~~~--~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
.+.++.|||||+++.. +.+||++++... ....+.|+++|||||+|.++..+|..... ...|.+.+.|+.+|++++
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t~--~~~~~~~~~L~ddGnlvl 100 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNTT--GANGNYVLVLLDDGNLVI 100 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEeccc--CCCCceEEEEeCCCCEEE
Confidence 4556789999999765 579999998543 23678999999999999888888843322 457889999999999998
Q ss_pred Eec
Q 037189 178 NIA 180 (766)
Q Consensus 178 ~~~ 180 (766)
+-.
T Consensus 101 ~~~ 103 (114)
T smart00108 101 YDS 103 (114)
T ss_pred ECC
Confidence 743
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.4e-08 Score=87.90 Aligned_cols=87 Identities=23% Similarity=0.374 Sum_probs=65.7
Q ss_pred EEEec-cCcEEEeCCC-CCeeeeeeccC--CcceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 102 VKLTA-DQGLVLNDPQ-GKQVWSSKIDI--GTVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 102 l~~~~-~g~l~l~~~~-~~~~w~t~~~~--~~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
+.++. ||+||+++.. +.+||++|+.. .....+.|+++|||||+|.++.++|..... . ..+.+.+.|+.+|++++
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~~-~-~~~~~~~~L~ddGnlvl 101 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNTT-R-VNGNYVLVLLDDGNLVL 101 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEeccc-C-CCCceEEEEeCCCCEEE
Confidence 44565 9999999765 57999999864 244678999999999999888888832222 2 47889999999999998
Q ss_pred EeccCCccccccceeeccc
Q 037189 178 NIANLPTDFAYDAYYISHT 196 (766)
Q Consensus 178 ~~~~~~~~~~~~~y~~sg~ 196 (766)
+-..+ ...|.|..
T Consensus 102 ~~~~~------~~~W~Sf~ 114 (116)
T cd00028 102 YDSDG------NFLWQSFD 114 (116)
T ss_pred ECCCC------CEEEcCCC
Confidence 75432 34676654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.4e-07 Score=88.29 Aligned_cols=140 Identities=20% Similarity=0.285 Sum_probs=101.2
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEe-ecccc-------cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQ-------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l-~~~~~-------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.|-+|+-+.|+++... ++..+||.- ..... -..+...+|++++.+..--.|.-..=++.+...-.|
T Consensus 13 ~likQGAEArv~~~~~~-----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred eeeeccceeeEeeeccC-----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeE
Confidence 56889999999999875 445455532 21111 123457889999998876565555556667777889
Q ss_pred EeeccCC-CchhhhhccCC-CCccchh-hhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC---CeEEeccCccc
Q 037189 555 VYEFLNN-GTLASFLFGNL-KPNWNLR-TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---NARISDFGLAK 628 (766)
Q Consensus 555 V~Ey~~~-gsL~~~l~~~~-~l~~~~~-~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~ 628 (766)
+|||.++ .++.+++.... ....+.. ..++..|-+.+.-||. .+|+|+||..+||+|..++ .+.++|||++.
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999987 57888887542 2233333 6788999999999994 5999999999999996554 35899999986
Q ss_pred cc
Q 037189 629 LL 630 (766)
Q Consensus 629 ~~ 630 (766)
..
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 53
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.7e-08 Score=111.83 Aligned_cols=151 Identities=18% Similarity=0.248 Sum_probs=104.3
Q ss_pred HHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-------eecccccCcccccccccC
Q 037189 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-------KTSIRGTKGYVAPEWFRN 656 (766)
Q Consensus 584 ~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 656 (766)
.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+........... .....-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445599999997 68999999999999999999999999998775544211100 011123457999999999
Q ss_pred CCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccc
Q 037189 657 SKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQ 735 (766)
Q Consensus 657 ~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~ 735 (766)
...+.++|+||+|++++-+.. |+..+........... ....+.-.........+.++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 889999999999999999994 5554443321111100 00011111111234567788888889999
Q ss_pred cCCCCCCCHHHHHH
Q 037189 736 EDPSLRPTIKKVLQ 749 (766)
Q Consensus 736 ~dp~~RPt~~~vl~ 749 (766)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.9e-07 Score=87.91 Aligned_cols=126 Identities=20% Similarity=0.199 Sum_probs=81.3
Q ss_pred EEEEEEecCCCceeEEEEEEeecccc-------------c-------------CHHHHHHHHHHHccCCCC--CeeeEee
Q 037189 493 VYKGVIQTTRTSTTAVAVKKLDIVFQ-------------D-------------GEREFKNEVFVIGQTHHK--NLVRLLG 544 (766)
Q Consensus 493 Vy~~~~~~~~~~~~~vavK~l~~~~~-------------~-------------~~~~f~~E~~~l~~l~H~--niv~l~g 544 (766)
||.|... ++..+|||.-+.... . ......+|.+.|.++... ++.+++.
T Consensus 2 Vy~~~~~----~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~ 77 (188)
T PF01163_consen 2 VYHAIDP----DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD 77 (188)
T ss_dssp EEEEEEC----TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred EEEEECC----CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence 7888765 466899998753110 0 012357899999999865 5677775
Q ss_pred eeecCCceEEEeeccC--CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 545 FCDEGQNRLLVYEFLN--NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 545 ~~~~~~~~~lV~Ey~~--~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
+- ...|||||++ +..+....... ++.+....++.++++.+..+++ ..+|+|+||.+.||+++++ .+.|+
T Consensus 78 ~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 78 YN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp EE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE-
T ss_pred Ee----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEE
Confidence 53 4589999998 54554432211 1245567788888886666532 5699999999999999988 99999
Q ss_pred ccCcccccc
Q 037189 623 DFGLAKLLT 631 (766)
Q Consensus 623 Dfgla~~~~ 631 (766)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.1e-07 Score=93.85 Aligned_cols=130 Identities=15% Similarity=0.075 Sum_probs=93.4
Q ss_pred eEEEEEEecCCCceeEEEEEEeecccc-----------cCHHHHHHHHHHHccCCCCC--eeeEeeeeec-----CCceE
Q 037189 492 IVYKGVIQTTRTSTTAVAVKKLDIVFQ-----------DGEREFKNEVFVIGQTHHKN--LVRLLGFCDE-----GQNRL 553 (766)
Q Consensus 492 ~Vy~~~~~~~~~~~~~vavK~l~~~~~-----------~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~-----~~~~~ 553 (766)
.|.+..+. ++.+.||+...... .....+.+|...+.++...+ .++++++... ....+
T Consensus 37 rvvr~~~~-----g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~ 111 (268)
T PRK15123 37 RTLRFELA-----GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSF 111 (268)
T ss_pred eEEEEEEC-----CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeE
Confidence 35566543 45788886632210 11124788998888875433 3455556543 23578
Q ss_pred EEeeccCCC-chhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-------CCCeEEec
Q 037189 554 LVYEFLNNG-TLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-------HYNARISD 623 (766)
Q Consensus 554 lV~Ey~~~g-sL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-------~~~~kl~D 623 (766)
||+|++++- +|.+++.. ....+...+..++.++++.+.-||+ .+|+|+|++++|||++. +..+.++|
T Consensus 112 LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 112 IITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred EEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 999999985 89998853 2344556777899999999999995 59999999999999975 46789999
Q ss_pred cCcccc
Q 037189 624 FGLAKL 629 (766)
Q Consensus 624 fgla~~ 629 (766)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.7e-06 Score=86.38 Aligned_cols=136 Identities=16% Similarity=0.161 Sum_probs=97.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc----------------------cCHHHHHHHHHHHccCCCC
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ----------------------DGEREFKNEVFVIGQTHHK 537 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~----------------------~~~~~f~~E~~~l~~l~H~ 537 (766)
.+.++||.|--+.||.|..+ ++..+|||.=+.... -......+|.+.|.++...
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~ 169 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE 169 (304)
T ss_pred hhccccccCccceEEEEECC----CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence 45688999999999999976 467889886542110 0123457888899888755
Q ss_pred --CeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 538 --NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 538 --niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
.+.+.+++ +...+||||.++--|...- ++.+....|+..|++-+.-+-+ .+|+|+|+++-||++++
T Consensus 170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 66666664 5668999999986665432 1333444455555555544442 48999999999999999
Q ss_pred CCCeEEeccCcccccc
Q 037189 616 HYNARISDFGLAKLLT 631 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~ 631 (766)
++.+.++||-.+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999998776443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.9e-06 Score=85.99 Aligned_cols=107 Identities=20% Similarity=0.219 Sum_probs=85.6
Q ss_pred HHHHHHHHHHHccCCC--CCeeeEeeeeecCC----ceEEEeeccCC-CchhhhhccCCCCccchhhhHHHHHHHHHHHh
Q 037189 521 EREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ----NRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593 (766)
Q Consensus 521 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yL 593 (766)
...+.+|...+.++.. -...+.+++..... ..+||+|++++ .+|.+++.....++...+..++.++++.++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3467888887777753 34566777765532 45899999988 58999998755577778889999999999999
Q ss_pred hhcCCCceecCCCccceEEEcCCC---CeEEeccCccccc
Q 037189 594 HEDCSSQIIHCDMKPQNILLDDHY---NARISDFGLAKLL 630 (766)
Q Consensus 594 H~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 630 (766)
|+ .+|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 135 H~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 95 4999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.5e-06 Score=82.36 Aligned_cols=135 Identities=16% Similarity=0.107 Sum_probs=101.4
Q ss_pred cccccceEEEEEEecCCCceeEEEEEEeecc-----c-ccCHHHHHHHHHHHccCCCC--CeeeEeeeeec-----CCce
Q 037189 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-----F-QDGEREFKNEVFVIGQTHHK--NLVRLLGFCDE-----GQNR 552 (766)
Q Consensus 486 G~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-----~-~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~-----~~~~ 552 (766)
|+||-+.|++..+. ++.+=+|+-..- . +-+...|.+|...|.++... .+.++. ++.. ....
T Consensus 27 ~rgG~SgV~r~~~~-----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA 100 (216)
T PRK09902 27 RRNGMSGVQCVERN-----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRA 100 (216)
T ss_pred CCCCcceEEEEEeC-----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEE
Confidence 66899999998765 235777776411 1 33567899999999998643 355555 3321 1246
Q ss_pred EEEeeccCC-CchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC--eEEeccCcc
Q 037189 553 LLVYEFLNN-GTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN--ARISDFGLA 627 (766)
Q Consensus 553 ~lV~Ey~~~-gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla 627 (766)
+||+|-+++ .+|.+++... .+++...+..++.++++.++-||+ .++.|+|+.+.||+++.++. ++++||.-+
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 799997765 6899998653 355777888999999999999995 59999999999999986667 999999876
Q ss_pred cc
Q 037189 628 KL 629 (766)
Q Consensus 628 ~~ 629 (766)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 54
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=2e-06 Score=96.15 Aligned_cols=144 Identities=21% Similarity=0.274 Sum_probs=93.0
Q ss_pred hhh-hhccccccceEEEEEEecCCCceeEEEEEEeeccccc--------------------------C------------
Q 037189 480 NFK-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--------------------------G------------ 520 (766)
Q Consensus 480 ~f~-~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--------------------------~------------ 520 (766)
+|. +-|+.++-|.||+|++. +++.||||..+..-.. .
T Consensus 127 eF~~~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 127 EFEPEPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HcCCCchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 344 35999999999999998 4789999998642111 0
Q ss_pred --HHHHHHHHHHHccCC----CCCeeeEeeee-ecCCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHH-H
Q 037189 521 --EREFKNEVFVIGQTH----HKNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGL-L 591 (766)
Q Consensus 521 --~~~f~~E~~~l~~l~----H~niv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL-~ 591 (766)
+-++.+|...+.+++ ...-+++=.++ +-.+...|+|||++|-.+.+...-. ...+ +..++..++++. .
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d---~k~ia~~~~~~f~~ 279 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID---RKELAELLVRAFLR 279 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence 111344444444432 22223333333 3456789999999999888874221 2233 233443333321 1
Q ss_pred HhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 592 yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
.+- ..+++|.|.+|.||+++.++++.+.|||+...+.+.
T Consensus 280 q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 280 QLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 111 239999999999999999999999999999877654
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.5e-06 Score=72.52 Aligned_cols=92 Identities=22% Similarity=0.345 Sum_probs=62.4
Q ss_pred eeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEe-cCCCCCCCCCCCcEEEEeccCcEEEeCCCCCeeee
Q 037189 44 RWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYT-DNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWS 122 (766)
Q Consensus 44 ~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWva-n~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 122 (766)
++.+.+|.+.|-|...|. |-|.-. ..++||.. +... .....+.+.|++||||||+|.++.+||+
T Consensus 13 p~~~~s~~~~L~l~~dGn---------Lvl~~~---~~~~iWss~~t~~---~~~~~~~~~L~~~GNlvl~d~~~~~lW~ 77 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN---------LVLYDS---NGSVIWSSNNTSG---RGNSGCYLVLQDDGNLVLYDSSGNVLWQ 77 (114)
T ss_dssp EEEECETTEEEEEETTSE---------EEEEET---TTEEEEE--S-TT---SS-SSEEEEEETTSEEEEEETTSEEEEE
T ss_pred ccccccccccceECCCCe---------EEEEcC---CCCEEEEecccCC---ccccCeEEEEeCCCCEEEEeecceEEEe
Confidence 444544888888876542 555322 25779988 4343 1114588999999999999999999999
Q ss_pred eeccCCcceEEEecc--CCCEEEecCCCCeee
Q 037189 123 SKIDIGTVAVGHMND--TGNFMLASSSSSRAF 152 (766)
Q Consensus 123 t~~~~~~~~~~~l~d--~GN~vl~~~~~~~~w 152 (766)
|... .....+..++ +||++ +.......|
T Consensus 78 Sf~~-ptdt~L~~q~l~~~~~~-~~~~~~~sw 107 (114)
T PF01453_consen 78 SFDY-PTDTLLPGQKLGDGNVT-GKNDSLTSW 107 (114)
T ss_dssp STTS-SS-EEEEEET--TSEEE-EESTSSEEE
T ss_pred ecCC-CccEEEeccCcccCCCc-cccceEEeE
Confidence 9543 4556677777 89999 765555666
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-05 Score=83.77 Aligned_cols=255 Identities=14% Similarity=0.128 Sum_probs=150.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeee----e--ecCC-ce
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGF----C--DEGQ-NR 552 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~----~--~~~~-~~ 552 (766)
.+..||+|+-+.+|-.-- ....+-|+.......... ..+..|... .||-+-.-+.+ . -+.+ ..
T Consensus 15 ~gr~LgqGgea~ly~l~e------~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE------VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecch------hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 346799999999985421 112233444332222211 122233332 45543221111 1 1222 25
Q ss_pred EEEeeccCCC-chhhhhc------cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccC
Q 037189 553 LLVYEFLNNG-TLASFLF------GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625 (766)
Q Consensus 553 ~lV~Ey~~~g-sL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 625 (766)
-++|..+++. -...++. +....+|...++.+..++.+.+-||+. +.+-+|++++|+|+.++..+.|.|-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 5777776653 2333332 124568999999999999999999954 99999999999999999999999865
Q ss_pred cccccccCCCcceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhC-CcCCCchhhhhh--hhHHHHH
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEY--AILTDWA 697 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg-~~p~~~~~~~~~--~~~~~~~ 697 (766)
.-.... .........|...|.+||.-. +..-+...|-|.||+++++++.| ++||........ .....
T Consensus 163 sfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~-- 237 (637)
T COG4248 163 SFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET-- 237 (637)
T ss_pred ceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--
Confidence 433321 122234567889999999764 33456789999999999999986 999975321100 00000
Q ss_pred HHHhhcCccceeccC------cccCCCcHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHhcC
Q 037189 698 FDCYRNGKLDALVGG------DMEAMNDVECLEKLVMVSIWCIQED--PSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 698 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~l~~~Cl~~d--p~~RPt~~~vl~~Le~~ 754 (766)
.+-.+......+. ......-.-.+..+..+..+|+... +.-|||++..+..|..+
T Consensus 238 --~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 238 --DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred --hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0011111111110 0111111223455667778888654 56899999988887553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.3e-05 Score=78.20 Aligned_cols=102 Identities=25% Similarity=0.392 Sum_probs=83.3
Q ss_pred HHHHHHHccCCC-CCeeeEeeeeecCCceEEEeeccCCCchhh---hhccCCCCccchhhhHHHHHHHHHHHhhhcCCCc
Q 037189 525 KNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYEFLNNGTLAS---FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600 (766)
Q Consensus 525 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~---~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 600 (766)
..|.-++..+++ +++++++|+|- .++|.||...+++.. .+..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 69999999994 378999998776642 1222235689999999999999999999865566
Q ss_pred eecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 601 IIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 601 ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+.-+|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.6e-05 Score=85.02 Aligned_cols=144 Identities=19% Similarity=0.248 Sum_probs=90.1
Q ss_pred hhh-hhccccccceEEEEEEecCCCceeEEEEEEeeccccc-------------------------------------CH
Q 037189 480 NFK-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-------------------------------------GE 521 (766)
Q Consensus 480 ~f~-~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-------------------------------------~~ 521 (766)
.|. +.||.-..|.||+|+++ ++..||||.-+..-+. .+
T Consensus 163 ~f~~~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 163 EFDEEPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred hcCcchhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 455 46999999999999998 4778999987542211 11
Q ss_pred HHHHHHHHHHcc----CCCCCe---eeEeeee-ecCCceEEEeeccCCCchhhhh--ccCCCCccchhhhHHHHHHHHHH
Q 037189 522 REFKNEVFVIGQ----THHKNL---VRLLGFC-DEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 591 (766)
Q Consensus 522 ~~f~~E~~~l~~----l~H~ni---v~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l--~~~~~l~~~~~~~i~~~ia~gL~ 591 (766)
-+|.+|.+-..+ +.|-++ |.+=.++ .-...+.|+||||+|..+.|.- .+. .++.. .|+..+.++.
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~---~i~~~l~~~~- 313 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR-GISPH---DILNKLVEAY- 313 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc-CCCHH---HHHHHHHHHH-
Confidence 224455443333 335551 1122222 2345789999999998777653 222 23323 3333333322
Q ss_pred HhhhcCCCceecCCCccceEEEc----CCCCeEEeccCcccccccC
Q 037189 592 YLHEDCSSQIIHCDMKPQNILLD----DHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 592 yLH~~~~~~ivH~dlk~~NIll~----~~~~~kl~Dfgla~~~~~~ 633 (766)
++.-...|++|+|=+|.||++. .++.+.+.|||+...+...
T Consensus 314 -~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 314 -LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred -HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 2221233899999999999998 3678999999998876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00012 Score=74.11 Aligned_cols=137 Identities=15% Similarity=0.168 Sum_probs=83.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC--eeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.||+|..+.||+.. +...++|..... .......+|.+.+..+..-. +.+.++++...+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~-------~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK-------TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec-------CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 468999999999831 224566766532 23456788999998886443 4778888888778889999999
Q ss_pred CCc-hhhhh---------------------ccC--CCCccchhh-hHHH----------HHHH-HHHHhhhc-CCCceec
Q 037189 561 NGT-LASFL---------------------FGN--LKPNWNLRT-NIAF----------QIAR-GLLYLHED-CSSQIIH 603 (766)
Q Consensus 561 ~gs-L~~~l---------------------~~~--~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivH 603 (766)
|.+ +...+ +.- .......+. .+.. .+.+ ...+|... ....++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 21111 110 000100000 0000 0111 11222211 1345789
Q ss_pred CCCccceEEEcCCCCeEEeccCcccc
Q 037189 604 CDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 604 ~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=1.1e-05 Score=88.75 Aligned_cols=180 Identities=17% Similarity=0.137 Sum_probs=126.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC-eeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
..+++|+++.++|.+-.. .+...++.+.. ..+..-++++|.+.+||| .++.++-+..++...++++++..
T Consensus 248 h~fvK~altknpKkRpta----eklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTA----EKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHhcCCCccCCCh----hhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcC
Confidence 456788899999876432 22333444432 245566889999999999 77777777778888899999887
Q ss_pred C-ch-hhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 562 G-TL-ASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 562 g-sL-~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
+ +- .........+..-+...+...-++++++||+ ..-+|+| ||+..+ ...|..||+....+.... ..
T Consensus 319 ~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~ 387 (829)
T KOG0576|consen 319 GRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KP 387 (829)
T ss_pred CccccccCChhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cc
Confidence 6 22 1111111223333444566667789999994 2458888 766655 678999999888776543 12
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
....+|+.++|||+.....+..+.|+|++|+=-.++--|-+|-
T Consensus 388 ~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 4566899999999999999999999999998766776666654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.0003 Score=72.21 Aligned_cols=137 Identities=14% Similarity=0.044 Sum_probs=82.3
Q ss_pred cccccc-ceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 485 VGRGSF-GIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 485 LG~G~f-g~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
|..|.. ..||+.... +..+.||...... ..++.+|++++..+. +--+.+++++....+..++|||++++.
T Consensus 6 ~~~g~~~~~v~~~~~~-----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK-----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC-----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444545 788988643 2467777764322 345678888887774 444667888877777789999999998
Q ss_pred chhhhhc-------------------cCCC--Cccc----hhhhHHH--------------------HHHHHHHHhhhc-
Q 037189 563 TLASFLF-------------------GNLK--PNWN----LRTNIAF--------------------QIARGLLYLHED- 596 (766)
Q Consensus 563 sL~~~l~-------------------~~~~--l~~~----~~~~i~~--------------------~ia~gL~yLH~~- 596 (766)
+|..... .-.. .+.. .+..... .+.+.+..|-..
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764321 0000 0000 0000000 011112222111
Q ss_pred ---CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 597 ---CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 597 ---~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
....++|+|+.|.|||++++....|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 135689999999999999987788999997653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00025 Score=69.84 Aligned_cols=68 Identities=22% Similarity=0.342 Sum_probs=52.8
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...+|+|||++|..|.++.. ++ -.++..+++++.-||+ .|++|+|.+|.|++++++ .++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~----e~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----ID----EDLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh----cC----HHHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 45578999999988876531 11 1355678888999995 499999999999999855 499999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00019 Score=72.84 Aligned_cols=140 Identities=21% Similarity=0.179 Sum_probs=82.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC--CeeeEeeeeec---CCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK--NLVRLLGFCDE---GQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~---~~~~~lV~E 557 (766)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++.++.. ....+++|+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-----~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-----GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEESSSSEEEEEEETT-----SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-----cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 468899999999998752 37888886543 3456778888888777533 35677765432 234689999
Q ss_pred ccCCCchhh----------------hhc---cC----CCCccch---------hhhH------------HHHHHH-HHHH
Q 037189 558 FLNNGTLAS----------------FLF---GN----LKPNWNL---------RTNI------------AFQIAR-GLLY 592 (766)
Q Consensus 558 y~~~gsL~~----------------~l~---~~----~~l~~~~---------~~~i------------~~~ia~-gL~y 592 (766)
++++..+.. .+. .. ....+.. .... ...+.+ .+..
T Consensus 76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (239)
T PF01636_consen 76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQE 155 (239)
T ss_dssp EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred EeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHH
Confidence 999988877 110 11 0000000 0000 112222 3333
Q ss_pred hhh----cCCCceecCCCccceEEEc-CCCCeEEeccCcccc
Q 037189 593 LHE----DCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKL 629 (766)
Q Consensus 593 LH~----~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~ 629 (766)
+++ .....++|+|+.+.||+++ +++.+-|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 156 LEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 332 1356799999999999999 666667999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00036 Score=69.39 Aligned_cols=136 Identities=19% Similarity=0.195 Sum_probs=88.7
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccccC-------------------HHH-----HHHHHHHHccCC--CC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-------------------ERE-----FKNEVFVIGQTH--HK 537 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-------------------~~~-----f~~E~~~l~~l~--H~ 537 (766)
.|..|--+.||+|... ++..+|||+.+...... .++ ..+|..-|.++. +-
T Consensus 55 ~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 55 CISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4777778899998753 46789999886432111 111 245666666653 34
Q ss_pred CeeeEeeeeecCCceEEEeeccCCCchhh-hhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC
Q 037189 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLAS-FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH 616 (766)
Q Consensus 538 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 616 (766)
.+.+.+++. +-.|||||+....+.. .|.. ..+.......+..++++.+.-|-. ..++||+||..-|||+. +
T Consensus 131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-C
Confidence 445555543 3479999986642111 1111 122222456677788888877774 25899999999999999 8
Q ss_pred CCeEEeccCcccccc
Q 037189 617 YNARISDFGLAKLLT 631 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~ 631 (766)
+.+.|+|++.+....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 899999999887544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00062 Score=82.33 Aligned_cols=81 Identities=12% Similarity=0.226 Sum_probs=56.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCC-CCCe--eeEeeeeecC---CceEEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTH-HKNL--VRLLGFCDEG---QNRLLV 555 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 555 (766)
+.|+.|.+..+|+.....++ ....+++|+..... ......+.+|.++++.+. |.++ .+++.+|.+. +..++|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEeCCCCcCceEEEEECCCC-cceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56889999999998765321 12356667654322 223457889999999985 6654 8888888765 467899
Q ss_pred eeccCCCch
Q 037189 556 YEFLNNGTL 564 (766)
Q Consensus 556 ~Ey~~~gsL 564 (766)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0012 Score=62.25 Aligned_cols=128 Identities=17% Similarity=0.311 Sum_probs=87.5
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCee-eEeeeeecCCceEEEeecc
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV-RLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~ 559 (766)
..+.|++|.+|.||+|.+. +..+|+|.-+. +.....+..|.++|..++-.++- +++.|-.+ ++.|||+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-----~~~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i 94 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-----GGEVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYI 94 (201)
T ss_pred hhhhhhcccccEEEEeecc-----CceEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhh
Confidence 3467999999999999875 45788888764 34456899999999998866553 44554332 4459999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCc-cceEEEcCCCCeEEeccCcccc
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMK-PQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk-~~NIll~~~~~~kl~Dfgla~~ 629 (766)
.+-.|.+.-... + .+-...+++.-.-|. ..+|-|+.|. |..++|..+..+.|+||.-|+.
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998877654321 1 222334455533344 4589999987 5555555555999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0015 Score=66.69 Aligned_cols=73 Identities=16% Similarity=0.177 Sum_probs=44.7
Q ss_pred hhccccccc-eEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC---CeeeEeeeeecCC---ceEEE
Q 037189 483 EEVGRGSFG-IVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK---NLVRLLGFCDEGQ---NRLLV 555 (766)
Q Consensus 483 ~~LG~G~fg-~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV 555 (766)
+.|+.|+.. .||+.. ..+++|..+. ......+.+|.+.+..+... .+.++++.....+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~~--------~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG--------DDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC--------CceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 346766666 588751 1356665432 22345788999888877532 3445555443322 34789
Q ss_pred eeccCCCchh
Q 037189 556 YEFLNNGTLA 565 (766)
Q Consensus 556 ~Ey~~~gsL~ 565 (766)
||++++.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0024 Score=67.51 Aligned_cols=75 Identities=8% Similarity=0.040 Sum_probs=53.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC---CCeeeEeeeeec---CCceEEEe
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH---KNLVRLLGFCDE---GQNRLLVY 556 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~---~~~~~lV~ 556 (766)
+.||.|..+.||+....+ + .+.+|..+. ......|.+|.+.|+.+.- ..+.+++++|.. .+..+|||
T Consensus 20 ~~i~~G~~~~vy~~~~~~----~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 20 ECISEQPYAALWALYDSQ----G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eecCCccceeEEEEEcCC----C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 469999999999986431 2 345555332 1134578999998888753 468888988854 36689999
Q ss_pred eccCCCch
Q 037189 557 EFLNNGTL 564 (766)
Q Consensus 557 Ey~~~gsL 564 (766)
|+++++++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0016 Score=63.44 Aligned_cols=133 Identities=26% Similarity=0.343 Sum_probs=92.3
Q ss_pred ccccCHHHHHHHHHhhhhhcccccc-ceEEEEEEecCCCceeEEEEEEeec---cc--------c----------cCHHH
Q 037189 466 LRCFSYKELEEATDNFKEEVGRGSF-GIVYKGVIQTTRTSTTAVAVKKLDI---VF--------Q----------DGERE 523 (766)
Q Consensus 466 ~~~~~~~~l~~~t~~f~~~LG~G~f-g~Vy~~~~~~~~~~~~~vavK~l~~---~~--------~----------~~~~~ 523 (766)
++.|+.. .+..+|.+.||.|.- |.|||+.+. +..+|+|..+. .. . .-...
T Consensus 29 L~~F~~h---~~~I~flefLg~g~~~~~V~kv~I~-----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 29 LEPFTHH---GDDIEFLEFLGHGSHDGYVFKVEID-----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred cCCcCCC---CCcEeeeeecCCCCceeEEEEEEEC-----CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 4556662 266778899999999 999999985 66999999321 00 0 11235
Q ss_pred HHHHHHHHccCC---CCCe--eeEeeeeecC------------------CceEEEeeccCCCchhhhhccCCCCccchhh
Q 037189 524 FKNEVFVIGQTH---HKNL--VRLLGFCDEG------------------QNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 580 (766)
Q Consensus 524 f~~E~~~l~~l~---H~ni--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~ 580 (766)
|..|++...+++ +.++ |+.+||..-. ....||.||.+... ....
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~ 167 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI 167 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch
Confidence 889999888876 4456 8999987322 12246677665422 2233
Q ss_pred hHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 581 ~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
+-+.+|.+-|..+| ..+|+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 44567777888888 569999999999975 5689999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0036 Score=61.47 Aligned_cols=131 Identities=18% Similarity=0.241 Sum_probs=86.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccc----------------ccCHHHHHHHHHHHccCC------CCCee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----------------QDGEREFKNEVFVIGQTH------HKNLV 540 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv 540 (766)
..||+|+.=.||.-- ......||...... ....+++.+|+.....+. +.+|.
T Consensus 7 ~~i~~G~~R~cy~HP------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~ 80 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP 80 (199)
T ss_pred cccccCCCceEEECC------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence 468999999999632 22345566665433 123466777776555544 88999
Q ss_pred eEeeeeecCCceEEEeeccCC------CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 541 RLLGFCDEGQNRLLVYEFLNN------GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 541 ~l~g~~~~~~~~~lV~Ey~~~------gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
+++|+.+.+...-+|+|.+.+ -+|.+++.... ++. .+...+-+-..||-+ ..|+.+|++|.||++.
T Consensus 81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-~~~----~~~~~L~~f~~~l~~---~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-LTE----ELRQALDEFKRYLLD---HHIVIRDLNPHNIVVQ 152 (199)
T ss_pred cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-ccH----HHHHHHHHHHHHHHH---cCCeecCCCcccEEEE
Confidence 999999999999999998643 36777775443 333 233333344455553 3799999999999995
Q ss_pred CC--C--CeEEec-cCcc
Q 037189 615 DH--Y--NARISD-FGLA 627 (766)
Q Consensus 615 ~~--~--~~kl~D-fgla 627 (766)
.. + .+.|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 32 2 467776 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00077 Score=79.72 Aligned_cols=196 Identities=21% Similarity=0.185 Sum_probs=134.3
Q ss_pred HHHHHHHHccCCCCCeeeEeeeeecCCceE----EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCC
Q 037189 524 FKNEVFVIGQTHHKNLVRLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599 (766)
Q Consensus 524 f~~E~~~l~~l~H~niv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 599 (766)
...|+..+.++.|+|+++++.|-.+....- +..|++...++...+.+-...+.+..+.+..++.+||+|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 345677888899999999999986654333 3457888888888888888888899999999999999999964
Q ss_pred ceecCCCccc---eEEEcCCCCeEEe--ccCcccccccCCCcceeecccccCcccccccccCCCCCc--ccCeeehhHHH
Q 037189 600 QIIHCDMKPQ---NILLDDHYNARIS--DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITA--KVDVYSFGVLL 672 (766)
Q Consensus 600 ~ivH~dlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDV~s~Gvvl 672 (766)
...|.-+..+ +--.+..+...++ ||+.++........ ....-+..+.++|......+.. ..|+|++|..+
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 3333333333 3334455566666 88887766543321 1122345677888877665544 47999999999
Q ss_pred HHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 037189 673 LEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751 (766)
Q Consensus 673 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~L 751 (766)
..+..|..+-....... .++ +.....++.+....|+..++++|+.+.+++...
T Consensus 383 ~~~~~~~~i~~~~~~~~------------------~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAVPV------------------SLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccchh------------------hhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 99988776543211100 000 001111566778889999999999999998775
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.01 Score=64.82 Aligned_cols=75 Identities=15% Similarity=0.131 Sum_probs=51.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecc-----c--ccCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCce
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-----F--QDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 552 (766)
+.||.|.+..||++...+ ..+.++||.-... . ......+..|.+.|..+. ..++++++.+ +.+..
T Consensus 32 ~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~ 106 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELA 106 (401)
T ss_pred eEcCCCceEEEEEEEeCC---CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCC
Confidence 579999999999998752 2247899985311 0 123456677777777753 3467778877 33567
Q ss_pred EEEeeccCCC
Q 037189 553 LLVYEFLNNG 562 (766)
Q Consensus 553 ~lV~Ey~~~g 562 (766)
++||||+++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 8999998864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.006 Score=63.07 Aligned_cols=135 Identities=11% Similarity=0.076 Sum_probs=75.0
Q ss_pred ccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEeeccCCCc
Q 037189 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNGT 563 (766)
Q Consensus 485 LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gs 563 (766)
+..|-...+|+... .+..+++|........-.-...+|.++++.+....+ .+++..+. ..+||||+++..
T Consensus 4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe-----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 55677789998863 244677776543222111235778888887764333 34444432 368999999876
Q ss_pred hhhh-----------------hccCCC----Cccchh-hhHH---------HHHHHHHHHhhhc-----CCCceecCCCc
Q 037189 564 LASF-----------------LFGNLK----PNWNLR-TNIA---------FQIARGLLYLHED-----CSSQIIHCDMK 607 (766)
Q Consensus 564 L~~~-----------------l~~~~~----l~~~~~-~~i~---------~~ia~gL~yLH~~-----~~~~ivH~dlk 607 (766)
+... |+.... ++...+ .... ..+.+.+..+... ....++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 6431 111111 111100 0110 0111112222111 13468999999
Q ss_pred cceEEEcCCCCeEEeccCcccc
Q 037189 608 PQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 608 ~~NIll~~~~~~kl~Dfgla~~ 629 (766)
|.||++++++ +.|+||..+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999876 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0085 Score=60.98 Aligned_cols=76 Identities=17% Similarity=0.125 Sum_probs=44.8
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC-eeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.|..|-...+|+.....+ +...+++|...... .....-.+|+.++..+.... .+++++.+. ..++|||+++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 4567788889998865310 13467777654321 11122346777777775333 344544433 2479999998
Q ss_pred Cchh
Q 037189 562 GTLA 565 (766)
Q Consensus 562 gsL~ 565 (766)
.++.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0051 Score=65.10 Aligned_cols=139 Identities=16% Similarity=0.148 Sum_probs=82.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC--CeeeEeee------eecCCceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK--NLVRLLGF------CDEGQNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~l 554 (766)
+.|..|....+|+.... +..+++|.... ....+...|++++..+.+. .+.+++.. ....+..++
T Consensus 20 ~~i~~G~~n~~y~v~~~-----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 20 EGISAGIENTNYFVTTD-----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred ecccCccccceEEEEeC-----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 35777877899987653 23577787653 3345566777777776433 24455442 123446689
Q ss_pred EeeccCCCchhh----hh----------cc---C-C-------CCccchhh----------hHHHHHHHHHHHhhh----
Q 037189 555 VYEFLNNGTLAS----FL----------FG---N-L-------KPNWNLRT----------NIAFQIARGLLYLHE---- 595 (766)
Q Consensus 555 V~Ey~~~gsL~~----~l----------~~---~-~-------~l~~~~~~----------~i~~~ia~gL~yLH~---- 595 (766)
|++|++|..+.. .. +. . . ...|.... .....+.+.+.++.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876533 11 10 0 0 00111100 011223344455443
Q ss_pred cCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 596 ~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
.....++|+|+.|.||+++++..+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1245799999999999999987778999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.0017 Score=51.46 Aligned_cols=52 Identities=15% Similarity=0.051 Sum_probs=38.0
Q ss_pred ceeEEEecCCCCCCCCccc-cCCCCccccccccccCCC----------CcccccccCcceeec
Q 037189 341 LFDVYELKETDWPMSDYDF-FSPYDEEHCWLKRLPLSN----------GRADTSVTGKAFIKY 392 (766)
Q Consensus 341 ~~~~~~~~~~~~p~~~~~~-~~~~~~~~C~~~~l~l~n----------~~~~~~~~~~~l~~~ 392 (766)
.++|++|++|++|+++... ..+.++++|+..|+.... +...|.+|.+.++++
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 3599999999999986653 467899998888775221 345677787777654
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.025 Score=59.97 Aligned_cols=141 Identities=21% Similarity=0.255 Sum_probs=79.1
Q ss_pred hccccccceEEEEEEecC---CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC-eeeEeeeeecCCceEEEeecc
Q 037189 484 EVGRGSFGIVYKGVIQTT---RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~---~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.|..|--..+|+.....+ ...+..+++|...... ....+..+|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 455666678898875421 0123567778754432 22234567777777765333 3455555542 3589999
Q ss_pred CCCchhhh-h----------------ccCC-CC-c---------cchhhh--------------------------HHHH
Q 037189 560 NNGTLASF-L----------------FGNL-KP-N---------WNLRTN--------------------------IAFQ 585 (766)
Q Consensus 560 ~~gsL~~~-l----------------~~~~-~l-~---------~~~~~~--------------------------i~~~ 585 (766)
+|..+... + +... .. . |..... +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88766431 1 1100 00 0 000000 1112
Q ss_pred HHHHHHHhhh------cCCCceecCCCccceEEEcCC----CCeEEeccCcccc
Q 037189 586 IARGLLYLHE------DCSSQIIHCDMKPQNILLDDH----YNARISDFGLAKL 629 (766)
Q Consensus 586 ia~gL~yLH~------~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~ 629 (766)
+.+.+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2223334432 135678999999999999975 8899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.073 Score=56.94 Aligned_cols=32 Identities=25% Similarity=0.354 Sum_probs=27.2
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..+++|+|+++.||+++++...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 55899999999999999765568999998753
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.057 Score=58.37 Aligned_cols=141 Identities=19% Similarity=0.170 Sum_probs=78.2
Q ss_pred hccccccceEEEEEEecCC-CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEeeccCC
Q 037189 484 EVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
.|-.|-.-.+|+....... .....+++|.......... .-.+|..++..+...++ .++++.+..+ .|+||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence 3445777789998754321 1235677887654322211 22667777777764444 3455655432 57999987
Q ss_pred Cchhhh-----------------hccCCC-----C-ccchhhhHHH-----------------HHHHHHHHhhh-----c
Q 037189 562 GTLASF-----------------LFGNLK-----P-NWNLRTNIAF-----------------QIARGLLYLHE-----D 596 (766)
Q Consensus 562 gsL~~~-----------------l~~~~~-----l-~~~~~~~i~~-----------------~ia~gL~yLH~-----~ 596 (766)
.+|... ++.... . .+....++.. .+...+..|.. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 666421 111110 1 1122112211 11111222221 1
Q ss_pred CCCceecCCCccceEEEcC-CCCeEEeccCcccc
Q 037189 597 CSSQIIHCDMKPQNILLDD-HYNARISDFGLAKL 629 (766)
Q Consensus 597 ~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~ 629 (766)
....++|+|+++.||++++ +..+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2446899999999999986 47899999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.01 Score=61.22 Aligned_cols=134 Identities=13% Similarity=0.128 Sum_probs=87.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----------------cc------CHHHHHHHHHHHccCCC
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----------------QD------GEREFKNEVFVIGQTHH 536 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----------------~~------~~~~f~~E~~~l~~l~H 536 (766)
..+.++||-|--+.+|.+... .+.+.++|.-+... .. ..-...+|...|+.+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e 169 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE 169 (465)
T ss_pred hhhccccccccccceEEEecC----CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence 346689999999999999876 35566666332100 00 11234567777777753
Q ss_pred --CCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 537 --KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 537 --~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
--+.+.+++ ++.++|||++.+-.|...-+- .....+...++.-+.-|. ..++||+|.+-=||+++
T Consensus 170 ~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la---~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 170 RGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLA---NHGLIHGDFNEFNIMVK 236 (465)
T ss_pred cCCCCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHH---HcCceecccchheeEEe
Confidence 224444443 466899999988776554221 112234444555555565 34999999999999999
Q ss_pred CCCCeEEeccCcccc
Q 037189 615 DHYNARISDFGLAKL 629 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~ 629 (766)
++..++++||-....
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999986543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.097 Score=54.63 Aligned_cols=31 Identities=29% Similarity=0.591 Sum_probs=25.6
Q ss_pred CceecCCCccceEEEcCCCC-eEEeccCcccc
Q 037189 599 SQIIHCDMKPQNILLDDHYN-ARISDFGLAKL 629 (766)
Q Consensus 599 ~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~ 629 (766)
..++|+|+++.||+++++++ .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.084 Score=56.74 Aligned_cols=141 Identities=18% Similarity=0.259 Sum_probs=76.8
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEeeccCCC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
.|..|-.-.+|+............+++|....... ..-.-.+|..+++.+...++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 45557777889887643222234677776643322 11223577777777765444 4566665322 589998776
Q ss_pred chhhh-------h----------ccCC-----CC-ccchhhhHHHH----------------------HHHHHHHhhh--
Q 037189 563 TLASF-------L----------FGNL-----KP-NWNLRTNIAFQ----------------------IARGLLYLHE-- 595 (766)
Q Consensus 563 sL~~~-------l----------~~~~-----~l-~~~~~~~i~~~----------------------ia~gL~yLH~-- 595 (766)
.|..- + +... .+ -|....++..+ +.+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 55321 1 1111 01 12211111111 1111111111
Q ss_pred ---cCCCceecCCCccceEEEcC-CCCeEEeccCcccc
Q 037189 596 ---DCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKL 629 (766)
Q Consensus 596 ---~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~ 629 (766)
....-.+|+|+.+.|||+++ ++.++++||..+..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234789999999999974 57899999998864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.17 Score=52.97 Aligned_cols=72 Identities=19% Similarity=0.293 Sum_probs=45.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC---CCCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT---HHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.++.|....+|+... ++..+.||.-. ......|..|.+-|+.+ .--.+.+++++....+..+||+||+
T Consensus 23 ~~v~GG~i~~a~~~~~-----~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 23 EPVSGGDINEAYRLDT-----DGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp EEE--SSSSEEEEEET-----TS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred EecCCCChhheEEEEC-----CCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4588888899998762 45678888876 23345688888777666 3456888999887777889999998
Q ss_pred CCC
Q 037189 560 NNG 562 (766)
Q Consensus 560 ~~g 562 (766)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.19 Score=53.48 Aligned_cols=139 Identities=15% Similarity=0.194 Sum_probs=78.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC--CeeeEeeee------ecCCceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK--NLVRLLGFC------DEGQNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~------~~~~~~~l 554 (766)
+.++.|.-..+|+.... ++ .+++|+.+.. ....+...|++++..+... .+.+++... ...+..++
T Consensus 28 ~~~~~G~~n~~y~v~t~----~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD----VG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred cccCCccccceEEEEeC----CC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 45677777899987643 12 4667765432 1234455566666665322 244444422 22456789
Q ss_pred EeeccCCCchhhh--------------hccC-CC-----------Cccchhh------------hHHHHHHHHHHHhhh-
Q 037189 555 VYEFLNNGTLASF--------------LFGN-LK-----------PNWNLRT------------NIAFQIARGLLYLHE- 595 (766)
Q Consensus 555 V~Ey~~~gsL~~~--------------l~~~-~~-----------l~~~~~~------------~i~~~ia~gL~yLH~- 595 (766)
++||++|..+... ++.. .. ..|.... .....+.+.++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 9999988654211 1110 00 0111100 011123334555532
Q ss_pred ---cCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 596 ---DCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 596 ---~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
....+++|+|+++.||++++++...|+||+.+.
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 235789999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.1 Score=51.22 Aligned_cols=102 Identities=19% Similarity=0.212 Sum_probs=68.5
Q ss_pred EEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHH
Q 037189 507 AVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQ 585 (766)
Q Consensus 507 ~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ 585 (766)
+..+|+++...-. ...-|.++.+++++++ .|++|..- .....-++.|+|..-. ... ..++..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~------------i~~-~N~i~a 149 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK------------INF-SNFITA 149 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc------------cch-hHHHHH
Confidence 5667777654433 4456788888888876 46666622 3335568888874311 111 112222
Q ss_pred HHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 586 ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
=++.|.-.|++ +.+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 150 gi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 150 GIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred hHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 24677788876 77899999999999999999999998653
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.21 Score=53.57 Aligned_cols=81 Identities=20% Similarity=0.159 Sum_probs=48.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecc-------cccCHHHHHHHHHHHccCC--CC-CeeeEeeeeecCCce
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-------FQDGEREFKNEVFVIGQTH--HK-NLVRLLGFCDEGQNR 552 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-------~~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~ 552 (766)
++||.|-...||++.... .++.++||.-... .+-...+...|.+.|.... .| .+++++.+ +....
T Consensus 1 ~EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~ 75 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMA 75 (370)
T ss_pred CcCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccc
Confidence 368999999999999642 2357899875321 1222344455666665543 24 45555554 44566
Q ss_pred EEEeeccCC-Cchhhhh
Q 037189 553 LLVYEFLNN-GTLASFL 568 (766)
Q Consensus 553 ~lV~Ey~~~-gsL~~~l 568 (766)
.+|||+++. ..|.+.|
T Consensus 76 ~~vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 76 VTVMEDLSHHKIARKGL 92 (370)
T ss_pred eehHhhCccchHHHHHH
Confidence 799999854 3454544
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.24 Score=54.07 Aligned_cols=79 Identities=18% Similarity=0.154 Sum_probs=49.9
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecc----cc---cCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCce
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV----FQ---DGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 552 (766)
+.||.|..-.||+.... +..++||+-... .. .....-..|.+.|..+. ..++.+++.++. +..
T Consensus 38 ~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-----SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEcCCCceeeEEEEEcC-----CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCC
Confidence 57899999999997753 235888876411 11 12233334455555443 357888999887 446
Q ss_pred EEEeeccCC--Cchhhhh
Q 037189 553 LLVYEFLNN--GTLASFL 568 (766)
Q Consensus 553 ~lV~Ey~~~--gsL~~~l 568 (766)
+++||++++ ..|.+-+
T Consensus 111 vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 111 LIGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEEeecCCcceehhhhh
Confidence 788999976 3454443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.11 Score=51.99 Aligned_cols=31 Identities=29% Similarity=0.495 Sum_probs=22.1
Q ss_pred CceecCCCccceEEE-cCCCCeEEeccCcccc
Q 037189 599 SQIIHCDMKPQNILL-DDHYNARISDFGLAKL 629 (766)
Q Consensus 599 ~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~ 629 (766)
..+.|+||.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 457899999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.046 Score=59.88 Aligned_cols=164 Identities=21% Similarity=0.242 Sum_probs=89.6
Q ss_pred HHHHHHHHHHHccCCCCCeeeEeeeeecCC-ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCC
Q 037189 521 EREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599 (766)
Q Consensus 521 ~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 599 (766)
..+.....+.++.++|+|+...+++-.... +..+|+|++. .+|++.+..+. +.. ....+ |
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~------~s~~~------~----- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKD------ESLLA------H----- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cch------hhhcc------c-----
Confidence 345667778889999999999999886544 4567899874 58888875543 111 11111 1
Q ss_pred ceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCC
Q 037189 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACR 679 (766)
Q Consensus 600 ~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~ 679 (766)
++.| .|| .+++| -++.. | | .+..+|+|||++|.++.|+.-|.
T Consensus 87 ~~~~-----~~~-------~~~td-~~~t~------------------~--~-----~~~~pKsdVwsl~~i~~el~L~~ 128 (725)
T KOG1093|consen 87 GVLH-----LNI-------IYITD-HFLTK------------------Y--P-----SPIGPKSDVWSLGFIILELYLGI 128 (725)
T ss_pred ccce-----ehh-------hhccc-ccccc------------------C--C-----CCCCcchhhhhHHHHHHHHHHhh
Confidence 1211 111 12222 00000 0 1 11125999999999999999988
Q ss_pred cCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 037189 680 KSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 680 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
..+......+.......+. ...+....+..+. ....++...++++...|+-..|..||...+
T Consensus 129 ~l~~~~~~s~~l~~i~k~~--~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~ 190 (725)
T KOG1093|consen 129 SLEAELTESEYLEILLKYY--TDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPME 190 (725)
T ss_pred HHHHHHHHHHHHHHHHHhc--cCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhH
Confidence 7654332222111111000 0000000000000 123456677889999999999998886543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.28 Score=51.76 Aligned_cols=112 Identities=22% Similarity=0.315 Sum_probs=67.8
Q ss_pred HHHHHHHHHHHccCCC--CCeeeEeeeeecCC--ceEEEeeccCCCchhhhhccCC------------------------
Q 037189 521 EREFKNEVFVIGQTHH--KNLVRLLGFCDEGQ--NRLLVYEFLNNGTLASFLFGNL------------------------ 572 (766)
Q Consensus 521 ~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~l~~~~------------------------ 572 (766)
.....+|..+|+.+.- .-+.+.++.|.++. ..+.||+|.++..+.+.+....
T Consensus 65 ~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~ 144 (321)
T COG3173 65 AHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAG 144 (321)
T ss_pred hhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcC
Confidence 3445667777776643 34566788887776 7799999998843322221000
Q ss_pred -CC-------------ccchhhhH--------HHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEEeccC
Q 037189 573 -KP-------------NWNLRTNI--------AFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARISDFG 625 (766)
Q Consensus 573 -~l-------------~~~~~~~i--------~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfg 625 (766)
.. .|...+.. .-....-..+|++.. ...++|+|+++.|++++.+.-+=|.||+
T Consensus 145 ~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe 224 (321)
T COG3173 145 LPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWE 224 (321)
T ss_pred CCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecc
Confidence 00 01111100 011222344554432 3569999999999999998889999999
Q ss_pred ccccccc
Q 037189 626 LAKLLTL 632 (766)
Q Consensus 626 la~~~~~ 632 (766)
++..-.+
T Consensus 225 ~~~lGDP 231 (321)
T COG3173 225 LATLGDP 231 (321)
T ss_pred ccccCCc
Confidence 9876443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.39 Score=51.10 Aligned_cols=32 Identities=16% Similarity=0.331 Sum_probs=28.7
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..+++|+|+.+.||+++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 55799999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.016 Score=70.78 Aligned_cols=156 Identities=12% Similarity=-0.025 Sum_probs=107.2
Q ss_pred HHHHHHHccCCCCCeeeEeeeee--cCCceEEEeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhc--
Q 037189 525 KNEVFVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHED-- 596 (766)
Q Consensus 525 ~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~-- 596 (766)
..|...++...|+++.....=.. +..+.+.+++|+..|.+.+.|.++ ..++.........+......-+|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 33444555568888776554332 334567889999999999988654 2222222222223324444444432
Q ss_pred CCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHH
Q 037189 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676 (766)
Q Consensus 597 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ell 676 (766)
...-.+|++||+-|.+|..+.++|+.++|+.+...+.. .......+++-|+.|+....-.++.++|+|..++-+|+..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23457899999999999999999999999998433221 1113345677899999888888999999999999999998
Q ss_pred hCCcCC
Q 037189 677 ACRKSF 682 (766)
Q Consensus 677 tg~~p~ 682 (766)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.16 Score=54.41 Aligned_cols=61 Identities=20% Similarity=0.253 Sum_probs=41.6
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
...|+-+|+++-++..++..... ++..+.+++.-.+.|+--+-. -...+|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~~-pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKSQ-PEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhcccC-hHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence 44567788889899888866543 334555566555555443321 23799999999999995
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=92.66 E-value=0.37 Score=52.35 Aligned_cols=81 Identities=20% Similarity=0.231 Sum_probs=49.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecc------cccCHHHHHHHHHHHccCC--CC-CeeeEeeeeecCCceE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV------FQDGEREFKNEVFVIGQTH--HK-NLVRLLGFCDEGQNRL 553 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~------~~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~ 553 (766)
+.||.|--..||++.+.. .++.++||+-... -+-..++...|.+.|+... .| .+++++.+ +.....
T Consensus 35 ~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC 109 (409)
T ss_pred eEcCCCceEEEEEEeeCC---CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence 568999999999998742 2356888875321 1223445556666666543 33 45566655 444667
Q ss_pred EEeeccCC-Cchhhhh
Q 037189 554 LVYEFLNN-GTLASFL 568 (766)
Q Consensus 554 lV~Ey~~~-gsL~~~l 568 (766)
+|||+++. ..|.+.|
T Consensus 110 ~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 110 CVMEDLSDHTILRTAL 125 (409)
T ss_pred HHHHhCcccHHHHHHH
Confidence 88998854 3344443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 766 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-41 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-39 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-22 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-21 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-20 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-20 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-20 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-20 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-20 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-20 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-20 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-20 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-20 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-20 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-20 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-20 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-20 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-20 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-20 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-19 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-17 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-16 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-15 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-13 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-13 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 6e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-123
Identities = 122/298 (40%), Positives = 180/298 (60%), Gaps = 14/298 (4%)
Query: 465 NLRCFSYKELEEATDNFKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI-VFQDGE 521
L+ FS +EL+ A+DNF + +GRG FG VYKG + T VAVK+L Q GE
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGE 71
Query: 522 REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----NWN 577
+F+ EV +I H+NL+RL GFC RLLVY ++ NG++AS L + +W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
R IA ARGL YLH+ C +IIH D+K NILLD+ + A + DFGLAKL+ +
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-H 190
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDI--EMVEEYAILTD 695
+ T++RGT G++APE+ K + K DV+ +GV+LLE+I +++FD+ ++ +L D
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753
W + KL+ALV D++ E +E+L+ V++ C Q P RP + +V++MLEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-113
Identities = 104/308 (33%), Positives = 161/308 (52%), Gaps = 13/308 (4%)
Query: 456 SPGDGTIETNLRCFSYKELEEATDNFKEE--VGRGSFGIVYKGVIQTTRTSTTAVAVKKL 513
+ +LEEAT+NF + +G G FG VYKGV++ VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRR 71
Query: 514 DIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK 573
G EF+ E+ + H +LV L+GFCDE +L+Y+++ NG L L+G+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 574 P----NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629
P +W R I ARGL YLH IIH D+K NILLD+++ +I+DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
T + T ++GT GY+ PE+F ++T K DVYSFGV+L E++ R + + E
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
L +WA + + NG+L+ +V ++ E L K ++ C+ RP++ VL
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 750 MLEGVVEV 757
LE + +
Sbjct: 309 KLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-110
Identities = 108/309 (34%), Positives = 161/309 (52%), Gaps = 28/309 (9%)
Query: 463 ETNLRCFSYKELEEATDNFKEE--------VGRGSFGIVYKGVIQTTRTSTTAVAVKKLD 514
+T FS+ EL+ T+NF E +G G FG+VYKG + + T VAVKKL
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLA 63
Query: 515 IVFQD----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 570
+ +++F E+ V+ + H+NLV LLGF +G + LVY ++ NG+L L
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 571 --NLKP-NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627
P +W++R IA A G+ +LHE+ IH D+K NILLD+ + A+ISDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687
+ + + I GT Y+APE R +IT K D+YSFGV+LLEII + D
Sbjct: 181 RASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239
Query: 688 EEYAILTDWAFDCYRN-GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746
+ L D + ++ + M + +E + V+ C+ E + RP IKK
Sbjct: 240 PQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKK 296
Query: 747 VLQMLEGVV 755
V Q+L+ +
Sbjct: 297 VQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-72
Identities = 73/308 (23%), Positives = 123/308 (39%), Gaps = 31/308 (10%)
Query: 469 FSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN 526
+ L + + E RG FG V+K + VAVK I + + +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY-----VAVKIFPIQDKQSW-QNEY 67
Query: 527 EVFVIGQTHHKNLVRLLGFCDEGQN----RLLVYEFLNNGTLASFLFGNLKPNWNLRTNI 582
EV+ + H+N+++ +G G + L+ F G+L+ FL N +WN +I
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 583 AFQIARGLLYLHEDCSSQ-------IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
A +ARGL YLHED I H D+K +N+LL ++ A I+DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 636 KTIKTSIRGTKGYVAPEWFRNS-----KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY 690
GT+ Y+APE + ++D+Y+ G++L E+ + + D + E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 691 AILTDWAFDCYRNGKLDALVGGDM------EAMNDVECLEKLVMVSIWCIQEDPSLRPTI 744
+ + +V + + L C D R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 745 KKVLQMLE 752
V + +
Sbjct: 307 GCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 3e-63
Identities = 78/296 (26%), Positives = 140/296 (47%), Gaps = 33/296 (11%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEV 528
+ +L KE++G GSFG V++ + VAVK L E EF EV
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWHGS-----DVAVKILMEQDFHAERVNEFLREV 85
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQ 585
++ + H N+V +G + N +V E+L+ G+L L + + + R ++A+
Sbjct: 86 AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD 145
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+A+G+ YLH + I+H ++K N+L+D Y ++ DFGL++L + S GT
Sbjct: 146 VAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGT 202
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
++APE R+ K DVYSFGV+L E+ ++ + + ++ F C R
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKR--- 257
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPP 761
+E + ++ + C +P RP+ ++ +L +++ +VPP
Sbjct: 258 --------LEIPRN--LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-60
Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 35/295 (11%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVI 531
+ + E +G+G FG K T R + + +K+L ++ +R F EV V+
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKV---THRETGEVMVMKELIRFDEETQRTFLKEVKVM 61
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGL 590
H N+++ +G + + + E++ GTL + W+ R + A IA G+
Sbjct: 62 RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS------------KTI 638
YLH S IIH D+ N L+ ++ N ++DFGLA+L+ ++ +
Sbjct: 122 AYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTDWA 697
+ ++ G ++APE KVDV+SFG++L EII + D L
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
F + C +++ C DP RP+ K+ LE
Sbjct: 239 F--LD-----------RYCPPN--CPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-60
Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 40/303 (13%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV 530
YKE+E +E VGRG+FG+V K + VA+K+++ + + F E+
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKA-----KWRAKDVAIKQIES--ESERKAFIVELRQ 54
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---NWNLRTNIAFQIA 587
+ + +H N+V+L G C LV E+ G+L + L G + Q +
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYN-ARISDFGLAKLLTLNQSKTIKTSIRGTK 646
+G+ YLH +IH D+KP N+LL +I DFG A + +T T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSA 167
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
++APE F S + K DV+S+G++L E+I RK FD + I + + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MWAVHNGTRP 223
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV---SVPPNP 763
+ + + C +DPS RP+++++++++ ++ + P
Sbjct: 224 PL----------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 764 YPF 766
YP
Sbjct: 274 YPC 276
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 1e-59
Identities = 82/294 (27%), Positives = 120/294 (40%), Gaps = 42/294 (14%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL----DIVFQDGEREFKN 526
+ EL +E +G G FG VY+ VAVK D +
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWIGD-----EVAVKAARHDPDEDISQTIENVRQ 55
Query: 527 EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 586
E + H N++ L G C + N LV EF G L L G + ++ N A QI
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQI 114
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLD--------DHYNARISDFGLAKLLTLNQSKTI 638
ARG+ YLH++ IIH D+K NIL+ + +I+DFGLA+ +T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTT 170
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
K S G ++APE R S + DV+S+GVLL E++ F ++ A+ A
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAVAYGVAM 228
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ + + C E + C DP RP+ +L L
Sbjct: 229 NKLA-----------LPIPST--CPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-59
Identities = 78/321 (24%), Positives = 121/321 (37%), Gaps = 46/321 (14%)
Query: 469 FSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN 526
+ E DN K E +GRG +G VYKG + VAVK + F N
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-----PVAVKVFS---FANRQNFIN 54
Query: 527 E--VFVIGQTHHKNLVRLLGFCDEG-----QNRLLVYEFLNNGTLASFLFGNLKPNWNLR 579
E ++ + H N+ R + + LLV E+ NG+L +L + +W
Sbjct: 55 EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSS 113
Query: 580 TNIAFQIARGLLYLHEDCSS------QIIHCDMKPQNILLDDHYNARISDFGLAKLLT-- 631
+A + RGL YLH + I H D+ +N+L+ + ISDFGL+ LT
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 632 ----LNQSKTIKTSIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEII-ACR 679
+ S GT Y+APE + +VD+Y+ G++ EI C
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 680 KSFDIEMVEEYAI-LTDWAFDCYRNGKLDALVGGD-------MEAMNDVECLEKLVMVSI 731
F E V EY + + + LV + + + L
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 732 WCIQEDPSLRPTIKKVLQMLE 752
C +D R T + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-56
Identities = 72/280 (25%), Positives = 124/280 (44%), Gaps = 31/280 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKN 538
+ +G GSFG VYKG VAVK L++ + + FKNEV V+ +T H N
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
++ +G+ +V ++ +L L K +IA Q ARG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH--- 137
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN- 656
+ IIH D+K NI L + +I DFGLA + + G+ ++APE R
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 657 --SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714
+ + + DVY+FG++L E++ + + + I+ G
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII--EMVGR----------GSLS 244
Query: 715 EAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
++ V C +++ + C+++ RP+ ++L +E
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-56
Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEV 528
+++LE E +G+G FG VY G VA++ +DI + + + FK EV
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWHGE------VAIRLIDIERDNEDQLKAFKREV 80
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIA 587
QT H+N+V +G C + ++ TL S + + + N IA +I
Sbjct: 81 MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIV 140
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS---KTIKTSIRG 644
+G+ YLH + I+H D+K +N+ D+ I+DFGL + + Q+ + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 645 TKGYVAPEWFRNSKI---------TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD 695
++APE R + DV++ G + E+ A F + AI
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAEAI--- 251
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ K + ++ + +++ + ++C + RPT K++ MLE
Sbjct: 252 -IWQMGTGMKPN---------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-56
Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-------RE 523
E+E +++++G+G FG+V+KG + ++ VA+K L + +GE +E
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSV---VAIKSLILGDSEGETEMIEKFQE 69
Query: 524 FKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNI 582
F+ EVF++ +H N+V+L G +V EF+ G L L P W+++ +
Sbjct: 70 FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRL 127
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-----DHYNARISDFGLAKLLTLNQSKT 637
IA G+ Y+ + + I+H D++ NI L A+++DFGL++
Sbjct: 128 MLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-----H 181
Query: 638 IKTSIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD 695
+ + G ++APE T K D YSF ++L I+ FD + +
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ R D C +L V C DP RP +++ L
Sbjct: 242 IREEGLR-----------PTIPED--CPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 42/291 (14%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEV 528
+K+L F ++ G ++KG Q + VK L + R+F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQGN-----DIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 529 FVIGQTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAF 584
+ H N++ +LG C + L+ ++ G+L + L N + + A
Sbjct: 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRG 644
+ARG+ +LH I + +++++D+ ARIS +
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMY 170
Query: 645 TKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701
+VAPE + D++SF VLL E++ F ++ I A +
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DL-SNMEIGMKVALEGL 228
Query: 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
R + + C+ EDP+ RP ++ +LE
Sbjct: 229 R-----------PTIPPG--ISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 8e-50
Identities = 73/310 (23%), Positives = 123/310 (39%), Gaps = 61/310 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE--VFVIGQTHHKN 538
E VG+G +G V++G Q VAVK +D E+ + E ++ H+N
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE-----NVAVKIFSS--RD-EKSWFRETELYNTVMLRHEN 63
Query: 539 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
++ + ++ L+ + G+L +L + I IA GL +LH
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLH 122
Query: 595 EDCSSQ-----IIHCDMKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTSIRGTKG 647
+ I H D+K +NIL+ + I+D GLA + + NQ GTK
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 648 YVAPEWFRNS------KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701
Y+APE + +VD+++FG++L E+ S I VE+Y F
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI--VEDYKP----PF--- 233
Query: 702 RNGKLDALVGGD--MEAMNDVECLEKL---------------VMVSI--WCIQEDPSLRP 742
+V D E M V C+++ + + C ++PS R
Sbjct: 234 -----YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 743 TIKKVLQMLE 752
T ++ + L
Sbjct: 289 TALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-49
Identities = 67/298 (22%), Positives = 122/298 (40%), Gaps = 37/298 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE--VFVIGQTHHKN 538
+++G+G +G V+ G + + VAVK + E + E ++ H+N
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK-----VAVKVFFT--TE-EASWFRETEIYQTVLMRHEN 92
Query: 539 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
++ + +G L+ ++ NG+L +L + + +A+ GL +LH
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 595 EDCSSQ-----IIHCDMKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTSIRGTKG 647
+ S I H D+K +NIL+ + I+D GLA N+ + GTK
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 648 YVAPE------WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDWAFDC 700
Y+ PE + + D+YSFG++L E+ R+ +VEEY + D
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 701 YRNGKLDALVGGDM------EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ +V + ECL ++ + C +P+ R T +V + L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-48
Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 61/310 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE--VFVIGQTHHKN 538
+E +G+G FG V++G + VAVK ER + E ++ H+N
Sbjct: 46 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFS---SREERSWFREAEIYQTVMLRHEN 97
Query: 539 LVRLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
++ + ++ LV ++ +G+L +L +A A GL +LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLH 156
Query: 595 EDCSSQ-----IIHCDMKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTSIRGTKG 647
+ I H D+K +NIL+ + I+D GLA + GTK
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 648 YVAPEWFRNSKITA------KVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701
Y+APE +S + D+Y+ G++ EI R+ + E+Y + Y
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGGIHEDYQL-------PY 267
Query: 702 RNGKLDALVGGDM--EAMNDVECLEKL---------------VMVSI--WCIQEDPSLRP 742
+ LV D E M V C +KL VM I C + + R
Sbjct: 268 YD-----LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 743 TIKKVLQMLE 752
T ++ + L
Sbjct: 323 TALRIKKTLS 332
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 29/296 (9%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDIVFQDGEREFKNEVFV 530
EE + ++G+G+FG V +T VAVK+L D +R+F+ E+ +
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77
Query: 531 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 586
+ H +V+ G Q+ LV E+L +G L FL + + + + QI
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQI 136
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----- 641
+G+ YL S + +H D+ +NIL++ + +I+DFGLAKLL L++ +
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDC 700
I APE ++ + + DV+SFGV+L E+ C KS E+ + D
Sbjct: 194 IFWY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC--SPSAEFLRMMGCERDV 247
Query: 701 YRNGKLDALV--GGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
+L L+ G + A C ++ +M W P RP+ + L+
Sbjct: 248 PALSRLLELLEEGQRLPAPPA--CPAEVHELMKLCW--APSPQDRPSFSALGPQLD 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-41
Identities = 72/294 (24%), Positives = 131/294 (44%), Gaps = 26/294 (8%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDIVFQDGEREFKNEVFVI 531
+ EE F +++G+G+FG V + +T VAVKKL ++ R+F+ E+ ++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 532 GQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 587
H N+V+ G C +N L+ E+L G+L +L + K + QI
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQIC 124
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----I 642
+G+ YL + + IH D+ +NIL+++ +I DFGL K+L ++ I
Sbjct: 125 KGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI 181
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702
APE SK + DV+SFGV+L E+ + E ++ +
Sbjct: 182 FWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
Query: 703 NGKLDALV--GGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
L L+ G + + C +++ +M W + + RP+ + + ++
Sbjct: 238 VFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 6e-41
Identities = 74/314 (23%), Positives = 135/314 (42%), Gaps = 26/314 (8%)
Query: 453 IRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTST-TAVAVK 511
N G + + + EE F +++G+G+FG V + +T VAVK
Sbjct: 17 TENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 512 KLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLF 569
KL ++ R+F+ E+ ++ H N+V+ G C +N L+ E+L G+L +L
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 570 GNLKPNWNLRT--NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627
+ K + QI +G+ YL + + IH D+ +NIL+++ +I DFGL
Sbjct: 137 KH-KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192
Query: 628 KLLTLNQSKTIKTS-----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
K+L ++ I APE SK + DV+SFGV+L E+ +
Sbjct: 193 KVLPQDKEYYKVKEPGESPIFWY----APESLTESKFSVASDVWSFGVVLYELFTYIEKS 248
Query: 683 DIEMVEEYAILTDWAFDCYRNGKLDALV--GGDMEAMNDVECLEKL--VMVSIWCIQEDP 738
E ++ + L L+ G + + C +++ +M W +
Sbjct: 249 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDG--CPDEIYMIMTECW--NNNV 304
Query: 739 SLRPTIKKVLQMLE 752
+ RP+ + + ++
Sbjct: 305 NQRPSFRDLALRVD 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 74/278 (26%), Positives = 125/278 (44%), Gaps = 34/278 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKN 538
F E+GRGSF VYKG+ T T VA + + + + FK E ++ H N
Sbjct: 30 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86
Query: 539 LVRLLGFC---DEGQNRLLVY-EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
+VR +G+ +++ E + +GTL ++L + + QI +GL +LH
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 595 EDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
+ IIH D+K NI + + +I D GLA L + +K + GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEM 201
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSF-DIE-MVEEYAILTDWAFDCYRNGKLDALVG 711
+ K VDVY+FG+ +LE+ + + + + Y +T +G A
Sbjct: 202 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT--------SGVKPAS-- 250
Query: 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + E E + CI+++ R +IK +L
Sbjct: 251 --FDKVAIPEVKEIIEG----CIRQNKDERYSIKDLLN 282
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 51/292 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNL 539
E++GRG+FG V+ G + R T VAVK + + D + +F E ++ Q H N+
Sbjct: 118 LGEQIGRGNFGEVFSGRL---RADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCS 598
VRL+G C + Q +V E + G +FL + + A G+ YL S
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---S 231
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ----SKTIKTSIRGTKGYVAPEWF 654
IH D+ +N L+ + +ISDFG+++ + ++ T APE
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEAL 287
Query: 655 RNSKITAKVDVYSFGVLLLEIIAC-------RKSFD-IEMVEEYAILTDWAFDCYRNGKL 706
+ +++ DV+SFG+LL E + + E VE+
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK----------------- 330
Query: 707 DALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
GG + C + + +M W +P RP+ + Q L+ + +
Sbjct: 331 ----GGRLPCPEL--CPDAVFRLMEQCW--AYEPGQRPSFSTIYQELQSIRK 374
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-40
Identities = 72/299 (24%), Positives = 136/299 (45%), Gaps = 51/299 (17%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFV 530
+E+E + + ++ +G G G V G ++ VA+K L + + +R +F +E +
Sbjct: 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 588
+GQ H N++RL G G+ ++V E++ NG+L +FL + + + + +
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IR 643
G+ YL +H D+ +N+L+D + ++SDFGL+++L + T+ IR
Sbjct: 163 GMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTD 695
T APE ++ DV+SFGV++ E++A + + I VEE
Sbjct: 220 WT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE------ 269
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + A C L +M+ W +D + RP +++ +L+
Sbjct: 270 ---------------GYRLPAPMG--CPHALHQLMLDCW--HKDRAQRPRFSQIVSVLD 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 73/305 (23%), Positives = 129/305 (42%), Gaps = 40/305 (13%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTT-RTSTTAVAVKKL-DIVFQDGEREFKNEVFV 530
E+ ++G G FG V + VAVK L + + K E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 531 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 586
+ +H+N+V+ G C D G L+ EFL +G+L +L N K NL+ A QI
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQI 135
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----- 641
+G+ YL S Q +H D+ +N+L++ + +I DFGL K + ++
Sbjct: 136 CKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII-------ACRKSFDIEMVEEYAILT 694
+ APE SK DV+SFGV L E++ + F + + +T
Sbjct: 193 VFWY----APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 695 DW-AFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQML 751
+ + GK + + C +++ +M W + PS R + + +++
Sbjct: 249 VTRLVNTLKEGKR-------LPCPPN--CPDEVYQLMRKCW--EFQPSNRTSFQNLIEGF 297
Query: 752 EGVVE 756
E +++
Sbjct: 298 EALLK 302
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 71/292 (24%), Positives = 113/292 (38%), Gaps = 53/292 (18%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL---DIVFQDGEREFKNEVFVIGQTHHK 537
E++G GSFG+V +G T +VAVK L + + +F EV + H+
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
NL+RL G +V E G+L L + + ++ L T A Q+A G+ YL
Sbjct: 82 NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLE- 138
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IRGTKGYVA 650
S + IH D+ +N+LL +I DFGL + L N + A
Sbjct: 139 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC----A 192
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYR 702
PE + + D + FGV L E+ ++ + + +++ + R
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK---------EGER 243
Query: 703 NGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ D C + + VMV W P RPT + L
Sbjct: 244 -----------LPRPED--CPQDIYNVMVQCW--AHKPEDRPTFVALRDFLL 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 5e-39
Identities = 67/290 (23%), Positives = 122/290 (42%), Gaps = 52/290 (17%)
Query: 481 FKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKN 538
+ +G G+FG VYKG+ I VA+K+L + +E +E +V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 596
+ RLLG C L+ + + G L ++ + K N + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTSIRGTKGYVAPE 652
+++H D+ +N+L+ + +I+DFGLAKLL + + K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNG 704
+ T + DV+S+GV + E++ K +D ++E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------------- 234
Query: 705 KLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + C + +M W D RP ++++
Sbjct: 235 ------GERLPQPPI--CTIDVYMIMRKCW--MIDADSRPKFRELIIEFS 274
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-39
Identities = 79/288 (27%), Positives = 127/288 (44%), Gaps = 53/288 (18%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
K ++G G +G VY+GV + + VAVK L ++ EF E V+ + H
Sbjct: 224 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 276
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
NLV+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPE 652
IH ++ +N L+ +++ +++DFGL++L+T + K I+ T APE
Sbjct: 336 --KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APE 389
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIACRKS----FD----IEMVEEYAILTDWAFDCYRNG 704
+K + K DV++FGVLL EI S D E++E+
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------------- 434
Query: 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
ME C EK+ + C Q +PS RP+ ++ Q E
Sbjct: 435 ------DYRMERPEG--CPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-39
Identities = 76/299 (25%), Positives = 139/299 (46%), Gaps = 51/299 (17%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFV 530
KEL+ + + VG G FG V G ++ +VA+K L + + + +R +F E +
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 588
+GQ H N++RL G + + ++V E++ NG+L SFL + + + + IA
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIAS 158
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IR 643
G+ YL +H D+ +NIL++ + ++SDFGL ++L + T IR
Sbjct: 159 GMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTD 695
T +PE K T+ DV+S+G++L E+++ + + I+ V+E
Sbjct: 216 WT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE------ 265
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + D C L +M+ W Q+D + RP ++++ +L+
Sbjct: 266 ---------------GYRLPPPMD--CPAALYQLMLDCW--QKDRNNRPKFEQIVSILD 305
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE---FKNEVFVIGQ 533
NF+ +++GRG F VY+ VA+KK+ I + E+ ++ Q
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGV---PVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARG 589
+H N+++ E +V E + G L+ + K + Q+
Sbjct: 89 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L ++H S +++H D+KP N+ + ++ D GL + + + S+ GT Y+
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYM 203
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
+PE + K D++S G LL E+ A + F + + Y++ +
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KI 250
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
D + E+L + CI DP RP + V +
Sbjct: 251 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 32/296 (10%)
Query: 473 ELEEATDNFKEEVGRGSFGIVYKGVIQ-TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFV 530
+ ++G G FG V T + VAVK L R +K E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 531 IGQTHHKNLVRLLGFC--DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
+ +H+++++ G C + LV E++ G+L +L + A QI
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICE 145
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IR 643
G+ YLH + IH D+ +N+LLD+ +I DFGLAK + +
Sbjct: 146 GMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY-- 701
APE + K DV+SFGV L E++ + +
Sbjct: 203 WY----APECLKEYKFYYASDVWSFGVTLYELL----THCDSSQSPPTKFLELIGIAQGQ 254
Query: 702 -RNGKLDALV--GGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
+L L+ G + + C ++ +M + W + + S RPT + ++ +L+
Sbjct: 255 MTVLRLTELLERGERLPRPDK--CPAEVYHLMKNCW--ETEASFRPTFENLIPILK 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 69/307 (22%), Positives = 127/307 (41%), Gaps = 51/307 (16%)
Query: 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVF 529
+F E +GRG FG VY G + AVK L+ + GE +F E
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 530 VIGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 586
++ H N++ LLG C + L+V ++ +G L +F+ N ++ Q+
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQV 201
Query: 587 ARGLLYLHEDCSSQ-IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS---- 641
A+G+ +L +S+ +H D+ +N +LD+ + +++DFGLA+ + + ++
Sbjct: 202 AKGMKFL----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 642 --IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF------DIEMVEEYAIL 693
++ A E + K T K DV+SFGVLL E++ + D+ + L
Sbjct: 258 LPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYL 309
Query: 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQML 751
G + C + L VM+ W +RP+ +++ +
Sbjct: 310 LQ---------------GRRLLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRI 350
Query: 752 EGVVEVS 758
+
Sbjct: 351 SAIFSTF 357
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 71/299 (23%), Positives = 126/299 (42%), Gaps = 41/299 (13%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFV 530
+F E +GRG FG VY G + AVK L+ + GE +F E +
Sbjct: 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79
Query: 531 IGQTHHKNLVRLLGFCDEGQN-RLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 587
+ H N++ LLG C + L+V ++ +G L +F+ N ++ Q+A
Sbjct: 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVA 138
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL------TLNQSKTIKTS 641
+G+ YL S + +H D+ +N +LD+ + +++DFGLA+ + +++ K
Sbjct: 139 KGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 642 IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII--ACRKSFDIEMVEEYAILTDWAFD 699
++ A E + K T K DV+SFGVLL E++ D+ + L
Sbjct: 196 VKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---- 247
Query: 700 CYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
G + C + L VM+ W +RP+ +++ + +
Sbjct: 248 -----------GRRLLQPEY--CPDPLYEVMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 66/298 (22%), Positives = 127/298 (42%), Gaps = 53/298 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNL 539
+G+G FG+VY G + A+K L + + + F E ++ +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 540 VRLLGFCDEGQNRLL-VYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 596
+ L+G + + ++ +G L F+ + N ++ + Q+ARG+ YL
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA-- 141
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL------TLNQSKTIKTSIRGTKGYVA 650
+ +H D+ +N +LD+ + +++DFGLA+ + ++ Q + + ++ T A
Sbjct: 142 -EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----A 196
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIAC-------RKSFD-IEMVEEYAILTDWAFDCYR 702
E + + T K DV+SFGVLL E++ FD + +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ------------- 243
Query: 703 NGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
G + C + L VM W + DP++RPT + ++ +E +V
Sbjct: 244 --------GRRLPQPEY--CPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 50/288 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNL 539
+G G FG VY+GV + VAVK D + +F +E ++ H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 597
V+L+G +E + ++ E G L +L N K + + T + QI + + YL
Sbjct: 76 VKLIGIIEE-EPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE--- 130
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWF 654
S +H D+ +NIL+ ++ DFGL++ + + + I+ +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESI 186
Query: 655 RNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKL 706
+ T DV+ F V + EI++ ++ F I ++E+
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK----------------- 229
Query: 707 DALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + + C L +M W DPS RP +++ L
Sbjct: 230 ----GDRLPKPDL--CPPVLYTLMTRCW--DYDPSDRPRFTELVCSLS 269
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 70/298 (23%), Positives = 137/298 (45%), Gaps = 48/298 (16%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVF 529
E+ + ++ +G G FG VYKG+ ++ VA+K L + + +R +F E
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 530 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 587
++GQ H N++RL G + + +++ E++ NG L FL +++ + IA
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIA 157
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
G+ YL + +H D+ +NIL++ + ++SDFGL+++L + T TS G K
Sbjct: 158 AGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKI 212
Query: 648 YV---APEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDW 696
+ APE K T+ DV+SFG+++ E++ + + ++ + +
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND------- 265
Query: 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + D C + +M+ W Q++ + RP ++ +L+
Sbjct: 266 --------------GFRLPTPMD--CPSAIYQLMMQCW--QQERARRPKFADIVSILD 305
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 74/287 (25%), Positives = 124/287 (43%), Gaps = 57/287 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKN 538
+ +G+G FG V G + + VAVK + ++ + F E V+ Q H N
Sbjct: 25 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 75
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
LV+LLG E + L +V E++ G+L +L + + + + YL
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 134
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
+ +H D+ +N+L+ + A++SDFGL K + Q K ++ T APE R
Sbjct: 135 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 187
Query: 656 NSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKLD 707
K + K DV+SFG+LL EI + R + + VE+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------ 229
Query: 708 ALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M+A + C + VM + W D ++RP+ ++ + LE
Sbjct: 230 ---GYKMDAPDG--CPPAVYEVMKNCW--HLDAAMRPSFLQLREQLE 269
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 50/288 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNL 539
+G G FG V++G+ + AVA+K D R +F E + Q H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 597
V+L+G E ++ E G L SFL K + +L + A+Q++ L YL
Sbjct: 79 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE--- 133
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWF 654
S + +H D+ +N+L+ + ++ DFGL++ + + + K I+ APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 189
Query: 655 RNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKL 706
+ T+ DV+ FGV + EI+ K F I +E
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------- 232
Query: 707 DALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + + C L +M W DPS RP ++ L
Sbjct: 233 ----GERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 272
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 70/303 (23%), Positives = 125/303 (41%), Gaps = 52/303 (17%)
Query: 472 KELEEATDNFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVF 529
+ +E + +G G FG V+KGV I + V +K ++ + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 530 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 587
IG H ++VRLLG C G + LV ++L G+L + + + + N QIA
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIA 125
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT----IKTSIR 643
+G+ YL E ++H ++ +N+LL +++DFG+A LL + + KT I+
Sbjct: 126 KGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTD 695
A E K T + DV+S+GV + E++ + + +++E+
Sbjct: 183 WM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK------ 232
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEG 753
G + C + VMV W D ++RPT K++
Sbjct: 233 ---------------GERLAQPQI--CTIDVYMVMVKCW--MIDENIRPTFKELANEFTR 273
Query: 754 VVE 756
+
Sbjct: 274 MAR 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 64/300 (21%), Positives = 118/300 (39%), Gaps = 54/300 (18%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDIVFQDGERE-FKNEVFVIGQT 534
+F+ + +GRG FG+V++ A+K++ + ++ RE EV + +
Sbjct: 5 TDFEPIQCLGRGGFGVVFEA----KNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 535 HHKNLVRLLG-FCDEG--------QNRLLVY---EFLNNGTLASFLF---GNLKPNWNLR 579
H +VR + ++ ++ +Y + L ++ + ++
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--------- 630
+I QIA + +LH S ++H D+KP NI ++ DFGL +
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 631 -TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
T + T GTK Y++PE + + KVD++S G++L E++ F +M E
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-ER 233
Query: 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
LTD RN K L +V + P RP +++
Sbjct: 234 VRTLTD-----VRNLKFPPLFTQKYPC------EYVMVQ---DMLSPSPMERPEAINIIE 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 69/290 (23%), Positives = 125/290 (43%), Gaps = 59/290 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
+E+G G FG+V G + VAVK + ++G E EF E + + H
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQ----YDVAVKMI----KEGSMSEDEFFQEAQTMMKLSHP 63
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
LV+ G C + +V E+++NG L ++L + + + + G+ +L
Sbjct: 64 KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLE- 121
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPE 652
S Q IH D+ +N L+D ++SDFG+ + + +Q S K ++ + APE
Sbjct: 122 --SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APE 175
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNG 704
F K ++K DV++FG+L+ E+ + + +D + V +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ--------------- 220
Query: 705 KLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + + + + +M S W E P RPT +++L +E
Sbjct: 221 ------GHRLYRPHL--ASDTIYQIMYSCW--HELPEKRPTFQQLLSSIE 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 57/290 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
K ++G G +G VY+GV + + VAVK L ++ EF E V+ + H
Sbjct: 17 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 69
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
NLV+LLG C ++ EF+ G L +L + + +A QI+ + YL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPE 652
IH D+ +N L+ +++ +++DFGL++L+T + K I+ T APE
Sbjct: 129 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APE 182
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNG 704
+K + K DV++FGVLL EI + E++E+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK--------------- 227
Query: 705 KLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
ME C EK+ +M + W Q +PS RP+ ++ Q E
Sbjct: 228 ------DYRMERPEG--CPEKVYELMRACW--QWNPSDRPSFAEIHQAFE 267
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-37
Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 57/287 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKN 538
+ +G+G FG V G + + VAVK + ++ + F E V+ Q H N
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCI----KNDATAQAFLAEASVMTQLRHSN 247
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
LV+LLG E + L +V E++ G+L +L + + + + YL
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE- 306
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
+ +H D+ +N+L+ + A++SDFGL K + Q K ++ T APE R
Sbjct: 307 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-KLPVKWT----APEALR 359
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKS-------FD-IEMVEEYAILTDWAFDCYRNGKLD 707
K + K DV+SFG+LL EI + + D + VE+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------ 401
Query: 708 ALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M+A + C + VM + W D + RPT ++ + LE
Sbjct: 402 ---GYKMDAPDG--CPPAVYDVMKNCW--HLDAATRPTFLQLREQLE 441
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 51/286 (17%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
E+G G+FG V KG Q + VAVK K + + E E V+ Q + +VR
Sbjct: 24 ELGSGNFGTVKKGYYQM-KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
++G C E ++ +LV E G L +L N + Q++ G+ YL E S
Sbjct: 83 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-E--ESNF 138
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IRGTKGYVAPEWFRN 656
+H D+ +N+LL + A+ISDFGL+K L +++ + ++ APE
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY----APECINY 194
Query: 657 SKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKLDA 708
K ++K DV+SFGVL+ E + +K + M+E+
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------------- 235
Query: 709 LVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M C ++ +M W D RP V L
Sbjct: 236 --GERMGCPAG--CPREMYDLMNLCW--TYDVENRPGFAAVELRLR 275
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 47/297 (15%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKN 538
+ +G G FG V +G ++ ++ VAVK KLD Q EF +E + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 539 LVRLLGFCDEGQNR-----LLVYEFLNNGTLASFL----FGNLKPNWNLRT--NIAFQIA 587
++RLLG C E ++ +++ F+ G L ++L + L+T IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----IR 643
G+ YL + +H D+ +N +L D ++DFGL+K + ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCY 701
A E + T+K DV++FGV + EI + ++ E Y L
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH------ 264
Query: 702 RNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
G ++ D CL++L +M S W + DP RPT + LE ++E
Sbjct: 265 ---------GHRLKQPED--CLDELYEIMYSCW--RTDPLDRPTFSVLRLQLEKLLE 308
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 71/294 (24%), Positives = 130/294 (44%), Gaps = 59/294 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHK 537
F +E+G G FG+V G + VA+K + ++G E EF E V+ H+
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ----YDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHE 595
LV+L G C + + ++ E++ NG L ++L + + + + + + YL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE- 137
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPE 652
S Q +H D+ +N L++D ++SDFGL++ + ++ S K +R + PE
Sbjct: 138 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPE 191
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNG 704
SK ++K D+++FGVL+ EI + + ++ E + +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------------- 236
Query: 705 KLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
G + + EK+ +M S W E RPT K +L + V++
Sbjct: 237 ------GLRLYRPHL--ASEKVYTIMYSCW--HEKADERPTFKILLSNILDVMD 280
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 49/285 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ ++G+G FG V+ G T T VA+K L E F E V+ + H+ LV
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 242
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWFR 655
+H D++ NIL+ ++ +++DFGLA+L+ N+ + K I+ T APE
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 354
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKS-------FD-IEMVEEYAILTDWAFDCYRNGKLD 707
+ T K DV+SFG+LL E+ + + ++ VE
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------ 396
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M + C E L + C +++P RPT + + LE
Sbjct: 397 ---GYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 69/290 (23%), Positives = 119/290 (41%), Gaps = 45/290 (15%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREF-KNEVFVIGQT 534
++++ +G GS+G K ++ + K+LD + E++ +EV ++ +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKI---LVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 535 HHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIAR 588
H N+VR D L +V E+ G LAS + K L + Q+
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 589 GLLYLHE--DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
L H D ++H D+KP N+ LD N ++ DFGLA++L + S KT + GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KTFV-GTP 180
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
Y++PE K D++S G LL E+ A F AF
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------------AFS------Q 221
Query: 707 DALVG----GDMEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
L G G + + L +++ + RP+++++L+
Sbjct: 222 KELAGKIREGKFRRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN 268
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 69/291 (23%), Positives = 124/291 (42%), Gaps = 53/291 (18%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
F +E+G G FG+V+ G VA+K + E +F E V+ + H LV
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNK----DKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 66
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+L G C E LV EF+ +G L+ +L + + T + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYL---EE 122
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWFR 655
+ +IH D+ +N L+ ++ ++SDFG+ + + +Q S K ++ +PE F
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFS 178
Query: 656 NSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKLD 707
S+ ++K DV+SFGVL+ E+ + + ++ +E +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------------ 220
Query: 708 ALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
G + + +M W +E P RP ++L+ L + E
Sbjct: 221 ---GFRLYKPRL--ASTHVYQIMNHCW--RERPEDRPAFSRLLRQLAEIAE 264
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-37
Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 49/285 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ ++G+G FG V+ G T T VA+K L E F E V+ + H+ LV
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLV 325
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+L E + +V E+++ G+L FL G L ++A QIA G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 381
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWFR 655
+H D++ NIL+ ++ +++DFGLA+L+ N+ + K I+ T APE
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAAL 437
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKS-------FD-IEMVEEYAILTDWAFDCYRNGKLD 707
+ T K DV+SFG+LL E+ + + ++ VE
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------------ 479
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M + C E L + C +++P RPT + + LE
Sbjct: 480 ---GYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 54/288 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E +G G FG V+K R +K++ + + EV + + H N+V
Sbjct: 17 ELIGSGGFGQVFKA---KHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHY 69
Query: 543 LG-FCDEGQNRL---------------LVYEFLNNGTLASFL---FGNLKPNWNLRTNIA 583
G + + + EF + GTL ++ G +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL-ELF 128
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
QI +G+ Y+H S ++I+ D+KP NI L D +I DFGL L + +T +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK---NDGKRTRSK 182
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703
GT Y++PE + +VD+Y+ G++L E++ + E + + L R+
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-ETSKFFTDL--------RD 233
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQML 751
G + + + L+ + + P RP ++L+ L
Sbjct: 234 GIISDIFDKK---------EKTLLQ---KLLSKKPEDRPNTSEILRTL 269
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 64/296 (21%), Positives = 115/296 (38%), Gaps = 60/296 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH 536
F E +G+G+F ++KGV + + T V +K LD ++ F ++ + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN---LKPNWNLRTNIAFQIARGLLYL 593
K+LV G C G +LV EF+ G+L ++L N + W L +A Q+A + +L
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL 129
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNAR--------ISDFGLAKLLTLNQSKTIKTSIRGT 645
+ +IH ++ +NILL + + +SD G++ + + I
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL--QERIPWV 184
Query: 646 KGYVAPEWFRNSKI-TAKVDVYSFGVLLLEII-------ACRKSFD-IEMVEEYAILTDW 696
PE N K D +SFG L EI + S ++ E+
Sbjct: 185 ----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED------- 233
Query: 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ A E ++ + +P RP+ + +++ L
Sbjct: 234 --------------RHQLPAPKAAELAN--LINNCM--DYEPDHRPSFRAIIRDLN 271
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 46/286 (16%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREF-KNEVFVIGQT 534
+ + +++G GSFG +K+++I ERE + EV V+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ---YVIKEINISRMSSKEREESRREVAVLANM 80
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGL 590
H N+V+ +E + +V ++ G L + N + + + QI L
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLAL 138
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
++H +I+H D+K QNI L ++ DFG+A++L + GT Y++
Sbjct: 139 KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYLS 193
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710
PE N K D+++ G +L E+ + +F+ A + LV
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFE-------------AGS------MKNLV 234
Query: 711 G----GDMEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
G ++ L LV + +P RP++ +L+
Sbjct: 235 LKIISGSFPPVSLHYSYDLRSLVS---QLFKRNPRDRPSVNSILEK 277
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 65/298 (21%), Positives = 118/298 (39%), Gaps = 48/298 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKN 538
+G+G FG V + ++ S VAVK K DI+ EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 539 LVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKPNWNLR------TNIAFQI 586
+ +L+G + + +++ F+ +G L +FL + I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----I 642
A G+ YL S IH D+ +N +L + ++DFGL++ + + +
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
+ A E ++ T DV++FGV + EI+ ++ IE E Y L
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG----- 254
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
G ++ + C+E++ +M W DP RP+ + LE ++
Sbjct: 255 ----------GNRLKQPPE--CMEEVYDLMYQCW--SADPKQRPSFTCLRMELENILG 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 72/314 (22%), Positives = 125/314 (39%), Gaps = 72/314 (22%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
K E+G G+FG V+ VAVK L ++F+ E ++ H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----------------I 582
+V+ G C +G ++V+E++ +G L FL + L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS- 641
A QIA G++YL S +H D+ +N L+ + +I DFG+++ + +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 642 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD------------IEM 686
IR PE K T + DV+SFGV+L EI ++ IE
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIF----TYGKQPWFQLSNTEVIEC 247
Query: 687 VEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTI 744
+ + G +E C +++ VM+ W Q +P R I
Sbjct: 248 ITQ---------------------GRVLERPRV--CPKEVYDVMLGCW--QREPQQRLNI 282
Query: 745 KKVLQMLEGVVEVS 758
K++ ++L + + +
Sbjct: 283 KEIYKILHALGKAT 296
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-37
Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 49/285 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
++++G G FG V+ T VAVK + F E V+ H LV
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH----TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+L + + ++ EF+ G+L FL + L + + QIA G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWFR 655
IH D++ NIL+ +I+DFGLA+++ N+ + K I+ T APE
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAIN 358
Query: 656 NSKITAKVDVYSFGVLLLEIIA-CRKSFD-------IEMVEEYAILTDWAFDCYRNGKLD 707
T K DV+SFG+LL+EI+ R + I +E YR
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER----------GYR----- 403
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
M + C E+L + + C + P RPT + + +L+
Sbjct: 404 ------MPRPEN--CPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 52/290 (17%)
Query: 481 FKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKN 538
+ +G G+FG VYKG+ I VA+K+L + +E +E +V+ + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHED 596
+ RLLG C L+ + + G L ++ + K N + N QIA+G+ YL +
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED- 135
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTSIRGTKGYVAPE 652
+++H D+ +N+L+ + +I+DFGLAKLL + + K I+ A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM----ALE 189
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNG 704
+ T + DV+S+GV + E++ K +D ++E+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--------------- 234
Query: 705 KLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + C + +MV W D RP ++++
Sbjct: 235 ------GERLPQPPI--CTIDVYMIMVKCW--MIDADSRPKFRELIIEFS 274
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 72/305 (23%), Positives = 135/305 (44%), Gaps = 47/305 (15%)
Query: 481 FKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
E+G+GSFG+VY+GV + T VA+K ++ ER EF NE V+ + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------FGNLKPNWNLR----TNIAFQIA 587
++VRLLG +GQ L++ E + G L S+L N +A +IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS----IR 643
G+ YL+ +++ +H D+ +N ++ + + +I DFG+ + + +R
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCY 701
+PE ++ T DV+SFGV+L EI + + + + +
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 255
Query: 702 RNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759
GG ++ ++ C + L +M W Q +P +RP+ +++ ++ +E
Sbjct: 256 ---------GGLLDKPDN--CPDMLFELMRMCW--QYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 760 PPNPY 764
+
Sbjct: 303 REVSF 307
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 80/291 (27%), Positives = 123/291 (42%), Gaps = 61/291 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
E +G G FG V+ G T VAVK L + F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGH----TKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
RL + + ++ E++ NG+L FL + ++A QIA G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ---SKTIKTSIRGTKGYVAPEWFR 655
IH D++ NIL+ D + +I+DFGLA+L+ N+ + K I+ T APE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAIN 183
Query: 656 NSKITAKVDVYSFGVLLLEIIACRKSFD------------IEMVEEYAILTDWAFDCYRN 703
T K DV+SFG+LL EI+ + I+ +E
Sbjct: 184 YGTFTIKSDVWSFGILLTEIV----THGRIPYPGMTNPEVIQNLER-------------- 225
Query: 704 GKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G M ++ C E+L +M W +E P RPT + +LE
Sbjct: 226 -------GYRMVRPDN--CPEELYQLMRLCW--KERPEDRPTFDYLRSVLE 265
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 53/289 (18%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHKNLV 540
E+G G+FG V +GV R VA+K L + E E ++ Q + +V
Sbjct: 15 DIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCS 598
RL+G C + + +LV E G L FL G + P N+ + Q++ G+ YL
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV-AELLHQVSMGMKYL---EE 128
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-----IRGTKGYVAPEW 653
+H D+ +N+LL + + A+ISDFGL+K L + S S ++ APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----APEC 184
Query: 654 FRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGK 705
K +++ DV+S+GV + E ++ +K + + +E+
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------------- 228
Query: 706 LDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G ME + C +L +M W RP V Q +
Sbjct: 229 -----GKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 268
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 70/275 (25%), Positives = 116/275 (42%), Gaps = 36/275 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLG 544
+G+G++GIVY G + + +A+K++ + E+ + HKN+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQV---RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 545 FCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
E + E + G+L++ L +G LK N QI GL YLH +QI
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQI 143
Query: 602 IHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI- 659
+H D+K N+L++ + +ISDFG +K L T + GT Y+APE
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGPRG 201
Query: 660 -TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL--VGGDM-- 714
D++S G ++E+ + F E+ E A + ++ G + M
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPF-YELGEPQAAM-------FKVGMFKVHPEIPESMSA 253
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
EA + C + DP R +L
Sbjct: 254 EAKAFILK----------CFEPDPDKRACANDLLV 278
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 77/310 (24%), Positives = 122/310 (39%), Gaps = 75/310 (24%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQTHHK 537
F EE+G FG VYKG + T AVA+K L D EF++E + + H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 581
N+V LLG + Q +++ + ++G L FL + T+
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 582 IAFQIARGLLYLHEDCSSQ-IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+ QIA G+ YL SS ++H D+ +N+L+ D N +ISD GL + + +
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 641 S----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD------------I 684
+ IR APE K + D++S+GV+L E+ S+ +
Sbjct: 189 NSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVF----SYGLQPYCGYSNQDVV 240
Query: 685 EMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRP 742
EM+ + +D C + +M+ W E PS RP
Sbjct: 241 EMIRN---------------------RQVLPCPDD--CPAWVYALMIECW--NEFPSRRP 275
Query: 743 TIKKVLQMLE 752
K + L
Sbjct: 276 RFKDIHSRLR 285
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 71/313 (22%), Positives = 122/313 (38%), Gaps = 71/313 (22%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
K E+G G+FG V+ VAVK L + ++F+ E ++ H++
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------IA 583
+VR G C EG+ L+V+E++ +G L FL + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS-- 641
Q+A G++YL +H D+ +N L+ +I DFG+++ + +
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
Query: 642 --IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD------------IEMV 687
IR PE K T + DV+SFGV+L EI ++ I+ +
Sbjct: 222 LPIRWM----PPESILYRKFTTESDVWSFGVVLWEIF----TYGKQPWYQLSNTEAIDCI 273
Query: 688 EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIK 745
+ G ++E C ++ +M W Q +P R +IK
Sbjct: 274 TQ---------------------GRELERPRA--CPPEVYAIMRGCW--QREPQQRHSIK 308
Query: 746 KVLQMLEGVVEVS 758
V L+ + +
Sbjct: 309 DVHARLQALAQAP 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 79/313 (25%), Positives = 122/313 (38%), Gaps = 55/313 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
+G G+FG VY+G + S VAVK L V + + +F E +I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGL 590
N+VR +G + R ++ E + G L SFL + ++A IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 591 LYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
YL + IH D+ +N LL A+I DFG+A+ + +G
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCA 205
Query: 648 YV-----APEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
+ PE F T+K D +SFGVLL EI + E +T
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS----- 260
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEG----- 753
GG M+ + C + +M W Q P RP +L+ +E
Sbjct: 261 ----------GGRMDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIEYCTQDP 306
Query: 754 -VVEVSVPPNPYP 765
V+ ++P P
Sbjct: 307 DVINTALPIEYGP 319
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 50/288 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHKNL 539
+G G FG V++G+ + AVA+K D R +F E + Q H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDC 597
V+L+G E ++ E G L SFL K + +L + A+Q++ L YL
Sbjct: 454 VKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE--- 508
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN---QSKTIKTSIRGTKGYVAPEWF 654
S + +H D+ +N+L+ + ++ DFGL++ + + ++ K I+ APE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564
Query: 655 RNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTDWAFDCYRNGKL 706
+ T+ DV+ FGV + EI+ K F I +E
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------------- 607
Query: 707 DALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G + + C L +M W DPS RP ++ L
Sbjct: 608 ----GERLPMPPN--CPPTLYSLMTKCW--AYDPSRRPRFTELKAQLS 647
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 72/312 (23%), Positives = 130/312 (41%), Gaps = 56/312 (17%)
Query: 481 FKEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQ-T 534
+ +G G+FG V + + VAVK L D + + +E+ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------------- 581
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 582 ---IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+Q+ARG+ YL S + IH D+ +N+L+ ++ +I+DFGLA+ +
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 639 KTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII--ACRKSFDIEMVEEYAI 692
T+ ++ APE + T + DV+SFGVL+ EI I + E + +
Sbjct: 216 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQM 750
L + G M+ + C +L +M W PS RPT K++++
Sbjct: 272 LKE---------------GHRMDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQLVED 312
Query: 751 LEGVVEVSVPPN 762
L+ ++ ++
Sbjct: 313 LDRILTLTTNEE 324
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 72/312 (23%), Positives = 130/312 (41%), Gaps = 64/312 (20%)
Query: 481 FKEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQ-T 534
+ +G G FG V + + VAVK L D + + +E+ ++
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------------- 581
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 582 ---IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+Q+ARG+ YL S + IH D+ +N+L+ ++ +I+DFGLA+ +
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 639 KTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF------DIEMVE 688
T+ ++ APE + T + DV+SFGVL+ EI + I + E
Sbjct: 262 TTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIF----TLGGSPYPGIPVEE 313
Query: 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKK 746
+ +L + G M+ + C +L +M W PS RPT K+
Sbjct: 314 LFKLLKE---------------GHRMDKPAN--CTNELYMMMRDCW--HAVPSQRPTFKQ 354
Query: 747 VLQMLEGVVEVS 758
+++ L+ ++ ++
Sbjct: 355 LVEDLDRILTLT 366
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+G+G+FG V K A+KK+ ++ +EV ++ +H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRY---YAIKKIRHT-EEKLSTILSEVMLLASLNHQYVV 65
Query: 541 RLLGFCDEGQNRL-------------LVYEFLNNGTLASFL-FGNLKPNWNLRTNIAFQI 586
R E +N + + E+ NGTL + NL + + QI
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT------------LNQ 634
L Y+H S IIH D+KP NI +D+ N +I DFGLAK + L
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 635 SKTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAIL 693
S TS GT YVA E + K+D+YS G++ E + S +E V L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-MIYPFSTGMERVNILKKL 241
Query: 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
R+ ++ N ++ +K++ I DP+ RP + +L
Sbjct: 242 --------RSVSIEFP---PDFDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-35
Identities = 71/284 (25%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKN 538
K+ +G G+ G + + R VAVK++ EV ++ + H N
Sbjct: 27 CPKDVLGHGAEGTIVYRGMFDNR----DVAVKRILPECFSFAD---REVQLLRESDEHPN 79
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-NIAFQIARGLLYLHEDC 597
++R + Q + + E L TL ++ + L + Q GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 598 SSQIIHCDMKPQNILL-----DDHYNARISDFGLAKLLTLNQ-SKTIKTSIRGTKGYVAP 651
S I+H D+KP NIL+ A ISDFGL K L + + S + ++ + GT+G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 652 EWFR---NSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCYRNGKL 706
E T VD++S G + + S F + + IL L
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL-------LGACSL 247
Query: 707 DALVGGDMEAMNDVECLEK-LVMVSIWCIQEDPSLRPTIKKVLQ 749
D L + + + L+ I DP RP+ K VL+
Sbjct: 248 DCL-----HPEKHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 63/284 (22%), Positives = 122/284 (42%), Gaps = 42/284 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIG--QTHHKN 538
+++G G V++ + + + A+K +++ D + ++NE+ + Q H
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
++RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 71 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ- 126
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---- 652
I+H D+KP N L+ D ++ DFG+A + + + +K S GT Y+ PE
Sbjct: 127 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 653 -------WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
SKI+ K DV+S G +L + + F +++ + + K
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQIS-------------K 229
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
L A++ + E + L V C++ DP R +I ++L
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 75/309 (24%), Positives = 131/309 (42%), Gaps = 57/309 (18%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQ-THH 536
F + +G G+FG V + + VAVK L ER +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 581
N+V LLG C G L++ E+ G L +FL +T+
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 582 ---IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 639 KTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEE-YA 691
K + ++ APE N T + DV+S+G+ L E+ + S + + + Y
Sbjct: 204 KGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 692 ILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQ 749
++ + G M + ++ +M + W DP RPT K+++Q
Sbjct: 260 MIKE---------------GFRMLSPEH--APAEMYDIMKTCW--DADPLKRPTFKQIVQ 300
Query: 750 MLEGVVEVS 758
++E + S
Sbjct: 301 LIEKQISES 309
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 58/284 (20%), Positives = 120/284 (42%), Gaps = 42/284 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNL- 539
+++G G V++ + + + A+K +++ D + ++NE+ + + +
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 540 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
+RL + Q +V E N L S+L ++ P R + + + +H
Sbjct: 90 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIH-- 144
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---- 652
I+H D+KP N L+ D ++ DFG+A + + + +K S GT Y+ PE
Sbjct: 145 -QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 653 -------WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
SKI+ K DV+S G +L + + F +++ + + L +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL---------HAI 252
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+D + + + + + L C++ DP R +I ++L
Sbjct: 253 IDPNHEIEFPDIPEKDLQDVL----KCCLKRDPKQRISIPELLA 292
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 76/294 (25%), Positives = 116/294 (39%), Gaps = 49/294 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
+G G+FG VY+G + S VAVK L V + + +F E +I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGL 590
N+VR +G + R ++ E + G L SFL + ++A IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 591 LYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
YL + IH D+ +N LL A+I DFG+A+ + +G
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR-----KGGCA 246
Query: 648 YV-----APEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDC 700
+ PE F T+K D +SFGVLL EI + E +T
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS----- 301
Query: 701 YRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
GG M+ + C + +M W Q P RP +L+ +E
Sbjct: 302 ----------GGRMDPPKN--CPGPVYRIMTQCW--QHQPEDRPNFAIILERIE 341
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 8e-35
Identities = 76/309 (24%), Positives = 129/309 (41%), Gaps = 56/309 (18%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQ-THH 536
+ +GRG+FG V + + VAVK L E +E+ ++ HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 537 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN-------------- 581
N+V LLG C G +++ EF G L+++L +
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 582 --IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 640 TS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEE-YAI 692
++ APE + T + DV+SFGVLL EI + S +++ EE
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQM 750
L + G M A + ++ M+ W +PS RPT ++++
Sbjct: 264 LKE---------------GTRMRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEH 304
Query: 751 LEGVVEVSV 759
L +++ +
Sbjct: 305 LGNLLQANA 313
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 82/331 (24%), Positives = 139/331 (41%), Gaps = 58/331 (17%)
Query: 453 IRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKK 512
++ + N Y L+ F++ +G G+FG V K I+ A+K+
Sbjct: 1 MKKHHHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKR 59
Query: 513 L-DIVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG 570
+ + +D R+F E+ V+ + HH N++ LLG C+ L E+ +G L FL
Sbjct: 60 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119
Query: 571 NLKPNWNLRTN----------------IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614
+ + A +ARG+ YL Q IH D+ +NIL+
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVG 176
Query: 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV-----APEWFRNSKITAKVDVYSFG 669
++Y A+I+DFGL S+ + ++ T G + A E S T DV+S+G
Sbjct: 177 ENYVAKIADFGL--------SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228
Query: 670 VLLLEIIACRKS--FDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL- 726
VLL EI++ + + E Y L G +E + C +++
Sbjct: 229 VLLWEIVSLGGTPYCGMTCAELYEKLPQ---------------GYRLEKPLN--CDDEVY 271
Query: 727 -VMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
+M W +E P RP+ ++L L ++E
Sbjct: 272 DLMRQCW--REKPYERPSFAQILVSLNRMLE 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 42/292 (14%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
F +++G G F V A+K++ Q E + E + +H N++
Sbjct: 33 FIQKLGEGGFSYVDLV---EGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 541 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLRT----NIAFQIARGLLY 592
RL+ +C + L+ F GTL + + L + I RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK-------TSIRGT 645
+H + H D+KP NILL D + D G ++ + + + R T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 646 KGYVAPEWF---RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702
Y APE F + I + DV+S G +L ++ +D+ + ++
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-------- 258
Query: 703 NGKLDALVGGDMEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
A+ + L +L+ + DP RP I +L LE
Sbjct: 259 -----AVQNQLSIPQSPRHSSALWQLL---NSMMTVDPHQRPHIPLLLSQLE 302
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 76/308 (24%), Positives = 135/308 (43%), Gaps = 56/308 (18%)
Query: 481 FKEEVGRGSFGIVYKG----VIQTTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQ-T 534
+ +G G+FG V + + T VAVK L + + + +E+ ++
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL------------FGNLKPNWNLR--- 579
HKN++ LLG C + ++ E+ + G L +L + P L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 580 -TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 639 KTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAI 692
T+ ++ APE + T + DV+SFGVLL EI S + + E + +
Sbjct: 250 TTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQM 750
L + G M+ ++ C +L +M W PS RPT K++++
Sbjct: 306 LKE---------------GHRMDKPSN--CTNELYMMMRDCW--HAVPSQRPTFKQLVED 346
Query: 751 LEGVVEVS 758
L+ +V ++
Sbjct: 347 LDRIVALT 354
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 56/284 (19%), Positives = 120/284 (42%), Gaps = 42/284 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNL- 539
+++G G V++ + + + A+K +++ D + ++NE+ + + +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQI----YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 540 -VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
+RL + Q +V E N L S+L ++ P R + + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE--RKSYWKNMLEAVHTIHQ- 173
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---- 652
I+H D+KP N L+ D ++ DFG+A + + + +K S G Y+ PE
Sbjct: 174 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 653 -------WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
SKI+ K DV+S G +L + + F +++ + + L +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-QIINQISKL-------HAIID 282
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + + + + + + L C++ DP R +I ++L
Sbjct: 283 PNHEI--EFPDIPEKDLQDVL----KCCLKRDPKQRISIPELLA 320
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 74/314 (23%), Positives = 129/314 (41%), Gaps = 67/314 (21%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
+ +G G FG V K R T VAVK L E + +E V+ Q +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR------------------ 579
++++L G C + LL+ E+ G+L FL + K
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 580 ------TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633
+ A+QI++G+ YL +++H D+ +NIL+ + +ISDFGL++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----- 198
Query: 634 QSKTIKTSI--RGTKGYV-----APEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDI 684
+ + ++G + A E + T + DV+SFGVLL EI+ + I
Sbjct: 199 --DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 685 EMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRP 742
+ +L G ME ++ C E++ +M+ W +++P RP
Sbjct: 257 PPERLFNLLKT---------------GHRMERPDN--CSEEMYRLMLQCW--KQEPDKRP 297
Query: 743 TIKKVLQMLEGVVE 756
+ + LE ++
Sbjct: 298 VFADISKDLEKMMV 311
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-34
Identities = 72/299 (24%), Positives = 121/299 (40%), Gaps = 49/299 (16%)
Query: 470 SYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL-DIVFQDGEREFKNEV 528
+ E+G G+FG V +GV R VA+K L + E E
Sbjct: 329 KLFLKRDNLLIADIELGCGNFGSVRQGVY-RMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQI 586
++ Q + +VRL+G C + + +LV E G L FL G + + + Q+
Sbjct: 388 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQV 445
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
+ G+ YL +H ++ +N+LL + + A+ISDFGL+K L + S T+ K
Sbjct: 446 SMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS--YYTARSAGK 500
Query: 647 GYV---APEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFD-------IEMVEEYAILTD 695
+ APE K +++ DV+S+GV + E ++ +K + + +E+
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------ 554
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLE 752
G ME + C +L +M W RP V Q +
Sbjct: 555 ---------------GKRMECPPE--CPPELYALMSDCW--IYKWEDRPDFLTVEQRMR 594
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 53/303 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQ-THH 536
F + +G G+FG V + + VAVK L E+ +E+ ++ H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL----------FGNLKPNWNLRTN----I 582
+N+V LLG C G L++ E+ G L +FL N T
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS- 641
+ Q+A+G+ +L S IH D+ +N+LL + + A+I DFGLA+ + + + +K +
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 642 ---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEE-YAILTD 695
++ APE + T + DV+S+G+LL EI + + I + + Y ++ D
Sbjct: 227 RLPVKWM----APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEG 753
G M + + +M + W +P+ RPT +++ L+
Sbjct: 283 ---------------GYQMAQPAF--APKNIYSIMQACW--ALEPTHRPTFQQICSFLQE 323
Query: 754 VVE 756
+
Sbjct: 324 QAQ 326
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-34
Identities = 79/303 (26%), Positives = 123/303 (40%), Gaps = 58/303 (19%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKN 538
++ +G GS G V R VAVK++ I F D E+ ++ ++ H N
Sbjct: 18 VSEKILGYGSSGTVVFQGSFQGR----PVAVKRMLIDFCD---IALMEIKLLTESDDHPN 70
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-------NIAFQIARGLL 591
++R + + E L N L + + NL+ ++ QIA G+
Sbjct: 71 VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 592 YLHEDCSSQIIHCDMKPQNILLD-------------DHYNARISDFGLAKLLTLNQSKTI 638
+LH S +IIH D+KPQNIL+ ++ ISDFGL K L QS
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 639 KT--SIRGTKGYVAPEWFRNS-------KITAKVDVYSFGVLLLEIIACRKS--FDIEMV 687
+ GT G+ APE S ++T +D++S G + I + F +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYS 245
Query: 688 EEYAILT-DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746
E I+ ++ D + +L EA + L+ I DP RPT K
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSL---IAEATD-------LIS---QMIDHDPLKRPTAMK 292
Query: 747 VLQ 749
VL+
Sbjct: 293 VLR 295
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 67/321 (20%), Positives = 125/321 (38%), Gaps = 81/321 (25%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
+ ++G G+FG V++ T VAVK L + +F+ E ++ + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN---------------- 581
N+V+LLG C G+ L++E++ G L FL ++
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 582 --------IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633
IA Q+A G+ YL + +H D+ +N L+ ++ +I+DFGL++ +
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 634 QSKTIKTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD------ 683
+ IR PE ++ T + DV+++GV+L EI S+
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIF----SYGLQPYYG 279
Query: 684 ------IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQ 735
I V + G + + C +L +M W
Sbjct: 280 MAHEEVIYYVRD---------------------GNILACPEN--CPLELYNLMRLCW--S 314
Query: 736 EDPSLRPTIKKVLQMLEGVVE 756
+ P+ RP+ + ++L+ + E
Sbjct: 315 KLPADRPSFCSIHRILQRMCE 335
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 62/276 (22%), Positives = 99/276 (35%), Gaps = 41/276 (14%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQ-THHKNL 539
+G GS+G V+K ++ AVK+ F+ EV + H
Sbjct: 63 SRLGHGSYGEVFKVR---SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
VRL +EG L E +L +G P + L +LH
Sbjct: 120 VRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLH--- 174
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
S ++H D+KP NI L ++ DFGL L + G Y+APE +
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG---TAGAGEVQEGDPRYMAPELLQG- 230
Query: 658 KITAKVDVYSFGVLLLEIIACRKS--FDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM- 714
DV+S G+ +LE +AC E ++ R G L +
Sbjct: 231 SYGTAADVFSLGLTILE-VACNMELPHGGEGWQQ-----------LRQGYLPPEFTAGLS 278
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+ +++ ++ DP LR T + +L +
Sbjct: 279 SELRS------VLV---MMLEPDPKLRATAEALLAL 305
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-33
Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 62/314 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKLDIVFQDGER-EFKNEVFVIGQ-THH 536
F + +G G+FG V + + VAVK L ER +E+ ++ Q H
Sbjct: 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--------------- 581
+N+V LLG C L++E+ G L ++L +
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 582 --------IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633
A+Q+A+G+ +L +H D+ +N+L+ +I DFGLA+ + +
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 634 QSKTIKTS----IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMV 687
+ ++ + ++ APE T K DV+S+G+LL EI + + I +
Sbjct: 226 SNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 688 EE-YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTI 744
Y ++ + G M+ E++ +M S W D RP+
Sbjct: 282 ANFYKLIQN---------------GFKMDQPFY--ATEEIYIIMQSCW--AFDSRKRPSF 322
Query: 745 KKVLQMLEGVVEVS 758
+ L + +
Sbjct: 323 PNLTSFLGCQLADA 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 64/224 (28%), Positives = 91/224 (40%), Gaps = 21/224 (9%)
Query: 459 DGTIETNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV 516
+G + T E E VGRGSFG V++ + T AVKK+ +
Sbjct: 38 EGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ---CAVKKVRL- 93
Query: 517 FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKP 574
E E+ +V L G EG + E L G+L + G L
Sbjct: 94 ----EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE 149
Query: 575 NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLT-- 631
+ Q GL YLH + +I+H D+K N+LL D A + DFG A L
Sbjct: 150 D--RALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 632 -LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
L +S I GT+ ++APE AKVD++S ++L
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 58/296 (19%), Positives = 110/296 (37%), Gaps = 62/296 (20%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQ-THHKNL 539
E++G G FG V+K V R A+K+ E+ EV+ H ++
Sbjct: 17 EKIGSGEFGSVFKCV---KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHE 595
VR E + L+ E+ N G+LA + N + + ++ Q+ RGL Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH- 132
Query: 596 DCSSQIIHCDMKPQNILLD-------------------DHYNARISDFGLAKLLTLNQSK 636
S ++H D+KP NI + + +I D G ++ Q +
Sbjct: 133 --SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 637 TIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRK--SFDIEMVEEYAIL 693
G ++A E + + K D+++ + ++ A + + + + I
Sbjct: 191 E------GDSRFLANEVLQENYTHLPKADIFALALTVVC-AAGAEPLPRNGDQW--HEI- 240
Query: 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
R G+L + + + L+ I DP RP+ +++
Sbjct: 241 --------RQGRLPRIPQVLSQEFTE------LLK---VMIHPDPERRPSAMALVK 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 65/311 (20%), Positives = 111/311 (35%), Gaps = 51/311 (16%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLV 540
+ + G F VY+ + A+K+L ++ R EV + + + H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 541 RLLGFC-------DEGQNRLLVYEFLNNGTLASFLF-----GNLKPNWNLRTNIAFQIAR 588
+ D GQ L+ L G L FL G L + L+ I +Q R
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK--IFYQTCR 147
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR----- 643
+ ++H IIH D+K +N+LL + ++ DFG A ++ + R
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 644 -----GTKGYVAPE---WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD 695
T Y PE + N I K D+++ G +L + + F+ I+
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--LRIV-- 262
Query: 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
NGK L+ +Q +P R +I +V+ L+ +
Sbjct: 263 -------NGKYSIPPHDTQY-----TVFHSLI---RAMLQVNPEERLSIAEVVHQLQEIA 307
Query: 756 EVSVPPNPYPF 766
P
Sbjct: 308 AARNVNPKSPI 318
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 34/214 (15%), Positives = 69/214 (32%), Gaps = 21/214 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDIVFQDGEREFKNEVFVIGQTHHKN 538
+G G+F VY+ + +K + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNW-----NLRTNIAFQIARGLLYL 593
++ +LV E + GTL + + L + A ++ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNA-----------RISDFGLAKLLTLNQSKTIKTSI 642
H +IIH D+KP N +L + + + D G + + L TI T+
Sbjct: 189 H---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
T G+ E N ++D + + ++
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
++G GS GIV + + VAVK +D+ Q NEV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQ---VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM 107
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
G+ ++ EFL G L + L IA + + L YLH +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---A 159
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+IH D+K +ILL ++SDFG ++ + K + S+ GT ++APE S
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSL 217
Query: 659 ITAKVDVYSFGVLLLEII 676
+VD++S G++++E++
Sbjct: 218 YATEVDIWSLGIMVIEMV 235
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 17/198 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G VY + T VA++++++ Q + NE+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFL-FGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
L G +V E+L G+L + + IA + + L +LH S
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLH---S 134
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+Q+IH D+K NILL + +++DFG +T QSK ++++ GT ++APE
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKA 192
Query: 659 ITAKVDVYSFGVLLLEII 676
KVD++S G++ +E+I
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 29/212 (13%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKN 538
+ +G+G+ V++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 539 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLY 592
+V+L +E R L+ EF G+L + L + L + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNH 127
Query: 593 LHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
L + I+H ++KP NI+ D +++DFG A+ L + + GT+ Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEEY 181
Query: 649 VAPE--------WFRNSKITAKVDVYSFGVLL 672
+ P+ K A VD++S GV
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 483 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKN 538
+++G G VY VA+K + I ++ E + F+ EV Q H+N
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIK----VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+V ++ +E LV E++ TL+ ++ + + + N QI G+ + H+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+I+H D+KPQNIL+D + +I DFG+AK L+ S T + GT Y +PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFD 683
D+YS G++L E++ F+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFN 213
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-30
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKN 538
+ +G+G+ V++G + T A+K + + + E V+ + +HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDL---FAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 539 LVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARGLL 591
+V+L +E R L+ EF G+L + L N + + G+
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 592 YLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
+L + I+H ++KP NI+ D +++DFG A+ L + + GT+
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY-GTEE 180
Query: 648 YVAPE--------WFRNSKITAKVDVYSFGVLL 672
Y+ P+ K A VD++S GV
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 21/199 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+G FG VY + S +A+K L + E + + EV + H N++RL
Sbjct: 18 GKGKFGNVYLA---REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCS 598
G+ + L+ E+ GT+ + L+ ++A L Y H S
Sbjct: 75 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH---S 127
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
++IH D+KP+N+LL +I+DFG + ++ + GT Y+ PE
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRM 183
Query: 659 ITAKVDVYSFGVLLLEIIA 677
KVD++S GVL E +
Sbjct: 184 HDEKVDLWSLGVLCYEFLV 202
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-30
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 34/207 (16%)
Query: 557 EFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL 613
+ L ++ + +I QIA + +LH S ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 614 DDHYNARISDFGLAKLLTLNQSK----------TIKTSIRGTKGYVAPEWFRNSKITAKV 663
++ DFGL + ++ + T GTK Y++PE + + KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 664 DVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECL 723
D++S G++L E++ S +E V + RN K L
Sbjct: 258 DIFSLGLILFELL-YSFSTQMERVRIITDV--------RNLKFPLLFT------QKYPQE 302
Query: 724 EKLVMVSIWCIQEDPSLRPTIKKVLQM 750
+V + P+ RP +++
Sbjct: 303 HMMVQ---DMLSPSPTERPEATDIIEN 326
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-29
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNL 539
KE +G G FG V + + Q T VA+K+ RE + E+ ++ + +H N+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 540 VRLLGFCDEGQN------RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARG 589
V D Q LL E+ G L +L + L+ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSA 133
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
L YLHE ++IIH D+KP+NI+L +I D G AK L Q + + GT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFV-GTL 187
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677
Y+APE K T VD +SFG L E I
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 48/199 (24%), Positives = 88/199 (44%), Gaps = 21/199 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+G FG VY + + +A+K L + + E + + E+ + H N++R+
Sbjct: 23 GKGKFGNVYLAR---EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCS 598
+ + + L+ EF G L + L+ + + ++A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
++IH D+KP+N+L+ +I+DFG + + +T+ GT Y+ PE
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKT 188
Query: 659 ITAKVDVYSFGVLLLEIIA 677
KVD++ GVL E +
Sbjct: 189 HDEKVDLWCAGVLCYEFLV 207
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 483 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKN 538
E +G G V+ ++ R VAVK L F+ E +H
Sbjct: 18 EILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 539 LVRLL--GFCDEGQNRLLVY---EFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLL 591
+V + G E L Y E+++ TL + G + P + + + L
Sbjct: 74 IVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE--VIADACQALN 130
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-SIRGTKGYVA 650
+ H+ + IIH D+KP NI++ ++ DFG+A+ + + + +T ++ GT Y++
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
PE R + A+ DVYS G +L E++ F
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGERE-FKNEVFVIGQ 533
+ EE+G G F IV K +++ A K + + RE + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARG 589
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 590 LLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+ YLH + +I H D+KP+NI+L + ++ DFGLA + K GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLL 672
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 43/199 (21%), Positives = 90/199 (45%), Gaps = 19/199 (9%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
E++GRG FGIV++ V +++ + K + + D K E+ ++ H+N+
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTDQV-LVKKEISILNIARHRNI 63
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLHE 595
+ L + + ++++EF++ + + + L + Q+ L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH- 119
Query: 596 DCSSQIIHCDMKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
S I H D++P+NI+ ++ +I +FG A+ L + Y APE
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLLF-TAPEYYAPEV 174
Query: 654 FRNSKITAKVDVYSFGVLL 672
++ ++ D++S G L+
Sbjct: 175 HQHDVVSTATDMWSLGTLV 193
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
+ EE+G G+FG+V++ V + T K ++ + + KNE+ ++ Q HH L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT-----NIAFQIARGLLYLH 594
+ L ++ +L+ EFL+ G LF + + N Q GL ++H
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
I+H D+KP+NI+ + + I DFGLA LN + +K + T + APE
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPE 220
Query: 653 WFRNSKITAKVDVYSFGVLL 672
+ D+++ GVL
Sbjct: 221 IVDREPVGFYTDMWAIGVLG 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 61/198 (30%), Positives = 104/198 (52%), Gaps = 16/198 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI-VFQDGEREFKNEVFVIGQTHHKNLVR 541
E++G+GSFG V+KG+ T+ VA+K +D+ +D + + E+ V+ Q + +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKV---VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHEDCS 598
G + ++ E+L G+ L +P T IA +I +GL YLH S
Sbjct: 85 YYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH---S 137
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+ IH D+K N+LL +H +++DFG+A LT Q K + + GT ++APE + S
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEVIKQSA 195
Query: 659 ITAKVDVYSFGVLLLEII 676
+K D++S G+ +E+
Sbjct: 196 YDSKADIWSLGITAIELA 213
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--VFQDGEREFKNEVFVIGQ-THHKN 538
+E+GRG F +V + ++++ A K L QD E +E+ V+
Sbjct: 34 SKELGRGKFAVVRQC---ISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLHED 596
++ L + +L+ E+ G + S L + + QI G+ YLH
Sbjct: 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-- 148
Query: 597 CSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
+ I+H D+KPQNILL + +I DFG+++ + + ++ + GT Y+APE
Sbjct: 149 -QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIM-GTPEYLAPEI 204
Query: 654 FRNSKITAKVDVYSFGVLL 672
IT D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E+G G+FG VYK + T A K ++ ++ ++ E+ ++ H +V+L
Sbjct: 25 GELGDGAFGKVYKAKNKETGAL---AAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAF---QIARGLLYLHEDCS 598
LG ++ EF G + + + + L I Q+ L +LH S
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVVCRQMLEALNFLH---S 135
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE-----W 653
+IIH D+K N+L+ + R++DFG++ K + S GT ++APE
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCET 193
Query: 654 FRNSKITAKVDVYSFGVLLLEII 676
+++ K D++S G+ L+E+
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMA 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 22/214 (10%)
Query: 483 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL------DIVFQDGEREFKNEVFVIGQTH 535
VGRG G VY+ R VA+K + D VF+ R + E G+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERI----VALKLMSETLSSDPVFR--TR-MQREARTAGRLQ 92
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYL 593
++V + F + + +N LA+ L G L P + I QI L
Sbjct: 93 EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA--IVRQIGSALDAA 150
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H H D+KP+NIL+ A + DFG+A T ++ T + GT Y+APE
Sbjct: 151 HAA---GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPER 206
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687
F S T + D+Y+ +L E + + + +
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 55/198 (27%), Positives = 93/198 (46%), Gaps = 20/198 (10%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
E +G G FG V+K + +A K + + E KNE+ V+ Q H NL++
Sbjct: 94 TEILGGGRFGQVHKC---EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLR----TNIAFQIARGLLYLHED 596
L + + +LV E+++ G LF + ++NL QI G+ ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH-- 204
Query: 597 CSSQIIHCDMKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
I+H D+KP+NIL + +I DFGLA+ + +K + GT ++APE
Sbjct: 205 -QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVNF-GTPEFLAPEVV 260
Query: 655 RNSKITAKVDVYSFGVLL 672
++ D++S GV+
Sbjct: 261 NYDFVSFPTDMWSVGVIA 278
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 33/308 (10%), Positives = 70/308 (22%), Gaps = 60/308 (19%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHK 537
E + G +V+ A+K + + F + +
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLED---FALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 538 NLV------RLLGFCDEGQ--------------------NRLLVYEFL--NNGTLASFLF 569
+ RLL D N LL+ + L S L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 570 GNLKPNWNL----RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625
+ + Q+ R L S ++H P N+ + + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWF--RNSKITAKVDVYSFGVLLLEIIACRKSFD 683
+ T + Y E+ + T ++ + G+ + + F
Sbjct: 240 ALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 684 IEMVEEYAILTDWAFDCYRNGKLDALVGGDM--EAMNDVECLEKLVMVSIWCIQEDPSLR 741
+ + L + + + D R
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF----------LNFDRRRR 344
Query: 742 PTIKKVLQ 749
+ ++
Sbjct: 345 LLPLEAME 352
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 38/227 (16%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD-----------------IVFQDGEREFKNEV 528
+G F + A+KK + I + +FKNE+
Sbjct: 40 NQGKFNKIILC-----EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRT------ 580
+I ++ + G ++YE++ N ++ F F L N+
Sbjct: 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
I + Y+H I H D+KP NIL+D + ++SDFG ++ + K IK
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKG 209
Query: 641 SIRGTKGYVAPEWFRNSKIT--AKVDVYSFGVLLLEIIACRKSFDIE 685
S RGT ++ PE+F N AKVD++S G+ L + F ++
Sbjct: 210 S-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGERE-FKNEVFVIGQ 533
+ EE+G G F IV K +++ A K + + RE + EV ++ Q
Sbjct: 15 DIGEELGSGQFAIVKKC---REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARG 589
H N++ L + + +L+ E ++ G L F L +L T+ QI G
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDG 127
Query: 590 LLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+ YLH + +I H D+KP+NI+L + ++ DFGLA + K GT
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF-GT 181
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLL 672
+VAPE + + D++S GV+
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 8e-28
Identities = 59/291 (20%), Positives = 116/291 (39%), Gaps = 51/291 (17%)
Query: 397 DPSPP--LVPRPPDPEDKKKRKMMNATGSVLLGSSVFVNFALVCAFVLGFFFIYKKKWIR 454
P P V P D +++ ++ G ++ + K
Sbjct: 92 KPCEPTAPVLIPGDERKRRRGYDVDEQGKIV-----------------------RGKGTV 128
Query: 455 NSPGDGTIETNLRCFSYKELEEATDNFK------EEVGRGSFGIVYKGVIQTTRTSTTAV 508
+S D + + + + +E D+ EE+G G+FG+V++ + T +
Sbjct: 129 SSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNN---F 185
Query: 509 AVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL 568
A K + + + + E+ + H LV L ++ +++YEF++ G L
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL---- 241
Query: 569 FGNLKPNWNLRT-----NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI-- 621
F + N + Q+ +GL ++H + +H D+KP+NI+ + +
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKL 298
Query: 622 SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
DFGL L + +++K + GT + APE + D++S GVL
Sbjct: 299 IDFGLTAHL--DPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGERE-FKNEVFVIGQ 533
EE+G G F IV K + T A K +L + RE + EV ++ +
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGK---EYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARG 589
H N++ L + + +L+ E ++ G L F L +L T QI G
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDG 120
Query: 590 LLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+ YLH S +I H D+KP+NI+L + ++ DFG+A + K GT
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF-GT 174
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLL 672
+VAPE + + D++S GV+
Sbjct: 175 PEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+GSF VY+ + + VA+K +D + + +NEV + Q H +++ L
Sbjct: 20 GKGSFAGVYRA---ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCS 598
+ ++ LV E +NG + +L +KP N A QI G+LYLH S
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLH---S 130
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
I+H D+ N+LL + N +I+DFGLA L + K T GT Y++PE S
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYTLC-GTPNYISPEIATRSA 188
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+ DV+S G + ++ R FD + V+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 53/222 (23%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI---------VFQDGEREFKNEVFVI 531
KE +GRG +V + + + AVK +D+ Q+ EV ++
Sbjct: 21 PKEILGRGVSSVVRRC---IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 532 GQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNW 576
+ + H N+++L + LV++ + G L +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM------- 130
Query: 577 NLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636
+ + LH I+H D+KP+NILLDD N +++DFG + L+ +
Sbjct: 131 -------RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGE 178
Query: 637 TIKTSIRGTKGYVAPEWFRNSKITA------KVDVYSFGVLL 672
++ GT Y+APE S +VD++S GV++
Sbjct: 179 KLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 54/198 (27%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G GS+G VYK + + T VA+K++ + + +E E+ ++ Q ++V+
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQI---VAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR-TNIAF---QIARGLLYLHEDCS 598
G + + +V E+ G+++ + K L IA +GL YLH
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTLKGLEYLH---F 143
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+ IH D+K NILL+ +A+++DFG+A LT +K + ++ GT ++APE +
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIQEIG 201
Query: 659 ITAKVDVYSFGVLLLEII 676
D++S G+ +E+
Sbjct: 202 YNCVADIWSLGITAIEMA 219
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 62/334 (18%), Positives = 129/334 (38%), Gaps = 52/334 (15%)
Query: 449 KKKWIRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAV 508
++ + T + + + E+ E+G G+ G+V+K + S +
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI-----SELGAGNGGVVFKVSH---KPSGLVM 61
Query: 509 AVKKLDIVFQDGEREF-KNEVFVIGQTHHKNLVRLLG-FCDEGQNRLLVY---EFLNNGT 563
A K + + + R E+ V+ + + +V G F +G+ + E ++ G+
Sbjct: 62 ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGS 117
Query: 564 LASFL-FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622
L L P L ++ + +GL YL E +I+H D+KP NIL++ ++
Sbjct: 118 LDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLC 174
Query: 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE-------I 675
DFG++ L ++ S GT+ Y++PE + + + + D++S G+ L+E I
Sbjct: 175 DFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
Query: 676 IACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMV------ 729
M L M++ + E L +
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 730 ----SIW----------CIQEDPSLRPTIKKVLQ 749
++ C+ ++P+ R +K+++
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 48/204 (23%), Positives = 80/204 (39%), Gaps = 20/204 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGEREFKNEVFVIGQTH 535
E +G+G F +V + + + T AVK K + K E +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQ---FAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLL 591
H ++V LL +V+EF++ L + + ++ QI L
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 592 YLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
Y H + IIH D+KP +LL ++ ++ FG+A L + GT +
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHF 199
Query: 649 VAPEWFRNSKITAKVDVYSFGVLL 672
+APE + VDV+ GV+L
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 27/207 (13%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGERE-FKNEVFVIGQ 533
+ EE+G G F +V K +++ A K + + RE + EV ++ +
Sbjct: 14 DTGEELGSGQFAVVKKC---REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARG 589
H N++ L + + +L+ E + G L F L +L T QI G
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNG 126
Query: 590 LLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+ YLH S QI H D+KP+NI+L +I DFGLA + + K GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF-GT 180
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLL 672
+VAPE + + D++S GV+
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 52/221 (23%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--------VFQDGEREFKNEVFVIG 532
K+ +GRG +V + V + T AVK +++ ++ + E ++
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGH---EFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 533 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWN 577
Q H +++ L+ + LV++ + G L +
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM-------- 206
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
+ + +LH ++ I+H D+KP+NILLDD+ R+SDFG + L +
Sbjct: 207 ------RSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEK 255
Query: 638 IKTSIRGTKGYVAPEWFRNSKITA------KVDVYSFGVLL 672
++ GT GY+APE + S +VD+++ GV+L
Sbjct: 256 LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 62/287 (21%), Positives = 114/287 (39%), Gaps = 41/287 (14%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+G F ++ T+ A K + ++ + E+ + H+++V
Sbjct: 24 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCS 598
GF ++ +V E +L K L A QI G YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---R 133
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+++IH D+K N+ L++ +I DFGLA + + + K + GT Y+APE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 191
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-YAILTDWAFDCYRNGKLDALVGGDMEAM 717
+ +VDV+S G ++ ++ + F+ ++E Y + + ++ A
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA--------- 242
Query: 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ---MLEGVVEVSVPP 761
L+ +Q DP+ RPTI ++L G + +P
Sbjct: 243 ------ASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 41/210 (19%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
F E +G G+F V+ R + A+K + + +NE+ V+ + H+N+
Sbjct: 12 IFMEVLGSGAFSEVFLV---KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 585
V L + + LV + ++ G L AS + Q
Sbjct: 69 VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI--------------QQ 114
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+ + YLH + I+H D+KP+N+L +++ I+DFGL+K+ Q+ + T+
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTAC 168
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT GYVAPE + VD +S GV+
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 38/316 (12%), Positives = 88/316 (27%), Gaps = 84/316 (26%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQ------ 533
+G+ + Q T S V + + ++ K EV +
Sbjct: 79 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 534 -------------------THHKNLVRLLGFCDEGQ--NRLLVYEFLNN------GTLAS 566
K ++R+ + +R +Y + + L S
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 567 FLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWF-----------RNSKITAKVDVYSFGVLLLEI 675
+ ++G+ PE R + +T D ++ G+++
Sbjct: 253 LVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI--- 303
Query: 676 IACRKSFDIEMVEEYAILT-DWAFDCYRNGKLDALVGGDMEAMNDV-ECLEKLVMVSIWC 733
Y I D + ++ + + L+
Sbjct: 304 --------------YWIWCADLPIT---KDAALGGSEWIFRSCKNIPQPVRALLE---GF 343
Query: 734 IQEDPSLRPTIKKVLQ 749
++ R + ++
Sbjct: 344 LRYPKEDRLLPLQAME 359
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 44/213 (20%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHH 536
+ KEE+G+G+F +V + V +TT A K ++ + +D ++ + E + + H
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQK-LEREARICRKLQH 64
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNI 582
N+VRL E LV++ + G L AS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI------------- 111
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA---RISDFGLAKLLTLNQSKTIK 639
QI + Y H S+ I+H ++KP+N+LL +++DFGLA + N S+
Sbjct: 112 -QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWH 165
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT GY++PE + + VD+++ GV+L
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 53/293 (18%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+G F ++ T+ A K + ++ + E+ + H+++V
Sbjct: 50 GKGGFAKCFEISDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA----FQIARGLLYLHEDCS 598
GF ++ +V E +L K L A QI G YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---R 159
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+++IH D+K N+ L++ +I DFGLA + + + K + GT Y+APE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 217
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
+ +VDV+S G ++ ++ + F+ ++E Y K N
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----------TYLRIK-----------KN 256
Query: 719 DVEC-------LEKLVMVSIWCIQEDPSLRPTIKKVLQ---MLEGVVEVSVPP 761
+ L+ +Q DP+ RPTI ++L G + +P
Sbjct: 257 EYSIPKHINPVAASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPARLPI 306
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 45/212 (21%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKN 538
KE++G GS+ + + + + T AVK +D +D E+ ++ + H N
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATN---MEFAVKIIDKSKRDPTE----EIEILLRYGQHPN 77
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAF 584
++ L D+G+ +V E + G L AS + F
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL--------------F 123
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAKLLTLNQSKTIKT 640
I + + YLH + ++H D+KP NIL + + RI DFG AK L
Sbjct: 124 TITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--M 178
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
+ T +VAPE A D++S GVLL
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 18/201 (8%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKN 538
FK ++G G+FG V+ R+S +K ++ E + E+ V+ H N
Sbjct: 25 IFKRKLGSGAFGDVHLV---EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYLH 594
++++ ++ N +V E G L + L + Q+ L Y H
Sbjct: 82 IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 595 EDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
S ++H D+KP+NIL H +I DFGLA+L + + GT Y+AP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAA-GTALYMAP 195
Query: 652 EWFRNSKITAKVDVYSFGVLL 672
E F+ +T K D++S GV++
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVM 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-26
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 45/245 (18%)
Query: 458 GDGT-IETNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD 514
G G+ + N + + + D F+ G+G+FG V G ++T S VA+KK
Sbjct: 1 GPGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMS---VAIKK-- 55
Query: 515 IVFQDGEREFKN----EVFVIGQTHHKNLVRLL------GFCDEGQNRL-LVYEFLNNGT 563
V QD F+N + + HH N+V+L G D L +V E++ + T
Sbjct: 56 -VIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-T 111
Query: 564 LASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA 619
L + FQ+ R + LH S + H D+KP N+L+++
Sbjct: 112 LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170
Query: 620 -RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVL 671
++ DFG AK L+ ++ Y+ ++R N T VD++S G +
Sbjct: 171 LKLCDFGSAKKLSPSEPNV---------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 672 LLEII 676
E++
Sbjct: 222 FAEMM 226
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-26
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHH 536
+ +G+GSFG V + + AVK K + + + EV ++ Q H
Sbjct: 29 KGQRVLGKGSFGEVILC---KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLY 592
N+++L F ++ LV E G LF + I Q+ G+ Y
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 593 LHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
+H ++I+H D+KP+N+LL N RI DFGL+ SK +K I GT Y+
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKI-GTAYYI 195
Query: 650 APEWFRNSKITAKVDVYSFGVLL 672
APE K DV+S GV+L
Sbjct: 196 APEVLHG-TYDEKCDVWSTGVIL 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 57/243 (23%), Positives = 86/243 (35%), Gaps = 57/243 (23%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK-----KLDIVFQDGEREFKNEVFVIGQTH 535
K +G+GS+G+V + TR A+K K+ + K EV ++ + H
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRA---IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTL------------------------------A 565
H N+ RL ++ Q LV E + G L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 566 SFLFGNLKPNWNLRTNIAF----------QIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615
+ + QI L YLH + I H D+KP+N L
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFST 203
Query: 616 HYNAR--ISDFGLAKLLTLNQSKTIK--TSIRGTKGYVAPEWFRNS--KITAKVDVYSFG 669
+ + + DFGL+K + T+ GT +VAPE + K D +S G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 670 VLL 672
VLL
Sbjct: 264 VLL 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHHKNLVR 541
+ +G GSFG+VY+ + + VA+KK V QD + FKN E+ ++ + H N+VR
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGEL---VAIKK---VLQD--KRFKNRELQIMRKLDHCNIVR 111
Query: 542 LLG-FCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLL 591
L F G+ + LV +++ T+ + L +Q+ R L
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTSIRGTKGYV- 649
Y+H S I H D+KPQN+LLD ++ DFG AK L + Y+
Sbjct: 171 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV---------SYIC 218
Query: 650 -----APEW-FRNSKITAKVDVYSFGVLLLEIIACR 679
APE F + T+ +DV+S G +L E++ +
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 33/213 (15%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVR 541
E VG G++G VYKG T A+K +D+ D E E K E+ ++ + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQL---AAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 542 LLG-----FCDEGQNRL-LVYEFLNNGTLA----SFLFGNLKPNWNLRTNIAF---QIAR 588
G ++L LV EF G++ + LK W IA+ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILR 140
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
GL +LH ++IH D+K QN+LL ++ ++ DFG++ L + + + GT +
Sbjct: 141 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYW 195
Query: 649 VAPE-----WFRNSKITAKVDVYSFGVLLLEII 676
+APE ++ K D++S G+ +E+
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 41/210 (19%), Positives = 77/210 (36%), Gaps = 27/210 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL----DIVFQDGEREFKNEVFVIGQTHHKN 538
+ G G +Y + + V +K L D Q E + + H +
Sbjct: 86 GCIAHGGLGWIYLAL--DRNVNGRPVVLKGLVHSGDAEAQ--AM-AMAERQFLAEVVHPS 140
Query: 539 LVRLLGFCDEGQNRL-----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
+V++ F + +V E++ +L L + +I L YL
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLEILPALSYL 198
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H +++ D+KP+NI+L + ++ D G + + GT G+ APE
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN--SF----GYLYGTPGFQAPEI 248
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
R + T D+Y+ G L + + +
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPTRN 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 44/212 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHHK 537
KEE+G+G+F +V + V +TT A K + +D ++ + E + + H
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGL---EFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 583
N+VRL E LV++ + G L AS
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI-------------- 134
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 640
QI + Y H S+ I+H ++KP+N+LL +++DFGLA + N S+
Sbjct: 135 QQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG 189
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT GY++PE + + VD+++ GV+L
Sbjct: 190 FA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 42/209 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ E+GRG+ IVY+ + T+ +KK ++ + E+ V+ + H N++
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSHPNII 111
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 586
+L + LV E + G L A+ QI
Sbjct: 112 KLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK--------------QI 157
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
+ YLH + I+H D+KP+N+L +I+DFGL+K++ +KT
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVC- 211
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT GY APE R +VD++S G++
Sbjct: 212 GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 41/210 (19%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
+ +GRGS+G V + + A KK+ F + FK E+ ++ H N+
Sbjct: 12 TLENTIGRGSWGEVKIA---VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQ 585
+RL ++ + LV E G L A+ +
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM--------------KD 114
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSI 642
+ + Y H + H D+KP+N L ++ DFGLA K ++T +
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV 169
Query: 643 RGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT YV+P+ + D +S GV++
Sbjct: 170 -GTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-25
Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 43/212 (20%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHHK 537
EE+G+G+F +V + + A + +D ++ + E + H
Sbjct: 15 LFEELGKGAFSVVRRC---VKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 583
N+VRL E + L+++ + G L AS
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-------------- 116
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 640
QI +L+ H ++H ++KP+N+LL +++DFGLA + Q
Sbjct: 117 QQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--F 171
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT GY++PE R VD+++ GV+L
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 60/216 (27%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHHKNLVR 541
+ +G GSFG+V++ + + VA+KK V QD + FKN E+ ++ H N+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDE----VAIKK---VLQD--KRFKNRELQIMRIVKHPNVVD 96
Query: 542 LLGF-----CDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLL 591
L F + + L LV E++ T+ K + +Q+ R L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTSIRGTKGYV- 649
Y+H S I H D+KPQN+LLD ++ DFG AK+L + Y+
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV---------SYIC 203
Query: 650 -----APEW-FRNSKITAKVDVYSFGVLLLEIIACR 679
APE F + T +D++S G ++ E++ +
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 45/213 (21%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHH 536
N +G+GSFG V K R + AVK K +D EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNI 582
N+++L ++ + +V E G L A+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII------------- 127
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIK 639
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ Q+ +K
Sbjct: 128 -KQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
I GT Y+APE R K DV+S GV+L
Sbjct: 182 DRI-GTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 24/207 (11%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--------IVFQDGEREFKNEVFVI 531
+ +G G+ G V R + VA++ + D + E+ ++
Sbjct: 138 IMSKTLGSGACGEVKLAF---ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 591
+ +H ++++ F D ++ +V E + G L + GN + +Q+ +
Sbjct: 195 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 592 YLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
YLH + IIH D+KP+N+LL ++ +I+DFG +K+L ++ ++T GT Y
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLC-GTPTY 307
Query: 649 VAPEWFRNSKI---TAKVDVYSFGVLL 672
+APE + VD +S GV+L
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 55/202 (27%), Positives = 87/202 (43%), Gaps = 25/202 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHHK 537
+++G G++G V + + A+K K + + EV V+ H
Sbjct: 41 RVKKLGSGAYGEVLLC---RDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLR----TNIAFQIARGLLYL 593
N+++L F ++ +N LV E G LF + I Q+ G+ YL
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 594 HEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
H I+H D+KP+N+LL + +I DFGL+ + + GT Y+A
Sbjct: 153 H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIA 206
Query: 651 PEWFRNSKITAKVDVYSFGVLL 672
PE R K K DV+S GV+L
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVIL 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 55/212 (25%), Positives = 89/212 (41%), Gaps = 43/212 (20%)
Query: 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHK 537
D + +G GSF I K V + + A AVK I+ + E + E+ + H
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQ---AFAVK---IISKRMEANTQKEITALKLCEGHP 66
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIA 583
N+V+L + + LV E LN G L AS I
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS--------------YIM 112
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKT 640
++ + ++H ++H D+KP+N+L +D+ +I DFG A+L + + +KT
Sbjct: 113 RKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKT 168
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
T Y APE + D++S GV+L
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 52/221 (23%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--------IVFQDGEREFKNEVFVI 531
+ +G G+ G V R + VA+K + D + E+ ++
Sbjct: 13 IMSKTLGSGACGEVKLA---FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWN 577
+ +H ++++ F D ++ +V E + G L F
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-------- 120
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQ 634
+Q+ + YLH + IIH D+KP+N+LL ++ +I+DFG +K+L +
Sbjct: 121 ------YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--E 169
Query: 635 SKTIKTSIRGTKGYVAPEWFRNSKI---TAKVDVYSFGVLL 672
+ ++T GT Y+APE + VD +S GV+L
Sbjct: 170 TSLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 45/213 (21%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFKNEVFVIGQTHH 536
N +G+GSFG V K R + AVK K +D EV ++ + H
Sbjct: 25 NIVCMLGKGSFGEVLKC---KDRITQQEYAVKVINKASAKNKDTST-ILREVELLKKLDH 80
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNI 582
N+++L ++ + +V E G L A+ I
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------------RI 126
Query: 583 AFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIK 639
Q+ G+ Y+H I+H D+KP+NILL + + +I DFGL+ N
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KM 180
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
GT Y+APE R K DV+S GV+L
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 54/222 (24%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-------------IVFQDGEREFKNE 527
++G G++G V + + A+K + + E NE
Sbjct: 40 KVRKLGSGAYGEVLLC---KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 528 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLK 573
+ ++ H N+++L ++ + LV EF G L A+
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA------- 149
Query: 574 PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLL 630
NI QI G+ YLH I+H D+KP+NILL + N +I DFGL+
Sbjct: 150 -------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF- 198
Query: 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
++ ++ + GT Y+APE + K K DV+S GV++
Sbjct: 199 -FSKDYKLRDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIM 237
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 73/294 (24%), Positives = 122/294 (41%), Gaps = 54/294 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI-VFQDGEREFKNEVFVIGQTHHKNLVR 541
E +G G+ +V + VA+K++++ Q E E+ + Q HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEK---VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN------IAF---QIARGLLY 592
LV + L+ G++ + ++ ++ IA ++ GL Y
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLD-IIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI----KTSIRGTKGY 648
LH + IH D+K NILL + + +I+DFG++ L T KT + GT +
Sbjct: 137 LH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCW 192
Query: 649 VAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA-----FDCYR 702
+APE + K D++SFG I A IE+ A + +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFG-----ITA------IELATGAAPYHKYPPMKVLMLTLQ 241
Query: 703 NG--KLDALVGGDMEAMNDVECLEKLV-----MVSIWCIQEDPSLRPTIKKVLQ 749
N L+ + D E L+K M+S C+Q+DP RPT ++L+
Sbjct: 242 NDPPSLE-------TGVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPTAAELLR 287
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLV 540
+GRG FG V+ +T + A KKL+ + + G + E ++ + H + +V
Sbjct: 193 LGRGGFGEVF----ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYLHE 595
L + E + L LV +N G + ++ + N + A F QI GL +LH
Sbjct: 249 SLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH- 306
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
II+ D+KP+N+LLDD N RISD GLA L Q+KT GT G++APE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGTPGFMAPELLL 362
Query: 656 NSKITAKVDVYSFGVLLLEIIA 677
+ VD ++ GV L E+IA
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIA 384
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 50/312 (16%), Positives = 94/312 (30%), Gaps = 54/312 (17%)
Query: 483 EEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER--EFKNEVFVIGQTHHKN 538
+G+G V + T V V+++++ E + E+ V +H N
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEY---VTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAF---QIARGLLYLHE 595
+V +V F+ G+ L + IA+ + + L Y+H
Sbjct: 88 IVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMNELAIAYILQGVLKALDYIH- 145
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV------ 649
+H +K +IL+ +S + + + + K V
Sbjct: 146 --HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ-RVVHDFPKYSVKVLPWL 202
Query: 650 APEWFRNSKI--TAKVDVYSFGVLLLEIIACRKSF---------------------DIEM 686
+PE + + AK D+YS G+ E+ F D
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 687 VEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLV---------MVSIWCIQED 737
+ + + +G D+L N V C+Q +
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRN 321
Query: 738 PSLRPTIKKVLQ 749
P RP+ +L
Sbjct: 322 PDARPSASTLLN 333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 1e-23
Identities = 29/234 (12%), Positives = 65/234 (27%), Gaps = 48/234 (20%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQT----- 534
+G+ + Q T S V + + ++ K EV +
Sbjct: 84 TVLGQEDPYAYLEATDQETGES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 140
Query: 535 -----------------HHKNLVRLLGFCDEGQNRLLVYEFL-------NNGTLASFLFG 570
+++ + ++ ++ F N T L
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200
Query: 571 NLK----PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626
+ + R + Q+ R L LH ++H ++P +I+LD ++ F
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEI 675
+ + A + +T D ++ G+ + I
Sbjct: 258 LVRDG-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 28/205 (13%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK---NEVFVIGQTHHKNL 539
E+G GSFG VY VA+KK+ + +++ EV + + H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEV---VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 540 VRLLGFCDEGQNRLLVYEFLNNG--TLASFLFGNLKPNWNLRTNIAF---QIARGLLYLH 594
++ G LV E+ L L+ IA +GL YLH
Sbjct: 117 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLH 171
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE-- 652
S +IH D+K NILL + ++ DFG A ++ S GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----P--ANSFVGTPYWMAPEVI 222
Query: 653 -WFRNSKITAKVDVYSFGVLLLEII 676
+ KVDV+S G+ +E+
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEV-FVIGQTHHKNLV 540
E+GRG++G+V K + +AVK++ E++ ++ + V
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQ---IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 541 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARGLLY 592
G EG V+ E ++ +L F + + + IA I + L +
Sbjct: 70 TFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH +IH D+KP N+L++ ++ DFG++ L + +K G K Y+APE
Sbjct: 125 LHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD--IDA-GCKPYMAPE 179
Query: 653 ----WFRNSKITAKVDVYSFGVLLLEI 675
+ K D++S G+ ++E+
Sbjct: 180 RINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 67/200 (33%), Positives = 104/200 (52%), Gaps = 18/200 (9%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLV 540
+G+G FG V +T + A KKL+ I + GE NE ++ + + + +V
Sbjct: 192 LGKGGFGEVC----ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNI--AFQIARGLLYLHEDC 597
L + E ++ L LV +N G L ++ + + + A +I GL LH
Sbjct: 248 SL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--- 303
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+I++ D+KP+NILLDDH + RISD GLA + +TIK + GT GY+APE +N
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--QTIKGRV-GTVGYMAPEVVKNE 360
Query: 658 KITAKVDVYSFGVLLLEIIA 677
+ T D ++ G LL E+IA
Sbjct: 361 RYTFSPDWWALGCLLYEMIA 380
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD----IVFQDGEREFKNEVFVIGQTHHKNLVR 541
G GS+G V + + T AVK L +GE K E+ ++ + HKN+++
Sbjct: 14 GEGSYGKVKEVLDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 542 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHE 595
L+ +E + ++ +V E+ G + ++ P A F Q+ GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH- 126
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL-TLNQSKTIKTSIRGTKGYVAPEWF 654
S I+H D+KP N+LL +IS G+A+ L T +TS +G+ + PE
Sbjct: 127 --SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIA 183
Query: 655 RNSKI--TAKVDVYSFGVLLLEIIACRKSFD 683
KVD++S GV L I F+
Sbjct: 184 NGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 65/305 (21%), Positives = 110/305 (36%), Gaps = 61/305 (20%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD------IVFQDGEREFKNEV----FVIG 532
+G+G FG V+ G T R VA+K + EV V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIAR 588
H ++RLL + + + +LV E LF + L + F Q+
Sbjct: 94 GGGHPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNA-RISDFGLAKLLTLNQSKTIKTSIRGTKG 647
+ + H S ++H D+K +NIL+D ++ DFG LL + GT+
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFD-GTRV 203
Query: 648 YVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIE---MVEEYAILTDWAFDCYRN 703
Y PEW + V+S G+LL +++ F+ + + E + DC
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDC--- 260
Query: 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ---MLEGVVEVSVP 760
L+ C+ PS RP+++++L M +V +
Sbjct: 261 --------------------CALIR---RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297
Query: 761 PNPYP 765
P+
Sbjct: 298 PSKGG 302
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 49/219 (22%), Positives = 85/219 (38%), Gaps = 48/219 (21%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLV 540
++ +G G+ V ++ AVK ++ EV ++ Q H+N++
Sbjct: 18 EDVLGEGAHARVQTC---INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTL--------------ASFLFGNLKPNWNLRTNIAFQI 586
L+ F +E LV+E + G++ AS + +
Sbjct: 75 ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--------------VVVQDV 120
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
A L +LH + I H D+KP+NIL + +I DF L + LN + ++
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 644 -----GTKGYVAPEWFRNSKITAK-----VDVYSFGVLL 672
G+ Y+APE A D++S GV+L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAV-AVK---KLDIVFQDGEREFKNEVFVIGQTH 535
F + +G GSF V +T+ A+K K I+ ++ E V+ +
Sbjct: 33 KFGKILGEGSFSTVV----LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 536 HKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARG 589
H V+L F D+ +L + NG L ++ + F +I
Sbjct: 89 HPFFVKLYFTFQDD--EKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L YLH IIH D+KP+NILL++ + +I+DFG AK+L+ + S GT YV
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIA 677
+PE D+++ G ++ +++A
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQT-HHKNLV 540
E+GRG++G V K V + + +AVK++ + E++ ++ V+ ++ +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQ---IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 541 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTN------IAFQIARGL 590
+ G EG + E ++ + F + + I + L
Sbjct: 85 QFYGALFREGD----CWICMELMS-TSFDKFY-KYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTSIRGTKGY 648
+L E+ +IIH D+KP NILLD N ++ DFG++ L ++ +++ G + Y
Sbjct: 139 NHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPY 191
Query: 649 VAPE----WFRNSKITAKVDVYSFGVLLLEI 675
+APE + DV+S G+ L E+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLG 544
G G++G V V + T + VAVK +D+ D K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCSSQ 600
EG + L E+ + G L F ++P+ + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLN-QSKTIKTSIRGTKGYVAPEWFRNSKI 659
I H D+KP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 660 T-AKVDVYSFGVLLLEIIACRKSFD 683
VDV+S G++L ++A +D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLG 544
G G++G V V + T + VAVK +D+ D K E+ + +H+N+V+ G
Sbjct: 16 GEGAYGEVQLAVNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 545 FCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCSSQ 600
EG + L E+ + G L F ++P+ + A F Q+ G++YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIG 125
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTL-NQSKTIKTSIRGTKGYVAPEWFRNSKI 659
I H D+KP+N+LLD+ N +ISDFGLA + N+ + + GT YVAPE + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184
Query: 660 T-AKVDVYSFGVLLLEIIACRKSFD 683
VDV+S G++L ++A +D
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--------IVFQDGEREFKNEVFVIGQT 534
+G G+FG V+ V + V VK + + + E+ ++ +
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGL 590
H N++++L + LV E +G LF + + L +A F Q+ +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YL IIH D+K +NI++ + + ++ DFG A L + K T GT Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE--RGKLFYTFC-GTIEYCA 197
Query: 651 PEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFD 683
PE + +++++S GV L ++ F
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 52/201 (25%), Positives = 84/201 (41%), Gaps = 25/201 (12%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLV 540
K+ +G G G V + + T A+K L D + + EV Q + ++V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTG---QKCALKLLY----DSPK-ARQEVDHHWQASGGPHIV 85
Query: 541 RLLGFCDEGQNR----LLVYEFLNNGTLASFLFGNLKPNWNLR--TNIAFQIARGLLYLH 594
+L + + L++ E + G L S + + R I I + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 595 EDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
S I H D+KP+N+L + +++DFG AK T N +T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVAP 198
Query: 652 EWFRNSKITAKVDVYSFGVLL 672
E K D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTH-HKNLV 540
E+G G+ G V+K + T +AVK++ E + ++ V+ ++H +V
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGH---VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 541 RLLG-FCDEGQNRLLVY---EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 596
+ G F V+ E + + + I + L YL E
Sbjct: 88 QCFGTFITNTD----VFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE---- 652
+IH D+KP NILLD+ ++ DFG++ L +++K S G Y+APE
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD--RSA-GCAAYMAPERIDP 198
Query: 653 -WFRNSKITAKVDVYSFGVLLLEI 675
+ DV+S G+ L+E+
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVEL 222
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 58/284 (20%), Positives = 109/284 (38%), Gaps = 56/284 (19%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD------IVFQDGEREFKNEVFVIGQTHH 536
+G G FG VY G+ + VA+K ++ EV ++ +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLP---VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 537 K--NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGL 590
++RLL + + + +L+ E LF + L+ +A F Q+ +
Sbjct: 106 GFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 591 LYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
+ H + ++H D+K +NIL+D + ++ DFG LL + GT+ Y
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD-GTRVYS 215
Query: 650 APEWFRNSKITA-KVDVYSFGVLLLEIIACRKSFDIE---MVEEYAILTDWAFDCYRNGK 705
PEW R + V+S G+LL +++ F+ + + + + +C
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC----- 270
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ L+ WC+ PS RPT +++
Sbjct: 271 ------------------QHLIR---WCLALRPSDRPTFEEIQN 293
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 51/191 (26%), Positives = 88/191 (46%), Gaps = 14/191 (7%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G+G+F V T VA+K +D + ++ EV ++ +H N+V+L
Sbjct: 24 GKGNFAKVKLARHILTGRE---VAIKIIDKTQLNPTSLQK-LFREVRIMKILNHPNIVKL 79
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
+ + L+ E+ + G + +L + + + QI + Y H+ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT-A 661
H D+K +N+LLD N +I+DFG + T+ + G Y APE F+ K
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFC-GAPPYAAPELFQGKKYDGP 193
Query: 662 KVDVYSFGVLL 672
+VDV+S GV+L
Sbjct: 194 EVDVWSLGVIL 204
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 52/216 (24%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNL 539
+ +G G G V + + + A+K L D + + EV + + + ++
Sbjct: 66 TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHI 117
Query: 540 VRLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPNWNLR 579
VR++ + L+V E L+ G L AS
Sbjct: 118 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 164
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSK 636
I I + YLH S I H D+KP+N+L + +++DFG AK T +
Sbjct: 165 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218
Query: 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
++ T T YVAPE K D++S GV++
Sbjct: 219 SLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 8e-21
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKLD---IVFQDGEREFKNE--VFV-IGQTHHK 537
+GRG FG VY + T + A+K LD I + GE NE + +
Sbjct: 197 IGRGGFGEVY----GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 538 NLVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLY 592
+V + + ++L + + +N G L +L + F +I GL +
Sbjct: 253 FIVCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
+H + +++ D+KP NILLD+H + RISD GLA + + GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 653 -WFRNSKITAKVDVYSFGVLLLEIIA------CRKSFDIEMVEEYAILTD 695
+ + D +S G +L +++ K+ D ++ LT
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTM 409
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 72/245 (29%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-EVFVIGQTHHKNLVR 541
+ +G GSFGIV + + A+KK V QD +KN E+ ++ H N+++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKR---FALKK---VLQD--PRYKNRELDIMKVLDHVNIIK 64
Query: 542 LL-GFCDEGQNRL-------------------------------------LVYEFLNNGT 563
L+ F G ++ E++ + T
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-T 123
Query: 564 LASFLFGNLKPNWNLRTN----IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYN 618
L L ++ ++ N +Q+ R + ++H S I H D+KPQN+L++
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNT 180
Query: 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVL 671
++ DFG AK L ++ Y+ ++R ++ T +D++S G +
Sbjct: 181 LKLCDFGSAKKLIPSEPSV---------AYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231
Query: 672 LLEII 676
E+I
Sbjct: 232 FGELI 236
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 59/195 (30%), Positives = 96/195 (49%), Gaps = 21/195 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G G+FG V G Q T VAVK L+ I D + K E+ + H ++++L
Sbjct: 20 GVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCS 598
+ +V E+++ G L F + + + A F QI + Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVDYCH---R 129
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
++H D+KP+N+LLD H NA+I+DFGL+ +++ + ++TS G+ Y APE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 186
Query: 659 IT-AKVDVYSFGVLL 672
+VD++S GV+L
Sbjct: 187 YAGPEVDIWSCGVIL 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 55/216 (25%), Positives = 91/216 (42%), Gaps = 40/216 (18%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHHKN 538
+G G+ GIV + VA+KKL FQ+ RE ++ +HKN
Sbjct: 33 IGSGAQGIVCAAYDAILERN---VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKN 85
Query: 539 LVRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 592
++ LL +E Q+ +V E ++ L + L + + +Q+ G+ +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHE-RMSY-LLYQMLCGIKH 142
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH S+ IIH D+KP NI++ +I DFGLA+ + T YV
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVVTR 190
Query: 653 WFR------NSKITAKVDVYSFGVLLLEIIACRKSF 682
++R VD++S G ++ E+I F
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 226
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
VG G++G V + + + VA+KKL FQ RE ++ H
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEK---VAIKKLSRPFQSEIFAKRAYRELL----LLKHMQH 82
Query: 537 KNLVRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+N++ LL + LV F+ L + ++ + +Q+ +GL
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE-KIQ-YLVYQMLKGL 139
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
Y+H S+ ++H D+KP N+ +++ +I DFGLA+ + T GYV
Sbjct: 140 KYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMT---------GYVV 185
Query: 651 PEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
W+R VD++S G ++ E++ + F
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 37/218 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTT-AVAV-KKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G+GSFG V ++Q T A+ K V ++ R E+ ++ H LV L
Sbjct: 23 IGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 543 LG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGL 590
F DE + +V + L G L ++L+ N+ F ++ L
Sbjct: 81 WYSFQDEE--DMFMVVDLLLGGDL----R------YHLQQNVHFKEETVKLFICELVMAL 128
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YL + +IIH DMKP NILLD+H + I+DF +A +L +T T++ GTK Y+A
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP---RETQITTMAGTKPYMA 182
Query: 651 PEWFRNSKI---TAKVDVYSFGVLLLEIIACRKSFDIE 685
PE F + K + VD +S GV E++ R+ + I
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 38/216 (17%)
Query: 476 EATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEVFVIG 532
D+++ ++GRG + V++ + T V VK L V + +RE K I
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILKPVKKKKIKREIK-----IL 84
Query: 533 Q--THHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
+ N++ L D LV+E +NN L+ L ++R + ++I +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDY-DIRFYM-YEILK 141
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
L Y H S I+H D+KP N+++D +H R+ D+GLA+ Q
Sbjct: 142 ALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---------V 189
Query: 648 YVAPEWFR------NSKI-TAKVDVYSFGVLLLEII 676
VA +F+ + ++ +D++S G +L +I
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 21/206 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G G+FG V G + T VAVK L+ I D + + E+ + H ++++L
Sbjct: 25 GVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCS 598
+ +V E+++ G L F + N L + F QI G+ Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
++H D+KP+N+LLD H NA+I+DFGL+ +++ + ++TS G+ Y APE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSC-GSPNYAAPEVISGRL 191
Query: 659 -ITAKVDVYSFGVLLLEIIACRKSFD 683
+VD++S GV+L ++ FD
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 37/301 (12%), Positives = 75/301 (24%), Gaps = 78/301 (25%)
Query: 483 EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKN 538
G ++ + R VA+ +D + +E + + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQ----VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+ R+L L+V E++ G+L + P +R +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR--AMQSLAAAADAAHR--- 147
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+ + P + +S G L +
Sbjct: 148 AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA------ 179
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT-DWAFDCYRNGKLDALVGGDMEAM 717
+ D+ G L YA+L W G L + +
Sbjct: 180 -NPQDDIRGIGASL-----------------YALLVNRWPLP--EAGVRSGLAPAERDTA 219
Query: 718 NDV-----------ECLEKLVMVSIWCIQEDPSLRP--TIKKVLQMLEGVVEVSVPPNPY 764
+ + +Q D +R T+ ++Q V + + P
Sbjct: 220 GQPIEPADIDRDIPFQISAVAA---RSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPI 276
Query: 765 P 765
Sbjct: 277 D 277
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 51/228 (22%), Positives = 83/228 (36%), Gaps = 49/228 (21%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVF---------VI 531
+ GS+G V GV VA+K++ DG + ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIP----VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83
Query: 532 GQTHHKNLVRLL-----GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN----- 581
HH N++ L LV E + + L + + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQHIQY 138
Query: 582 IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTS 641
+ I GL LH + ++H D+ P NILL D+ + I DF LA+ T + +KT
Sbjct: 139 FMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT---- 191
Query: 642 IRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
YV W+R T VD++S G ++ E+ + F
Sbjct: 192 -----HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 49/223 (21%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQT 534
K +G G++G+V + T VA+KK++ F RE K ++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEI---VAIKKIE-PFDKPLFALRTLREIK----ILKHF 66
Query: 535 HHKNLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIAR 588
H+N++ + + ++ E + T L + + + +++ +Q R
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQY-FIYQTLR 123
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK-- 646
+ LH S +IH D+KP N+L++ + + ++ DFGLA+++ + + + + + +
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 647 GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
+VA W+R ++K + +DV+S G +L E+ R F
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-19
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 22/163 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFV 530
+ ++ ++G GS+G+V+K T + VA+KK + + E+ +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQI----VAIKK---FLESEDDPVIKKIALREIRM 55
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIAR 588
+ Q H NLV LL + LV+E+ ++ T+ L + P ++ +I +Q +
Sbjct: 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTLQ 113
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631
+ + H IH D+KP+NIL+ H ++ DFG A+LLT
Sbjct: 114 AVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQTHHKNLVRL 542
G GSFG V T+ VA+K + + D + E+ + H ++++L
Sbjct: 18 GEGSFGKVKLATHYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAF-QIARGLLYLHEDCSS 599
+ ++V E+ G L ++ + + R F QI + Y H
Sbjct: 75 YDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRF---FQQIICAIEYCH---RH 127
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
+I+H D+KP+N+LLDD+ N +I+DFGL+ ++T +KTS G+ Y APE
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKTSC-GSPNYAAPEVINGKLY 184
Query: 660 T-AKVDVYSFGVLLLEIIACRKSFD 683
+VDV+S G++L ++ R FD
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 5e-19
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 40/218 (18%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
+ +G G+ GIV + VA+KKL FQ+ RE ++ +H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNH 120
Query: 537 KNLVRLL------GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
KN++ LL +E Q+ LV E ++ L + L + + +Q+ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHER--MSYLLYQMLCGI 177
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
+LH S+ IIH D+KP NI++ +I DFGLA+ + T YV
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------PYVV 225
Query: 651 PEWFR------NSKITAKVDVYSFGVLLLEIIACRKSF 682
++R VD++S G ++ E++ + F
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 263
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 48/226 (21%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREF-------------- 524
K+E+G+GS+G+V + T A+K L ++ Q G
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 525 ---------KNEVFVIGQTHHKNLVRLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLK 573
E+ ++ + H N+V+L+ D ++ L +V+E +N G + LK
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--MEVPTLK 132
Query: 574 PNWNLRTNIA---F-QIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629
P L + A F + +G+ YLH +IIH D+KP N+L+ + + +I+DFG++
Sbjct: 133 P---LSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT---AKVDVYSFGVLL 672
+ ++ GT ++APE ++ +DV++ GV L
Sbjct: 187 FK-GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
+G+GSFG V+ + + A+K L + K E ++ + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 543 LGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARGLL 591
+ + + +L L+ +FL G L F L + F ++A L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL----F------TRLSKEVMFTEEDVKFYLAELALALD 140
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+LH S II+ D+KP+NILLD+ + +++DFGL+K ++ K S GT Y+AP
Sbjct: 141 HLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA--YSFCGTVEYMAP 195
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
E T D +SFGVL+ E++ F + +E IL
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 29/188 (15%)
Query: 454 RNSPGDGTIETNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAV 510
+S G NL ++ + ++ VG GS+G+V K T R VA+
Sbjct: 7 HHSSGVDLGTENLYF-------QSMEKYENLGLVGEGSYGMVMKCRNKDTGRI----VAI 55
Query: 511 KKLDIVFQDGERE-FKN----EVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLA 565
KK + + + K E+ ++ Q H+NLV LL C + + LV+EF+++ T+
Sbjct: 56 KK---FLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TIL 111
Query: 566 SFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623
L F N ++ FQI G+ + H S IIH D+KP+NIL+ ++ D
Sbjct: 112 DDLELFPNGLDYQVVQ-KYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCD 167
Query: 624 FGLAKLLT 631
FG A+ L
Sbjct: 168 FGFARTLA 175
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 21/205 (10%)
Query: 486 GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGF 545
G G+FG+ + T+ VAVK ++ E + E+ H N+VR
Sbjct: 29 GSGNFGVARLMRDKLTKEL---VAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEV 84
Query: 546 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA---F-QIARGLLYLHEDCSSQI 601
+ ++ E+ + G L + + + A F Q+ G+ Y H S QI
Sbjct: 85 ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQI 137
Query: 602 IHCDMKPQNILLDDHY--NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI 659
H D+K +N LLD +I DFG +K L+ K+++ GT Y+APE +
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTV-GTPAYIAPEVLLRQEY 194
Query: 660 T-AKVDVYSFGVLLLEIIACRKSFD 683
DV+S GV L ++ F+
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 58/228 (25%), Positives = 110/228 (48%), Gaps = 41/228 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQT 534
+++G+G++GIV+K + + T VAVKK+ FQ+ RE + +
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEV---VAVKKIFDAFQNSTDAQRTFREIM---ILTELS 66
Query: 535 HHKNLVRLLG-FCDEGQNRL-LVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARGLL 591
H+N+V LL + + LV++++ T L + + N+ + + + +Q+ + +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQY-VVYQLIKVIK 123
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK----- 646
YLH S ++H DMKP NILL+ + +++DFGL++ + T + +
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 647 --------GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACR 679
YVA W+R ++K T +D++S G +L EI+ +
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 50/233 (21%), Positives = 101/233 (43%), Gaps = 50/233 (21%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEVFVIGQTHHKN 538
+ +G GS+G V + + + VA+KK+ VF+ D +R + E+ ++ + +H +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRV---VAIKKILRVFEDLIDCKRILR-EIAILNRLNHDH 113
Query: 539 LVRLLGFC----DEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQIARG 589
+V++L E + L +V E + S + L + + + G
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK--- 646
+ Y+H S+ I+H D+KP N L++ + ++ DFGLA+ + ++ + I +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 647 ----------------GYVAPEWFR------NSKI-TAKVDVYSFGVLLLEII 676
G+V W+R + T +DV+S G + E++
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 68/232 (29%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
+ VG G++G V V T VA+KKL FQ RE + ++ H
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAK---VAIKKLYRPFQSELFAKRAYRELR----LLKHMRH 83
Query: 537 KNLVRLL------GFCDEGQNRLLVYEF-------------LNNGTLASFLFGNLKPNWN 577
+N++ LL D+ + LV F L + ++
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVY-------- 135
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
Q+ +GL Y+H ++ IIH D+KP N+ +++ +I DFGLA+ + T
Sbjct: 136 -------QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMT 183
Query: 638 IKTSIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
GYV W+R + T VD++S G ++ E+I + F
Sbjct: 184 ---------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
VG G++G V T VAVKKL FQ RE + ++ H
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSIIHAKRTYRELR----LLKHMKH 87
Query: 537 KNLVRLL------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARG 589
+N++ LL +E + LV + G L + + + +++ + +QI RG
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQ-FLIYQILRG 144
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L Y+H S+ IIH D+KP N+ +++ +I DFGLA+ T GYV
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMT---------GYV 190
Query: 650 APEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
A W+R VD++S G ++ E++ R F
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 59/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNEVFVIGQTHHKNLV 540
+G+G+FG K VI +T A+K L +++ E E V+ + H L
Sbjct: 156 LGKGTFG---K-VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 589
L + + +RL V E+ N G L F ++L F +I
Sbjct: 212 ALK-YSFQTHDRLCFVMEYANGGEL----F------FHLSRERVFSEDRARFYGAEIVSA 260
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L YLH + + +++ D+K +N++LD + +I+DFGL K + + + GT Y+
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM--KTFCGTPEYL 316
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
APE ++ VD + GV++ E++ R F + E+ IL +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 53/236 (22%), Positives = 94/236 (39%), Gaps = 51/236 (21%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTH 535
K +GRGS+G VY + T + VA+KK++ +F+D RE ++ +
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKN---VAIKKVNRMFEDLIDCKRILREIT----ILNRLK 83
Query: 536 HKNLVRLLG-FCDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTN----IAFQI 586
++RL + + +V E + S L K L I + +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKKLFKTPIFLTEEHIKTILYNL 138
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
G ++H S IIH D+KP N LL+ + ++ DFGLA+ + + I + +
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 647 --------------GYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKS 681
+V W+R T +D++S G + E++ +S
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 57/233 (24%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
+ +G G G+V+ V VA+KK IV D + RE K +I + H
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKR---VAIKK--IVLTDPQSVKHALREIK----IIRRLDH 67
Query: 537 KNLVRLL--------------GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTN 581
N+V++ G E + +V E++ T LA+ L L
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG-----PLLEE 120
Query: 582 ----IAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSK 636
+Q+ RGL Y+H S+ ++H D+KP N+ ++ + +I DFGLA+++ + S
Sbjct: 121 HARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 637 TIKTSIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
S + +W+R + T +D+++ G + E++ + F
Sbjct: 178 KGHLS-----EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 8e-18
Identities = 50/184 (27%), Positives = 86/184 (46%), Gaps = 27/184 (14%)
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT 640
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS--FDIEMVEE-YAILTDWA 697
R ++APE + T + DV+SFGVLL EI + S +++ EE L +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-- 311
Query: 698 FDCYRNGKLDALVGGDMEAMNDVECLEKL--VMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755
G M A + ++ M+ W +PS RPT ++++ L ++
Sbjct: 312 -------------GTRMRAPDY--TTPEMYQTMLDCW--HGEPSQRPTFSELVEHLGNLL 354
Query: 756 EVSV 759
+ +
Sbjct: 355 QANA 358
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 35/153 (22%), Positives = 60/153 (39%), Gaps = 12/153 (7%)
Query: 481 FKEEVGRGSFGIVYKGVIQ--TTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQ-THH 536
+ +GRG+FG V + + VAVK L + R +E+ ++ HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 537 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
N+V LLG C G +++ EF G L+++L + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
I D+K + + ++ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 8e-18
Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFVI 531
+ + E++G G++G+VYK T A+KK+ + + E E E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRL---EKEDEGIPSTTIREISIL 54
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARG 589
+ H N+V+L + +LV+E L+ L L + T + Q+ G
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLL-DVCEGGLESVTAKSFLLQLLNG 112
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
+ Y H +++H D+KPQN+L++ +I+DFGLA+
Sbjct: 113 IAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-18
Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 23/160 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFVI 531
+ ++ E+VG G++G+VYK R VA+K++ + D E E E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRI----VALKRIRL---DAEDEGIPSTAIREISLL 73
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIAR 588
+ HH N+V L+ + LV+EF+ L L L+ + ++ +Q+ R
Sbjct: 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDS-QIKI-YLYQLLR 130
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
G+ + H +I+H D+KPQN+L++ +++DFGLA+
Sbjct: 131 GVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 49/212 (23%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 479 DNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFV 530
++ E++G G++G V+K +T VA+K++ + D + E E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRVRL---DDDDEGVPSSALREICL 54
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARG 589
+ + HKN+VRL + LV+EF + L + + + + FQ+ +G
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L + H S ++H D+KPQN+L++ + ++++FGLA+ + + ++ T Y
Sbjct: 114 LGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCY-SAEVVTLWYR 168
Query: 650 APEWFRNSKI-TAKVDVYSFGVLLLEIIACRK 680
P+ +K+ + +D++S G + E+ +
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 43/160 (26%), Positives = 83/160 (51%), Gaps = 23/160 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----REFKNEVFVI 531
+ + +++G G++ VYKG + T VA+K++ + ++G RE ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDN---LVALKEIRLEHEEGAPCTAIREVS----LL 54
Query: 532 GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIAR 588
H N+V L ++ LV+E+L+ L +L + + N++ FQ+ R
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMH-NVKL-FLFQLLR 111
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
GL Y H +++H D+KPQN+L+++ +++DFGLA+
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 21/160 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFV 530
+NF+ E++G G++G+VYK T VA+KK+ + D E E E+ +
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEV----VALKKIRL---DTETEGVPSTAIREISL 55
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIAR 588
+ + +H N+V+LL LV+EFL+ L F+ + L + FQ+ +
Sbjct: 56 LKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
GL + H S +++H D+KPQN+L++ +++DFGLA+
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 37/228 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNEVFVIGQTHHKNLV 540
+G+G+FG K VI +T A+K L +++ E E V+ T H L
Sbjct: 13 LGKGTFG---K-VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 589
L + + +RL V E+ N G L F ++L F +I
Sbjct: 69 ALK-YAFQTHDRLCFVMEYANGGEL----F------FHLSRERVFTEERARFYGAEIVSA 117
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L YLH S +++ D+K +N++LD + +I+DFGL K + + + GT Y+
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYL 172
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
APE ++ VD + GV++ E++ R F + E IL +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREF-KNEVFVIGQTHHKNLV 540
+G+G +G V++ T + A+K K IV + K E ++ + H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIARG 589
L+ + + +L L+ E+L+ G L F L F +I+
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL----F------MQLEREGIFMEDTACFYLAEISMA 133
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
L +LH II+ D+KP+NI+L+ + +++DFGL K + + T + GT Y+
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT--HTFCGTIEYM 188
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
APE S VD +S G L+ +++ F E ++ IL
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC 236
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 24/164 (14%)
Query: 477 ATDNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGE-----REFKNEV 528
++ FK E++G G++ VYKG+ T VA+K++ + ++G RE
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVY----VALKEVKLDSEEGTPSTAIREIS--- 55
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN---GTLASFLFGNLKPNWNLRT--NIA 583
++ + H+N+VRL LV+EF++N + S GN L
Sbjct: 56 -LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627
+Q+ +GL + H ++I+H D+KPQN+L++ ++ DFGLA
Sbjct: 115 WQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 477 ATDNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV--- 530
AT ++ E+G G++G VYK + VA+K + + + +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHF----VALKSVRV---PNGGGGGGGLPISTV 59
Query: 531 --------IGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWN 577
+ H N+VRL+ + + ++ LV+E ++ L ++L P
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 578 LRT--NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
T ++ Q RGL +LH ++ I+H D+KP+NIL+ +++DFGLA++ + +
Sbjct: 119 AETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
T T Y APE S VD++S G + E+
Sbjct: 176 LTPVVV---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 54/219 (24%), Positives = 101/219 (46%), Gaps = 38/219 (17%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE------REFKNEVFVIGQTHH 536
+G G++G+V + VA+KK+ F+ RE K ++ + H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVR---VAIKKIS-PFEHQTYCQRTLREIK----ILLRFRH 84
Query: 537 KNLVRLL-----GFCDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRTNIAFQIARGL 590
+N++ + ++ ++ +V + + T L L N ++ +QI RGL
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICY-FLYQILRGL 141
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
Y+H S+ ++H D+KP N+LL+ + +I DFGLA++ + T + YVA
Sbjct: 142 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVA 193
Query: 651 PEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSF 682
W+R + T +D++S G +L E+++ R F
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 4e-17
Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR 541
+VGRG++G VYK + + A+K+++ E+ ++ + H N++
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKD-YALKQIE--GTGISMSACREIALLRELKHPNVIS 82
Query: 542 LLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTN---------IAFQIARGL 590
L F ++ L++++ + L + + N + + +QI G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNAR----ISDFGLAKLLTL-NQSKTIKTSIRGT 645
YLH ++ ++H D+KP NIL+ R I+D G A+L + + T
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 646 KGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACR 679
Y APE ++ T +D+++ G + E++
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 42/163 (25%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGEREFKN-----EVFV 530
D ++ ++G G++G VYK + T T VA+K++ + + E E EV +
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET----VAIKRIRL---EHEEEGVPGTAIREVSL 86
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+ + H+N++ L L++E+ N L ++ N + + + +Q+ G+
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNAR-----ISDFGLAK 628
+ H S + +H D+KPQN+LL + I DFGLA+
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 65/229 (28%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNEVFVIGQ-THHKNL 539
+G+GSFG K V+ + AVK L + + E + +E V+ + H L
Sbjct: 46 IGKGSFG---K-VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 540 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIAR 588
V L F + ++L V +++N G L F ++L+ F +IA
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGEL----F------YHLQRERCFLEPRARFYAAEIAS 150
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
L YLH S I++ D+KP+NILLD + ++DFGL K + S T ++ GT Y
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEY 205
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
+APE VD + G +L E++ F E IL
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-17
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 26/202 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVK---KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+G GSFG V + A+K K +V NE ++ + LV
Sbjct: 49 LGTGSFGRVM----LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFL-----FGNLKPNWNLRTNIAFQIARGLLYLHE 595
+L + N +V E++ G + S L F + R A QI YLH
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF----SEPHARFYAA-QIVLTFEYLH- 158
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
S +I+ D+KP+N+L+D +++DFG AK + + +T ++ GT +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRT--WTLCGTPEALAPEIIL 211
Query: 656 NSKITAKVDVYSFGVLLLEIIA 677
+ VD ++ GVL+ E+ A
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAA 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 56/219 (25%), Positives = 101/219 (46%), Gaps = 37/219 (16%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE------------F 524
++ E+G G++G V+K + + VA+K++ + E
Sbjct: 11 QQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRV---QTGEEGMPLSTIREVAVL 65
Query: 525 KNEVFVIGQTHHKNLVRLL----GFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLR 579
++ + H N+VRL + + +L LV+E ++ L ++L +P
Sbjct: 66 RH----LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 580 T--NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
T ++ FQ+ RGL +LH S +++H D+KPQNIL+ +++DFGLA++ + + T
Sbjct: 121 TIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEII 676
T Y APE S VD++S G + E+
Sbjct: 178 SVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 21/203 (10%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL---DIVFQDGEREFKNEVFVIGQTHHKNLV 540
+GRG+FG V ST V A+K L +++ + F E ++ + +V
Sbjct: 77 IGRGAFGEVQ----LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 541 RLLG-FCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
+L F D+ L +V E++ G L + + P R A ++ L +H S
Sbjct: 133 QLFYAFQDD--RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---S 186
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
IH D+KP N+LLD + +++DFG + T++ GT Y++PE ++
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 659 ITAK----VDVYSFGVLLLEIIA 677
D +S GV L E++
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLV 268
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 32/205 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGERE-FKNEVFVIGQTHHKNLV 540
+G GSFG V+ A+K L +IV + + E +E ++ H ++
Sbjct: 14 LGTGSFGRVH----LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 69
Query: 541 RLLG-FCDEGQNRL-LVYEFLNNGTLASFL-----FGNLKPNWNLRTNI-AFQIARGLLY 592
R+ G F D ++ ++ +++ G L S L F N A ++ L Y
Sbjct: 70 RMWGTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEY 121
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH S II+ D+KP+NILLD + + +I+DFG AK T ++ GT Y+APE
Sbjct: 122 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVT--YTLCGTPDYIAPE 173
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIA 677
+D +SFG+L+ E++A
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGERE-FKNEVFVIGQTHHKNLV 540
+GRG+FG V + V A+K L + + E F+ E V+ K +
Sbjct: 82 IGRGAFGEVA----VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 541 RLLG-FCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHED 596
L F D+ N L LV ++ G L + L F + P R +A ++ + +H
Sbjct: 138 TLHYAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVH-- 192
Query: 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656
+H D+KP NIL+D + + R++DFG L + + ++ GT Y++PE +
Sbjct: 193 -QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
Query: 657 SKITAK-----VDVYSFGVLLLEIIA 677
+ D +S GV + E++
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGERE-FKNEVFVIGQTHHKNLV 540
+GRG+F V T V A+K + + + GE F+ E V+ + +
Sbjct: 69 IGRGAFSEVA----VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
+L F + +N L LV E+ G L + L FG P R +A +I + +H
Sbjct: 125 QLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVH--- 179
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+H D+KP NILLD + R++DFG L + + ++ GT Y++PE +
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAV 238
Query: 658 KITAKVDVY-------SFGVLLLEIIA 677
Y + GV E+
Sbjct: 239 GGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 52/225 (23%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 479 DNFK--EEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKLDIVFQDGERE-FKN----EVFV 530
++ ++G+G+FG V+K +T + VA+KK+ + + E+E F E+ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK----VALKKVLM---ENEKEGFPITALREIKI 69
Query: 531 IGQTHHKNLVRLLGFCDEGQNRL--------LVYEFLNN---GTLAS----FLFGNLKPN 575
+ H+N+V L+ C + LV++F + G L++ F +K
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-- 127
Query: 576 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
+ + GL Y+H ++I+H DMK N+L+ +++DFGLA+ +L ++
Sbjct: 128 -----RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 636 KTIK--TSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIA 677
T+ T Y PE + +D++ G ++ E+
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 68/224 (30%), Positives = 107/224 (47%), Gaps = 28/224 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNE--VFVIGQTHHKN 538
+G+GSFG K V+ T + AVK L D++ QD + E E + + +H
Sbjct: 31 LGKGSFG---K-VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPF 85
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYL 593
L +L C + +RL V EF+N G L +++ + A F +I L++L
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H II+ D+K N+LLD + +++DFG+ K N T + GT Y+APE
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFCGTPDYIAPEI 195
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
+ VD ++ GVLL E++ F+ E ++ AIL D
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNE--VFVIGQTHHKN 538
+G+GSFG K V+ + R T + AVK L D+V QD + E E V +
Sbjct: 28 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPF 82
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYL 593
L +L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
S II+ D+K N++LD + +I+DFG+ K + T + GT Y+APE
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEI 192
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
VD ++FGVLL E++A + F+ E +E +I+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 3e-16
Identities = 70/224 (31%), Positives = 109/224 (48%), Gaps = 28/224 (12%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNE--VFVIGQTHHKN 538
+G+GSFG K V+ + R T + AVK L D+V QD + E E V +
Sbjct: 349 LGKGSFG---K-VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-GKPPF 403
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIA-F---QIARGLLYL 593
L +L C + +RL V E++N G L +++ + A F +IA GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFL 458
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
S II+ D+K N++LD + +I+DFG+ K + T + GT Y+APE
Sbjct: 459 Q---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KTFCGTPDYIAPEI 513
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
VD ++FGVLL E++A + F+ E +E +I+
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 25/163 (15%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKN--------EV 528
++ + +G G F VYK + T+ VA+KK+ + E K+ E+
Sbjct: 10 KRYEKLDFLGEGQFATVYKA--RDKNTNQI-VAIKKIKL---GHRSEAKDGINRTALREI 63
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQ 585
++ + H N++ LL N LV++F+ L + L P+ +++
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPS-HIKA-YMLM 120
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628
+GL YLH I+H D+KP N+LLD++ +++DFGLAK
Sbjct: 121 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 70/230 (30%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGERE-FKNE--VFVIGQTHHKN 538
+G+GSFG K V T A+K L D+V D + E E V + H
Sbjct: 25 LGKGSFG---K-VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPF 79
Query: 539 LVRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIA 587
L + + + L V E+LN G L +++++ F +I
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDL----M------YHIQSCHKFDLSRATFYAAEII 128
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
GL +LH S I++ D+K NILLD + +I+DFG+ K L +KT + GT
Sbjct: 129 LGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPD 183
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTD 695
Y+APE K VD +SFGVLL E++ + F + EE ++I D
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREF-KNEVFVIGQT-HHKNL 539
+G G++G V+ + + A+K K IV + E + E V+ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 540 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIAR 588
V L + + + +L L+ +++N G L F +L F +I
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL----F------THLSQRERFTEHEVQIYVGEIVL 170
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
L +LH II+ D+K +NILLD + + ++DFGL+K ++++ GT Y
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEY 226
Query: 649 VAPEWFRNSKI--TAKVDVYSFGVLLLEIIACRKSFDIE 685
+AP+ R VD +S GVL+ E++ F ++
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 39/226 (17%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV------FQDGEREFK-----NEVFVI 531
++G G F V+ T VA+K IV + E E K N+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNT---HVAMK---IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 532 GQTH--HKNLVRLLG-FCDEGQNRL---LVYEFLNNGTLASFLFGNLKPNWNLRT--NIA 583
+ ++++LL F +G N + +V+E L L + + L I+
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQIS 137
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDD------HYNARISDFGLAKLLTLNQSKT 637
Q+ GL Y+H C IIH D+KP+N+L++ +I+D G A + + +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
I+T Y +PE + D++S L+ E+I F+
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 36/221 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNEVFVIGQ-THHKNL 539
+GRGS+ K V+ T + A+K + ++V D + ++ + E V Q ++H L
Sbjct: 17 IGRGSYA---K-VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 540 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIAR 588
V L C + ++RL V E++N G L ++++ +I+
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDL----M------FHMQRQRKLPEEHARFYSAEISL 121
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
L YLH II+ D+K N+LLD + +++D+G+ K T ++ GT Y
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNY 176
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+APE R VD ++ GVL+ E++A R FDI +
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAV-AVKKL--DIVFQDGEREF-KNEVFVIGQ-THHKNL 539
+GRGS+ K V+ T + A++ + ++V D + ++ + E V Q ++H L
Sbjct: 60 IGRGSYA---K-VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 540 VRLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKPNWNLRTNIAF----------QIAR 588
V L C + ++RL V E++N G L ++++ +I+
Sbjct: 116 VGLH-SCFQTESRLFFVIEYVNGGDL----M------FHMQRQRKLPEEHARFYSAEISL 164
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY 648
L YLHE II+ D+K N+LLD + +++D+G+ K T ++ GT Y
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNY 219
Query: 649 VAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689
+APE R VD ++ GVL+ E++A R FDI +
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/216 (20%), Positives = 75/216 (34%), Gaps = 73/216 (33%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNL 539
+ +G G G V + + + A+K L D + + EV + + + ++
Sbjct: 22 TSQVLGLGINGKVLQI---FNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHI 73
Query: 540 VRLLGFCDEGQNR----LLVYEFLNNGTL----------------ASFLFGNLKPNWNLR 579
VR++ + L+V E L+ G L AS
Sbjct: 74 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS------------- 120
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSK 636
I I + YLH S I H D+KP+N+L + +++DFG AK T
Sbjct: 121 -EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----- 171
Query: 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLL 672
+ Y D++S GV++
Sbjct: 172 --------GEKY-----------DKSCDMWSLGVIM 188
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 51/217 (23%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV------FQDGEREFK-----NEVFVI 531
+ +G+GSFG V K VA+K +V + E + +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQH---VALK---MVRNEKRFHRQAAEEIRILEHLRK---Q 153
Query: 532 GQTHHKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 580
+ + N++ +L E N +YE + F ++
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMN---LYELIKKNKFQGFSLPLVRK------ 204
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTI 638
A I + L LH ++IIHCD+KP+NILL + ++ DFG + + + +
Sbjct: 205 -FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY----EHQRV 256
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEI 675
T I+ ++ Y APE ++ +D++S G +L E+
Sbjct: 257 YTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.9 bits (157), Expect = 2e-11
Identities = 35/240 (14%), Positives = 64/240 (26%), Gaps = 69/240 (28%)
Query: 477 ATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI--------VFQDGEREFKN 526
T+ + E++G G FG V++ T VA+K + I Q E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQT-----IADHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 527 EVFV---------IGQTHHKNLVRLLGFC------------------------------D 547
E+ + + + L
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 548 EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMK 607
+ +V EF G + L + +I Q+ L + H D+
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKL-SSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189
Query: 608 PQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGY-VAPEWFRNSKITAKVDVY 666
N+LL ++ K T+ + G V+ + S++ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTI-----------PSCGLQVSIIDYTLSRLERDGIVV 238
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFK-----NEVFVIGQT 534
+G+GSFG V K + + VA+K + E + N+
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEW---VAIKIIKNKKAFLNQAQIEVRLLELMNK---HDTE 113
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLN-NGTLASFLFGNLKPN----WNLRT--NIAFQIA 587
+V L + LV+E L+ N L+ L+ +L A Q+
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA--RISDFGLAKLLTLNQSKTIKTSIRGT 645
LL+L IIHCD+KP+NILL + + +I DFG + + I I+ +
Sbjct: 168 TALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ----LGQRIYQYIQ-S 221
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
+ Y +PE +D++S G +L+E
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 20/155 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+++G G+FG + G T VA+K + E++ + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IP 68
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
++ F G+ +V E L G LF ++L+T IA Q+ + Y+H S
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---S 123
Query: 599 SQIIHCDMKPQNILLDDHYNAR-----ISDFGLAK 628
+I+ D+KP+N L+ N I DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 45/210 (21%), Positives = 73/210 (34%), Gaps = 63/210 (30%)
Query: 536 HKNLVRLLG-FCDEGQN---RLLVYEFL--NNGTLASFLFGNLKPNWNLRTNIAFQIARG 589
+ +V+LL F G N +V+E L + P ++ I Q+ +G
Sbjct: 100 REMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKK-IIQQVLQG 158
Query: 590 LLYLHEDCSSQIIHCDMKPQNILL--DDHY------------------------------ 617
L YLH C +IIH D+KP+NILL ++ Y
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 618 -----------------NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT 660
+I+D G A + + ++ I+T Y + E S
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYN 271
Query: 661 AKVDVYSFGVLLLEIIACRKSFDIEMVEEY 690
D++S + E+ F+ EEY
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 34/161 (21%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQT 534
++K +G GSFG++++G VA+K E++ + G T
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQ---QVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLY 592
+ + F EG + +LV + L G L ++++T A Q+ +
Sbjct: 67 G---IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 121
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNAR-----ISDFGLAK 628
+H +++ D+KP N L+ + + DFG+ K
Sbjct: 122 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.6 bits (146), Expect = 2e-09
Identities = 82/606 (13%), Positives = 169/606 (27%), Gaps = 175/606 (28%)
Query: 278 NLDGELGSGACGFNSICSLNGDK-RPMCDCPKGYSLLDKTDKYGSCKADFD---LSCNGG 333
++D E G + I S+ D DC + D S K + D +S +
Sbjct: 6 HMDFETGEHQYQYKDILSVFEDAFVDNFDC---KDVQDMPKSILS-KEEIDHIIMSKDAV 61
Query: 334 GQGYNKELFDVYELKETDWPMSDYDFF--SPYDEEHCWLKRLPLSNGRADTSVTGKAFIK 391
LF K F + +L P+ + S+ + +I+
Sbjct: 62 SGTL--RLFWTLLSK----QEEMVQKFVEEVLRINYKFLMS-PIKTEQRQPSMMTRMYIE 114
Query: 392 YR----KGDDPSPPL-VPRPPDPEDKKKRKM-------------MNATG-SVLLGSSVFV 432
R + V R P K ++ + + +G + + V +
Sbjct: 115 QRDRLYNDNQVFAKYNVSRL-QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA-LDVCL 172
Query: 433 NFALVCAFVLGFFFIYKKKWI----RNSPGD---------GTIETNL--RCFSYKELEEA 477
++ + C F W+ NSP I+ N R ++
Sbjct: 173 SYKVQCKMDFKIF------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226
Query: 478 TDNFKEEVGR-----------------------GSFGIVYKGVIQTTR----------TS 504
+ + E+ R +F + K ++ TTR +
Sbjct: 227 IHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCK-ILLTTRFKQVTDFLSAAT 285
Query: 505 TTAVAVKKLDIVFQDGEREFKNEVF--VIGQ----------THHKNLVRLLG-FCDEGQN 551
TT +++ + E + + + T + + ++ +G
Sbjct: 286 TTHISLDHHSMTLTPDEVK---SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLA 342
Query: 552 RLLVYEFLNNGTLASFL---FGNLKPNWNLRTN-----IAFQ----IARGLL-------- 591
++ +N L + + L+P R + F I LL
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPA-EYRKMFDRLSV-FPPSAHIPTILLSLIWFDVI 400
Query: 592 ------YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
+++ ++ K I + Y L + L + SI
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIY--------LELKVKLENEYALHRSIVDH 452
Query: 646 KGYVAPEWFRNSKITA-KVDVYSFGVL---LLEIIACRKSFDIEMVEEYAILTDWAFDCY 701
Y P+ F + + +D Y + + L +IE E + D +
Sbjct: 453 --YNIPKTFDSDDLIPPYLDQYFYSHIGHHL---------KNIEHPERMTLFRMVFLD-F 500
Query: 702 R--------NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753
R + G + + ++ + + DP + +L L
Sbjct: 501 RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYI------CDNDPKYERLVNAILDFLPK 554
Query: 754 VVEVSV 759
+ E +
Sbjct: 555 IEENLI 560
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 44/225 (19%), Positives = 80/225 (35%), Gaps = 51/225 (22%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK---KLDIVFQDGEREFK-----NEVFVIGQT 534
+G G+FG V + + R + VA+K + + E E +
Sbjct: 25 GNLGEGTFGKVVE-CLDHARGKSQ-VALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82
Query: 535 HHKNLVRLLGFCDE-----------GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIA 583
V + + + G+N +EFL + ++A
Sbjct: 83 L---CVLMSDWFNFHGHMCIAFELLGKN---TFEFLKENNFQPY-------PLPHVRHMA 129
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK---- 639
+Q+ L +LHE +Q+ H D+KP+NIL + + + + ++ +I+
Sbjct: 130 YQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 640 ----------TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
T+I T+ Y PE DV+S G +L E
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 32/165 (19%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTA-----VAVK------KLDIVFQDGEREFKNEVFVIGQ 533
R + GI+Y+ +T T + ++K +L +R K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 534 THHKNLV----RLLGF-CDEGQNRLLVYEFLNNGT-LASFLFGNLKPNWNLRT--NIAFQ 585
+ + +GF + + R LV L G L S L + K + R+ +A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI--SDFGLAK 628
+ L +LH ++ +H ++ +NI +D +++ + +G A
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 58/343 (16%), Positives = 116/343 (33%), Gaps = 110/343 (32%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV------FQDGEREFK-----NEVFVI 531
+ +G G+FG V + + VAVK IV + E + N
Sbjct: 20 DTLGEGAFGKVVEC--IDHKAGGRHVAVK---IVKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 532 GQTHHKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 580
V++L + + E G + Y+F+ F ++R
Sbjct: 75 STFR---CVQMLEWFEHHGHICIVFELLGLS---TYDFIKENGFLPF------RLDHIR- 121
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK- 639
+A+QI + + +LH +++ H D+KP+NIL + + + + IK
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 640 -------------TSIRGTKGYVAPE------WFRNSKITAKVDVYSFGVLLLE------ 674
+++ T+ Y APE W + DV+S G +L+E
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYLGFT 232
Query: 675 -------------IIACRKSFDIEMVEE-------YAILTDWAFDCYRNGKL-------- 706
+ M+++ + DW +
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ ++ D+E + ++K ++ DP+ R T+++ L+
Sbjct: 293 EFMLSQDVEHERLFDLIQK-------MLEYDPAKRITLREALK 328
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 45/178 (25%), Positives = 68/178 (38%), Gaps = 23/178 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
++G GSFG +Y G VA+K + E K + G +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGE---EVAIKLECVKTKHPQLHIESKIYKMMQGGVG---IP 68
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLYLHEDCS 598
+ EG ++V E L G LF ++L+T +A Q+ + Y+H S
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123
Query: 599 SQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQSKTI-----KTSIRGTKGY 648
IH D+KP N L+ I DFGLAK ++ ++ GT Y
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 51/234 (21%), Positives = 80/234 (34%), Gaps = 65/234 (27%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV------FQDGEREFK-----NEVFVI 531
++G G+FG V + AVK +V + + E
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKY---YAVK---VVRNIKKYTRSAKIEADILKKIQN---- 90
Query: 532 GQTHHKNLVRLLGFCD---------E--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT 580
++ N+V+ G E G + +YE + F +++
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFEPLGPS---LYEIITRNNYNGF------HIEDIK- 140
Query: 581 NIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD------HYNARISDFGLAKLLTLNQ 634
+I + L YL + + H D+KP+NILLDD R G + +
Sbjct: 141 LYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 635 SKTIK--------------TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLE 674
S IK SI T+ Y APE N D++SFG +L E
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 48/184 (26%), Positives = 74/184 (40%), Gaps = 25/184 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVK--KLDIVFQDGEREFKNEVFVIGQT 534
+ F+ ++G GSFG +Y G T VA+K + E K ++ I Q
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKHPQLLYESK--IYRILQ- 60
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIARGLLY 592
+ + F EG +LV + L G LF +L+T +A Q+ + +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNAR---ISDFGLAKLLTLNQSKTI-----KTSIRG 644
+H S +H D+KP N L+ A I DFGLAK + ++ G
Sbjct: 119 VH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175
Query: 645 TKGY 648
T Y
Sbjct: 176 TARY 179
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 30/163 (18%), Positives = 54/163 (33%), Gaps = 25/163 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFK-----NEVFVIGQTHHKNL 539
+G G FG++Y VK E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 540 VRLLGF----------CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQIA 587
+ LG R +V E L G + + T + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRML 161
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI--SDFGLAK 628
L Y+H ++ +H D+K N+LL ++ +D+GL+
Sbjct: 162 DVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 29/165 (17%), Positives = 63/165 (38%), Gaps = 26/165 (15%)
Query: 485 VGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDIVFQDGEREFK-----NEVFVIGQTHHK 537
+G+G FG +Y + ++ + + VK E K + I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 538 NLVRLLGFC----------DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRT--NIAFQ 585
++ LG + R ++ + G+ ++ ++ +T ++ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI--SDFGLAK 628
I L Y+H + +H D+K N+LL+ ++ D+GLA
Sbjct: 161 ILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.1 bits (100), Expect = 2e-04
Identities = 42/288 (14%), Positives = 70/288 (24%), Gaps = 41/288 (14%)
Query: 24 AQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTV 83
+P TL AG LSP+ F + N L I N
Sbjct: 11 GVGTSVLPAYQTLSAGQY---LLSPNQRFKLLLQ-----GDGN----LVIQDNGATVWVA 58
Query: 84 VWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT------VAVGHMND 137
+ + + G L+D ++VW + T + D
Sbjct: 59 NEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQD 118
Query: 138 TGNFMLASSSSSRAFFPKIGHQFSR----------GLFQFRLLKDGNLVLNIANLPTDFA 187
GN +L S + P I L Q + G L A
Sbjct: 119 DGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVA 178
Query: 188 YDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTTGRVVPAADFYHRATLN 247
Y + T++ R +F G + + + + L
Sbjct: 179 YGPNG-AATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVL-WHSH---TGGHASAVLRLQ 233
Query: 248 FDGVFAQYYYPRHGNGNWSVVWSQPDNICVNLDGELGSGACGFNSICS 295
+G A + VW++ + I +
Sbjct: 234 ANGSIAIL--------DEKPVWARFGFQPTYRHIRKINPDQKPIDIWT 273
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.81 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.8 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.79 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.71 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.71 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.7 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.66 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.63 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.56 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.51 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.49 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.48 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.41 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.34 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.34 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.3 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.26 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.22 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.99 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.89 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.89 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.78 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.53 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.99 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.97 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.27 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.26 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.94 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.33 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.23 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.19 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.97 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.91 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.94 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.86 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.97 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.72 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=448.92 Aligned_cols=269 Identities=26% Similarity=0.381 Sum_probs=219.9
Q ss_pred CHHHHHHHHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeee
Q 037189 470 SYKELEEATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFC 546 (766)
Q Consensus 470 ~~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (766)
++.|+..++.+|.++||+|+||.||+|.+.. ....++.||||+++... ....++|.+|+.++++++|||||+++|+|
T Consensus 19 ~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 19 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3445555667789999999999999999753 22356789999997543 33457899999999999999999999999
Q ss_pred ecCCceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccce
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQN 610 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 610 (766)
.+++..+||||||++|+|.++|... ..++|..+++|+.|||+||+|||+ .+|+||||||+|
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~N 175 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRN 175 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccc
Confidence 9999999999999999999999643 347889999999999999999995 499999999999
Q ss_pred EEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhh
Q 037189 611 ILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEE 689 (766)
Q Consensus 611 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~ 689 (766)
|||++++.+||+|||+++.+.............||++|||||++.++.++.++|||||||+||||+| |+.||......+
T Consensus 176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~ 255 (308)
T 4gt4_A 176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 255 (308)
T ss_dssp EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999998765544433355679999999999999999999999999999999999 899997654322
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
+...+..+.. ...+..++.++.+|+.+||+.||++||||.||++.|+....+
T Consensus 256 -------~~~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 256 -------VVEMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp -------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred -------HHHHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 1122222221 122445678899999999999999999999999999986544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=445.11 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=207.9
Q ss_pred hhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.++||+|+||.||+|++.. ...+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456889999999999999763 223578999999987666667889999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC---------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 558 FLNNGTLASFLFGN---------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 558 y~~~gsL~~~l~~~---------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
||++|+|.++|+.. ..++|.+++.|+.||++||+|||+ .+|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 99999999999753 357899999999999999999995 599999999999999999999999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|||+++...............||++|||||++.+..++.++|||||||+||||+| |+.||......+. ...+
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~-------~~~i 273 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-------IDCI 273 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-------HHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-------HHHH
Confidence 9999998765544444455679999999999999999999999999999999999 8999976543221 1112
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
..+. +...+..+++++.+|+.+||+.||++||||.||+++|+.+.+.
T Consensus 274 ~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 274 TQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 2221 1122345677899999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=439.81 Aligned_cols=259 Identities=25% Similarity=0.469 Sum_probs=215.0
Q ss_pred HhhhhhccccccceEEEEEEecC--CCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|++... ..++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 44678999999999999997632 2356889999998766666788999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 557 EFLNNGTLASFLFGN-------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
|||++|+|.++|+.. ..++|.+++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECC
Confidence 999999999999753 468999999999999999999995 4999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+++...............||++|||||++.+..++.++|||||||+||||+| |+.||......+ +...+.
T Consensus 172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~i~ 244 (299)
T 4asz_A 172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECIT 244 (299)
T ss_dssp CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHH
T ss_pred cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHH
Confidence 999997765544333344569999999999999999999999999999999999 899997654322 112222
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+.. ...+..+++++.+|+.+||+.||++||||++|++.|+++.+
T Consensus 245 ~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 245 QGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221 11234567789999999999999999999999999988654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=430.75 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=203.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.++||+|+||+||+|++.. .||||.++... ....++|.+|++++++++|||||+++|+|.+ +..+|||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECC------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3467899999999999998652 48999886433 2335679999999999999999999999865 5689999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||++|+|.++|+.. ..++|.+++.|+.|||+||+|||+ .+|+||||||+||||++++.+||+|||+|+.......
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999754 579999999999999999999995 4999999999999999999999999999987765433
Q ss_pred cceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.......+||+.|||||++.+ .+++.++|||||||+||||+||+.||....... .+...+..+... +
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~~----p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYAS----P 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCCC----C
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----C
Confidence 333355689999999999964 468999999999999999999999997543221 111112222111 1
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp~ 762 (766)
.. ...+..+++++.+|+.+||+.||++||||.||++.|+.+. -+.|+.
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~-~~lpk~ 305 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ-HSLPKI 305 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH-TTCCC-
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh-ccCCCC
Confidence 11 1123346778999999999999999999999999998764 344543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=430.86 Aligned_cols=266 Identities=26% Similarity=0.373 Sum_probs=216.0
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccccc-CHHHHHHHHHHHccCCC-CCeeeEeeeeecC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHH-KNLVRLLGFCDEG 549 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~ 549 (766)
+....+.+.++||+|+||.||+|.+...+ ...+.||||+++..... ..++|.+|+++|.+++| ||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 33445566789999999999999987533 24578999999754332 34679999999999965 8999999999765
Q ss_pred -CceEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 550 -QNRLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 550 -~~~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
+..+||||||++|+|.++|+.. ..+++..++.++.|||+||+|||+ .+|+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 5689999999999999999642 347889999999999999999995 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYA 691 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~ 691 (766)
+++++.+||+|||+|+.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999998766555444456779999999999999999999999999999999998 899997543222
Q ss_pred hHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 692 ILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
.+...+.++. +...+..++.++.+++.+||+.||++||||.+|+++|+.+++.
T Consensus 296 ----~~~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 ----EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 1112222221 1122334567899999999999999999999999999887653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=416.32 Aligned_cols=249 Identities=25% Similarity=0.354 Sum_probs=210.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+++.++||+|+||.||+|+... .++.||||+++.......+.+.+|+++|++++|||||++++++.+++..+|||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4456789999999999999875 4679999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
|++|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 226 (346)
T 4fih_A 153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 226 (346)
T ss_dssp CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc--
Confidence 999999999875 468999999999999999999995 49999999999999999999999999999977544322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. ...+..+.. .....
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~-------~~~~~ 292 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLP-------PRLKN 292 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSSC-------CCCSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCC-------CCCCc
Confidence 2457899999999999999999999999999999999999999976543221 111111111 11112
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23456788999999999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=412.54 Aligned_cols=247 Identities=22% Similarity=0.270 Sum_probs=211.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||+||+|+... .++.||||.++.. .....+.+.+|+++|++++|||||++++++.+++..+||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 5677899999999999999875 4679999999743 344567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999999988889999999999999999999995 5999999999999999999999999999998765544
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.......+||+.|||||++.+..++.++||||+||+||||++|+.||...+..+. ...+.++..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~--------- 251 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-------FAKIIKLEY--------- 251 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC---------
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence 4444567899999999999999999999999999999999999999976543321 111122221
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
..+...+.++.+|+.+||+.||++|||++|++
T Consensus 252 -~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11223456789999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=406.97 Aligned_cols=247 Identities=29% Similarity=0.426 Sum_probs=198.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec----CCceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 553 (766)
.|.++||+|+||.||+|.+.. .+..||||++.... ....+.|.+|++++++++|||||++++++.+ +...+
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 356789999999999999874 46789999996532 2334679999999999999999999999864 34579
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~ 632 (766)
||||||++|+|.+++.....+++..+..++.||+.||+|||+. .++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999999999888899999999999999999999964 234999999999999984 78999999999986443
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.. ....+||+.|||||++.+ +++.++|||||||+||||+||+.||....... .+...+..+....
T Consensus 185 ~~----~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~~~~~---- 249 (290)
T 3fpq_A 185 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA---- 249 (290)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcCCCCC----
Confidence 22 245689999999999875 69999999999999999999999996433211 1112222221110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=412.58 Aligned_cols=266 Identities=23% Similarity=0.305 Sum_probs=200.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC----ceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----NRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 555 (766)
.+.++||+|+||.||+|++. ++.||||+++... .....+..|+..+.+++|||||+++++|.+++ ..+||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-----g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45688999999999999874 5789999996432 12223445667778899999999999997654 57899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
||||++|+|.++|+.. .++|+.+.+|+.|+++||+|||+++ .++|+||||||+||||++++++||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999999999764 5899999999999999999999652 458999999999999999999999999999877
Q ss_pred ccCCCcc--eeecccccCcccccccccCC------CCCcccCeeehhHHHHHHHhCCcCCCchhhhh--h------hhHH
Q 037189 631 TLNQSKT--IKTSIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--Y------AILT 694 (766)
Q Consensus 631 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~--~------~~~~ 694 (766)
....... ......||++|+|||++.+. .++.++|||||||+||||+||++|+....... . ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 6543221 12345799999999999764 47789999999999999999998775322110 0 0001
Q ss_pred HHHHHHhhcCccceeccCccc-CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 695 DWAFDCYRNGKLDALVGGDME-AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
......+..+.. .+... .....++++.+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 239 ~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 239 EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111122211111 11111 11234577889999999999999999999999999988754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=416.83 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=199.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
|.+.++||+|+||.||+|+... .++.||||.++... ....+.|.+|+++|++++|||||++++++.+++..+|||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 5567899999999999999874 46799999997543 233467999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||++|+|.++|... ..+++...+.|+.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999654 456788899999999999999995 599999999999999999999999999998765322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. .. .+..+...
T Consensus 180 ~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~-~i~~~~~~------- 243 (350)
T 4b9d_A 180 E--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VL-KIISGSFP------- 243 (350)
T ss_dssp H--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HH-HHHHTCCC-------
T ss_pred c--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HH-HHHcCCCC-------
Confidence 1 12346799999999999999999999999999999999999999986543321 11 11112111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 244 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 --PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112345678899999999999999999999986
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=413.33 Aligned_cols=249 Identities=22% Similarity=0.228 Sum_probs=203.1
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.+.++||+|+||.||+|++.. .++.||||+++... .+.+|+.++++++|||||++++++.+++..+||||||
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 345689999999999999875 46799999997532 2357999999999999999999999999999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccCCCcc-
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQSKT- 637 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~~- 637 (766)
++|+|.++|.....+++..+..++.||+.||+||| +.+|+||||||+||||+.++ .+||+|||+++.+.......
T Consensus 133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccc
Confidence 99999999998888999999999999999999999 55999999999999999887 69999999999876543211
Q ss_pred --eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 638 --IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 638 --~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....+||+.|||||++.+..++.++|||||||+||||++|+.||......+.. ..+ . .+.. ..
T Consensus 210 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i---~-~~~~-------~~ 275 (336)
T 4g3f_A 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKI---A-SEPP-------PI 275 (336)
T ss_dssp ----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHH---H-HSCC-------GG
T ss_pred eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHH---H-cCCC-------Cc
Confidence 123467999999999999999999999999999999999999999764432211 111 1 1110 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
...+..++..+.+++.+||+.||.+|||+.|+++.|..
T Consensus 276 ~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11234456788999999999999999999999988755
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=416.91 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=209.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.++||+|+||.||+|.... .++.||||+++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 4456789999999999999875 4679999999876666677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
|++|+|.+++... .+++.++..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 230 ~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-- 303 (423)
T 4fie_A 230 LEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-- 303 (423)
T ss_dssp CTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC--
T ss_pred CCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc--
Confidence 9999999998654 58999999999999999999995 49999999999999999999999999999977544322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....+||+.|||||++.+..++.++|||||||+||||++|+.||......+. ...+..+... ....
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~~~-------~~~~ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNLPP-------RLKN 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCCC-------CCSC
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCCCC-------CCcc
Confidence 2457899999999999999999999999999999999999999976543221 1111111110 1111
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 22346788999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=394.57 Aligned_cols=245 Identities=25% Similarity=0.371 Sum_probs=193.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||+|.... .++.||||.++... ....+.+.+|++++++++|||||++++++.+++..++
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35667899999999999998764 46799999986432 3345679999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+ +|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99999 68999999988899999999999999999999995 499999999999999999999999999998765432
Q ss_pred CcceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
. ....+||+.|+|||++.+..+ +.++||||+||+||||++|+.||........ ...+..+..
T Consensus 167 ~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~~~------- 229 (275)
T 3hyh_A 167 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNGVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC-------
T ss_pred c---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC-------
Confidence 2 245689999999999998876 5799999999999999999999976543221 111222221
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 112234577889999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=405.47 Aligned_cols=250 Identities=24% Similarity=0.260 Sum_probs=201.3
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
.+++.+.||+|+||.||+|+...+...++.||||.++... ......+.+|+++|++++|||||++++++.+++..+||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3567789999999999999986555567899999986432 22345789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 181 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 181 (304)
T ss_dssp ECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C
T ss_pred EEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc
Confidence 9999999999999988889999999999999999999995 5999999999999999999999999999987544322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+. ...+.++..
T Consensus 182 ~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~--------- 243 (304)
T 3ubd_A 182 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTMILKAKL--------- 243 (304)
T ss_dssp C--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---------
T ss_pred c--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHHHHcCCC---------
Confidence 2 2456899999999999999999999999999999999999999986544321 111111211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~ 749 (766)
..+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 244 -~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112335677899999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=384.95 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=185.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCC-------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------- 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 550 (766)
+++.+.||+|+||.||+|+... +++.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred CEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4566899999999999999864 4679999999754332 3467999999999999999999999986544
Q ss_pred -----ceEEEeeccCCCchhhhhccCCCCc---cchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 551 -----NRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 551 -----~~~lV~Ey~~~gsL~~~l~~~~~l~---~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
..++||||+++|+|.+++.....++ +..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998765543 44578899999999999995 499999999999999999999999
Q ss_pred ccCcccccccCCCcc----------eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh
Q 037189 623 DFGLAKLLTLNQSKT----------IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692 (766)
Q Consensus 623 Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~ 692 (766)
|||+|+.+....... ..+..+||+.|||||++.+..++.++|||||||+||||++ ||....... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~-~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV-RT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-HH
Confidence 999999875433211 1234579999999999999999999999999999999996 775432111 01
Q ss_pred HHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........... ........+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 -----LTDVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----HHHHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111110 11233456778999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.90 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=201.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeec------CC
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~ 550 (766)
+.+.+.||+|+||.||+|.... .++.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred eEEEEEEecccCeEEEEEEECC---CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 4567899999999999999875 467999999965332 234578999999999999999999998753 46
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..+||||||+ |+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 7899999996 7899999988899999999999999999999995 59999999999999999999999999999876
Q ss_pred ccCCC--cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc-
Q 037189 631 TLNQS--KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL- 706 (766)
Q Consensus 631 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 706 (766)
..... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||...+..+.... +.........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCCCChH
Confidence 54321 2223457899999999998875 569999999999999999999999986554332111 1111110000
Q ss_pred --c--------eeccCc-ccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 --D--------ALVGGD-MEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 --~--------~~~~~~-~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. ..+... .....+ ...+.++.+|+.+||+.||.+|||+.|++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 000000 000000 1234678899999999999999999999874
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=372.61 Aligned_cols=271 Identities=36% Similarity=0.643 Sum_probs=232.6
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
+.+.||+|+||.||+|.+. ++..||||++........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCCSCBCSSSEEEEEECT----TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred ccceeecCCCeeEEEEEEC----CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 3468999999999999864 467899999877666667889999999999999999999999999999999999999
Q ss_pred CCchhhhhccCC----CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 561 NGTLASFLFGNL----KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 561 ~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+|+|.+++.... .+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999997643 57899999999999999999995 49999999999999999999999999999876543333
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||......+......|.......+.+..++++....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD 275 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc
Confidence 22244568999999999999999999999999999999999999997665544444555555556666677777776666
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
......+..+.+++.+||+.||++|||+.+|++.|+.++++.
T Consensus 276 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 667889999999999999999999999999999999877654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=372.33 Aligned_cols=287 Identities=42% Similarity=0.731 Sum_probs=241.7
Q ss_pred ccccccCHHHHHHHHHhhh--hhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCee
Q 037189 464 TNLRCFSYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLV 540 (766)
Q Consensus 464 ~~~~~~~~~~l~~~t~~f~--~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv 540 (766)
...+.|++.++...+.+|. +.||+|+||.||+|... +++.||||++..... .....|.+|++++++++||||+
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 90 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLL 90 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCcc
Confidence 3467899999998888775 68999999999999754 467899999875432 2334799999999999999999
Q ss_pred eEeeeeecCCceEEEeeccCCCchhhhhccCC----CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC
Q 037189 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNL----KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH 616 (766)
Q Consensus 541 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 616 (766)
++++++.+.+..++||||+++|+|.+++.... .+++..+..|+.|++.||+|||+.+..+|+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~ 170 (326)
T 3uim_A 91 RLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEE 170 (326)
T ss_dssp CCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTT
T ss_pred ceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCC
Confidence 99999999999999999999999999997643 48899999999999999999997656699999999999999999
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh--hhhhhHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV--EEYAILT 694 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~--~~~~~~~ 694 (766)
+.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 249 (326)
T 3uim_A 171 FEAVVGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249 (326)
T ss_dssp CCEEECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred CCEEeccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence 999999999998775443332 2445699999999999999999999999999999999999999975432 2223345
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.|+...........+.+...........+..+.+++.+||+.||.+|||+.+|+++|++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 5666666666777777777777778889999999999999999999999999999998743
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.12 Aligned_cols=199 Identities=21% Similarity=0.335 Sum_probs=169.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|+.+.....++.||||++... .....+.+|+++|.++ +||||+++++++.+.++.+||||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 45567899999999999998654446789999998643 3456789999999988 69999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++. .+++.++..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+........
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 48899999999999999999995 599999999999999876 79999999999865432211
Q ss_pred --------------------------ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCch
Q 037189 637 --------------------------TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIE 685 (766)
Q Consensus 637 --------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~ 685 (766)
......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 111345799999999999876 4899999999999999999999999543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=393.93 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=208.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .++.||||.+........+.+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 5567899999999999999875 4678999999765555567799999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC--CCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH--YNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~ 635 (766)
|++|+|.++|... ..+++.++..++.||+.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999998654 578999999999999999999995 499999999999999854 8999999999998765432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ...+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...... ..
T Consensus 313 ~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~~------~~ 376 (573)
T 3uto_A 313 V---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDWN------MD 376 (573)
T ss_dssp E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC------CC
T ss_pred e---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCCC------CC
Confidence 2 456799999999999999999999999999999999999999986554321 1111121110 01
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......++++.+|+.+||+.||.+|||+.|++++
T Consensus 377 ~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 377 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112345778899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=389.02 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=201.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHH---HHHHHccCCCCCeeeEeeeeecCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKN---EVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
+.+.+.||+|+||.||+|+... .++.||||.++... ......+.+ ++.+++.++|||||++++++.+.+..
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred eEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4456889999999999999875 56799999996421 223333444 46777888999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+|||||+++|+|.++|.....+++.....++.||+.||.||| +.+|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999999998888999999999999999999999 56999999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
... ...+||+.|||||++.. ..++.++|+|||||+||||++|++||..........+. ........
T Consensus 345 ~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~i~~~~~----- 411 (689)
T 3v5w_A 345 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTMAV----- 411 (689)
T ss_dssp CCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HHHHHCCC-----
T ss_pred CCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhhcCCCC-----
Confidence 332 34689999999999964 57999999999999999999999999765432221111 11111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~ 749 (766)
..+...+.++.+|+.+||+.||.+|++ ++||++
T Consensus 412 -----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 412 -----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 123345678899999999999999998 677764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=360.19 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=200.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|... +..||||.+..... ...++|.+|++++++++||||+++++++.+....++||
T Consensus 39 y~i~~~lG~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEWH-----GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ceeeeEeecCCCeEEEEEEEC-----CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 445678999999999999763 56799999865432 23457899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCC---CccchhhhHHHHHHHHHHHhhhcCCCc--eecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 557 EFLNNGTLASFLFGNLK---PNWNLRTNIAFQIARGLLYLHEDCSSQ--IIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
||+++|+|.+++..... +++..++.++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999987653 88999999999999999999954 6 9999999999999999999999999998654
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ......
T Consensus 191 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------~~~~~~------- 255 (309)
T 3p86_A 191 STFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------AVGFKC------- 255 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------HHHHSC-------
T ss_pred ccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhcC-------
Confidence 33211 234578999999999999999999999999999999999999997654322111 000010
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCCC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPY 764 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp~p~ 764 (766)
.....+...+.++.+++.+||+.||.+|||+.++++.|+.+++-..||.++
T Consensus 256 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~ 306 (309)
T 3p86_A 256 --KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306 (309)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--------
T ss_pred --CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCc
Confidence 111123345677899999999999999999999999999988777666654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=360.62 Aligned_cols=262 Identities=23% Similarity=0.426 Sum_probs=213.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|.+..++..+..||||.++... ....+.|.+|+.++++++||||+++++++.+.+..++||
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 129 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVT 129 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEE
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEe
Confidence 3455678999999999999998766667889999997542 333567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 130 EYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred eCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 999999999999754 578999999999999999999995 4999999999999999999999999999987755432
Q ss_pred cc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 636 KT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 636 ~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+
T Consensus 207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-------~~~~~~~--------- 270 (325)
T 3kul_A 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-------ISSVEEG--------- 270 (325)
T ss_dssp CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTT---------
T ss_pred ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHcC---------
Confidence 22 1123456788999999999999999999999999999999 9999965443221 1111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
.....+..++..+.+++.+||+.||.+|||+.+|++.|+.++..+
T Consensus 271 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 111123345678999999999999999999999999999977544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=364.40 Aligned_cols=261 Identities=27% Similarity=0.422 Sum_probs=212.1
Q ss_pred HHhhhhhccccccceEEEEEEec----CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT----TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~----~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (766)
.+.+.+.||+|+||.||+|.... ....+..||||.++.... ...+++.+|+.+++++ +||||++++++|.+.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 34566889999999999998753 223567899999975432 2346799999999999 89999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 552 RLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
.++||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECC
Confidence 999999999999999997542 46788899999999999999995 49999999999999999
Q ss_pred CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHH
Q 037189 616 HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILT 694 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 694 (766)
++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~---- 314 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 314 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH----
Confidence 99999999999987654433222234567889999999999999999999999999999999 9999976443221
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
...+..+. ....+..++.++.+++.+||+.||.+|||+.++++.|+.++.+
T Consensus 315 ---~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 ---FKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ---HHHHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111211 1112334567899999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.82 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=209.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .+..+|+|++........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeccceecCCCCEEEEEEEECC---CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3456789999999999999864 4678999998765566677899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 999999999986 5678999999999999999999995 499999999999999999999999999998765433211
Q ss_pred ------------eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh---hHHHHHHHHhh
Q 037189 638 ------------IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA---ILTDWAFDCYR 702 (766)
Q Consensus 638 ------------~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~ 702 (766)
......||+.|+|||++.+..++.++||||||+++|||++|..|+......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~----- 240 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL----- 240 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-----
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-----
Confidence 011456999999999999999999999999999999999999998643321110 000000
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 241 ------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 241 ------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001122345678899999999999999999999999988763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=347.63 Aligned_cols=279 Identities=38% Similarity=0.639 Sum_probs=225.1
Q ss_pred cccccCHHHHHHHHHhhhh--------hccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHc
Q 037189 465 NLRCFSYKELEEATDNFKE--------EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIG 532 (766)
Q Consensus 465 ~~~~~~~~~l~~~t~~f~~--------~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~ 532 (766)
....|++.++..++.+|.+ .||+|+||.||+|... +..+|||++.... ....+.|.+|+.+++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~ 85 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-----NTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-----SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-----CceEEEEEEecccCcchHHHHHHHHHHHHHHH
Confidence 4678999999999999974 4999999999999863 5689999986432 233567999999999
Q ss_pred cCCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhcc---CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccc
Q 037189 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQ 609 (766)
Q Consensus 533 ~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 609 (766)
+++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+|+||||||+
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~ 162 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSA 162 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGG
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHH
Confidence 99999999999999999999999999999999999864 3468899999999999999999995 49999999999
Q ss_pred eEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh
Q 037189 610 NILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689 (766)
Q Consensus 610 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~ 689 (766)
||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||.......
T Consensus 163 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 163 NILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp GEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred HEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 99999999999999999987665433333344678999999998875 58899999999999999999999997644322
Q ss_pred hhhHHHHHHHHhh-cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 690 YAILTDWAFDCYR-NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 690 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
. +..+...... ...+...++..+ ...+...++.+.+++.+||+.||.+|||+.+|++.|+++.
T Consensus 242 ~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 242 L--LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp B--TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred H--HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 1111111111 112222333322 2345677889999999999999999999999999998864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=347.90 Aligned_cols=249 Identities=25% Similarity=0.369 Sum_probs=207.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .++.||||.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 3455789999999999998754 5679999999877667778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (297)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc--
Confidence 9999999999765 58889999999999999999995 49999999999999999999999999999876544332
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ......+. .....
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~--------~~~~~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGT--------PELQN 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHCS--------CCCSC
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCC--------CCCCC
Confidence 24467999999999999999999999999999999999999999755432211 11111111 11112
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 33456778999999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=359.00 Aligned_cols=267 Identities=28% Similarity=0.391 Sum_probs=206.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc----eEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----RLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----~~l 554 (766)
+.+.+.||+|+||.||+|+.. ++.||||++... ......+.+|+.++++++||||+++++++.+... .++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-----NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-----TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhheecccCceEEEEEEEC-----CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 345688999999999999864 578999999653 2334556779999999999999999999987543 699
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-------CCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-------SSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
||||+++|+|.+++... .+++..++.++.|+++||+|||+.+ +.+|+||||||+|||++.++.+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999999999764 4899999999999999999999421 229999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh----------h
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA----------I 692 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~----------~ 692 (766)
+...............||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 87765444333344679999999999986 35677899999999999999999999654321110 0
Q ss_pred HHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.... ............+.. .......+.++.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 259 ~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 259 LEDM-QEVVVHKKKRPVLRD---YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHH-HHHHTTSCCCCCCCG---GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhh-hhhhhcccCCCCccc---cccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 111111111111111 11133567789999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.36 Aligned_cols=261 Identities=24% Similarity=0.346 Sum_probs=215.2
Q ss_pred cccCHHHHHHHHHhh------------hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC
Q 037189 467 RCFSYKELEEATDNF------------KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT 534 (766)
Q Consensus 467 ~~~~~~~l~~~t~~f------------~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l 534 (766)
..|+++++..++... .+.||+|+||.||+|.... .++.||||.+........+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 568889998888642 3479999999999999864 4679999999877667778899999999999
Q ss_pred CCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 535 ~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
+||||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||.|||+ .+|+||||||+||+++
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT 175 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence 999999999999999999999999999999999865 468999999999999999999995 4999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT 694 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 694 (766)
.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---- 249 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---- 249 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----
T ss_pred CCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 9999999999999876543322 1345799999999999999999999999999999999999999975443221
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+....... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 250 ---~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 ---MKRLRDSPPPK-------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp ---HHHHHHSSCCC-------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---HHHHhcCCCCC-------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111110 11122345678899999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.58 Aligned_cols=267 Identities=25% Similarity=0.409 Sum_probs=207.7
Q ss_pred HHHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 553 (766)
..+.+.++||+|+||.||+|.+.. ....++.||||++........+.|.+|++++++++||||+++++++.. ....+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 345567899999999999998642 223578999999986655556789999999999999999999999854 35689
Q ss_pred EEeeccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999997653 58899999999999999999995 4999999999999999999999999999987754
Q ss_pred CCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh---------hHHHHHHHHhh
Q 037189 633 NQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA---------ILTDWAFDCYR 702 (766)
Q Consensus 633 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~~ 702 (766)
.... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......... ...........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 3321 1123345778899999999999999999999999999999999998654322110 00011111111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
. ......+..++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus 247 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 247 N---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp T---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred c---------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 1122223456678999999999999999999999999998865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=364.03 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=199.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|++......+..||||.++... ....++|.+|+.++++++||||+++++++.+.+..++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3445678999999999999987555567789999997542 233567999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 999999999999765 468999999999999999999995 4999999999999999999999999999987654332
Q ss_pred cce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 636 KTI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 636 ~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~-------~~~i~~~~-------- 267 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-------IKAVDEGY-------- 267 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-------HHHHHTTE--------
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC--------
Confidence 211 122345778999999999999999999999999999998 9999975443221 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+..++..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 268 -~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 268 -RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp -ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111233456789999999999999999999999999988653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=352.42 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=205.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.+.. .++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4456889999999999999864 46789999997543 233467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++|+|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 999999999999888889999999999999999999995 4999999999999999999999999999987654432
Q ss_pred ceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....+||+.|+|||++.+..+. .++|||||||++|||++|+.||......+.. ..+..+..
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~i~~~~~--------- 231 (328)
T 3fe3_A 170 --LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR-------ERVLRGKY--------- 231 (328)
T ss_dssp --GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC---------
T ss_pred --cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCC---------
Confidence 2456799999999999988765 7999999999999999999999865433211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122345678899999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=361.48 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=209.4
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCc-e
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN-R 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~-~ 552 (766)
.+.+.+.||+|+||.||+|.+.. ....++.||||.++.... ...+.+.+|++++.++ +||||+++++++.+.+. .
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 34456889999999999999754 334678999999975432 2346799999999999 79999999999987654 8
Q ss_pred EEEeeccCCCchhhhhccCCC-----------------------------------------------------------
Q 037189 553 LLVYEFLNNGTLASFLFGNLK----------------------------------------------------------- 573 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 573 (766)
++||||+++|+|.+++.....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999976432
Q ss_pred -------CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccC
Q 037189 574 -------PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646 (766)
Q Consensus 574 -------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 646 (766)
+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...............||+
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~ 259 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCc
Confidence 7888899999999999999995 499999999999999999999999999998775544433334567899
Q ss_pred cccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHH
Q 037189 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEK 725 (766)
Q Consensus 647 ~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (766)
.|+|||++.+..++.++||||||+++|||++ |+.||......+. .......+.. ...+...+.+
T Consensus 260 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~ 324 (359)
T 3vhe_A 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTR---------MRAPDYTTPE 324 (359)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCC---------CCCCTTCCHH
T ss_pred eeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCC---------CCCCCCCCHH
Confidence 9999999999999999999999999999998 9999975443221 1111111111 1112234567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 726 LVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 726 l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+.+++.+||+.||.+|||+.+++++|+.+++
T Consensus 325 l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 325 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 8999999999999999999999999988653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=360.61 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=214.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCC----CceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (766)
..+.+.+.||+|+||.||+|...... .....||||+++.... ...+++.+|+++++++ +||||+++++++.+.+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 34556789999999999999975422 3457899999975432 2346789999999999 8999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
..++||||+++|+|.+++.... .+++..++.|+.||++||+|||+ .+|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 9999999999999999997543 47899999999999999999995 4999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAIL 693 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 693 (766)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---- 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999987765443333344567889999999999999999999999999999999 999997554322
Q ss_pred HHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 037189 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759 (766)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~ 759 (766)
....+..+.. ...+..++.++.+++.+||+.||++|||+.+|++.|+.+.....
T Consensus 302 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 ---LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp ---HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred ---HHHHHHcCCC---------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1112222211 11123346788999999999999999999999999998875543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.62 Aligned_cols=260 Identities=28% Similarity=0.395 Sum_probs=208.3
Q ss_pred HHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
..+.+.+.||+|+||.||+|+... ....+..||||+++.. ......++.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 345567899999999999999753 2235678999998643 2334567999999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccC-------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC---CeEEec
Q 037189 554 LVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---NARISD 623 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~D 623 (766)
+||||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 999999999999999753 347888999999999999999995 4999999999999999554 599999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+. ...+.
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~-------~~~i~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEFVT 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHH
Confidence 999986644333222244568999999999999999999999999999999998 9999976543221 11111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.+. ....+..++..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 301 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111 11112344567899999999999999999999999997765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.78 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=208.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.+....... .+.|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4566889999999999998764 46789999986543322 36789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ........ .... .
T Consensus 167 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~-----~ 233 (294)
T 4eqm_A 167 TQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPNV-----T 233 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCCH-----H
T ss_pred cc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCCc-----c
Confidence 21 1345689999999999999999999999999999999999999976543221 11111111 1100 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~Le~~~~~~~p 760 (766)
.......+..+.+++.+||+.||.+|| +++++.+.|+.+..-...
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 011223467889999999999999998 999999999987755443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=352.91 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=211.1
Q ss_pred HhhhhhccccccceEEEEEEecCC--CceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|...... ..++.||||.++.... ...+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 345678999999999999987422 3468999999975432 2346799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC------------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 556 YEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
|||+++|+|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceE
Confidence 9999999999999753 467889999999999999999995 4999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 284 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 284 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence 999999999999999987654433222244568899999999999999999999999999999999 999997544322
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+..+... ..+..++..+.+++.+||+.||++|||+.++++.|+++.+-
T Consensus 285 ------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 285 ------VIYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp ------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred ------HHHHHhCCCcC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 11122222221 11233457889999999999999999999999999997653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=365.37 Aligned_cols=256 Identities=25% Similarity=0.385 Sum_probs=207.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|.... .++.||||.++.... ...++|.+|++++++++||||+++++++.+.+..++||
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 34566899999999999999864 467899999875322 22356899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999764 468899999999999999999995 4999999999999999999999999999986543321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~~--------- 332 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-------REFVEKGG--------- 332 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH-------HHHHHTTC---------
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC---------
Confidence 111122345778999999999999999999999999999998 9999976443221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 333 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11123345678899999999999999999999999998765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=341.72 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|... .+..||||.++.. ....+++.+|++++.+++||||+++++++.+....++|||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred heeeeeeeccCCCceEEEEEec----CceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 4456688999999999999876 3567999999753 3356789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999999765 458999999999999999999995 49999999999999999999999999999876544322
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... .....+..
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~--------- 223 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-------LKVSQGHR--------- 223 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTCC---------
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-------HHHHcCCC---------
Confidence 2 134456778999999999899999999999999999999 99999754432211 11111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+.+-.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1112223567889999999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.93 Aligned_cols=257 Identities=24% Similarity=0.399 Sum_probs=202.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.+..++.. ...||+|.++.. .....++|.+|+.++++++||||++++++|.+. ..++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~ 95 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 95 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEE
Confidence 44568899999999999997643322 345789988543 234567899999999999999999999999875 478999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp ECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 99999999999976 46789999999999999999999954 999999999999999999999999999998765544
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........+|..|+|||++.+..++.++||||||+++|||++ |+.||......... ..+..+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-------~~~~~~~--------- 236 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE--------- 236 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC---------
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-------HHHHcCC---------
Confidence 333344567889999999999999999999999999999999 99999765433211 1111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11123345677899999999999999999999999997764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=341.56 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=207.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|... .+..||||++... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ceeeheecCCCccEEEEEEec----CCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 445688999999999999976 3557999999753 34567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999999654 568899999999999999999995 49999999999999999999999999999876433211
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+. ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~-------~~~~~~~~---------~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGF---------RL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTC---------CC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHHhcCc---------cC
Confidence 1133456788999999999999999999999999999999 9999976443221 11111111 11
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
..+...+..+.+++.+||+.||++|||+.+++++|+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 1122345678999999999999999999999999988754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=372.84 Aligned_cols=256 Identities=27% Similarity=0.422 Sum_probs=212.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.++||+|+||.||+|.+.. .+..||||.++.. ....++|.+|+.++++++||||++++++|.+....++|||
T Consensus 221 ~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 221 DITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34567899999999999999874 4678999999754 3456789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999999753 458899999999999999999995 4999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ......++..|+|||++.+..++.++||||||++||||++ |+.||......+. ...+..+ .
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~---------~ 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YELLEKD---------Y 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-------HHHHHTT---------C
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcC---------C
Confidence 1 1133456789999999999999999999999999999999 9999975443221 1111111 1
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+..++..+.+|+.+||+.||++|||+.+|++.|+.+..-
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 1122344567899999999999999999999999999997643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=346.54 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=205.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|||.++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 3456889999999999999864 4678999999753 344567789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999986433222
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ....+||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+..+..
T Consensus 161 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~--------- 222 (337)
T 1o6l_A 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI--------- 222 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---------
T ss_pred c--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence 1 2456799999999999999999999999999999999999999976543221 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||.+|| ++++++++
T Consensus 223 -~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223467789999999999999999 89999764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.56 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=208.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.+. .+..||||.++.. ....++|.+|+.++++++||||+++++++. .+..++|||
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 3456689999999999999986 3567999999754 345788999999999999999999999986 567899999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 99999999999754 367888999999999999999995 4999999999999999999999999999987643221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ......+|..|+|||++....++.++||||||++||||++ |+.||......+. . ..+..+.
T Consensus 340 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~---~----~~i~~~~--------- 402 (454)
T 1qcf_A 340 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---I----RALERGY--------- 402 (454)
T ss_dssp H-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---H----HHHHHTC---------
T ss_pred e-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH---H----HHHHcCC---------
Confidence 1 1123446788999999999999999999999999999999 9999975443221 1 1111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+..+++++.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1112334567899999999999999999999999999998653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.69 Aligned_cols=259 Identities=28% Similarity=0.427 Sum_probs=211.2
Q ss_pred HhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|..... ...+..||||.++... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 44568899999999999987532 2356899999997533 23346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCC------------------------CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 556 YEFLNNGTLASFLFGNLK------------------------PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
|||+++++|.+++..... +++..++.++.||++||+|||+ .+|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence 999999999999976432 7788899999999999999995 4999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987765443333334567889999999999999999999999999999999 9999976543321
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+..+.. ...+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 262 -------~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 262 -------FNLLKTGHR---------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp -------HHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHhhcCCc---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11223456788999999999999999999999999988653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=343.42 Aligned_cols=257 Identities=23% Similarity=0.361 Sum_probs=197.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|.....+..+..||||.+..... ...+.|.+|+.++++++||||+++++++. ++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEE
Confidence 45567889999999999999876555677899999875332 23467899999999999999999999984 46789999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++++|.+++... ..+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 171 (281)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCcccc
Confidence 999999999999765 368999999999999999999995 4999999999999999999999999999987654332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. .+..+..
T Consensus 172 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~----~i~~~~~-------- 235 (281)
T 1mp8_A 172 YK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IG----RIENGER-------- 235 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HH----HHHTTCC--------
T ss_pred cc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HH----HHHcCCC--------
Confidence 21 123456789999999999999999999999999999997 9999975443221 11 1111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 236 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1122345678899999999999999999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=346.49 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=204.8
Q ss_pred HHHhhhhhccccccceEEEEEEecCCC----ceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRT----STTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
..+.+.+.||+|+||.||+|....++. ....||+|.+........+.|.+|++++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 345567899999999999999875432 2367999999876666778899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCC-CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC--------eEEec
Q 037189 553 LLVYEFLNNGTLASFLFGNLK-PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN--------ARISD 623 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~D 623 (766)
++||||+++++|.+++..... +++..++.++.||++||.|||+ .+|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999987644 8899999999999999999995 49999999999999998887 99999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCC-CchhhhhhhhHHHHHHHHh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~-~~~~~~~~~~~~~~~~~~~ 701 (766)
||++...... ....+|..|+|||.+.+ ..++.++||||||+++|||++|..|+ ......... ...
T Consensus 165 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-------~~~ 231 (289)
T 4fvq_A 165 PGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-------QFY 231 (289)
T ss_dssp CCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHH
T ss_pred CcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-------HHh
Confidence 9998755322 23457899999999987 67999999999999999999965544 332221110 011
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPP 761 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp 761 (766)
.... . .+...+.++.+++.+||+.||++|||+.++++.|+.+..-..++
T Consensus 232 ~~~~-------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 232 EDRH-------Q----LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp HTTC-------C----CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred hccC-------C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 1100 0 01112456789999999999999999999999999988654433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=345.08 Aligned_cols=249 Identities=25% Similarity=0.326 Sum_probs=205.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
+.+.+.||+|+||.||++.... .+..+|||.++..... ..+.+.+|+.++.+++||||+++++++.+....
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4567889999999999999874 4678999998754322 356899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----CeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY----NARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~ 628 (766)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||+++++ .+||+|||+++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 9999999999999999888889999999999999999999995 4999999999999998777 79999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ...+..+...
T Consensus 168 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~~- 236 (361)
T 2yab_A 168 EIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVSYD- 236 (361)
T ss_dssp ECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCCC-
T ss_pred EcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcCCC-
Confidence 7654332 1346799999999999999999999999999999999999999976543221 1111111110
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.........+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -----FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000001123567889999999999999999999885
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.50 Aligned_cols=252 Identities=28% Similarity=0.409 Sum_probs=203.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.||||.+..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3456789999999999998864 467899999865332 234668999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999988889999999999999999999995 499999999999999999999999999998765444333
Q ss_pred eeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+ .... ...
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~-----~~~~--------~~~ 228 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKK--------TYL 228 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH-----HTTC--------TTS
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH-----hccc--------ccC
Confidence 3345679999999999988775 7899999999999999999999975443211 11111 1110 001
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1122345678899999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.44 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=212.4
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||+|.... ....+..||||.++.... ...+.+.+|+.++.++ +||||+++++++.+.+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 44567899999999999998743 234678999999975433 2346799999999999 9999999999999999999
Q ss_pred EEeeccCCCchhhhhccCC------------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 554 LVYEFLNNGTLASFLFGNL------------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
+||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcC
Confidence 9999999999999997543 37899999999999999999995 49999999999999999
Q ss_pred CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHH
Q 037189 616 HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILT 694 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 694 (766)
++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~- 257 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F- 257 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H-
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--H-
Confidence 99999999999988766544433345567889999999999999999999999999999999 9999975433221 1
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
......+. ....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 258 ---~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ---YKMIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ---HHHHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHhccCC---------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11111111 11112334678899999999999999999999999998765
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=351.16 Aligned_cols=262 Identities=22% Similarity=0.368 Sum_probs=194.8
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce--
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR-- 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-- 552 (766)
..+.+.+.||+|+||.||+|....++.....||||.++.. .....+.|.+|++++++++||||+++++++......
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 3455678999999999999998765444458999998754 233457899999999999999999999999877655
Q ss_pred ----EEEeeccCCCchhhhhccC------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 553 ----LLVYEFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 553 ----~lV~Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
++||||+++|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEEC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEe
Confidence 9999999999999998643 258899999999999999999995 499999999999999999999999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ...
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~ 252 (323)
T 3qup_A 180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-------NYL 252 (323)
T ss_dssp CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHH
T ss_pred eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH-------HHH
Confidence 9999987755443333334557889999999999999999999999999999999 89999764432211 111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
..+. ....+...+..+.+++.+||+.||++|||+.++++.|++++.-
T Consensus 253 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1112334567889999999999999999999999999987644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.43 Aligned_cols=254 Identities=26% Similarity=0.411 Sum_probs=205.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||++... .+..||||.++.. ....+++.+|++++.+++||||+++++++.+.+..++|||
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET----TTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 3456689999999999999876 4567999999754 3346789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 9999999999976 4668999999999999999999995 49999999999999999999999999999876433211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ..+..+. .
T Consensus 177 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~---------~ 239 (283)
T 3gen_A 177 S-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA-------EHIAQGL---------R 239 (283)
T ss_dssp S-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HHHHTTC---------C
T ss_pred c-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH-------HHHhccc---------C
Confidence 1 123456788999999999999999999999999999998 99999764432211 1111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+...++.+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11122335678899999999999999999999999987653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.11 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=210.8
Q ss_pred HHHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (766)
..+.+.+.||+|+||.||+|..... ...+..||||.+.... ....+.+.+|+.++.++ +||||+++++++...+..
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 124 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 124 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence 4455678999999999999997432 2356789999997532 23456799999999999 899999999999999999
Q ss_pred EEEeeccCCCchhhhhccCC-----------------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccc
Q 037189 553 LLVYEFLNNGTLASFLFGNL-----------------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQ 609 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 609 (766)
++||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+
T Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~ 201 (344)
T 1rjb_A 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 201 (344)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChh
Confidence 99999999999999997643 26888999999999999999995 49999999999
Q ss_pred eEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhh
Q 037189 610 NILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVE 688 (766)
Q Consensus 610 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~ 688 (766)
||+++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 281 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence 99999999999999999987765544433345567889999999999999999999999999999998 99999754322
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.. .......+ .....+...+.++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 282 ~~------~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 282 AN------FYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp HH------HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HH------HHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 21 11111111 1111223346788999999999999999999999999988654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.58 Aligned_cols=252 Identities=25% Similarity=0.333 Sum_probs=206.3
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
..+.+.+.||+|+||.||++.... .+..+|||.+...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 87 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT 87 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 446677899999999999999864 4678999998754321 3578999999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----CeEEeccCc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY----NARISDFGL 626 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgl 626 (766)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 88 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 999999999999999999888889999999999999999999995 4999999999999999887 899999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .+.....
T Consensus 165 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------~~~~~~~ 234 (326)
T 2y0a_A 165 AHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA-------NVSAVNY 234 (326)
T ss_dssp CEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH-------HHHHTCC
T ss_pred CeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH-------HHHhcCC
Confidence 9877543321 34569999999999999999999999999999999999999997654322111 1111110
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .........+..+.+++.+||+.||++|||+.++++.
T Consensus 235 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000011235678899999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=362.14 Aligned_cols=254 Identities=29% Similarity=0.443 Sum_probs=203.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.++||+|+||.||+|.+.. ...||||.++... ...++|.+|++++++++||||+++++++.+ +..++||||
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ceeeeeecCCCCeEEEEEEECC----CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 3456889999999999999863 4579999997543 346789999999999999999999999976 678999999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999753 568899999999999999999995 49999999999999999999999999999876543221
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+. .
T Consensus 337 ~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~---------~ 399 (452)
T 1fmk_A 337 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGY---------R 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTC---------C
T ss_pred c-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC---------C
Confidence 1 133457889999999999999999999999999999999 9999975443221 11111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
...+..+++.+.+++.+||+.||++|||+.++++.|+.+..-.
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1123345678999999999999999999999999999977543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=361.91 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=203.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC-ceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ-NRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~E 557 (766)
+.+.+.||+|+||.||+|... +..||||.++.. ...+.|.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred eEEEeeecCcCCeeEEEEEec-----CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 345678999999999999874 458999999753 35678999999999999999999999987765 7899999
Q ss_pred ccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 999999999998643 36889999999999999999995 499999999999999999999999999998543221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~--------- 403 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGY--------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH-------HHHHHTTC---------
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC---------
Confidence 22357889999999999999999999999999999998 9999975443221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1122344677899999999999999999999999999987644
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=339.84 Aligned_cols=250 Identities=29% Similarity=0.488 Sum_probs=195.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|+.. ++.||||++.. ....+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-----AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-----TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred eeeeeEeecCCCceEEEEEEC-----CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 345678999999999999874 46799999864 3345789999999999999999999999874 58999999
Q ss_pred cCCCchhhhhccCCC---CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC-eEEeccCcccccccCC
Q 037189 559 LNNGTLASFLFGNLK---PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN-ARISDFGLAKLLTLNQ 634 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~---l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~ 634 (766)
+++++|.+++..... +++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 999999999987643 567888999999999999999643368999999999999998887 7999999997654321
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .. ....+...
T Consensus 161 -----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~-~~~~~~~~------- 223 (307)
T 2eva_A 161 -----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI----MW-AVHNGTRP------- 223 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH----HH-HHHTTCCC-------
T ss_pred -----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH----HH-HHhcCCCC-------
Confidence 33468999999999999999999999999999999999999997533221111 11 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
......+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 224 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 --PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122345678899999999999999999999999988653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.89 Aligned_cols=250 Identities=28% Similarity=0.522 Sum_probs=200.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCH-------HHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-------REFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~-------~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
+.+.+.||+|+||.||+|.... .++.||||.+........ +.+.+|++++++++||||+++++++.+..
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred ceehhccccCCceeEEEEEEcC---CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 4566889999999999999864 467899999865332221 67899999999999999999999987654
Q ss_pred eEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCc--eecCCCccceEEEcCCCC-----eEEec
Q 037189 552 RLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQ--IIHCDMKPQNILLDDHYN-----ARISD 623 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~D 623 (766)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999999888654 5689999999999999999999954 6 999999999999988776 99999
Q ss_pred cCcccccccCCCcceeecccccCccccccccc--CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR--NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
||+++..... .....||+.|+|||.+. ...++.++||||||+++|||++|+.||............ ...
T Consensus 173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MIR 243 (287)
T ss_dssp CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HHH
T ss_pred CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HHh
Confidence 9999754332 24467899999999984 456789999999999999999999999754432211111 111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
..+ .....+..++.++.+++.+||+.||.+|||+.++++.|+++
T Consensus 244 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 11122334567899999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=347.83 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=204.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.+..++.. ...||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 34567899999999999998654322 3458888875432 333457889999999999999999999986 46789999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp ECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999765 5789999999999999999999954 999999999999999999999999999998765544
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+..
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~-------- 235 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP-------DLLEKGER-------- 235 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-------HHHHTTCB--------
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH-------HHHHcCCC--------
Confidence 433355668889999999999999999999999999999999 99999765432211 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 236 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 -LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112223456788999999999999999999999998765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=338.21 Aligned_cols=261 Identities=17% Similarity=0.200 Sum_probs=207.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.||||.+... ...+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4456789999999999999754 5679999998643 2345688999999999 79999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC-----eEEeccCcccccc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN-----ARISDFGLAKLLT 631 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~ 631 (766)
|+ +++|.+++... ..+++..+..++.||++||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999864 45899999999999999999999 459999999999999987766 9999999998776
Q ss_pred cCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 632 LNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 632 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 543221 123457999999999999999999999999999999999999999764322111111111111111111
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
..+ ...+++.+.+++.+||+.||++|||+.+|++.|+++.+-
T Consensus 243 ~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 243 REL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 000 112457889999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.39 Aligned_cols=268 Identities=19% Similarity=0.231 Sum_probs=209.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC--ceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4456889999999999999874 46799999997543 344677899999999999999999999997765 77999
Q ss_pred eeccCCCchhhhhccCC---CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE----cCCCCeEEeccCccc
Q 037189 556 YEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAK 628 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 628 (766)
|||+++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997653 38999999999999999999995 499999999999999 788889999999998
Q ss_pred ccccCCCcceeecccccCccccccccc--------CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh-hhhHHHHHHH
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFR--------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-YAILTDWAFD 699 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~ 699 (766)
........ ....||+.|+|||++. +..++.++||||||+++|||++|+.||....... .......+..
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 76554322 3456899999999986 5788999999999999999999999996433211 1111111111
Q ss_pred HhhcCccceec-----------cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 700 CYRNGKLDALV-----------GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 700 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.........+. .-.............+.+++.+||+.||++|||++|+++...+..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 11111111110 001112335677888999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=353.34 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=205.8
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+.+.+.||+|+||.||++.... .+..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3445667899999999999998764 46789999986533 223457899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLL 630 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~ 630 (766)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++..
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999999988889999999999999999999995 4999999999999998 4678999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ...+..+....
T Consensus 164 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~-- 232 (444)
T 3soa_A 164 EGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-------YQQIKAGAYDF-- 232 (444)
T ss_dssp CTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCCCC--
T ss_pred cCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhCCCCC--
Confidence 543322 1346799999999999999999999999999999999999999976543221 11122222110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+.++.+++.+||+.||.+|||+.|+++.
T Consensus 233 ----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 ----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001112345778899999999999999999999874
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.96 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=206.4
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+.+.+.||+|+||.||++.... .+..+|||.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4456677899999999999999864 467899999975432 23457899999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEeccCccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISDFGLAKLL 630 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~ 630 (766)
+||||+++|+|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.+ +.+||+|||++...
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 999999999999999888889999999999999999999995 499999999999999865 45999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+....
T Consensus 182 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------~~~i~~~~~~~-- 249 (362)
T 2bdw_A 182 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAYDY-- 249 (362)
T ss_dssp TTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCC--
T ss_pred cCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCCC--
Confidence 54322 1346799999999999999999999999999999999999999976443221 11112221110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+.++.+++.+||+.||++|||+.+++++
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000112345778999999999999999999998864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=342.23 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=198.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc----
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN---- 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 551 (766)
.+.+.+.||+|+||.||+|........+..||||.++... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 114 (313)
T 3brb_A 35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP 114 (313)
T ss_dssp GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence 3455678999999999999988766667899999987542 2234679999999999999999999999977653
Q ss_pred -eEEEeeccCCCchhhhhc------cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEecc
Q 037189 552 -RLLVYEFLNNGTLASFLF------GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 552 -~~lV~Ey~~~gsL~~~l~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
.++||||+++++|.+++. ....+++..++.++.||++||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeec
Confidence 499999999999999984 3356889999999999999999999 459999999999999999999999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
|+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... . ....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~----~~~~ 264 (313)
T 3brb_A 192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D----YLLH 264 (313)
T ss_dssp SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H----HHHT
T ss_pred CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H----HHHc
Confidence 99987654433222234557889999999999999999999999999999999 88888754432211 1 1111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+. ....+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 265 ~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 265 GH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 11122345678899999999999999999999999998865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=333.93 Aligned_cols=251 Identities=31% Similarity=0.435 Sum_probs=193.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc----cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ----DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+|... +..+|||.++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred eeeeeeeccCCCeEEEEEEEc-----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 445678999999999999864 56899999865322 234678999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--------CCCeEEeccCc
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD--------HYNARISDFGL 626 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--------~~~~kl~Dfgl 626 (766)
||||+++++|.+++.. ..+++..++.++.|+++||+|||+....+|+||||||+||+++. ++.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999864 46889999999999999999999752233999999999999986 77899999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
+........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 163 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~--- 229 (271)
T 3dtc_A 163 AREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV------AYGVAMN--- 229 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH------HHHHHTS---
T ss_pred ccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHhhhcC---
Confidence 986554322 234689999999999999999999999999999999999999975443221 1111111
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
......+..++..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 230 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 ------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111112334567889999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.32 Aligned_cols=257 Identities=26% Similarity=0.478 Sum_probs=196.7
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeec-CCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 557 (766)
.+.+.||+|+||.||+|.+.........+|||.++... ....++|.+|+.++++++||||++++++|.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 35578999999999999987655556789999986533 2345789999999999999999999999755 457899999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999765 457889999999999999999995 49999999999999999999999999999876543221
Q ss_pred c--eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 637 T--IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 637 ~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
. ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......+. .. ....+.
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~----~~~~~~-------- 313 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLLQGR-------- 313 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH----HHHTTC--------
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH----HHHcCC--------
Confidence 1 1133457889999999999999999999999999999999 6777754432221 11 111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 314 -~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 314 -RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112335678899999999999999999999999998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=341.95 Aligned_cols=249 Identities=20% Similarity=0.300 Sum_probs=203.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||++.... .+..+|+|.+... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4456889999999999999864 4678999998743 33456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--CCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD--HYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999765 478999999999999999999995 49999999999999987 78999999999988764432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+.... .
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~------~ 223 (321)
T 1tki_A 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYTF------D 223 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCCC------C
T ss_pred ---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH-------HHHHHcCCCCC------C
Confidence 2345689999999999998899999999999999999999999976543221 11111111100 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011235678999999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.61 Aligned_cols=243 Identities=26% Similarity=0.324 Sum_probs=204.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+++... .++.+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4456889999999999999864 4679999998753 234456788999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999999998888999999999999999999999 559999999999999999999999999999875432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...+..+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~~~--------- 220 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAEL--------- 220 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCC---------
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC---------
Confidence 1346799999999999999999999999999999999999999976543221 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+|| +++++++
T Consensus 221 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11223456788999999999999999 8888884
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=337.88 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=205.3
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce-EEEeecc
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR-LLVYEFL 559 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV~Ey~ 559 (766)
.+.||+|+||.||+|.+..+......+|+|.+..... ...+.|.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4789999999999999876666677899999875333 3346789999999999999999999999876665 9999999
Q ss_pred CCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc--
Q 037189 560 NNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-- 636 (766)
Q Consensus 560 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 636 (766)
.+++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (298)
T 3pls_A 106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182 (298)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence 99999999987 45688999999999999999999954 9999999999999999999999999999866443211
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCC-CchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF-DIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.......+|..|+|||.+.+..++.++||||||+++|||++|+.|+ ......+ ... ....+. .
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~----~~~~~~---------~ 246 (298)
T 3pls_A 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTH----FLAQGR---------R 246 (298)
T ss_dssp CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHH----HHHTTC---------C
T ss_pred ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHH----HhhcCC---------C
Confidence 1123456789999999999999999999999999999999966554 3322221 111 111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 247 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11123345678999999999999999999999999988653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=343.71 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=183.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||++.... .++.||||.+.. .....+.+|+.++.++. ||||+++++++.+....++||||+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK---SNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETT---TCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence 579999999999999864 467999999864 34567889999999997 99999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC---CeEEeccCcccccccCCCcce
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---NARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~ 638 (766)
|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++........
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 9999999988889999999999999999999995 4999999999999997665 7999999999866543221
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..+.... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 1345689999999999999999999999999999999999999976443211111111222222222110 0000
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+.++.+++.+||+.||.+|||+.++++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12346788999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=348.90 Aligned_cols=247 Identities=25% Similarity=0.354 Sum_probs=201.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||+|+... .++.+|||.++.. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 45567899999999999999874 4678999999753 234456788999999987 7999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 999999999999999888889999999999999999999995 49999999999999999999999999999864332
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 178 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~------- 241 (353)
T 3txo_A 178 GV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDEV------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-------
T ss_pred Cc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC-------
Confidence 21 12456799999999999999999999999999999999999999976554321 111111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTI------KKVLQ 749 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~~vl~ 749 (766)
..+...+..+.+++.+||+.||.+||++ .++++
T Consensus 242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122345678899999999999999998 66764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=361.96 Aligned_cols=251 Identities=20% Similarity=0.248 Sum_probs=201.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.++||+|+||.||+|+... .++.+|||+++... ......+.+|+.++.+++||||+++++++.+.+..+||||
T Consensus 78 ~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 78 ILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp EEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 34689999999999999874 46789999996522 2233458999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 155 y~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 9999999999987 5678999999999999999999995 59999999999999999999999999999876544332
Q ss_pred ceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 637 TIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
. ....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+..... .. .+
T Consensus 232 ~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~~--~~-~~-- 302 (437)
T 4aw2_A 232 Q-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKE--RF-QF-- 302 (437)
T ss_dssp E-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHH--HC-CC--
T ss_pred c-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhccc--cc-cC--
Confidence 2 23467999999999997 5678999999999999999999999997654332111 1100000 00 00
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~ 750 (766)
+ ......+.++.+|+.+||+.+|++ ||+++|++++
T Consensus 303 p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 P----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp C----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred C----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 001124567889999999888888 9999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=339.39 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=198.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc--CCCCCeeeEeeeeec----CCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDE----GQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~----~~~ 551 (766)
.+.+.+.||+|+||.||+|... ++.||||++.. .....+.+|.+++.. ++||||+++++++.. ...
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSWQ-----GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEET-----TEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cEEEEEeeccCCCcEEEEEEEC-----CEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 3456689999999999999873 56899999864 234566666666655 899999999998754 345
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
.++||||+++|+|.+++.. ..+++..++.++.|+++||+|||... +.+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 7899999999999999954 46899999999999999999999321 45999999999999999999999999999
Q ss_pred ccccccCCCcce--eecccccCcccccccccCC------CCCcccCeeehhHHHHHHHhC----------CcCCCchhhh
Q 037189 627 AKLLTLNQSKTI--KTSIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIIAC----------RKSFDIEMVE 688 (766)
Q Consensus 627 a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~------~~s~~sDV~s~Gvvl~elltg----------~~p~~~~~~~ 688 (766)
++.......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 987654433211 1234799999999999876 556799999999999999999 7777543221
Q ss_pred hhhhHHHHHHHHhhc-CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 689 EYAILTDWAFDCYRN-GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
... ... ....... .....+ .........+..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 240 ~~~-~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DPS-FED-MRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCC-HHH-HHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-hhh-hhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 110 001 1111111 111111 01112345778999999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.61 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=211.2
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.+.||+|+||.||+|.... .+..+|||.+... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3445566889999999999999874 4678999998753 33457899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999753 4588999999999999999999965 9999999999999999999999999999876644
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......... . .....
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---~----~~~~~-------- 228 (288)
T 3kfa_A 165 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---E----LLEKD-------- 228 (288)
T ss_dssp SSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H----HHHTT--------
T ss_pred ccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHhcc--------
Confidence 322 2234557889999999999999999999999999999999 99998754433211 1 11111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.....+...++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 229 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 111223345678999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.76 Aligned_cols=258 Identities=18% Similarity=0.189 Sum_probs=204.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEeeccCCceEEEEEECC---CCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 3456789999999999999754 56799999987532 345689999999999 99999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC-----eEEeccCcccccc
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN-----ARISDFGLAKLLT 631 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~ 631 (766)
|+ +++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 9999999976 4678999999999999999999995 49999999999999998887 9999999999765
Q ss_pred cCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 632 LNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 632 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 433221 113467999999999999999999999999999999999999999764332211111111111000000
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..+ ....+ ++.+++.+||+.||.+||++.+|++.|+++.
T Consensus 242 ~~~---------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 242 EVL---------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HHH---------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHH---------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 01123 8899999999999999999999999997654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=334.99 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=205.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|...........||||.+.... ....+.|.+|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 445678999999999999987665567789999987542 2345679999999999999999999999865 45689999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..+..++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999754 458899999999999999999995 49999999999999999999999999999876543322
Q ss_pred ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......... . ....+..
T Consensus 170 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~----~~~~~~~--------- 232 (281)
T 3cc6_A 170 K-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---G----VLEKGDR--------- 232 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---H----HHHHTCC---------
T ss_pred c-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---H----HHhcCCC---------
Confidence 1 133457889999999998999999999999999999998 99999654332211 1 1111110
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+..+++.+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11122345778999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.68 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=198.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+|+... .++.+|||.++... ....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4556889999999999999874 46789999997543 22335688999999886 89999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999888889999999999999999999995 499999999999999999999999999998633222
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh--hhhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..............+..
T Consensus 208 ~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 208 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp C--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 1 1245679999999999999999999999999999999999999996432211 01111112222222211
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTI 744 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~ 744 (766)
..+...+.++.+|+.+||+.||.+||++
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1123356778899999999999999995
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.03 Aligned_cols=262 Identities=27% Similarity=0.417 Sum_probs=210.9
Q ss_pred HHHhhhhhccccccceEEEEEEecC----CCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~----~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (766)
..+.+.+.||+|+||.||+|..... ...+..||||.++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 4455678999999999999997532 13467899999975432 2346789999999999 8999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
..++||||+++|+|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||+++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 9999999999999999997643 37888899999999999999995 4999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAIL 693 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 693 (766)
.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+.
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--- 268 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--- 268 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH---
Confidence 999999999999987765443332234567889999999998899999999999999999999 9999975543221
Q ss_pred HHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 694 TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
...+..+.. ...+..++..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 269 ----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 269 ----FKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111 111233457789999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=344.79 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=204.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|+|.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 4566889999999999999864 4678999998643 234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 9999999999999988889999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+... .....
T Consensus 171 ---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~----~~~~~------- 236 (384)
T 4fr4_A 171 ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT----FETTV------- 236 (384)
T ss_dssp ---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH----HHHCC-------
T ss_pred ---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH----Hhhcc-------
Confidence 245679999999999974 4589999999999999999999999975443222111111 11111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPT-IKKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-~~~vl~ 749 (766)
...+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 237 ---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1112334678899999999999999998 777764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=332.65 Aligned_cols=250 Identities=22% Similarity=0.343 Sum_probs=201.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (766)
+.+.+.||+|+||.||+|+.. +..+|||.+.... ....+.|.+|+.++++++||||+++++++.+. ...++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred hHHHHHhcCCCcceEEEEEEC-----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 446688999999999999974 5679999987543 23346799999999999999999999999887 78899
Q ss_pred EeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 555 VYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||||+++|+|.+++.... .+++..++.++.|+++||+|||+. ...|+||||||+||+++.++.++|+|||+......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999998765 479999999999999999999954 22299999999999999999999999988764322
Q ss_pred CCCcceeecccccCcccccccccCCCCCc---ccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITA---KVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
....+|+.|+|||.+.+...+. ++||||||+++|||++|+.||........ .......+
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~----- 227 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALEG----- 227 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHSC-----
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhcC-----
Confidence 2346899999999998765544 89999999999999999999975443221 11111111
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.....+...+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 ----LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 1111233456778999999999999999999999999988653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.22 Aligned_cols=247 Identities=22% Similarity=0.346 Sum_probs=194.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--------------------------cCHHHHHHHHHHHc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--------------------------DGEREFKNEVFVIG 532 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--------------------------~~~~~f~~E~~~l~ 532 (766)
+.+.+.||+|+||.||+|.... .++.||||.+..... ...+.+.+|+++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred eEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4456889999999999998764 467899999864321 12356899999999
Q ss_pred cCCCCCeeeEeeeeec--CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccce
Q 037189 533 QTHHKNLVRLLGFCDE--GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQN 610 (766)
Q Consensus 533 ~l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~N 610 (766)
+++||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||+|||+. +|+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 9999999999999986 567899999999999998764 34689999999999999999999954 99999999999
Q ss_pred EEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCC---CCcccCeeehhHHHHHHHhCCcCCCchhh
Q 037189 611 ILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIIACRKSFDIEMV 687 (766)
Q Consensus 611 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~s~Gvvl~elltg~~p~~~~~~ 687 (766)
||++.++.+||+|||+++........ .....||+.|+|||.+.+.. .+.++||||||+++|||++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999876543321 23457999999999998765 47889999999999999999999975443
Q ss_pred hhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 688 EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
... .......... .......++.+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~-------~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCL-------HSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHH-------HHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHH-------HHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 221 1111111111 1111234567899999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.74 Aligned_cols=257 Identities=25% Similarity=0.454 Sum_probs=200.6
Q ss_pred hhhhhccccccceEEEEEEecCC-CceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTR-TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~-~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||+|.....+ .....||||.++.... .....|.+|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34578999999999999987532 2356799999975432 234578999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++++|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999764 6789999999999999999999954 9999999999999999999999999999876543322
Q ss_pred ce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 637 TI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 637 ~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~~--------- 267 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------MKAINDGF--------- 267 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTC---------
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHHCCC---------
Confidence 11 122346788999999999999999999999999999999 9999965433221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+..++..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112345677899999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.06 Aligned_cols=267 Identities=24% Similarity=0.353 Sum_probs=212.2
Q ss_pred HHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee--cCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 554 (766)
.+.+.+.||+|+||.||++.+.. ....+..||||++........+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 34567899999999999998642 22357899999998765555677999999999999999999999886 4556889
Q ss_pred EeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999976 3568999999999999999999995 49999999999999999999999999999877544
Q ss_pred CCcc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh--------HHHHHHHHhhcC
Q 037189 634 QSKT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI--------LTDWAFDCYRNG 704 (766)
Q Consensus 634 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~--------~~~~~~~~~~~~ 704 (766)
.... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||.......... ..........
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 258 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE-- 258 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH--
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh--
Confidence 3322 1233557888999999999999999999999999999999999986543321110 0011111111
Q ss_pred ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 705 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.......+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 259 -------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 259 -------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp -------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred -------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112222344567789999999999999999999999999988754
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=342.59 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=201.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCc-eeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTS-TTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~-~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|....++.. ...||+|.+... .....+++.+|+.++++++||||+++++++.... .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 44568899999999999998654322 245788888543 3445678999999999999999999999998754 88999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 96 ~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp CCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999999976 4568899999999999999999995 4999999999999999999999999999987755443
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+.. .....+.
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-------~~~~~~~--------- 236 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE--------- 236 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-------HHHHTTC---------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHcCC---------
Confidence 333344557889999999999999999999999999999999 99999765443311 1111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111233356678999999999999999999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.37 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=202.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4456889999999999999864 4678999998643 223346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+ +|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||++........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9999 789999998888899999999999999999999965 999999999999999999999999999987654432
Q ss_pred cceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ...+||+.|+|||.+.+..+ ++++||||||+++|+|++|+.||........ ...+....
T Consensus 164 ~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~~- 224 (336)
T 3h4j_B 164 L---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSCV- 224 (336)
T ss_dssp T---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSSC-
T ss_pred c---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcCC-
Confidence 2 34579999999999988876 7899999999999999999999975432210 01111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 225 -~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 -YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11233356778899999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=335.24 Aligned_cols=252 Identities=31% Similarity=0.475 Sum_probs=205.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|... .+..||||.+... ....+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred hhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 4456688999999999999875 3567999998754 3456789999999999999999999999864 56899999
Q ss_pred ccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++++|.+++.... .+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 999999999997643 68899999999999999999995 4999999999999999999999999999987654332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.
T Consensus 165 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~~~--------- 227 (279)
T 1qpc_A 165 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQNLERGY--------- 227 (279)
T ss_dssp EC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTC---------
T ss_pred cc-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-------HHHHhccc---------
Confidence 11 133456789999999998899999999999999999999 8999875433221 11111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
....+...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 11112334678899999999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=345.92 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=205.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .++.+|+|.+..........+.+|+.++++++||||+++++++.+....++||||
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCEEEEEEEECC---CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4566889999999999999864 4678999998765544566899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--CCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD--HYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999765 468999999999999999999995 49999999999999974 47799999999987754432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. + . .+...... ..
T Consensus 207 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~-~----~i~~~~~~------~~ 270 (387)
T 1kob_A 207 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--L-Q----NVKRCDWE------FD 270 (387)
T ss_dssp E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--H-H----HHHHCCCC------CC
T ss_pred e---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--H-H----HHHhCCCC------CC
Confidence 2 345699999999999999999999999999999999999999976543221 1 1 11111110 01
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+.++.+++.+||+.||++|||+.++++.
T Consensus 271 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11122346778999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.90 Aligned_cols=268 Identities=25% Similarity=0.380 Sum_probs=209.3
Q ss_pred HHHHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC--Cc
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QN 551 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 551 (766)
...+.+.+.||+|+||.||+|.+.. ....++.||||.+.... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3345667899999999999998532 22357899999997433 34457899999999999999999999999876 66
Q ss_pred eEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 552 RLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 8999999999999999954 4678999999999999999999995 49999999999999999999999999999877
Q ss_pred ccCCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh--------hhHHHHHHHHh
Q 037189 631 TLNQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--------AILTDWAFDCY 701 (766)
Q Consensus 631 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~ 701 (766)
...... .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+........ ...........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 654332 222345688889999999999999999999999999999999998653321100 00011111111
Q ss_pred hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..+ .....+..+++.+.+++.+||+.||.+|||+.++++.|+.++
T Consensus 257 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEG---------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcc---------CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 111223445678999999999999999999999999998865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=370.81 Aligned_cols=251 Identities=29% Similarity=0.401 Sum_probs=203.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
++||+|+||.||+|.+... ..++.||||+++.... ...++|.+|++++.+++||||++++++|.. +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECS-SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCC-CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999977543 2568899999975432 335789999999999999999999999964 56889999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc-cee
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIK 639 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~ 639 (766)
+|+|.+++.....+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...... ...
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 99999999988889999999999999999999995 49999999999999999999999999999877544322 112
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....+|..|+|||++.+..++.++||||||++||||++ |+.||......+. ...+..+.. ...
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~~---------~~~ 593 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER---------MGC 593 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC---------CCC
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCCC---------CCC
Confidence 33456789999999999999999999999999999998 9999976543321 112222211 112
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
+..++.++.+++.+||+.||++|||+.+|++.|+++
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 334567899999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.37 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=205.1
Q ss_pred hhhh-hccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 480 NFKE-EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 480 ~f~~-~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+ .||+|+||.||+|..... ..++.||||.++..... ..++|.+|++++++++||||+++++++ +.+..++||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhccCccccccCeeeEeeeecCC-CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 3445 899999999999976532 25788999999754322 256799999999999999999999999 567789999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 97 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999999999988889999999999999999999995 49999999999999999999999999999877544332
Q ss_pred ce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 637 TI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 637 ~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~~~~~~-------- 238 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-------TAMLEKGER-------- 238 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHHHHTTCC--------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 11 123446789999999998899999999999999999999 9999976543221 111122111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..++..+.+++.+||+.||.+||++.++++.|+++.
T Consensus 239 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1122345678999999999999999999999999998865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=351.00 Aligned_cols=245 Identities=26% Similarity=0.403 Sum_probs=204.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.+.. .++.||||.+.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4456889999999999999864 46789999996532 23456789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999999998888999999999999999999999 45999999999999999999999999999987654332
Q ss_pred cceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....+||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ...+..+..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~-------- 233 (476)
T 2y94_A 172 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------FKKICDGIF-------- 233 (476)
T ss_dssp ---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------HHHHHTTCC--------
T ss_pred ---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCCc--------
Confidence 234579999999999998765 7899999999999999999999976543221 111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+|||+.++++
T Consensus 234 --~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 234 --YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 012223567889999999999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=332.26 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=199.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|.... .++.||||+++..... ....+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 3456789999999999999864 4678999999754322 2467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||++++.+..+......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 999875555555556789999999999999999999995 49999999999999999999999999999876533221
Q ss_pred ceeecccccCcccccccccCCC-CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc------cee
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL------DAL 709 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 709 (766)
.....||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+........ ....+......... ...
T Consensus 158 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 158 --YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp --CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred --ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence 23456899999999998765 79999999999999999998888643222111 11111111111000 000
Q ss_pred cc---------CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 710 VG---------GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+ ...........+.++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000011122356778899999999999999999999873
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=341.63 Aligned_cols=268 Identities=15% Similarity=0.148 Sum_probs=202.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-----------CHHHHHHHHHHHccCCCCCeeeEeeee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-----------GEREFKNEVFVIGQTHHKNLVRLLGFC 546 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (766)
.+.+.+.||+|+||.||+|.....+..+..+|||........ ....+.+|+..+..++||||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred eEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 355678999999999999999765556788999998754321 123467888899999999999999999
Q ss_pred ec----CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC--CeE
Q 037189 547 DE----GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY--NAR 620 (766)
Q Consensus 547 ~~----~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~--~~k 620 (766)
.. ....++||||+ +++|.+++.....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEE
Confidence 77 67889999999 99999999887789999999999999999999995 4999999999999999887 999
Q ss_pred EeccCcccccccCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHH
Q 037189 621 ISDFGLAKLLTLNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTD 695 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 695 (766)
|+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~-- 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ-- 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH--
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH--
Confidence 99999998765432111 11345689999999999999999999999999999999999999965322211111
Q ss_pred HHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.............+ ... ......+.++.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 272 ~~~~~~~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 272 TAKTNLLDELPQSV-LKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHTTTHHH-HHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHhhcccccHHH-Hhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111100000 000 001134568999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.87 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=203.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+|+... .++.||||.++... ......+..|..++.++ +||||+++++++.+.+..++
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 4456889999999999999864 46789999997532 34556788899999876 89999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999999887889999999999999999999995 499999999999999999999999999998654322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 173 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~-------- 235 (345)
T 1xjd_A 173 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMDNP-------- 235 (345)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC--------
T ss_pred Cc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHhCCC--------
Confidence 21 2456799999999999999999999999999999999999999976543221 111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIK-KVL 748 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl 748 (766)
..+...+.++.+++.+||+.||.+||++. +++
T Consensus 236 --~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 236 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11223457788999999999999999997 665
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=344.74 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=203.2
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-----ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
....+.+.+.||+|+||.||+|.... .++.||||.++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34556777899999999999998864 46789999986422 22467899999999999999999999999999
Q ss_pred CceEEEeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEe
Q 037189 550 QNRLLVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARIS 622 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~ 622 (766)
+..++||||+++++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++. +||+
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEe
Confidence 9999999999999999887542 357889999999999999999995 49999999999999986655 9999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.
T Consensus 176 Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~i~ 245 (351)
T 3c0i_A 176 GFGVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL--------FEGII 245 (351)
T ss_dssp CCTTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHH--------HHHHH
T ss_pred cCcceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHH--------HHHHH
Confidence 99999877543321 234579999999999999999999999999999999999999997643211 11111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+..... .. .....+.++.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~--~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 246 KGKYKMN--PR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HTCCCCC--HH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCCCCCC--cc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111000 00 00123567899999999999999999999985
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=337.64 Aligned_cols=259 Identities=26% Similarity=0.473 Sum_probs=201.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeee-cCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCD-EGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~-~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|...........+|||.+..... ...+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 3456789999999999999876555567899999875332 33467999999999999999999999864 456789999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++++|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 107 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp ECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred eCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 999999999999764 567899999999999999999995 4999999999999999999999999999987654332
Q ss_pred c--ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 636 K--TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 636 ~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ +.+|+......+. .. ....+.
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~----~~~~~~------- 249 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLLQGR------- 249 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH----HHHTTC-------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH----HHhcCC-------
Confidence 1 11234567889999999999999999999999999999999 5555544332221 11 111111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus 250 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 250 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111122345678999999999999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.25 Aligned_cols=251 Identities=22% Similarity=0.246 Sum_probs=196.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||++........++.+|||.++... ......+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 4556789999999999999986544567899999987532 223456889999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999999999998877889999999999999999999954 9999999999999999999999999999864432
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .. +.....
T Consensus 175 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~-i~~~~~------- 238 (327)
T 3a62_A 175 GT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DK-ILKCKL------- 238 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HHHTCC-------
T ss_pred Cc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhCCC-------
Confidence 21 123467999999999999999999999999999999999999999765432211 11 111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||.+|| ++.+++++
T Consensus 239 ---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 ---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 11223457789999999999999999 77788753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.25 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=206.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.... .+..+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45566889999999999999864 467899999987766778899999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 99999999999888889999999999999999999995 499999999999999 788999999999998765443
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+. ...+..+..... .
T Consensus 164 ~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~~---~- 228 (277)
T 3f3z_A 164 MM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGTFTFP---E- 228 (277)
T ss_dssp CB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCCC---H-
T ss_pred ch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCCCCCC---c-
Confidence 22 345689999999998764 89999999999999999999999976543221 111111111100 0
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 229 --~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 --KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000123577899999999999999999999985
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.68 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=209.4
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeeccccc-CHHHHHHHHHHHccC-CCCCeeeEeeeeecCC-ce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ-NR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~ 552 (766)
.+.+.+.||+|+||.||+|.... ....++.||||.++..... ..+.+.+|+.++.++ +||||+++++++...+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 34556889999999999998754 2345789999999754322 345789999999999 7999999999987755 58
Q ss_pred EEEeeccCCCchhhhhccCCC----------------CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC
Q 037189 553 LLVYEFLNNGTLASFLFGNLK----------------PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH 616 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~----------------l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 616 (766)
++||||+++++|.+++..... +++..++.++.|+++||.|||+ .+|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCC
Confidence 999999999999999976543 7888999999999999999995 499999999999999999
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTD 695 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 695 (766)
+.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----- 259 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----- 259 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-----
T ss_pred CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-----
Confidence 9999999999987765444333344567899999999999999999999999999999998 9999965432221
Q ss_pred HHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.......+.. ...+...+.++.+++.+||+.||.+|||+.++++.|+.+++
T Consensus 260 -~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 -FCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp -HHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111111 11122345678999999999999999999999999988653
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=348.02 Aligned_cols=269 Identities=14% Similarity=0.170 Sum_probs=203.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCC--ceeEEEEEEeecccccC-----------HHHHHHHHHHHccCCCCCeeeEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRT--STTAVAVKKLDIVFQDG-----------EREFKNEVFVIGQTHHKNLVRLLG 544 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~--~~~~vavK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~l~g 544 (766)
.+.+.+.||+|+||.||+|.+..+.. .++.||||.+....... ...+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45567899999999999999875321 24789999986543211 122445666778889999999999
Q ss_pred eeecC----CceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCC
Q 037189 545 FCDEG----QNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHY 617 (766)
Q Consensus 545 ~~~~~----~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~ 617 (766)
++.+. ...+|||||+ +++|.+++... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCC
Confidence 98765 4479999999 99999999765 678999999999999999999995 4999999999999999 889
Q ss_pred CeEEeccCcccccccCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh
Q 037189 618 NARISDFGLAKLLTLNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692 (766)
Q Consensus 618 ~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~ 692 (766)
.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~- 270 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY- 270 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH-
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH-
Confidence 99999999998765432211 112345999999999999999999999999999999999999999854332211
Q ss_pred HHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.......... .+..+++..+. ...++.++.+++..||+.+|.+||++.+|++.|+.+++
T Consensus 271 -~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 271 -VRDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp -HHHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111111 11122221111 12235778999999999999999999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=340.96 Aligned_cols=244 Identities=24% Similarity=0.240 Sum_probs=205.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+++... .++.+|||.+... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4456789999999999999864 4679999998643 234457789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~- 195 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence 9999999999999887789999999999999999999995 499999999999999999999999999998764331
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
...+||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ...+..+..
T Consensus 196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~~~--------- 255 (350)
T 1rdq_E 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSGKV--------- 255 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---------
T ss_pred ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence 345799999999999999999999999999999999999999976543221 111112211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||.+||+ +++++++
T Consensus 256 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112234677899999999999999998 8888753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=343.73 Aligned_cols=246 Identities=25% Similarity=0.311 Sum_probs=197.2
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
.+.||+|+||.||+|.... .+..||||.++.......++|.+|++++.+++||||+++++++.+.+..+|||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA---TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcC---CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 3579999999999998864 4678999999865555667899999999999999999999999999999999999999
Q ss_pred CchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE--cCCCCeEEeccCcccccccCCCcce
Q 037189 562 GTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL--DDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 562 gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
++|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++........
T Consensus 171 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~-- 245 (373)
T 2x4f_A 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL-- 245 (373)
T ss_dssp CEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence 9999988654 468899999999999999999995 499999999999999 56788999999999877544322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +. .... .... .....
T Consensus 246 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~----~i~~-~~~~------~~~~~ 311 (373)
T 2x4f_A 246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN----NILA-CRWD------LEDEE 311 (373)
T ss_dssp -CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHH-TCCC------SCSGG
T ss_pred -ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHh-ccCC------CChhh
Confidence 335699999999999999999999999999999999999999976543221 11 1111 1100 00001
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
....++++.+++.+||+.||.+|||+.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1234578899999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=339.16 Aligned_cols=260 Identities=27% Similarity=0.454 Sum_probs=209.4
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||+|.... ....++.||||.+..... .....|.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 34566899999999999998763 123467899999875332 234568999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEecc
Q 037189 555 VYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
||||+++|+|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcC
Confidence 99999999999998642 346888999999999999999995 49999999999999999999999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
|+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~~~~ 255 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------LRFVME 255 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-------HHHHHT
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH-------HHHHHc
Confidence 99987654433222233457889999999999999999999999999999999 8899875433221 111122
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+... ..+...+..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 256 ~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 GGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2111 1123356778999999999999999999999999988644
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=332.09 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=207.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||++... .+..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred eeeeeEecCCCceeEEEEEec----CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 445678999999999999986 35679999997543 3457899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 160 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 160 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccc-
Confidence 9999999999765 568899999999999999999995 49999999999999999999999999999876432111
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+. ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~i~~~~---------~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGF---------RL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTTC---------CC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHHHhcCC---------cC
Confidence 1123456788999999998899999999999999999999 8999875443221 11111111 01
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
..+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122345678899999999999999999999999988654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=367.69 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=208.9
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
..+.+.++||+|+||.||+|.+.. ...||||.++... ...++|.+|+++|++++|+||+++++++.+ +..+|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT----TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhheecccCCCeEEEEEEECC----CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 344567889999999999999863 4579999997543 346789999999999999999999999976 6789999
Q ss_pred eccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 999999999999753 568899999999999999999995 499999999999999999999999999998765322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ......++..|+|||++.+..++.++||||||++||||++ |+.||......+. ...+..+.
T Consensus 418 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~-------~~~i~~~~-------- 481 (535)
T 2h8h_A 418 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQVERGY-------- 481 (535)
T ss_dssp HH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH-------HHHHHTTC--------
T ss_pred ee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHcCC--------
Confidence 11 1123456789999999999999999999999999999999 9999975443221 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
....+..++..+.+|+.+||+.||++|||+.+|++.|+.+..-.
T Consensus 482 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 -RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 11123345678999999999999999999999999999987543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=334.41 Aligned_cols=262 Identities=20% Similarity=0.219 Sum_probs=200.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+....... .+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 4566889999999999999764 46789999987543322 36789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999999887889999999999999999999995 4999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ......... . .
T Consensus 190 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~-~------~ 254 (309)
T 2h34_A 190 TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM-------GAHINQAIP-R------P 254 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-------HHHHHSCCC-C------G
T ss_pred cc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH-------HHHhccCCC-C------c
Confidence 21 1345689999999999999999999999999999999999999976543211 111111110 0 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGVVEVSVPP 761 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~Le~~~~~~~pp 761 (766)
.......+.++.+++.+||+.||++|| +++++++.|+..+....+.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 011233456788999999999999999 9999999999877655443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.24 Aligned_cols=248 Identities=25% Similarity=0.295 Sum_probs=204.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||+|+... .++.+|||.++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34566889999999999999864 5789999999753 234556788999999987 7999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 999999999999999887789999999999999999999995 49999999999999999999999999999864322
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 175 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~------- 238 (353)
T 2i0e_A 175 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEHNV------- 238 (353)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC-------
T ss_pred Cc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhCCC-------
Confidence 21 12456799999999999999999999999999999999999999976543221 111111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||.+||+ +++++++
T Consensus 239 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112335678899999999999999995 5777653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.81 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=196.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|... .++.||||++..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 445678999999999999875 367899999865332 22467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++ +|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 99985 777777654 458899999999999999999995 4999999999999999999999999999987653322
Q ss_pred cceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc-------
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD------- 707 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 707 (766)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ............
T Consensus 175 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 175 S--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp -----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTT
T ss_pred c--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhhc
Confidence 1 134568999999999876 568999999999999999999999997654332211 111111110000
Q ss_pred ---------eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 ---------ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 ---------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...............+.++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000001123467889999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.07 Aligned_cols=275 Identities=24% Similarity=0.353 Sum_probs=209.7
Q ss_pred hhhhhccccccceEEEEEEec-CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecC--CceEEE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--QNRLLV 555 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 555 (766)
.+.++||+|+||.||++.... ....++.||||++..... ...+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 456889999999999997643 233578999999975432 3346799999999999999999999999874 567899
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.... +++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 99999999999997654 8899999999999999999995 4999999999999999999999999999988765432
Q ss_pred c-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 K-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........... .+.........+...+....
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-GIAQGQMTVLRLTELLERGE 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-CSCCHHHHHHHHHHHHHTTC
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-cccccchhHHHHHHHHhccc
Confidence 2 112345678889999999999999999999999999999999999875432210000 00000000000111111112
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~ 759 (766)
....+..++.++.+++.+||+.||.+|||+.++++.|+.+.+--.
T Consensus 269 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 269 RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 222234456789999999999999999999999999998765433
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=338.02 Aligned_cols=266 Identities=21% Similarity=0.299 Sum_probs=200.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeeeEeeeeecCCce---
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR--- 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~--- 552 (766)
+.+.+.||+|+||.||++.... .++.||||.++...... ...|.+|+.++.+++||||+++++++......
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4566889999999999999764 56799999997643332 35789999999999999999999998765543
Q ss_pred -EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 553 -LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 553 -~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
++||||+++++|.+++.....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999999999887889999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~-- 239 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIPP-- 239 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCCH--
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCCCc--
Confidence 43222 112345689999999999999999999999999999999999999976543221 111111111100
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHHHHhcCcCCCCCCCC
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIK-KVLQMLEGVVEVSVPPNP 763 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl~~Le~~~~~~~pp~p 763 (766)
.......+.++.+++.+||+.||++||++. ++.+.|..+.....|+.|
T Consensus 240 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~ 288 (311)
T 3ork_A 240 -----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAP 288 (311)
T ss_dssp -----HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSC
T ss_pred -----ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCC
Confidence 000112456788999999999999999654 455666665544444433
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.34 Aligned_cols=253 Identities=25% Similarity=0.311 Sum_probs=201.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+++... .++.+|||.++..... ..+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 4456889999999999999864 4679999999754322 235678999999887 89999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999887889999999999999999999995 499999999999999999999999999998643222
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh--hhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--AILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ .............+..
T Consensus 165 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 165 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 1 12456799999999999999999999999999999999999999964221110 0111112222222211
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTI------KKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~------~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+||++ .++++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1123346778899999999999999995 56654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=365.75 Aligned_cols=251 Identities=27% Similarity=0.413 Sum_probs=202.2
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
+||+|+||.||+|.+.... .+..||||.++... ....++|.+|++++++++||||++++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSS-CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCC-CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999886433 46789999997643 3356789999999999999999999999976 5689999999999
Q ss_pred chhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc-eee
Q 037189 563 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKT 640 (766)
Q Consensus 563 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 640 (766)
+|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999999754 568999999999999999999995 499999999999999999999999999998765433211 112
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...+++.|+|||++.+..++.++|||||||+||||++ |+.||......+. ...+..+. ....+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-------~~~i~~~~---------~~~~p 561 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGK---------RMECP 561 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH-------HHHHHTTC---------CCCCC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHcCC---------CCCCC
Confidence 2345789999999999999999999999999999998 9999976543221 11222221 11223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..++.++.+|+.+||+.||++||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 446788999999999999999999999999998753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=345.44 Aligned_cols=261 Identities=25% Similarity=0.409 Sum_probs=209.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCC--ceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRT--STTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~--~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (766)
..+.+.+.||+|+||.||+|.....+. ....||||.+..... ...+.+.+|+.+++++ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 344566889999999999999865332 235899999975432 2346789999999999 899999999999999999
Q ss_pred EEEeeccCCCchhhhhccC--------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC
Q 037189 553 LLVYEFLNNGTLASFLFGN--------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN 618 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~ 618 (766)
++||||+++|+|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence 9999999999999998642 356888999999999999999995 49999999999999999999
Q ss_pred eEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHH
Q 037189 619 ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWA 697 (766)
Q Consensus 619 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 697 (766)
+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ .
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~---- 276 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F---- 276 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H----
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H----
Confidence 99999999987765544333344567889999999999999999999999999999999 8999875432211 1
Q ss_pred HHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
......+. ....+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus 277 ~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 277 YKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11111111 11112234567899999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=334.56 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=190.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|.... .++.||||.++.... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp -------------CEEEEEECSS---SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 35567899999999999998764 467999999875432 33467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 557 EFLNNGTLASFLFGN------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
||++ ++|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9998 5999988643 357888999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc---c
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK---L 706 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 706 (766)
...... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... .+........ .
T Consensus 159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK---LIFDIMGTPNESLW 233 (317)
T ss_dssp TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCTTTC
T ss_pred CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCChhHh
Confidence 533221 134568999999999976 468999999999999999999999997655432211 1111111000 0
Q ss_pred c---eec--cCc------------ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 D---ALV--GGD------------MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~---~~~--~~~------------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .+. ... .........+.++.+++.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0 000 000 0000111235678999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.44 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=193.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+++... .++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 5567899999999999999874 46789999997533 3346789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC--eEEeccCcccccccCCCc
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN--ARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~~ 636 (766)
+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.......
T Consensus 98 ~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 98 ASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC-
Confidence 9999999999887889999999999999999999995 49999999999999987765 99999999975432221
Q ss_pred ceeecccccCcccccccccCCCCCcc-cCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSKITAK-VDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~~s~~-sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....||+.|+|||++.+..++.+ +||||||+++|||++|+.||........ ......... .. ...
T Consensus 174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~-~~--------~~~ 240 (361)
T 3uc3_A 174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRIL-SV--------KYS 240 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHH-TT--------CCC
T ss_pred --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHh-cC--------CCC
Confidence 134569999999999988887665 8999999999999999999976443211 111111111 11 111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11112245678899999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.25 Aligned_cols=250 Identities=23% Similarity=0.245 Sum_probs=195.0
Q ss_pred HHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccC-CCCCeeeEeeeeec
Q 037189 472 KELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQT-HHKNLVRLLGFCDE 548 (766)
Q Consensus 472 ~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 548 (766)
.++....+.+.++||+|+||+||+|.... +++.||||++...... ...++..|+..+.++ +||||++++++|.+
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 45556667777899999999999999874 4679999998643222 233455666555554 89999999999999
Q ss_pred CCceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
++..++||||+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999999 6688888765 35689999999999999999999964 8999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
........ .....||+.|+|||++.+ .++.++||||||+++|||++|..++...... ..+..+...
T Consensus 205 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~ 270 (311)
T 3p1a_A 205 VELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGYLP 270 (311)
T ss_dssp EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTCCC
T ss_pred eecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccCCC
Confidence 87654322 234568999999999876 7899999999999999999997776543211 111111111
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. ......+.++.+++.+||+.||++|||+.++++.
T Consensus 271 ~--------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 271 P--------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp H--------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred c--------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 0 0112245778999999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.35 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=198.0
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc-CCCCCeeeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.||+|+||.||+|.... .++.||||.+..........+.+|++++.+ .+||||+++++++.+.+..++||||+++
T Consensus 19 ~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRG 95 (316)
T ss_dssp CCCCCCSSEEEEEEECSS---SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ceecCCceEEEEEEEEcC---CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCC
Confidence 579999999999998764 467899999987666667889999999988 4799999999999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEeccCcccccccCCCc--
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARISDFGLAKLLTLNQSK-- 636 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~~-- 636 (766)
++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++. +||+|||+++........
T Consensus 96 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 96 GSILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 99999998878899999999999999999999954 9999999999999998776 999999999866432211
Q ss_pred ---ceeecccccCcccccccccC-----CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh--------hhHHHHHHHH
Q 037189 637 ---TIKTSIRGTKGYVAPEWFRN-----SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--------AILTDWAFDC 700 (766)
Q Consensus 637 ---~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~ 700 (766)
.......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..........
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFES 252 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHH
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHH
Confidence 11123458999999999875 5688999999999999999999999975432110 0000111112
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCCCC
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEVSVPPN 762 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~~~pp~ 762 (766)
+..+.... ... .....+..+.+++.+||+.||.+|||+.|+++. +.+......+|.
T Consensus 253 i~~~~~~~-~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 310 (316)
T 2ac3_A 253 IQEGKYEF-PDK-----DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPT 310 (316)
T ss_dssp HHHCCCCC-CHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----------
T ss_pred HhccCccc-Cch-----hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCC
Confidence 22221110 000 001235678999999999999999999999984 444433333333
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.78 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=201.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--------cCHHHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
.+.+.+.||+|+||.||+|.... .++.||||.++.... .....+.+|+.++++++||||+++++++.+.
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred ceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34455789999999999998764 567899999875431 1334678899999999999999999999999
Q ss_pred CceEEEeeccCCC-chhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 550 QNRLLVYEFLNNG-TLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 550 ~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
+..++||||+..| +|.+++.....+++..+..|+.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 9999999999777 999999988889999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
........ ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .
T Consensus 179 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----------------~ 238 (335)
T 3dls_A 179 YLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV-----------------E 238 (335)
T ss_dssp ECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----------------T
T ss_pred ECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----------------h
Confidence 76544322 34568999999999988876 889999999999999999999996422110 0
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .. ..+...+.++.+++.+||+.||++|||+.++++.
T Consensus 239 ~----~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 A----AI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp T----CC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred h----cc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 0112245678999999999999999999999985
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.79 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=206.4
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.+.||+|+||.||+|.... .++.||||.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 345567889999999999999864 467899999875432 3356789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 9999999999999888889999999999999999999995 4999999999999999999999999999987654433
Q ss_pred cceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+ .....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~-------- 226 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKT-------- 226 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCT--------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhccc--------
Confidence 222345678999999999987765 7899999999999999999999976443211 11111 11110
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+..+.+++.+||+.||.+|||+.++++.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 001122345678899999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=343.01 Aligned_cols=266 Identities=25% Similarity=0.409 Sum_probs=209.7
Q ss_pred HHhhhhhccccccceEEEEEEec-CCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC--ceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT-TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~-~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~l 554 (766)
.+.+.+.||+|+||.||++.... ....+..||||++........+.|.+|++++++++||||+++++++...+ ..++
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 121 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence 34567889999999999998642 22357899999998765556678999999999999999999999987654 7899
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+++++|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 122 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 122 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp EECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred EEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 99999999999999765 468999999999999999999995 49999999999999999999999999999877654
Q ss_pred CCcc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh---------hhHHHHHHHHhhc
Q 037189 634 QSKT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY---------AILTDWAFDCYRN 703 (766)
Q Consensus 634 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~ 703 (766)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .............
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 3221 11234577889999999998999999999999999999999998864321110 0000111111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
......+..++.++.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 279 ---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 279 ---------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---------CCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111223345678999999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.03 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=193.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCC--CCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHH--KNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||++... .+..||||++.... ....+.+.+|+.++.+++| +||+++++++.++...++
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 345688999999999999874 46789999987543 2234678999999999986 999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||| +.+++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 87 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~ 161 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 161 (343)
T ss_dssp EEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence 999 57889999999888899999999999999999999954 999999999999997 5789999999998876544
Q ss_pred CcceeecccccCcccccccccC-----------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
.........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~-- 234 (343)
T 3dbq_A 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-- 234 (343)
T ss_dssp --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHH--
T ss_pred ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-----HHHHHHh--
Confidence 3333345679999999999865 678999999999999999999999996432211 0111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 235 -------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111222234678899999999999999999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.70 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=195.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .+..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4456889999999999999864 5679999999753 233446788999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||++ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 99999999999998888899999999999999999999951 4899999999999999999999999999986433222
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+..+..
T Consensus 305 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i~~~~~--------- 366 (446)
T 4ejn_A 305 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEI--------- 366 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHCCC---------
T ss_pred c--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHHHhCCC---------
Confidence 1 24567999999999999999999999999999999999999999765432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+|| +++|+++
T Consensus 367 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 367 -RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11223457788999999999999999 9999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=341.50 Aligned_cols=249 Identities=25% Similarity=0.316 Sum_probs=189.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .++.||||.++.. ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 4456789999999999999864 4578999998753 2346788999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 130 VTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 9999999999888889999999999999999999995 49999999999999975 88999999999987653321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+....... .
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~i~~~~~~~------~ 271 (349)
T 2w4o_A 207 ---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF------MFRRILNCEYYF------I 271 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH------HHHHHHTTCCCC------C
T ss_pred ---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH------HHHHHHhCCCcc------C
Confidence 1345689999999999999999999999999999999999999975443221 111111111110 0
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+..+.+++.+||+.||++|||+.++++.
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01112345778899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.44 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=206.8
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
...+.+.+.||+|+||.||+|.... .+..+|||.+...... ..+++.+|+.++.+++||||+++++++.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3446677899999999999999864 4678999998754322 357899999999999999999999999999
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----CeEEeccC
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY----NARISDFG 625 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 625 (766)
...++||||+++++|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 9999999999999999999888889999999999999999999995 4999999999999999887 79999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
+++........ ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+....
T Consensus 165 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~i~~~~ 234 (321)
T 2a2a_A 165 LAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL-------ANITSVS 234 (321)
T ss_dssp TCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-------HHHHTTC
T ss_pred cceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH-------HHHHhcc
Confidence 99876543221 3456899999999999999999999999999999999999999765432211 1111111
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.. .........+..+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YD------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CC------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cc------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 0000011235678899999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=331.33 Aligned_cols=251 Identities=28% Similarity=0.415 Sum_probs=203.7
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
.||+|+||.||+|...... .+..||||.++... ....+++.+|++++++++||||+++++++ +.+..++||||++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred cccccCceeEEEeEeccCC-CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 8999999999999875322 46789999997643 23456799999999999999999999999 556789999999999
Q ss_pred chhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc-eee
Q 037189 563 TLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT-IKT 640 (766)
Q Consensus 563 sL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 640 (766)
+|.+++... ..+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.+||+|||+++......... ...
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999754 568999999999999999999995 499999999999999999999999999998775443221 112
Q ss_pred cccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCc
Q 037189 641 SIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMND 719 (766)
Q Consensus 641 ~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 719 (766)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.. ...+
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~i~~~~~---------~~~~ 235 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-------MAFIEQGKR---------MECP 235 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH-------HHHHHTTCC---------CCCC
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH-------HHHHhcCCc---------CCCC
Confidence 3456889999999998899999999999999999999 9999975443221 111111111 1123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 720 VECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 720 ~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
..++..+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 236 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 236 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 345678999999999999999999999999998865
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.91 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=203.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (766)
.+.+.+.||+|+||.||+|....++ ....+|||.++.. .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCC-cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 3456789999999999999987532 2235699988643 233456799999999999 899999999999999999999
Q ss_pred eeccCCCchhhhhccCC----------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCe
Q 037189 556 YEFLNNGTLASFLFGNL----------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA 619 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~----------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 619 (766)
|||+++++|.+++.... .+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997653 68899999999999999999995 499999999999999999999
Q ss_pred EEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHH
Q 037189 620 RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAF 698 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 698 (766)
||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LY 251 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HH
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HH
Confidence 9999999875432211 123456889999999998899999999999999999998 999997554322 11
Q ss_pred HHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
..+..+. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus 252 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 252 EKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 111223446788999999999999999999999999987654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=328.02 Aligned_cols=245 Identities=26% Similarity=0.360 Sum_probs=200.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .+..+|||.+.... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3456789999999999998864 46789999986432 23456789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 999999999999988788999999999999999999999 45999999999999999999999999999865443221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+... ......
T Consensus 165 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~~~~~---------- 223 (279)
T 3fdn_A 165 ----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------RISRVE---------- 223 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------HHHHTC----------
T ss_pred ----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH-------HHHhCC----------
Confidence 34568999999999999999999999999999999999999997654332111 111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01122345678899999999999999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.43 Aligned_cols=263 Identities=27% Similarity=0.456 Sum_probs=195.5
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
|+....+.+.++||+|+||.||+|+... .+|||.++... ....+.|.+|+.++++++||||+++++++ ...
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 3344455677899999999999998642 48999886543 23346799999999999999999999976 456
Q ss_pred ceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 551 NRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccc
Confidence 78999999999999999964 4568899999999999999999995 4999999999999999999999999999986
Q ss_pred cccCCCcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
..............||+.|+|||.+. +..++.++||||||+++|||++|+.||......+. .......+..
T Consensus 170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~ 243 (289)
T 3og7_A 170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSL 243 (289)
T ss_dssp --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSC
T ss_pred cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhccccc
Confidence 65433222224467899999999986 66788999999999999999999999975432221 1111222221
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.... ......++.++.+++.+||+.||.+|||+.++++.|+++.+
T Consensus 244 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1110 01122456789999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=335.67 Aligned_cols=249 Identities=21% Similarity=0.332 Sum_probs=194.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-----
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----- 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 551 (766)
.+.+.+.||+|+||.||+|+... +++.||||+++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34556889999999999999864 467899999975433 345779999999999999999999999865432
Q ss_pred ----------------------------------------------------eEEEeeccCCCchhhhhccCCCC---cc
Q 037189 552 ----------------------------------------------------RLLVYEFLNNGTLASFLFGNLKP---NW 576 (766)
Q Consensus 552 ----------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~l---~~ 576 (766)
.++||||+++++|.+++...... ++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 78999999999999999876443 34
Q ss_pred chhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc----------ceeecccccC
Q 037189 577 NLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK----------TIKTSIRGTK 646 (766)
Q Consensus 577 ~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~~gt~ 646 (766)
..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 4588999999999999995 49999999999999999999999999999877654211 1123456999
Q ss_pred cccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHH
Q 037189 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKL 726 (766)
Q Consensus 647 ~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 726 (766)
.|+|||.+.+..++.++||||||+++|||++|..|+..... ........... .........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~---------~~~~~~~~~~~---------~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR---------IITDVRNLKFP---------LLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---------HHHHHHTTCCC---------HHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---------HHHHhhccCCC---------cccccCChhH
Confidence 99999999999999999999999999999998776432110 11111111110 0123345677
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 037189 727 VMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 727 ~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+++.+||+.||++|||+.|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999873
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.70 Aligned_cols=249 Identities=19% Similarity=0.244 Sum_probs=200.6
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.||+|+||.||+|+... .++.+|+|.++.. .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 73 ~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E 149 (410)
T 3v8s_A 73 VVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 149 (410)
T ss_dssp EEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 44789999999999999874 4678999998642 22334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 150 ~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~- 224 (410)
T 3v8s_A 150 YMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV- 224 (410)
T ss_dssp CCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-
T ss_pred CCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-
Confidence 99999999998754 58889999999999999999995 49999999999999999999999999999876543321
Q ss_pred eeecccccCcccccccccCCC----CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 638 IKTSIRGTKGYVAPEWFRNSK----ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~----~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+... .+ ..+.. .
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~---~i----~~~~~------~ 291 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS---KI----MNHKN------S 291 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HH----HTHHH------H
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH---HH----Hhccc------c
Confidence 123567999999999998765 7899999999999999999999997654332111 01 00000 0
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSL--RPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPt~~~vl~~ 750 (766)
.........+.++.+|+.+||+.+|.+ ||+++||+++
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000111124577889999999999988 9999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.45 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=204.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee----cCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----EGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----~~~~~~ 553 (766)
.+.+.+.||+|+||.||++.... .++.||||.+........+.+.+|++++++++||||+++++++. .....+
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 34567899999999999999754 46799999987655556678999999999999999999999986 334778
Q ss_pred EEeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 554 LVYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
+||||+++++|.+++.. ...+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999875 46789999999999999999999954 999999999999999999999999999876
Q ss_pred cccCCCcc-------eeecccccCcccccccccCCC---CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH
Q 037189 630 LTLNQSKT-------IKTSIRGTKGYVAPEWFRNSK---ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 630 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 699 (766)
........ ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~---- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VAL---- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhH----
Confidence 54221110 012245799999999987654 689999999999999999999999643221111 111
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~ 759 (766)
.... ..........+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 0111 01111123345789999999999999999999999999998765433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.77 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=204.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
+.+.+.||+|+||.||++........++.||||.++... ....+.+.+|++++.++ +||||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 456689999999999999986544467899999986432 23446678899999999 6999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+++++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 999999999999999887889999999999999999999995 49999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ......... ..
T Consensus 213 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~-~~------ 282 (355)
T 1vzo_A 213 ETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK-SE------ 282 (355)
T ss_dssp GGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH-CC------
T ss_pred CCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc-cC------
Confidence 3222 134579999999999986 35789999999999999999999999754322111 111111111 10
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQML 751 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~L 751 (766)
...+...+..+.+++.+||+.||.+|| ++.++++..
T Consensus 283 ----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111233456788999999999999999 999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=346.64 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=194.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC--CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||++... .+..||||++.... ....+.+.+|+.++.+++ ||||+++++++...+..++
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 456688999999999999865 36789999986533 233467999999999996 5999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||| +.+++|.+++.....+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+....
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999 678899999998888899999999999999999999 45999999999999995 5899999999999876544
Q ss_pred CcceeecccccCcccccccccC-----------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
.........||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .......
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~~~-- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAII-- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHHHH--
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHHHh--
Confidence 3333345679999999999865 468899999999999999999999996532211 1111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
++......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 282 -------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 282 -------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111111122224678899999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=331.71 Aligned_cols=263 Identities=25% Similarity=0.309 Sum_probs=199.0
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-----cCHHHHHHHHHHHccCC---CCCeeeEeeee
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-----DGEREFKNEVFVIGQTH---HKNLVRLLGFC 546 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~f~~E~~~l~~l~---H~niv~l~g~~ 546 (766)
....+.+.++||+|+||.||+|.... .++.||||.+..... .....+.+|+.++++++ ||||+++++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 34455667899999999999998754 467899999874321 22356778887777665 99999999999
Q ss_pred ecCC-----ceEEEeeccCCCchhhhhccCCC--CccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCe
Q 037189 547 DEGQ-----NRLLVYEFLNNGTLASFLFGNLK--PNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNA 619 (766)
Q Consensus 547 ~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~--l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~ 619 (766)
.... ..++||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 7755 4789999998 599999987644 89999999999999999999954 89999999999999999999
Q ss_pred EEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH
Q 037189 620 RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 699 (766)
||+|||+++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+... .+..
T Consensus 160 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~ 233 (308)
T 3g33_A 160 KLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFD 233 (308)
T ss_dssp EECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH---HHHH
T ss_pred EEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHH
Confidence 99999999876543222 44678999999999999999999999999999999999999997655433211 1111
Q ss_pred HhhcCcccee------ccCcccC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 CYRNGKLDAL------VGGDMEA-------MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ~~~~~~~~~~------~~~~~~~-------~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......... ....... ....+.++.+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1111000000 0000000 0011345778899999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.97 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=203.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .+..+|||.+... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 4556789999999999999864 4678999998643 233457899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|+++||.||| +.+|+||||||+||+++.++.+||+|||++........
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999999999988778999999999999999999999 45999999999999999999999999999876543221
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ........
T Consensus 170 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~--------- 229 (284)
T 2vgo_A 170 ----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH-------RRIVNVDL--------- 229 (284)
T ss_dssp ----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC---------
T ss_pred ----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH-------HHHhcccc---------
Confidence 3456899999999999999999999999999999999999999765432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+..+.+++.+||+.||.+|||+.++++
T Consensus 230 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 -KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 112234567889999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=328.41 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=196.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|... .++.+|||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred chhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 345678999999999999874 46789999986533 223467899999999999999999999999999999999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++ +|.+++... ..+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 99986 898888754 678899999999999999999995 4999999999999999999999999999987643221
Q ss_pred cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc------cce
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK------LDA 708 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 708 (766)
. .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+... .......... ...
T Consensus 156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGG
T ss_pred c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhc
Confidence 1 1345689999999999764 58999999999999999999999997654322111 1111111100 000
Q ss_pred e--ccCccc-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 L--VGGDME-------AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ~--~~~~~~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .++... .......++++.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 000000 00112345778899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=333.31 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=200.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+.+.+.||+|+||.||+|.+.........||||.++... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 3456688999999999999986554456689999986532 234567999999999999999999999998754 889
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+||+++++|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999764 568899999999999999999995 49999999999999999999999999999877554
Q ss_pred CCcc-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 QSKT-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.... ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+. .......+.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~~~------ 242 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGE------ 242 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSCC------
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH------HHHHHccCC------
Confidence 3322 1223457889999999998889999999999999999999 9999975543221 111111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
....+...+..+.+++.+||+.||.+|||+.++++.|+++..-
T Consensus 243 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 ---RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ---CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1112234567899999999999999999999999999886643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=333.99 Aligned_cols=261 Identities=21% Similarity=0.350 Sum_probs=197.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... +++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4566899999999999999764 46789999987532 22346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
|||+++++|.+++.. ...+++..++.++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864 4568899999999999999999995 499999999999999999999999999998765
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ............
T Consensus 188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~--- 257 (310)
T 2wqm_A 188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIEQCDYPP--- 257 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH-----HHHHHHTTCSCC---
T ss_pred CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH-----HHHHhhcccCCC---
Confidence 43221 13356899999999999999999999999999999999999999654322111 111111211111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~p 760 (766)
......+.++.+++.+||+.||++|||+.+|++.|+.+.....+
T Consensus 258 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 258 -----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -----CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 11123456789999999999999999999999999988755443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=343.53 Aligned_cols=270 Identities=16% Similarity=0.188 Sum_probs=202.0
Q ss_pred Hhhhhhcccc--ccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRG--SFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G--~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+| +||.||+|+... .++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4566899999 999999999874 46799999997543 2234668889999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 555 VYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999765 678999999999999999999995 4999999999999999999999999999875533
Q ss_pred CCCc-----ceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh--HHHHHHHHhh-
Q 037189 633 NQSK-----TIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI--LTDWAFDCYR- 702 (766)
Q Consensus 633 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~- 702 (766)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 2111 11123468999999999987 679999999999999999999999997543221110 0000000000
Q ss_pred -----------------cCccceecc---------CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 037189 703 -----------------NGKLDALVG---------GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV 754 (766)
Q Consensus 703 -----------------~~~~~~~~~---------~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~ 754 (766)
......... ...........+..+.+|+.+||+.||++|||+.|+++. ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 000000000 000001123345678999999999999999999999865 4443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=339.50 Aligned_cols=263 Identities=28% Similarity=0.396 Sum_probs=203.6
Q ss_pred HHHHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
....+.+.+.||+|+||.||+|.... ....+..||||.+... ......++.+|+.++++++||||+++++++.+...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 33455677899999999999998643 1235678999998643 23345679999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccC-------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEE
Q 037189 552 RLLVYEFLNNGTLASFLFGN-------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARI 621 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl 621 (766)
.++||||+++++|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+|||++ ++..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999754 347788899999999999999995 4999999999999998 4456999
Q ss_pred eccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHH
Q 037189 622 SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------LEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------HHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------HHH
Confidence 99999986654433222234567899999999999999999999999999999998 9999875443221 111
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+..+.. ...+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 258 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 VTSGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 111111 11123345778999999999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=333.00 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=199.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|.... .++.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3456789999999999999864 4678999988654322 2456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 999999999999888889999999999999999999995 49999999999999999999999999999876533221
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH--------HHHhhcCc-c
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA--------FDCYRNGK-L 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~-~ 706 (766)
.....||..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........ ........ .
T Consensus 159 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (311)
T 4agu_A 159 --YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred --cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence 134568999999999976 67899999999999999999999999765543322111100 00000000 0
Q ss_pred ceeccCcccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+......+ ...+..+.+++.+||+.||.+|||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000 2345678899999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.15 Aligned_cols=255 Identities=25% Similarity=0.282 Sum_probs=196.9
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-----cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-----FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
..+.+.+.||+|+||.||+|.... .+..+|||.+... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 345567899999999999998764 5678999998643 23445789999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccC----------------------------------------CCCccchhhhHHHHHHHHHH
Q 037189 552 RLLVYEFLNNGTLASFLFGN----------------------------------------LKPNWNLRTNIAFQIARGLL 591 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~~ia~gL~ 591 (766)
.++||||+++|+|.+++... ..+++..+..++.||++||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998521 11245667789999999999
Q ss_pred HhhhcCCCceecCCCccceEEEcCCC--CeEEeccCcccccccCCCcc--eeecccccCcccccccccC--CCCCcccCe
Q 037189 592 YLHEDCSSQIIHCDMKPQNILLDDHY--NARISDFGLAKLLTLNQSKT--IKTSIRGTKGYVAPEWFRN--SKITAKVDV 665 (766)
Q Consensus 592 yLH~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~s~~sDV 665 (766)
|||+. +|+||||||+||+++.++ .+||+|||+++.+....... ......||+.|+|||.+.+ ..++.++||
T Consensus 183 ~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99954 999999999999998776 89999999998764432211 1234679999999999975 678999999
Q ss_pred eehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 037189 666 YSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 666 ~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 745 (766)
||||+++|||++|+.||......+.. ....... .. .........+..+.+++.+||+.||.+|||+.
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~------~~~~~~~-~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 326 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTI------SQVLNKK-LC------FENPNYNVLSPLARDLLSNLLNRNVDERFDAM 326 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-CC------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHH------HHHHhcc-cc------cCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence 99999999999999999765433211 1111111 00 00011122457789999999999999999999
Q ss_pred HHHHH
Q 037189 746 KVLQM 750 (766)
Q Consensus 746 ~vl~~ 750 (766)
++++.
T Consensus 327 ~~l~h 331 (345)
T 3hko_A 327 RALQH 331 (345)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99873
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=331.92 Aligned_cols=272 Identities=23% Similarity=0.327 Sum_probs=201.3
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc--CCCCCeeeEeeeeecC-
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDEG- 549 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~- 549 (766)
+.....+.+.+.||+|+||.||+|+.. +..||||.+... ....+.+|.+++.. ++||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344456677789999999999999874 578999998642 33455556655555 4899999999999877
Q ss_pred ---CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEE
Q 037189 550 ---QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 550 ---~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
...++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6789999999999999999654 5889999999999999999999431 229999999999999999999999
Q ss_pred eccCcccccccCCCcce--eecccccCcccccccccCCCCCcc------cCeeehhHHHHHHHhC----------CcCCC
Q 037189 622 SDFGLAKLLTLNQSKTI--KTSIRGTKGYVAPEWFRNSKITAK------VDVYSFGVLLLEIIAC----------RKSFD 683 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~------sDV~s~Gvvl~elltg----------~~p~~ 683 (766)
+|||+++.......... .....||+.|+|||++.+...+.+ +||||||+++|||++| +.||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 99999987654332211 124579999999999987766655 9999999999999999 55554
Q ss_pred chhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 684 IEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
........ ................. ........+++++.+++.+||+.||++|||+.+|++.|+.+.+-.
T Consensus 264 ~~~~~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 264 DLVPSDPS--YEDMREIVCIKKLRPSF---PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCCCC---CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred hhcCCCCc--hhhhHHHHhhhccCccc---cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 32211100 01111111111111000 011112367889999999999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.98 Aligned_cols=252 Identities=17% Similarity=0.171 Sum_probs=202.6
Q ss_pred HHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccccCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 552 (766)
.+.+.+.||+|+||.||+|.... ....++.||||.++. ....++.+|++++.+++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 34456789999999999996432 123567899999864 34567888888888776 99999999999999999
Q ss_pred EEEeeccCCCchhhhhcc-----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-----------C
Q 037189 553 LLVYEFLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-----------H 616 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----------~ 616 (766)
++||||+++|+|.+++.. ...+++..++.|+.||++||+|||+ .+|+||||||+|||++. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999973 4678999999999999999999994 59999999999999998 8
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 696 (766)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 99999999999876544333344567899999999999999999999999999999999999999864332110
Q ss_pred HHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHhcCcC
Q 037189 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLR-PTIKKVLQMLEGVVE 756 (766)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Pt~~~vl~~Le~~~~ 756 (766)
.+....... ...+.+.+++..|++.+|.+| |+++++.+.|++.++
T Consensus 294 ------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 294 ------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp ------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred ------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 011111111 124567789999999999998 688888888877543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=324.84 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=203.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3456789999999999999864 467899999865432 23467889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEeccCcccccccC
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARISDFGLAKLLTLN 633 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~ 633 (766)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999999888889999999999999999999995 49999999999999986655 999999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ......+....
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~----- 226 (284)
T 3kk8_A 162 EAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAYDY----- 226 (284)
T ss_dssp CBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCC-----
T ss_pred ccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHHHhccccC-----
Confidence 322 345689999999999999999999999999999999999999976543221 11111111110
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+.++.+++.+||+.||++|||+.++++.
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 -PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001112345678899999999999999999999873
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.23 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=201.0
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.+.||+|+||.||++.... .++.+|||.++.... .+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 345566889999999999999864 467999999975433 345688888777 799999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC----CCeEEeccCcccccc
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH----YNARISDFGLAKLLT 631 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~~ 631 (766)
|||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999988889999999999999999999995 499999999999998543 349999999998765
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... +...+..+...
T Consensus 172 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~---- 241 (342)
T 2qr7_A 172 AENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFS---- 241 (342)
T ss_dssp CTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCC----
T ss_pred CCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCcc----
Confidence 43322 234678999999999998889999999999999999999999997532221111 11222222211
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+.++.+++.+||+.||++|||+.+++++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111122346788999999999999999999998863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=341.54 Aligned_cols=243 Identities=27% Similarity=0.295 Sum_probs=191.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHH-HccCCCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFV-IGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||+++... .++.+|||.++... ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4567899999999999999864 46789999997543 2234456777776 577899999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 99999999999999887888999999999999999999995 499999999999999999999999999998643322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..+..
T Consensus 194 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~~~~-------- 256 (373)
T 2r5t_A 194 S--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------YDNILNKPL-------- 256 (373)
T ss_dssp C--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-------HHHHHHSCC--------
T ss_pred C--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhccc--------
Confidence 1 12456799999999999999999999999999999999999999976543321 111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
..+...+..+.+++.+||+.||.+||++.+
T Consensus 257 --~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 257 --QLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 112234567889999999999999999853
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=325.34 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=196.4
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
..+.+.++||+|+||.||++.... .+..+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEcc---CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 456677899999999999999764 46789999987643 33467899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCccc
Q 037189 556 YEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAK 628 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~ 628 (766)
|||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999854 3678999999999999999999995 499999999999999 456789999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
....... .....||+.|+|||.+. ..++.++||||||+++|||++|+.||......+.... ........
T Consensus 176 ~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~-------~~~~~~~~ 244 (285)
T 3is5_A 176 LFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-------ATYKEPNY 244 (285)
T ss_dssp C-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCCCC
T ss_pred ecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh-------hccCCccc
Confidence 7654322 13456899999999886 5689999999999999999999999976543321111 00011000
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.. .....+..+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 AV-------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00113467889999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.44 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=206.1
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.+.||+|+||.||++.... .++.+|||.++.......+.+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRL---TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3455667899999999999999864 4678999999865555566799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCccccccc
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~ 632 (766)
|||+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||++ ++++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999877788999999999999999999995 499999999999999 7889999999999976543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+.++...
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~~----- 225 (304)
T 2jam_A 162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------FEKIKEGYYE----- 225 (304)
T ss_dssp BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHCCCC-----
T ss_pred Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCC-----
Confidence 21 1234689999999999999999999999999999999999999975443221 1111122111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCc
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ--MLEGVV 755 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~Le~~~ 755 (766)
.........+..+.+++.+||+.||++|||+.++++ .+++..
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 011112234577899999999999999999999986 344433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.39 Aligned_cols=262 Identities=18% Similarity=0.220 Sum_probs=203.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeee-ecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC-DEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ...++.+|+.++.+++|++++..+.++ .+....++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3456789999999999999754 56799999986533 345799999999999998877666665 56667899999
Q ss_pred ccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCcccccccC
Q 037189 558 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 558 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+ +++|.+++. ....+++..++.++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 999999997 34678999999999999999999995 499999999999999 58899999999999877654
Q ss_pred CCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 634 QSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 634 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+...........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 3211 11345789999999999999999999999999999999999999975432211111111111100000000
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
+ ....+.++.+++.+||+.||++|||+.+|++.|+.+..-.
T Consensus 242 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 242 L---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp H---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H---------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0 1123567899999999999999999999999998866443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=337.97 Aligned_cols=244 Identities=25% Similarity=0.323 Sum_probs=197.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+...+.||+|+||.||+|.... .++.||||++...... ..+++.+|++++++++||||+++++++.+.+..++|
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 4455789999999999998754 5678999999754322 235789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+. |+|.+++. ....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 99998 68888775 456789999999999999999999954 9999999999999999999999999999876432
Q ss_pred CcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
....||+.|+|||++. ...++.++||||||+++|||++|+.||........ ..........
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~~~~----- 271 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESP----- 271 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCCC-----
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcCCC-----
Confidence 3356899999999984 56789999999999999999999999975433221 1111111110
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......++.+.+++.+||+.||++|||+.++++.
T Consensus 272 ----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 272 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11122345678899999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.58 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=202.6
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc------cCHHHHHHHHHHHccCCCCCeeeEeeeeecC
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ------DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG 549 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (766)
...+.+.+.||+|+||.||++.... .++.+|||.++.... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 3456677899999999999999864 467899998865321 1367899999999999999999999999999
Q ss_pred CceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----CeEEeccC
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY----NARISDFG 625 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 625 (766)
...++||||+++++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999999887789999999999999999999995 4999999999999998877 89999999
Q ss_pred cccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 626 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
++......... ....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+....
T Consensus 158 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL-------TNISAVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTC
T ss_pred cceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH-------HHhHhcc
Confidence 99876543221 3456899999999999999999999999999999999999999765432211 1111111
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.. .........+..+.+++.+||+.||++|||+.++++
T Consensus 228 ~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 10 000001123567889999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=344.42 Aligned_cols=250 Identities=20% Similarity=0.206 Sum_probs=198.8
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.||+|+||.||+++... .++.||||+++... ....+.+.+|..++.+++||||+++++++.+.+..+||||
T Consensus 65 ~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 65 ILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp EEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 34689999999999999864 46799999996422 2233458899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 142 ~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~ 218 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218 (412)
T ss_dssp CCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc
Confidence 99999999999764 478999999999999999999995 49999999999999999999999999999876544322
Q ss_pred ceeecccccCccccccccc-------CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 637 TIKTSIRGTKGYVAPEWFR-------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
. ....+||+.|+|||++. ...++.++|||||||++|||++|+.||......+... .+......-..
T Consensus 219 ~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~---~i~~~~~~~~~--- 291 (412)
T 2vd5_A 219 R-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG---KIVHYKEHLSL--- 291 (412)
T ss_dssp E-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHHHHCCC---
T ss_pred c-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccCcCC---
Confidence 1 13467999999999997 4578999999999999999999999997654332111 01000000000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLR---PTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Pt~~~vl~~ 750 (766)
+ ......+.++.+++.+||+ +|.+| |+++|++++
T Consensus 292 --p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 --P----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --C----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0 0012345788999999999 99998 689998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.92 Aligned_cols=268 Identities=19% Similarity=0.237 Sum_probs=209.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC--ceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ--NRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred eEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4456889999999999999864 46799999997533 344677899999999999999999999998765 67999
Q ss_pred eeccCCCchhhhhccCC---CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE----cCCCCeEEeccCccc
Q 037189 556 YEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGLAK 628 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~ 628 (766)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997643 38999999999999999999995 499999999999999 777889999999998
Q ss_pred ccccCCCcceeecccccCcccccccccC--------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHH
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN--------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
........ ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .......
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~ 239 (396)
T 4eut_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI 239 (396)
T ss_dssp ECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred EccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence 76543321 34568999999999865 56788999999999999999999999643321110 1111111
Q ss_pred hhcC---ccceec-----------cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 701 YRNG---KLDALV-----------GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 701 ~~~~---~~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
.... ....+. .-.............+.+++.+||+.||++||++.++++.++.+++.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111 110000 00111223467788899999999999999999999999999887653
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.01 Aligned_cols=264 Identities=17% Similarity=0.177 Sum_probs=203.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCC-----ceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeee-----------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRT-----STTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVR----------- 541 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~-----~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~----------- 541 (766)
.+.+.+.||+|+||.||+|....+.. .++.||||.+... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34566899999999999999875321 3678999998643 46899999999999999988
Q ss_pred ----Eeeeeec-CCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 542 ----LLGFCDE-GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 542 ----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
+++++.. +...++||||+ +++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 5667765 67889999999 99999999875 6789999999999999999999954 999999999999999
Q ss_pred CCC--CeEEeccCcccccccCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh
Q 037189 615 DHY--NARISDFGLAKLLTLNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687 (766)
Q Consensus 615 ~~~--~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~ 687 (766)
.++ .+||+|||+++.+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 99999999998765432211 11335789999999999999999999999999999999999999976542
Q ss_pred hhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 688 EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 688 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.... +...... ... ....+..... .....+.++.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 274 ~~~~-~~~~~~~-~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 274 NTED-IMKQKQK-FVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CHHH-HHHHHHH-HHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHH-HHHHHHh-ccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 2211 1111111 111 1111111110 011235778999999999999999999999999988663
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.86 Aligned_cols=248 Identities=27% Similarity=0.403 Sum_probs=196.1
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-CceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-QNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~ 556 (766)
.+.+.+.||+|+||.||++... +..+|||.++.. ...+.|.+|++++++++||||+++++++.+. +..++||
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~-----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET-----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hceEEeEEecCCCceEEEEEEc-----CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 3456688999999999999863 568999998743 3567899999999999999999999997654 4789999
Q ss_pred eccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 557 EFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||+++++|.+++.... .+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 9999999999997653 37888999999999999999995 499999999999999999999999999988654322
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+.
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-------~~~~~~~~-------- 231 (278)
T 1byg_A 172 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRVEKGY-------- 231 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH-------HHHHTTTC--------
T ss_pred -----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 23357889999999999999999999999999999998 9999975443221 11111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
....+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 232 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 232 -KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 111233456788999999999999999999999999988754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=352.77 Aligned_cols=250 Identities=26% Similarity=0.294 Sum_probs=204.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 3445789999999999999864 4679999999653 234556789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999997654 48899999999999999999995 49999999999999999999999999999876544
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..+.........
T Consensus 340 ~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i~~~i~~~~~------- 406 (576)
T 2acx_A 340 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPE------- 406 (576)
T ss_dssp CC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHHHHHHHHCCC-------
T ss_pred cc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHHHHHhhcccc-------
Confidence 32 13457999999999999999999999999999999999999999764321110 011111111111
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...+.++.+|+.+||+.||.+|| ++.||+++
T Consensus 407 ---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11233467889999999999999999 78888753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.74 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=204.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECC---CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3456789999999999999864 46789999986543 22346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 9999999999999887889999999999999999999995 4999999999999999999999999999987653322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. .....+..
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~--------- 232 (294)
T 2rku_A 171 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNEY--------- 232 (294)
T ss_dssp C--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHTTCC---------
T ss_pred c--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhhccC---------
Confidence 1 13456899999999999999999999999999999999999999765432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122345678899999999999999999999974
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.79 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=181.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3456789999999999998754 46789999986432 23357799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++... ..+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999875 5689999999999999999999954 99999999999999999999999999998765332
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..+.....
T Consensus 167 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~---------~~~~~~~~ 229 (278)
T 3cok_A 167 EK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------L---------NKVVLADY 229 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSSCC
T ss_pred Cc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------H---------HHHhhccc
Confidence 21 1235689999999999999999999999999999999999999975432211 0 00000111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+.++.+++.+||+.||++|||+.++++
T Consensus 230 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 230 --EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 112334567889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=326.29 Aligned_cols=253 Identities=25% Similarity=0.348 Sum_probs=204.4
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec----
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE---- 548 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---- 548 (766)
......+...+.||+|+||.||+|.... +++.||||.+.... ..+.+|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred chhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 3344556667899999999999999864 46789999987532 467899999999999999999998854
Q ss_pred ------------CCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc
Q 037189 549 ------------GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD 614 (766)
Q Consensus 549 ------------~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~ 614 (766)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEc
Confidence 34578999999999999999653 568899999999999999999995 4999999999999999
Q ss_pred CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH
Q 037189 615 DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT 694 (766)
Q Consensus 615 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 694 (766)
.++.+||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------- 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK------- 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------
T ss_pred CCCCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------
Confidence 9999999999999876544322 345689999999999999999999999999999999999988642211
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCC
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSV 759 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~ 759 (766)
.......+.+ +...+..+.+++.+||+.||.+|||+.++++.|+.+..-..
T Consensus 227 --~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 227 --FFTDLRDGII------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp --HHHHHHTTCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred --HHHHhhcccc------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1111111111 11234568899999999999999999999999988765443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=340.49 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=203.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||++.... .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 4456789999999999999864 46789999987542 2334678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||++.......
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 999999999998878899999999999999999999952 279999999999999999999999999997654321
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH------------------
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD------------------ 699 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------------------ 699 (766)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......+..........
T Consensus 187 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 187 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp -----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred -ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 1345789999999999999999999999999999999999999976443221111000000
Q ss_pred -----HhhcC----ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 700 -----CYRNG----KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 700 -----~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..... ....+.............+.++.+++.+||+.||++|||+.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000 000001111111112234567899999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.10 Aligned_cols=261 Identities=18% Similarity=0.219 Sum_probs=201.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeee-ecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFC-DEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 556 (766)
.+.+.+.||+|+||.||+|.... .++.||||.+.... ...++.+|++++.+++|++++..+..+ .+.+..++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 45567899999999999999764 46789999875432 234688999999999988877776666 6667789999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCccccccc
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~ 632 (766)
||+ +++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 9999999974 4578999999999999999999995 499999999999999 7899999999999987765
Q ss_pred CCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 633 NQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 633 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 43211 1134578999999999999999999999999999999999999997543221111111111110000000
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.. ....+..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 241 ~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 241 VL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 01235688999999999999999999999999988653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.77 Aligned_cols=273 Identities=22% Similarity=0.314 Sum_probs=209.2
Q ss_pred HHHHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc--CCCCCeeeEeeeeec
Q 037189 471 YKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ--THHKNLVRLLGFCDE 548 (766)
Q Consensus 471 ~~~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~ 548 (766)
..+.....+.+.+.||+|+||.||+|+.. ++.||||.+.. .....+.+|++++.. ++||||+++++++..
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEET-----TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEEc-----CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 34556667778899999999999999873 57899999864 345678888888877 789999999999988
Q ss_pred CC----ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCe
Q 037189 549 GQ----NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNA 619 (766)
Q Consensus 549 ~~----~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~ 619 (766)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||+|||... +.+|+||||||+|||++.++.+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence 76 789999999999999999754 5889999999999999999999321 3599999999999999999999
Q ss_pred EEeccCcccccccCCCcc--eeecccccCcccccccccCC------CCCcccCeeehhHHHHHHHhC----------CcC
Q 037189 620 RISDFGLAKLLTLNQSKT--IKTSIRGTKGYVAPEWFRNS------KITAKVDVYSFGVLLLEIIAC----------RKS 681 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~~sDV~s~Gvvl~elltg----------~~p 681 (766)
||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765543221 12345789999999999875 344789999999999999999 667
Q ss_pred CCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 682 FDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 682 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
|........ .... .......+.....+. .......++..+.+++.+||+.||++|||+.+|+++|+.+.+-
T Consensus 267 ~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDP-SVEE-MRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSC-CHHH-HHHHHTTSCCCCCCC---GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcc-cHHH-HHHHHHHHHhCCCCc---ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 754322110 0111 111111111111000 0011346778899999999999999999999999999987643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=325.17 Aligned_cols=248 Identities=29% Similarity=0.425 Sum_probs=196.8
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec----CCceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 553 (766)
.+.+.||+|+||.||+|.... .+..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeeccCCCCeEEEEeEecC---CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 355689999999999998764 46789999987533 2334678999999999999999999998865 34579
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+++++|.+++.....+++..++.++.|++.||.|||+. ..+|+||||||+||+++ +++.+||+|||++.....
T Consensus 106 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999998878899999999999999999999954 12399999999999998 789999999999976543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........ .......+....
T Consensus 185 ~~~----~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~---- 249 (290)
T 1t4h_A 185 SFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPA---- 249 (290)
T ss_dssp TSB----EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCCCG----
T ss_pred ccc----ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCCcc----
Confidence 321 34568999999998874 589999999999999999999999975332211 111111111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||.+|||+.++++.
T Consensus 250 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0112234578899999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.28 Aligned_cols=267 Identities=26% Similarity=0.370 Sum_probs=193.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHH--HccCCCCCeeeEeeeee-----cCCc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFV--IGQTHHKNLVRLLGFCD-----EGQN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~-----~~~~ 551 (766)
+.+.+.||+|+||.||+|+. .++.||||.+... ....+..|.++ +..++||||+++++.+. ....
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hheeeecccCCCeEEEEEEE-----CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 34568899999999999976 3578999998643 23445555444 55689999999998553 2335
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC------CCceecCCCccceEEEcCCCCeEEeccC
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------SSQIIHCDMKPQNILLDDHYNARISDFG 625 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~dlk~~NIll~~~~~~kl~Dfg 625 (766)
.++||||+++|+|.+++.... .++..+..++.||++||+|||+.+ ..+|+||||||+|||++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 689999999999999996654 488889999999999999999431 1299999999999999999999999999
Q ss_pred cccccccCCC------cceeecccccCcccccccccC-------CCCCcccCeeehhHHHHHHHhCCcCCCchhh-hhhh
Q 037189 626 LAKLLTLNQS------KTIKTSIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIACRKSFDIEMV-EEYA 691 (766)
Q Consensus 626 la~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~-~~~~ 691 (766)
+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+..... .+..
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 9987654321 111234569999999999987 4567899999999999999999877643221 1000
Q ss_pred hH----------HHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 692 IL----------TDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 692 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.. ................+.. ........+..+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 00 0001111111111000000 111234577889999999999999999999999999988763
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=336.69 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=185.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeee--------c
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCD--------E 548 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~--------~ 548 (766)
.+.+.+.||+|+||.||+|.... .++.||||++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred eEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34566899999999999999864 46789999987655555678999999999996 999999999983 3
Q ss_pred CCceEEEeeccCCCchhhhhcc---CCCCccchhhhHHHHHHHHHHHhhhcCCCc--eecCCCccceEEEcCCCCeEEec
Q 037189 549 GQNRLLVYEFLNNGTLASFLFG---NLKPNWNLRTNIAFQIARGLLYLHEDCSSQ--IIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivH~dlk~~NIll~~~~~~kl~D 623 (766)
....++||||+. |+|.+++.. ...+++..++.++.||+.||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 345789999996 799998864 45689999999999999999999954 6 99999999999999999999999
Q ss_pred cCcccccccCCCcc----------eeecccccCcccccccc---cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh
Q 037189 624 FGLAKLLTLNQSKT----------IKTSIRGTKGYVAPEWF---RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY 690 (766)
Q Consensus 624 fgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~ 690 (766)
||+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~- 260 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR- 260 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence 99998765432211 11134589999999998 56778999999999999999999999996432211
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+.............+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 261 ------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 ------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000011111111223457889999999999999999999999988764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.77 Aligned_cols=259 Identities=20% Similarity=0.321 Sum_probs=192.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||.||+|.... .++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4456889999999999998764 567999999865432 22456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-----CCCCeEEeccCcccccc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-----DHYNARISDFGLAKLLT 631 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~Dfgla~~~~ 631 (766)
||++ |+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9998 4999999988889999999999999999999995 4999999999999994 45569999999998765
Q ss_pred cCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc---c-
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK---L- 706 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~- 706 (766)
..... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+... . ......... .
T Consensus 189 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 189 IPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--K-IFEVLGLPDDTTWP 263 (329)
T ss_dssp -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H-HHHHHCCCCTTTST
T ss_pred Ccccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--H-HHHHhCCCchhhhh
Confidence 33221 1345689999999999875 58999999999999999999999997654322111 1 111110000 0
Q ss_pred ------------ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 707 ------------DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 707 ------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
................+.++.+++.+||+.||.+|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000000001113567889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=333.28 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=204.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||++.... .++.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3456789999999999999864 46789999986542 22346789999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999999887889999999999999999999995 4999999999999999999999999999987653322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. .....||..|+|||++.+..++.++||||||+++|||++|+.||......+.. ..+..+..
T Consensus 197 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~--------- 258 (335)
T 2owb_A 197 R--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY-------LRIKKNEY--------- 258 (335)
T ss_dssp C--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHHHHTCC---------
T ss_pred c--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH-------HHHhcCCC---------
Confidence 1 13456899999999999999999999999999999999999999765432211 11111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...+..+.+++.+||+.||++|||+.++++
T Consensus 259 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 012233567889999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.33 Aligned_cols=254 Identities=24% Similarity=0.350 Sum_probs=192.7
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--------ccCHHHHHHHHHHHccCCCCCeeeEeeee
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--------QDGEREFKNEVFVIGQTHHKNLVRLLGFC 546 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (766)
....+.+.+.||+|+||.||+|.... .++.||||.+.... ......+.+|+.++++++||||+++++++
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 33455667899999999999999875 46789999986532 11223588999999999999999999998
Q ss_pred ecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEec
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISD 623 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~D 623 (766)
.. +..++||||+++|+|.+++.....+++..+..++.|+++||+|||+. +|+||||||+|||++.+ ..+||+|
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred ec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 54 55799999999999999999888899999999999999999999954 99999999999999754 4599999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHH
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
||+++....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ + ...
T Consensus 286 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~----~~~ 356 (419)
T 3i6u_A 286 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--L----KDQ 356 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--H----HHH
T ss_pred cccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--H----HHH
Confidence 999987654321 234679999999999863 5788999999999999999999999975432111 1 111
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...+...... ......+..+.+++.+||+.||++|||+.+++++
T Consensus 357 i~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCc------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111111100 0011235778999999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=328.80 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=204.9
Q ss_pred cCHHHHHHHHHhhh-hhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC-CCCeeeEee
Q 037189 469 FSYKELEEATDNFK-EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH-HKNLVRLLG 544 (766)
Q Consensus 469 ~~~~~l~~~t~~f~-~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g 544 (766)
|...+.....+.+. +.||+|+||.||+|.... .++.||||.+.... .....++.+|+.++.+++ ||||+++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34444445555555 789999999999999864 46799999987533 334678999999999985 699999999
Q ss_pred eeecCCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCe
Q 037189 545 FCDEGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNA 619 (766)
Q Consensus 545 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~ 619 (766)
++.+.+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCE
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcE
Confidence 999999999999999999999998654 678999999999999999999995 49999999999999987 7899
Q ss_pred EEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH
Q 037189 620 RISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699 (766)
Q Consensus 620 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 699 (766)
||+|||+++........ ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+....
T Consensus 174 kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~------ 244 (327)
T 3lm5_A 174 KIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN------ 244 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------
T ss_pred EEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH------
Confidence 99999999876543221 345689999999999999999999999999999999999999976543321110
Q ss_pred HhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...... ..........+..+.+++.+||+.||++|||++++++.
T Consensus 245 -i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 -ISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp -HHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred -HHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111110 01111122346778899999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=343.80 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=188.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCC--ce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQ--NR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~~ 552 (766)
.+.+.+.||+|+||.||+|.... .++.||||++.... ....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TEEEEEC-------CEEEEEETT---TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 45566899999999999998864 46789999986432 233456889999999997 999999999997544 68
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++|||||+ ++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence 99999998 589998876 468888999999999999999995 4999999999999999999999999999987543
Q ss_pred CC-------------------CcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh
Q 037189 633 NQ-------------------SKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692 (766)
Q Consensus 633 ~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~ 692 (766)
.. .........||+.|+|||++.+ ..++.++|||||||++|||++|++||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 11 1111234679999999999986 678999999999999999999999997654322111
Q ss_pred HHHHHHHHhhcCccc---eec------------------cCcccC------------CCcHHHHHHHHHHHHHccccCCC
Q 037189 693 LTDWAFDCYRNGKLD---ALV------------------GGDMEA------------MNDVECLEKLVMVSIWCIQEDPS 739 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~---~~~------------------~~~~~~------------~~~~~~~~~l~~l~~~Cl~~dp~ 739 (766)
. +.......... .+. ...... ......+.++.+|+.+||+.||+
T Consensus 242 ~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 242 R---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp H---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred H---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 1 11110000000 000 000000 00012356788999999999999
Q ss_pred CCCCHHHHHHH
Q 037189 740 LRPTIKKVLQM 750 (766)
Q Consensus 740 ~RPt~~~vl~~ 750 (766)
+|||+.|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999876
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.72 Aligned_cols=263 Identities=25% Similarity=0.351 Sum_probs=198.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred heeeeEEeecCCEEEEEEEECC---CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4456789999999999999864 4678999998654332 2456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 999999999998878889999999999999999999995 49999999999999999999999999999876543221
Q ss_pred ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH--------HHHHhhcCc-c
Q 037189 637 TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW--------AFDCYRNGK-L 706 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~-~ 706 (766)
.....||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....... ....+.... .
T Consensus 181 --~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 181 --YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred --cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 1345689999999999875 789999999999999999999999976543221110000 000001000 0
Q ss_pred ceeccCcccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 707 DALVGGDMEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 707 ~~~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.....+...... ....++.+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000001111001 1134678999999999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=322.58 Aligned_cols=252 Identities=25% Similarity=0.330 Sum_probs=198.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc----ccCHHHHHHHHHHHccCCCCCeeeEeeee--ecCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----QDGEREFKNEVFVIGQTHHKNLVRLLGFC--DEGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~--~~~~~~ 552 (766)
+.+.+.||+|+||.||++.... .+..+|||.+.... ......+.+|++++++++||||+++++++ .+....
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred eeEeeEEecCCCeEEEEEEECC---CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4466889999999999998754 46789999986532 23457799999999999999999999998 445688
Q ss_pred EEEeeccCCCchhhhhcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
++||||++++ |.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 6666654 4568899999999999999999995 49999999999999999999999999999877
Q ss_pred ccCCCcceeecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.............||+.|+|||.+.+.. .+.++||||||+++|||++|+.||........ ...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~-- 230 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKGSY-- 230 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCC--
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcCCC--
Confidence 5443333334567899999999998654 47899999999999999999999976543221 111111111
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV 754 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~ 754 (766)
..+..++..+.+++.+||+.||.+|||+.++++. +.+.
T Consensus 231 --------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 --------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp --------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred --------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1122345678899999999999999999999964 4443
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.59 Aligned_cols=266 Identities=24% Similarity=0.294 Sum_probs=194.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+.+.+.||+|+||.||+|.... .++.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 4456789999999999999864 467899999854322 23467899999999999999999999997653
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 459999999 8899999876 468899999999999999999995 49999999999999999999999999999875
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHH--------HHHh
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWA--------FDCY 701 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~ 701 (766)
... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||......+........ ...+
T Consensus 179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 432 134578999999999887 67999999999999999999999999765432211100000 0000
Q ss_pred hcCc-------cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCC
Q 037189 702 RNGK-------LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEVS 758 (766)
Q Consensus 702 ~~~~-------~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~~ 758 (766)
.... +......... ......+..+.+|+.+||+.||.+|||+.+++++ ++.+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 318 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC---
T ss_pred hhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCc
Confidence 0000 0000000000 0112345678899999999999999999999984 56555443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=327.49 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=199.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeee--cCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~l 554 (766)
+.+.+.||+|+||.||++.... +++.+|+|.+.... ....+.+.+|+.++++++||||+++++++. .....++
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred eeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 3456789999999999999864 46789999987532 233467899999999999999999999874 4567899
Q ss_pred EeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcC--CCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 555 VYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
||||+++++|.+++... ..+++..++.++.|++.||+|||+.. ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999753 34899999999999999999999751 1229999999999999999999999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
........ .....|+..|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+..+....
T Consensus 165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~~~~~ 235 (279)
T 2w5a_A 165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKIREGKFRR 235 (279)
T ss_dssp HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCC
T ss_pred eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------HHHHhhccccc
Confidence 76543221 1235689999999999999999999999999999999999999976543221 11122222111
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
.+...+.++.+++.+||+.||.+|||+.+|++.+..
T Consensus 236 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 236 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ---------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 122346788999999999999999999999987744
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=320.41 Aligned_cols=246 Identities=27% Similarity=0.394 Sum_probs=195.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECC---CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 3456789999999999999864 46789999986532 33456899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++.....+++..+..++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 99999999999998877889999999999999999999965 999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ......+..
T Consensus 167 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~-------- 228 (276)
T 2h6d_A 167 ---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGGVF-------- 228 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC--------
T ss_pred ---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcCcc--------
Confidence 134568999999999988765 6899999999999999999999976443221 111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 229 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 --YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0122235678899999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=346.00 Aligned_cols=252 Identities=26% Similarity=0.348 Sum_probs=200.7
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
...+.+.+.||+|+||.||+|.... .+..+|||.+.... ......+.+|+.++++++||||+++++++.+....+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 3456677899999999999999864 46789999987532 334578999999999999999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEeccCccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISDFGLAKLL 630 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~ 630 (766)
+||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||+++..
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 999999999999999888889999999999999999999995 499999999999999764 45999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
..... .....||+.|+|||++. ..++.++|||||||++|+|++|+.||......+. ...+..+....
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~-- 256 (494)
T 3lij_A 190 ENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVEKGKYTF-- 256 (494)
T ss_dssp BTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCC--
T ss_pred CCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC--
Confidence 54332 23467999999999986 5699999999999999999999999976544321 11111221110
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+..+.+++.+||+.||.+|||+.+++++
T Consensus 257 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 ----DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ----CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ----CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000012345678899999999999999999998853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.91 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=205.6
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
....+.+.+.||+|+||.||++.... .++.||||.+... .......+.+|++++++++||||+++++++.+....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 34557778899999999999999864 4678999998643 234567899999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCcccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKL 629 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~ 629 (766)
++||||+++|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999999999888889999999999999999999995 4999999999999995 456799999999987
Q ss_pred cccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 630 LTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 630 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||......+. ...+..+....
T Consensus 174 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~- 241 (486)
T 3mwu_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYAF- 241 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCCS-
T ss_pred CCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCCC-
Confidence 654322 134579999999999976 589999999999999999999999976543221 11111221110
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........+..+.+++.+||+.||.+|||+.+++++
T Consensus 242 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -----CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -----CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001112346778999999999999999999999974
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=338.62 Aligned_cols=244 Identities=24% Similarity=0.292 Sum_probs=188.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHc-cCCCCCeeeEeeeeec----CCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG-QTHHKNLVRLLGFCDE----GQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~----~~~~~lV~E 557 (766)
+.||+|+||.||++.... .++.||||+++. ...+.+|+.++. ..+||||+++++++.. ....+||||
T Consensus 68 ~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E 139 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 139 (400)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeccCeEEEEEEECC---CCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEE
Confidence 579999999999999864 467899999863 246788888874 4589999999998865 557899999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 632 (766)
|+++|+|.+++... ..+++..+..|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 140 ~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 140 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp CCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred eCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999999999865 358999999999999999999995 49999999999999997 78999999999986553
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh-hHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-ILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 711 (766)
... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .+..+...
T Consensus 217 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~---- 285 (400)
T 1nxk_A 217 HNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYE---- 285 (400)
T ss_dssp -------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCC----
T ss_pred CCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCccc----
Confidence 322 23467899999999999999999999999999999999999999754432110 0111 11111110
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+.++.+|+.+||+.||++|||+.+++++
T Consensus 286 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 --FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000112346778999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=347.51 Aligned_cols=252 Identities=25% Similarity=0.319 Sum_probs=207.4
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
....+.+.+.||+|+||.||++.... .++.||||.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34566677899999999999999864 46789999986432 3456789999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAK 628 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~ 628 (766)
.++||||+.+|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999999999988889999999999999999999995 499999999999999 567899999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
........ ....||+.|+|||++.+ .++.++|||||||++|+|++|++||......+. ...+..+....
T Consensus 178 ~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~~ 246 (484)
T 3nyv_A 178 HFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-------LKKVEKGKYTF 246 (484)
T ss_dssp HBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC
T ss_pred Eccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCCC
Confidence 76544322 34569999999999876 689999999999999999999999976543321 11122221110
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
........+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ------ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ------CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 00111234677899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.03 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=195.8
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccCCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNG 562 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (766)
..||+|+||.||+|.... .+..||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 28 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLS---NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp CEEEECSSSEEEEEEETT---TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEeecCcEEEEEEEECC---CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 379999999999999764 46789999998766666778999999999999999999999999999999999999999
Q ss_pred chhhhhccC---CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCcccccccCCCcce
Q 037189 563 TLASFLFGN---LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 563 sL~~~l~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+|.+++... ..+++..+..++.|+++||.|||+ .+|+|+||||+||+++. ++.+||+|||++.........
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 999999754 245678888999999999999995 49999999999999987 899999999999876543211
Q ss_pred eecccccCcccccccccCCC--CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 639 KTSIRGTKGYVAPEWFRNSK--ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~--~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....|++.|+|||.+.+.. ++.++||||||+++|||++|+.||........... ..... . ...
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~-~---------~~~ 245 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF----KVGMF-K---------VHP 245 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH----HHHHH-C---------CCC
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH----hhccc-c---------ccc
Confidence 13456899999999997654 88999999999999999999999964332211100 00000 0 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||++|||+.++++.
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1123346788899999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=323.17 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=203.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+...+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHhhhhcccCCeEEEEEEECC---CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3456789999999999998764 46789999987543 3445789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++++|.+++.. ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 9999999999865 468899999999999999999995 49999999999999999999999999999876543321
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... .....+... .
T Consensus 176 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~---------~ 238 (303)
T 3a7i_A 176 -RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-------FLIPKNNPP---------T 238 (303)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------HHHHHSCCC---------C
T ss_pred -cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-------HHhhcCCCC---------C
Confidence 13456899999999999999999999999999999999999999754332211 111111111 1
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 122345678899999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=343.20 Aligned_cols=260 Identities=23% Similarity=0.269 Sum_probs=191.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------C
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------Q 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 550 (766)
+.+.+.||+|+||.||+|.... .++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4456789999999999998764 4678999999753 233356789999999999999999999999654 3
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+.++||||++++ |.+.+.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 569999999865 5555543 48889999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHH-------------
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDW------------- 696 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~------------- 696 (766)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +...
T Consensus 215 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 215 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp --CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred CCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 54322 245679999999999999999999999999999999999999997654322111 1000
Q ss_pred --HHHHhhcCc-cc-----eeccCccc---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 697 --AFDCYRNGK-LD-----ALVGGDME---AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 697 --~~~~~~~~~-~~-----~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......... .. ........ .......+.++.+|+.+||+.||++|||++|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00 00000000 00011236778999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=359.65 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=206.9
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+.+.+.||+|+||.||+|.+...+.....||||.++.... ...+.|.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3445667889999999999999876655678899999875332 23467999999999999999999999985 456899
Q ss_pred EeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
||||+++|+|.+++... ..+++..++.++.|+++||.|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 99999999999999755 468899999999999999999995 49999999999999999999999999999876543
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. . ..+..+..
T Consensus 545 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~----~~i~~~~~------ 610 (656)
T 2j0j_A 545 TYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I----GRIENGER------ 610 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H----HHHHHTCC------
T ss_pred ccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---H----HHHHcCCC------
Confidence 3221 123456789999999999999999999999999999997 9999975443221 1 11111111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..++..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 611 ---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1123345678899999999999999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.56 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=199.7
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-----CCCeeeEeeeeecC
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-----HKNLVRLLGFCDEG 549 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----H~niv~l~g~~~~~ 549 (766)
....+.+.++||+|+||.||+|.... .++.||||.++.. ....+.+..|+.++.+++ ||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 33445566899999999999999864 4678999998642 234456788999998886 99999999999999
Q ss_pred CceEEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC------------
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD------------ 615 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~------------ 615 (766)
+..++||||+ +++|.+++.... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence 9999999999 999999997653 58889999999999999999995 59999999999999975
Q ss_pred -------------CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 616 -------------HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 616 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998654322 3456899999999999999999999999999999999999999
Q ss_pred CchhhhhhhhHHHH---------HHHHhhcCccceeccCccc-----CCCc---------------HHHHHHHHHHHHHc
Q 037189 683 DIEMVEEYAILTDW---------AFDCYRNGKLDALVGGDME-----AMND---------------VECLEKLVMVSIWC 733 (766)
Q Consensus 683 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~-----~~~~---------------~~~~~~l~~l~~~C 733 (766)
......+....... ................... .... ....+.+.+++.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 76543222111110 0000000000000000000 0000 00125678999999
Q ss_pred cccCCCCCCCHHHHHH
Q 037189 734 IQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 734 l~~dp~~RPt~~~vl~ 749 (766)
|+.||++|||+.|+++
T Consensus 340 L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 340 LQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCSSGGGSCCHHHHTT
T ss_pred hcCChhhCCCHHHHhc
Confidence 9999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=321.15 Aligned_cols=243 Identities=22% Similarity=0.313 Sum_probs=197.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
..+.+.+.||+|+||.||+|.... .++.||||.+.... .....++.+|+..+.++ +||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 445566899999999999999864 46799999987532 33456789999999998 9999999999999999999
Q ss_pred EEeeccCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--------------
Q 037189 554 LVYEFLNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-------------- 615 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-------------- 615 (766)
+||||+++++|.+++... ..+++..++.++.||++||+|||+ .+|+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999999999764 568999999999999999999995 49999999999999984
Q ss_pred -----CCCeEEeccCcccccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhh
Q 037189 616 -----HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689 (766)
Q Consensus 616 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~ 689 (766)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||+++|||++|.+++......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~- 237 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW- 237 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH-
T ss_pred cccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH-
Confidence 4479999999998765432 23589999999999876 6678999999999999999999877543211
Q ss_pred hhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 690 YAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+..+.... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 238 ---------~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 238 ---------HEIRQGRLPR---------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---------HHHHTTCCCC---------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------HHHHcCCCCC---------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1112222211 122345778999999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.59 Aligned_cols=258 Identities=23% Similarity=0.342 Sum_probs=182.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .+..||||.+.... ....+++.+|+.++++++||||+++++++...+..++|||
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CEEEEECC---CCCEEEEEC-------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhheeccccceEEEEEEECC---CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 4456889999999999998753 45789999986433 3345678999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc--------CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 558 FLNNGTLASFLFG--------NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 558 y~~~gsL~~~l~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
|+++++|.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999863 4568899999999999999999995 4999999999999999999999999999987
Q ss_pred cccCCCc---ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 630 LTLNQSK---TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 630 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..... +.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~~ 243 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ-ND 243 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHT-SS
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhc-cC
Confidence 6543211 11234568999999999876 56899999999999999999999999764432211 01111 11
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.................+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11110000001111234567889999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=343.45 Aligned_cols=236 Identities=14% Similarity=0.144 Sum_probs=184.4
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHH---HHHccCCCCCeeeEe-------eee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEV---FVIGQTHHKNLVRLL-------GFC 546 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~~ 546 (766)
.+.+.||+|+||.||+|.... .++.||||.+... .....+.|.+|+ +++++++||||++++ +++
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred EEcceeecCCCEEEEEEEECC---CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 345789999999999999754 4679999999743 233457789999 556666899999998 555
Q ss_pred ecCC-----------------ceEEEeeccCCCchhhhhccCCCCc-------cchhhhHHHHHHHHHHHhhhcCCCcee
Q 037189 547 DEGQ-----------------NRLLVYEFLNNGTLASFLFGNLKPN-------WNLRTNIAFQIARGLLYLHEDCSSQII 602 (766)
Q Consensus 547 ~~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~l~-------~~~~~~i~~~ia~gL~yLH~~~~~~iv 602 (766)
.+.+ ..++||||+ +|+|.+++.....++ +..++.|+.||++||+|||+. +|+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iv 228 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 228 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 5443 278999999 689999997644343 478889999999999999954 999
Q ss_pred cCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCC-----------CCCcccCeeehhHH
Q 037189 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-----------KITAKVDVYSFGVL 671 (766)
Q Consensus 603 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDV~s~Gvv 671 (766)
||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999986332 1244567 999999999887 89999999999999
Q ss_pred HHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 672 LLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 672 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+|||++|+.||........ ...+... ....+.++.+++.+||+.||++|||+.++++
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC---------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc---------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999965432111 1111110 1123567889999999999999999999985
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.47 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=199.8
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.+.||+|+||.||+|.... .++.||||.+... ...+++.+|+.++.+++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 3345566889999999999998864 4678999998753 3457899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++. ....+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999997 45678999999999999999999995 499999999999999999999999999998765432
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ..... .
T Consensus 180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~-------~ 243 (314)
T 3com_A 180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMI-PTNPP-------P 243 (314)
T ss_dssp SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH-HHSCC-------C
T ss_pred cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHH-hcCCC-------c
Confidence 21 1345689999999999999999999999999999999999999975433211 0111 11110 0
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11112334577899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.14 Aligned_cols=261 Identities=25% Similarity=0.301 Sum_probs=197.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-----CHHHHHHHHHHHccCCCCCeeeEeeeeecCCce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
.+.+.+.||+|+||.||+|.... .++.||||.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred ccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 45566899999999999999764 4678999998643221 134688999999999999999999999999999
Q ss_pred EEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 553 LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
++||||+++ +|.+++... ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 999999986 888888764 468899999999999999999995 489999999999999999999999999998765
Q ss_pred cCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce--
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA-- 708 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 708 (766)
..... .....+|+.|+|||.+.+. .++.++||||||+++|||++|.+||......+. +. .+...........
T Consensus 164 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~-~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 164 SPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LT-RIFETLGTPTEEQWP 238 (346)
T ss_dssp SCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-HHHHHHCCCCTTTSS
T ss_pred CCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HH-HHHHHcCCCChhhhh
Confidence 33221 2345789999999999764 589999999999999999999999976543221 11 1111111100000
Q ss_pred ----eccC---cccCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 709 ----LVGG---DMEAMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 709 ----~~~~---~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
+.+. ......+ ...+..+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 0000001 2235788999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=342.74 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=184.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeec-----CCc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 551 (766)
+.+.+.||+|+||.||+|.... .++.||||++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp EEECCC-------CEEEEEECC-----CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred eEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4567899999999999999864 467999999865322 234678999999999999999999999843 357
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.++||||+. ++|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 899999975 7999999888889999999999999999999995 499999999999999999999999999998765
Q ss_pred cCCCc-------------------------ceeecccccCcccccccc-cCCCCCcccCeeehhHHHHHHHh--------
Q 037189 632 LNQSK-------------------------TIKTSIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIIA-------- 677 (766)
Q Consensus 632 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~s~Gvvl~ellt-------- 677 (766)
..... .......||+.|+|||++ ....++.++|||||||+||||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 32211 112445789999999986 56679999999999999999999
Q ss_pred ---CCcCCCchhhhh-----------------hhhHHHHHHHHhhcCccc-----------eecc---Ccc---cCCCcH
Q 037189 678 ---CRKSFDIEMVEE-----------------YAILTDWAFDCYRNGKLD-----------ALVG---GDM---EAMNDV 720 (766)
Q Consensus 678 ---g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~-----------~~~~---~~~---~~~~~~ 720 (766)
|+++|....... .......+...+...... ..+. ... ......
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 566664322100 000000111111000000 0000 000 000012
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 721 ~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+.++.+|+.+||+.||++|||++|++++
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 235778899999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=342.71 Aligned_cols=259 Identities=18% Similarity=0.221 Sum_probs=203.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|.... .++.||||.+.... ...++.+|++++..++| +++..+..++.+.+..+||||
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4456889999999999999764 46789999876533 23468899999999987 566666677778888999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---cCCCCeEEeccCcccccccC
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL---DDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~ 633 (766)
|+ +++|.+++.. ...+++..++.|+.||+.||+|||+ .+|+||||||+|||| +.++.+||+|||+++.+...
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 9999999974 5678999999999999999999995 499999999999999 68899999999999877654
Q ss_pred CCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 634 QSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 634 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.... ......||..|+|||.+.+..++.++|||||||+||||++|+.||..............+........+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 3221 11256799999999999999999999999999999999999999976433221111111111111111111
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+. ..++.++.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 240 l~---------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 240 LC---------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HH---------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred Hh---------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 10 123568899999999999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=357.02 Aligned_cols=247 Identities=25% Similarity=0.301 Sum_probs=205.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (766)
.+.+.+.||+|+||.||+|.... .++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 34556789999999999999875 4678999999743 234456788999999987 7999999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.....
T Consensus 419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 999999999999999988889999999999999999999995 49999999999999999999999999999864332
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
... ....+||+.|+|||++.+..++.++||||||++||||++|+.||......+. ...+.++..
T Consensus 496 ~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~------- 559 (674)
T 3pfq_A 496 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEHNV------- 559 (674)
T ss_dssp TCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHSSCC-------
T ss_pred Ccc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhCCC-------
Confidence 221 2456799999999999999999999999999999999999999986543321 111122211
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTI-----KKVLQ 749 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~ 749 (766)
..+...+.++.+|+.+||+.||++||++ +||++
T Consensus 560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1123456788999999999999999997 67764
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.75 Aligned_cols=259 Identities=22% Similarity=0.340 Sum_probs=192.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC-HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.+.||+|+||.||+|.... .++.||||.+....... ...+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 3456789999999999999864 46789999986533222 2246689999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|++ ++|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc
Confidence 998 5888888764 458899999999999999999995 49999999999999999999999999999865433211
Q ss_pred ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---ccceeccC
Q 037189 637 TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---KLDALVGG 712 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 712 (766)
.....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... +....... ........
T Consensus 157 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 157 --YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF---IFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCTTTSTTGGGC
T ss_pred --cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHhchhhhcc
Confidence 134568999999999876 5689999999999999999999999976554332111 11111110 00000000
Q ss_pred ---------cccC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 713 ---------DMEA----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 713 ---------~~~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 001123567889999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.17 Aligned_cols=266 Identities=20% Similarity=0.260 Sum_probs=197.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec-------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------- 548 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------- 548 (766)
.+.+.+.||+|+||.||+|.... .++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 34566889999999999999864 46789999986433 2234678899999999999999999999976
Q ss_pred -CCceEEEeeccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 549 -GQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 549 -~~~~~lV~Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
.+..++||||+++ +|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999986 66666654 4678999999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCCCc--ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 627 AKLLTLNQSK--TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 627 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
++.+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....................
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9876532221 11234568999999999876 45899999999999999999999999875543322211111110000
Q ss_pred Cccceecc----Ccc----c-CCCcHH------HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVG----GDM----E-AMNDVE------CLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~----~~~----~-~~~~~~------~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........ ... . ...... ....+.+|+.+||+.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000 000 0 000001 13568899999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.74 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=201.4
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--------CHHHHHHHHHHHccC-CCCCeeeEeeeeec
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--------GEREFKNEVFVIGQT-HHKNLVRLLGFCDE 548 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 548 (766)
.+.+.+.||+|+||.||+|.+.. ++..||||.++..... ..+.+.+|+.++.++ +||||+++++++..
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 34445789999999999999864 4678999998754321 134678999999998 79999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
....++||||+++++|.+++.....+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 99999999999999999999887789999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCCCcceeecccccCcccccccccC------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
.+...... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...+.
T Consensus 249 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-------~~~i~ 318 (365)
T 2y7j_A 249 HLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM-------LRMIM 318 (365)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred ccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHH
Confidence 77644322 34679999999999863 3588999999999999999999999975433221 11111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+..... .+. ....+..+.+++.+||+.||++|||+.++++.
T Consensus 319 ~~~~~~~-~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 319 EGQYQFS-SPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HTCCCCC-HHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hCCCCCC-Ccc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111100 000 01234678899999999999999999999873
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=323.71 Aligned_cols=250 Identities=20% Similarity=0.314 Sum_probs=197.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.+.||+|+||.||+|.... .+..+|+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred eeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 4456789999999999999864 4678999999876666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++++|.+++.. ...+++..+..++.|+++||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-- 172 (302)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH--
T ss_pred CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc--
Confidence 999999999875 4668999999999999999999995 4999999999999999999999999998764322111
Q ss_pred eeecccccCcccccccc-----cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 638 IKTSIRGTKGYVAPEWF-----RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~-----~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ....... ...
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~-~~~----- 240 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS-DPP----- 240 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-CCC-----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhcc-CCc-----
Confidence 11335689999999998 466789999999999999999999999975443221 1111111 110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 241 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 --TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111233446778999999999999999999998763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.46 Aligned_cols=247 Identities=27% Similarity=0.319 Sum_probs=200.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
.+.||+|+||.||+++... .++.+|||++.... ......+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 4579999999999999864 46799999996432 34456789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC----CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 559 LNNGTLASFLFGN----LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 559 ~~~gsL~~~l~~~----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 267 ~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp CTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 9999999998753 368899999999999999999995 499999999999999999999999999998765443
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +.........
T Consensus 344 ~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~i~~~~~-------- 410 (543)
T 3c4z_A 344 TK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQRVLEQAV-------- 410 (543)
T ss_dssp CC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHHHHHCCC--------
T ss_pred cc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHHHhhccc--------
Confidence 22 1345799999999999999999999999999999999999999976432110 001 1111111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTI-----KKVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~-----~~vl~ 749 (766)
..+...+..+.+++.+||+.||.+||++ .++++
T Consensus 411 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 --TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1123456788899999999999999975 56653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=344.21 Aligned_cols=249 Identities=25% Similarity=0.331 Sum_probs=200.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-------------cCHHHHHHHHHHHccCCCCCeeeEeee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-------------DGEREFKNEVFVIGQTHHKNLVRLLGF 545 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 545 (766)
+.+.++||+|+||.||+|.... .+..+|||.+..... ...+.+.+|+.++++++||||++++++
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4566899999999999999864 467899999865321 335679999999999999999999999
Q ss_pred eecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC---CeEEe
Q 037189 546 CDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---NARIS 622 (766)
Q Consensus 546 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---~~kl~ 622 (766)
+.+....++||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 99999999999999999999999888889999999999999999999995 4999999999999998775 69999
Q ss_pred ccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
|||+++........ ....||+.|+|||++. ..++.++||||||+++|+|++|+.||......+. ...+.
T Consensus 192 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~ 260 (504)
T 3q5i_A 192 DFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-------IKKVE 260 (504)
T ss_dssp CCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred ECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH
Confidence 99999877544321 3457999999999987 4689999999999999999999999986543321 11112
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+...... ......+.++.+++.+||+.||.+|||+.++++.
T Consensus 261 ~~~~~~~~------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 261 KGKYYFDF------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HCCCCCCH------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cCCCCCCc------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22111000 0001235678999999999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=337.46 Aligned_cols=198 Identities=26% Similarity=0.416 Sum_probs=164.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----C
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----Q 550 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~ 550 (766)
.+.+.+.||+|+||.||+|.... .++.||||++..... ...+.+.+|++++++++||||+++++++... .
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 34567899999999999999864 467899999975322 2346789999999999999999999999766 5
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+. ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 7899999987 5999999988889999999999999999999995 49999999999999999999999999999976
Q ss_pred ccCCCc--------------------ceeecccccCcccccccc-cCCCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 631 TLNQSK--------------------TIKTSIRGTKGYVAPEWF-RNSKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 631 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
...... .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 543221 112456799999999986 5667999999999999999999855444
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=324.61 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=197.2
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--------ccCHHHHHHHHHHHccCCCCCeeeEeeee
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--------QDGEREFKNEVFVIGQTHHKNLVRLLGFC 546 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (766)
....+.+.+.||+|+||.||+|.... .++.||||.+.... ......+.+|++++++++||||+++++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 34556677899999999999999864 46789999986432 11234588999999999999999999998
Q ss_pred ecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEec
Q 037189 547 DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARISD 623 (766)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 623 (766)
.... .++||||+++++|.+++.....+++..+..++.||++||.|||+ .+|+||||||+||+++.++. +||+|
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 7654 89999999999999999888889999999999999999999995 49999999999999987654 99999
Q ss_pred cCcccccccCCCcceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHH
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
||+++....... .....||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.. .
T Consensus 161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 231 (322)
T 2ycf_A 161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q 231 (322)
T ss_dssp CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence 999987643221 13356899999999974 56789999999999999999999999975432211 111 1
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+..+...... ......+..+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNFIP------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCCCH------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccccCc------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111111000 001123567899999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=318.72 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=202.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---------cCHHHHHHHHHHHccCC-CCCeeeEeeeeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---------DGEREFKNEVFVIGQTH-HKNLVRLLGFCDE 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 548 (766)
+.+.+.||+|+||.||+|.... .++.||||.++.... ...+.+.+|++++.++. ||||+++++++.+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cceeeeecCCCceEEEEEEEcC---cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 3455789999999999999864 467899999875431 12356889999999995 9999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
....++||||+++++|.+++.....+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999887889999999999999999999995 499999999999999999999999999998
Q ss_pred ccccCCCcceeecccccCccccccccc------CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFR------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
........ ....+++.|+|||.+. ...++.++||||||+++|||++|+.||........ ...+.
T Consensus 173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~ 242 (298)
T 1phk_A 173 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMIM 242 (298)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred hcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH-------HHHHh
Confidence 76543322 3456899999999985 45688999999999999999999999975443221 11111
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+... .........+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111 001112345678899999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=334.51 Aligned_cols=250 Identities=10% Similarity=0.044 Sum_probs=179.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc---cCHHHHHHHH---HHHccCCCCCeeeEe-------ee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ---DGEREFKNEV---FVIGQTHHKNLVRLL-------GF 545 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~---~~~~~f~~E~---~~l~~l~H~niv~l~-------g~ 545 (766)
+.+.+.||+|+||.||+|.... .++.||||.+..... ...+.+.+|+ ..|+. +||||++++ ++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred eeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 3456789999999999999864 467999999986432 2345577774 55555 799988755 34
Q ss_pred eecC-----------------CceEEEeeccCCCchhhhhccC-CCCccchh------hhHHHHHHHHHHHhhhcCCCce
Q 037189 546 CDEG-----------------QNRLLVYEFLNNGTLASFLFGN-LKPNWNLR------TNIAFQIARGLLYLHEDCSSQI 601 (766)
Q Consensus 546 ~~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~i 601 (766)
+... ...++||||++ |+|.+++... ..+.+..+ ..++.||++||+|||+ .+|
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~i 215 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGL 215 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCC
Confidence 4322 23799999999 8999999763 34566666 7888999999999995 499
Q ss_pred ecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCC
Q 037189 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACR 679 (766)
Q Consensus 602 vH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~ 679 (766)
+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998664221 24557799999999987 67999999999999999999999
Q ss_pred cCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 680 KSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 680 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.||.......... +.....................+..+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997653321100 0000000111111111112345678999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=320.45 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=197.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeec--CCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDE--GQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.++. ...+.+.+|++++.+++ ||||+++++++.+ ....++|
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred eEEEEEecccCCeEEEEEEECC---CCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 4566889999999999998764 467899999863 34678999999999997 9999999999987 6678999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~ 634 (766)
|||+++++|.+++. .+++..+..++.||++||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 112 ~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999985 37888999999999999999995 4999999999999999776 89999999998765443
Q ss_pred CcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh--hHHH-----HHHHHhhcCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA--ILTD-----WAFDCYRNGKL 706 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~--~~~~-----~~~~~~~~~~~ 706 (766)
.. ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... .... ...........
T Consensus 186 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 186 EY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred cc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 22 34568999999999987 67899999999999999999999999543221110 0000 00000100000
Q ss_pred --------------ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 --------------DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 --------------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
................+.++.+++.+||+.||.+|||++|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000011111122356789999999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=333.03 Aligned_cols=256 Identities=24% Similarity=0.295 Sum_probs=179.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------C
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------Q 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 550 (766)
+.+.+.||+|+||.||+|.... .+..||||++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp EEEEEECC----CCEEEEEETT---TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred eEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4456789999999999998764 56799999986532 22346788999999999999999999998654 5
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 679999999 6899998865 568999999999999999999995 49999999999999999999999999999875
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC-----
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG----- 704 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 704 (766)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+.... +.......
T Consensus 183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~~ 254 (367)
T 2fst_X 183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELL 254 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHH
T ss_pred ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHHH
Confidence 432 134578999999999887 6789999999999999999999999976543221111 11111000
Q ss_pred ------ccceeccCccc-CCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 ------KLDALVGGDME-AMND-----VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 ------~~~~~~~~~~~-~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.....+..... .... ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000000 0000 1224678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=320.99 Aligned_cols=248 Identities=22% Similarity=0.305 Sum_probs=183.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CH-HHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GE-REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||++.... .++.||||+++..... .. +.+.++...++.++||||+++++++.+.+..++||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred hhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 4456889999999999999864 5679999998654222 22 33445556688899999999999999999999999
Q ss_pred eccCCCchhhhhc----cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 557 EFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 557 Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||++ |+|.+++. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9998 48877765 356789999999999999999999952 3899999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccc----cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.... ....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ . ..........
T Consensus 163 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~~~~~-- 232 (290)
T 3fme_A 163 DVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-Q----LKQVVEEPSP-- 232 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-H----HHHHHHSCCC--
T ss_pred cccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-H----HHHHhccCCC--
Confidence 3322 334689999999996 566789999999999999999999999974322111 1 1111111111
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.......+.++.+++.+||+.||++|||+.++++
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 233 -------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1112234577899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=332.07 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=191.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC---------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG--------- 549 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------- 549 (766)
+.+.+.||+|+||.||+|.... .++.||||++..... ...+|++++++++||||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred EEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 4556899999999999999864 467999999864322 235799999999999999999998432
Q ss_pred -----------------------------CceEEEeeccCCCchhhhhc----cCCCCccchhhhHHHHHHHHHHHhhhc
Q 037189 550 -----------------------------QNRLLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHED 596 (766)
Q Consensus 550 -----------------------------~~~~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~ 596 (766)
...++||||+++ +|.+.+. ....+++..+..++.||++||+|||
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-- 158 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-- 158 (383)
T ss_dssp ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 337899999994 7666654 4577899999999999999999999
Q ss_pred CCCceecCCCccceEEEc-CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHH
Q 037189 597 CSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLE 674 (766)
Q Consensus 597 ~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~e 674 (766)
+.+|+||||||+|||++ .++.+||+|||+++........ ....+|+.|+|||.+.+. .++.++|||||||++||
T Consensus 159 -~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 159 -SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp -TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred -HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 55999999999999998 6889999999999876544322 345689999999998765 48999999999999999
Q ss_pred HHhCCcCCCchhhhhhhhHHHHHHHHhhcC---------------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCC
Q 037189 675 IIACRKSFDIEMVEEYAILTDWAFDCYRNG---------------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPS 739 (766)
Q Consensus 675 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~ 739 (766)
|++|+.||......+... .. ....... ....+.........+...+..+.+|+.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~--~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLV--RI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHH--HH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHH--HH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999998654332111 10 0000000 00000011111111223466789999999999999
Q ss_pred CCCCHHHHHH
Q 037189 740 LRPTIKKVLQ 749 (766)
Q Consensus 740 ~RPt~~~vl~ 749 (766)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.96 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=196.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .+|+|.++... ....+.|.+|+.++++++||||+++++++.+....++||
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred eEEeeEeccCCceEEEEEEEcC------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4466899999999999998752 38888886432 233456889999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++++|.+++.... .+++..++.++.||++||+|||+. +|+||||||+||+++ ++.+||+|||+++.......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 9999999999998754 689999999999999999999954 999999999999998 67999999999876542211
Q ss_pred ---cceeecccccCcccccccccC---------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 636 ---KTIKTSIRGTKGYVAPEWFRN---------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 636 ---~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~ 257 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-------IWQMGT 257 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-------HHHHHT
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHhcc
Confidence 111133458999999999874 4578999999999999999999999976543221 111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCC
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~ 758 (766)
+..... .....+.++.+++.+||+.||++|||+.++++.|+.+.+-.
T Consensus 258 ~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 258 GMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp TCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111111 01123456889999999999999999999999999987553
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=314.01 Aligned_cols=254 Identities=25% Similarity=0.327 Sum_probs=204.6
Q ss_pred HHHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC
Q 037189 473 ELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ 550 (766)
Q Consensus 473 ~l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (766)
......+.+.+.||+|+||.||+|.... .++.||||.+.... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS 94 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC
Confidence 3445566777899999999999999864 46789999986533 335678999999999999999999999999999
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC---CCeEEeccCcc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH---YNARISDFGLA 627 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla 627 (766)
..++|+||+++++|.+++.....+++..++.++.||++||.|||+ .+++|+||||+||+++.+ ..+||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 999999999999999999877789999999999999999999995 499999999999999754 46999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
......... ....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||......+. ...+..+...
T Consensus 172 ~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~ 240 (287)
T 2wei_A 172 TCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYA 240 (287)
T ss_dssp GTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC
T ss_pred eeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCC
Confidence 876543221 23458899999999876 489999999999999999999999976543221 1111122111
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. ........+.++.+++.+||+.||++|||+.++++
T Consensus 241 ~------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 F------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp C------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00001234567899999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.20 Aligned_cols=255 Identities=20% Similarity=0.332 Sum_probs=201.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCH-----------------HHHHHHHHHHccCCCCCee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-----------------REFKNEVFVIGQTHHKNLV 540 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~-----------------~~f~~E~~~l~~l~H~niv 540 (766)
.+.+.+.||+|+||.||+|.. .+..||||.+........ +.|.+|+.++++++||||+
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345668899999999999987 367999999875332211 7899999999999999999
Q ss_pred eEeeeeecCCceEEEeeccCCCchhhh------hcc--CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 541 RLLGFCDEGQNRLLVYEFLNNGTLASF------LFG--NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 541 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
++++++.+.+..++||||+++++|.++ +.. ...+++..++.++.|++.||.|||+ ..+|+||||||+||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 999999999999999999999999999 665 5678999999999999999999995 159999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCC-CCCc-ccCeeehhHHHHHHHhCCcCCCchhhhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITA-KVDVYSFGVLLLEIIACRKSFDIEMVEEY 690 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDV~s~Gvvl~elltg~~p~~~~~~~~~ 690 (766)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999999999999876443 22456789999999999887 6666 9999999999999999999997644311
Q ss_pred hhHHHHHHHHhhcCccceeccC---------cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 691 AILTDWAFDCYRNGKLDALVGG---------DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
. ....+..+........ ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 260 -~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 -E----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp -H----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -H----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1111222211110000 0000001334678899999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.65 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=191.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCC--CCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||.||++... ++..+|||.+.... ....+.+.+|++++.+++ |+||+++++++.+.+..++
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred EEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 445678999999999999875 36789999986532 233467899999999997 5999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||| +.+++|.+++.....+++..+..++.|+++||.|||+ .+|+||||||+||++++ +.+||+|||+++......
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-----
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCcc
Confidence 999 6788999999988889999999999999999999995 49999999999999964 899999999998776544
Q ss_pred CcceeecccccCcccccccccC-----------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN-----------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
.........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........ ........
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~ 255 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAIIDP 255 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHCT
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----HHHHHHhc
Confidence 3322234568999999999875 4788899999999999999999999965322111 11111111
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 256 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 256 ---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111122235678899999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.96 Aligned_cols=260 Identities=23% Similarity=0.259 Sum_probs=188.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+.+.+.||+|+||.||+|.... .++.||||++.... ....+.+.+|+.++++++||||+++++++....
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred eeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4456789999999999998764 46789999987532 223467899999999999999999999997654
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCC-CHHHHHhh--ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 67999999985 78888753 47888999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HH---------------
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LT--------------- 694 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~--------------- 694 (766)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+... +.
T Consensus 178 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 178 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 53321 134578999999999999999999999999999999999999997654322110 00
Q ss_pred HHHHHHhhcCc------cceeccCccc---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 695 DWAFDCYRNGK------LDALVGGDME---AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 695 ~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........... .......... .......+..+.+|+.+||+.||.+|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000000 0000000000 00112346789999999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=331.11 Aligned_cols=196 Identities=24% Similarity=0.334 Sum_probs=168.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC------CCCCeeeEeeeeecCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT------HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 552 (766)
+.+.+.||+|+||.||+|.... .++.||||.++.. ....+++.+|++++..+ +|+||+++++++......
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred EEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4566899999999999998764 4679999999743 22345677888777776 577999999999999999
Q ss_pred EEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC--eEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN--ARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~ 628 (766)
++||||+. ++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++.++. +||+|||++.
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 6899988765 3488999999999999999999965 9999999999999999887 9999999997
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~ 687 (766)
...... ....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 251 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 654322 345789999999999999999999999999999999999999976554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.75 Aligned_cols=256 Identities=25% Similarity=0.283 Sum_probs=190.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC----C--ce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG----Q--NR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~ 552 (766)
+.+.+.||+|+||.||+|++.. .++.||||++.... ..+.+|++++++++||||+++++++... + ..
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 3456789999999999999864 46799999986432 2345799999999999999999988432 2 35
Q ss_pred EEEeeccCCCchhhhhc----cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-CCeEEeccCcc
Q 037189 553 LLVYEFLNNGTLASFLF----GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-YNARISDFGLA 627 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla 627 (766)
++||||+++ +|.+.+. ....+++..+..++.||++||+||| +.+|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 789999986 5555543 3567899999999999999999999 4599999999999999955 56899999999
Q ss_pred cccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHH-------
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD------- 699 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~------- 699 (766)
+.+...... ....+|+.|+|||++.+. .++.++|||||||+||||++|+.||......+.. ...+..
T Consensus 205 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTRE 279 (420)
T ss_dssp EECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHH
T ss_pred hhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHH
Confidence 876543322 345789999999999765 7999999999999999999999999765432211 111100
Q ss_pred Hhh--cCccceeccCcccC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 700 CYR--NGKLDALVGGDMEA-----MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 700 ~~~--~~~~~~~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+. .........+.... ......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000 00001110010000 0112345788999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.32 Aligned_cols=263 Identities=23% Similarity=0.284 Sum_probs=192.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc------e
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------R 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~ 552 (766)
+.+.+.||+|+||.||+|+... ...+|+|++..... ...+|++++++++||||+++++++..... .
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4566899999999999999863 33488888854322 23479999999999999999999854433 7
Q ss_pred EEEeeccCCCchhhhh---ccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASFL---FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~ 628 (766)
++||||++++.+.... .....+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8999999986544332 235678899999999999999999995 4999999999999999 79999999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhh-HHHHH-------HH
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI-LTDWA-------FD 699 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~-------~~ 699 (766)
........ ....+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+... +.... ..
T Consensus 191 ~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 191 ILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp ECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 76544322 345689999999998765 58999999999999999999999997654322111 11000 00
Q ss_pred H----hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 037189 700 C----YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVV 755 (766)
Q Consensus 700 ~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~ 755 (766)
. +.......+.............+.++.+|+.+||+.||.+|||+.|++++ ++++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 00000000000000011112245688999999999999999999999975 55543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.94 Aligned_cols=246 Identities=25% Similarity=0.394 Sum_probs=191.0
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeec------CCce
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDE------GQNR 552 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~------~~~~ 552 (766)
.+.+.||+|+||.||+|.... .++.||||.+... ......+.+|+.++.++ +||||+++++++.. ....
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred EEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 356889999999999999864 4678999998753 34457899999999998 79999999999976 4678
Q ss_pred EEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 LLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+||+++.++.+||+|||++...
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 9999999999999999764 467888999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
...... .....||+.|+|||++. +..++.++||||||+++|||++|+.||......... .... ...
T Consensus 180 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~-~~~ 250 (326)
T 2x7f_A 180 DRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIP-RNP 250 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHH-HSC
T ss_pred CcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH------HHhh-cCc
Confidence 432211 13456899999999987 567899999999999999999999999654332211 1111 111
Q ss_pred cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 706 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 251 APR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 112224567889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=321.04 Aligned_cols=261 Identities=22% Similarity=0.314 Sum_probs=200.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC------eeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN------LVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 551 (766)
.+.+.+.||+|+||.||+|.... ..+..||||.++.. ....+.+.+|++++.+++|+| ++++++++.+.+.
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHK--AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred ceEEEEEEecCCCeEEEEEEecC--CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45567899999999999998742 24678999998643 233467889999998887665 9999999999999
Q ss_pred eEEEeeccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--------------
Q 037189 552 RLLVYEFLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-------------- 615 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-------------- 615 (766)
.++||||+ +++|.+++.... .+++..+..++.||++||+|||+ .+|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999997654 57889999999999999999995 49999999999999987
Q ss_pred -----CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhh
Q 037189 616 -----HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY 690 (766)
Q Consensus 616 -----~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~ 690 (766)
++.+||+|||+++...... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6789999999998654322 345689999999999999999999999999999999999999976544332
Q ss_pred hhHHHHHH--------HHhhcCcc------c------------eeccC-cccCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 037189 691 AILTDWAF--------DCYRNGKL------D------------ALVGG-DMEAMNDVECLEKLVMVSIWCIQEDPSLRPT 743 (766)
Q Consensus 691 ~~~~~~~~--------~~~~~~~~------~------------~~~~~-~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt 743 (766)
........ ........ . ..... ..........++++.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 11111110 00000000 0 00000 0001123456788999999999999999999
Q ss_pred HHHHHHH
Q 037189 744 IKKVLQM 750 (766)
Q Consensus 744 ~~~vl~~ 750 (766)
+.|+++.
T Consensus 323 ~~ell~h 329 (339)
T 1z57_A 323 LREALKH 329 (339)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999854
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=329.38 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=198.4
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC--------CCCeeeEeeeee
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH--------HKNLVRLLGFCD 547 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~ 547 (766)
...+.+.++||+|+||.||+|.... .++.||||.++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 3446677899999999999998764 4678999999743 334567889999999885 788999999987
Q ss_pred ----cCCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----
Q 037189 548 ----EGQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY---- 617 (766)
Q Consensus 548 ----~~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~---- 617 (766)
+....++||||+. ++|.+++... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHHHH
T ss_pred ecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchhhh
Confidence 5668899999995 5555555433 5689999999999999999999952 2899999999999998775
Q ss_pred ---------------------------------------------CeEEeccCcccccccCCCcceeecccccCcccccc
Q 037189 618 ---------------------------------------------NARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652 (766)
Q Consensus 618 ---------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE 652 (766)
.+||+|||+++...... ....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCCh
Confidence 89999999998765432 3456899999999
Q ss_pred cccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh---hHHHHHHHHhhc--------Cc-----------cceec
Q 037189 653 WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA---ILTDWAFDCYRN--------GK-----------LDALV 710 (766)
Q Consensus 653 ~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~--------~~-----------~~~~~ 710 (766)
++.+..++.++|||||||+||||++|+.||......+.. ............ +. ...+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999754322111 001111111100 00 00000
Q ss_pred cCc---------ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 711 GGD---------MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 711 ~~~---------~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
... .....+...+..+.+|+.+||+.||++|||+.|++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0112346678889999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=325.86 Aligned_cols=264 Identities=20% Similarity=0.222 Sum_probs=185.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN------- 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------- 551 (766)
+.+.+.||+|+||.||+|.... .+..||||++... ......+.+|++.+..++||||+++++++.....
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp EEEC----------CEEEEETT---TCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence 3455789999999999999864 4678999998653 2334567788888999999999999999865433
Q ss_pred eEEEeeccCCCchh---hhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCcc
Q 037189 552 RLLVYEFLNNGTLA---SFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLA 627 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~---~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla 627 (766)
.++||||++++.+. .++.....+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+||+|||++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 78999999975332 3334566788899999999999999999943 459999999999999996 899999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH--------HH
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW--------AF 698 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------~~ 698 (766)
+........ ....||+.|+|||++.+. .++.++||||||+++|||++|+.||.............. ..
T Consensus 180 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3e3p_A 180 KKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256 (360)
T ss_dssp BCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence 876644322 345689999999998665 489999999999999999999999976543321111000 00
Q ss_pred HHhhcCcc-ceeccC------cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 699 DCYRNGKL-DALVGG------DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 699 ~~~~~~~~-~~~~~~------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........ ...... ..........+.++.+|+.+||+.||.+|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 000000 00011122246789999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.24 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=190.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee-----------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD----------- 547 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~----------- 547 (766)
+...+.||+|+||.||+|.... .++.||||++........+++.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp EEEEEECC-----CEEEEEETT---TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred eeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 3455789999999999999864 46799999997665556678999999999999999999999873
Q ss_pred ---cCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEec
Q 037189 548 ---EGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISD 623 (766)
Q Consensus 548 ---~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~D 623 (766)
+....++||||++ |+|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++ +++.+||+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999998 699999865 467889999999999999999995 4999999999999997 567999999
Q ss_pred cCcccccccCCCc-ceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHh
Q 037189 624 FGLAKLLTLNQSK-TIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCY 701 (766)
Q Consensus 624 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 701 (766)
||+++........ .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+... ......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ---LILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhc
Confidence 9999876533221 11133457899999998865 678999999999999999999999997654322111 000000
Q ss_pred hc----------CccceeccCccc-CC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 702 RN----------GKLDALVGGDME-AM-----NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 702 ~~----------~~~~~~~~~~~~-~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.. ..+......... .. .....+.++.+++.+||+.||++|||+.++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 000000000000 00 011246778999999999999999999999873
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=326.01 Aligned_cols=261 Identities=21% Similarity=0.293 Sum_probs=197.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----Cce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (766)
+.+.+.||+|+||.||+|.... .+..||||++..... ...+.+.+|++++.+++||||+++++++... ...
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred EEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4566889999999999998764 467899999975332 2346789999999999999999999998654 368
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++||||+. ++|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEcccC-cCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 99999998 5999988654 58899999999999999999995 4999999999999999999999999999987654
Q ss_pred CCCcc-eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc---
Q 037189 633 NQSKT-IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD--- 707 (766)
Q Consensus 633 ~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 707 (766)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... +..........
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCHHHHH
Confidence 33221 1134579999999998754 4589999999999999999999999976543322111 11000000000
Q ss_pred e--------eccC-cccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 A--------LVGG-DMEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~--------~~~~-~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .... ...... ....+..+.+++.+||+.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000 000000 01235678899999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=330.90 Aligned_cols=262 Identities=20% Similarity=0.304 Sum_probs=180.2
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeee--cCCceEEEeecc
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCD--EGQNRLLVYEFL 559 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~~lV~Ey~ 559 (766)
.++||+|+||.||+|...... .++.||||++... .....+.+|+.++++++||||+++++++. .....++||||+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~-~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGK-DDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp SCCCC-----EEEEEEESSSS-CCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred CcEeeecCCeEEEEEEEccCC-CCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 357999999999999976432 4678999998643 33457899999999999999999999994 467889999999
Q ss_pred CCCchhhhhccC---------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE----cCCCCeEEeccCc
Q 037189 560 NNGTLASFLFGN---------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL----DDHYNARISDFGL 626 (766)
Q Consensus 560 ~~gsL~~~l~~~---------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgl 626 (766)
.+ +|.+++... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 178 (405)
T 3rgf_A 103 EH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGF 178 (405)
T ss_dssp SE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred CC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence 75 787777521 248889999999999999999995 499999999999999 7789999999999
Q ss_pred ccccccCCCc-ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhh------hhHHHHHH
Q 037189 627 AKLLTLNQSK-TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY------AILTDWAF 698 (766)
Q Consensus 627 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~------~~~~~~~~ 698 (766)
++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......+.
T Consensus 179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~ 258 (405)
T 3rgf_A 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 258 (405)
T ss_dssp CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHH
T ss_pred ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHH
Confidence 9876543211 122346789999999999874 589999999999999999999999965432100 00011111
Q ss_pred HHhhcCc---ccee-------------ccCcccCCC--------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 699 DCYRNGK---LDAL-------------VGGDMEAMN--------DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 699 ~~~~~~~---~~~~-------------~~~~~~~~~--------~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
....... ...+ ......... .......+.+|+.+||+.||.+|||+.|++++
T Consensus 259 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 259 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111000 0000 000000000 00114567899999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.82 Aligned_cols=199 Identities=27% Similarity=0.333 Sum_probs=168.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CC-----CeeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HK-----NLVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~~~ 551 (766)
.+.+.+.||+|+||.||+|.... .++.||||.++.. .....++.+|+.++..++ |+ +|+++++++...+.
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34566889999999999998864 4678999999743 233466788888888775 44 49999999999999
Q ss_pred eEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCCCeEEeccCcc
Q 037189 552 RLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHYNARISDFGLA 627 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla 627 (766)
.++||||++ ++|.+++... ..+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999996 4999998765 4588999999999999999999953 46899999999999995 5788999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhh
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMV 687 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~ 687 (766)
+...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 209 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 209 CQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 8764322 345689999999999999999999999999999999999999986543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.96 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=192.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCce----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR---- 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 552 (766)
+.+.+.||+|+||.||+|.... .++.||||++..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred EEEEeEEecCCCeEEEEEEECC---CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 4456789999999999999864 567999999975322 2246789999999999999999999999877655
Q ss_pred --EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 553 --LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 553 --~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999998 688888743 488999999999999999999954 9999999999999999999999999999865
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc----
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK---- 705 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 705 (766)
.... ....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... .........
T Consensus 195 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~ 266 (371)
T 4exu_A 195 DAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ---ILKVTGVPGTEFV 266 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHH
T ss_pred ccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCcHHHH
Confidence 4322 34568999999999987 6899999999999999999999999976543221111 000000000
Q ss_pred -------cceecc---CcccC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 -------LDALVG---GDMEA---MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 -------~~~~~~---~~~~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
...... ..... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 00000 0011235788999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.78 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=189.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec---------
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--------- 548 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------- 548 (766)
.+.+.+.||+|+||.||+|+... .++.||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 34556889999999999999764 4678999998643 3345678999999999999999999998855
Q ss_pred ----CCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 549 ----GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 549 ----~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
....++||||+++++|.+++... ..+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence 34678999999999999999754 4567888999999999999999954 999999999999999999999999
Q ss_pred cCcccccccCCC------------cceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhh
Q 037189 624 FGLAKLLTLNQS------------KTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY 690 (766)
Q Consensus 624 fgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~ 690 (766)
||++........ ........||+.|+|||.+.+. .++.++||||||+++|||++ |+.......
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~- 235 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV- 235 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH-
Confidence 999987643211 1111345689999999999864 78999999999999999998 454322111
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
. .......... ......+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 236 -~----~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 236 -N----ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -H----HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -H----HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 1111111111 11112233455678899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=326.13 Aligned_cols=255 Identities=23% Similarity=0.283 Sum_probs=186.6
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC-----------HHHHHHHHHHHccCCCCCeeeEeeeeec-
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG-----------EREFKNEVFVIGQTHHKNLVRLLGFCDE- 548 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~l~g~~~~- 548 (766)
+.+.||+|+||.||+|... .+..||||++....... .+.+.+|++++++++||||+++++++..
T Consensus 26 ~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp EEEEEEEETTEEEEEEECT----TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred EeEEeccCCCEEEEEEECC----CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 4578999999999999865 36789999986432221 2679999999999999999999999843
Q ss_pred ----CCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 549 ----GQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 549 ----~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
....++||||++ |+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 335799999998 5888877654 4689999999999999999999954 999999999999999999999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
||+++....... .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... .......
T Consensus 178 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~ 251 (362)
T 3pg1_A 178 FNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN---KIVEVVG 251 (362)
T ss_dssp TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHC
T ss_pred cCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcC
Confidence 999985543322 134568999999999877 678999999999999999999999997654322111 0111000
Q ss_pred cC-------------------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NG-------------------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~-------------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.. .......... .......+..+.+++.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 00 0000000000 00011235678899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=319.66 Aligned_cols=244 Identities=24% Similarity=0.338 Sum_probs=192.9
Q ss_pred HHHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccC----CCCCeeeEe
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQT----HHKNLVRLL 543 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l----~H~niv~l~ 543 (766)
.....+.+.+.||+|+||.||+|.... .++.||||.++..... ....+.+|+.++.++ +|+||++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 344556677899999999999998754 4678999999654321 223466788888888 899999999
Q ss_pred eeeecCCceEEEeec-cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEE
Q 037189 544 GFCDEGQNRLLVYEF-LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARI 621 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl 621 (766)
+++.+.+..++|+|| +.+++|.+++.....+++..++.++.||++||.|||+. +|+||||||+||+++ .++.+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999 78999999998877899999999999999999999965 999999999999999 8899999
Q ss_pred eccCcccccccCCCcceeecccccCcccccccccCCCCC-cccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHH
Q 037189 622 SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKIT-AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 700 (766)
+|||+++....... ....|+..|+|||++.+..+. .++||||||+++|||++|+.||.......
T Consensus 182 ~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----------- 246 (312)
T 2iwi_A 182 IDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----------- 246 (312)
T ss_dssp CCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH-----------
T ss_pred EEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh-----------
Confidence 99999987654322 345689999999999877664 58999999999999999999997532100
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.... ..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 247 --~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 --EAEL----------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp --HTCC----------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --hhcc----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 1122345678899999999999999999999983
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.33 Aligned_cols=266 Identities=21% Similarity=0.286 Sum_probs=198.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecC-----Cce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-----QNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (766)
+.+.+.||+|+||.||+|.... .++.||||.+..... .....+.+|++++++++||||+++++++... ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred eEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 3456789999999999999864 467899999964322 2345788999999999999999999988654 678
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++||||+. ++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99999998 699998876 468899999999999999999995 4999999999999999999999999999987654
Q ss_pred CCCcc--------eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 633 NQSKT--------IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 633 ~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL---IFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCC
Confidence 32211 1123468999999998764 6789999999999999999999999976543221111 1111100
Q ss_pred Cc----cc--------eeccCcc-cCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 037189 704 GK----LD--------ALVGGDM-EAM-----NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVV 755 (766)
Q Consensus 704 ~~----~~--------~~~~~~~-~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~ 755 (766)
.. .. ....... ... .....+.++.+++.+||+.||++|||+.++++. +....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 00 00 0000000 000 011345678899999999999999999999973 44443
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.12 Aligned_cols=240 Identities=24% Similarity=0.410 Sum_probs=198.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccCC--CCCeeeEeeeeecC
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTH--HKNLVRLLGFCDEG 549 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~ 549 (766)
.+.+.+.||+|+||.||+|.... +++.||||.++..... ....+.+|+.++++++ |+||+++++++.+.
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 35567899999999999998764 4679999999754322 2345788999999986 59999999999999
Q ss_pred CceEEEeeccCC-CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCcc
Q 037189 550 QNRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLA 627 (766)
Q Consensus 550 ~~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla 627 (766)
+..++|+|++.+ ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++ +++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999986 8999999888889999999999999999999995 4999999999999999 7899999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
+....... ....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... . +..
T Consensus 198 ~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------------~-~~~ 260 (320)
T 3a99_A 198 ALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII------------R-GQV 260 (320)
T ss_dssp EECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH------------H-CCC
T ss_pred cccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh------------c-ccc
Confidence 87654321 34568999999999987765 688999999999999999999997532100 0 000
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||++|||+.++++.
T Consensus 261 ----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 261 ----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0112235678899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.75 Aligned_cols=254 Identities=22% Similarity=0.289 Sum_probs=193.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----- 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 551 (766)
+.+.+.||+|+||.||+|.... .++.||||.+..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred EEEeeeEecCCCeEEEEEEECC---CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 3456789999999999999864 467999999865322 224678999999999999999999999987654
Q ss_pred -eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 552 -RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 552 -~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
.++||||+. ++|.+++.. .+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 699888754 488999999999999999999954 9999999999999999999999999999865
Q ss_pred ccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC-----
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG----- 704 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----- 704 (766)
.... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+... . ........
T Consensus 177 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~-i~~~~~~~~~~~~ 248 (353)
T 3coi_A 177 DAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--Q-ILKVTGVPGTEFV 248 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--H-HHHHHCBCCHHHH
T ss_pred CCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCCHHHH
Confidence 4321 34568999999999887 678999999999999999999999997654322111 0 00000000
Q ss_pred -------------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 705 -------------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 705 -------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.+........ .......+..+.+++.+||+.||++|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01122456788999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.69 Aligned_cols=260 Identities=24% Similarity=0.325 Sum_probs=196.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccC---CCCCeeeEeeeee-----c
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQT---HHKNLVRLLGFCD-----E 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~-----~ 548 (766)
+.+.+.||+|+||.||+|.... ..++.||||.++.... .....+.+|+.+++++ +||||+++++++. .
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLK--NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETT--TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred eeeeeeecccccEEEEEEEecC--CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 4456789999999999999742 1467899999865332 2234677787777666 8999999999987 5
Q ss_pred CCceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGL 626 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 626 (766)
....++||||+. |+|.+++... ..+++..+..++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 567899999998 6999998764 348899999999999999999995 4999999999999999999999999999
Q ss_pred ccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 627 AKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 627 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
++....... .....||..|+|||.+.+..++.++||||||+++|||++|+.||......... ..+.........
T Consensus 167 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~ 240 (326)
T 1blx_A 167 ARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE 240 (326)
T ss_dssp CCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCG
T ss_pred cccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCc
Confidence 987653321 13456899999999999999999999999999999999999999765432211 111111110000
Q ss_pred cee----------cc---CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 707 DAL----------VG---GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 707 ~~~----------~~---~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
... .. ...........+..+.+++.+||+.||.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00 000001122346778899999999999999999999953
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=323.73 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=200.6
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-----------CCCeeeEeee
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-----------HKNLVRLLGF 545 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~ 545 (766)
..+.+.+.||+|+||.||+|+... .++.||||.+... ......+.+|+.++.+++ |+||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 345667899999999999998764 4679999998642 233567889999988876 8999999999
Q ss_pred eecCC----ceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-----
Q 037189 546 CDEGQ----NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD----- 614 (766)
Q Consensus 546 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~----- 614 (766)
+...+ ..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETT
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCC
Confidence 87654 688999999 89999999753 4588999999999999999999952 2899999999999994
Q ss_pred -CCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh--
Q 037189 615 -DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA-- 691 (766)
Q Consensus 615 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~-- 691 (766)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 44579999999998765432 3456899999999999999999999999999999999999999754321110
Q ss_pred --hHHHHHHHHhhc--------C-----------ccceeccC---------cccCCCcHHHHHHHHHHHHHccccCCCCC
Q 037189 692 --ILTDWAFDCYRN--------G-----------KLDALVGG---------DMEAMNDVECLEKLVMVSIWCIQEDPSLR 741 (766)
Q Consensus 692 --~~~~~~~~~~~~--------~-----------~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~R 741 (766)
.+.. +...... + ....+... ......+...+.++.+|+.+||+.||++|
T Consensus 247 ~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 247 DDHIAQ-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHH-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHH-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111 1110000 0 00000000 00112346778899999999999999999
Q ss_pred CCHHHHHH--HHhcCcCCC
Q 037189 742 PTIKKVLQ--MLEGVVEVS 758 (766)
Q Consensus 742 Pt~~~vl~--~Le~~~~~~ 758 (766)
||+.|+++ .+.+....+
T Consensus 326 pt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp BCHHHHHTCGGGTTCTTCT
T ss_pred CCHHHHhhChhhhcccCcc
Confidence 99999997 455554444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.59 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=174.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHH-HHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVF-VIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||+|.... .++.||||.++.... ....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hehheeccCCCEEEEEEEEcC---CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 456789999999999999864 467999999975432 23345666665 7788899999999999999999999999
Q ss_pred ccCCCchhhhhcc-----CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFG-----NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
|+++ +|.+++.. ...+++..+..++.|+++||.|||+. .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 88777753 56788999999999999999999952 2899999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccc----cCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWF----RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.... ....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... .... ....+...
T Consensus 179 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~-~~~~~~~~- 248 (327)
T 3aln_A 179 SIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLT-QVVKGDPP- 248 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-CCCCSCCC-
T ss_pred cccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHH-HHhcCCCC-
Confidence 3221 234689999999998 45678999999999999999999999997532211 0000 00011100
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..........+..+.+++.+||+.||++|||+.++++
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 249 ----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111112234678899999999999999999999865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=325.38 Aligned_cols=245 Identities=28% Similarity=0.337 Sum_probs=184.4
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeeccC
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
.+.||+|+||+||.+... .++.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 20 ~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSF----QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp EEEEEECSTTCEEEEEES----SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred cCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 367999999999865433 4679999998642 345688999999876 89999999999999999999999996
Q ss_pred CCchhhhhccCCCC-------ccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC-------------CCeE
Q 037189 561 NGTLASFLFGNLKP-------NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH-------------YNAR 620 (766)
Q Consensus 561 ~gsL~~~l~~~~~l-------~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~-------------~~~k 620 (766)
|+|.+++...... ++..++.++.||+.||+|||+ .+|+||||||+|||++.+ ..+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999765332 344567899999999999995 499999999999999754 4899
Q ss_pred EeccCcccccccCCCcc--eeecccccCcccccccccC-------CCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhh
Q 037189 621 ISDFGLAKLLTLNQSKT--IKTSIRGTKGYVAPEWFRN-------SKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEY 690 (766)
Q Consensus 621 l~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~ 690 (766)
|+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 99999999876543211 1234579999999999975 578999999999999999999 9999975432221
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.... +... .+..........+.++.+++.+||+.||.+|||+.+|++
T Consensus 249 ----~i~~-----~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ----NIIR-----GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ----HHHH-----TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----HHhc-----CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 1100 011122234567889999999999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=317.69 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=198.3
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC------eeeEeeeeecCC
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN------LVRLLGFCDEGQ 550 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~ 550 (766)
..+.+.+.||+|+||.||+|..... .+..||||.++.. ....+.+.+|+.++++++|++ ++.+.+++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHAR--GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCC--CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3456678999999999999997643 2368999998643 234567888999999988766 999999999999
Q ss_pred ceEEEeeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEE---------------
Q 037189 551 NRLLVYEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILL--------------- 613 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll--------------- 613 (766)
..++||||+ +++|.+++... ..+++..+..++.||++||+||| +.+|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 55666666544 46889999999999999999999 4599999999999999
Q ss_pred ----cCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhh
Q 037189 614 ----DDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE 689 (766)
Q Consensus 614 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~ 689 (766)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 678899999999998654322 34568999999999999999999999999999999999999997654332
Q ss_pred hhhHHHHHHHH-----hhc-CccceeccC---------------------cccCCCcHHHHHHHHHHHHHccccCCCCCC
Q 037189 690 YAILTDWAFDC-----YRN-GKLDALVGG---------------------DMEAMNDVECLEKLVMVSIWCIQEDPSLRP 742 (766)
Q Consensus 690 ~~~~~~~~~~~-----~~~-~~~~~~~~~---------------------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 742 (766)
........... ... ......... ..........+..+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 21111111000 000 000000000 000112334567899999999999999999
Q ss_pred CHHHHHH
Q 037189 743 TIKKVLQ 749 (766)
Q Consensus 743 t~~~vl~ 749 (766)
|+.++++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=314.90 Aligned_cols=250 Identities=21% Similarity=0.241 Sum_probs=170.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeec----CCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey 558 (766)
+.||+|+||.||+|.... .++.||||.+... .....+....+..++||||+++++++.. ....++||||
T Consensus 35 ~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRR---TGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeeeeCCCeEEEEEEECC---CCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 469999999999999874 4678999998642 2222233344667799999999999865 4457899999
Q ss_pred cCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCcccccccC
Q 037189 559 LNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLTLN 633 (766)
Q Consensus 559 ~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~ 633 (766)
+++|+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 9999999999865 3689999999999999999999954 9999999999999976 455999999999865533
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.. ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ........+.. .
T Consensus 185 ~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~------~ 251 (336)
T 3fhr_A 185 AL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY------G 251 (336)
T ss_dssp -----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------------C
T ss_pred cc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc------c
Confidence 21 34568999999999998899999999999999999999999996544322100 00000000000 0
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCc
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ--MLEGVV 755 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~Le~~~ 755 (766)
.........+..+.+++.+||+.||.+|||+.++++ .+.+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 111111235678899999999999999999999997 445433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.19 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=175.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CH-HHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GE-REFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~-~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.+.||+|+||.||+|.... .++.||||.+...... .. +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccceeeecCCeeEEEEEEec---CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 3455789999999999999864 4678999999754322 22 23445556788889999999999999999999999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+ ++.+..+... ...+++..+..++.|+++||.|||+. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 999 4455554433 46788999999999999999999951 2899999999999999999999999999976654322
Q ss_pred cceeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 636 KTIKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
. ....+|+.|+|||++. ...++.++||||||+++|||++|+.||........ ......... ...+
T Consensus 181 ~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~~-~~~~- 250 (318)
T 2dyl_A 181 K---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-----VLTKVLQEE-PPLL- 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHHHSC-CCCC-
T ss_pred c---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-----HHHHHhccC-CCCC-
Confidence 1 3456899999999994 45688999999999999999999999975322111 111111111 1100
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
......+..+.+++.+||+.||.+|||+.++++
T Consensus 251 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 ------PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ------CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011124567889999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=319.62 Aligned_cols=244 Identities=25% Similarity=0.315 Sum_probs=181.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEeecc
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
..+.||+|+||+|+..... +++.||||++.... ...+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 28 ~~~~LG~G~~G~V~~~~~~----~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 28 PKDVLGHGAEGTIVYRGMF----DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEECGGGCEEEEEES----SSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCeeecCcCEEEEEEEEe----CCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 4578999999996543322 46789999986422 23467899999998 7999999999999999999999999
Q ss_pred CCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-----CCCeEEeccCcccccccC
Q 037189 560 NNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-----HYNARISDFGLAKLLTLN 633 (766)
Q Consensus 560 ~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~ 633 (766)
. |+|.+++.... ...+..+..++.||++||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 7 59999997653 45566778999999999999995 49999999999999943 346889999999877543
Q ss_pred CCc-ceeecccccCccccccccc---CCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 634 QSK-TIKTSIRGTKGYVAPEWFR---NSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 634 ~~~-~~~~~~~gt~~y~aPE~~~---~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......... .........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~~~~~~- 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLGACSLD- 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTTCCCCT-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhccCCcc-
Confidence 221 2224467999999999997 4567889999999999999999 89998644322211 111111110
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
...........+.+++.+||+.||.+|||+.+|++
T Consensus 249 ------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 ------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01112345667889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=333.85 Aligned_cols=256 Identities=26% Similarity=0.300 Sum_probs=195.7
Q ss_pred HHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeec------C
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------G 549 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~ 549 (766)
..+.+.+.||+|+||.||+|.... .+..||||.++.. .....+.|.+|++++++++||||+++++++.. .
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 346677899999999999998764 4678999998653 23335679999999999999999999999765 6
Q ss_pred CceEEEeeccCCCchhhhhccCC---CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC---eEEec
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNL---KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---ARISD 623 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D 623 (766)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999998643 58899999999999999999995 49999999999999997665 99999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
||++......... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .|.......
T Consensus 168 FG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~ 239 (676)
T 3qa8_A 168 LGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREK 239 (676)
T ss_dssp CCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC--
T ss_pred ccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcc
Confidence 9999876544322 34678999999999999999999999999999999999999996542211 000000000
Q ss_pred C----ccceeccC--------cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 037189 704 G----KLDALVGG--------DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKK 746 (766)
Q Consensus 704 ~----~~~~~~~~--------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~ 746 (766)
. .......+ ..........+..+.+++.+||+.||++|||+.+
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 00000000 0111223457788999999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.77 Aligned_cols=229 Identities=13% Similarity=0.082 Sum_probs=180.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccC---HHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG---EREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|.... .++.||||.+....... .+.|.+|+..+.+++||||+++++++.+.+..++|
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4566899999999999999864 46799999997643322 36799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++++|.+++... .......+|+.|+++||+|||+ .+|+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 9999999999999654 3455678899999999999995 499999999999999999999997443
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
|++ +++.++||||||+++|||++|+.||.......... ...........
T Consensus 175 ------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 ------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAGQPI 223 (286)
T ss_dssp ------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTSCBC
T ss_pred ------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhccCCC
Confidence 333 36889999999999999999999997644321000 00000000000
Q ss_pred --CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 716 --AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 716 --~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
.......+.++.+++.+||+.||++| |+.++++.|+.+...
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00112346778999999999999999 999999999875543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=334.69 Aligned_cols=239 Identities=21% Similarity=0.296 Sum_probs=190.5
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc-----
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN----- 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 551 (766)
.+.+.+.||+|+||.||+|.+... .++.||||.+.... ......|.+|++++.+++||||+++++++.+.+.
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 355678899999999999998632 35789999886432 2334578999999999999999999999987665
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.+|||||+++++|.+++.. .+++..++.|+.||++||.|||+ .+|+||||||+|||++.+ .+||+|||+++...
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 6999999999999998765 68999999999999999999995 499999999999999986 99999999998765
Q ss_pred cCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
.. ....||+.|+|||++.+.. +.++||||||+++|||++|.+|+....... +
T Consensus 233 ~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-------------------~-- 284 (681)
T 2pzi_A 233 SF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-------------------L-- 284 (681)
T ss_dssp CC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-------------------C--
T ss_pred cC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-------------------c--
Confidence 43 3456999999999987664 899999999999999999988875321110 0
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcC
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGV 754 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~Le~~ 754 (766)
............+.+++.+||+.||.+|| +++++.+.|.++
T Consensus 285 --~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 --PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00011123456788999999999999999 566677766554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=291.61 Aligned_cols=230 Identities=23% Similarity=0.293 Sum_probs=177.6
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHH-ccCCCCCeeeEeeeeec----CCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVI-GQTHHKNLVRLLGFCDE----GQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~lV~E 557 (766)
+.||+|+||.||++.... .++.||||.++. ...+.+|+.++ +..+||||+++++++.. ....++|||
T Consensus 24 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 95 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 95 (299)
T ss_dssp EEEEEETTEEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cccccCCCeEEEEEEEcC---CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEe
Confidence 679999999999999864 467999999863 34678888887 66799999999999876 667899999
Q ss_pred ccCCCchhhhhccCC--CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFGNL--KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~~~--~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 632 (766)
|+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 96 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp CCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 999999999997653 68999999999999999999995 49999999999999998 7889999999986432
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
+..++.++||||||+++|||++|+.||........ .......+...
T Consensus 172 -----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~ 217 (299)
T 3m2w_A 172 -----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMG 217 (299)
T ss_dssp -----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT
T ss_pred -----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhc
Confidence 23467899999999999999999999965432110 00000111111
Q ss_pred cccCCC--cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCC
Q 037189 713 DMEAMN--DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEVS 758 (766)
Q Consensus 713 ~~~~~~--~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~~ 758 (766)
...... ....+.++.+++.+||+.||.+|||+.|+++. +.+....+
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 111000 02346789999999999999999999999973 44444333
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=287.47 Aligned_cols=214 Identities=19% Similarity=0.234 Sum_probs=164.6
Q ss_pred hccCCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCC--CCCcE
Q 037189 24 AQNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAV--PRGSQ 101 (766)
Q Consensus 24 ~~~~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~--~~~~~ 101 (766)
+++.|+|.+|++|.+|+ +|+|++|.|+||||.++ .+|| |+ +.+ +||+|||++|+..- ..++.
T Consensus 11 ~~~~~~l~~g~~l~~~~---~l~S~~g~F~lgf~~~~-------~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~ 74 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQ---YLLSPNQRFKLLLQGDG-------NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKK 74 (276)
T ss_dssp CTTSSEECTTEEBCTTC---EEECTTSSEEEEECTTS-------CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTT
T ss_pred cccCCEecCCCEecCCC---EEEcCCCcEEEEEECCC-------CeEE---EC--CCC-eEEECCCCCCcCCcccccceE
Confidence 44568999999999998 88999999999999421 3677 76 777 99999999976431 12678
Q ss_pred EEEeccCcEEE--eCCCCCeeeeeeccC------CcceEEEeccCCCEEEecCCCCeee--------eec----------
Q 037189 102 VKLTADQGLVL--NDPQGKQVWSSKIDI------GTVAVGHMNDTGNFMLASSSSSRAF--------FPK---------- 155 (766)
Q Consensus 102 l~~~~~g~l~l--~~~~~~~~w~t~~~~------~~~~~~~l~d~GN~vl~~~~~~~~w--------~~~---------- 155 (766)
|+|+.|||||| .|++|++||+|+++. ..+.+|+|+|+|||||+| +..+| +|+
T Consensus 75 l~l~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS~ptdtlLpg~~~~~~l~~g 152 (276)
T 3m7h_A 75 APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNGTPAIPLVPGAIDSLLLAPG 152 (276)
T ss_dssp CCSEEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEESCTTSCCCCSCTTCEEECSS
T ss_pred EEEeCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCcccccccccccccccccccC
Confidence 99999999999 788889999999864 235789999999999998 55677 121
Q ss_pred ----cCCCCCCCceEEEEecCCceEEEeccCCccccccceeecccccCCCCCCCCceEEEccCCcEEEEecCcceeeecc
Q 037189 156 ----IGHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTT 231 (766)
Q Consensus 156 ----~~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~y~~sg~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (766)
++.||++|.|++.++++|+++++ .... ..||++|+|++. . ....++..|.+..+..++..+..+.
T Consensus 153 ~~L~S~~dps~G~fsl~l~~dGnlvLy-~~~~-----~~yW~Sgt~~~~----~-~~l~l~~dGnLvl~d~~~~~vWsS~ 221 (276)
T 3m7h_A 153 SELVQGVVYGAGASKLVFQGDGNLVAY-GPNG-----AATWNAGTQGKG----A-VRAVFQGDGNLVVYGAGNAVLWHSH 221 (276)
T ss_dssp EEECTTCEEEETTEEEEECTTSCEEEE-CTTS-----SEEEECCCTTTT----C-CEEEECTTSCEEEECTTSCEEEECS
T ss_pred cccccCCCCCCceEEEeecCCceEEEE-eCCC-----eEEEECCCCCCc----c-EEEEEcCCCeEEEEeCCCcEEEEec
Confidence 34578999999999999987664 2333 679999999753 1 4556777787777766555554443
Q ss_pred CccccCCCceEEEEeccCccEEEEeccCCCCCCceEEecccCC
Q 037189 232 GRVVPAADFYHRATLNFDGVFAQYYYPRHGNGNWSVVWSQPDN 274 (766)
Q Consensus 232 ~~~~~~~~~~~rl~Ld~~G~l~~~~w~~~~~~~W~~~~~~p~~ 274 (766)
.. ....+|++|+.||++++|.| ...|..+|.+|+.
T Consensus 222 t~----~~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 222 TG----GHASAVLRLQANGSIAILDE----KPVWARFGFQPTY 256 (276)
T ss_dssp CT----TCTTCEEEECTTSCEEEEEE----EEEEESSSCCTTS
T ss_pred CC----CCCCEEEEEcCCccEEEEcC----CCeEEccCccCCc
Confidence 32 12248999999999999998 3468888887765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=304.72 Aligned_cols=234 Identities=15% Similarity=0.123 Sum_probs=174.5
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCC-CCee---------------e
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHH-KNLV---------------R 541 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H-~niv---------------~ 541 (766)
..+.||+|+||.||+|.+.. .++.||||.+...... ..+.|.+|+.++..++| +|.. .
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred EecccccCCCEEEEEEEecC---CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 34689999999999999764 4669999998743322 35779999999999987 3211 1
Q ss_pred E------eeeeec-----CCceEEEeeccCCCchhhhhc------c-CCCCccchhhhHHHHHHHHHHHhhhcCCCceec
Q 037189 542 L------LGFCDE-----GQNRLLVYEFLNNGTLASFLF------G-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIH 603 (766)
Q Consensus 542 l------~g~~~~-----~~~~~lV~Ey~~~gsL~~~l~------~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 603 (766)
+ ..++.. ....+++|+++ +++|.+++. . ...+++..++.|+.||++||+|||+ .+|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence 1 111111 22356667754 579998884 1 2346788999999999999999995 49999
Q ss_pred CCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccc----------cCCCCCcccCeeehhHHHH
Q 037189 604 CDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF----------RNSKITAKVDVYSFGVLLL 673 (766)
Q Consensus 604 ~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~sDV~s~Gvvl~ 673 (766)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 999999999999999999999998865432 244567 999999999 5566889999999999999
Q ss_pred HHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 674 EIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 674 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
||++|+.||........ ...+.... ...++.+.+|+.+||+.||++|||+.+++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975443221 11111111 12346789999999999999999976654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-33 Score=298.05 Aligned_cols=243 Identities=16% Similarity=0.149 Sum_probs=183.2
Q ss_pred HHHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--------ccCHHHHHHHHHHHccCC---------CC
Q 037189 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--------QDGEREFKNEVFVIGQTH---------HK 537 (766)
Q Consensus 475 ~~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~ 537 (766)
....+.+.+.||+|+||.||+|+. .++.||||++.... ....+.+.+|+.++++++ ||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred ccccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 345677788999999999999987 25799999997542 223477899999888885 77
Q ss_pred CeeeEeeee-----------------ec-------------CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHH
Q 037189 538 NLVRLLGFC-----------------DE-------------GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 587 (766)
Q Consensus 538 niv~l~g~~-----------------~~-------------~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia 587 (766)
||+++.+.+ .+ ....+|||||+++|+|.+.+.. ..+++..+..++.||+
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLT 171 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHH
Confidence 777666653 22 6789999999999987776644 5678999999999999
Q ss_pred HHHHHhh-hcCCCceecCCCccceEEEcCCC--------------------CeEEeccCcccccccCCCcceeecccccC
Q 037189 588 RGLLYLH-EDCSSQIIHCDMKPQNILLDDHY--------------------NARISDFGLAKLLTLNQSKTIKTSIRGTK 646 (766)
Q Consensus 588 ~gL~yLH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~~gt~ 646 (766)
.||+||| +. +|+||||||+|||++.++ .+||+|||+++..... ...||+
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 65 899999999999999887 8999999999876532 346899
Q ss_pred cccccccccCCCCCcccCeeehhHH-HHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHH
Q 037189 647 GYVAPEWFRNSKITAKVDVYSFGVL-LLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEK 725 (766)
Q Consensus 647 ~y~aPE~~~~~~~s~~sDV~s~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 725 (766)
.|+|||++.+.. +.++||||++++ .+++++|..||....... .+.. ........ ............+.+
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~--~~~~---~~~~~~~~----~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH--YLTD---KMLKQMTF----KTKCNTPAMKQIKRK 311 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH--HHHH---HHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh--HHHH---hhhhhhcc----CcccchhhhhhcCHH
Confidence 999999998776 899999998777 778888999884321000 0111 11101000 001111123467889
Q ss_pred HHHHHHHccccCCCCCCCHHHHH
Q 037189 726 LVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 726 l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
+.+|+.+||+.| |+.|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899888
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-26 Score=230.66 Aligned_cols=191 Identities=17% Similarity=0.159 Sum_probs=142.7
Q ss_pred ccCCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEE
Q 037189 25 QNNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKL 104 (766)
Q Consensus 25 ~~~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~ 104 (766)
++.|+|.+|++|.+|+ +| ++|.|+|||+.++. +.+ |.. +|+||+|||+.| ..+.|+|
T Consensus 6 ~~~~~i~~g~~L~~g~---~l--~~g~f~l~f~~~gn---------l~l-y~~---~~~vW~an~~~~-----~~~~l~l 62 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQ---SL--ELSSFRFTMQSDCN---------LVL-FDS---DVRVWASNTAGA-----TGCRAVL 62 (236)
T ss_dssp CSSSSSCSCSCCCTTC---EE--CSTTEEEEECTTSC---------EEE-EES---SSEEECCCCCSC-----SCCBCCB
T ss_pred eccceeCCCCEECCCC---EE--EcCCEEEEECCCCc---------EEE-EEC---CEEEEECCCCCC-----CCeEEEE
Confidence 3458999999999999 56 49999999986432 334 432 799999999974 4588999
Q ss_pred eccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeecc---------------------------
Q 037189 105 TADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKI--------------------------- 156 (766)
Q Consensus 105 ~~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~--------------------------- 156 (766)
+.||||||+|.+|++||+|++... ....|+|+|+|||||++. .+| +++
T Consensus 63 ~~dGnLvl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W-~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~ 138 (236)
T 1dlp_A 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLW-DSGTSNKGSVVVANNGNSILYSTQGNDNHP 138 (236)
T ss_dssp CSSSCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEE-ECSCCCSSCCCCSSCCCEECCCC--CCCCC
T ss_pred cCCCcEEEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEE-ECCCCCCcccccCCccceEEecCCcCCCcc
Confidence 999999999999999999998643 335899999999999964 555 332
Q ss_pred -----CCCCCCCceEEEEecCCceEEEeccCCccccccceeecccccCCCCCCCCceEEEccCCcEEEEecCcceeeecc
Q 037189 157 -----GHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHTYDGANSSNSGYRVMFSESGYMYILKRNSQRFDLTT 231 (766)
Q Consensus 157 -----~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~y~~sg~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (766)
..||++|.|++.++++|++++ +... ..||++++|++. +..... +...+.++.+..++.++.+.+
T Consensus 139 ~~L~s~~d~s~G~~~l~l~~dG~LvL--~~~~-----~~~W~s~~~~~~---~~~~~~-L~~~Gnl~ly~~~~~~vw~s~ 207 (236)
T 1dlp_A 139 QTLHATQSLQLSPYRLSMETDCNLVL--FDRD-----DRVWSTNTAGKG---TGCRAV-LQPNGRMDVLTNQNIAVWTSG 207 (236)
T ss_dssp CEECSSCCCBCSSCEEEEETTTEEEE--EBTT-----BCCSCCCCCSSC---SSCEEE-EETTTEEEEEETTTEEEEECC
T ss_pred ceEEcCcEeecCcEEEEECCCCcEEE--EcCC-----EeEEeCCCcCCC---CceEEE-ECCCCcEEEEeCCCcEEEEeC
Confidence 346778999999999996655 3433 579999999653 333333 455666666665665555554
Q ss_pred CccccCCCceEEEEeccCccEEEEe
Q 037189 232 GRVVPAADFYHRATLNFDGVFAQYY 256 (766)
Q Consensus 232 ~~~~~~~~~~~rl~Ld~~G~l~~~~ 256 (766)
.. .. ...+|++||+||++++|.
T Consensus 208 ~~--~~-~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 208 NS--RS-AGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp CC--CS-SSCCEEEECSSSCEEEEC
T ss_pred CC--CC-CCCEEEEEcCCCcEEEeC
Confidence 32 12 235899999999999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=274.15 Aligned_cols=186 Identities=19% Similarity=0.108 Sum_probs=130.1
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeeccc----------ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCce
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF----------QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (766)
.++.|++|.+.++.... -+..++||.+.... +...++|.+|+++|+++ +|+||+++++++++++..
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 45666666666544432 24578888886431 12235799999999999 699999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
||||||++|++|.++|.....++.. +|+.||+.||+|||+ .+|+||||||+||||++++++||+|||+++....
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999999988777653 589999999999995 4999999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKS 681 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p 681 (766)
.... ....+||++|+|||++.+ .+..++|+|++|++++++.++..+
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 4322 245679999999999976 467789999999999988766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=247.10 Aligned_cols=183 Identities=17% Similarity=0.238 Sum_probs=144.2
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeeccccc--------CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceE
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--------GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (766)
.+.||+|+||.||+|... +..+++|+....... ..+.|.+|++++++++||||+++..++...++.+
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-----DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp -------CCEEEEEEECS-----SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred CCEEeeCCCEEEEEEEEC-----CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence 468999999999999543 457888876432211 1345899999999999999997777777778889
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||||+++++|.+++.. +..++.|+++||.|||+ .+|+||||||+|||+++ ++||+|||+++.....
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999999865 67899999999999995 49999999999999999 9999999999987653
Q ss_pred CCcc-----eeecccccCcccccccccC--CCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 634 QSKT-----IKTSIRGTKGYVAPEWFRN--SKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 634 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
.... ......||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 1135679999999999987 56888899999888888877776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=9.3e-21 Score=197.68 Aligned_cols=141 Identities=14% Similarity=0.109 Sum_probs=112.7
Q ss_pred hhhccccccceEEEEEEecCCCceeEEEEEEeecccc------------------cCHHHHHHHHHHHccCCCCCeeeEe
Q 037189 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ------------------DGEREFKNEVFVIGQTHHKNLVRLL 543 (766)
Q Consensus 482 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~ 543 (766)
.+.||+|+||.||+|... .+..||||.++.... .....+.+|+.++++++ | +++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp EEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred cCEeccCCCceEEEEEeC----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 378999999999999982 467999999864321 12456899999999999 4 5666
Q ss_pred eeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEec
Q 037189 544 GFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISD 623 (766)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 623 (766)
+++.. +..++||||+++++|.+ +. ......++.|+++||.|||+ .+|+||||||+|||++ ++.+||+|
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 65433 56799999999999998 42 23456799999999999995 4999999999999999 99999999
Q ss_pred cCcccccccCCCcceeecccccCcccccccccC
Q 037189 624 FGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRN 656 (766)
Q Consensus 624 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 656 (766)
||+++. +..+.|||++..
T Consensus 236 FG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 236 FPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CTTCEE---------------TTSTTHHHHHHH
T ss_pred CCCCeE---------------CCCCCHHHHHHH
Confidence 999863 234678888753
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.80 E-value=3.7e-19 Score=158.60 Aligned_cols=104 Identities=16% Similarity=0.200 Sum_probs=87.0
Q ss_pred cCCCcCCCCeeeeCCCcceee--cCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEE
Q 037189 26 NNGTVPVGATLIAGSTSFRWL--SPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVK 103 (766)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~~v--S~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~ 103 (766)
+.++|.+|++|.+|+ +|+ |++|.|+|+|+.++. | +||++ +++||+||++.+. .++.|+
T Consensus 7 ~~~~l~~g~~L~~g~---~l~~~S~~g~~~L~~~~dgn---------l-vly~~---~~~vW~sn~~~~~----~~~~l~ 66 (119)
T 1b2p_A 7 KQPDDNHPQILHATE---SLEILFGTHVYRFIMQTDCN---------L-VLYDN---NNPIWATNTGGLG----NGCRAV 66 (119)
T ss_dssp SCSSSCCCCEEETTC---EEEEEETTEEEEEEECTTSC---------E-EEEET---TEEEEECCCTTSC----SSCEEE
T ss_pred cCcccCCCCEEcCCC---EEEEeCCCCCEEEEEecCCC---------E-EEEEC---CEEEEeCCCccCC----CceEEE
Confidence 457999999999999 778 999999999987542 2 57875 7999999998642 348899
Q ss_pred EeccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 104 LTADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 104 ~~~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|++||||||+|.++.+||+|++... +...++|+|+|||||++. .+|
T Consensus 67 l~~dGNLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~---~~W 113 (119)
T 1b2p_A 67 LQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALW 113 (119)
T ss_dssp ECTTSCEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES---EEE
T ss_pred EccCCEEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc---cEe
Confidence 9999999999999999999997643 345789999999999972 555
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.79 E-value=5.3e-19 Score=153.86 Aligned_cols=101 Identities=20% Similarity=0.349 Sum_probs=84.7
Q ss_pred CCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEecc
Q 037189 28 GTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTAD 107 (766)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~ 107 (766)
|+|.+||+|.+|+ +|+| |.|.|.|..+++ |.++. ..++||+|||+.|. ...+.|+|+.|
T Consensus 2 n~L~~g~~L~~g~---~L~s--g~y~l~~q~DgN---------Lvly~----~~~~vW~ant~~~~---~~~~~L~l~~d 60 (105)
T 4h3o_A 2 NILDNNEGLYAGQ---SLDV--EPYHFIMQDDCN---------LVLYD----HSTSTWASNTEIGG---KSGCSAVLQSD 60 (105)
T ss_dssp CEECTTEEECTTC---EEEE--TTEEEEECTTSC---------EEEEE----TTEEEEECCCCCTT---CCSCEEEECTT
T ss_pred CCcCCCCEEcCCC---EEEE--CCEEEEECCCCe---------EEEEE----CCEEEEEecCCCCC---CccEEEEEeCC
Confidence 6899999999999 6777 889999977553 67754 35899999999843 35689999999
Q ss_pred CcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 108 QGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 108 g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|||||+|+++++||+|++... ...+++|+||||||||+. .+|
T Consensus 61 GnLvL~d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W 103 (105)
T 4h3o_A 61 GNFVVYDSSGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIW 103 (105)
T ss_dssp SCEEEECTTCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEE
T ss_pred ccEEEECCCcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEe
Confidence 999999999999999998654 346899999999999974 466
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=143.19 Aligned_cols=106 Identities=13% Similarity=0.270 Sum_probs=86.1
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
+|+|.+||+|.+|+ +|+ ++|.|+|+|+.+|+ | |+|+ .+++||.||++.+. .++.++|+.
T Consensus 1 ~d~l~~g~~L~~g~---~l~-~~~~~~l~~~~dGn---------l-vl~~---~~~~vW~sn~~~~~----~~~~l~l~~ 59 (110)
T 3a0c_A 1 VNSLSSPNSLFTGH---SLE-VGPSYRLIMQGDCN---------F-VLYD---SGKPVWASNTGGLG----SGCRLTLHN 59 (110)
T ss_dssp CCEEETTCEECTTC---EEE-ETTTEEEEECTTSC---------E-EEEE---TTEEEEECCCTTSC----SSCEEEECT
T ss_pred CCEeCCCCEECCCC---EEE-ECCCEEEEEcCCCc---------E-EEEE---CCEEEEECCCCCCC----CcEEEEEeC
Confidence 37899999999999 778 99999999977543 3 6676 37999999998632 347899999
Q ss_pred cCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccC
Q 037189 107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIG 157 (766)
Q Consensus 107 ~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~ 157 (766)
||||||+|.++.+||+|++... +...++|+|+|||||++. .+| ++++
T Consensus 60 dGNLVl~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W-~S~~ 107 (110)
T 3a0c_A 60 NGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVW-ATGS 107 (110)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEE-ECSC
T ss_pred CCCEEEECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEe-cCCC
Confidence 9999999998999999998644 334889999999999974 455 5543
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=4.6e-17 Score=143.05 Aligned_cols=100 Identities=19% Similarity=0.375 Sum_probs=81.7
Q ss_pred CCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEecc
Q 037189 28 GTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTAD 107 (766)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~ 107 (766)
+||.+||+|.+|+ +|+ +|.|+|+|+.+|+ .+| |.. .++||++|+..+ ..++.|+|+.|
T Consensus 2 ntL~~gq~L~~g~---~L~--~g~~~L~~q~dGn-------Lvl---y~~---~~~vW~snt~~~----~~~~~l~l~~d 59 (109)
T 3dzw_A 2 NILYSGETLSPGE---FLN--NGRYVFIMQEDCN-------LVL---YDV---DKPIWATNTGGL----DRRCHLSMQSD 59 (109)
T ss_dssp CEEETTEEECTTC---EEE--ETTEEEEECTTSC-------EEE---EET---TEEEEECCCTTS----SSSCEEEECTT
T ss_pred CCcCCCCEeCCCC---EEE--CCCEEEEEcCCCc-------EEE---EeC---CEEEEECCcccC----CCCEEEEEeCC
Confidence 6899999999999 555 7999999977543 333 654 589999999863 23478999999
Q ss_pred CcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeee
Q 037189 108 QGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 108 g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|||||+|.++.++|+|++.... ..+|+|+||||||||++ .+|
T Consensus 60 GNLvl~~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W 102 (109)
T 3dzw_A 60 GNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARW 102 (109)
T ss_dssp SCEEEECTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCC
T ss_pred CCEEEECCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEE
Confidence 9999999988999999986443 35899999999999984 577
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=8e-17 Score=143.06 Aligned_cols=106 Identities=17% Similarity=0.311 Sum_probs=83.8
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
.|||.+||+|.+|+ +|+ +|.|+|+|+.+++ .. +|+ .+++||+||++.|. .++.|+|+.
T Consensus 2 ~dtl~~gq~L~~g~---~L~--~g~~~L~~~~dgn-------lv---ly~---~~~~vW~sn~~~~~----~~~~l~l~~ 59 (115)
T 2dpf_A 2 DNVLLSGQTLHADH---SLQ--AGAYTLTIQNKCN-------LV---KYQ---NGRQIWASNTDRRG----SGCRLTLLS 59 (115)
T ss_dssp CCEEETTCEEETTE---EEE--ETTEEEEECTTSC-------EE---EEE---TTEEEEECSCTTSC----SSCEEEECT
T ss_pred CCEeCCCCEECCCC---EEE--CCCEEEEEcCCCc-------EE---EEe---CCEEEEeCCCCCCC----CceEEEECC
Confidence 37999999999999 667 8999999976542 22 354 37999999998742 357899999
Q ss_pred cCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccCC
Q 037189 107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIGH 158 (766)
Q Consensus 107 ~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~ 158 (766)
||||||+|.++.+||+|++... ....++|+|+|||||++. .+| ++++.
T Consensus 60 ~GnLvl~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W-~S~~~ 108 (115)
T 2dpf_A 60 DGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLW-SLGPN 108 (115)
T ss_dssp TSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEE-CSSTT
T ss_pred CCcEEEECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEE-ECCCC
Confidence 9999999988899999998643 345799999999999964 444 55443
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=8.8e-17 Score=142.14 Aligned_cols=107 Identities=17% Similarity=0.350 Sum_probs=80.1
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
+|||.+||+|.+|+ +| ++|.|+|+|+.++. | +||++ +++||+||+..+ ..++.++|+.
T Consensus 1 tdtl~~gq~L~~g~---~L--~~~~~~L~~~~dgn---------l-vl~~~---~~~vW~sn~~~~----~~~~~l~l~~ 58 (112)
T 1xd5_A 1 SDRLNSGHQLDTGG---SL--AEGGYLFIIQNDCN---------L-VLYDN---NRAVWASGTNGK----ASGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTC---EE--EETTEEEEECTTSC---------E-EEEET---TEEEEECCCTTS----CSSEEEEECT
T ss_pred CCCCCCCCEECCCC---EE--eCCCEEEEEcCCCc---------E-EEEEC---CEEEEeCCCcCC----CCCEEEEEeC
Confidence 47999999999999 66 47999999987653 2 35654 689999998752 1347899999
Q ss_pred cCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccC
Q 037189 107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIG 157 (766)
Q Consensus 107 ~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~ 157 (766)
||||||+| ++.+||+|++... +...++|+++|||||++..+..+| ++++
T Consensus 59 ~GNLvl~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W-~S~~ 108 (112)
T 1xd5_A 59 DGNLVIYS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIW-ATHT 108 (112)
T ss_dssp TSCEEEEE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEE-ECCC
T ss_pred CCCEEEEc-CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEE-ECCC
Confidence 99999998 7789999987543 335788888888888875444444 4433
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.5e-17 Score=167.61 Aligned_cols=135 Identities=18% Similarity=0.147 Sum_probs=103.3
Q ss_pred hhhhccccccceEEEEEEecCCCceeE--EEEEEeeccccc------------------------CHHHHHHHHHHHccC
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDIVFQD------------------------GEREFKNEVFVIGQT 534 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~--vavK~l~~~~~~------------------------~~~~f~~E~~~l~~l 534 (766)
+.+.||+|+||.||+|.... ++.. ||||.++..... ....+.+|+..+.++
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 45679999999999999842 3556 999987542111 013688999999999
Q ss_pred CCCCe--eeEeeeeecCCceEEEeeccCC-C----chhhhhccCCCCccchhhhHHHHHHHHHHHhh-hcCCCceecCCC
Q 037189 535 HHKNL--VRLLGFCDEGQNRLLVYEFLNN-G----TLASFLFGNLKPNWNLRTNIAFQIARGLLYLH-EDCSSQIIHCDM 606 (766)
Q Consensus 535 ~H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~dl 606 (766)
+|+++ +.++++ ...+|||||+.+ | +|.++... .++.....++.|++.+|.||| +. +|+||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCC
Confidence 88754 444443 367899999942 4 66665432 245677899999999999999 54 9999999
Q ss_pred ccceEEEcCCCCeEEeccCccccc
Q 037189 607 KPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 607 k~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
||+|||+++ .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.66 E-value=3e-16 Score=137.74 Aligned_cols=101 Identities=18% Similarity=0.263 Sum_probs=80.6
Q ss_pred cCCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEe
Q 037189 26 NNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLT 105 (766)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~ 105 (766)
++|||.+||+|..|+ +|+| |.|.|-|...|+ |.+ |.. ++||.+|+... ..++.|+|+
T Consensus 5 ~~dtL~~gq~L~~g~---~L~s--g~~~L~~q~dGn---------Lvl-~~~----~~vW~snt~~~----~~~~~l~l~ 61 (110)
T 3r0e_B 5 TNNLLFSGQVLYGDG---RLTA--KNHQLVMQGDCN---------LVL-YGG----KYGWQSNTHGN----GEHCFLRLN 61 (110)
T ss_dssp BTTEEETTCEEETTE---EEEC--SSCEEEECTTSC---------EEE-ECS----SSCEECCCTTS----SSSCEEEEC
T ss_pred ccCEECCCCEecCCC---EEEe--CCEEEEEcCCCe---------EEE-ECC----eEEEECCCcCC----CcCEEEEEe
Confidence 458999999999999 7787 569997754332 555 654 48999998762 134789999
Q ss_pred ccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 106 ADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 106 ~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
.||||||+|.++.++|+|++... ...+|+|+||||||||+ ..+|
T Consensus 62 ~dGNLvl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W 106 (110)
T 3r0e_B 62 HKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIF 106 (110)
T ss_dssp TTSCEEEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEE
T ss_pred CCCcEEEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEe
Confidence 99999999999999999998643 33589999999999998 3677
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.63 E-value=2e-15 Score=133.35 Aligned_cols=104 Identities=12% Similarity=0.148 Sum_probs=83.4
Q ss_pred cCCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEe
Q 037189 26 NNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLT 105 (766)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~ 105 (766)
+.|+|.+||+|..|+ +|. +|.|.|-|..+|. |-++..+ ..++||.+|+..+. .++.|.|+
T Consensus 5 ~~~tL~~gq~L~~g~---~L~--~g~~~L~~q~dGN---------LvL~~~~--~~~~vWssnt~~~~----~~~~l~l~ 64 (113)
T 3mez_B 5 VRNVLFSSQVMYDNA---QLA--TRDYSLVMRDDCN---------LVLTKGS--KTNIVWESGTSGRG----QHCFMRLG 64 (113)
T ss_dssp CSSEEETTCEEETTC---EEE--ETTEEEEECTTSC---------EEEEETT--TTEEEEECCCTTSC----SSCEEEEC
T ss_pred cCCEeCCCCEECCCC---EeE--cCCEEEEEcCCCE---------EEEEECC--CCEEEEECCcccCC----cCEEEEEe
Confidence 347999999999999 666 4899999976542 6664331 36899999998632 34789999
Q ss_pred ccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 106 ADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 106 ~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
.||||||+|.++.++|+|++... ...+|+|+||||||||+ ..+|
T Consensus 65 ~dGNLVl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W 109 (113)
T 3mez_B 65 HSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVW 109 (113)
T ss_dssp TTSCEEEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEE
T ss_pred CCCcEEEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEe
Confidence 99999999999999999998643 33589999999999997 4677
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-14 Score=127.72 Aligned_cols=91 Identities=27% Similarity=0.380 Sum_probs=74.7
Q ss_pred CcEEEEeccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
...|.|+.||||||++. +++||++++... ...+++|+++|||||+| ++..+| +++ .+|++|.|++.++++|++++
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W-~S~-~~~~~g~~~l~l~~dGnlvl 95 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIW-ASN-TNRQNGNYYLILQRDRNVVI 95 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEE-ECC-CCCSCCCCEEEECTTSCEEE
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEE-ECC-ccCCCCCEEEEEeCCCcEEE
Confidence 47899999999999987 789999998643 34689999999999999 555555 655 56789999999999999877
Q ss_pred EeccCCccccccceeecccccC
Q 037189 178 NIANLPTDFAYDAYYISHTYDG 199 (766)
Q Consensus 178 ~~~~~~~~~~~~~y~~sg~~~g 199 (766)
+- ... ..||++++|+|
T Consensus 96 ~~-~~~-----~~~W~S~~~~g 111 (112)
T 1xd5_A 96 YD-NSN-----NAIWATHTNVG 111 (112)
T ss_dssp EC-TTS-----CEEEECCCCCC
T ss_pred EC-CCC-----ceEEECCCccC
Confidence 63 222 57999999987
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.6e-14 Score=125.14 Aligned_cols=99 Identities=21% Similarity=0.373 Sum_probs=77.7
Q ss_pred cCCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEe
Q 037189 26 NNGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLT 105 (766)
Q Consensus 26 ~~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~ 105 (766)
+.|||.+||.|..|+ +| .+|.|.|.|..+|+ |-+ |.. +|.+|+..+ ...+.|+|+
T Consensus 2 ~~dtL~~gq~L~~g~---~L--~~g~~~L~~q~dGN---------Lvl-~~~------~Wssnt~~~----~~~~~l~l~ 56 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEG---HL--KNGDFDLVMQDDCN---------LVL-YNG------NWQSNTANN----GRDCKLTLT 56 (109)
T ss_dssp CCSEEETTCEECTTC---EE--EETTEEEEECTTSC---------EEE-ETT------TEECCCTTS----CSSCEEEEC
T ss_pred ccCCcCCCCCcCCCC---Ee--ECCCEEEEEecCCe---------EEE-EeC------eEEcCCCCC----CCcEEEEEc
Confidence 358999999999999 56 46999999976542 333 432 699988763 135889999
Q ss_pred ccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeee
Q 037189 106 ADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 106 ~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
.||||||+|.++.++|+|++.... ...|+|+||||||||+ ..+|
T Consensus 57 ~dGnLvl~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W 101 (109)
T 3r0e_A 57 DYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVF 101 (109)
T ss_dssp TTSCEEEECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEE
T ss_pred CCCeEEEEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEE
Confidence 999999999988999999986433 3589999999999997 4666
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=5.1e-15 Score=158.34 Aligned_cols=135 Identities=11% Similarity=0.089 Sum_probs=94.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--------------cCHHHH--------HHHHHHHccCCCC
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--------------DGEREF--------KNEVFVIGQTHHK 537 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--------------~~~~~f--------~~E~~~l~~l~H~ 537 (766)
.+.+.||+|++|.||+|... .++.||||.++.... ...... .+|...|.++.+.
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp EEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecCEeeeCCceEEEEEECC----CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34567999999999999865 477899998753210 011122 2344555555433
Q ss_pred Ce--eeEeeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 538 NL--VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 538 ni--v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
++ ...+++ ...+|||||+++++|..... .+....++.|++.+|.|||+. +|+||||||.|||+++
T Consensus 174 gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 174 GFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp TCSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 32 122221 23479999999999876542 234567899999999999964 9999999999999987
Q ss_pred CCC----------eEEeccCcccccc
Q 037189 616 HYN----------ARISDFGLAKLLT 631 (766)
Q Consensus 616 ~~~----------~kl~Dfgla~~~~ 631 (766)
++. +.|+||+.+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 763 8999999876543
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.51 E-value=6.1e-14 Score=123.19 Aligned_cols=87 Identities=18% Similarity=0.239 Sum_probs=72.0
Q ss_pred CcEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
...|.|+.||||||++ .+++||++++.... ...++|+|+|||||+|.++..+| +++ .++++|.|++.++++|++++
T Consensus 21 ~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W-~S~-t~~~~g~~~l~l~~dGnlvl 97 (110)
T 3a0c_A 21 SYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIW-QTK-TNGKEDHYVLVLQQDRNVVI 97 (110)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEE-ECC-CCCSSSCCEEEECTTSCEEE
T ss_pred CEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEE-ecC-CCCCCCCEEEEEeCCccEEE
Confidence 4789999999999998 57899999986433 46899999999999998777776 554 56788999999999999877
Q ss_pred EeccCCccccccceeecccc
Q 037189 178 NIANLPTDFAYDAYYISHTY 197 (766)
Q Consensus 178 ~~~~~~~~~~~~~y~~sg~~ 197 (766)
+- . .||+++++
T Consensus 98 ~~--~-------~~W~S~~~ 108 (110)
T 3a0c_A 98 YG--P-------VVWATGSG 108 (110)
T ss_dssp EC--S-------EEEECSCC
T ss_pred EC--C-------CEecCCCc
Confidence 52 1 49999876
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.49 E-value=1.1e-13 Score=123.24 Aligned_cols=85 Identities=18% Similarity=0.256 Sum_probs=71.3
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||||++. +++||++++.... ...++|+|+|||||+|.++..+| +++ .+|++|.|++.++++|+++++
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW-~S~-~~~~~g~~~l~l~~~Gnlvl~ 108 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVW-QSP-VAGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEE-ECS-CCCCSSCEEEEECTTSCEEEE
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEE-cCC-CCCCCCCEEEEEECCCcEEEE
Confidence 6789999999999987 7899999986443 46899999999999998777776 554 578899999999999998775
Q ss_pred eccCCccccccceeeccc
Q 037189 179 IANLPTDFAYDAYYISHT 196 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~ 196 (766)
- ..||++|+
T Consensus 109 ~---------~~~W~Sg~ 117 (119)
T 1b2p_A 109 G---------DALWATQT 117 (119)
T ss_dssp E---------SEEEECCC
T ss_pred C---------ccEeCCCC
Confidence 3 25999986
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.48 E-value=1.2e-13 Score=121.31 Aligned_cols=100 Identities=11% Similarity=0.199 Sum_probs=73.5
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
+|+|.+||.|.+|+ +| .+|.|.|.|..+|+ |-+ |.. .. ||.+|+..+. ..+.|.|+.
T Consensus 2 ~~~l~~gq~L~~g~---~L--~~g~~~L~~q~dGn---------Lvl-~~~---~~-vW~snt~~~~----~~~~l~l~~ 58 (111)
T 3mez_A 2 NNVLLTGDVIHTDN---QL--SYESAAFVMQGDCN---------LVL-YNE---AG-GFQSNTHGRG----VDCTLRLNN 58 (111)
T ss_dssp TTEEETTCEECTTC---EE--EETTEEEEECTTSC---------EEE-ECS---SC-CEECCCTTSC----SSCEEEECT
T ss_pred cCEeCCCCEeCCCC---EE--ecCCEEEEEccCCe---------EEE-ECC---CC-EEECCcccCC----cCEEEEEcC
Confidence 57999999999999 55 36889999866542 333 432 23 9988887632 247889999
Q ss_pred cCcEEEeCCCCC-eeeeeeccC--C-cceEEEeccCCCEEEecCCCCeee
Q 037189 107 DQGLVLNDPQGK-QVWSSKIDI--G-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 107 ~g~l~l~~~~~~-~~w~t~~~~--~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
||||||+|.++. +||+|++.. . ...+++|++|||||||+ ..+|
T Consensus 59 dGNLVl~~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W 105 (111)
T 3mez_A 59 RGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIW 105 (111)
T ss_dssp TSCEEEECSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEE
T ss_pred CCcEEEEeCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEE
Confidence 999999988765 599988531 2 23578899999999997 4677
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=6.7e-13 Score=117.66 Aligned_cols=89 Identities=17% Similarity=0.251 Sum_probs=73.0
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||+|++ .+++||++++.... ...++|+++|||||+|.++..+| ++++ .+++|.|++.++++|+++++
T Consensus 22 ~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW-~S~~-~~~~g~~~l~l~~dGnlvl~ 98 (115)
T 2dpf_A 22 YTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVW-GSAC-WGDNGKYALVLQKDGRFVIY 98 (115)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEE-ECCC-CCSSSCCEEEECTTSCEEEE
T ss_pred EEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEE-EcCC-CCCCCCEEEEEeCCCeEEEE
Confidence 789999999999998 57899999986433 46899999999999998777776 5554 36789999999999998775
Q ss_pred eccCCccccccceeecccccCC
Q 037189 179 IANLPTDFAYDAYYISHTYDGA 200 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~~~g~ 200 (766)
.. .||+|++|...
T Consensus 99 --~~-------~~W~S~~~~~~ 111 (115)
T 2dpf_A 99 --GP-------VLWSLGPNGCR 111 (115)
T ss_dssp --CS-------EEECSSTTCBC
T ss_pred --CC-------CEEECCCCCCc
Confidence 21 49999999653
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.9e-12 Score=111.63 Aligned_cols=86 Identities=17% Similarity=0.190 Sum_probs=69.3
Q ss_pred CcEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCe-eeeeccC-CCCCCCceEEEEecCCce
Q 037189 99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSR-AFFPKIG-HQFSRGLFQFRLLKDGNL 175 (766)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~-~w~~~~~-~dps~G~~~~~~~~~g~~ 175 (766)
...|.|+.||||||++.++ +|++++.... ...++|+++|||||+|.++.. +| ++.. .....|.|.+.++.||++
T Consensus 21 ~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW-~S~t~~~~~~~~~~l~Lq~dGNl 97 (111)
T 3mez_A 21 SAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVW-VYPRSVNTVRGNYAATLGPDQHV 97 (111)
T ss_dssp TEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSE-EESSSCCCCSSCCEEEECTTSCE
T ss_pred CEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEE-EeccccCCCCcCEEEEECCCCeE
Confidence 3789999999999999876 9999986443 368999999999999987664 77 4432 234568999999999999
Q ss_pred EEEeccCCccccccceeeccc
Q 037189 176 VLNIANLPTDFAYDAYYISHT 196 (766)
Q Consensus 176 ~l~~~~~~~~~~~~~y~~sg~ 196 (766)
++|- .++|.+++
T Consensus 98 vly~---------~~~W~s~t 109 (111)
T 3mez_A 98 TIYG---------PAIWSTPA 109 (111)
T ss_dssp EEEC---------SEEEECCC
T ss_pred EEec---------cCEEccCC
Confidence 9983 35898875
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.9e-12 Score=112.12 Aligned_cols=87 Identities=16% Similarity=0.209 Sum_probs=69.6
Q ss_pred CcEEEEeccCcEEEeCC-CCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceE
Q 037189 99 GSQVKLTADQGLVLNDP-QGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLV 176 (766)
Q Consensus 99 ~~~l~~~~~g~l~l~~~-~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~ 176 (766)
...|.|+.||||||++. .++++|++++... ....++|+++|||||+|.++..+| ++.... ..|.|.+.++.||+++
T Consensus 25 ~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW-~S~t~~-~~~~~~~~L~~dGnlv 102 (113)
T 3mez_B 25 DYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVF-VSNTVG-QEGDYVLILQINGQAV 102 (113)
T ss_dssp TEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEE-ECSCCC-SSSCCEEEECTTSCEE
T ss_pred CEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEE-ECCCcC-CCCCEEEEEcCCceEE
Confidence 47899999999999998 4889999998643 346899999999999998777777 443322 2477999999999999
Q ss_pred EEeccCCccccccceeeccc
Q 037189 177 LNIANLPTDFAYDAYYISHT 196 (766)
Q Consensus 177 l~~~~~~~~~~~~~y~~sg~ 196 (766)
+|- .+.|.+|+
T Consensus 103 ly~---------~~~W~s~~ 113 (113)
T 3mez_B 103 VYG---------PAVWSTAA 113 (113)
T ss_dssp EEC---------SEEEESCC
T ss_pred Eec---------CCEecCCC
Confidence 873 34788874
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=108.70 Aligned_cols=85 Identities=22% Similarity=0.241 Sum_probs=68.0
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||||++. +++||++++.... ...++|+++|||||+|.++..+| ++... ...+.|.+.++.+|++++|
T Consensus 21 ~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W-~S~t~-~~~~~~~~~L~ddGNlvly 97 (109)
T 3dzw_A 21 YVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIW-ASNTG-GENGNYVCVLQKDRNVVIY 97 (109)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEE-ECCCC-CSSSCEEEEECTTSCEEEE
T ss_pred EEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEE-ECCCC-CCCCCEEEEEeCCCEEEEE
Confidence 7899999999999987 6899999986433 46899999999999998777777 44322 2347789999999999987
Q ss_pred eccCCccccccceeeccc
Q 037189 179 IANLPTDFAYDAYYISHT 196 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~ 196 (766)
- .+.|.|++
T Consensus 98 ~---------~~~W~s~t 106 (109)
T 3dzw_A 98 G---------TARWATGT 106 (109)
T ss_dssp E---------SCCCCCCC
T ss_pred C---------CCEEeCCC
Confidence 4 23787775
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.9e-11 Score=106.83 Aligned_cols=84 Identities=18% Similarity=0.234 Sum_probs=68.0
Q ss_pred CcEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 99 GSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 99 ~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
...|.|+.||||||+++ +|+|++.... ...++|+++|||||+|.++..+|. +. .....+.|.+.+++||++++
T Consensus 22 ~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWs-s~-t~~~~~~~~~~L~~dGNlvl 95 (109)
T 3r0e_A 22 DFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWK-SG-AQSVKGNYAAVVHPDGRLVV 95 (109)
T ss_dssp TEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEE-CC-CCCSSSCCEEEEETTTEEEE
T ss_pred CEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEc-CC-CcCCCcCEEEEEcCCCeEEE
Confidence 37899999999999984 8999987533 468999999999999988888883 22 22245788999999999998
Q ss_pred EeccCCccccccceeecccc
Q 037189 178 NIANLPTDFAYDAYYISHTY 197 (766)
Q Consensus 178 ~~~~~~~~~~~~~y~~sg~~ 197 (766)
|- .+.|.+++|
T Consensus 96 y~---------~~~W~s~t~ 106 (109)
T 3r0e_A 96 FG---------PSVFKIDPW 106 (109)
T ss_dssp EC---------SEEEEECTT
T ss_pred Ee---------cCEECCCCc
Confidence 73 358999987
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.9e-11 Score=104.39 Aligned_cols=84 Identities=19% Similarity=0.261 Sum_probs=66.8
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||||++. +++|++++.... ...++|+++|||||+|.++..+| ++.... ..|.|.+.++.||++++|
T Consensus 26 ~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW-~S~t~~-~~~~~~~~L~~dGNlvly 101 (110)
T 3r0e_B 26 HQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIW-SSRSSS-KQGEYVLILQDDGFGVIY 101 (110)
T ss_dssp CEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEE-ECCCCC-SSSCCEEEECTTSCEEEE
T ss_pred EEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEE-EcCCcC-CCCCEEEEEcCCccEEEe
Confidence 7899999999999986 589999986433 35899999999999998777777 443322 357799999999999987
Q ss_pred eccCCccccccceeeccc
Q 037189 179 IANLPTDFAYDAYYISHT 196 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~ 196 (766)
- .+.|.+|+
T Consensus 102 ~---------~~~W~t~~ 110 (110)
T 3r0e_B 102 G---------PAIFETSS 110 (110)
T ss_dssp C---------SEEEESCC
T ss_pred c---------CCEecCCC
Confidence 3 24788764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-10 Score=100.82 Aligned_cols=76 Identities=25% Similarity=0.440 Sum_probs=62.9
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCC--cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIG--TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~--~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
..|.|+.||||||++. +++||++++... ....+.|+++|||||+|.++..+|.-. .....+.+.+.++.+|++++
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~--t~~~~~~~~l~L~ddGNlVl 97 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASH--STRGSGNYILILQDDGNVII 97 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECC--CCCCSSCEEEEECTTSCEEE
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEec--CCCCCCCEEEEEeCCCeEEE
Confidence 6799999999999984 589999998643 346899999999999999999998432 22346789999999999998
Q ss_pred E
Q 037189 178 N 178 (766)
Q Consensus 178 ~ 178 (766)
|
T Consensus 98 y 98 (105)
T 4h3o_A 98 Y 98 (105)
T ss_dssp E
T ss_pred E
Confidence 7
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=3e-10 Score=116.70 Aligned_cols=139 Identities=15% Similarity=0.052 Sum_probs=108.4
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeecc
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+...++.|+.+.||++... +..+++|............+.+|+++++.+. |..+.++++++.+.+..++||||+
T Consensus 18 ~~~~~~g~s~~~v~~~~~~-----~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 92 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE-----NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp EEECCSCCSSSEEEEEECS-----SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred eEeeccCCCCCeEEEEECC-----CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence 3456788888999998642 4579999986532233456889999998884 678889999999888999999999
Q ss_pred CCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhc-------------------------------------------
Q 037189 560 NNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED------------------------------------------- 596 (766)
Q Consensus 560 ~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 596 (766)
++.+|.+.+. +......++.+++++|+.||+.
T Consensus 93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 9999987632 2334457889999999999971
Q ss_pred -------------CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 597 -------------CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 597 -------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
....++|+|+++.||+++++..+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 014589999999999998766667999997653
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.99 E-value=2.1e-09 Score=110.22 Aligned_cols=119 Identities=16% Similarity=0.253 Sum_probs=86.8
Q ss_pred cCCCcCCCCe----eeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcE
Q 037189 26 NNGTVPVGAT----LIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQ 101 (766)
Q Consensus 26 ~~~~~~~~~~----l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~ 101 (766)
.+||+.||+. |..|+ .|+|+ ..++.|+|...-..+. ..+ + |.+ ..+++|.+++.++ . ...
T Consensus 135 ptdtlLpg~~~~~~l~~g~---~L~S~-~dps~G~fsl~l~~dG--nlv--L-y~~--~~~~yW~Sgt~~~---~--~~~ 198 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGS---ELVQG-VVYGAGASKLVFQGDG--NLV--A-YGP--NGAATWNAGTQGK---G--AVR 198 (276)
T ss_dssp TTSCCCCSCTTCEEECSSE---EECTT-CEEEETTEEEEECTTS--CEE--E-ECT--TSSEEEECCCTTT---T--CCE
T ss_pred cccccccccccccccccCc---ccccC-CCCCCceEEEeecCCc--eEE--E-EeC--CCeEEEECCCCCC---c--cEE
Confidence 4589999999 88887 56664 5666666665422221 233 3 332 2589999988763 2 278
Q ss_pred EEEeccCcEEEeCCCCCeeeeeeccCCcceEEEeccCCCEEEecCCCCeeeeeccCCCCCCC
Q 037189 102 VKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRG 163 (766)
Q Consensus 102 l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G 163 (766)
|+|+.||||+++|.++.++|++++.......++|++|||||||+. . ..|+++++.|.--
T Consensus 199 l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~--~-~~Wqsf~~~P~~~ 257 (276)
T 3m7h_A 199 AVFQGDGNLVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE--K-PVWARFGFQPTYR 257 (276)
T ss_dssp EEECTTSCEEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE--E-EEEESSSCCTTSC
T ss_pred EEEcCCCeEEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC--C-CeEEccCccCCcc
Confidence 999999999999998889999998654457899999999999985 3 3458888876543
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.89 E-value=8e-09 Score=103.98 Aligned_cols=87 Identities=18% Similarity=0.217 Sum_probs=68.8
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCcceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEEe
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLNI 179 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~~ 179 (766)
..|.|+.||||++++. +++||++|+.......++|+++|||||+|.++..+| .++.. ...|.|.+.++.+|+++++-
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~~~~~vW-~s~~~-~~~~~~~~~l~d~Gnlvl~~ 104 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRW-SSGTK-GSIGNYVLVLQPDRTVTIYG 104 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSC-CCCCC-CCSSCCEEEECSSSCEEEEC
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcCCCcEEE-eCCcc-ccCCcEEEEEeCCCCEEEec
Confidence 6788889999999986 689999998655556889999999999998888887 44332 33578899999999999861
Q ss_pred ccCCccccccceeeccccc
Q 037189 180 ANLPTDFAYDAYYISHTYD 198 (766)
Q Consensus 180 ~~~~~~~~~~~y~~sg~~~ 198 (766)
..+|.+..+.
T Consensus 105 ---------~~~W~S~~~p 114 (236)
T 1dlp_A 105 ---------PGLWDSGTSN 114 (236)
T ss_dssp ---------SEEEECSCCC
T ss_pred ---------CCEEECCCCC
Confidence 2478777553
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.89 E-value=3.8e-09 Score=107.97 Aligned_cols=130 Identities=15% Similarity=0.051 Sum_probs=96.1
Q ss_pred cc-ccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC--eeeEeeeeecCCceEEEeeccCC
Q 037189 485 VG-RGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN--LVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG-~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
++ .|..+.||++... ++..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+++
T Consensus 27 ~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp CSCTTSSCEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cccCCCCceEEEEecC----CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 44 5556899998643 3456888986543 2346788999888886544 56689988888889999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC--------------------------------------------
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-------------------------------------------- 597 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 597 (766)
.+|. ... .....++.++++.|+.||...
T Consensus 100 ~~l~--~~~------~~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 100 QDLL--SSH------LAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp EETT--TSC------CCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccC--cCc------CCHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 9884 211 123467788888888888531
Q ss_pred -----------CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 -----------SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 -----------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.78 E-value=1.9e-08 Score=108.27 Aligned_cols=141 Identities=16% Similarity=0.193 Sum_probs=104.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEee--ccc-ccCHHHHHHHHHHHccCC--CCCeeeEeeeeecC---CceEE
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IVF-QDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEG---QNRLL 554 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~l 554 (766)
+.|+.|.++.||+.... +..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..++
T Consensus 44 ~~l~~G~sn~~y~v~~~-----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EECCC-CCSCEEEEECS-----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred EEcCCcccceEEEEEEC-----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 46899999999998754 2467788765 221 122356888999998887 45688999998776 45899
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-------------------------------------
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC------------------------------------- 597 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 597 (766)
||||+++..|.+... ..++...+..++.++++.|+.||...
T Consensus 119 vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999988754221 23567778889999999999999721
Q ss_pred ------------------CCceecCCCccceEEEcCCCC--eEEeccCccccc
Q 037189 598 ------------------SSQIIHCDMKPQNILLDDHYN--ARISDFGLAKLL 630 (766)
Q Consensus 598 ------------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~ 630 (766)
...++|+|+++.||+++.++. +.|+||+.+..-
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 257999999999999997753 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.53 E-value=2e-08 Score=105.47 Aligned_cols=186 Identities=19% Similarity=0.153 Sum_probs=118.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCC--eeeEeeeeecCC---ceEEEe
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKN--LVRLLGFCDEGQ---NRLLVY 556 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~ 556 (766)
+.++.|....||+.. ..+++|..... .....+.+|.+++..+. +.. +.+++....... ..++||
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 358899999999852 24777875422 23467889999998773 332 455665554433 347899
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhc----------------------------------------
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED---------------------------------------- 596 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~---------------------------------------- 596 (766)
|++++.+|.+... ..++..++..++.++++.|+.||..
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875432 2345666777888888888888851
Q ss_pred ---------------CCCceecCCCccceEEEcC--CCCeEEeccCcccccccCCCcceeecc---cc---------cCc
Q 037189 597 ---------------CSSQIIHCDMKPQNILLDD--HYNARISDFGLAKLLTLNQSKTIKTSI---RG---------TKG 647 (766)
Q Consensus 597 ---------------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~---~g---------t~~ 647 (766)
....++|+|+++.||++++ ...+.|+||+.+..-.+.......... .+ ..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1245899999999999998 556789999988754321110000000 00 001
Q ss_pred ccc-cccccCCCCCcccCeeehhHHHHHHHhCCcCC
Q 037189 648 YVA-PEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682 (766)
Q Consensus 648 y~a-PE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~ 682 (766)
... |+.... .....+.|+++.++|++.+|+.++
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 121110 112258899999999999998775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.6e-05 Score=79.87 Aligned_cols=136 Identities=17% Similarity=0.121 Sum_probs=93.3
Q ss_pred hccccccc-eEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccCC
Q 037189 484 EVGRGSFG-IVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 484 ~LG~G~fg-~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
.+..|..+ .||+..... ++..+++|.-.. ....++.+|...|+.+. +--+.++++++.+.+..++|||++++
T Consensus 31 ~~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP---NAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCT---TCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecC---CCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34455555 589876542 345677887543 23457888998888774 44478899999999999999999999
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhc---------------------------------------------
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED--------------------------------------------- 596 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 596 (766)
.++.+.... .......+..++++.|+-||..
T Consensus 105 ~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887665421 1122334555555555555531
Q ss_pred ----------CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 597 ----------CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 597 ----------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
....++|+|+.+.|||++++..+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877777999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.5e-05 Score=81.69 Aligned_cols=135 Identities=19% Similarity=0.194 Sum_probs=90.5
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC---CeeeEeeeee-cCCceEEEeec
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK---NLVRLLGFCD-EGQNRLLVYEF 558 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey 558 (766)
+.++.|....||+. +..+++|+-.. ......+.+|.++|..+.+. .+.+++.++. ..+..++||||
T Consensus 25 ~~l~~G~~n~v~~v--------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEECSSEEEEEE--------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eecCCCcceeEEEE--------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 35778888899987 12467776421 22346789999999998752 3667777774 45567899999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhc------------------------------------------
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED------------------------------------------ 596 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 596 (766)
+++..|.+.... .++...+..++.++++.|+.||..
T Consensus 95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999888763211 123334444455555555555432
Q ss_pred ---------------CCCceecCCCccceEEEcC---CCC-eEEeccCcccc
Q 037189 597 ---------------CSSQIIHCDMKPQNILLDD---HYN-ARISDFGLAKL 629 (766)
Q Consensus 597 ---------------~~~~ivH~dlk~~NIll~~---~~~-~kl~Dfgla~~ 629 (766)
....++|+|+++.||+++. ++. ..|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=2.1e-05 Score=84.09 Aligned_cols=84 Identities=7% Similarity=-0.017 Sum_probs=55.4
Q ss_pred hhc-cccccceEEEEEEec--CCC-ceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCC---CCeeeEeeeeecC---
Q 037189 483 EEV-GRGSFGIVYKGVIQT--TRT-STTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHH---KNLVRLLGFCDEG--- 549 (766)
Q Consensus 483 ~~L-G~G~fg~Vy~~~~~~--~~~-~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~--- 549 (766)
+.| +.|....+|+..... .+. .+..+++|...... ......+.+|+.+++.+.. ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 788889999887541 000 14567788764322 1112467888888887742 3577888888665
Q ss_pred CceEEEeeccCCCchhh
Q 037189 550 QNRLLVYEFLNNGTLAS 566 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~ 566 (766)
...++||||+++..|.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35789999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00015 Score=78.72 Aligned_cols=75 Identities=16% Similarity=0.065 Sum_probs=48.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc-------cCHHHHHHHHHHHccCCC--C-CeeeEeeeeecCCce
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-------DGEREFKNEVFVIGQTHH--K-NLVRLLGFCDEGQNR 552 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~-niv~l~g~~~~~~~~ 552 (766)
+.||.|..+.||++.... .+..++||....... .....+..|.+++..+.+ + .+.+++.+. .+..
T Consensus 36 ~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~ 110 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 110 (397)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EECCCCceEEEEEEEECC---CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCcc
Confidence 468999999999997542 245788997643211 123456778888877642 3 345666543 4456
Q ss_pred EEEeeccCCC
Q 037189 553 LLVYEFLNNG 562 (766)
Q Consensus 553 ~lV~Ey~~~g 562 (766)
++||||+++.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 8999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00096 Score=69.54 Aligned_cols=74 Identities=18% Similarity=0.144 Sum_probs=57.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.|+.|....+|+.... +..+++|..... ....|..|...|+.+. ...+++++.++...+..++||||+
T Consensus 42 ~~l~gG~~n~~y~v~~~-----~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-----VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEECCSSSSEEEEEESS-----SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred EEeCCccceeeeEEEEC-----CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 45899999999998642 346778876532 3567888988888774 356888999988888899999999
Q ss_pred CCCch
Q 037189 560 NNGTL 564 (766)
Q Consensus 560 ~~gsL 564 (766)
++..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98765
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00079 Score=71.09 Aligned_cols=32 Identities=22% Similarity=0.323 Sum_probs=28.6
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 57899999999999998888999999997753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0012 Score=72.01 Aligned_cols=80 Identities=9% Similarity=0.029 Sum_probs=47.2
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCC---CCCcccCeeehhHHHHH
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS---KITAKVDVYSFGVLLLE 674 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDV~s~Gvvl~e 674 (766)
...++|+|+++.|||++.++ ++|+||+.+..-.+...... ....-...|.+|+..... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 56899999999999998776 99999998875432211100 000011345566544311 11123445567777777
Q ss_pred HHhCC
Q 037189 675 IIACR 679 (766)
Q Consensus 675 lltg~ 679 (766)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0024 Score=65.78 Aligned_cols=74 Identities=18% Similarity=0.192 Sum_probs=52.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC---CCeeeEeeeeecCCceEEEeecc
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH---KNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H---~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
+.+|.|..+.||+..+. +++.++||+-..........|..|...|+.+.- --+.+++++. ..++||||+
T Consensus 21 ~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l 92 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA----DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWV 92 (288)
T ss_dssp EEEEEETTEEEEEEEET----TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECC
T ss_pred EecCCCCCeEEEEEEEC----CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEee
Confidence 46899999999999886 467899998765444444568889888887742 2345556543 347899998
Q ss_pred CCCch
Q 037189 560 NNGTL 564 (766)
Q Consensus 560 ~~gsL 564 (766)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0052 Score=67.17 Aligned_cols=76 Identities=12% Similarity=0.179 Sum_probs=48.9
Q ss_pred hhccccccceEEEEEEecCC----CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~E 557 (766)
+.|+.|....+|+....... ..+..+++|+.... .....+.+|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 45788888999999865311 12356777776321 222566688888887753333 567776643 38999
Q ss_pred ccCCCch
Q 037189 558 FLNNGTL 564 (766)
Q Consensus 558 y~~~gsL 564 (766)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.36 E-value=0.016 Score=60.86 Aligned_cols=33 Identities=30% Similarity=0.319 Sum_probs=28.2
Q ss_pred CCceecCCCccceEEEcCC----CCeEEeccCccccc
Q 037189 598 SSQIIHCDMKPQNILLDDH----YNARISDFGLAKLL 630 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~ 630 (766)
...++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4579999999999999874 67899999988653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.013 Score=62.60 Aligned_cols=142 Identities=17% Similarity=0.217 Sum_probs=80.5
Q ss_pred hhccccccceEEEEEEecC----CCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTT----RTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~----~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.|..|....+|+...... ..+...+++|+-.. .......+.+|.++++.+. +.-..++++++.++ +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 3566777888999876421 11235777887532 2234556778988887774 22236677776542 9999
Q ss_pred ccCCCchhhh-h----------------ccC-----CCCc--cchhhhHHHHHH-------------------HHHHHhh
Q 037189 558 FLNNGTLASF-L----------------FGN-----LKPN--WNLRTNIAFQIA-------------------RGLLYLH 594 (766)
Q Consensus 558 y~~~gsL~~~-l----------------~~~-----~~l~--~~~~~~i~~~ia-------------------~gL~yLH 594 (766)
|+++..|..- + +.. .... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665421 0 111 1111 223333332221 1222332
Q ss_pred h-----cCCCceecCCCccceEEEcCC----CCeEEeccCcccc
Q 037189 595 E-----DCSSQIIHCDMKPQNILLDDH----YNARISDFGLAKL 629 (766)
Q Consensus 595 ~-----~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~ 629 (766)
+ .....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 123468999999999999876 7899999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.004 Score=64.50 Aligned_cols=31 Identities=26% Similarity=0.358 Sum_probs=25.9
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 345899999999999 5667889999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0076 Score=62.91 Aligned_cols=139 Identities=12% Similarity=0.094 Sum_probs=76.0
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC--eeeEeee------eecCCceEEE
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN--LVRLLGF------CDEGQNRLLV 555 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~------~~~~~~~~lV 555 (766)
.|+.|....+|+..... + .+++|..... ....++..|+.++..+.... +.+++.. ....+..+++
T Consensus 29 ~i~~G~~n~~~~v~~~~----g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTK----D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EECC---EEEEEEEESS----C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ccCCCcccceEEEEeCC----c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 46778788899987542 2 5778877542 12235566776666654222 3334322 1223557899
Q ss_pred eeccCCCchhhh--------------hcc---C---CC------Cccchh--------h----hHHHHHHHHHHHhhhc-
Q 037189 556 YEFLNNGTLASF--------------LFG---N---LK------PNWNLR--------T----NIAFQIARGLLYLHED- 596 (766)
Q Consensus 556 ~Ey~~~gsL~~~--------------l~~---~---~~------l~~~~~--------~----~i~~~ia~gL~yLH~~- 596 (766)
++|+++..+... ++. . .. ..|... . .+...+.+.+..+++.
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 999998654210 111 0 00 012110 0 0111244455555532
Q ss_pred ---CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 597 ---CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 597 ---~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
....++|+|+++.|||++++..+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 245799999999999999876568999997753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.022 Score=62.60 Aligned_cols=75 Identities=13% Similarity=0.092 Sum_probs=45.1
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe-eeEeeeeecCCceEEEeeccCC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL-VRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+.|+.|....+|+..... .+..+++|........ .-.-.+|..++..+...++ .++++.+.. .+||||+++
T Consensus 114 ~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS---KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETT---TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECC---CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 467888889999987642 1356777765332111 1112578888877764444 567777632 359999988
Q ss_pred Cchh
Q 037189 562 GTLA 565 (766)
Q Consensus 562 gsL~ 565 (766)
.+|.
T Consensus 186 ~~l~ 189 (458)
T 2qg7_A 186 YALS 189 (458)
T ss_dssp EECC
T ss_pred ccCC
Confidence 6553
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.97 E-value=0.024 Score=59.16 Aligned_cols=138 Identities=12% Similarity=0.031 Sum_probs=76.8
Q ss_pred hccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCC--CeeeEeee-----eecCCceEEEe
Q 037189 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHK--NLVRLLGF-----CDEGQNRLLVY 556 (766)
Q Consensus 484 ~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~lV~ 556 (766)
.|+ |....||+.... ++..+++|..... ......+..|..++..+... .+++++.. ....+..+++|
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 355 777889987543 2446888887532 12345677787777766422 24445443 11234567899
Q ss_pred eccCCCchhh-----h---------hcc----C-----CCCccchh----h---------------hHHHHHHHHHHHhh
Q 037189 557 EFLNNGTLAS-----F---------LFG----N-----LKPNWNLR----T---------------NIAFQIARGLLYLH 594 (766)
Q Consensus 557 Ey~~~gsL~~-----~---------l~~----~-----~~l~~~~~----~---------------~i~~~ia~gL~yLH 594 (766)
||+++..+.. . ++. . ...++... . .+...+.+.+..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 9998865431 0 110 0 01111100 0 00111112233332
Q ss_pred hc----CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 595 ED----CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 595 ~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
+. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 245689999999999999 4 899999987653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.91 E-value=0.012 Score=56.75 Aligned_cols=99 Identities=14% Similarity=0.037 Sum_probs=65.0
Q ss_pred CCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCccee
Q 037189 561 NGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639 (766)
Q Consensus 561 ~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 639 (766)
.-+|.+.|.. ..+++++++|.++.|.++.|.-+-.... . ..+=+.|..|++..+|.+.+.+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 3488898875 4688999999999999999877622101 1 1333457899999999998764 1110
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA 677 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt 677 (766)
.....+.|||... ...+.+.=|||+|++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888764 355678899999999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.034 Score=59.28 Aligned_cols=77 Identities=13% Similarity=0.079 Sum_probs=41.7
Q ss_pred hhccccccceEEEEEEecCC-----CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC-eeeEeeeeecCCceEEEe
Q 037189 483 EEVGRGSFGIVYKGVIQTTR-----TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~-----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 556 (766)
+.|+.|..-.+|+....... .....+++|........ ......|..++..+...+ ..++++... -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 45777888899998765210 01246777765432111 112356777777664333 446665542 36899
Q ss_pred eccCCCch
Q 037189 557 EFLNNGTL 564 (766)
Q Consensus 557 Ey~~~gsL 564 (766)
||+++..|
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.94 E-value=0.16 Score=53.23 Aligned_cols=32 Identities=22% Similarity=0.348 Sum_probs=28.2
Q ss_pred CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.86 E-value=0.13 Score=55.75 Aligned_cols=77 Identities=12% Similarity=0.045 Sum_probs=44.9
Q ss_pred hhccccccceEEEEEEecCCCc----eeEEEEEEeecccccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTS----TTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~----~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 557 (766)
+.|..|....+|+........+ ...+++|+-.... ...-.-.+|..+++.+.. .-..++++.+. -.+|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 3577788889999887532211 4567777753322 111123567777766642 22355565442 378999
Q ss_pred ccCCCch
Q 037189 558 FLNNGTL 564 (766)
Q Consensus 558 y~~~gsL 564 (766)
|+++..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.97 E-value=0.69 Score=49.66 Aligned_cols=30 Identities=27% Similarity=0.393 Sum_probs=25.4
Q ss_pred ceecCCCccceEEE------cCCCCeEEeccCcccc
Q 037189 600 QIIHCDMKPQNILL------DDHYNARISDFGLAKL 629 (766)
Q Consensus 600 ~ivH~dlk~~NIll------~~~~~~kl~Dfgla~~ 629 (766)
.++|+|+.+.|||+ +++..++++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.72 E-value=2.6 Score=40.57 Aligned_cols=85 Identities=12% Similarity=0.088 Sum_probs=61.7
Q ss_pred CCCCeeeEeeeeecCCceEEEeeccCCC-chhhhhccCCCCccchhhhHHHHHHHHHH-HhhhcCCCceecCCCccceEE
Q 037189 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNG-TLASFLFGNLKPNWNLRTNIAFQIARGLL-YLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 535 ~H~niv~l~g~~~~~~~~~lV~Ey~~~g-sL~~~l~~~~~l~~~~~~~i~~~ia~gL~-yLH~~~~~~ivH~dlk~~NIl 612 (766)
.||++ -...-.+++...+.|+--+++ ++.. + ...+...+++++.+|+.... +++ .-+|--|+|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEE
Confidence 57777 444446677777777765443 3332 2 34677888999999888777 666 5678889999999
Q ss_pred EcCCCCeEEeccCccccc
Q 037189 613 LDDHYNARISDFGLAKLL 630 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~ 630 (766)
++.++.++|.-.|+-..+
T Consensus 117 f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESL 134 (219)
T ss_dssp ECTTCCEEESCCEETTTB
T ss_pred EeCCCcEEEEEcCCcccC
Confidence 999999999888765443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 766 | ||||
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-67 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-55 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-35 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-19 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 4e-06 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 222 bits (566), Expect = 4e-67
Identities = 72/304 (23%), Positives = 137/304 (45%), Gaps = 34/304 (11%)
Query: 469 FSYKELEEATDNFKEEV-----------GRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF 517
F++++ EA F +E+ G G FG V G ++ VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 518 -QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-N 575
+ R+F +E ++GQ H N++ L G + +++ EF+ NG+L SFL N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 576 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
+ IA G+ YL + +H D+ +NIL++ + ++SDFGL++ L + S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 636 KTIKTS---IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAI 692
TS + + APE + K T+ DV+S+G+++ E+++ +
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ N + + D ++C L + + C Q+D + RP +++ L+
Sbjct: 234 -----YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
Query: 753 GVVE 756
++
Sbjct: 289 KMIR 292
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-66
Identities = 73/286 (25%), Positives = 126/286 (44%), Gaps = 28/286 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKN 538
+ +G GSFG VYKG VAVK L++ + + FKNEV V+ +T H N
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 539 LVRLLGFCDEGQNRLLVYEFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDC 597
++ +G+ Q +V ++ +L L K +IA Q A+G+ YLH
Sbjct: 66 ILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR-- 655
IIH D+K NI L + +I DFGLA + + + G+ ++APE R
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 656 -NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714
+ + + DVY+FG++L E++ + + + + Y + L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYS--NINNRDQIIFMVGRGYLSPDLSKVRS--- 236
Query: 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVP 760
C + + + C+++ RP ++L +E + S+P
Sbjct: 237 ------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR-SLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-62
Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 27/274 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
E +G G FG V+ G VAVK L F E ++ Q H+ LV
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTK----VAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQIARGLLYLHEDCS 598
RL + ++ E++ NG+L FL +K N ++A QIA G+ ++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
IH D++ NIL+ D + +I+DFGLA+L+ N+ + + + APE
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-REGAKFPIKWTAPEAINYGT 186
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
T K DV+SFG+LL EI+ + + N ++ + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP---------------YPGMTNPEVIQNLERGYRMVR 231
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
C E+L + C +E P RPT + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 2e-61
Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 25/274 (9%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
F +E+G G FG+V G + VA+K + E EF E V+ H+ L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYD----VAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCS 598
V+L G C + + ++ E++ NG L ++L + + + YL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+H D+ +N L++D ++SDFGL++ + + T + + PE SK
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
++K D+++FGVL+ EI + K ++ + N + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
EK+ + C E RPT K +L +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-61
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 26/287 (9%)
Query: 472 KELEEATDNFK---EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNE 527
K+L DN E+G G+FG V +GV + + VA+K L + + E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-IDVAIKVLKQGTEKADTEEMMRE 59
Query: 528 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQI 586
++ Q + +VRL+G C + + +LV E G L FL G + + + Q+
Sbjct: 60 AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGT 645
+ G+ YL E +H D+ +N+LL + + A+ISDFGL+K L + S T +++ +
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
+ APE K +++ DV+S+GV + E ++ + + + +
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ---------------KPYKKMKGPE 220
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ A + EC +L + C RP V Q +
Sbjct: 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 3e-61
Identities = 69/278 (24%), Positives = 121/278 (43%), Gaps = 25/278 (8%)
Query: 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL 539
F +E+G G FG+V+ G VA+K + E +F E V+ + H L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDK----VAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCS 598
V+L G C E LV+EF+ +G L+ +L + + G+ YL E C
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+IH D+ +N L+ ++ ++SDFG+ + + +Q T T + + +PE F S+
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
++K DV+SFGVL+ E+ + K ++ N ++ +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIP---------------YENRSNSEVVEDISTGFRLYK 223
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
+ + C +E P RP ++L+ L + E
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 3e-61
Identities = 68/293 (23%), Positives = 126/293 (43%), Gaps = 23/293 (7%)
Query: 475 EEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE-REFKNEVFVIGQ 533
+F E +GRG FG VY G + AVK L+ + GE +F E ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 534 THHKNLVRLLGFCDEGQNR-LLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLL 591
H N++ LLG C + L+V ++ +G L +F+ P Q+A+G+
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI--KTSIRGTKGYV 649
S + +H D+ +N +LD+ + +++DFGLA+ + + ++ KT + ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
A E + K T K DV+SFGVLL E++ ++ D + +L
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGRRL--- 253
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPN 762
+ C + L V + C +RP+ +++ + + + +
Sbjct: 254 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 6e-61
Identities = 58/306 (18%), Positives = 125/306 (40%), Gaps = 39/306 (12%)
Query: 474 LEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFV 530
+E D+F+ E+G G+ G+V+K + + +A K + + + R E+ V
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGL---VMARKLIHLEIKPAIRNQIIRELQV 57
Query: 531 IGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+ + + +V G + E ++ G+L L + + ++ + +GL
Sbjct: 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 117
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
YL E I+H D+KP NIL++ ++ DFG++ L ++ S GT+ Y++
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMS 171
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAIL---------TDWAFDCY 701
PE + + + + D++S G+ L+E+ R +E ++ +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIW------------------CIQEDPSLRPT 743
G+ + G D + L ++ C+ ++P+ R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 744 IKKVLQ 749
+K+++
Sbjct: 292 LKQLMV 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 5e-59
Identities = 69/316 (21%), Positives = 128/316 (40%), Gaps = 47/316 (14%)
Query: 470 SYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTT--AVAVKKLDI-VFQDGEREF 524
LE +N + ++G G+FG V++ VAVK L D + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 525 KNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP---------- 574
+ E ++ + + N+V+LLG C G+ L++E++ G L FL
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 575 --------------NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNAR 620
+ + IA Q+A G+ YL E +H D+ +N L+ ++ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180
Query: 621 ISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRK 680
I+DFGL++ + + ++ PE ++ T + DV+++GV+L EI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 681 SFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSL 740
M E R+G + A C +L + C + P+
Sbjct: 241 QPYYGMAHE------EVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPAD 285
Query: 741 RPTIKKVLQMLEGVVE 756
RP+ + ++L+ + E
Sbjct: 286 RPSFCSIHRILQRMCE 301
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 9e-59
Identities = 59/298 (19%), Positives = 116/298 (38%), Gaps = 29/298 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+E +G+G FG V++G + VAVK ++ + E++ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEE-----VAVKIFSSR-EERSWFREAEIYQTVMLRHENIL 60
Query: 541 RLLGFCDEGQNRL----LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHED 596
+ ++ LV ++ +G+L +L +A A GL +LH +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHME 119
Query: 597 C-----SSQIIHCDMKPQNILLDDHYNARISDFGLAKLL--TLNQSKTIKTSIRGTKGYV 649
I H D+K +NIL+ + I+D GLA + GTK Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 650 APEWFRNS------KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY----AILTDWAFD 699
APE +S + + D+Y+ G++ EI I + + +D + +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 700 CYRNGKLDALVGGDM-EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
R + + ++ E L + + C + + R T ++ + L + +
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-58
Identities = 75/300 (25%), Positives = 127/300 (42%), Gaps = 39/300 (13%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDIVFQDGERE-FKNEVFVIGQ-THH 536
F + +G G+FG V + S A VAVK L ERE +E+ V+ +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------------------NWNL 578
N+V LLG C G L++ E+ G L +FL +
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 579 RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ ++Q+A+G+ +L S IH D+ +NILL +I DFGLA+ + + + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
K + R ++APE N T + DV+S+G+ L E+ + S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYP 249
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ K ++ ++ ++ + C DP RPT K+++Q++E + S
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 23/272 (8%)
Query: 484 EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNLVR 541
E+G G+FG V KG Q + T VAVK L D E E V+ Q + +VR
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 542 LLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQI 601
++G C E ++ +LV E G L +L N + Q++ G+ YL E S
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNF 128
Query: 602 IHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS-KTIKTSIRGTKGYVAPEWFRNSKIT 660
+H D+ +N+LL + A+ISDFGL+K L +++ +T + + APE K +
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 661 AKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720
+K DV+SFGVL+ E + + + + ++ A++
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
C ++ + C D RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 69/339 (20%), Positives = 131/339 (38%), Gaps = 51/339 (15%)
Query: 448 YKKKW----IRNSPGDGTIETNLRCFSY-KELEEATDNFK--EEVGRGSFGIVYKGVIQT 500
Y+ + + S + + R + Y + E +N + + +G G+FG V
Sbjct: 1 YESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYG 60
Query: 501 TRTSTTA--VAVKKLDIVFQDGERE-FKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVY 556
+ + VAVK L ERE +E+ ++ Q H+N+V LLG C L++
Sbjct: 61 ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120
Query: 557 EFLNNGTLASFLFGNLKP-----------------------NWNLRTNIAFQIARGLLYL 593
E+ G L ++L + + A+Q+A+G+ +L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
+H D+ +N+L+ +I DFGLA+ + + + ++ + R ++APE
Sbjct: 181 E---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
T K DV+S+G+LL EI + + + + L+
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY--------------KLIQNG 283
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+ E++ ++ C D RP+ + L
Sbjct: 284 FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 1e-57
Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 27/283 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ ++G+G FG V+ G T TT VA+K L F E V+ + H+ LV
Sbjct: 21 LEVKLGQGCFGEVWMG----TWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDCS 598
+L + +V E+++ G+L FL G ++A QIA G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+H D++ NIL+ ++ +++DFGLA+L+ N+ T + + + APE +
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGR 190
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
T K DV+SFG+LL E+ + + N ++ V
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVP---------------YPGMVNREVLDQVERGYRMPC 235
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPP 761
EC E L + C +++P RPT + + LE + P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 196 bits (498), Expect = 1e-57
Identities = 78/293 (26%), Positives = 131/293 (44%), Gaps = 27/293 (9%)
Query: 470 SYKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNE 527
+Y + E + ++G G +G VY+GV + VAVK L + E EF E
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSL---TVAVKTLKEDTMEVE-EFLKE 63
Query: 528 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLF--GNLKPNWNLRTNIAFQ 585
V+ + H NLV+LLG C ++ EF+ G L +L + + + +A Q
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 586 IARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGT 645
I+ + YL IH D+ +N L+ +++ +++DFGL++L+T + T +
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 646 KGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705
+ APE +K + K DV++FGVLL EI S + +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224
Query: 706 LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ L+ D C EK+ + C Q +PS RP+ ++ Q E + + S
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 69/301 (22%), Positives = 138/301 (45%), Gaps = 32/301 (10%)
Query: 461 TIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTST-TAVAVKKLDIVFQD 519
T E + C + +++ +G G FG VYKG+++T+ VA+K L + +
Sbjct: 1 TTEIHPSCVTRQKV----------IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
Query: 520 GER-EFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWN 577
+R +F E ++GQ H N++RL G + + +++ E++ NG L FL +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 578 LRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637
+ IA G+ YL +H D+ +NIL++ + ++SDFGL+++L + T
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167
Query: 638 IKTS-IRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW 696
TS + + APE K T+ DV+SFG+++ E++ +
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------- 213
Query: 697 AFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
+ N ++ + ++C + + + C Q++ + RP ++ +L+ ++
Sbjct: 214 -YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
Query: 757 V 757
Sbjct: 273 A 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-57
Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 33/277 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
+ +G+G FG V G + + VAVK + + F E V+ Q H NLV
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNK-----VAVKCIKN--DATAQAFLAEASVMTQLRHSNLV 63
Query: 541 RLLGFCDEGQNRL-LVYEFLNNGTLASFLFGNLKP--NWNLRTNIAFQIARGLLYLHEDC 597
+LLG E + L +V E++ G+L +L + + + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+ +H D+ +N+L+ + A++SDFGL K + + + + + + APE R
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREK 175
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
K + K DV+SFG+LL EI + + + + G M+A
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEKGY-------KMDAP 222
Query: 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754
+ C + V C D ++RP+ ++ + LE +
Sbjct: 223 DG--CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 60/279 (21%), Positives = 114/279 (40%), Gaps = 21/279 (7%)
Query: 477 ATD-NFKEEVGRGSFGIVYKGV-IQTTRTSTTAVAVKKL-DIVFQDGEREFKNEVFVIGQ 533
T+ + +G G+FG VYKG+ I VA+K+L + +E +E +V+
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
+ ++ RLLG C +L+ L N QIA+G+ YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
+++H D+ +N+L+ + +I+DFGLAKLL + + + ++A E
Sbjct: 128 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ T + DV+S+GV + E++ +D ++ +++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKG 229
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
C + M+ + C D RP ++++
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-56
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 22/278 (7%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIGQTHHKNL 539
+G G FG V++G+ + AVA+K D RE F E + Q H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCS 598
V+L+G E ++ E G L SFL + A+Q++ L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSK 658
+H D+ +N+L+ + ++ DFGL++ + + + + + ++APE +
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 659 ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718
T+ DV+ FGV + EI+ + NG+ +
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERLPM--------- 230
Query: 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
C L + C DPS RP ++ L ++E
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-56
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 33/283 (11%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQT 534
++++ +G GS+G K ++ + K+LD + +EV ++ +
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGK---ILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 535 HHKNLVRLLGFCDEGQNRLL--VYEFLNNGTLASFLFGNLKP----NWNLRTNIAFQIAR 588
H N+VR + N L V E+ G LAS + K + + Q+
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 589 GLLYLHE--DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
L H D ++H D+KP N+ LD N ++ DFGLA++L + S + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706
Y++PE K D++S G LL E+ A F +E R GK
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKF 231
Query: 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + +N+ ++ + RP+++++L+
Sbjct: 232 RRIPYRYSDELNE------IIT---RMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-55
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 45/311 (14%)
Query: 464 TNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD-IVFQDGER 522
T + +++ F++ +G G+FG V K I+ A+K++ +D R
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGL-RMDAAIKRMKEYASKDDHR 55
Query: 523 EFKNEVFVIGQ-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP------- 574
+F E+ V+ + HH N++ LLG C+ L E+ +G L FL +
Sbjct: 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 115
Query: 575 ---------NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFG 625
+ + A +ARG+ YL Q IH D+ +NIL+ ++Y A+I+DFG
Sbjct: 116 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 172
Query: 626 LAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIE 685
L++ + KT R ++A E S T DV+S+GVLL EI++ +
Sbjct: 173 LSR---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--- 226
Query: 686 MVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIK 745
+ +L + + C +++ + C +E P RP+
Sbjct: 227 ------------YCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA 274
Query: 746 KVLQMLEGVVE 756
++L L ++E
Sbjct: 275 QILVSLNRMLE 285
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 1e-55
Identities = 73/276 (26%), Positives = 117/276 (42%), Gaps = 30/276 (10%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD--IVFQDGEREFKNEVFVIGQTHHKN 538
F E+GRGSF VYKG+ T T VA +L + + + FK E ++ H N
Sbjct: 13 FDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 539 LVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
+VR + +LV E + +GTL ++L + + QI +GL +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 595 EDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
IIH D+K NI + + +I D GLA L + +K + GT ++APE
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEM 184
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ K VDVY+FG+ +LE+ + + G
Sbjct: 185 YEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------------YRRVTSGV 229
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
A D + ++ + CI+++ R +IK +L
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-55
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 28/277 (10%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI-VFQDGEREFKNEVFVIGQTH 535
+++ + +G G++G V V + T AVAVK +D+ D K E+ + +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE---AVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHE 595
H+N+V+ G EG + L E+ + G L + ++ Q+ G++YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH- 120
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR 655
I H D+KP+N+LLD+ N +ISDFGLA + N + + + GT YVAPE +
Sbjct: 121 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 656 NSKI-TAKVDVYSFGVLLLEIIACRKSFDI--EMVEEYAILTDWAFDCYRNGKLDALVGG 712
+ VDV+S G++L ++A +D + +EY+ + K+D
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID----- 233
Query: 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
L+ + E+PS R TI + +
Sbjct: 234 --------SAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-55
Identities = 66/281 (23%), Positives = 107/281 (38%), Gaps = 25/281 (8%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
+ + E++G GSFG+V +G T +VAVK L + + +F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLY 592
H+NL+RL G + +V E G+L L + + A Q+A G+ Y
Sbjct: 68 LDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTSIRGTKGYVAP 651
L IH D+ +N+LL +I DFGL + L N ++ + + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711
E + + D + FGV L E+ + I + L +
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--------------LHKIDK 229
Query: 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+C + + V + C P RPT + L
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-55
Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 27/269 (10%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL 542
E++G+G+ G VY + T VA++++++ Q + NE+ V+ + + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQ---EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQII 602
L G +V E+L G+L + + + + + L +LH S+Q+I
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 603 HCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAK 662
H D+K NILL + +++DFG +T QSK +++ GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 663 VDVYSFGVLLLEIIACRKSF--DIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMNDV 720
VD++S G++ +E+I + + + Y I T+ + KL
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS------------- 243
Query: 721 ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ C+ D R + K++LQ
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 1e-54
Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 34/277 (12%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQ 533
++F+ +G+G FG VY + ++ +A+K L E + + EV +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKF---ILALKVLFKAQLEKAGVEHQLRREVEIQSH 62
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
H N++RL G+ + L+ E+ GT+ L K + ++A L Y
Sbjct: 63 LRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S ++IH D+KP+N+LL +I+DFG + ++ T+ GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEM 175
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
KVD++S GVL E + + F+ +E + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---------------YKRISRVE 220
Query: 714 MEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ V E L+ ++ +PS RP +++VL+
Sbjct: 221 FTFPDFVTEGARDLIS---RLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 3e-54
Identities = 62/273 (22%), Positives = 99/273 (36%), Gaps = 33/273 (12%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE---REFKNEVFVIGQTHHKNL 539
E+G GSFG VY VA+KK+ + ++ EV + + H N
Sbjct: 21 REIGHGSFGAVYFARDVRNSE---VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
++ G LV E+ + +GL YLH S
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 600 QIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFR---N 656
+IH D+K NILL + ++ DFG A ++ S GT ++APE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDE 188
Query: 657 SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716
+ KVDV+S G+ +E+ + F+ L + + A
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPL---------------FNMNAMSALYHIAQNESPA 233
Query: 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ E C+Q+ P RPT + +L+
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 34/282 (12%)
Query: 478 TDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH 535
D ++ E+G G+FG VYK + T A K +D ++ ++ E+ ++
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSV---LAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 536 HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLH 594
H N+V+LL N ++ EF G + + + +P + + Q L YLH
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
++IIH D+K NIL + +++DFG++ T + S GT ++APE
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVV 182
Query: 655 -----RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE--YAILTDWAFDCYRNGKLD 707
++ K DV+S G+ L+E+ I + +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + C++++ R T ++LQ
Sbjct: 243 -------------SNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 7e-51
Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 31/289 (10%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTT--AVAVKKLDIVFQDGER-EFKNEVFVIGQTHHK 537
E+G+GSFG+VY+GV + VA+K ++ ER EF NE V+ + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIA 587
++VRLLG +GQ L++ E + G L S+L P+ + +A +IA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
G+ YL +++ +H D+ +N ++ + + +I DFG+ + +
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707
+++PE ++ T DV+SFGV+L EI + + E G L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVMEGGLL 254
Query: 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756
C + L + C Q +P +RP+ +++ ++ +E
Sbjct: 255 DKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-51
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 40/300 (13%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTST----TAVAVKKLDI-VFQDGEREFKNEVFVIGQ-T 534
+ +G G+FG V T VAVK L + + +E+ ++
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP----------------NWNL 578
HKN++ LLG C + ++ E+ + G L +L P +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 579 RTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638
+ A+Q+ARG+ YL S + IH D+ +N+L+ + +I+DFGLA+ +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF 698
T+ R ++APE + T + DV+SFGVLL EI S + E F
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELF 247
Query: 699 DCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ G C +L M+ C PS RPT K++++ L+ +V ++
Sbjct: 248 KLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-50
Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 38/299 (12%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTA--VAVKKLDI-VFQDGEREFKNEVFVIGQT-HH 536
+ +GRG+FG V + + T VAVK L R +E+ ++ HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 537 KNLVRLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKP----------------NWNLR 579
N+V LLG C G +++ EF G L+++L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 580 TNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIK 639
+FQ+A+G+ +L S + IH D+ +NILL + +I DFGLA+ + + K
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFD 699
R ++APE + T + DV+SFGVLL EI + S + + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCR 248
Query: 700 CYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVS 758
+ G M A + ++ + C +PS RPT ++++ L +++ +
Sbjct: 249 RLKEGT-------RMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 171 bits (435), Expect = 4e-48
Identities = 59/273 (21%), Positives = 112/273 (41%), Gaps = 27/273 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
EE+G G+FG+V++ + T + A K + + + + E+ + H LV
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNN---FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHEDCSS 599
L ++ +++YEF++ G L + + + Q+ +GL ++HE+
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144
Query: 600 QIIHCDMKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
+H D+KP+NI+ + + DFGL L K GT + APE
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGK 200
Query: 658 KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
+ D++S GVL +++ F E +E ++ + D A
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDWNM----DDSAF 249
Query: 718 NDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + E + + + DP+ R TI + L+
Sbjct: 250 SGISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 9e-48
Identities = 60/279 (21%), Positives = 106/279 (37%), Gaps = 28/279 (10%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
++FK + +G GSF V T A+K L+ I+ ++ E V+ +
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSRE---YAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
H V+L + + + NG L ++ + +I L YL
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H IIH D+KP+NILL++ + +I+DFG AK+L+ + S GT YV+PE
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
D+++ G ++ +++A F F + D
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IFQKIIKLEYDFPEKFF 234
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752
+A + VE + D + R +++
Sbjct: 235 PKARDLVE----------KLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 1e-47
Identities = 61/283 (21%), Positives = 117/283 (41%), Gaps = 24/283 (8%)
Query: 471 YKELEEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNE 527
+K+ E+ D + + +G G+F V + T+ VA+K + +G+ +NE
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQK---LVAIKCIAKKALEGKEGSMENE 57
Query: 528 VFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIA 587
+ V+ + H N+V L + G + L+ + ++ G L + + + FQ+
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVL 117
Query: 588 RGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKG 647
+ YLH+ LD+ ISDFGL+K+ ++ ++ GT G
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPG 174
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707
YVAPE + VD +S GV+ ++ F E + F+ + +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-------LFEQILKAEYE 227
Query: 708 ALVGGDMEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
D +D+ + + + +++DP R T ++ LQ
Sbjct: 228 F----DSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 165 bits (418), Expect = 1e-45
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 29/277 (10%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH 536
D + EE+G G+FG+V++ V + T K ++ + + KNE+ ++ Q HH
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRV---FVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 537 KNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYLHE 595
L+ L ++ +L+ EFL+ G L + + N Q GL ++H
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH- 144
Query: 596 DCSSQIIHCDMKPQNILLDDHYNARI--SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
I+H D+KP+NI+ + + + DFGLA L I T + APE
Sbjct: 145 --EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEI 199
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ D+++ GVL +++ F E E + + D
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-------TLQNVKRCDWEF----D 248
Query: 714 MEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+A + V + + +Q++P R T+ L+
Sbjct: 249 EDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 1e-44
Identities = 55/281 (19%), Positives = 119/281 (42%), Gaps = 30/281 (10%)
Query: 475 EEATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIG 532
+E + + E++GRG FGIV++ V +++ + K + + D + K E+ ++
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT---YMAKFVKVKGTD-QVLVKKEISILN 56
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLL 591
H+N++ L + + ++++EF++ + + + N + Q+ L
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNAR--ISDFGLAKLLTLNQSKTIKTSIRGTKGYV 649
+LH S I H D++P+NI+ ++ I +FG A+ L + + Y
Sbjct: 117 FLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
APE ++ ++ D++S G L+ +++ F E ++ + N +
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYTF- 222
Query: 710 VGGDMEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
D EA ++ V + ++ R T + LQ
Sbjct: 223 ---DEEAFKEISIEAMDFVD---RLLVKERKSRMTASEALQ 257
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 4e-43
Identities = 71/276 (25%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
++F + +G+GSFG V+ + T A+K L ++ D E V+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ---FFAIKALKKDVVLMDDDVECTMVEKRVLSL 58
Query: 534 T-HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 592
H L + +N V E+LN G L + K + + T A +I GL +
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
LH I++ D+K NILLD + +I+DFG+ K L +K + GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173
Query: 653 WFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712
K VD +SFGVLL E++ + F + EE F R
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPFYPRWL 226
Query: 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748
+ EA + + +P R ++ +
Sbjct: 227 EKEAKDLLV----------KLFVREPEKRLGVRGDI 252
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (391), Expect = 7e-43
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---------QDGEREFKNE 527
+N++ E +GRG +V + + + T AVK +D+ Q+ E
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKE---YAVKIIDVTGGGSFSAEEVQELREATLKE 59
Query: 528 VFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQI 586
V ++ + H N+++L + LV++ + G L +L + + I +
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
+ LH I+H D+KP+NILLDD N +++DFG + L + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 647 GYVAPEWFR------NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDC 700
Y+APE + +VD++S GV++ ++A F
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRM 226
Query: 701 YRNGKLDALVGGDMEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+G +D + ++ LV + P R T ++ L
Sbjct: 227 IMSGNYQF----GSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (393), Expect = 3e-42
Identities = 63/275 (22%), Positives = 104/275 (37%), Gaps = 33/275 (12%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVI-- 531
++F +GRG FG VY T A+K LD I + GE NE ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKM---YAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 532 -GQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGL 590
+V + + + +N G L L + + A +I GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 591 LYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
++H +++ D+KP NILLD+H + RISD GLA SK + GT GY+A
Sbjct: 121 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMA 173
Query: 651 PEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
PE + + D +S G +L +++ F ++ + ++
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTMAVELP 229
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTI 744
E + +E +Q D + R
Sbjct: 230 DSFSPELRSLLE----------GLLQRDVNRRLGC 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 151 bits (382), Expect = 1e-41
Identities = 59/291 (20%), Positives = 108/291 (37%), Gaps = 36/291 (12%)
Query: 478 TDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIG 532
+D ++ E +G G V+ VAVK L F+ E
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 533 QTHHKNLVRLLGFC----DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIAR 588
+H +V + G +V E+++ TL + + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 589 GLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKT-SIRGTKG 647
L + + IIH D+KP NI++ ++ DFG+A+ + + + +T ++ GT
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 648 YVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA---ILTDWAFDCYRNG 704
Y++PE R + A+ DVYS G +L E++ F + A + D R+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239
Query: 705 KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGV 754
L L+ +V+ + ++P R T ++ L V
Sbjct: 240 GLS-------------ADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (379), Expect = 3e-41
Identities = 56/287 (19%), Positives = 110/287 (38%), Gaps = 24/287 (8%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQT 534
+ + E++G G++G+VYK T A+KK+ + +D E+ ++ +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGET----FALKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
H N+V+L + +LV+E L+ + Q+ G+ Y H
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
+ ++H D+KPQN+L++ +I+DFGLA+ + K I
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-----YAILTDWAFDCYRNGKLDAL 709
+ K + +D++S G + E++ F + + IL + N
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 710 VGGDMEAMNDVECLEKLVMVSI-------WCIQEDPSLRPTIKKVLQ 749
+ + L + ++ DP+ R T K+ L+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-41
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 25/285 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-----QDGEREFKNEVFVIGQTHHK 537
+ +G G F VYK + T VA+KK+ + R E+ ++ + H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQ---IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 538 NLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC 597
N++ LL N LV++F+ +L + +GL YLH+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 598 SSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNS 657
I+H D+KP N+LLD++ +++DFGLAK + T T+ Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 658 K-ITAKVDVYSFGVLLLEIIACRKSF----DIEMVEEYAILTDWAFDCYRNGKLDALVGG 712
+ VD+++ G +L E++ D++ + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 713 DMEAMNDVECLEKLVMVSI-------WCIQEDPSLRPTIKKVLQM 750
++ + +P R T + L+M
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (379), Expect = 5e-41
Identities = 53/295 (17%), Positives = 96/295 (32%), Gaps = 26/295 (8%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
++G GSFG +Y G VA+K + + + E + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEE---VAIKLECV--KTKHPQLHIESKIYKMMQGGVGI 65
Query: 541 RLLGFC-DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
+ +C EG ++V E L F F + K + +A Q+ + Y+H S
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 600 QIIHCDMKPQNIL---LDDHYNARISDFGLAKLLTLNQSKTI-----KTSIRGTKGYVAP 651
IH D+KP N L I DFGLAK ++ ++ GT Y +
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711
+ + + D+ S G +L+ + + + + ++ L
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242
Query: 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
G + +C +P + Q+ + Y F
Sbjct: 243 GYPSEFAT------YLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF 288
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (375), Expect = 2e-40
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
+F+ +G GSFG V+ + A+K L +V +E ++
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRY---YAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
H ++R+ G + Q ++ +++ G L S L + + + A ++ L YL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H II+ D+KP+NILLD + + +I+DFG AK + + ++ GT Y+APE
Sbjct: 121 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
+D +SFG+L+ E++A F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 62/278 (22%), Positives = 112/278 (40%), Gaps = 33/278 (11%)
Query: 482 KEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLV 540
+ +G G G V + + T+ A+K L + + EV + + + ++V
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEK---FALKMLQ-----DCPKARREVELHWRASQCPHIV 68
Query: 541 RLLGFCD----EGQNRLLVYEFLNNGTLASFL--FGNLKPNWNLRTNIAFQIARGLLYLH 594
R++ + + L+V E L+ G L S + G+ + I I + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 595 EDCSSQIIHCDMKPQNILLDDHYN---ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
S I H D+KP+N+L +++DFG AK T + S T+ T YVAP
Sbjct: 129 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAP 182
Query: 652 EWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711
E K D++S GV++ ++ F ++ R G+
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRIRMGQY----- 234
Query: 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ E E++ M+ ++ +P+ R TI + +
Sbjct: 235 -EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 67/296 (22%), Positives = 119/296 (40%), Gaps = 31/296 (10%)
Query: 477 ATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFV-- 530
A ++ E+G G++G V+K + + VA+K++ + + EV V
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKA--RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62
Query: 531 -IGQTHHKNLVRLLGFC-----DEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIA 583
+ H N+VRL C D LV+E ++ ++
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 584 FQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIR 643
FQ+ RGL +LH ++H D+KPQNIL+ +++DFGLA++ + + TS+
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVV 176
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF----DIEMVEE--YAILTDWA 697
T Y APE S VD++S G + E+ + F D++ + + I
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 698 FDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSI----WCIQEDPSLRPTIKKVLQ 749
D R+ L A + + + + C+ +P+ R + L
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 46/281 (16%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL------DIVFQDGEREFKNEVFVIGQ- 533
+G G FG VY G+ + VA+K + D EV ++ +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNL---PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 534 -THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLL 591
+ ++RLL + + + +L+ E L + +Q+ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 592 YLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
+ H ++H D+K +NIL+D + ++ DFG LL T+ T GT+ Y
Sbjct: 125 HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSP 177
Query: 651 PEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
PEW R + V+S G+LL +++ F+ + + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEI 216
Query: 710 VGGDMEAMNDV-ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ G + V + L+ WC+ PS RPT +++
Sbjct: 217 IRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (362), Expect = 7e-39
Identities = 44/297 (14%), Positives = 94/297 (31%), Gaps = 28/297 (9%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNL 539
+G GSFG++++G VA+K + + ++E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQ---VAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63
Query: 540 VRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSS 599
+ F EG + +LV + L K + A Q+ + +H
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EK 120
Query: 600 QIIHCDMKPQNILLDDHYN-----ARISDFGLAKLLTLNQSKTI-----KTSIRGTKGYV 649
+++ D+KP N L+ + + DFG+ K +K K ++ GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 650 APEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709
+ + + + D+ + G + + + + + + ++ L L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240
Query: 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNPYPF 766
G E+ + P + + V+E F
Sbjct: 241 CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF 288
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-39
Identities = 65/279 (23%), Positives = 106/279 (37%), Gaps = 32/279 (11%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGER------EFKNEVFVIGQT 534
EE+G G F +V K ++T A K + R + + EV ++ +
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQ---YAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
H N++ L + + +L+ E + G L FL T QI G ++
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNG---VY 127
Query: 595 EDCSSQIIHCDMKPQNILLDDH----YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVA 650
S QI H D+KP+NI+L D +I DFGLA + I GT +VA
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFVA 184
Query: 651 PEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710
PE + + D++S GV+ +++ F + +E +
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-------TLANVSAVNYEFE- 236
Query: 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
D N + + + +DP R TI+ LQ
Sbjct: 237 --DEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 28/296 (9%)
Query: 476 EATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGERE-FKNEVFVIG 532
+ + +G G++G+V + VA+KK+ + E+ ++
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKV---RVAIKKISPFEHQTYCQRTLREIKILL 61
Query: 533 QTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPN---WNLRTNIAFQIARG 589
+ H+N++ + + +L + + L+ LK + +QI RG
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121
Query: 590 LLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK-TIKTSIRGTKGY 648
L Y+H S+ ++H D+KP N+LL+ + +I DFGLA++ + T T+ Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 649 VAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEE-----YAILTDWAFDCYR 702
APE NS T +D++S G +L E+++ R F + + IL + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 703 NGKLDALVGGDMEAMNDVECLEKLVMVSI---------WCIQEDPSLRPTIKKVLQ 749
+ + + + + + +P R +++ L
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-38
Identities = 68/289 (23%), Positives = 115/289 (39%), Gaps = 26/289 (8%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKL--DIVFQDGEREFKNEVFVIGQT 534
+NF+ E++G G++G+VYK + T VA+KK+ D + E+ ++ +
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEV---VALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 535 HHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKP-NWNLRTNIAFQIARGLLYL 593
+H N+V+LL LV+EFL+ L L + FQ+ +GL +
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H ++H D+KPQN+L++ +++DFGLA+ T T Y APE
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 173
Query: 654 FRNSK-ITAKVDVYSFGVLLLEIIACRKSFD----------IEMVEEYAILTDWAFDCYR 702
K + VD++S G + E++ R F I W
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 703 NGKLDALVGGDMEAMNDV--ECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749
+ + + V E + + DP+ R + K L
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-37
Identities = 53/295 (17%), Positives = 109/295 (36%), Gaps = 34/295 (11%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDG--EREFKNEVFVIGQTHHKNLV 540
++G+G+FG V+K + T VA+KK+ + + E+ ++ H+N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQK---VALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 541 RLLGFCDEGQNR--------LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLY 592
L+ C + LV++F + +K + + + GL
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL-- 130
Query: 593 LHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS--KTIKTSIRGTKGYVA 650
+ ++I+H DMK N+L+ +++DFGLA+ +L ++ T+ T Y
Sbjct: 131 -YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 651 PEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIE--------MVEEYAILTDWAFDCY 701
PE + +D++ G ++ E+ + + +T +
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249
Query: 702 RNGKLDALVGGDMEAMNDVECLEKLVMVSIW-------CIQEDPSLRPTIKKVLQ 749
N +L + V+ K + + + DP+ R L
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 56/283 (19%), Positives = 117/283 (41%), Gaps = 24/283 (8%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD--GEREFKNEVFVIGQTHHKNLV 540
E++G G++G V+K + T VA+K++ + D E+ ++ + HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 541 RLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQ 600
RL + LV+EF + F N + + + FQ+ +GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--- 121
Query: 601 IIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI- 659
++H D+KPQN+L++ + ++++FGLA+ + ++ T Y P+ +K+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLY 179
Query: 660 TAKVDVYSFGVLLLEIIACRKSF--DIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717
+ +D++S G + E+ + ++ ++ + D +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 718 NDVECLEKLVMVSI-----------WCIQEDPSLRPTIKKVLQ 749
LV V ++ +P R + ++ LQ
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 4e-35
Identities = 66/319 (20%), Positives = 118/319 (36%), Gaps = 44/319 (13%)
Query: 453 IRNSPGDGTIETNLRCFSYKELEEATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKK 512
+ +PG G SY + + +G GSFG+VY+ + + VA+KK
Sbjct: 6 VVATPGQGPDRPQE--VSYTDTKV--------IGNGSFGVVYQAKLCDSGE---LVAIKK 52
Query: 513 LDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLAS 566
+ +R E+ ++ + H N+VRL F + LV +++
Sbjct: 53 VL----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 567 FLFGNLKP---NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARIS 622
+ +Q+ R L Y+H S I H D+KPQN+LLD D ++
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLC 165
Query: 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSF 682
DFG AK L + + + I F + T+ +DV+S G +L E++ + F
Sbjct: 166 DFGSAKQL--VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 683 --DIEMVEEYAILT----------DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVS 730
D + + I+ Y K + + + + +
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 731 IWCIQEDPSLRPTIKKVLQ 749
++ P+ R T +
Sbjct: 284 SRLLEYTPTARLTPLEACA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 13/210 (6%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
++F + +G+G+FG V + T A+K L I+ +D E V+
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRY---YAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
T H L L V E+ N G L L +I L
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSAL--- 118
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
S +++ D+K +N++LD + +I+DFGL K + + GT Y+APE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFD 683
++ VD + GV++ E++ R F
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 4e-33
Identities = 62/281 (22%), Positives = 111/281 (39%), Gaps = 38/281 (13%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD---IVFQDGEREFKNEVFVIGQ 533
D F + +G GSFG V + + A+K LD +V NE ++
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGN---HYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
+ LV+L + N +V E++ G + S L + + A QI YL
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 594 HEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEW 653
H S +I+ D+KP+N+L+D +++DFG AK + K ++ GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 654 FRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713
+ VD ++ GVL+ E+ A F + + ++ +GK+
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IYEKIVSGKVRFPSHFS 262
Query: 714 MEAMNDVECLEKLVMVSIWCIQEDP-----SLRPTIKKVLQ 749
+ + + +Q D +L+ + +
Sbjct: 263 SDLKDLLR----------NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 72/310 (23%), Positives = 120/310 (38%), Gaps = 42/310 (13%)
Query: 469 FSYKELEEATDNFK------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE- 521
F +E+ + + + VG G++G V V T VA+KKL FQ
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGA---KVAIKKLYRPFQSELF 60
Query: 522 -REFKNEVFVIGQTHHKNLVRLLGFCDEGQNR------LLVYEFLNNGTLASFLFGNLKP 574
+ E+ ++ H+N++ LL + LV F+ GT L + K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKL 118
Query: 575 NWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634
+ + +Q+ +GL Y+H IIH D+KP N+ +++ +I DFGLA+ Q
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 170
Query: 635 SKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIE-MVEEYAI 692
+ + T T+ Y APE N + T VD++S G ++ E+I + F +++
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIW-------------CIQEDPS 739
+ M + LEK SI + D
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 290
Query: 740 LRPTIKKVLQ 749
R T + L
Sbjct: 291 QRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 13/216 (6%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLD----IVFQDGEREFKNEVFVIG 532
+NF+ + +G G++G V+ + + A+K L + + E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 533 Q-THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLL 591
LV L L+ +++N G L + L + + +I L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 592 YLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAP 651
+LH+ II+ D+K +NILLD + + ++DFGL+K GT Y+AP
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAP 199
Query: 652 EWFR--NSKITAKVDVYSFGVLLLEIIACRKSFDIE 685
+ R +S VD +S GVL+ E++ F ++
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 123 bits (310), Expect = 1e-31
Identities = 55/299 (18%), Positives = 116/299 (38%), Gaps = 43/299 (14%)
Query: 479 DNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-TH 535
D+++ ++GRG + V++ + T V VK L +++ K E+ ++
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEK---VVVKILK---PVKKKKIKREIKILENLRG 88
Query: 536 HKNLVRLLGFCDEGQNRL--LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYL 593
N++ L + +R LV+E +NN ++I + L Y
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYC 145
Query: 594 HEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPE 652
H I+H D+KP N+++D +H R+ D+GLA+ Q ++ ++ + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV---ASRYFKGPE 199
Query: 653 -WFRNSKITAKVDVYSFGVLLLEIIACRKSF-------DIEMVEEYAILTDWAFDCYRNG 704
+D++S G +L +I ++ F D + + T+ +D
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 705 KLDALVG-GDMEAMNDVECLEKLVMVSIW-------------CIQEDPSLRPTIKKVLQ 749
++ D+ + + E+ V ++ D R T ++ ++
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 62/303 (20%), Positives = 113/303 (37%), Gaps = 51/303 (16%)
Query: 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE--REFKNEVFVIGQTHHKNLV 540
+ +G G+ GIV + VA+KKL FQ+ + E+ ++ +HKN++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 541 RLLGFC------DEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLH 594
LL +E Q+ LV E ++ + + + + +Q+ G+ +LH
Sbjct: 80 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH 136
Query: 595 EDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWF 654
IIH D+KP NI++ +I DFGLA+ + + T T+ Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 655 RNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714
VD++S G ++ E++ + F + + + + +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QWNKVIEQLGTPCPEFMKKLQP 247
Query: 715 EAMNDVECLEKLVMVSI----------------------------WCIQEDPSLRPTIKK 746
N VE K ++ + DP+ R ++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 747 VLQ 749
LQ
Sbjct: 308 ALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-29
Identities = 68/328 (20%), Positives = 118/328 (35%), Gaps = 42/328 (12%)
Query: 469 FSYKELE----EATDNFK--EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGE- 521
F +EL E + ++ VG G++G V T VAVKKL FQ
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL---RVAVKKLSRPFQSIIH 60
Query: 522 -REFKNEVFVIGQTHHKNLVRLLGFCDEGQ-----NRLLVYEFLNNGTLASFLFGNLKPN 575
+ E+ ++ H+N++ LL + N + + L L + + K
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLT 119
Query: 576 WNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635
+ + +QI RGL Y+H IIH D+KP N+ +++ +I DFGLA +
Sbjct: 120 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA-----RHT 171
Query: 636 KTIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFD-------IEMV 687
T T+ Y APE N VD++S G ++ E++ R F ++++
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 231
Query: 688 EEYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSI-------WCIQEDPSL 740
+ + + M + + + + D
Sbjct: 232 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291
Query: 741 RPTIKKVLQM--LEGVVEVSVPPNPYPF 766
R T + L + P P+
Sbjct: 292 RITAAQALAHAYFAQYHDPDDEPVADPY 319
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 4e-25
Identities = 52/317 (16%), Positives = 101/317 (31%), Gaps = 54/317 (17%)
Query: 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLV 540
++G G F V+ T VA+K + E ++E+ ++ + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTH---VAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNT 72
Query: 541 RLLGFCDEGQNRLLVY----------------EFLNNGTLASFLFGNLKPNWNLRTNIAF 584
+ +LL + N + + I+
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 585 QIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTLNQSKTIKTSIR 643
Q+ GL Y+H C IIH D+KP+N+L++ + +A L T+
Sbjct: 133 QLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 644 GTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY-----------AI 692
T+ Y +PE + D++S L+ E+I F+ + Y +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 693 LTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSI--------------------W 732
L + RNGK + ++ L+ + +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 733 CIQEDPSLRPTIKKVLQ 749
+Q DP R ++
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 1e-19
Identities = 28/208 (13%), Positives = 56/208 (26%), Gaps = 30/208 (14%)
Query: 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDI----------VFQDGEREFKNEV 528
D + +G G V+ + VK + G+ F
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE----CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLA 57
Query: 529 FVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTN--IAFQI 586
+ + L +L G Y + N L + + + I
Sbjct: 58 IRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMI 112
Query: 587 ARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTK 646
+ + I+H D+ N+L+ + I DF + + + I
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILER----D 164
Query: 647 GYVAPEWFRNSKITAKVDVYSFGVLLLE 674
+F + D+ S +L+
Sbjct: 165 VRNIITYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 46.8 bits (111), Expect = 6e-07
Identities = 21/106 (19%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 72 SIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVA 131
SI Y+ T + Q+ + ++ + D LVL D + ++ GT
Sbjct: 11 SILYSTQGNDNHPQ-TLHATQSLQLSPY-RLSMETDCNLVLFDRDDRVWSTNTAGKGTGC 68
Query: 132 VGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177
+ G + ++ + + G+ S G + F L D NL +
Sbjct: 69 RAVLQPNGRMDVLTNQNIAVW--TSGNSRSAGRYVFVLQPDRNLAI 112
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 44.2 bits (104), Expect = 4e-06
Identities = 24/116 (20%), Positives = 42/116 (36%), Gaps = 22/116 (18%)
Query: 33 GATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQ 92
G L AG + + F +L L Y+ T VW ++
Sbjct: 7 GEGLYAGQSL-----DVEPYHFIM------QEDCNLVL----YDH---STSVWASNT--- 45
Query: 93 NSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSS 147
+G + L +D V+ D +G+ +W+S G V + + GN ++ S
Sbjct: 46 GILGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD 101
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 766 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.81 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.73 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.72 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.7 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.66 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.32 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.23 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.2 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.17 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.04 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.98 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.0 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.27 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.98 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.71 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.82 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.27 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 83.31 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.76 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.4e-50 Score=421.08 Aligned_cols=272 Identities=25% Similarity=0.449 Sum_probs=211.8
Q ss_pred ccccCHHHHHHHHHhhh-----------hhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHcc
Q 037189 466 LRCFSYKELEEATDNFK-----------EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQ 533 (766)
Q Consensus 466 ~~~~~~~~l~~~t~~f~-----------~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~ 533 (766)
+..++++++.+++.+|. +.||+|+||+||+|.+..++.....||||++.... ....++|.+|+++|++
T Consensus 4 ~d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~ 83 (299)
T d1jpaa_ 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83 (299)
T ss_dssp CCGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTT
T ss_pred cCCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHh
Confidence 34567788888888774 46999999999999987665556789999986533 3345679999999999
Q ss_pred CCCCCeeeEeeeeecCCceEEEeeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEE
Q 037189 534 THHKNLVRLLGFCDEGQNRLLVYEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNIL 612 (766)
Q Consensus 534 l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIl 612 (766)
++|||||+++|+|.+++..++|||||++|+|.+++... ..+++.+++.++.||++||+|||+ .+|+||||||+|||
T Consensus 84 l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNIL 160 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEE
Confidence 99999999999999999999999999999999988764 568999999999999999999995 59999999999999
Q ss_pred EcCCCCeEEeccCcccccccCCCcce---eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhh
Q 037189 613 LDDHYNARISDFGLAKLLTLNQSKTI---KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVE 688 (766)
Q Consensus 613 l~~~~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~ 688 (766)
|+.++.+||+|||+++.+........ .....||+.|+|||.+.+..++.++|||||||+||||+| |+.||......
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999998765433221 123457999999999999999999999999999999998 89999755432
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+. ...+..+ .+...+..+++++.+|+.+||+.||++||||.+|++.|+.+++
T Consensus 241 ~~-------~~~i~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 241 DV-------INAIEQD---------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HH-------HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HH-------HHHHHcC---------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 21 1111111 1112234567789999999999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-49 Score=404.57 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=198.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.++||+|+||.||+|.+. ++..||||+++.. ....++|.+|++++++++||||++++|+|.+++..++||||
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 346789999999999999986 3457999999753 44567899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++|+|.+++... ..++++.++.|+.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999998765 567899999999999999999995 499999999999999999999999999998775543322
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhC-CcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
. ....||..|+|||++.+..++.++|||||||++|||+|+ ++|+......+. ...+..+. +.
T Consensus 159 ~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~-------~~~i~~~~---------~~ 221 (263)
T d1sm2a_ 159 S-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VEDISTGF---------RL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH-------HHHHHHTC---------CC
T ss_pred e-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH-------HHHHHhcC---------CC
Confidence 2 345789999999999999999999999999999999995 555543332221 11111111 11
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
..+..+++++.+++.+||+.||++||||++|+++|+++.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1233446788999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=407.14 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=201.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+.+.++||+|+||+||+|+++ ..||||.++.. .....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred EEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 345688999999999999864 24999998643 23445789999999999999999999999865 5689999
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++... ..+++..+..|+.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999999754 568999999999999999999995 4999999999999999999999999999988765444
Q ss_pred cceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 636 KTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
........||+.|+|||++.+ ..++.++|||||||+||||+||+.||........ +......+....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~~~~p---- 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP---- 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHTSCCC----
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCCCC----
Confidence 333355679999999999864 3589999999999999999999999975432211 111111111110
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.. ...+..+++++.+|+.+||+.||++||||++|++.|+.+.+
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 11133456789999999999999999999999999998764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.8e-49 Score=408.29 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=213.0
Q ss_pred HHHHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 476 EATDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 476 ~~t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
...+.+.++||+|+||+||+|.+.. .++.||||+++.. ....++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 3345567899999999999999874 4678999998754 34567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 556 YEFLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
|||+++|+|.+++... ..+++..++.|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999653 578899999999999999999995 49999999999999999999999999999987654
Q ss_pred CCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGD 713 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (766)
.... .....|++.|+|||++.+..++.++|||||||++|||++|+.|+....... .+...+..+
T Consensus 169 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~------~~~~~i~~~--------- 232 (287)
T d1opja_ 169 TYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKD--------- 232 (287)
T ss_dssp SSEE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHTT---------
T ss_pred Ccee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH------HHHHHHhcC---------
Confidence 3322 244568999999999999999999999999999999999777664332211 111122221
Q ss_pred ccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 714 MEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 714 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.....+..+++++.+|+.+||+.||++||||.+|++.|+.+.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122234456789999999999999999999999999988754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=400.84 Aligned_cols=250 Identities=29% Similarity=0.409 Sum_probs=204.7
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeeccC
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLN 560 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (766)
++||+|+||.||+|.+.... .++.||||+++.... ...++|.+|++++++++|||||+++|+|.. +..+|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKK-VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSS-SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCC-cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 46999999999999986433 567899999965332 234679999999999999999999999965 56789999999
Q ss_pred CCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce-e
Q 037189 561 NGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI-K 639 (766)
Q Consensus 561 ~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~ 639 (766)
+|+|.+++.....+++..++.|+.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+........ .
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 99999999988899999999999999999999995 4899999999999999999999999999998765443322 2
Q ss_pred ecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 640 TSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 640 ~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
....||++|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+..+. +...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~~---------~~~~ 231 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------RMGC 231 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---------CCCC
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcCC---------CCCC
Confidence 34578999999999999999999999999999999998 899997644322 112222221 1122
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhc
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEG 753 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~ 753 (766)
+..++.++.+|+.+||+.||++||||.+|++.|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 34456789999999999999999999999998875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=399.74 Aligned_cols=251 Identities=27% Similarity=0.392 Sum_probs=205.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+++.++||+|+||.||+|+... +++.||||.++... .+..+.|.+|++++++++||||+++++++.+++..+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4566899999999999999874 46789999987543 2334579999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.......
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999988899999999999999999999995 499999999999999999999999999999876554443
Q ss_pred eeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
.....+||+.|+|||++.+..+ +.++|||||||+||||++|+.||......... .. ...... ...
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~-----~~~~~~--------~~~ 226 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YS-----DWKEKK--------TYL 226 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HH-----HHHTTC--------TTS
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HH-----HHhcCC--------CCC
Confidence 3456789999999999988876 57899999999999999999999754432111 00 011111 011
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
......++++.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234577889999999999999999999876
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=395.46 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=207.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|+... +++.||||.+... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 5567899999999999999874 4678999998642 234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 9999999999999988889999999999999999999995 5999999999999999999999999999987654321
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+.....
T Consensus 162 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~--------- 221 (263)
T d2j4za1 162 ----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRVEF--------- 221 (263)
T ss_dssp ----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC---------
T ss_pred ----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC---------
Confidence 346799999999999999999999999999999999999999976543321 111112111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 222 -~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 112335678899999999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=403.28 Aligned_cols=252 Identities=31% Similarity=0.474 Sum_probs=205.0
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.++||+|+||.||+|.++ ++..||||+++.. ....++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 4456788999999999999976 3568999999753 3456789999999999999999999998865 56799999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.+++... ..+++..+++|+.||++||+|||+ .+|+||||||+||||++++.+||+|||+++.+.....
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 99999999987654 358999999999999999999995 4999999999999999999999999999998765432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.|+....... . +...+..+ .+
T Consensus 165 ~~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~----~~~~i~~~---------~~ 228 (272)
T d1qpca_ 165 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--E----VIQNLERG---------YR 228 (272)
T ss_dssp EC-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H----HHHHHHTT---------CC
T ss_pred cc-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--H----HHHHHHhc---------CC
Confidence 22 244678999999999999999999999999999999999665553322111 1 11112221 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
...+..+++++.+|+.+||+.||++||||++|+++|+.+
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 122334567899999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=392.15 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=210.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.|.++||+|+||+||+|+++ ++..||||+++.. ....++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET----TTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred EEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 46789999999999999985 4678999999754 445678999999999999999999999999999999999999
Q ss_pred CCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 560 NNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 560 ~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
++|+|.+++... ..+++..+++++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++.+........
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 999999997654 568899999999999999999995 4999999999999999999999999999987765443322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAM 717 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (766)
....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......+. ...+.++. +..
T Consensus 159 -~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~~~i~~~~---------~~~ 221 (258)
T d1k2pa_ 159 -VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------AEHIAQGL---------RLY 221 (258)
T ss_dssp -CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------HHHHHTTC---------CCC
T ss_pred -cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------HHHHHhCC---------CCC
Confidence 44678999999999999999999999999999999998 8999976554331 11122221 111
Q ss_pred CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 718 NDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 718 ~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.+...++++.+++.+||+.||++|||++++++.|.+|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2334557899999999999999999999999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=401.42 Aligned_cols=260 Identities=25% Similarity=0.456 Sum_probs=202.1
Q ss_pred hhhhhccccccceEEEEEEecCCC-ceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.||+|+||.||+|.++.++. ....||||+++.... ....+|.+|++++++++|||||+++|+|.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 456789999999999999875432 346799999965432 334579999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+.+++|.+++... ..+++.+++.++.||++||+|||+ .+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999987654 678999999999999999999995 59999999999999999999999999999987554332
Q ss_pred c-eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 637 T-IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 637 ~-~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ......||+.|+|||++.+..++.++|||||||++|||++++.|+....... . +...+..+ .+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~----~~~~i~~~---------~~ 231 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--E----VMKAINDG---------FR 231 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--H----HHHHHHTT---------CC
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--H----HHHHHhcc---------CC
Confidence 2 2234568999999999999999999999999999999999766654332211 1 11222222 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
...+..++.++.+|+.+||+.||++||||.+|++.|+.+++.
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 222344667899999999999999999999999999887653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=395.26 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=208.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+.+.++||+|+||.||+|.... .++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4556889999999999999764 4679999999876666778899999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcce
Q 037189 559 LNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKTI 638 (766)
Q Consensus 559 ~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 638 (766)
+++|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++.+......
T Consensus 99 ~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-- 172 (293)
T d1yhwa1 99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (293)
T ss_dssp CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC--
T ss_pred cCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc--
Confidence 9999999987654 68999999999999999999995 49999999999999999999999999999987544322
Q ss_pred eecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccCCC
Q 037189 639 KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEAMN 718 (766)
Q Consensus 639 ~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 718 (766)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+. .....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~--------~~~~~ 238 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGT--------PELQN 238 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCS--------CCCSS
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCCC--------CCCCC
Confidence 2456799999999999999999999999999999999999999975443221 111111111 11122
Q ss_pred cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 719 DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 719 ~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
+...+.++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3445678899999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=396.84 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=205.7
Q ss_pred hh-hccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeecc
Q 037189 482 KE-EVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEFL 559 (766)
Q Consensus 482 ~~-~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (766)
.+ +||+|+||.||+|.+...+ ++..||||.++.... ...++|.+|+++|++++|||||+++|+|.. +..+|||||+
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC----CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCcEEecccCeEEEEEEEecCC-CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 35 5999999999999876433 456899999975432 335689999999999999999999999865 5689999999
Q ss_pred CCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc-
Q 037189 560 NNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT- 637 (766)
Q Consensus 560 ~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 637 (766)
++|+|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 99999999765 4678999999999999999999995 599999999999999999999999999999876543322
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcccC
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDMEA 716 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (766)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+.++.. .
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~---------~ 231 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKR---------M 231 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCC---------C
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCC---------C
Confidence 2234568999999999999999999999999999999998 899997644322 1122222221 1
Q ss_pred CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 717 MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 717 ~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
..+..++.++.+|+.+||+.||++||||.+|++.|+.+
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22345667899999999999999999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=409.52 Aligned_cols=258 Identities=24% Similarity=0.389 Sum_probs=210.3
Q ss_pred HHHhhhhhccccccceEEEEEEecCCC--ceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCce
Q 037189 477 ATDNFKEEVGRGSFGIVYKGVIQTTRT--STTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 477 ~t~~f~~~LG~G~fg~Vy~~~~~~~~~--~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (766)
..+.+.++||+|+||+||+|+...... ....||||++.... ......|.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345677899999999999999875432 34579999986432 33456799999999998 899999999999999999
Q ss_pred EEEeeccCCCchhhhhccCC-----------------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccc
Q 037189 553 LLVYEFLNNGTLASFLFGNL-----------------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQ 609 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~ 609 (766)
++||||+++|+|.++|+... .+++..++.++.||++||+|||+ .+|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 99999999999999997542 47888999999999999999995 49999999999
Q ss_pred eEEEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhh
Q 037189 610 NILLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVE 688 (766)
Q Consensus 610 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~ 688 (766)
|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998776655444455678999999999999999999999999999999998 89999754332
Q ss_pred hhhhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHh
Q 037189 689 EYAILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLE 752 (766)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le 752 (766)
.. + ...+..+ .+...+..+++++.+|+.+||+.||++||||+||+++|.
T Consensus 274 ~~--~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN--F----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH--H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--H----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1 1112221 112223445678999999999999999999999999995
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=397.36 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=204.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|.+.. ...||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++|||
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~----~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT----TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HEEEeeEEeeCCCeEEEEEEECC----CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 46677899999999999999863 457999999754 4456789999999999999999999999854 56899999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.+++... ..++|.+++.|+.||++||+|||+. +|+||||||+||||+.++++||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999999998753 5689999999999999999999954 899999999999999999999999999987754433
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.. .....||+.|+|||++.++.++.++||||||++||||++|+.|+........ + ...+..+. .
T Consensus 169 ~~-~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~----~~~i~~~~---------~ 232 (285)
T d1fmka3 169 TA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V----LDQVERGY---------R 232 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H----HHHHHTTC---------C
T ss_pred ee-eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--H----HHHHHhcC---------C
Confidence 22 2446789999999999999999999999999999999997666543322111 1 11111111 1
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEVSVPPNP 763 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~~~pp~p 763 (766)
...+..+++++.+++.+||+.||++||||++|+++|+....-..|+.+
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 122344567899999999999999999999999999997755544433
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=397.00 Aligned_cols=247 Identities=22% Similarity=0.269 Sum_probs=204.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+.+.+.||+|+||.||+|+... +++.||||.++.. .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 5677899999999999999864 4678999998642 244557899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999999988899999999999999999999995 5999999999999999999999999999998765444
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
........||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+..+..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~--------- 227 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------FQKIIKLEY--------- 227 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCC---------
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-------HHHHHcCCC---------
Confidence 3333456799999999999999999999999999999999999999986543221 111122211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVL 748 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl 748 (766)
..+...++++.+|+.+||+.||++|||++|++
T Consensus 228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 11223457789999999999999999999863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-47 Score=389.46 Aligned_cols=247 Identities=29% Similarity=0.425 Sum_probs=198.2
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec----CCceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE----GQNRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 553 (766)
+|.++||+|+||+||+|.+.. .+..||+|++.... ....+.|.+|+++|++++|||||++++++.+ ....+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence 456789999999999999864 46789999987543 2334679999999999999999999999864 34578
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc-CCCCeEEeccCccccccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD-DHYNARISDFGLAKLLTL 632 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~ 632 (766)
+||||+++|+|.+++.....+++..+..++.||++||+|||+. ..+|+||||||+|||++ +++.+||+|||+++....
T Consensus 89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999999998888899999999999999999999964 23499999999999996 578999999999986543
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.. .....||+.|+|||++.+ +++.++|||||||++|||++|+.||....... .+...+..+....
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~~~~~---- 232 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSGVKPA---- 232 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTTCCCG----
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcCCCCc----
Confidence 32 245679999999999875 59999999999999999999999996433211 1112222221111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 112223456889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=391.34 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=193.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec--CCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE--GQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 554 (766)
+++.+.||+|+||.||+|+... +++.||||.++... +...+.|.+|++++++++|||||++++++.+ ++..++
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 4566899999999999999875 46789999987543 2234568999999999999999999999865 456899
Q ss_pred EeeccCCCchhhhhcc----CCCCccchhhhHHHHHHHHHHHhhhcC--CCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 555 VYEFLNNGTLASFLFG----NLKPNWNLRTNIAFQIARGLLYLHEDC--SSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999863 467899999999999999999999752 2359999999999999999999999999999
Q ss_pred ccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccce
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDA 708 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 708 (766)
.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+.++....
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~i~~~~~~~ 233 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRR 233 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCC
Confidence 87543322 245679999999999999999999999999999999999999997654332 111222222211
Q ss_pred eccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 709 LVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 709 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.+...++++.+|+.+||+.||.+|||+.|+++
T Consensus 234 ---------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12335678899999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=404.68 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=204.4
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||+||+|.... .++.||||+++.... ...+++.+|+.+|++++|||||+++++|.++++.++|||
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4456889999999999999864 467999999975433 335679999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+++|+|.+++.+...+++..+..++.|+++||.|||+. .+|+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~-- 160 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-- 160 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC--
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcc--
Confidence 999999999998888899999999999999999999952 3799999999999999999999999999997654321
Q ss_pred eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHH-HHHHhh--------------
Q 037189 638 IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDW-AFDCYR-------------- 702 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~-------------- 702 (766)
....||+.|+|||++.+.+++.++||||+||++|||++|+.||......+....... ......
T Consensus 161 --~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (322)
T d1s9ja_ 161 --NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS 238 (322)
T ss_dssp -----CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred --ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence 346799999999999999999999999999999999999999976443221110000 000000
Q ss_pred ----cC----c----cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 703 ----NG----K----LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 703 ----~~----~----~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.. . ...+.............+.++.+++.+||+.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 0 00000000001111123567889999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-46 Score=395.19 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=211.4
Q ss_pred HhhhhhccccccceEEEEEEec--CCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+++.++||+|+||.||+|+... ...+++.||||+++..... ..++|.+|++++++++||||++++++|.+....++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 4456899999999999999864 2235678999999754333 356799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccC------------------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 556 YEFLNNGTLASFLFGN------------------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
|||+++|+|.+++... ..+++..++.|+.|+++||+|||+ .+|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 9999999999998642 236788999999999999999995 5999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCC-cCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACR-KSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~-~p~~~~~~~~~ 690 (766)
|++.++.+||+|||+++.+.............+|+.|+|||.+.+..++.++|||||||++|||++|. +||......+.
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~ 251 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHH
Confidence 99999999999999998776554444445567899999999999999999999999999999999986 56765443321
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...+.++... ..+..++.++.+|+.+||+.+|++||||.||+++|+++.+
T Consensus 252 -------~~~v~~~~~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 252 -------IYYVRDGNIL---------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HHHHHcCCCC---------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1222333221 1133456788999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-47 Score=392.75 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=206.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+++.++||+|+||.||+|.... .+..||||+++.......+.|.+|++++++++|||||++++++.+++..++||||
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 3456889999999999999874 4678999999876666678899999999999999999999999999999999999
Q ss_pred cCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 559 LNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 559 ~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
+++|+|.+++.. ...+++..+..++.||++||.|||+ .+|+||||||+|||++.++++||+|||+++.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--
Confidence 999999999765 4568999999999999999999995 4999999999999999999999999999976543211
Q ss_pred eeecccccCccccccccc-----CCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 638 IKTSIRGTKGYVAPEWFR-----NSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~-----~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
......||+.|+|||++. ...++.++|||||||++|||++|+.||......+. + .... .+..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~----~~i~-~~~~------ 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--L----LKIA-KSEP------ 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--H----HHHH-HSCC------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--H----HHHH-cCCC------
Confidence 113467999999999984 45688999999999999999999999976543321 1 1111 1111
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.....+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223445678999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=392.58 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=199.8
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc-CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
.+++.+.||+|+||.||+|.+...+.....||||.++..... ..+.|.+|++++++++||||+++++++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 455678999999999999998766656788999998654333 3467999999999999999999999996 46789999
Q ss_pred eccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+++|+|.+++.. ...+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 99999999998765 4568999999999999999999995 5999999999999999999999999999987654433
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+. ...+.++..
T Consensus 164 ~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~-------~~~i~~~~~-------- 227 (273)
T d1mp8a_ 164 YK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------IGRIENGER-------- 227 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-------HHHHHTTCC--------
T ss_pred ee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 22 234568999999999999999999999999999999998 8889876544321 111222211
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+..+++++.+|+.+||+.||++|||+.||++.|+.++
T Consensus 228 -~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 228 -LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1123445678999999999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-46 Score=389.95 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=191.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+++.+.||+|+||.||+|.... .++.||||.+.... ......+.+|+.++++++|||||++++++.+++..+||||
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5677899999999999999864 46789999987543 2334568899999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~ 634 (766)
|+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+. +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999999988899999999999999999999995 4999999999999994 57899999999998765433
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. .....||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+..+... .
T Consensus 165 ~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~~------~ 228 (307)
T d1a06a_ 165 V---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-------FEQILKAEYE------F 228 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHTTCCC------C
T ss_pred e---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHhccCCC------C
Confidence 2 2346799999999999999999999999999999999999999976543221 1111111111 1
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........++++.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111123456788999999999999999999999984
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-46 Score=393.12 Aligned_cols=259 Identities=25% Similarity=0.469 Sum_probs=206.3
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeec-CCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-GQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 557 (766)
+|.++||+|+||+||+|.+..++.....||||+++.. .....++|.+|++++++++||||++++|+|.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999998765545568999999743 33345789999999999999999999999875 457899999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
||++|+|.+++... ..+++..++.++.|+++||.|||+ .+|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998865 456788899999999999999995 59999999999999999999999999999987654332
Q ss_pred c--eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 637 T--IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 637 ~--~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.|+....... .+... +..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~--------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGR--------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTC---------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCC---------
Confidence 2 2234568999999999999999999999999999999999888876433211 11111 11121
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+...+..+++++.+|+.+||+.||++||||.||+++|++++.
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111233456789999999999999999999999999988753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-46 Score=391.98 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=202.7
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
.+...++||+|+||.||+|+... +++.||||.++..... ..+.|.+|++++++++|||||++++++.+++..++
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence 34556789999999999999864 4678999998754322 23568999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||||++|+|..++.....+++..+..++.||+.||.|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~- 168 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence 99999999998888888889999999999999999999995 49999999999999999999999999999875432
Q ss_pred CcceeecccccCcccccccccC---CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRN---SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ........ .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~~-~----- 231 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNE-S----- 231 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSC-C-----
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCC-C-----
Confidence 34579999999999864 4689999999999999999999999975443221 11111111 1
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
....+...++++.+++.+||+.||.+|||+.|+++
T Consensus 232 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11112234678899999999999999999999976
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=384.80 Aligned_cols=257 Identities=25% Similarity=0.357 Sum_probs=201.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+++.+.||+|+||.||+|++.........||||+++... ....++|.+|+.++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 456789999999999999987655566789999986532 2334689999999999999999999999976 467899
Q ss_pred eeccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 556 YEFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
|||+++|+|.+++... ..+++..++.++.||++||.|||+ .+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887654 568999999999999999999995 499999999999999999999999999999876554
Q ss_pred Ccce-eecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 635 SKTI-KTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 635 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||......+. .....+.+
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~~~~-------- 231 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEG-------- 231 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHHTSC--------
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------HHHHHhCC--------
Confidence 4332 234567889999999999999999999999999999998 8999976543321 11111221
Q ss_pred cccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 713 DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 713 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
.....+..++..+.+|+.+||+.||++||||.+|++.|++.
T Consensus 232 -~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122334567899999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.6e-45 Score=391.19 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=208.2
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
.+.+.+.||+|+||.||+|+... .+..||||++........+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 35677899999999999999864 467899999976655556789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhcc-CCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFG-NLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~ 634 (766)
||++|+|.+++.. ...+++..+..|+.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.+....
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 9999999999864 4579999999999999999999995 5999999999999996 46789999999998876543
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..+...... .
T Consensus 181 ~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~-------~~i~~~~~~------~ 244 (350)
T d1koaa2 181 SV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL-------RNVKSCDWN------M 244 (350)
T ss_dssp CE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHTCCC------S
T ss_pred cc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHH-------HHHHhCCCC------C
Confidence 32 4467999999999999999999999999999999999999999765433211 111111110 0
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........++++.+|+.+||+.||++|||++|++++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122345778999999999999999999999985
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=384.53 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=196.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC-CceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG-QNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~E 557 (766)
+.|.+.||+|+||.||+|.++ +..||||+++. ....++|.+|++++++++||||++++|+|.++ +..++|||
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-----GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-----TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEEC-----CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 346788999999999999974 45799999964 34557899999999999999999999999654 56899999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|+++|+|.++|... ..+++..+++|+.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~- 157 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 157 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-
Confidence 99999999999754 358999999999999999999995 599999999999999999999999999998754332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
....+|..|+|||++.+..+++++||||||+++|||+| |++|+......+ +... +.++ .
T Consensus 158 ----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~----i~~~---------~ 217 (262)
T d1byga_ 158 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKG---------Y 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHH----HTTT---------C
T ss_pred ----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcC---------C
Confidence 33467899999999999999999999999999999998 677776543322 1111 1221 1
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+...+...+.++.+|+.+||+.||.+||||.+|+++|+.+.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12223445678899999999999999999999999998765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=383.74 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=206.6
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc------ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF------QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (766)
.+++.+.||+|+||.||+|.... +++.||||.++... ....+.|.+|+++|++++|||||++++++.+.+.
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 35667899999999999999864 46789999986432 1235789999999999999999999999999999
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC----CeEEeccCcc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY----NARISDFGLA 627 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla 627 (766)
.+||||||++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999999888889999999999999999999995 4999999999999998776 4999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
+........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+......
T Consensus 165 ~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNYE 234 (293)
T ss_dssp EECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCCC
T ss_pred hhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCCC
Confidence 887544322 345789999999999999999999999999999999999999986543321 1111111110
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.........+..+.+|+.+||+.||++|||++|++++
T Consensus 235 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 235 ------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000012245678899999999999999999999873
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=389.15 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=203.6
Q ss_pred HhhhhhccccccceEEEEEEecCCC-ceeEEEEEEeecc-cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRT-STTAVAVKKLDIV-FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
+++.+.||+|+||+||+|.+..++. ....||||+++.. .....++|.+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 4566899999999999999865432 2347999998643 344567899999999999999999999999864 567889
Q ss_pred eccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 557 EFLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
||+.+|+|.+++... ..+++..+++++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 999999999887654 678999999999999999999995 4999999999999999999999999999998766554
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
........||+.|+|||++.++.++.++|||||||+||||+| |++||......+. . ..+..+.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~----~~i~~~~--------- 230 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---S----SILEKGE--------- 230 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---H----HHHHHTC---------
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---H----HHHHcCC---------
Confidence 443345678999999999999999999999999999999999 7888875543321 1 1111111
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcC
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGV 754 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~ 754 (766)
+...+..+++++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1122344567899999999999999999999999998765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8e-45 Score=388.77 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=208.3
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
+++.+.||+|+||.||+|.... .++.||||.++.......+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5677899999999999999864 4679999999765555567789999999999999999999999999999999999
Q ss_pred cCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc--CCCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD--DHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+||||+ .++.+||+|||+++.+.....
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 9999999887655 468999999999999999999995 4999999999999998 678999999999998765433
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ....||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+..+... ..
T Consensus 185 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~~~------~~ 248 (352)
T d1koba_ 185 V---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDWE------FD 248 (352)
T ss_dssp E---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCCC------CC
T ss_pred e---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------CC
Confidence 2 446789999999999999999999999999999999999999976543321 1111111111 11
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.......+.++.+|+.+||+.||.+|||+.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123456788999999999999999999999874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=391.81 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=199.9
Q ss_pred HHhhhhhccccccceEEEEEEecCC--CceeEEEEEEeeccc-ccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCC-ce
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTR--TSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQ-NR 552 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~--~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~-~~ 552 (766)
.+.+.++||+|+||.||+|...... ..++.||||+++... ....+++.+|...+.++ +|+||+++++++.+.+ ..
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 93 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 93 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeE
Confidence 4556789999999999999986532 245789999997533 23346788888887776 6899999999986654 68
Q ss_pred EEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCC
Q 037189 553 LLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDH 616 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~ 616 (766)
++||||+++|+|.++++.. ..+++..++.++.||++||+|||+ .+|+||||||+||||+++
T Consensus 94 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 94 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGG
T ss_pred EEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCC
Confidence 9999999999999999643 247889999999999999999995 599999999999999999
Q ss_pred CCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCC-cCCCchhhhhhhhHHH
Q 037189 617 YNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACR-KSFDIEMVEEYAILTD 695 (766)
Q Consensus 617 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~ 695 (766)
+.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||......+
T Consensus 171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------ 244 (299)
T d1ywna1 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------ 244 (299)
T ss_dssp GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------
T ss_pred CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------
Confidence 999999999998776554444334567999999999999999999999999999999999975 5675433221
Q ss_pred HHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 696 WAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
.+...+..+.. ...+...++++.+++.+||+.||++||||.||+++|+++++
T Consensus 245 ~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 EFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11122222211 11223356778999999999999999999999999998753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=387.72 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=205.0
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecc-cccCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-FQDGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (766)
++.++||+|+||.||+|++..++ ....||||+++.. .....++|.+|+++|+++ +|||||+++++|.+++..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDG-LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETT-EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECCCC-eEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 35688999999999999987643 3457899998643 334566899999999998 79999999999999999999999
Q ss_pred ccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEE
Q 037189 558 FLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARI 621 (766)
Q Consensus 558 y~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl 621 (766)
|+++|+|.++|+.. ..+++..+++++.||++||.|||+ .+|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEE
Confidence 99999999999654 568999999999999999999995 49999999999999999999999
Q ss_pred eccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCc-CCCchhhhhhhhHHHHHHHH
Q 037189 622 SDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRK-SFDIEMVEEYAILTDWAFDC 700 (766)
Q Consensus 622 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~ 700 (766)
+|||+++........ ....||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ +...
T Consensus 169 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~~ 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEK 238 (309)
T ss_dssp CCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHH
T ss_pred ccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHHH
Confidence 999999865533222 33568999999999999999999999999999999999765 565443222 1112
Q ss_pred hhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 701 YRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
+.++. +...+..+++++.+|+.+||+.||++||||++|++.|+++.+-
T Consensus 239 i~~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22211 1122334567899999999999999999999999999887643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=385.41 Aligned_cols=261 Identities=28% Similarity=0.412 Sum_probs=209.6
Q ss_pred HHhhhhhccccccceEEEEEEecCC----CceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecCCc
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEGQN 551 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (766)
.+.+.++||+|+||.||+|+..... .....||||+++.... ....++.+|...+.++ +|||||+++++|.+++.
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 4456789999999999999876432 2346899999975443 3346788999888887 89999999999999999
Q ss_pred eEEEeeccCCCchhhhhccC----------------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC
Q 037189 552 RLLVYEFLNNGTLASFLFGN----------------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD 615 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~ 615 (766)
.++||||+++|+|.++|... ..+++.+++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence 99999999999999999644 357899999999999999999995 49999999999999999
Q ss_pred CCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHh-CCcCCCchhhhhhhhHH
Q 037189 616 HYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIA-CRKSFDIEMVEEYAILT 694 (766)
Q Consensus 616 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 694 (766)
++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++ |.+||.......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----- 245 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-----
Confidence 99999999999998876555444455678999999999999999999999999999999998 688886544322
Q ss_pred HHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcCC
Q 037189 695 DWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVEV 757 (766)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~~ 757 (766)
+...+..+.. ...+..++.++.+|+.+||+.||++||||.||++.|++++.+
T Consensus 246 --~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 --LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHcCCC---------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222222221 112333567899999999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=383.03 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=208.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+++.+.||+|+||.||+|+... +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 4567899999999999999864 5679999999743 244567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 9999999999999988889999999999999999999995 5999999999999999999999999999987654322
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
. ....+||+.|+|||++.+..++.++|||||||++|||++|++||......+. ......+.+
T Consensus 161 ~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~i~~~~~--------- 222 (337)
T d1o6la_ 161 T--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILMEEI--------- 222 (337)
T ss_dssp C--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---------
T ss_pred c--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-------HHHHhcCCC---------
Confidence 2 2456899999999999999999999999999999999999999987654321 111122211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~~ 750 (766)
..+...+.++.+|+.+||+.||.+||+ ++|++++
T Consensus 223 -~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 112335677889999999999999995 7888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-44 Score=379.87 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=207.1
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+++.++||+|+||+||+|+... .++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4567899999999999999864 4679999999642 234567899999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+++|+|..++.....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 999999999999999888999999999999999999999 5599999999999999999999999999998765432
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+..+..
T Consensus 159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~--------- 218 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKILNAEL--------- 218 (316)
T ss_dssp ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHCCC---------
T ss_pred ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHHHHcCCC---------
Confidence 456799999999999999999999999999999999999999976543321 111111111
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQM 750 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~~ 750 (766)
..+...++++.+++.+||+.||.+|| |+++++++
T Consensus 219 -~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 -RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11233456788999999999999996 89999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=388.28 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=214.0
Q ss_pred HHHHHHhhhhhccccccceEEEEEEec--CCCceeEEEEEEeecccc-cCHHHHHHHHHHHccC-CCCCeeeEeeeeecC
Q 037189 474 LEEATDNFKEEVGRGSFGIVYKGVIQT--TRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQT-HHKNLVRLLGFCDEG 549 (766)
Q Consensus 474 l~~~t~~f~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (766)
+....+.+.++||+|+||.||+|++.. ....++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 333456678899999999999999753 234678999999975433 3345799999999998 699999999999999
Q ss_pred CceEEEeeccCCCchhhhhccCC------------------CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceE
Q 037189 550 QNRLLVYEFLNNGTLASFLFGNL------------------KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNI 611 (766)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~------------------~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NI 611 (766)
+..++||||+++|+|.++++... .+++..+..++.||++||+|||+ .+++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccc
Confidence 99999999999999999986432 57888999999999999999995 4999999999999
Q ss_pred EEcCCCCeEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhC-CcCCCchhhhhh
Q 037189 612 LLDDHYNARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIAC-RKSFDIEMVEEY 690 (766)
Q Consensus 612 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg-~~p~~~~~~~~~ 690 (766)
+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+|+ .+++......+.
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999987765554444567899999999999999999999999999999999994 555544332211
Q ss_pred hhHHHHHHHHhhcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 691 AILTDWAFDCYRNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
+...+..+ .+...+...+.++.+|+.+||+.||.+||||.+|+++|++++
T Consensus 257 ------~~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 ------FYKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ------HHHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------HHHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11111211 112223345678999999999999999999999999998743
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-45 Score=382.95 Aligned_cols=260 Identities=27% Similarity=0.453 Sum_probs=210.7
Q ss_pred HHhhhhhccccccceEEEEEEecC--CCceeEEEEEEeeccc-ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTT--RTSTTAVAVKKLDIVF-QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (766)
...+.++||+|+||.||+|.+... ......||||+++... ......|.+|++++++++||||++++++|..+...++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 345668899999999999988532 2245789999997533 2233568999999999999999999999999999999
Q ss_pred EeeccCCCchhhhhccC----------CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEecc
Q 037189 555 VYEFLNNGTLASFLFGN----------LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDF 624 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 624 (766)
||||+++|+|.+++... ..+++..+.+++.|+++||.|||+ .+|+||||||+|||+++++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeec
Confidence 99999999999998632 346788999999999999999995 49999999999999999999999999
Q ss_pred CcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCC-cCCCchhhhhhhhHHHHHHHHhhc
Q 037189 625 GLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACR-KSFDIEMVEEYAILTDWAFDCYRN 703 (766)
Q Consensus 625 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 703 (766)
|+++.+.............+|+.|+|||.+.+..++.++||||||+++|||+||+ +|+......+ ....+..
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-------~~~~i~~ 250 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVME 250 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-------HHHHHHT
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHh
Confidence 9999776554443334456899999999999999999999999999999999985 6665443322 1112222
Q ss_pred CccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 704 GKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
+.. ...+..++..+.+++.+||+.+|++||||.+|+++|++.++
T Consensus 251 ~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 221 11233456789999999999999999999999999988654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=377.27 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=199.6
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHH--HHHHHHHccCCCCCeeeEeeeeecCC----ceE
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREF--KNEVFVIGQTHHKNLVRLLGFCDEGQ----NRL 553 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f--~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 553 (766)
-+.++||+|+||.||+|++. +..||||+++.. ..+++ ..|+..+.+++||||++++++|.+.+ ..+
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-----g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-----GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-----TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-----CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 35578999999999999863 578999998643 23344 44556667789999999999997654 578
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcC-----CCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDC-----SSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
+|||||++|+|.++|+.. .++|..+++++.|++.||+|||+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999999765 5899999999999999999999631 4699999999999999999999999999999
Q ss_pred ccccCCCcc--eeecccccCcccccccccCCC------CCcccCeeehhHHHHHHHhCCcCCCchhhhhh--------hh
Q 037189 629 LLTLNQSKT--IKTSIRGTKGYVAPEWFRNSK------ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEY--------AI 692 (766)
Q Consensus 629 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~--------~~ 692 (766)
......... ......||++|+|||++.+.. ++.++|||||||+||||+||..|+........ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 876543221 223467999999999987642 67799999999999999999988754221110 00
Q ss_pred HHHHHHHHhhcCccceeccCcc-cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCcC
Q 037189 693 LTDWAFDCYRNGKLDALVGGDM-EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVVE 756 (766)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~~ 756 (766)
...........+.. .+.. ......+.+..+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 11111222211111 1111 111234567789999999999999999999999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=372.80 Aligned_cols=272 Identities=22% Similarity=0.274 Sum_probs=205.0
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeeccccc-----CHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD-----GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
+.||+|+||+||+|.... .++.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEETTEEEEEEECSS---CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eEeccCcCeEEEEEEECC---CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 679999999999999764 4678999998643322 13468999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+.++++..++.....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 99999988888778889999999999999999999995 59999999999999999999999999999876544322
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee-------
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL------- 709 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 709 (766)
.....||+.|+|||++... .++.++|||||||++|||++|+.||......+... .+.+..........
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccc
Confidence 1345799999999998654 57999999999999999999999997655433211 11111111000000
Q ss_pred ---ccCcccCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC-cCCCCCCCCCC
Q 037189 710 ---VGGDMEAMN----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV-VEVSVPPNPYP 765 (766)
Q Consensus 710 ---~~~~~~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~-~~~~~pp~p~~ 765 (766)
......... ....++++.+|+.+||+.||++|||++|++++ |.+. .+.+..+.|+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p~p 298 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRP 298 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSCCC
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCCCC
Confidence 000000000 01235678999999999999999999999974 5442 22333334544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6e-44 Score=370.95 Aligned_cols=258 Identities=22% Similarity=0.286 Sum_probs=202.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---CHHHHHHHHHHHccCCCCCeeeEeeeeecCCc----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---GEREFKNEVFVIGQTHHKNLVRLLGFCDEGQN---- 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 551 (766)
+.+.+.||+|+||.||+|.... .++.||||.++..... ..+.|.+|++++++++||||+++++++...+.
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred eEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4567899999999999999864 4679999999754332 24579999999999999999999999876543
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.+|||||+++++|.+++.....+++.++..++.||++||+|||+ .+|+||||||+|||++.++..+|+|||.+....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhc
Confidence 78999999999999999888889999999999999999999995 499999999999999999999999999987654
Q ss_pred cCCCc-ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceec
Q 037189 632 LNQSK-TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALV 710 (766)
Q Consensus 632 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 710 (766)
..... .......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .......+...
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCCC---
Confidence 43221 222456799999999999999999999999999999999999999976543221 12222222111
Q ss_pred cCcccCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHhcCc
Q 037189 711 GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-TIKKVLQMLEGVV 755 (766)
Q Consensus 711 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-t~~~vl~~Le~~~ 755 (766)
........++++.+++.+||+.||++|| |++++++.|.++.
T Consensus 234 ----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111223467889999999999999999 8999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=8.8e-44 Score=368.20 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=205.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc---------CHHHHHHHHHHHccCC-CCCeeeEeeeeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD---------GEREFKNEVFVIGQTH-HKNLVRLLGFCDE 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~---------~~~~f~~E~~~l~~l~-H~niv~l~g~~~~ 548 (766)
+.+.+.||+|+||+||+|+... +++.+|||+++..... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CEEceEEecCcCeEEEEEEECC---CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4566899999999999998764 5689999999754321 1235889999999997 9999999999999
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
++..+|||||+++|+|.++|.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhee
Confidence 999999999999999999998888899999999999999999999954 99999999999999999999999999999
Q ss_pred ccccCCCcceeecccccCcccccccccC------CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhh
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN------SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYR 702 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 702 (766)
........ ....||+.|+|||++.+ ..++.++||||+||+||||++|+.||........ ...+.
T Consensus 159 ~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-------~~~i~ 228 (277)
T d1phka_ 159 QLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-------LRMIM 228 (277)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH
T ss_pred EccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH-------HHHHH
Confidence 87654322 44679999999999863 3568899999999999999999999986543221 11112
Q ss_pred cCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 703 NGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
++... .........++++.+++.+||+.||.+|||++||+++
T Consensus 229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22211 1111223456789999999999999999999999764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-44 Score=376.22 Aligned_cols=246 Identities=28% Similarity=0.361 Sum_probs=204.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHc-cCCCCCeeeEeeeeecCCceEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIG-QTHHKNLVRLLGFCDEGQNRLL 554 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~l 554 (766)
+.+.+.||+|+||+||+|+... .++.||||.++.. .....+.+..|..++. .++||||+++++++.+++..+|
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 4567899999999999999874 5679999999743 2344566777777765 6899999999999999999999
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 634 (766)
||||+++|+|.+++.....+++..+..++.||+.||+|||+ .+|+||||||+|||+++++++||+|||+++......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 99999999999999988889999999999999999999995 499999999999999999999999999998765433
Q ss_pred CcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCcc
Q 037189 635 SKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDM 714 (766)
Q Consensus 635 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (766)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+..
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~~~-------- 220 (320)
T d1xjda_ 158 AK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMDNP-------- 220 (320)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC--------
T ss_pred cc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCC--------
Confidence 22 2446799999999999999999999999999999999999999986554321 111222211
Q ss_pred cCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 037189 715 EAMNDVECLEKLVMVSIWCIQEDPSLRPTIK-KVLQ 749 (766)
Q Consensus 715 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~-~vl~ 749 (766)
..+...+.++.+|+.+||+.||.+|||+. ++++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11233467789999999999999999995 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.6e-43 Score=377.10 Aligned_cols=247 Identities=23% Similarity=0.258 Sum_probs=199.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc---ccCHHHHHHH---HHHHccCCCCCeeeEeeeeecCCce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF---QDGEREFKNE---VFVIGQTHHKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~---~~~~~~f~~E---~~~l~~l~H~niv~l~g~~~~~~~~ 552 (766)
+.+.+.||+|+||.||+|+... .++.||||.+.... ......+.+| +.+++.++|||||++++++.+.+..
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred CeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4466899999999999999864 46799999986421 2233444444 6778888999999999999999999
Q ss_pred EEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccccc
Q 037189 553 LLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTL 632 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 632 (766)
++||||+++|+|.++|.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 9999999999999999888889999999999999999999995 5999999999999999999999999999987654
Q ss_pred CCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
... ....||+.|+|||++.. ..++.++|||||||+||||++|+.||..........+ .......
T Consensus 160 ~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----~~~~~~~------- 224 (364)
T d1omwa3 160 KKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------- 224 (364)
T ss_dssp SCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH----HHHSSSC-------
T ss_pred Ccc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcccC-------
Confidence 432 34579999999999974 5689999999999999999999999976543221111 1111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRPT-----IKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt-----~~~vl~ 749 (766)
....+...++++.+|+.+||+.||++||| ++|+++
T Consensus 225 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11112235677899999999999999999 688875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-43 Score=377.74 Aligned_cols=243 Identities=24% Similarity=0.243 Sum_probs=205.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc---cccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV---FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLV 555 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (766)
+++.++||+|+||.||+|++.. .++.||||.++.. .....+.+.+|+++|++++|||||++++++.+....++|
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 4566899999999999999864 4678999998642 234456799999999999999999999999999999999
Q ss_pred eeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCC
Q 037189 556 YEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 635 (766)
|||+.+|+|.+++.....+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~- 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT- 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc-
Confidence 9999999999999888889999999999999999999995 499999999999999999999999999998765332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
....||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...+..+..
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~--------- 255 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKIVSGKV--------- 255 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCC---------
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-------HHHHhcCCC---------
Confidence 346799999999999999999999999999999999999999976543221 111111211
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
..+...+.++.+++.+||+.||.+|+ |++++++
T Consensus 256 -~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11233467789999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-43 Score=369.32 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=203.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEeec
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYEF 558 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (766)
|.+.+.||+|+||+||+|.... .++.||||.++... .....+.+|+++|++++||||+++++++.+++..+|||||
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 4566899999999999999875 46789999997542 3345688999999999999999999999999999999999
Q ss_pred cCCCchhhhhccCC-CCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC--CCCeEEeccCcccccccCCC
Q 037189 559 LNNGTLASFLFGNL-KPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD--HYNARISDFGLAKLLTLNQS 635 (766)
Q Consensus 559 ~~~gsL~~~l~~~~-~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 635 (766)
+++|+|.+++.... .+++.++..|+.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+++.......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence 99999999998664 78999999999999999999995 49999999999999984 45899999999987654332
Q ss_pred cceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccCccc
Q 037189 636 KTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGGDME 715 (766)
Q Consensus 636 ~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (766)
.....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..+... ..
T Consensus 160 ---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-------~~~i~~~~~~------~~ 223 (321)
T d1tkia_ 160 ---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-------IENIMNAEYT------FD 223 (321)
T ss_dssp ---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHHTCCC------CC
T ss_pred ---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC------CC
Confidence 2345689999999999999999999999999999999999999976554321 1111111110 00
Q ss_pred CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 716 AMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 716 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.......+.++.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001123567889999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-43 Score=370.60 Aligned_cols=243 Identities=24% Similarity=0.278 Sum_probs=194.4
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHcc-CCCCCeeeEeeeeec----CCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQ-THHKNLVRLLGFCDE----GQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~lV~E 557 (766)
+.||+|+||.||+|.... +++.||||+++. ...+.+|+.++.+ .+|||||++++++.+ +...++|||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKR---TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp EEEEECSSCEEEEEEETT---TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEeeeccCeEEEEEEECC---CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEE
Confidence 459999999999999864 467899999863 3467889988765 589999999999865 456899999
Q ss_pred ccCCCchhhhhccC--CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC---CCCeEEeccCccccccc
Q 037189 558 FLNNGTLASFLFGN--LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD---HYNARISDFGLAKLLTL 632 (766)
Q Consensus 558 y~~~gsL~~~l~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~ 632 (766)
||++|+|.+++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||+++ ++.+||+|||+++....
T Consensus 90 y~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~ 166 (335)
T d2ozaa1 90 CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166 (335)
T ss_dssp CCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred CCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccC
Confidence 99999999999764 468999999999999999999995 59999999999999985 56799999999987765
Q ss_pred CCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceeccC
Q 037189 633 NQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVGG 712 (766)
Q Consensus 633 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (766)
.... ....||+.|+|||++.+..++.++|||||||+||||+||+.||......... ..... .+...
T Consensus 167 ~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~--------~i~~~ 232 (335)
T d2ozaa1 167 HNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKT--------RIRMG 232 (335)
T ss_dssp CCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCCSC
T ss_pred CCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHH--------HHhcC
Confidence 4332 4567999999999999999999999999999999999999999765432210 00111 11111
Q ss_pred cccC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 713 DMEA--MNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 713 ~~~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.... ......++++.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 1123456789999999999999999999999884
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=359.28 Aligned_cols=264 Identities=24% Similarity=0.329 Sum_probs=198.9
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...++||+|+||+||+|+... .++.||||+++... ....+++.+|++++++++|||||++++++.+++..++|||
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 445789999999999999864 46789999996533 2335789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 558 FLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 558 y~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|+.++.+..... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 998655544433 34668999999999999999999995 49999999999999999999999999999876543322
Q ss_pred ceeecccccCcccccccccCCC-CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhc---Cc---ccee
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRN---GK---LDAL 709 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~ 709 (766)
.....||+.|+|||.+.... .+.++|||||||++|||++|+.||......+.. .. ....... .. ....
T Consensus 159 --~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 159 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FR-IFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGS
T ss_pred --ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH--HH-HHHhcCCCchhhccccccc
Confidence 23457999999999887665 578999999999999999999999765432211 11 1111000 00 0000
Q ss_pred ccCc--c-c-CCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 037189 710 VGGD--M-E-AMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV 754 (766)
Q Consensus 710 ~~~~--~-~-~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~ 754 (766)
.+.. . . ... ....+.++.+++.+||+.||++|||++|+++. |+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000 0 0 000 11234678899999999999999999999986 5544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=361.71 Aligned_cols=239 Identities=23% Similarity=0.400 Sum_probs=196.8
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------CHHHHHHHHHHHccCC--CCCeeeEeeeeecCC
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------GEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~ 550 (766)
+.+.+.||+|+||.||+|.... +++.||||.++..... ...++.+|+.++++++ |||||++++++.+.+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred EEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4567899999999999999864 4678999998643211 2244788999999986 899999999999999
Q ss_pred ceEEEeeccCC-CchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-CCCeEEeccCccc
Q 037189 551 NRLLVYEFLNN-GTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-HYNARISDFGLAK 628 (766)
Q Consensus 551 ~~~lV~Ey~~~-gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~ 628 (766)
..++||||+.+ ++|.+++.....+++..+..++.||++||+|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 6888888888889999999999999999999995 59999999999999985 4799999999998
Q ss_pred ccccCCCcceeecccccCcccccccccCCCC-CcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccc
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRNSKI-TAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLD 707 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 707 (766)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....- . .+..
T Consensus 160 ~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i------------~-~~~~- 221 (273)
T d1xwsa_ 160 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI------------I-RGQV- 221 (273)
T ss_dssp ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH------------H-HCCC-
T ss_pred eccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH------------h-hccc-
Confidence 754332 245679999999999987765 57799999999999999999999753210 0 0110
Q ss_pred eeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 708 ALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..+...+.++.+++.+||+.||++|||++|++++
T Consensus 222 ---------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0112245678999999999999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-41 Score=355.21 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=199.5
Q ss_pred hhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEee
Q 037189 480 NFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 480 ~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (766)
...++||+|+||+||+|+.+ .++.||||+++... ....+.|.+|+.+|++++||||+++++++.+.+..++++|
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred eeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 45678999999999999875 45789999996532 3345789999999999999999999999999999999999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCcc
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSKT 637 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 637 (766)
|+.++.+..+......+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence 99998888888888889999999999999999999995 49999999999999999999999999999876543222
Q ss_pred eeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc------ccee-
Q 037189 638 IKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK------LDAL- 709 (766)
Q Consensus 638 ~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~- 709 (766)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+.. .. ......... ....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 -YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTTSTTGGGST
T ss_pred -cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HH-HHHhhCCCChhhccchhhhh
Confidence 1344689999999998754 5789999999999999999999999765432211 11 111110000 0000
Q ss_pred --------ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 710 --------VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 710 --------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
.............+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000001112234567889999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=353.83 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=197.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccC---CCCCeeeEeeeeec-----
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQT---HHKNLVRLLGFCDE----- 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 548 (766)
+++.++||+|+||+||+|+...+ .++.||||+++... ......+.+|+.+++.+ +||||++++++|..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred EEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 45668899999999999997542 35689999986532 22334567787776665 79999999999853
Q ss_pred CCceEEEeeccCCCchhhhhc-cCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcc
Q 037189 549 GQNRLLVYEFLNNGTLASFLF-GNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLA 627 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 627 (766)
....+++|||+.++++..... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 346789999999988765544 34668899999999999999999995 49999999999999999999999999999
Q ss_pred cccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc--
Q 037189 628 KLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK-- 705 (766)
Q Consensus 628 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 705 (766)
+....... .....||+.|+|||++.+.+++.++||||+||++|||++|+.||......+.... .........
T Consensus 164 ~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~~ 237 (305)
T d1blxa_ 164 RIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK---ILDVIGLPGEE 237 (305)
T ss_dssp CCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCGG
T ss_pred hhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhhCCCchh
Confidence 86544322 2456799999999999999999999999999999999999999986554322111 111110000
Q ss_pred -c------c-ee---ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 037189 706 -L------D-AL---VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV 754 (766)
Q Consensus 706 -~------~-~~---~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~ 754 (766)
. . .. .............++.+.+|+.+||+.||++|||+.|++++ |+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0 0 00 00000001122345678899999999999999999999874 5444
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=358.33 Aligned_cols=254 Identities=21% Similarity=0.232 Sum_probs=205.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc----cccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV----FQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRL 553 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~----~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~ 553 (766)
+++.++||+|+||+||+|+.......++.||||.++.. .....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 66778999999999999998665557889999998642 22345678999999999976 89999999999999999
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
+||||+.+|+|.+++.....+++.....++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 999999999999999888888889999999999999999995 59999999999999999999999999999876544
Q ss_pred CCcceeecccccCcccccccccCC--CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCccceecc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS--KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDALVG 711 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 711 (766)
..... ....|++.|+|||.+.+. .++.++|||||||+||||++|+.||........... +........
T Consensus 183 ~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~---i~~~~~~~~------ 252 (322)
T d1vzoa_ 183 ETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---ISRRILKSE------ 252 (322)
T ss_dssp GGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH---HHHHHHHCC------
T ss_pred ccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcccCC------
Confidence 33222 456799999999999765 468899999999999999999999976543221111 111111111
Q ss_pred CcccCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 037189 712 GDMEAMNDVECLEKLVMVSIWCIQEDPSLRP-----TIKKVLQ 749 (766)
Q Consensus 712 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----t~~~vl~ 749 (766)
...+...+.++.+++.+||+.||++|| |++|+++
T Consensus 253 ----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 112334578899999999999999999 4788886
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=351.35 Aligned_cols=266 Identities=19% Similarity=0.220 Sum_probs=197.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecc--cccCHHHHHHHHHHHccCCCCCeeeEeeeeec--------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV--FQDGEREFKNEVFVIGQTHHKNLVRLLGFCDE-------- 548 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-------- 548 (766)
+.+.++||+|+||+||+|+... +++.||||++... .....+++.+|+++|++++||||+++++++..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred EEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3456789999999999999864 5679999998543 23345779999999999999999999998855
Q ss_pred CCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 549 GQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
....++||||+.++.+..+......+++..+..++.||++||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceee
Confidence 34678999999998888777777888899999999999999999995 599999999999999999999999999998
Q ss_pred ccccCCCc--ceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc
Q 037189 629 LLTLNQSK--TIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK 705 (766)
Q Consensus 629 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 705 (766)
........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+................
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence 76543321 122335799999999998765 689999999999999999999999976544332222111111000000
Q ss_pred ccee--------ccCcccCCC-c------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 LDAL--------VGGDMEAMN-D------VECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 ~~~~--------~~~~~~~~~-~------~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
.... ......... . ......+.+|+.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000000000 0 1123467789999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=348.68 Aligned_cols=260 Identities=18% Similarity=0.188 Sum_probs=195.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeE-eeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRL-LGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l-~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|++.. .++.||||.+.... ...++..|++++++++|+|++.. ..+..+.+..++|||
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred EEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 4567899999999999999764 46789999887533 33468899999999987765555 555577778899999
Q ss_pred ccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEc---CCCCeEEeccCcccccccCC
Q 037189 558 FLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLD---DHYNARISDFGLAKLLTLNQ 634 (766)
Q Consensus 558 y~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~ 634 (766)
|+.++.+..+......+++..+..++.|+++||+|||+ .+|+||||||+|||++ .+..+||+|||+++.+....
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99654444444556789999999999999999999995 5999999999999985 45679999999999876443
Q ss_pred Cc-----ceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcccee
Q 037189 635 SK-----TIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKLDAL 709 (766)
Q Consensus 635 ~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 709 (766)
.. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........................+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 22 1123467999999999999999999999999999999999999999754432211111111110000000000
Q ss_pred ccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 710 VGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 710 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
...+++++.+++.+||+.+|++||++.++.+.|+.+.
T Consensus 241 ---------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 241 ---------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ---------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred ---------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1124577899999999999999999999998887653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.8e-40 Score=343.19 Aligned_cols=259 Identities=17% Similarity=0.192 Sum_probs=203.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCC-CCeeeEeeeeecCCceEEEee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHH-KNLVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 557 (766)
+.+.++||+|+||.||+|+... .++.||||.+.... ....+.+|++.+..++| +|++.+++++.++...++|||
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 4567899999999999999864 46799999886432 33467888999998875 899999999999999999999
Q ss_pred ccCCCchhhhhccC-CCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcC-----CCCeEEeccCcccccc
Q 037189 558 FLNNGTLASFLFGN-LKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDD-----HYNARISDFGLAKLLT 631 (766)
Q Consensus 558 y~~~gsL~~~l~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~ 631 (766)
|+ +++|.+++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 98 68999988754 46889999999999999999999 569999999999999974 5789999999999875
Q ss_pred cCCCcc-----eeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCcc
Q 037189 632 LNQSKT-----IKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGKL 706 (766)
Q Consensus 632 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 706 (766)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 432211 123467999999999999999999999999999999999999999754432211111111111111111
Q ss_pred ceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHhcCc
Q 037189 707 DALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQMLEGVV 755 (766)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~Le~~~ 755 (766)
.++ ...+++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 238 ~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 238 REL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred HHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 111 1123567889999999999999999999998887754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-40 Score=351.60 Aligned_cols=263 Identities=23% Similarity=0.260 Sum_probs=194.6
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCeeeEeeeeecC------Cce
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNLVRLLGFCDEG------QNR 552 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~~ 552 (766)
++..++||+|+||+||+|+... .++.||||++..... .+.+|+++|++++||||+++++++... ...
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred cEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 4455789999999999999874 467999999975432 335799999999999999999998532 346
Q ss_pred EEEeeccCCCchhhh---hccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCccc
Q 037189 553 LLVYEFLNNGTLASF---LFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAK 628 (766)
Q Consensus 553 ~lV~Ey~~~gsL~~~---l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~ 628 (766)
+|||||++++.+... ......+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 899999987654433 335667899999999999999999999 56999999999999999765 89999999998
Q ss_pred ccccCCCcceeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH---------HHHH
Q 037189 629 LLTLNQSKTIKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT---------DWAF 698 (766)
Q Consensus 629 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------~~~~ 698 (766)
.+...... ....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+..... ....
T Consensus 172 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 77554322 34579999999998865 57899999999999999999999999765432211110 0000
Q ss_pred HHh---hcCccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcC
Q 037189 699 DCY---RNGKLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGV 754 (766)
Q Consensus 699 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~ 754 (766)
... .....................+.++.+|+.+||+.||++|||+.|++++ ++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 0001111111111111122345678899999999999999999999963 4444
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-40 Score=352.46 Aligned_cols=269 Identities=24% Similarity=0.291 Sum_probs=193.2
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeecCC------
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ------ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (766)
+...++||+|+||+||+|.... .++.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp EEEEEEC------CEEEEEETT---TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred EEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4456789999999999999864 46789999997432 223457899999999999999999999997654
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
+.++||||+ +.+|..++. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceecc
Confidence 569999999 556776654 4568999999999999999999995 49999999999999999999999999999876
Q ss_pred ccCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHH--------HHh
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAF--------DCY 701 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~ 701 (766)
.... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||................ ...
T Consensus 172 ~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 172 DSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred CCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5432 456799999999998764 57899999999999999999999997654322111100000 000
Q ss_pred hcC-------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 037189 702 RNG-------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVVEVSVPP 761 (766)
Q Consensus 702 ~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~~~~~pp 761 (766)
... ........... ......+..+.+|+.+||+.||.+|||++|++++ |+++.+.+..|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~ 314 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEP 314 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------
T ss_pred cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccc
Confidence 000 00000000000 0112234677899999999999999999999986 77665444333
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-39 Score=339.09 Aligned_cols=262 Identities=20% Similarity=0.263 Sum_probs=203.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeecCCceEEEe
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQNRLLVY 556 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (766)
++..++||+|+||+||+|+... +++.||||+++.... ....++.+|+.++++++||||+++++++.+....++|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 3456899999999999999864 567899999865432 33578999999999999999999999999999999999
Q ss_pred eccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccCCCc
Q 037189 557 EFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLNQSK 636 (766)
Q Consensus 557 Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 636 (766)
|++.+++|..++.....+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||.++........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9999999999998888899999999999999999999964 9999999999999999999999999999887654322
Q ss_pred ceeecccccCcccccccccCCC-CCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC---c-------
Q 037189 637 TIKTSIRGTKGYVAPEWFRNSK-ITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG---K------- 705 (766)
Q Consensus 637 ~~~~~~~gt~~y~aPE~~~~~~-~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~------- 705 (766)
. ....++..|+|||.+.... ++.++|||||||++|||++|+.||......... + ..+....... .
T Consensus 158 ~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 158 Y--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-L-KRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp C--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-H-HHHHHHHCCCCTTTCTTGGGS
T ss_pred c--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-H-HHHHhhcCCCChhhhhhhhhc
Confidence 1 3345788899999987665 689999999999999999999997433221111 1 1111111100 0
Q ss_pred -----cceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 706 -----LDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 706 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
..................+.+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000011111223345678899999999999999999999873
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-40 Score=350.69 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=196.0
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc-cCHHHHHHHHHHHccCCCCCeeeEeeeeecCC----ceE
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ-DGEREFKNEVFVIGQTHHKNLVRLLGFCDEGQ----NRL 553 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~ 553 (766)
+...++||+|+||+||+|.... .++.||||+++.... ...+.+++|+.+|++++||||+++++++.... ..+
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp EEEEEECC---CCCEEEEEETT---TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred eEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3456889999999999999764 467899999975432 23467899999999999999999999996543 235
Q ss_pred EEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccccC
Q 037189 554 LVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLTLN 633 (766)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 633 (766)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 556677899999999654 68999999999999999999995 49999999999999999999999999999876544
Q ss_pred CCcc-eeecccccCcccccccccC-CCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcCc------
Q 037189 634 QSKT-IKTSIRGTKGYVAPEWFRN-SKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNGK------ 705 (766)
Q Consensus 634 ~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 705 (766)
.... ......||+.|+|||.+.. ..++.++||||+||+++||++|+.||......+................
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence 3221 1244679999999999854 4678999999999999999999999976543222111111000000000
Q ss_pred --cce-eccCcccCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HhcCc
Q 037189 706 --LDA-LVGGDMEAMN-----DVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM--LEGVV 755 (766)
Q Consensus 706 --~~~-~~~~~~~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~--Le~~~ 755 (766)
... .......... ....+.++.+++.+||+.||.+|||+.|++++ |+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000 0000000000 01223578899999999999999999999985 55443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-38 Score=339.23 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=195.9
Q ss_pred HHhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeec--CCceEE
Q 037189 478 TDNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDE--GQNRLL 554 (766)
Q Consensus 478 t~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~l 554 (766)
.+.+.++||+|+||+||+|+... .++.||||+++. ...+++.+|+++|++++ ||||+++++++.. ....++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 35567899999999999999864 567999999864 34578999999999985 9999999999874 456899
Q ss_pred EeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCC-CeEEeccCcccccccC
Q 037189 555 VYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHY-NARISDFGLAKLLTLN 633 (766)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 633 (766)
||||+++++|..+. +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999998764 458899999999999999999995 5999999999999998655 5999999999877654
Q ss_pred CCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh--hHHHH-----HHHHhhcCc
Q 037189 634 QSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA--ILTDW-----AFDCYRNGK 705 (766)
Q Consensus 634 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~--~~~~~-----~~~~~~~~~ 705 (766)
... ....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||......... .+... .........
T Consensus 184 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Ccc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 332 445789999999998765 4799999999999999999999999654322111 00000 000000000
Q ss_pred ------cceec--------cCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 037189 706 ------LDALV--------GGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ 749 (766)
Q Consensus 706 ------~~~~~--------~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~ 749 (766)
..... ............+.++.+|+.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000111112334567899999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=340.73 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=186.7
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeeccc--ccCHHHHHHHHHHHccCCCCCeeeEeeeeec------CC
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVF--QDGEREFKNEVFVIGQTHHKNLVRLLGFCDE------GQ 550 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~ 550 (766)
++..++||+|+||+||+|.+.. .++.||||++.... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETT---TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred eEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 3455789999999999999864 46789999997543 2234568999999999999999999999853 36
Q ss_pred ceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCccccc
Q 037189 551 NRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLL 630 (766)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 630 (766)
..++||||+.++.+... . ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 78999999987655544 3 457889999999999999999995 49999999999999999999999999998876
Q ss_pred ccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHH----------------
Q 037189 631 TLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILT---------------- 694 (766)
Q Consensus 631 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------------- 694 (766)
...... ....+|+.|+|||++.+..+++++||||+||+++||++|+.||............
T Consensus 170 ~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 170 GTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 543322 4457899999999999999999999999999999999999999754422211000
Q ss_pred HHHHHHhhcCc-c-----ceeccCcc---cCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 037189 695 DWAFDCYRNGK-L-----DALVGGDM---EAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQM 750 (766)
Q Consensus 695 ~~~~~~~~~~~-~-----~~~~~~~~---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~~ 750 (766)
........... . ........ ........+..+.+|+.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000001100 0 00000000 011123457789999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=341.99 Aligned_cols=269 Identities=24% Similarity=0.278 Sum_probs=197.5
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccc--cCHHHHHHHHHHHccCCCCCeeeEeeeeec-----CCc
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQ--DGEREFKNEVFVIGQTHHKNLVRLLGFCDE-----GQN 551 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~ 551 (766)
+...++||+|+||+||+|+... .++.||||+++.... ...+.+.+|+++|++++|||||++++++.. ...
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred eEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4456889999999999998764 567999999975432 234578999999999999999999999853 334
Q ss_pred eEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEeccCcccccc
Q 037189 552 RLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARISDFGLAKLLT 631 (766)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 631 (766)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||++....
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccC
Confidence 5677788899999999865 468999999999999999999995 499999999999999999999999999997654
Q ss_pred cCCCcceeecccccCcccccccccCC-CCCcccCeeehhHHHHHHHhCCcCCCchhhhhhhhHHHHHHHHhhcC------
Q 037189 632 LNQSKTIKTSIRGTKGYVAPEWFRNS-KITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYAILTDWAFDCYRNG------ 704 (766)
Q Consensus 632 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 704 (766)
... ....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||............ .......
T Consensus 173 ~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 173 DEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPGAELLK 244 (348)
T ss_dssp GGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCHHHHT
T ss_pred ccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChHHhh
Confidence 321 345689999999987665 4689999999999999999999999765432211111 0000000
Q ss_pred ------------ccceeccCcccCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHhcCcCCCCCCCC
Q 037189 705 ------------KLDALVGGDMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIKKVLQ--MLEGVVEVSVPPNP 763 (766)
Q Consensus 705 ------------~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~~vl~--~Le~~~~~~~pp~p 763 (766)
............ .....+.++.+|+.+||+.||.+|||++|+++ .+.+..+.+..|.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~ 316 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVA 316 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCC
T ss_pred hccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCC
Confidence 000000000000 00123467889999999999999999999998 46665544443333
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-33 Score=304.52 Aligned_cols=274 Identities=20% Similarity=0.229 Sum_probs=192.9
Q ss_pred HhhhhhccccccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-----------CCCeeeEeeeee
Q 037189 479 DNFKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-----------HKNLVRLLGFCD 547 (766)
Q Consensus 479 ~~f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~ 547 (766)
|.+.++||+|+||+||+|+... .++.||||+++... ...+.+.+|++++++++ |+||+++++++.
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 5677899999999999999864 46799999997532 23457788998888775 578999999885
Q ss_pred cC--CceEEEeeccCCCchhh-hh--ccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCC----
Q 037189 548 EG--QNRLLVYEFLNNGTLAS-FL--FGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYN---- 618 (766)
Q Consensus 548 ~~--~~~~lV~Ey~~~gsL~~-~l--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~---- 618 (766)
.. ...+++++++..+.... .. .....+++..+..++.||+.||+|||+ ..+|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccccc
Confidence 43 45566776665543322 22 234567888999999999999999996 358999999999999986553
Q ss_pred --eEEeccCcccccccCCCcceeecccccCcccccccccCCCCCcccCeeehhHHHHHHHhCCcCCCchhhhhhh----h
Q 037189 619 --ARISDFGLAKLLTLNQSKTIKTSIRGTKGYVAPEWFRNSKITAKVDVYSFGVLLLEIIACRKSFDIEMVEEYA----I 692 (766)
Q Consensus 619 --~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDV~s~Gvvl~elltg~~p~~~~~~~~~~----~ 692 (766)
+|++|||.+....... ....||+.|+|||.+....++.++||||+||+++||++|+.||......... .
T Consensus 169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 9999999998654322 3456999999999999999999999999999999999999999754321111 1
Q ss_pred HHHHHHH-------Hhhc----------C-ccceeccC---------cccCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 037189 693 LTDWAFD-------CYRN----------G-KLDALVGG---------DMEAMNDVECLEKLVMVSIWCIQEDPSLRPTIK 745 (766)
Q Consensus 693 ~~~~~~~-------~~~~----------~-~~~~~~~~---------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPt~~ 745 (766)
+...+.. .... . ....+... ..........+.++.+|+.+||+.||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 1111000 0000 0 00000000 011223456788899999999999999999999
Q ss_pred HHHHH--HhcC---cCCCCCCCC
Q 037189 746 KVLQM--LEGV---VEVSVPPNP 763 (766)
Q Consensus 746 ~vl~~--Le~~---~~~~~pp~p 763 (766)
|++++ +++. .++..|+.|
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~ 346 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRE 346 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSC
T ss_pred HHhcCcccCCCCCcccCCCCCcc
Confidence 99985 5543 344455544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.81 E-value=1.2e-20 Score=182.75 Aligned_cols=161 Identities=14% Similarity=0.155 Sum_probs=117.9
Q ss_pred hhhhccccccceEEEEEEecCCCceeEEEEEEeeccccc------------------CHHHHHHHHHHHccCCCCCeeeE
Q 037189 481 FKEEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIVFQD------------------GEREFKNEVFVIGQTHHKNLVRL 542 (766)
Q Consensus 481 f~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~------------------~~~~f~~E~~~l~~l~H~niv~l 542 (766)
+.++||+|+||.||+|... +++.||||.++..... ....+.+|...+.++.|.+++..
T Consensus 4 vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~ 79 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV 79 (191)
T ss_dssp EEEEEEECSSEEEEEEEET----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred hCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence 4578999999999999875 4678999987531110 01234568889999999999998
Q ss_pred eeeeecCCceEEEeeccCCCchhhhhccCCCCccchhhhHHHHHHHHHHHhhhcCCCceecCCCccceEEEcCCCCeEEe
Q 037189 543 LGFCDEGQNRLLVYEFLNNGTLASFLFGNLKPNWNLRTNIAFQIARGLLYLHEDCSSQIIHCDMKPQNILLDDHYNARIS 622 (766)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 622 (766)
+++.. .+++|||+++..+.+ ++......++.|++++|+|||+ .+|+||||||+|||++++ .++|+
T Consensus 80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence 87642 379999999876544 4556677899999999999995 499999999999999865 58999
Q ss_pred ccCcccccccCCCcceeecccccCccccc------ccccCCCCCcccCeeehhHH
Q 037189 623 DFGLAKLLTLNQSKTIKTSIRGTKGYVAP------EWFRNSKITAKVDVYSFGVL 671 (766)
Q Consensus 623 Dfgla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDV~s~Gvv 671 (766)
|||+++......... |+.. |.+ ...++.++|+||..--
T Consensus 145 DFG~a~~~~~~~~~~----------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWRE----------ILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHH----------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHH----------HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 999997654322111 1111 111 3467888999996543
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.73 E-value=9.8e-18 Score=144.55 Aligned_cols=101 Identities=21% Similarity=0.354 Sum_probs=82.9
Q ss_pred CCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEecc
Q 037189 28 GTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTAD 107 (766)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~ 107 (766)
|+|.+||+|.+|+ .|+ +|.|.|+|+.+++ |.++. ..++||+||++.|. ...+.|.|+.|
T Consensus 2 ~~L~~g~~L~~g~---~l~--~g~~~l~~q~dgn---------Lvl~~----~~~~vW~ant~~~~---~~~~~l~l~~d 60 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQ---SLD--VEPYHFIMQEDCN---------LVLYD----HSTSVWASNTGILG---KKGCKAVLQSD 60 (109)
T ss_dssp CEEETTCEEETTC---EEE--ETTEEEEECTTSC---------EEEEE----TTEEEEECCCCCTT---CCCCEEEECTT
T ss_pred CCccCCCEEeCCC---EEE--eCCEEEEecCCCe---------EEEEe----CCEEEEEeCCCCCC---ceeEEEEEcCC
Confidence 6899999999999 555 4899999976542 55654 35899999999843 35688999999
Q ss_pred CcEEEeCCCCCeeeeeeccC-CcceEEEeccCCCEEEecCCCCeee
Q 037189 108 QGLVLNDPQGKQVWSSKIDI-GTVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 108 g~l~l~~~~~~~~w~t~~~~-~~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|||||+|.+|++||+|++.. .+..+|+|+||||||||++ .+|
T Consensus 61 GnLvl~~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W 103 (109)
T d1kj1a_ 61 GNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIW 103 (109)
T ss_dssp SCEEEECSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEE
T ss_pred ceEEEEeCCCcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEe
Confidence 99999999999999999864 3445899999999999964 466
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.72 E-value=1.1e-17 Score=145.71 Aligned_cols=103 Identities=17% Similarity=0.338 Sum_probs=84.3
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
+|+|.|||+|.+|+ .|+| |.|.|.|+.+|+ |.|++. .++||.||+..+. ..+.|.|+.
T Consensus 1 tDtL~~gq~L~~g~---~l~~--g~~~l~~q~DGN---------Lvly~~----~~~vW~s~~~~~~----~~~~l~l~~ 58 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGG---SLAE--GGYLFIIQNDCN---------LVLYDN----NRAVWASGTNGKA----SGCVLKMQN 58 (112)
T ss_dssp CCEEETTEEECTTC---EEEE--TTEEEEECTTSC---------EEEEET----TEEEEECCCTTSC----SSEEEEECT
T ss_pred CCEecCCCEecCCC---EEEE--CCEEEEEcCCCC---------EEEEcC----CcEEEEccCccCC----CCcEEEEec
Confidence 48999999999999 6664 999999987653 666553 5899999998743 337899999
Q ss_pred cCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 107 DQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 107 ~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
||||||+|. +.++|++++... +..+++|+|+|||||||.++.++|
T Consensus 59 dGnLvl~~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W 104 (112)
T d1xd5a_ 59 DGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIW 104 (112)
T ss_dssp TSCEEEEET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEE
T ss_pred cccEEEEec-CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEe
Confidence 999999996 567888876544 445899999999999998888888
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.70 E-value=2.6e-17 Score=141.83 Aligned_cols=98 Identities=20% Similarity=0.352 Sum_probs=81.4
Q ss_pred CCCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEec
Q 037189 27 NGTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTA 106 (766)
Q Consensus 27 ~~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~ 106 (766)
.|+|.+||+|.+|+ +|. +|.|.|.|+.+|+ |.||.. .++||.||+..+. ..+.|.|+.
T Consensus 1 ~~~L~~g~~L~~G~---~l~--ng~~~l~~q~DGN---------Lvly~~----~~~vW~s~~~~~~----~~~~l~l~~ 58 (108)
T d1jpca_ 1 DNILYSGETLSTGE---FLN--YGSFVFIMQEDCN---------LVLYDV----DKPIWATNTGGLS----RSCFLSMQT 58 (108)
T ss_dssp CCEEETTEEECTTC---EEE--ETTEEEEECTTSC---------EEEEET----TEEEEECCCTTSC----SSCEEEECT
T ss_pred CCCccCCCEecCCC---EEE--cCCEEEEECCCCe---------EEEEeC----CceeeEeCCCCCC----CccEEEEec
Confidence 37899999999999 554 6999999988663 677653 5899999998743 347899999
Q ss_pred cCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecC
Q 037189 107 DQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASS 146 (766)
Q Consensus 107 ~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~ 146 (766)
||||+|+|++|.+||+|++.... ..+|+|+||||||||+.
T Consensus 59 ~Gnlvl~~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~ 99 (108)
T d1jpca_ 59 DGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT 99 (108)
T ss_dssp TSCEEEECTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC
T ss_pred cceEEEECCCccceEEccccCCCCcEEEEEcCCCCEEEeCC
Confidence 99999999999999999976543 34789999999999974
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.66 E-value=9.7e-17 Score=140.52 Aligned_cols=102 Identities=20% Similarity=0.262 Sum_probs=84.8
Q ss_pred EEEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCe
Q 037189 72 SIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSR 150 (766)
Q Consensus 72 gIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~ 150 (766)
-|||.++++++++|+++++.++.. ....|.|+.||||||++. +.++|++++...+ ...+.|+++|||||+|.++..
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~--g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~ 87 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQL--SPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIA 87 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBC--SSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEc--CCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCE
Confidence 489999999999999999996643 446899999999999985 6889999987543 468999999999999998888
Q ss_pred eeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 151 AFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 151 ~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
+| ++ ..+..+|.|.+.+++||++++|
T Consensus 88 lW-~S-~t~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VW-TS-GNSRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EE-EC-CCCCSSSCCEEEECSSSCEEEE
T ss_pred EE-Ee-CCCCCCCcEEEEECCCCcEEEe
Confidence 87 43 3455678999999999999987
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=2.5e-16 Score=136.38 Aligned_cols=110 Identities=17% Similarity=0.202 Sum_probs=90.4
Q ss_pred EEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEEEeCCCCCeeeeeeccCCcceEEEeccCCCEEEecCCCCeee
Q 037189 73 IFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLNDPQGKQVWSSKIDIGTVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 73 Iw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|||.-.++.+..|..+.+.++.. ...+|.|+.||||||++ ++.++|++++....+..+.|+++|||||+|.++..+|
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~--g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLEL--SSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTAQNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECS--TTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCTTTCCSC
T ss_pred EEEecCCCCCCcceecCCCcEEc--CCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEccCCCEEE
Confidence 67776677777888888886532 45689999999999998 4689999998766677899999999999999888888
Q ss_pred eeccCCCCCCCceEEEEecCCceEEEeccCCccccccceeeccc
Q 037189 153 FPKIGHQFSRGLFQFRLLKDGNLVLNIANLPTDFAYDAYYISHT 196 (766)
Q Consensus 153 ~~~~~~dps~G~~~~~~~~~g~~~l~~~~~~~~~~~~~y~~sg~ 196 (766)
- +..+.+.|.|.+.|++||++++| . .++|.+|+
T Consensus 80 s--S~t~~~~g~y~l~Lq~DGNlvlY--~-------~~~Wssgt 112 (115)
T d1dlpa1 80 S--SGTKGSIGNYVLVLQPDRTVTIY--G-------PGLWDSGT 112 (115)
T ss_dssp C--CCCCCCSSCCEEEECSSSCEEEE--C-------SEEEECSC
T ss_pred E--cCCCCCCCCEEEEECCCCcEEEe--C-------CCeecCCC
Confidence 2 34566789999999999999887 2 45898886
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=2.5e-14 Score=124.46 Aligned_cols=98 Identities=18% Similarity=0.252 Sum_probs=76.2
Q ss_pred CeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEEEe
Q 037189 34 ATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLVLN 113 (766)
Q Consensus 34 ~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~l~ 113 (766)
|+|.+++.+ ...+..|.|.|.|..+|+ |-+ |. ..++||.+|+..+. ..+.|.|+.||||+|+
T Consensus 15 ~~l~~~q~l-~~~~~~~~y~l~mQ~DGN---------LVL-y~---~~~~vWssnt~~~~----~~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 15 QILHATESL-EILFGTHVYRFIMQTDCN---------LVL-YD---NNNPIWATNTGGLG----NGCRAVLQPDGVLVVI 76 (119)
T ss_dssp CEEETTCEE-EEEETTEEEEEEECTTSC---------EEE-EE---TTEEEEECCCTTSC----SSCEEEECTTSCEEEE
T ss_pred CEEeCCCeE-EEecCCceEEEEECCCCc---------EEE-EE---CCeEEEEecCCCCC----cceEEEEEeCCCEEEE
Confidence 555555544 457779999999988764 544 33 36899999987632 3478999999999999
Q ss_pred CCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeee
Q 037189 114 DPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 114 ~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|++|.+||++++.... ..+++|+||||||||++ ++|
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg~---~~W 113 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD---ALW 113 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES---EEE
T ss_pred CCCCcEEEECCCcCCCCceEEEEcCCCCEEEECC---CEe
Confidence 9999999999986543 35789999999999963 577
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.32 E-value=1.1e-12 Score=113.05 Aligned_cols=93 Identities=20% Similarity=0.256 Sum_probs=71.7
Q ss_pred CCcCCCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEecc
Q 037189 28 GTVPVGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTAD 107 (766)
Q Consensus 28 ~~~~~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~ 107 (766)
+||.++|+|. +|.|.|.|..+|+ |.|+. ..++||.+|+.. . ..+.+.|+.|
T Consensus 15 ~tl~~~~~l~-----------~g~~~l~~q~DGN---------LvL~~----~~~~vW~s~t~~---~--~~~~l~l~~d 65 (115)
T d1dlpa1 15 QTLHAAQSLE-----------LSSFRFTMQSDCN---------LVLFD----SDVRVWASNTAG---A--TGCRAVLQSD 65 (115)
T ss_dssp SCCCTTCEEC-----------STTEEEEECTTSC---------EEEEE----SSSEEECCCCCS---C--SCCBCCBCSS
T ss_pred ceecCCCcEE-----------cCCEEEEECCCCe---------EEEEc----CCeeEEEcccCC---C--CceEEEEecc
Confidence 4666666663 4779999987653 66754 257899988754 2 3478999999
Q ss_pred CcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 108 QGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 108 g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|||||+|.++++||++++... +..+++|++|||||||+. ++|
T Consensus 66 GNLvl~d~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~~---~~W 108 (115)
T d1dlpa1 66 GLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLW 108 (115)
T ss_dssp SCBCCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEE
T ss_pred CCEEEEccCCCEEEEcCCCCCCCCEEEEECCCCcEEEeCC---Cee
Confidence 999999999999999998643 334799999999999953 577
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.23 E-value=2e-11 Score=105.83 Aligned_cols=85 Identities=18% Similarity=0.256 Sum_probs=68.8
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
-.|.|+.||||||+++ +.+||++++.... ...+.|+++|||||+|.++..+|--. ..-..|.|.+.|++||++++|
T Consensus 32 y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~--t~~~~~~~~l~Lq~DGNlvlY 108 (119)
T d1b2pa_ 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP--VAGKAGHYVLVLQPDRNVVIY 108 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS--CCCCSSCEEEEECTTSCEEEE
T ss_pred EEEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECC--CcCCCCceEEEEcCCCCEEEE
Confidence 5788999999999975 5799999986543 46899999999999999998988322 223468899999999999987
Q ss_pred eccCCccccccceeeccc
Q 037189 179 IANLPTDFAYDAYYISHT 196 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~ 196 (766)
- .+.|.|++
T Consensus 109 g---------~~~W~S~T 117 (119)
T d1b2pa_ 109 G---------DALWATQT 117 (119)
T ss_dssp E---------SEEEECCC
T ss_pred C---------CCEeccCC
Confidence 2 34888876
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.20 E-value=3.6e-11 Score=102.75 Aligned_cols=86 Identities=21% Similarity=0.242 Sum_probs=69.9
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCCc-ceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIGT-VAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~~-~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||||++ .+.+||++++.... ...+.|+++|||||++.++.++|... .....+.|.+.|+.||++++|
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS~--t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWASN--TGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECC--CCCSCSCEEEEECTTSCEEEE
T ss_pred EEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEcc--ccCCCCcEEEEEcCCCCEEEe
Confidence 679999999999998 45899999987543 45899999999999999999999532 334568899999999999987
Q ss_pred eccCCccccccceeecccc
Q 037189 179 IANLPTDFAYDAYYISHTY 197 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~~ 197 (766)
- .+.|.|++.
T Consensus 98 ~---------~~~W~S~t~ 107 (108)
T d1jpca_ 98 G---------TDRWATGTH 107 (108)
T ss_dssp E---------CCCCCCCCC
T ss_pred C---------CCcccCCCC
Confidence 2 337877753
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.17 E-value=6.1e-11 Score=101.30 Aligned_cols=86 Identities=23% Similarity=0.392 Sum_probs=68.7
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCC--cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIG--TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVL 177 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~--~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l 177 (766)
..|.|+.||||||++ .+.+||++++... ....+.|+++|||||+|+++.++|.-. .....|.|.+.|+++|++++
T Consensus 21 ~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~--t~~~~~~~~l~L~ddGNlvl 97 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH--SVRGNGNYVLVLQEDGNVVI 97 (109)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC--CCCCSSCCEEEECTTSCEEE
T ss_pred EEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe--eECCCCCEEEEEeCCCcEEE
Confidence 678999999999997 5589999998643 345789999999999999999998432 22346889999999999998
Q ss_pred EeccCCccccccceeecccc
Q 037189 178 NIANLPTDFAYDAYYISHTY 197 (766)
Q Consensus 178 ~~~~~~~~~~~~~y~~sg~~ 197 (766)
| . .+.|.|+++
T Consensus 98 y--~-------~~~W~S~t~ 108 (109)
T d1kj1a_ 98 Y--G-------SDIWSTGTY 108 (109)
T ss_dssp E--C-------CEEEECCCC
T ss_pred E--C-------CCEecCCCc
Confidence 7 2 347887764
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.04 E-value=2.4e-10 Score=99.24 Aligned_cols=96 Identities=17% Similarity=0.187 Sum_probs=70.4
Q ss_pred CCCeeeeCCCcceeecCCCceEEeeeeccCCCCCCCcEEEEEEeccCCCceEEEEecCCCCCCCCCCCcEEEEeccCcEE
Q 037189 32 VGATLIAGSTSFRWLSPSGDFAFGFRQLDEENSSNDLFLLSIFYNKIPEKTVVWYTDNKDQNSAVPRGSQVKLTADQGLV 111 (766)
Q Consensus 32 ~~~~l~~~~~~~~~vS~~g~F~lgf~~~~~~~s~~~~~ylgIw~~~~~~~~~vWvan~~~~~~~~~~~~~l~~~~~g~l~ 111 (766)
+.++|..++.+ ..|.|.|.|...| .|.|+. ...+||.++.... ...+.+.|+.+||||
T Consensus 22 ~~~~l~~~q~l-----~~g~y~L~~q~DG---------NLvL~~----~~~~vW~s~t~~~----~~~~~~~l~~~GnLv 79 (120)
T d1dlpa2 22 HPQTLHATQSL-----QLSPYRLSMETDC---------NLVLFD----RDDRVWSTNTAGK----GTGCRAVLQPNGRMD 79 (120)
T ss_dssp CCCEECSSCCC-----BCSSCEEEEETTT---------EEEEEB----TTBCCSCCCCCSS----CSSCEEEEETTTEEE
T ss_pred cccEEcCCCee-----EcCCEEEEEcCCC---------cEEEec----CCcEEEEEccccC----CCcEEEEEeCCeeEE
Confidence 45666666633 2477888886654 366653 2467898876541 244789999999999
Q ss_pred EeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeee
Q 037189 112 LNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAF 152 (766)
Q Consensus 112 l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w 152 (766)
|+|.++++||+|++... +...+.|++|||||||+. .+|
T Consensus 80 l~d~~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~~---~~W 118 (120)
T d1dlpa2 80 VLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG---ALW 118 (120)
T ss_dssp EEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC---CCC
T ss_pred EEcCCCCEEEEeCCCCCCCcEEEEECCCCcEEEeCC---Ccc
Confidence 99999999999998643 344789999999999953 466
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.98 E-value=1e-09 Score=94.41 Aligned_cols=88 Identities=25% Similarity=0.365 Sum_probs=68.8
Q ss_pred cEEEEeccCcEEEeCCCCCeeeeeeccCC-cceEEEeccCCCEEEecCCCCeeeeeccCCCCCCCceEEEEecCCceEEE
Q 037189 100 SQVKLTADQGLVLNDPQGKQVWSSKIDIG-TVAVGHMNDTGNFMLASSSSSRAFFPKIGHQFSRGLFQFRLLKDGNLVLN 178 (766)
Q Consensus 100 ~~l~~~~~g~l~l~~~~~~~~w~t~~~~~-~~~~~~l~d~GN~vl~~~~~~~~w~~~~~~dps~G~~~~~~~~~g~~~l~ 178 (766)
..|.|+.||||||++ .+.+||++++... ..+.+.|+.+|||||+|. +..+|+.+... ..|.+.+.|+.+|+++++
T Consensus 21 ~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-~~~~w~s~t~~--~~~~~~l~L~ddGNlvly 96 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWASNTNR--QNGNYYLILQRDRNVVIY 96 (112)
T ss_dssp EEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-TEEEEECCCCC--SCCCCEEEECTTSCEEEE
T ss_pred EEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEec-CCeEEEEeecc--CCCceEEEEcCCCCEEEE
Confidence 679999999999997 5689999997643 446899999999999996 56777655332 357899999999999987
Q ss_pred eccCCccccccceeecccc
Q 037189 179 IANLPTDFAYDAYYISHTY 197 (766)
Q Consensus 179 ~~~~~~~~~~~~y~~sg~~ 197 (766)
-..+ .+.|.|++-
T Consensus 97 ~~~~------~~~W~S~t~ 109 (112)
T d1xd5a_ 97 DNSN------NAIWATHTN 109 (112)
T ss_dssp CTTS------CEEEECCCC
T ss_pred CCCC------cEEecCCCc
Confidence 4322 457888753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.00 E-value=1.5e-05 Score=78.73 Aligned_cols=131 Identities=16% Similarity=0.061 Sum_probs=90.1
Q ss_pred ccceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC-CCCeeeEeeeeecCCceEEEeeccCCCchhhh
Q 037189 489 SFGIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH-HKNLVRLLGFCDEGQNRLLVYEFLNNGTLASF 567 (766)
Q Consensus 489 ~fg~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~ 567 (766)
....||+... ++..++||+...........+.+|...+..+. +--+.+++.+..+++..++||+++++.++.+.
T Consensus 26 s~~~v~rv~~-----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 26 SPAKVYKLVG-----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp SSSEEEEEEC-----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCcEEEEEe-----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 3468998753 24456788876555555556788888877664 44467888888888899999999999887654
Q ss_pred hccCCCCccchhhhHHHHHHHHHHHhhhcC--------------------------------------------------
Q 037189 568 LFGNLKPNWNLRTNIAFQIARGLLYLHEDC-------------------------------------------------- 597 (766)
Q Consensus 568 l~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------------- 597 (766)
.. +......++.++++.++.||+..
T Consensus 101 ~~-----~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 175 (263)
T d1j7la_ 101 YE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK 175 (263)
T ss_dssp TT-----TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred cc-----ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence 32 11223334455555555555310
Q ss_pred ------CCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 598 ------SSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 598 ------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
...++|+|+.|.|||++++...-|+||+.+..
T Consensus 176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12378999999999999876677999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.53 E-value=0.00027 Score=68.85 Aligned_cols=130 Identities=15% Similarity=0.077 Sum_probs=80.6
Q ss_pred cccccc-ceEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCC--CCCeeeEeeeeecCCceEEEeeccCC
Q 037189 485 VGRGSF-GIVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTH--HKNLVRLLGFCDEGQNRLLVYEFLNN 561 (766)
Q Consensus 485 LG~G~f-g~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (766)
+..|.. +.||+.... .+..+++|..... ....+..|...++.+. .-.+.+++.++.+++..++|||++++
T Consensus 18 ~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp CSCTTSSCEEEEEECT----TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred cCCcccCCeEEEEEeC----CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 344443 578988754 3445677765432 2334677777776654 23467788888888899999999998
Q ss_pred CchhhhhccCCCCccchhhhHHHHHHHH---------------------------------------------------H
Q 037189 562 GTLASFLFGNLKPNWNLRTNIAFQIARG---------------------------------------------------L 590 (766)
Q Consensus 562 gsL~~~l~~~~~l~~~~~~~i~~~ia~g---------------------------------------------------L 590 (766)
.++.+... ....++.++++. +
T Consensus 91 ~~~~~~~~--------~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 91 QDLLSSHL--------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp EETTTSCC--------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccccccc--------cHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 77644210 001111122222 2
Q ss_pred HHhhhc----CCCceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 591 LYLHED----CSSQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 591 ~yLH~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
..+.+. ....++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 222221 123479999999999999876678999997653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.27 E-value=0.00044 Score=72.22 Aligned_cols=76 Identities=16% Similarity=0.082 Sum_probs=47.3
Q ss_pred hhccccccceEEEEEEecCCCceeEEEEEEeecc-------cccCHHHHHHHHHHHccCC---CCCeeeEeeeeecCCce
Q 037189 483 EEVGRGSFGIVYKGVIQTTRTSTTAVAVKKLDIV-------FQDGEREFKNEVFVIGQTH---HKNLVRLLGFCDEGQNR 552 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~l~~~-------~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~ 552 (766)
+.||.|..-.||+..... .++.++||.-... ..........|.+.|..+. ...+++++.+. .+..
T Consensus 32 ~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~ 106 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMA 106 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTT
T ss_pred EEeCCCceEeEEEEEeCC---CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCC
Confidence 468999999999997653 3467888865321 1112234556777776553 24466666654 4566
Q ss_pred EEEeeccCCCc
Q 037189 553 LLVYEFLNNGT 563 (766)
Q Consensus 553 ~lV~Ey~~~gs 563 (766)
++|||++++..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 89999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.98 E-value=0.012 Score=60.83 Aligned_cols=77 Identities=10% Similarity=0.155 Sum_probs=48.9
Q ss_pred hhccccccceEEEEEEecCC----CceeEEEEEEeecccccCHHHHHHHHHHHccCCCCC-eeeEeeeeecCCceEEEee
Q 037189 483 EEVGRGSFGIVYKGVIQTTR----TSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKN-LVRLLGFCDEGQNRLLVYE 557 (766)
Q Consensus 483 ~~LG~G~fg~Vy~~~~~~~~----~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 557 (766)
+.|+.|--=.+|+....... .....+.++..- . ........+|..+++.+.-.+ ..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 45777888899999876432 123345555443 2 233445667888888775334 4578887754 68999
Q ss_pred ccCCCchh
Q 037189 558 FLNNGTLA 565 (766)
Q Consensus 558 y~~~gsL~ 565 (766)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876553
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.71 E-value=0.015 Score=58.36 Aligned_cols=131 Identities=14% Similarity=0.069 Sum_probs=73.8
Q ss_pred eEEEEEEecCCCceeEEEEEEeecccccCHHHHHHHHHHHccCCCCCe--eeEee-----eeecCCceEEEeeccCCCch
Q 037189 492 IVYKGVIQTTRTSTTAVAVKKLDIVFQDGEREFKNEVFVIGQTHHKNL--VRLLG-----FCDEGQNRLLVYEFLNNGTL 564 (766)
Q Consensus 492 ~Vy~~~~~~~~~~~~~vavK~l~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~g-----~~~~~~~~~lV~Ey~~~gsL 564 (766)
.||++... ++..+++|.-+.. ....+++..|...+..+....+ +..+. ....+...+.+++++++..+
T Consensus 37 ~vy~v~~~----dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 37 RVYQFQDE----DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp EEEEECCT----TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred eeEEEEcC----CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 78998775 4667888886542 3356778888887777653222 22211 22345567889999876543
Q ss_pred hh----hh----------c----c-----CCCCcc-------------------chhhhHHHHHHHHHHHhh----hcCC
Q 037189 565 AS----FL----------F----G-----NLKPNW-------------------NLRTNIAFQIARGLLYLH----EDCS 598 (766)
Q Consensus 565 ~~----~l----------~----~-----~~~l~~-------------------~~~~~i~~~ia~gL~yLH----~~~~ 598 (766)
.. .+ + . ....++ ..+..+...+.+.+..+. +...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 21 01 0 0 011111 111112222223333332 2235
Q ss_pred CceecCCCccceEEEcCCCCeEEeccCcccc
Q 037189 599 SQIIHCDMKPQNILLDDHYNARISDFGLAKL 629 (766)
Q Consensus 599 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 629 (766)
.+++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 678999999999999754 45899997753
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.82 E-value=0.033 Score=34.20 Aligned_cols=32 Identities=25% Similarity=0.565 Sum_probs=24.0
Q ss_pred CccccccCCCCccccCCCcccccCCCCCCcccCCCCCccC
Q 037189 274 NICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSLL 313 (766)
Q Consensus 274 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~Gf~~~ 313 (766)
|.|.+ -..|| +|-|+.- -..-.|.|-+||+|.
T Consensus 2 dECsi------gnpCG-nGTCtNv-iGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNV-IGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGT------TCSSS-SSCEEEC-SSSEEECCSSSSCCC
T ss_pred Ccccc------CCccC-Cceeeec-ccceEEeecCCcCCC
Confidence 67888 67888 6889632 244579999999974
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.27 E-value=0.55 Score=45.86 Aligned_cols=32 Identities=22% Similarity=0.310 Sum_probs=28.1
Q ss_pred CCCceecCCCccceEEEcCCCCeEEeccCccc
Q 037189 597 CSSQIIHCDMKPQNILLDDHYNARISDFGLAK 628 (766)
Q Consensus 597 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 628 (766)
...+++|+|+.+.||+++.+...-|+||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35689999999999999988777899999875
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.31 E-value=0.29 Score=32.18 Aligned_cols=32 Identities=31% Similarity=0.597 Sum_probs=24.0
Q ss_pred CCccccccCCCCccccCCCcccccCCCCCCcccCCCCCcc
Q 037189 273 DNICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYSL 312 (766)
Q Consensus 273 ~~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~Gf~~ 312 (766)
.|+|.. ..|+.++.|. |...+-.|.|++||+.
T Consensus 5 idEC~~-------~~~~~~~~C~-Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 5 MDECKE-------PDVCKHGQCI-NTDGSYRCECPFGYIL 36 (43)
T ss_dssp CCSSSS-------TTSCSSSCCC-CCSSCCCCCCCTTEEE
T ss_pred eeccCC-------cCCCCCCEeE-CCCCCeEeECCCCccc
Confidence 467866 3466789997 4446778999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.76 E-value=0.2 Score=32.90 Aligned_cols=32 Identities=22% Similarity=0.485 Sum_probs=24.3
Q ss_pred CccccccCCCCccccCCCcccccCCCCCCcccCCCCCc
Q 037189 274 NICVNLDGELGSGACGFNSICSLNGDKRPMCDCPKGYS 311 (766)
Q Consensus 274 ~~C~~~~~~~~~~~CG~~g~C~~~~~~~~~C~C~~Gf~ 311 (766)
|+|... ...|..+|.|.. ...+-.|.|++||+
T Consensus 4 deC~~~-----~~pC~n~g~C~n-~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLG-----ANPCEHAGKCIN-TLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSS-----SCSSSTTCEEEE-CSSSEEEECCTTEE
T ss_pred ccccCC-----CCCCCCCcEeEC-CCCCEEeECCCCCc
Confidence 567541 468999999974 33567899999997
|